data_1uap_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uap _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.452 0.644 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.33 -47.24 74.14 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.129 -0.938 . . . . 0.0 108.996 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -61.67 -48.11 82.29 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.322 0.965 . . . . 0.0 111.169 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -49.86 -56.75 9.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.719 0.808 . . . . 0.0 110.481 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -68.66 -40.48 80.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.789 -1.577 . . . . 0.0 111.898 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -54.61 -46.4 73.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.435 1.47 . . . . 0.0 110.617 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.7 m -71.88 -24.27 61.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.834 0.854 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.39 18.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -62.93 132.43 52.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 111.993 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -82.93 -8.16 59.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.523 0.729 . . . . 0.0 110.657 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.3 tp -134.83 124.48 25.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.457 1.503 . . . . 0.0 108.122 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.3 t -137.83 115.36 12.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.91 172.2 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.218 1.407 . . . . 0.0 110.303 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -129.24 139.93 51.65 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.88 175.33 13.71 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.746 -1.221 . . . . 0.0 110.918 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.7 m -121.79 134.55 54.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.13 114.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -77.48 -54.89 5.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 m -142.61 171.46 14.03 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.72 0.808 . . . . 0.0 110.677 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.2 mtp -138.05 133.15 33.18 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.639 1.976 . . . . 0.0 105.845 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.86 140.84 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.812 1.245 . . . . 0.0 107.798 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -70.24 151.68 45.07 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.393 0.997 . . . . 0.0 110.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -134.77 175.11 3.89 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.854 1.661 . . . . 0.0 108.173 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.62 160.18 18.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.299 3.333 . . . . 0.0 114.095 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 -141.89 43.53 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.66 17.3 3.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.895 0.878 . . . . 0.0 110.313 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.88 166.6 48.94 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-O 123.224 1.458 . . . . 0.0 115.143 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.35 139.83 16.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 106.195 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.04 145.95 31.74 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.04 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -89.84 133.37 34.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.81 173.37 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.082 0.953 . . . . 0.0 111.104 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -132.96 38.01 3.39 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.17 0.988 . . . . 0.0 112.965 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.7 mt 37.49 81.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.297 1.839 . . . . 0.0 115.061 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.04 -33.07 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.981 0.809 . . . . 0.0 110.911 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.84 161.87 33.12 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.028 1.299 . . . . 0.0 110.627 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.24 146.01 31.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.184 1.394 . . . . 0.0 109.513 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -131.02 -41.32 1.13 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.873 0.869 . . . . 0.0 110.991 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -140.3 123.79 17.05 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.42 59.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.077 2.151 . . . . 0.0 107.568 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.04 35.8 2.74 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 124.456 1.027 . . . . 0.0 113.702 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -10.65 0.04 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.511 2.005 . . . . 0.0 114.669 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.17 129.06 47.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.554 1.677 . . . . 0.0 110.515 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.84 67.86 10.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.26 152.54 41.81 Favored Pre-proline 0 CA--C 1.537 0.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.589 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.84 172.1 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.215 1.943 . . . . 0.0 111.523 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t -52.09 -60.12 6.87 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 117.637 -1.173 . . . . 0.0 109.307 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.88 139.6 40.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 N-CA-C 107.164 -1.898 . . . . 0.0 107.164 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.62 -157.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.89 2.393 . . . . 0.0 112.293 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.4 m -34.74 133.63 0.26 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 130.703 3.601 . . . . 0.0 112.42 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.47 34.58 0.28 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.776 1.655 . . . . 0.0 110.225 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.79 166.69 20.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.7 2.0 . . . . 0.0 108.572 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.5 p -103.3 149.62 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.003 0.906 . . . . 0.0 112.014 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.3 mt -145.07 170.83 15.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.758 1.223 . . . . 0.0 109.004 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -127.2 115.12 18.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -89.49 120.19 30.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.56 113.64 15.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.54 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.0 113.47 62.51 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.67 -1.31 11.41 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.124 1.883 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.0 m -134.12 113.59 12.23 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 110.083 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -75.54 -5.76 46.87 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.006 -1.059 . . . . 0.0 113.806 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -78.6 -53.27 7.36 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.378 0.671 . . . . 0.0 110.606 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.6 m -154.46 165.5 17.92 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 127.006 2.122 . . . . 0.0 110.282 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -64.66 151.93 74.95 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 119.625 0.902 . . . . 0.0 110.178 -3.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.23 138.79 44.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.405 2.07 . . . . 0.0 111.764 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 ttm -149.43 170.92 17.47 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.918 -1.114 . . . . 0.0 111.444 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.76 138.27 54.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.46 34.65 63.44 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.608 -1.106 . . . . 0.0 113.736 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.07 160.51 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.723 1.761 . . . . 0.0 107.963 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -99.61 136.38 39.62 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 125.354 1.461 . . . . 0.0 110.417 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -139.51 168.05 20.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.304 1.442 . . . . 0.0 112.615 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.94 123.62 50.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.9 113.98 21.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.0 mtm -117.66 113.21 21.57 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.97 -140.19 3.09 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 126.123 1.821 . . . . 0.0 109.687 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -135.38 175.28 9.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.289 1.045 . . . . 0.0 109.548 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -118.89 159.16 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -129.84 112.93 14.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.43 63.64 8.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -177.4 -32.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.202 2.601 . . . . 0.0 110.851 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -127.51 -9.69 5.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.91 -152.83 19.97 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.55 144.05 19.65 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.607 2.204 . . . . 0.0 111.708 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.27 8.5 p -126.7 149.76 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.257 1.6 tm? -137.53 75.23 45.08 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.22 -0.925 . . . . 0.0 108.827 -174.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.9 170.93 9.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.539 3.493 . . . . 0.0 112.91 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.71 -20.15 67.91 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.864 1.709 . . . . 0.0 114.079 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.65 22.99 1.01 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.718 1.207 . . . . 0.0 111.417 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.1 m -91.62 137.24 32.52 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.301 -1.499 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -86.85 114.39 23.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -127.64 126.7 67.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.65 0.738 . . . . 0.0 109.331 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -146.1 163.25 10.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.573 1.949 . . . . 0.0 107.018 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.03 149.33 47.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 123.99 24.47 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -119.99 155.34 55.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-O 117.073 -1.441 . . . . 0.0 107.88 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.07 -42.47 6.01 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.982 2.455 . . . . 0.0 110.452 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -55.05 -53.09 60.21 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 122.957 0.503 . . . . 0.0 110.669 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.85 -44.4 82.12 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.531 0.732 . . . . 0.0 110.612 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -56.52 -53.28 59.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.56 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -59.73 -36.45 76.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.31 1.044 . . . . 0.0 111.523 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.7 mt -65.33 -60.45 2.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 124.478 1.111 . . . . 0.0 108.766 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.81 -34.98 72.11 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.149 1.341 . . . . 0.0 110.949 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.53 -49.58 76.96 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -63.32 -31.58 72.77 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.606 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.1 mt -68.66 -31.38 70.47 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.295 0.952 . . . . 0.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 t -76.7 -34.57 58.17 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.421 0.555 . . . . 0.0 109.67 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -67.07 -58.79 4.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 . . . . . 0 N--CA 1.447 -0.601 0 C-N-CA 123.702 0.801 . . . . 0.0 110.489 179.183 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.236 0.391 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.71 -44.17 94.42 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.593 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -62.55 -49.22 76.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.278 0.944 . . . . 0.0 111.628 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -56.12 -46.62 79.09 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.428 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -73.8 -44.06 56.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.237 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.415 ' CD2' HG12 ' A' ' 50' ' ' VAL . 7.6 t80 -54.72 -44.29 73.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.843 1.656 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.7 -23.93 61.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.417 -0.802 . . . . 0.0 113.032 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -46.4 28.68 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 110.406 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.5 p -69.14 132.32 46.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.665 1.186 . . . . 0.0 111.181 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -81.32 -12.85 58.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.477 1.035 . . . . 0.0 109.361 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.5 tp -122.75 125.11 44.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.605 1.562 . . . . 0.0 109.93 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.415 HG12 ' CD2' ' A' ' 44' ' ' PHE . 42.2 t -141.01 114.03 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.2 166.76 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.575 1.55 . . . . 0.0 109.222 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 p -124.05 148.91 46.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.09 171.21 20.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.766 -1.209 . . . . 0.0 110.906 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.3 m -124.03 128.08 48.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.41 113.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.408 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 20.9 mmmt -84.21 -38.17 20.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.271 1.028 . . . . 0.0 110.042 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 m -151.25 165.86 32.67 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 121.227 -0.921 . . . . 0.0 110.138 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.8 mtp -143.75 124.67 14.31 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.52 146.1 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.56 152.31 44.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.486 -0.759 . . . . 0.0 109.889 -176.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -134.29 169.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.865 2.066 . . . . 0.0 109.481 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -38.59 134.06 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 125.084 3.856 . . . . 0.0 117.492 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.23 -123.61 33.5 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.814 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -88.72 22.55 2.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.364 1.465 . . . . 0.0 110.18 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.44 166.28 45.53 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.676 -1.265 . . . . 0.0 113.997 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -151.86 138.52 18.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.489 1.516 . . . . 0.0 108.349 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.54 128.89 55.52 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.45 123.28 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -93.43 125.14 37.88 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 m -122.89 174.17 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.432 1.493 . . . . 0.0 111.169 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 t -135.25 40.38 2.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.626 0.648 . . . . 0.0 109.91 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.4 mt 38.11 77.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.571 2.748 . . . . 0.0 114.19 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.54 -23.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.802 1.637 . . . . 0.0 111.133 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.81 159.06 32.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.76 141.33 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.195 0.998 . . . . 0.0 108.527 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -135.31 -33.36 0.9 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.258 0.623 . . . . 0.0 110.823 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -148.99 125.06 10.7 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.26 58.68 1.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.512 2.325 . . . . 0.0 107.782 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.64 36.19 2.82 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.276 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.04 -25.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 116.707 -2.163 . . . . 0.0 116.483 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.5 mt -116.39 155.09 29.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 121.101 2.451 . . . . 0.0 112.555 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.69 94.39 5.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 128.399 2.679 . . . . 0.0 109.047 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.14 131.57 95.04 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.72 -178.69 4.25 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 121.942 1.762 . . . . 0.0 111.103 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 t -53.58 -58.92 10.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.203 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.59 116.02 3.7 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.596 2.197 . . . . 0.0 110.805 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -78.14 -152.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.236 2.624 . . . . 0.0 110.677 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 24.1 m -33.17 123.76 0.39 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 130.625 3.57 . . . . 0.0 111.771 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.16 -16.71 6.33 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.394 2.426 . . . . 0.0 110.986 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.79 150.82 40.82 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.312 1.056 . . . . 0.0 111.363 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -86.01 145.51 27.07 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.4 mt -146.92 164.24 33.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 109.37 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -117.66 113.42 21.87 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.24 119.15 29.47 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -79.76 114.08 18.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.06 1.344 . . . . 0.0 109.94 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.14 114.24 59.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.83 -4.43 14.06 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.108 1.872 . . . . 0.0 113.225 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.7 m -138.17 113.63 9.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.087 1.755 . . . . 0.0 108.823 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -74.29 -7.49 52.98 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.257 -0.902 . . . . 0.0 112.787 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.98 -57.14 3.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.43 1.892 . . . . 0.0 108.97 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.4 m -152.59 160.49 31.11 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.044 1.338 . . . . 0.0 111.829 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.06 161.12 70.29 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.0 1.036 . . . . 0.0 111.887 3.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.42 139.76 91.09 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.163 2.575 . . . . 0.0 112.502 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -153.0 150.95 29.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.864 0.866 . . . . 0.0 110.157 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -144.37 150.8 38.34 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 109.872 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 56' ' ' LYS . 88.4 tttt -79.09 138.68 38.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.31 44.11 76.18 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.2 t -142.6 156.05 18.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 m -102.93 128.64 49.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.589 0.756 . . . . 0.0 110.393 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -126.46 171.3 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.383 1.873 . . . . 0.0 112.314 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.49 123.64 43.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 175.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.36 114.0 22.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 mtm -116.83 113.14 22.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.88 -142.71 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.606 1.098 . . . . 0.0 110.675 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.4 -178.87 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.971 0.891 . . . . 0.0 109.42 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.99 147.2 28.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -125.55 113.65 17.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -79.13 63.55 3.81 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -177.34 -26.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.386 1.875 . . . . 0.0 111.616 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 -7.37 3.17 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.706 0.802 . . . . 0.0 112.978 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.54 -164.19 20.96 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.724 0.693 . . . . 0.0 111.447 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.81 133.9 24.62 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.444 2.096 . . . . 0.0 109.8 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.265 2.9 p -118.83 134.76 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.96 76.11 21.84 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 0.0 109.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.72 172.8 8.92 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.922 3.748 . . . . 0.0 112.69 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -63.86 -34.36 60.97 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.68 2.253 . . . . 0.0 114.632 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.79 23.89 1.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.293 0.951 . . . . 0.0 111.59 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.3 m -85.11 146.93 26.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.469 1.507 . . . . 0.0 109.968 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -91.23 113.74 26.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.2 t -132.18 113.9 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.84 165.58 9.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.373 0.669 . . . . 0.0 109.272 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.04 147.75 52.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.7 149.62 49.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.067 0.947 . . . . 0.0 108.766 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -149.98 152.55 34.31 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 127.961 2.504 . . . . 0.0 105.234 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.01 -35.95 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.009 2.473 . . . . 0.0 112.434 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -61.72 -49.44 76.43 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.773 -0.579 . . . . 0.0 110.176 176.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -54.97 -54.27 44.94 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -44.9 -55.0 5.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.913 2.085 . . . . 0.0 111.8 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -56.24 -43.7 78.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.506 0.722 . . . . 0.0 111.708 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.9 mt -66.34 -40.11 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.709 -0.662 . . . . 0.0 109.479 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.5 mt -58.82 -43.26 90.58 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.7 m -62.08 -41.84 98.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.494 0.718 . . . . 0.0 111.031 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -57.56 -43.41 84.47 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.879 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 mt -76.21 -24.15 54.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.039 1.736 . . . . 0.0 112.819 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -74.24 -35.46 63.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.383 1.473 . . . . 0.0 109.645 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.53 -65.77 0.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.056 0.942 . . . . 0.0 109.1 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 . . . . . 0 CA--C 1.515 -0.392 0 CA-C-N 118.415 0.552 . . . . 0.0 110.636 -176.344 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -94.24 -54.96 3.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -65.0 -43.17 93.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.288 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -70.63 -47.89 57.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.093 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.94 -36.37 83.21 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.401 -1.285 . . . . 0.0 109.635 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -57.29 -43.69 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.897 1.226 . . . . 0.0 110.69 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.3 m -74.38 -23.58 59.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.52 -34.34 63.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.996 1.271 . . . . 0.0 111.527 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.8 p -76.52 126.69 31.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 t -79.69 -11.71 59.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.922 0.867 . . . . 0.0 108.814 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.3 tp -120.75 114.84 22.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.163 2.185 . . . . 0.0 108.978 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.88 112.89 7.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.62 167.06 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.908 1.683 . . . . 0.0 108.332 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 p -131.18 142.54 50.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.96 172.09 15.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.531 -0.731 . . . . 0.0 111.274 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.67 113.57 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -84.35 -53.77 5.24 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.35 1.06 . . . . 0.0 108.479 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m -140.23 169.09 18.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.167 1.387 . . . . 0.0 109.363 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.94 132.32 38.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 144.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.08 141.91 47.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 47.3 mm-40 -123.64 176.05 2.44 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 128.045 2.538 . . . . 0.0 109.365 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 61' ' ' GLU . 41.4 Cg_endo -60.94 150.53 83.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.681 2.254 . . . . 0.0 112.765 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.91 -123.95 29.53 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.99 23.75 14.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.463 1.105 . . . . 0.0 109.931 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.79 166.73 46.32 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 122.816 1.231 . . . . 0.0 111.874 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -150.38 131.27 14.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.4 137.63 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.5 t -108.38 123.46 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -97.66 126.41 42.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.49 176.67 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.168 1.387 . . . . 0.0 111.823 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -135.1 39.21 2.95 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.0 mt 36.07 83.16 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.56 -30.01 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 121.158 -0.964 . . . . 0.0 111.4 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.77 160.73 31.32 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.174 1.368 . . . . 0.0 109.761 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.84 143.31 26.21 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.299 1.04 . . . . 0.0 108.87 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -126.87 -49.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.59 1.156 . . . . 0.0 108.616 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -142.07 142.06 32.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 107.97 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 p -146.91 72.04 1.25 Allowed 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.298 2.639 . . . . 0.0 105.799 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 38.61 2.77 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 124.263 0.935 . . . . 0.0 112.881 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.63 -11.42 0.03 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.799 2.143 . . . . 0.0 112.91 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -116.35 123.17 46.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 120.623 2.211 . . . . 0.0 108.865 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -80.22 75.34 7.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.845 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -50.58 138.34 22.46 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.47 177.19 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.117 1.878 . . . . 0.0 111.636 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 t -48.74 -55.73 18.45 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.096 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.88 137.55 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.56 1.506 . . . . 0.0 108.634 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.18 -154.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.437 3.425 . . . . 0.0 112.068 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.8 m -33.06 123.9 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.828 3.251 . . . . 0.0 111.415 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.3 0.49 1.18 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.01 1.767 . . . . 0.0 113.75 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.94 150.07 21.21 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.396 1.598 . . . . 0.0 110.025 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -87.9 142.15 28.02 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.193 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -145.33 161.04 40.58 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.426 1.091 . . . . 0.0 109.85 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -116.39 125.12 51.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.212 2.205 . . . . 0.0 106.937 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.45 123.37 47.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.721 1.609 . . . . 0.0 110.132 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -78.09 114.55 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.743 1.617 . . . . 0.0 111.56 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.92 114.43 61.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -69.97 -9.16 25.38 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.707 2.272 . . . . 0.0 115.555 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 m -148.46 130.79 15.61 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.217 1.407 . . . . 0.0 108.513 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -73.55 -3.94 30.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.843 1.424 . . . . 0.0 114.843 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -73.05 -51.22 18.94 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.091 . . . . 0.0 113.181 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.2 m -140.02 164.39 37.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.833 1.653 . . . . 0.0 111.942 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.03 163.5 76.18 Favored 'Cis proline' 0 CA--C 1.546 1.098 0 CA-C-N 119.381 0.815 . . . . 0.0 111.831 -2.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.27 86.95 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.983 3.122 . . . . 0.0 113.85 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 ttp -114.3 162.83 16.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.44 1.896 . . . . 0.0 109.44 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -146.19 158.24 43.87 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.258 1.023 . . . . 0.0 110.69 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -70.74 139.11 51.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.283 1.433 . . . . 0.0 110.787 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.31 35.45 91.53 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.489 1.042 . . . . 0.0 115.058 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.54 152.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 108.531 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.9 m -96.38 134.66 39.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.95 0.881 . . . . 0.0 110.427 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -139.48 167.69 21.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.155 1.782 . . . . 0.0 112.759 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.9 tp -103.91 132.24 50.35 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.39 113.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.452 ' HE2' ' CD1' ' A' ' 129' ' ' PHE . 8.6 mtm -117.49 115.78 25.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.04 -143.7 3.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.048 1.308 . . . . 0.0 110.717 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -130.02 178.65 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.253 1.026 . . . . 0.0 108.943 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.8 t -136.1 141.93 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 120.786 -1.196 . . . . 0.0 108.304 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -108.22 113.08 25.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -83.06 63.58 7.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -170.01 -40.36 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.956 2.903 . . . . 0.0 109.209 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -126.18 -5.88 6.64 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.74 -164.7 15.33 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.22 137.34 51.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.038 1.419 . . . . 0.0 109.454 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.39 124.68 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 2.2 tm? -114.89 78.98 5.64 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.92 171.26 11.4 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.204 3.27 . . . . 0.0 112.246 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.85 -23.94 76.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.106 1.871 . . . . 0.0 113.126 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.06 23.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.97 1.259 . . . . 0.0 111.46 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.4 m -84.4 128.57 34.66 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.602 -1.311 . . . . 0.0 108.972 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.452 ' CD1' ' HE2' ' A' ' 113' ' ' MET . 40.2 t80 -80.04 113.51 18.26 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.58 116.55 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.96 174.5 7.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.719 0.808 . . . . 0.0 111.01 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.34 123.78 20.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.624 1.57 . . . . 0.0 109.14 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -75.99 142.46 41.91 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.706 -0.621 . . . . 0.0 109.491 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -154.5 156.01 31.22 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 128.124 2.57 . . . . 0.0 106.586 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.01 -35.15 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.614 2.209 . . . . 0.0 113.362 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -56.47 -50.92 70.32 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.952 0.882 . . . . 0.0 110.143 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -64.39 -32.52 74.17 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.673 -0.642 . . . . 0.0 111.651 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.14 -53.11 62.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.005 0.82 . . . . 0.0 110.445 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -62.75 -36.48 83.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.934 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.23 -51.66 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.844 0.747 . . . . 0.0 109.142 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -66.93 -41.72 86.57 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.12 0.568 . . . . 0.0 109.92 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.45 -44.87 95.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.582 0.628 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.48 -31.42 72.62 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.519 -0.738 . . . . 0.0 111.281 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.2 mt -75.82 -27.46 57.9 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 121.532 -0.73 . . . . 0.0 110.254 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -69.24 -45.56 69.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.237 1.415 . . . . 0.0 110.052 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -67.58 -39.33 84.87 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 125.814 1.645 . . . . 0.0 109.307 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.233 0.21 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.7 -40.03 95.77 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.92 -48.75 79.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.999 0.363 . . . . 0.0 111.195 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.5 m -65.9 -45.83 80.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.58 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.32 -33.38 75.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.497 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -61.34 -40.79 95.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.586 1.084 . . . . 0.0 109.956 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -75.22 -32.49 61.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.55 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.9 73.33 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -76.21 140.9 41.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.53 1.532 . . . . 0.0 110.571 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -85.08 -13.67 49.6 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.427 1.467 . . . . 0.0 110.4 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.3 tp -122.8 127.41 49.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.786 -1.196 . . . . 0.0 110.142 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.1 t -140.57 113.82 5.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.0 m -146.1 171.21 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -133.83 143.16 48.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.77 168.85 20.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.326 -0.859 . . . . 0.0 111.548 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.6 m -106.96 132.94 52.34 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.13 114.85 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -76.59 -57.25 3.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 m -147.35 172.16 14.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.22 1.408 . . . . 0.0 110.187 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 31.1 mtp -135.68 146.57 47.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.81 2.044 . . . . 0.0 107.37 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.16 138.96 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 154.06 42.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 121.646 2.021 . . . . 0.0 109.66 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.11 175.78 3.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 110.974 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -59.18 171.45 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.228 3.285 . . . . 0.0 113.02 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.84 -129.61 45.3 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -112.35 31.8 6.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.0 169.36 40.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 125.046 1.308 . . . . 0.0 113.597 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -156.18 124.33 5.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.748 2.019 . . . . 0.0 106.301 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.11 147.86 27.11 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.68 123.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -92.96 124.41 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -131.43 167.69 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.55 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -128.94 38.06 3.99 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt 40.65 79.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -72.26 -28.84 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.11 161.08 34.48 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.2 144.38 48.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -137.61 -24.04 1.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -156.73 129.46 7.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -137.33 73.45 1.44 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.403 3.081 . . . . 0.0 106.045 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.66 34.88 3.43 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.016 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.25 -69.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 128.122 2.772 . . . . 0.0 109.973 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 mt -45.24 134.51 6.36 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -85.13 65.03 9.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.089 2.155 . . . . 0.0 106.414 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.7 mt -57.98 125.62 74.52 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.46 176.14 8.44 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.891 1.727 . . . . 0.0 113.619 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 t -42.57 -58.89 3.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.118 1.767 . . . . 0.0 110.813 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.56 124.06 10.41 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-N 122.321 1.865 . . . . 0.0 107.731 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.35 -153.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.144 2.562 . . . . 0.0 112.946 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.2 m -34.61 125.19 0.53 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.484 2.714 . . . . 0.0 112.882 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.05 30.98 0.65 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.15 1.357 . . . . 0.0 113.017 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.65 158.81 29.22 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.187 1.795 . . . . 0.0 108.243 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.0 p -107.57 150.71 26.53 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.108 0.867 . . . . 0.0 111.996 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -143.55 163.23 33.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.143 2.177 . . . . 0.0 108.733 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.26 114.21 25.66 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.45 121.46 31.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.77 119.84 17.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.874 1.359 . . . . 0.0 107.563 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.46 113.83 40.61 Favored Pre-proline 0 C--O 1.225 -0.22 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.12 5.59 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.136 2.557 . . . . 0.0 112.956 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.4 m -131.14 113.52 13.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.021 1.329 . . . . 0.0 110.675 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -81.73 -32.78 31.42 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.277 -0.89 . . . . 0.0 111.173 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -59.06 -49.08 79.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.813 1.645 . . . . 0.0 112.82 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.6 m -155.09 165.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 129.006 2.923 . . . . 0.0 108.447 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.04 157.7 70.7 Favored 'Cis proline' 0 CA--C 1.536 0.601 0 CA-C-N 120.794 1.319 . . . . 0.0 111.647 -1.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.89 111.13 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.864 2.376 . . . . 0.0 111.01 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.9 tpp -122.18 141.53 51.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.575 1.95 . . . . 0.0 109.852 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.424 ' HB2' ' HH ' ' A' ' 110' ' ' TYR . 7.2 mttm -141.55 133.85 28.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -69.3 142.5 54.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.42 36.59 69.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.042 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.83 157.92 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.514 1.525 . . . . 0.0 107.449 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 m -100.63 141.0 34.11 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.709 1.203 . . . . 0.0 111.472 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' HH ' ' HB2' ' A' ' 105' ' ' LYS . 92.0 m-85 -135.79 176.37 8.74 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.244 1.818 . . . . 0.0 112.62 -175.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -122.92 123.64 41.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 100.916 -3.735 . . . . 0.0 100.916 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.51 113.71 21.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.1 mtm -117.87 113.14 21.31 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 100.566 -3.865 . . . . 0.0 100.566 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.57 -137.45 2.29 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -132.6 177.61 7.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.409 1.1 . . . . 0.0 111.522 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.45 125.32 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -104.84 113.05 26.41 Favored 'General case' 0 C--O 1.237 0.418 1 N-CA-C 96.339 -5.43 . . . . 0.0 96.339 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.257 8.0 tp10 -85.8 95.56 9.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.963 1.363 . . . . 0.0 108.667 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -179.08 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 133.395 4.678 . . . . 0.0 107.597 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -131.38 -8.57 3.73 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 112.768 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.25 -133.99 12.01 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.78 139.4 36.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.14 1.894 . . . . 0.0 114.753 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.55 132.68 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.261 0.4 OUTLIER -115.41 74.31 4.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 125.243 1.417 . . . . 0.0 109.612 -174.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.99 169.05 18.81 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.836 3.691 . . . . 0.0 112.765 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.92 -11.12 29.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 114.85 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -88.82 23.21 2.4 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.621 1.555 . . . . 0.0 110.779 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.1 m -96.69 145.1 26.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.127 1.371 . . . . 0.0 110.593 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -95.72 113.57 25.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 74.5 t -133.45 123.73 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.46 169.28 2.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 0.0 109.031 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.47 150.67 46.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -69.05 142.19 54.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -141.66 137.39 16.24 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.93 -37.97 82.0 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.057 1.838 . . . . 0.0 111.001 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -52.65 -45.46 66.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.21 1.004 . . . . 0.0 111.268 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.0 -42.91 72.41 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.486 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -53.72 -47.38 70.63 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.316 1.047 . . . . 0.0 110.271 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -58.07 -47.55 82.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.84 0.856 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.54 -50.05 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.335 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.42 -35.2 80.13 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.891 1.223 . . . . 0.0 109.744 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 71.7 m -61.04 -47.25 87.26 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -64.54 -38.36 90.75 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 121.717 -0.614 . . . . 0.0 111.064 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.84 -30.07 70.15 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.584 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.7 t -67.1 -40.98 86.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.677 1.126 . . . . 0.0 109.776 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -69.65 -42.78 73.77 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.44 0.696 . . . . 0.0 109.613 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 122.66 1.219 . . . . 0.0 109.243 176.126 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.9 -47.04 82.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.912 -175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -59.07 -46.0 89.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 119.393 0.997 . . . . 0.0 110.766 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -67.72 -41.05 84.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.062 0.392 . . . . 0.0 111.209 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.43 -33.16 71.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.741 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -59.51 -31.17 69.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.371 1.441 . . . . 0.0 109.904 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 m -71.14 -48.25 53.12 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.57 -50.21 70.38 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.919 0.888 . . . . 0.0 112.074 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -63.5 131.71 48.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.931 0.893 . . . . 0.0 109.811 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -92.87 -7.79 45.21 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.96 115.89 24.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.352 1.461 . . . . 0.0 108.6 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 37.6 t -135.52 114.18 15.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.34 172.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.431 1.493 . . . . 0.0 109.386 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.473 ' CG2' ' HD1' ' A' ' 133' ' ' HIS . 21.1 p -133.51 144.28 49.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.5 166.69 16.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.728 -0.607 . . . . 0.0 111.385 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.1 m -104.21 135.42 45.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.58 115.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.351 1.06 . . . . 0.0 109.56 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -83.53 -49.32 9.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -145.92 171.41 14.87 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 34.9 mtp -134.89 149.39 50.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.77 2.028 . . . . 0.0 106.86 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.95 139.91 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 131.51 41.96 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -113.7 176.25 1.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 124.465 1.106 . . . . 0.0 109.611 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.96 147.61 32.57 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.388 2.059 . . . . 0.0 113.893 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.48 -123.89 33.14 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.159 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -102.91 17.2 24.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.258 1.023 . . . . 0.0 110.582 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.61 170.43 51.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.869 1.26 . . . . 0.0 112.237 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -154.37 142.23 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.239 2.216 . . . . 0.0 105.459 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.28 150.02 35.05 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.28 123.26 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.7 m -90.53 124.57 35.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.74 173.46 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.547 0.739 . . . . 0.0 109.749 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -132.63 41.72 3.16 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.476 ' HB2' ' H ' ' A' ' 90' ' ' ALA 0.331 73.6 mt 39.06 80.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 174.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.5 mm -76.47 -27.64 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 121.859 -0.526 . . . . 0.0 110.169 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.97 156.54 28.12 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 125.226 1.393 . . . . 0.0 109.659 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.48 123.54 13.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -114.4 -29.32 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.817 0.847 . . . . 0.0 112.486 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.83 125.62 11.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.19 71.15 1.34 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.226 2.61 . . . . 0.0 107.589 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.85 46.27 3.62 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.78 -76.79 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 127.119 2.295 . . . . 0.0 110.03 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.85 127.21 11.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.946 1.298 . . . . 0.0 113.419 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -75.97 71.19 2.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.162 2.985 . . . . 0.0 108.319 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.45 132.1 90.69 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.4 179.16 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.525 1.484 . . . . 0.0 110.893 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.0 t -54.0 -55.14 39.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 175.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.24 121.35 8.63 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 N-CA-C 106.915 -1.994 . . . . 0.0 106.915 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.98 -152.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.081 4.521 . . . . 0.0 113.0 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.7 m -33.8 125.76 0.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.837 2.855 . . . . 0.0 112.226 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.14 53.64 0.23 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' H ' ' HB2' ' A' ' 72' ' ' LEU . . . -140.62 158.24 44.28 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.009 2.124 . . . . 0.0 105.741 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 p -87.83 154.33 20.63 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.386 -0.821 . . . . 0.0 111.234 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -147.37 141.16 25.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -108.4 112.54 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.69 123.14 33.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -76.63 113.74 14.6 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.364 1.065 . . . . 0.0 109.129 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.63 114.08 63.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.25 0.89 7.32 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.407 2.071 . . . . 0.0 113.842 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.38 113.33 9.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . 0.29 54.0 pttt -71.94 -4.7 29.89 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -94.15 -38.41 11.1 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -149.09 159.93 36.09 Favored Pre-proline 0 C--N 1.343 0.312 0 C-N-CA 124.014 0.926 . . . . 0.0 112.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.36 150.32 83.05 Favored 'Cis proline' 0 CA--C 1.54 0.819 0 O-C-N 122.722 0.854 . . . . 0.0 112.085 2.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.6 108.39 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 2.873 . . . . 0.0 111.301 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.1 ttp -140.85 149.71 42.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.194 1.798 . . . . 0.0 108.108 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -138.21 161.53 36.61 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.762 0.825 . . . . 0.0 110.858 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -70.09 132.17 45.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.36 25.81 58.44 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.33 152.06 34.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.487 1.515 . . . . 0.0 108.616 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -95.43 133.08 39.81 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.256 1.422 . . . . 0.0 111.365 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.03 175.54 9.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.967 1.307 . . . . 0.0 111.555 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.07 124.62 50.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 131.008 3.723 . . . . 0.0 102.597 175.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.25 114.1 22.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.275 1.03 . . . . 0.0 108.82 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.7 mtm -116.93 113.25 22.16 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 101.652 -3.462 . . . . 0.0 101.652 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.13 -142.7 3.5 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.788 1.661 . . . . 0.0 109.291 -175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -132.3 174.68 9.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.139 0.97 . . . . 0.0 111.122 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -130.14 138.24 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -120.34 113.08 19.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -76.95 64.85 2.51 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.397 1.479 . . . . 0.0 108.569 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -162.68 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.422 2.689 . . . . 0.0 108.306 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -120.29 -9.34 9.53 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.258 1.023 . . . . 0.0 112.891 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.97 -129.44 9.56 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.93 139.63 22.15 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.976 1.784 . . . . 0.0 112.749 -175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.56 152.76 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -135.05 74.21 63.58 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 174.18 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.987 3.791 . . . . 0.0 113.348 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.26 -21.14 65.53 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.012 1.808 . . . . 0.0 112.175 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.07 22.78 0.92 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 110.742 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.9 m -103.42 129.83 50.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.377 1.071 . . . . 0.0 113.04 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -88.56 120.21 29.73 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.48 123.75 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.52 171.3 4.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.253 1.021 . . . . 0.0 109.693 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.78 145.57 55.53 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.495 1.118 . . . . 0.0 108.454 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.473 ' HD1' ' CG2' ' A' ' 52' ' ' THR . 65.2 t60 -71.94 149.18 45.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 110.42 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -148.73 149.76 31.52 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.64 -39.5 87.5 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.515 2.144 . . . . 0.0 112.301 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -57.75 -49.22 77.29 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.248 0.619 . . . . 0.0 111.286 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -60.11 -43.94 95.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.032 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -54.16 -53.19 56.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.57 0.623 . . . . 0.0 110.598 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -56.69 -45.43 81.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.219 1.408 . . . . 0.0 111.125 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.87 -52.46 61.4 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.122 0.969 . . . . 0.0 109.649 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -37.13 82.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.078 -175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -63.16 -45.71 90.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.244 1.384 . . . . 0.0 108.399 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -57.49 -46.26 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.724 0.693 . . . . 0.0 110.049 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.31 -33.55 75.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.525 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.0 t -62.86 -48.06 80.68 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.707 1.14 . . . . 0.0 110.336 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -62.73 -51.44 67.15 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.908 -0.495 . . . . 0.0 109.942 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 126.764 2.026 . . . . 0.0 111.245 -178.528 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.14 -50.16 56.38 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -63.08 -48.68 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.697 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -55.76 -46.69 77.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.178 0.445 . . . . 0.0 110.479 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -76.0 -41.42 51.22 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.13 -1.891 . . . . 0.0 112.542 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.421 ' CD2' HG13 ' A' ' 50' ' ' VAL . 10.7 t80 -48.81 -49.05 40.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.035 1.743 . . . . 0.0 109.745 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.07 -32.17 73.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.374 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -56.82 4.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.291 1.036 . . . . 0.0 112.447 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 139.33 41.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.873 1.269 . . . . 0.0 112.729 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -76.97 -24.61 52.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.871 1.268 . . . . 0.0 109.462 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.9 tp -120.23 128.04 52.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.219 1.008 . . . . 0.0 110.157 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' A' ' 44' ' ' PHE . 35.4 t -141.33 113.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.9 171.12 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.897 1.279 . . . . 0.0 109.487 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -131.33 139.42 49.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.49 168.16 22.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.883 -1.136 . . . . 0.0 111.716 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.3 m -109.82 134.15 52.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.0 114.48 12.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -81.81 -51.66 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 m -148.98 174.25 12.48 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 125.209 1.404 . . . . 0.0 109.696 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 13.6 mtp -135.39 154.88 51.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.957 1.703 . . . . 0.0 107.363 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.87 138.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.697 1.599 . . . . 0.0 106.987 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -70.1 145.69 51.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.058 1.299 . . . . 0.0 108.705 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -131.67 164.7 40.91 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.841 0.857 . . . . 0.0 108.864 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -52.57 155.62 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.751 2.967 . . . . 0.0 115.715 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.42 -124.71 25.27 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.838 1.685 . . . . 0.0 110.854 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -105.02 25.71 10.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.151 1.381 . . . . 0.0 108.316 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.86 176.17 37.53 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.816 1.198 . . . . 0.0 114.255 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -161.82 141.36 9.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.796 2.438 . . . . 0.0 106.817 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.22 152.08 26.53 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 120.851 -1.155 . . . . 0.0 107.889 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.79 123.13 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -89.64 125.91 35.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -123.91 171.76 12.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.758 0.823 . . . . 0.0 109.93 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -132.67 37.19 3.49 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.067 0.947 . . . . 0.0 112.729 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.304 18.6 mt 39.17 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.37 -29.09 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 118.668 0.667 . . . . 0.0 109.625 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 168.48 39.34 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.322 1.439 . . . . 0.0 110.972 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.36 147.62 30.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.899 1.68 . . . . 0.0 109.306 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -141.38 -25.18 0.72 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -156.26 136.88 13.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.301 1.84 . . . . 0.0 106.502 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.0 p -145.31 71.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.614 2.766 . . . . 0.0 109.051 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 43.69 3.19 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.86 1.695 . . . . 0.0 110.088 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.88 -72.45 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 129.497 3.427 . . . . 0.0 109.683 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mt -51.05 132.23 27.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -82.84 76.07 9.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.0 mt -53.19 129.56 50.34 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.36 158.09 46.82 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.593 1.528 . . . . 0.0 112.281 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -52.85 -58.14 13.29 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.22 114.57 3.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 N-CA-C 103.554 -3.287 . . . . 0.0 103.554 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.06 -153.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.429 3.419 . . . . 0.0 116.328 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.2 m -35.01 134.44 0.24 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 130.76 3.624 . . . . 0.0 111.538 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.69 11.97 3.86 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.733 2.587 . . . . 0.0 110.577 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.6 154.72 20.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.739 1.216 . . . . 0.0 108.182 175.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -104.0 141.26 36.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.437 1.095 . . . . 0.0 111.835 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 mt -147.28 151.6 36.89 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.742 1.217 . . . . 0.0 111.861 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -103.67 114.89 29.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.33 122.36 30.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -80.55 114.92 19.79 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.951 1.3 . . . . 0.0 109.8 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.13 114.02 58.41 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 120.817 1.644 . . . . 0.0 107.195 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.15 -7.72 21.52 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.17 1.913 . . . . 0.0 112.43 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.6 m -121.07 113.61 20.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.467 1.907 . . . . 0.0 109.988 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -78.43 -15.85 58.22 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.387 -0.821 . . . . 0.0 112.55 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -83.4 -41.46 18.11 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.683 0.793 . . . . 0.0 112.337 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.7 m -149.63 156.47 38.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.022 1.329 . . . . 0.0 110.36 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.12 159.31 81.0 Favored 'Cis proline' 0 CA--C 1.544 1.008 0 CA-C-N 119.134 0.727 . . . . 0.0 110.802 -3.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.12 142.94 99.89 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.172 2.581 . . . . 0.0 112.848 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 33.0 tpp -149.3 155.15 40.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.513 1.525 . . . . 0.0 109.239 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -150.56 141.1 22.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.555 1.942 . . . . 0.0 106.328 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.65 146.83 54.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.93 45.04 96.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.708 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.7 t -144.07 154.64 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.907 2.083 . . . . 0.0 107.214 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.5 m -102.56 135.29 44.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.591 1.156 . . . . 0.0 111.577 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.8 175.16 9.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.34 1.456 . . . . 0.0 112.851 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.34 124.71 53.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 130.654 3.581 . . . . 0.0 102.554 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.42 114.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.0 mtm -116.42 113.13 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.63 -139.33 2.75 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.047 1.308 . . . . 0.0 111.142 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -131.69 179.05 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.043 0.921 . . . . 0.0 110.336 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.78 145.97 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.651 -0.656 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -111.73 113.42 25.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.46 72.41 6.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -178.18 -39.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 129.186 2.995 . . . . 0.0 111.062 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -130.67 -10.88 3.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.43 -157.82 15.3 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.353 0.979 . . . . 0.0 111.791 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.14 144.53 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.347 2.698 . . . . 0.0 113.464 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.26 2.9 p -127.23 142.13 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.254 1.8 tm? -132.72 79.37 64.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.616 -1.302 . . . . 0.0 109.98 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.65 171.95 8.84 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.349 3.366 . . . . 0.0 112.598 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.01 -33.03 95.72 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.126 1.884 . . . . 0.0 113.268 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -83.96 37.2 0.59 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.42 1.088 . . . . 0.0 112.181 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.6 m -97.32 130.52 44.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.867 1.667 . . . . 0.0 108.898 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.3 113.65 15.29 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.61 123.95 43.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -150.28 171.82 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.28 1.832 . . . . 0.0 109.18 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.14 141.93 58.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.928 1.291 . . . . 0.0 109.504 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -75.72 131.28 39.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.418 0.687 . . . . 0.0 109.913 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -139.16 146.75 50.54 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.072 1.749 . . . . 0.0 107.67 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -57.54 -34.25 97.76 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.006 2.47 . . . . 0.0 113.362 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -54.15 -54.55 38.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.401 0.68 . . . . 0.0 109.679 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.49 -43.19 97.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.884 0.874 . . . . 0.0 109.677 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -51.1 -55.19 18.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.393 1.477 . . . . 0.0 111.166 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -65.53 -30.65 71.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.902 0.481 . . . . 0.0 110.757 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.71 -52.12 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 120.599 -1.313 . . . . 0.0 109.282 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.12 -37.79 81.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.085 1.312 . . . . 0.0 109.432 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.7 m -56.62 -53.62 55.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.693 0.797 . . . . 0.0 108.9 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -61.64 -31.3 71.39 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.595 -0.691 . . . . 0.0 112.201 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.59 -23.9 56.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.134 0.879 . . . . 0.0 111.299 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.8 t -73.67 -38.09 65.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -76.09 -59.59 2.69 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.765 1.226 . . . . 0.0 111.5 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.561 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.35 -40.92 98.63 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -62.22 -54.22 43.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.981 0.809 . . . . 0.0 109.978 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -55.82 -46.39 78.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.92 0.867 . . . . 0.0 111.227 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -69.69 -37.65 76.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.201 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -61.35 -37.18 82.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.592 1.087 . . . . 0.0 109.757 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.7 -57.8 6.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.749 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -29.72 69.69 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -76.25 153.85 35.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.318 0.508 . . . . 0.0 111.895 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -102.85 -6.95 21.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.321 1.048 . . . . 0.0 108.717 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 tp -133.43 123.47 25.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.639 1.576 . . . . 0.0 109.117 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.58 114.55 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.81 172.04 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.807 1.243 . . . . 0.0 109.782 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -134.66 141.24 46.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.82 174.7 13.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 120.626 -1.296 . . . . 0.0 110.987 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.1 m -114.17 130.22 56.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 102.939 -2.985 . . . . 0.0 102.939 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.44 113.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -78.86 -43.33 25.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 108.808 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -152.77 167.76 27.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.248 1.419 . . . . 0.0 109.893 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 57.1 mtp -137.98 125.07 21.47 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.7 t -120.63 146.05 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.485 1.514 . . . . 0.0 107.82 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 -65.73 154.65 38.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.977 1.262 . . . . 0.0 107.877 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -135.13 170.9 9.99 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 124.728 1.211 . . . . 0.0 108.691 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 165.55 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.171 2.581 . . . . 0.0 113.318 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.2 -142.37 45.95 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 125.791 1.663 . . . . 0.0 109.298 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.467 ' OE1' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tp10 -97.56 25.19 5.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.917 1.287 . . . . 0.0 107.69 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.68 43.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.383 1.945 . . . . 0.0 114.794 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.48 155.77 35.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.381 2.673 . . . . 0.0 107.309 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.92 146.26 45.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.97 123.15 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 m -92.86 129.15 38.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 170.84 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.887 0.875 . . . . 0.0 111.559 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -135.01 35.38 3.07 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt 37.02 82.38 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.506 2.322 . . . . 0.0 116.003 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.3 mm -75.02 -23.02 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.701 0.8 . . . . 0.0 109.037 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.2 159.66 33.08 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.76 45.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.716 1.607 . . . . 0.0 106.695 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -141.42 -32.01 0.56 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.832 0.707 . . . . 0.0 111.246 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -148.21 129.61 14.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -139.4 70.03 1.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.324 2.249 . . . . 0.0 105.95 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.23 44.47 3.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.295 1.426 . . . . 0.0 109.61 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.77 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 130.075 3.702 . . . . 0.0 107.514 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -44.59 123.52 3.68 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 123.033 1.397 . . . . 0.0 114.408 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.59 64.86 5.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.348 3.059 . . . . 0.0 109.375 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -56.02 131.34 73.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.83 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.06 177.67 7.9 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.428 2.086 . . . . 0.0 112.107 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -48.92 -52.45 46.58 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.938 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.27 116.97 4.32 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 CA-C-N 121.843 1.694 . . . . 0.0 108.538 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 88' ' ' THR . 34.4 Cg_endo -78.18 -153.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.343 4.028 . . . . 0.0 111.529 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 75.5 m -33.36 125.44 0.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.838 2.455 . . . . 0.0 110.194 175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.55 2.09 5.89 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.294 1.902 . . . . 0.0 111.42 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.31 150.86 22.9 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.182 1.491 . . . . 0.0 110.112 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.9 p -95.08 150.5 20.11 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 mt -144.29 168.37 20.23 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.195 2.198 . . . . 0.0 109.773 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -127.26 115.01 18.38 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -95.63 124.79 39.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -72.34 139.93 48.19 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.309 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.31 113.64 18.31 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -60.73 -11.83 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.169 3.246 . . . . 0.0 115.451 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.5 m -137.42 118.39 14.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.539 1.535 . . . . 0.0 113.007 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HE3' ' OE1' ' A' ' 64' ' ' GLU . 22.0 pttp -73.98 -27.22 60.88 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.665 -0.647 . . . . 0.0 110.188 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -62.73 -52.13 64.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.217 1.407 . . . . 0.0 110.858 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -146.65 159.11 45.09 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 111.673 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.3 160.77 75.3 Favored 'Cis proline' 0 CA--C 1.543 0.928 0 CA-C-N 119.189 0.746 . . . . 0.0 112.554 -0.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.63 95.56 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.957 3.105 . . . . 0.0 111.752 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 34.1 tpp -93.66 160.98 14.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.882 1.673 . . . . 0.0 108.603 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -148.48 136.9 21.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -77.31 145.06 37.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.888 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.16 98.75 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.674 0.67 . . . . 0.0 113.483 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.73 156.96 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 125.915 1.686 . . . . 0.0 107.049 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -89.99 138.72 31.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.991 0.901 . . . . 0.0 110.758 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -136.05 174.66 10.37 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.723 2.409 . . . . 0.0 112.33 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.05 123.62 42.04 Favored 'General case' 0 N--CA 1.448 -0.553 1 C-N-CA 132.504 4.321 . . . . 0.0 101.955 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.9 113.93 19.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.0 mtm -115.56 113.29 23.42 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.55 -136.39 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.46 1.028 . . . . 0.0 112.67 -175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -135.43 176.12 8.97 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.949 1.3 . . . . 0.0 110.366 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.95 154.4 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -125.02 113.67 18.08 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -74.19 71.01 1.65 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 165.44 -24.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 1 C-N-CA 132.056 4.142 . . . . 0.0 112.134 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -113.78 -4.4 13.37 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.204 0.94 . . . . 0.0 111.628 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.25 -160.29 34.67 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 131.51 19.07 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.307 2.671 . . . . 0.0 111.935 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.76 125.95 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -114.65 84.17 9.78 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 125.973 1.709 . . . . 0.0 109.939 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.27 168.46 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.034 3.156 . . . . 0.0 113.01 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.84 -22.17 73.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.462 2.108 . . . . 0.0 113.318 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.02 23.19 5.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.96 1.304 . . . . 0.0 111.03 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.6 m -83.9 134.59 34.67 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.457 1.503 . . . . 0.0 108.491 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -76.93 113.77 14.98 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.65 116.25 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.8 168.38 7.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.838 0.855 . . . . 0.0 110.082 -175.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.86 145.95 54.87 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.662 0.785 . . . . 0.0 108.916 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -72.45 130.23 40.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.828 0.851 . . . . 0.0 109.702 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -137.21 148.05 60.81 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.889 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -37.8 39.25 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.046 2.497 . . . . 0.0 112.642 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -57.82 -50.98 71.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.018 0.527 . . . . 0.0 110.266 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -59.23 -51.94 67.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.18 -48.13 45.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.519 1.927 . . . . 0.0 111.491 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -44.02 97.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.723 1.209 . . . . 0.0 111.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.7 mt -66.41 -43.67 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.407 -1.282 . . . . 0.0 109.704 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.3 -43.32 96.42 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.651 1.569 . . . . 0.0 109.298 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -57.6 -49.27 76.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.88 -34.92 78.41 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.322 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.4 mt -69.29 -27.76 65.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.978 1.263 . . . . 0.0 111.688 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -71.32 -47.38 57.01 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -71.27 -43.6 66.87 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.634 -0.667 . . . . 0.0 110.81 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 N--CA 1.45 -0.447 0 C-N-CA 126.471 1.908 . . . . 0.0 108.657 175.724 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.234 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.2 -50.49 63.68 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.76 -45.26 90.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.883 0.765 . . . . 0.0 111.538 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m -63.62 -44.94 92.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.918 0.326 . . . . 0.0 110.343 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -67.85 -46.19 72.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 117.174 -1.394 . . . . 0.0 110.092 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -48.4 -48.44 36.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.832 1.196 . . . . 0.0 111.331 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.5 m -65.62 -34.29 77.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.882 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -43.41 50.11 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.504 1.122 . . . . 0.0 112.292 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 p -66.75 127.25 31.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.993 0.917 . . . . 0.0 110.352 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.0 t -73.08 -21.43 60.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.955 0.798 . . . . 0.0 110.321 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 tp -117.83 118.78 32.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.552 1.141 . . . . 0.0 109.493 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.8 t -136.62 113.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.41 173.47 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 126.043 1.737 . . . . 0.0 108.061 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.502 ' CG2' ' HD1' ' A' ' 133' ' ' HIS . 35.1 p -136.01 146.36 47.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -167.68 164.59 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.917 0.78 . . . . 0.0 111.991 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.0 m -96.44 133.27 41.07 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.42 113.74 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 27.2 mmmt -72.79 -42.55 63.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.864 0.865 . . . . 0.0 108.979 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -165.56 170.29 14.46 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.069 1.347 . . . . 0.0 110.158 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 42.5 mtp -129.55 134.55 47.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.956 1.702 . . . . 0.0 106.62 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -135.52 144.63 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 159.46 30.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.688 1.585 . . . . 0.0 111.371 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -132.29 172.04 8.07 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 129.372 3.069 . . . . 0.0 110.685 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.91 146.4 16.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.586 2.857 . . . . 0.0 114.013 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.25 -124.43 30.74 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.912 1.244 . . . . 0.0 111.149 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -86.88 -0.52 56.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.855 0.862 . . . . 0.0 112.037 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.62 163.13 40.38 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.704 1.145 . . . . 0.0 114.039 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -148.4 136.22 20.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.27 1.828 . . . . 0.0 106.641 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.73 134.22 45.23 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.61 123.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m -93.23 130.56 38.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -134.71 172.28 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.73 0.812 . . . . 0.0 110.704 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -137.35 41.92 2.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt 38.5 80.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.0 mm -72.95 -29.46 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.05 157.56 29.11 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.66 144.97 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.362 1.465 . . . . 0.0 108.077 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -145.08 -25.7 0.48 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -155.36 127.68 7.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -144.56 70.18 1.28 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.564 2.346 . . . . 0.0 108.155 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.2 35.03 2.8 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.13 -81.6 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 127.556 2.503 . . . . 0.0 107.423 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.53 133.1 7.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 117.965 2.58 . . . . 0.0 117.965 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.27 63.79 8.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.011 2.925 . . . . 0.0 108.332 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.78 133.2 47.33 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.07 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.49 175.94 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.363 2.042 . . . . 0.0 112.219 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -50.86 -55.79 24.62 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.582 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.81 126.11 14.8 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.927 1.367 . . . . 0.0 109.137 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.896 2.397 . . . . 0.0 110.89 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.6 m -33.08 127.26 0.32 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 129.378 3.071 . . . . 0.0 112.987 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.74 54.63 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.093 2.282 . . . . 0.0 109.789 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.84 156.55 43.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.126 2.57 . . . . 0.0 107.093 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 p -102.72 155.06 18.57 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.253 -0.904 . . . . 0.0 112.971 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 mt -145.66 163.05 36.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.885 1.674 . . . . 0.0 108.593 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -126.37 113.73 17.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.59 126.35 38.7 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.279 1.031 . . . . 0.0 108.997 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -79.5 113.58 17.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.237 1.015 . . . . 0.0 110.503 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.88 119.03 54.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.56 -13.4 30.05 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.023 1.815 . . . . 0.0 113.292 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.2 126.35 16.45 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.844 1.658 . . . . 0.0 109.402 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -14.14 60.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.863 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -63.77 -58.08 7.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.884 1.22 . . . . 0.0 111.592 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -145.45 158.54 50.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.95 159.73 86.72 Favored 'Cis proline' 0 CA--C 1.548 1.176 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -4.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.89 160.9 27.47 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.729 1.619 . . . . 0.0 111.295 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.4 tpp -152.33 150.84 30.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -139.81 145.98 38.84 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -72.98 138.71 46.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.21 58.83 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.765 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.39 144.44 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 108.62 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 m -92.26 126.99 37.57 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.592 1.157 . . . . 0.0 112.181 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.86 175.66 8.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 112.046 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.17 127.23 54.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.754 3.221 . . . . 0.0 103.359 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.96 114.29 20.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.846 0.858 . . . . 0.0 109.892 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.5 mtm -114.64 111.64 21.64 Favored 'General case' 0 C--N 1.32 -0.69 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.85 -148.32 4.76 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.548 2.023 . . . . 0.0 111.228 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -130.75 178.04 6.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.123 0.969 . . . . 0.0 108.972 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 t -135.71 145.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 121.708 -0.62 . . . . 0.0 109.348 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -114.16 113.85 25.23 Favored 'General case' 0 C--N 1.346 0.414 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.09 72.39 4.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -175.22 -35.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 130.593 3.557 . . . . 0.0 109.141 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -117.37 -16.71 10.24 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.02 -171.36 14.84 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.78 137.81 55.42 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.99 1.793 . . . . 0.0 110.173 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.262 7.2 p -114.65 162.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.289 1.7 tm? -150.9 76.27 8.07 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.9 170.44 11.53 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.973 3.116 . . . . 0.0 112.343 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.38 -19.23 66.61 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.899 1.733 . . . . 0.0 112.214 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -84.41 36.38 0.58 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.446 2.698 . . . . 0.0 109.898 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 m -113.48 133.24 55.32 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.682 1.593 . . . . 0.0 110.804 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -85.01 117.55 24.04 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.19 119.57 31.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.837 0.855 . . . . 0.0 110.134 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.0 m -143.58 168.82 11.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.97 1.708 . . . . 0.0 108.926 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.25 149.39 48.12 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.78 -0.575 . . . . 0.0 110.211 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.502 ' HD1' ' CG2' ' A' ' 52' ' ' THR . 51.6 t60 -72.5 144.34 48.05 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -142.64 149.58 50.96 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.72 -39.76 25.22 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 111.663 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -58.59 -48.04 82.29 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.894 0.316 . . . . 0.0 110.696 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -58.19 -46.88 85.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.763 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.59 -56.51 14.83 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.203 1.401 . . . . 0.0 110.772 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -63.73 -37.88 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.93 -49.77 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.609 1.095 . . . . 0.0 109.837 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.33 -34.2 77.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.575 1.079 . . . . 0.0 108.808 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -60.78 -47.92 84.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -59.11 -49.21 78.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.699 -0.626 . . . . 0.0 110.229 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.6 mt -59.05 -34.53 72.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.682 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 t -56.26 -58.02 9.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.371 0.987 . . . . 0.0 110.526 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -73.13 -38.92 66.12 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.693 0.397 . . . . 0.0 111.693 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 . . . . . 0 N--CA 1.454 -0.227 0 C-N-CA 124.61 1.164 . . . . 0.0 110.211 176.211 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.798 0.808 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.19 -53.55 10.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.88 1.672 . . . . 0.0 109.274 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -62.14 -31.28 71.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.14 0.882 . . . . 0.0 112.424 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -74.19 -52.39 12.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -59.2 -37.89 78.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.662 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.412 ' CD2' HG13 ' A' ' 50' ' ' VAL . 36.8 t80 -59.1 -41.64 88.59 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.444 1.02 . . . . 0.0 110.777 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -68.35 -41.1 81.17 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.694 -0.629 . . . . 0.0 111.131 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -55.71 11.48 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.698 0.681 . . . . 0.0 112.671 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 p -54.37 148.46 11.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.496 1.118 . . . . 0.0 111.629 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.1 t -99.07 -15.54 18.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.486 0.714 . . . . 0.0 111.551 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.77 115.49 22.77 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' A' ' 44' ' ' PHE . 22.4 t -134.86 113.6 16.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.12 170.36 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.629 1.172 . . . . 0.0 110.947 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -130.97 142.6 50.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.869 2.068 . . . . 0.0 106.953 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -168.56 176.78 5.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.257 -0.902 . . . . 0.0 110.938 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -114.77 136.03 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.69 113.6 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.15 -52.67 7.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -145.93 173.18 12.37 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.856 1.662 . . . . 0.0 109.542 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.5 mtp -139.55 153.29 47.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.149 2.18 . . . . 0.0 106.309 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.2 t -145.49 135.74 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 108.103 -175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -66.16 147.14 53.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.956 1.707 . . . . 0.0 108.757 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -139.59 169.37 12.36 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 119.331 0.969 . . . . 0.0 112.912 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.97 163.22 7.88 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.573 3.516 . . . . 0.0 114.629 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.58 -123.58 8.3 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -119.84 22.09 11.68 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.31 175.61 45.76 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-O 124.832 2.351 . . . . 0.0 118.934 -174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -156.42 135.19 11.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.472 2.709 . . . . 0.0 105.387 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.75 127.24 54.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.7 123.3 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -86.17 127.17 34.67 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.92 168.13 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.706 0.803 . . . . 0.0 108.933 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 t -129.94 35.9 4.09 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.307 81.7 mt 37.42 80.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.456 2.302 . . . . 0.0 116.273 173.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.58 -40.39 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 110.15 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.37 161.7 29.55 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.46 147.07 42.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.593 1.957 . . . . 0.0 107.637 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.68 -30.1 2.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.707 1.203 . . . . 0.0 110.359 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -150.77 137.43 18.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -142.41 70.17 1.33 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 129.072 2.949 . . . . 0.0 106.434 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.61 32.37 3.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.985 0.802 . . . . 0.0 111.912 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 126.765 2.126 . . . . 0.0 110.983 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.06 132.6 48.91 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.307 1.043 . . . . 0.0 111.199 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -85.72 94.05 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.79 1.636 . . . . 0.0 107.532 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.06 133.0 88.02 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.72 -179.06 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.437 2.758 . . . . 0.0 114.652 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 t -39.58 -60.33 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.371 1.868 . . . . 0.0 110.762 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.17 123.72 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.01 1.806 . . . . 0.0 108.392 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.32 -170.59 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.275 1.983 . . . . 0.0 112.712 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.0 m -38.3 127.55 1.38 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.044 2.138 . . . . 0.0 116.458 -175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.19 14.97 0.09 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 128.392 2.901 . . . . 0.0 110.61 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.38 168.07 9.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.728 1.611 . . . . 0.0 110.728 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.9 p -98.73 153.01 19.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.57 -0.706 . . . . 0.0 112.621 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 24.4 mt -152.37 154.04 34.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.833 1.253 . . . . 0.0 109.612 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -112.51 113.24 25.31 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -89.27 121.27 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.137 0.88 . . . . 0.0 109.106 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -73.76 114.27 11.85 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.038 1.335 . . . . 0.0 110.529 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.5 117.57 55.51 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.95 -4.16 14.26 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.268 2.645 . . . . 0.0 112.982 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.29 120.49 28.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.466 2.306 . . . . 0.0 111.33 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HZ2' ' NE2' ' A' ' 100' ' ' GLN . 2.0 pptp? -73.81 -25.92 60.35 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.507 -0.746 . . . . 0.0 110.102 175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.483 ' NE2' ' HZ2' ' A' ' 99' ' ' LYS . 15.6 mm-40 -69.7 -45.36 68.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.416 1.487 . . . . 0.0 113.059 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.3 m -148.56 163.51 25.83 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -62.57 157.66 62.96 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 O-C-N 122.493 0.733 . . . . 0.0 111.618 -1.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.32 92.71 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.839 3.026 . . . . 0.0 114.268 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.6 tpp -96.03 161.54 13.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.542 1.937 . . . . 0.0 111.563 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -153.48 139.76 18.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.342 1.857 . . . . 0.0 107.896 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.55 146.63 48.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.29 32.27 83.64 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.9 -0.944 . . . . 0.0 114.35 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.7 t -129.63 156.78 42.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.677 1.991 . . . . 0.0 106.636 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.3 m -103.6 136.55 43.1 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.486 0.715 . . . . 0.0 109.726 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.39 176.02 8.9 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.231 1.812 . . . . 0.0 112.773 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.46 123.66 43.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.0 114.24 22.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.142 0.977 . . . . 0.0 108.604 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -117.01 113.34 22.21 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.86 -143.04 3.67 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 126.118 1.818 . . . . 0.0 109.35 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -133.23 177.3 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.527 0.68 . . . . 0.0 110.234 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.98 130.95 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -109.9 113.2 25.73 Favored 'General case' 0 N--CA 1.449 -0.512 1 N-CA-C 98.208 -4.738 . . . . 0.0 98.208 174.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 72.16 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.504 1.621 . . . . 0.0 108.053 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -161.38 -47.38 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.695 2.798 . . . . 0.0 106.579 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.48 -4.49 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.661 1.584 . . . . 0.0 111.245 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.28 -122.72 6.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.267 1.413 . . . . 0.0 109.851 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.82 145.33 28.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.754 2.302 . . . . 0.0 114.931 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.37 151.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -142.6 76.3 18.02 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 120.742 -1.223 . . . . 0.0 108.572 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.73 171.95 6.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.649 3.566 . . . . 0.0 112.428 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.89 -19.13 68.02 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.059 1.414 . . . . 0.0 112.22 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.98 23.21 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.968 2.107 . . . . 0.0 111.773 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.8 m -91.59 132.95 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 110.557 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.85 113.64 18.17 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.59 119.21 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.75 167.77 8.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.102 1.361 . . . . 0.0 108.626 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.22 152.29 41.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -69.94 135.6 49.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -137.36 145.11 48.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.61 -46.24 14.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.926 1.751 . . . . 0.0 112.648 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.85 -38.0 89.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.792 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.72 -41.09 97.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.402 -0.811 . . . . 0.0 109.595 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -54.88 -49.83 70.22 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.381 1.473 . . . . 0.0 109.212 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -62.95 -45.23 93.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.132 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.0 mt -59.21 -47.38 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.804 1.184 . . . . 0.0 109.813 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.96 -38.07 87.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 109.4 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.2 m -61.64 -43.37 98.98 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.718 -0.614 . . . . 0.0 110.099 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -60.3 -52.71 64.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.6 mt -59.27 -32.48 70.05 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.699 0.8 . . . . 0.0 112.016 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.9 t -64.6 -51.24 63.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.081 1.352 . . . . 0.0 110.646 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -71.67 -38.94 70.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 126.456 1.902 . . . . 0.0 108.928 176.31 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.236 0.383 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -63.93 -40.87 97.44 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.61 -51.84 65.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.221 0.464 . . . . 0.0 110.845 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -53.02 -54.47 34.81 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.199 1.0 . . . . 0.0 110.194 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.91 -35.89 81.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.007 -0.996 . . . . 0.0 111.489 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -57.42 -39.91 77.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.889 1.222 . . . . 0.0 110.315 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.11 -42.67 46.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.865 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.79 78.47 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.106 . . . . 0.0 112.573 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -75.99 145.74 40.06 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.682 0.793 . . . . 0.0 111.459 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -95.12 -5.94 43.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.826 1.25 . . . . 0.0 108.268 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.0 tp -129.09 122.71 30.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.557 2.343 . . . . 0.0 108.272 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.3 t -142.56 113.81 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.92 163.34 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.209 1.404 . . . . 0.0 109.019 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 p -126.21 144.76 50.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.67 161.39 20.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.674 -1.266 . . . . 0.0 111.933 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 55.3 m -87.69 132.87 33.96 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.0 t -75.35 113.31 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -82.9 -46.44 12.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.57 1.548 . . . . 0.0 108.13 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -153.03 167.03 30.55 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.491 1.517 . . . . 0.0 108.967 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.3 mtp -135.34 123.98 23.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.943 2.897 . . . . 0.0 105.784 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.73 150.73 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.93 1.292 . . . . 0.0 107.899 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -67.69 154.46 41.43 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.609 -0.682 . . . . 0.0 109.26 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -140.02 168.34 15.21 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.408 1.083 . . . . 0.0 110.776 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.83 162.26 11.29 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.65 2.9 . . . . 0.0 112.915 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.93 -147.48 50.73 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -88.72 20.42 3.49 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.48 169.04 54.9 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-O 123.848 1.804 . . . . 0.0 117.547 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.96 134.11 16.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.735 2.814 . . . . 0.0 104.967 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.55 123.53 42.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.55 123.15 49.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 175.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.0 m -98.72 126.21 44.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.12 175.51 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.221 0.608 . . . . 0.0 111.305 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -133.1 40.84 3.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.278 91.8 mt 38.81 80.97 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.86 -29.5 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.77 0.714 . . . . 0.0 109.42 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.32 159.28 29.03 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.935 1.731 . . . . 0.0 109.408 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.56 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -135.34 -32.04 0.95 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.194 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -157.98 133.58 9.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -145.27 67.85 1.23 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.121 2.168 . . . . 0.0 106.548 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.62 43.83 3.22 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.479 1.514 . . . . 0.0 111.215 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.12 -31.77 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 125.93 1.728 . . . . 0.0 113.16 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.95 144.27 28.43 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.35 1.575 . . . . 0.0 109.993 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -100.55 63.37 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -57.54 141.08 79.37 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.962 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.39 171.51 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.192 1.928 . . . . 0.0 112.961 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.1 t -43.81 -56.13 7.86 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.896 2.078 . . . . 0.0 110.23 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.42 116.79 4.85 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 N-CA-C 106.597 -2.116 . . . . 0.0 106.597 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.46 -152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 1 C-N-CA 125.317 4.011 . . . . 0.0 112.129 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.292 97.5 m -33.77 124.39 0.45 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 129.089 2.956 . . . . 0.0 112.117 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.21 -4.05 1.75 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.186 1.85 . . . . 0.0 113.356 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.84 161.04 15.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.034 1.417 . . . . 0.0 109.446 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.2 p -105.32 143.8 32.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.799 0.809 . . . . 0.0 112.231 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -148.25 160.68 42.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.153 1.781 . . . . 0.0 109.48 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.32 121.22 43.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -94.04 122.59 36.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -75.64 113.44 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 124.259 0.974 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.48 114.02 62.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -11.7 29.12 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 111.926 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -117.49 113.25 21.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.993 1.317 . . . . 0.0 111.956 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -82.74 -20.29 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -60.24 -53.59 55.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 109.776 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.3 m -160.58 163.56 21.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 127.483 2.313 . . . . 0.0 108.407 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.13 141.97 41.85 Favored 'Cis proline' 0 CA--C 1.537 0.664 0 CA-C-N 120.678 1.278 . . . . 0.0 111.312 1.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 102.2 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.177 2.585 . . . . 0.0 111.558 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 tpp -93.36 158.41 15.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.045 1.738 . . . . 0.0 108.666 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -142.54 137.22 30.02 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.537 0.684 . . . . 0.0 110.107 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -74.94 144.42 43.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.242 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.11 45.62 55.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -151.13 161.31 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 127.742 2.417 . . . . 0.0 105.513 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.8 m -107.63 131.34 54.48 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -122.77 170.32 10.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.444 1.898 . . . . 0.0 112.622 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.23 123.74 47.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.572 3.549 . . . . 0.0 102.031 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.37 114.13 21.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.5 mtm -119.23 113.33 20.7 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.18 -134.2 1.91 Allowed Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.187 1.375 . . . . 0.0 111.366 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -134.96 -178.5 5.11 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.342 -1.093 . . . . 0.0 109.401 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.9 144.12 33.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.24 113.43 19.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -75.84 73.95 2.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.388 1.09 . . . . 0.0 108.527 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -168.94 -41.2 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 129.812 3.245 . . . . 0.0 108.343 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -119.2 -6.37 10.39 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.349 1.06 . . . . 0.0 112.682 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -151.32 21.33 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.86 141.95 38.13 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.613 1.542 . . . . 0.0 112.737 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.81 135.62 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.255 1.7 tm? -122.07 74.26 38.16 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 107.486 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.86 174.86 6.1 Favored 'Trans proline' 0 CA--C 1.542 0.888 1 C-N-CA 125.728 4.285 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.54 -22.85 61.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.728 2.285 . . . . 0.0 113.463 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -85.17 23.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.355 1.462 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.2 m -97.74 140.1 32.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.922 . . . . 0.0 111.252 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -92.55 117.05 29.56 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.8 117.41 34.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.795 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -147.12 168.68 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.228 1.411 . . . . 0.0 109.117 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.7 141.1 57.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.13 0.967 . . . . 0.0 109.954 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -68.45 136.32 53.06 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.777 1.631 . . . . 0.0 107.877 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -144.65 155.64 56.51 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.112 1.765 . . . . 0.0 106.912 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.44 -40.12 25.77 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.187 1.925 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -56.97 -52.71 64.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.013 0.37 . . . . 0.0 110.945 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -58.09 -44.11 87.45 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 123.091 0.556 . . . . 0.0 110.362 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.96 -50.65 70.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.34 1.056 . . . . 0.0 109.796 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -61.67 -39.57 91.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.275 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.3 mt -63.4 -50.36 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.116 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 mt -62.39 -36.91 83.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.207 1.367 . . . . 0.0 109.088 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.7 m -61.81 -45.36 94.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.15 -38.94 90.93 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.282 -0.886 . . . . 0.0 110.737 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.4 mt -68.65 -24.61 64.55 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.706 0.803 . . . . 0.0 111.582 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 t -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.184 0.902 . . . . 0.0 109.408 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -75.61 -48.88 20.33 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.625 0.77 . . . . 0.0 111.092 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 119.017 0.826 . . . . 0.0 109.496 176.51 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.82 -47.75 76.88 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.05 -48.0 80.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 118.62 0.646 . . . . 0.0 110.593 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 m -59.28 -48.15 82.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.346 0.659 . . . . 0.0 111.077 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -69.0 -33.89 74.41 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.249 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.416 ' CD2' HG13 ' A' ' 50' ' ' VAL . 15.9 t80 -57.52 -36.4 71.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.185 1.357 . . . . 0.0 110.033 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.8 m -69.26 -45.85 68.69 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.39 0.676 . . . . 0.0 111.115 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.28 50.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.511 0.724 . . . . 0.0 112.144 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -62.05 138.49 58.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.78 1.232 . . . . 0.0 109.994 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -94.3 -6.68 43.89 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.061 0.934 . . . . 0.0 109.882 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.6 tp -120.38 120.42 35.92 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 126.75 2.02 . . . . 0.0 107.709 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 HG13 ' CD2' ' A' ' 44' ' ' PHE . 40.1 t -142.88 113.32 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.49 166.8 5.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.776 1.231 . . . . 0.0 108.509 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -130.29 143.66 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -165.58 173.31 11.03 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 110.799 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.8 m -110.82 134.45 52.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.92 113.58 15.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 22.2 mmmt -86.49 -42.38 13.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.424 1.09 . . . . 0.0 110.327 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -147.37 168.99 20.42 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.198 1.399 . . . . 0.0 110.925 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 mtp -138.82 129.25 25.84 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 t -123.72 142.19 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.312 1.045 . . . . 0.0 108.663 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -72.49 139.69 47.78 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -123.62 176.11 2.41 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.339 1.856 . . . . 0.0 108.555 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.81 161.81 34.62 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.929 2.419 . . . . 0.0 112.24 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -154.2 40.17 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -72.2 0.27 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.914 1.285 . . . . 0.0 110.632 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.5 172.56 22.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 126.808 2.147 . . . . 0.0 117.873 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -161.87 141.99 10.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 129.569 3.148 . . . . 0.0 105.44 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.29 151.35 27.5 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.93 123.28 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 124.68 43.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.51 169.98 20.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 t -123.8 35.39 4.85 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.26 70.3 mt 36.3 82.58 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 128.071 2.549 . . . . 0.0 116.884 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.7 mm -72.15 -30.99 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.305 -0.872 . . . . 0.0 111.816 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.3 160.91 31.7 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.88 49.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -141.32 -25.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.396 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -156.15 125.54 6.23 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -139.57 67.95 1.38 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 127.709 2.404 . . . . 0.0 104.613 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 31.46 3.31 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.58 1.086 . . . . 0.0 111.939 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.58 -62.7 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.247 1.403 . . . . 0.0 111.4 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.12 148.59 30.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 117.147 0.474 . . . . 0.0 111.022 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.11 97.69 11.33 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.2 mt -63.23 147.44 94.81 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.68 178.7 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.539 1.493 . . . . 0.0 111.347 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.3 t -52.31 -61.02 5.06 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.614 1.166 . . . . 0.0 111.245 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 142.36 46.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 N-CA-C 107.36 -1.823 . . . . 0.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.36 -168.94 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.392 1.395 . . . . 0.0 110.846 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.1 m -38.17 130.93 1.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.258 2.223 . . . . 0.0 113.67 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 59.48 0.06 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 105.257 -3.137 . . . . 0.0 105.257 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.63 165.33 31.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 126.501 1.92 . . . . 0.0 106.608 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.9 p -104.0 147.72 27.05 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 120.907 -1.121 . . . . 0.0 111.443 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -147.26 158.77 44.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -125.02 113.84 18.32 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -98.81 121.19 40.45 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.86 0.864 . . . . 0.0 109.57 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.91 113.8 17.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 124.677 1.236 . . . . 0.0 109.994 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.54 120.01 54.31 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.32 0.02 8.0 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.685 2.257 . . . . 0.0 112.458 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 57.7 m -129.83 160.81 32.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.061 2.544 . . . . 0.0 109.121 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -132.01 -8.42 3.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -83.45 -48.03 10.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.482 1.037 . . . . 0.0 108.511 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -127.66 158.22 70.81 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.99 1.316 . . . . 0.0 111.519 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.7 153.26 79.38 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 -4.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.35 96.51 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.403 2.735 . . . . 0.0 112.622 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.5 tpp -94.67 160.94 14.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.135 1.374 . . . . 0.0 110.309 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -152.91 140.02 19.32 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.988 1.715 . . . . 0.0 109.093 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -78.2 147.06 34.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.45 46.6 84.87 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -146.32 147.86 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 126.477 1.911 . . . . 0.0 106.714 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.1 m -93.8 132.13 38.5 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.168 0.587 . . . . 0.0 110.096 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.76 172.38 11.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.631 1.972 . . . . 0.0 111.664 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -115.81 124.15 50.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.21 114.34 23.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.7 mtm -117.89 113.37 21.64 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 103.274 -2.861 . . . . 0.0 103.274 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.74 -134.01 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.802 1.191 . . . . 0.0 111.164 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -135.89 175.98 9.1 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.985 . . . . 0.0 110.991 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -130.21 145.78 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.789 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -123.76 113.7 18.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -81.01 65.32 6.11 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.378 1.085 . . . . 0.0 111.946 -175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -166.82 -39.42 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.982 1.713 . . . . 0.0 110.736 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -113.65 -30.67 6.73 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.96 -168.76 21.21 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.76 160.53 47.75 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.287 1.325 . . . . 0.0 111.342 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.47 157.21 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.44 74.73 12.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 120.67 -1.269 . . . . 0.0 108.664 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.05 174.19 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.552 3.501 . . . . 0.0 113.052 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.13 -16.37 50.05 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.847 1.698 . . . . 0.0 111.99 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.81 32.01 0.48 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.038 2.135 . . . . 0.0 110.826 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -113.66 128.73 56.54 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.111 1.364 . . . . 0.0 111.064 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -81.34 113.31 19.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -133.46 123.18 45.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -152.43 173.16 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.362 1.465 . . . . 0.0 110.682 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.91 134.25 54.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.875 1.67 . . . . 0.0 109.323 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -67.74 125.77 27.3 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -140.9 157.64 66.93 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.56 -1.209 . . . . 0.0 109.199 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.52 -44.85 16.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.63 2.887 . . . . 0.0 115.785 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -55.68 -43.42 76.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.542 1.065 . . . . 0.0 110.859 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.35 -44.28 83.66 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.94 -0.553 . . . . 0.0 109.556 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.37 -50.05 65.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.919 0.887 . . . . 0.0 111.657 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.59 -49.77 73.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.592 0.757 . . . . 0.0 109.335 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.73 -52.61 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.861 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.23 -32.82 74.32 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.771 1.169 . . . . 0.0 110.222 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.6 m -65.73 -46.84 77.37 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -60.32 -41.75 94.17 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.685 -0.635 . . . . 0.0 111.267 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.98 -35.64 80.41 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.5 1.12 . . . . 0.0 110.867 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -61.99 -45.61 92.85 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -67.41 -48.88 66.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.53 0.732 . . . . 0.0 110.5 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.457 0.646 . . . . 0.0 109.638 178.532 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.236 0.365 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.7 -38.31 90.64 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -64.83 -53.75 41.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.474 0.579 . . . . 0.0 111.376 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -59.54 -47.15 86.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.533 0.682 . . . . 0.0 109.183 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.85 -36.2 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.39 -1.29 . . . . 0.0 111.754 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -57.8 -43.43 85.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.55 1.523 . . . . 0.0 111.484 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.91 -34.34 69.02 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.312 0.645 . . . . 0.0 111.495 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.9 96.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.506 0.722 . . . . 0.0 112.261 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -76.08 148.45 37.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.901 1.28 . . . . 0.0 113.831 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 t -90.3 -13.92 34.26 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.643 1.977 . . . . 0.0 109.382 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -131.06 123.99 29.89 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.54 1.536 . . . . 0.0 109.111 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.74 114.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.59 168.92 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.516 1.126 . . . . 0.0 109.57 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.0 p -124.31 140.72 52.69 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.61 163.48 24.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.527 -1.358 . . . . 0.0 111.202 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 94.2 m -93.81 127.16 39.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.26 113.32 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -89.78 -47.6 7.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -141.27 166.87 23.58 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.731 0.812 . . . . 0.0 110.208 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.4 mtp -139.06 124.14 18.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.906 1.682 . . . . 0.0 106.83 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.09 146.92 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.249 1.42 . . . . 0.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -72.13 141.1 49.14 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.443 -0.786 . . . . 0.0 109.13 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -132.27 170.25 11.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.767 1.227 . . . . 0.0 109.954 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -62.1 170.32 6.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.028 3.152 . . . . 0.0 114.999 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.5 -123.33 28.96 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -113.94 19.61 16.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 108.255 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.82 171.52 55.15 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 123.37 1.539 . . . . 0.0 115.855 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.73 129.11 8.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.062 2.545 . . . . 0.0 105.264 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.03 123.82 40.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.1 123.17 47.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -95.39 123.73 39.07 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.36 169.04 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.232 1.013 . . . . 0.0 110.539 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -135.75 44.81 2.47 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt 37.8 81.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.746 3.239 . . . . 0.0 119.746 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.4 mm -79.98 -23.14 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.507 1.048 . . . . 0.0 110.305 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.05 160.26 32.58 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.68 35.46 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.632 1.173 . . . . 0.0 109.604 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -138.48 -33.1 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.307 0.643 . . . . 0.0 112.688 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -150.61 133.16 15.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -143.22 77.77 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.091 2.956 . . . . 0.0 103.496 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.61 36.4 2.64 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 125.568 1.556 . . . . 0.0 112.037 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.81 -67.2 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 126.681 2.086 . . . . 0.0 109.736 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.81 125.29 22.89 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 123.755 0.822 . . . . 0.0 108.863 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -78.54 91.28 4.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 124.628 1.205 . . . . 0.0 108.621 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.4 mt -65.84 129.63 94.33 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.64 178.17 7.73 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.45 1.433 . . . . 0.0 112.977 -175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.9 t -43.86 -58.8 4.21 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 116.902 -1.523 . . . . 0.0 109.892 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.77 122.0 9.11 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 N-CA-C 107.623 -1.722 . . . . 0.0 107.623 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -69.83 -153.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 1 C-N-CA 125.909 4.406 . . . . 0.0 110.407 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.1 m -31.57 123.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 110.54 -175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.31 39.21 0.26 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.569 1.081 . . . . 0.0 112.748 -175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.73 164.07 29.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.421 1.488 . . . . 0.0 107.216 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 p -110.38 153.29 25.16 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.874 0.761 . . . . 0.0 112.189 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.5 mt -144.31 159.89 41.94 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.097 1.359 . . . . 0.0 109.165 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -119.67 113.47 20.72 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -95.51 118.59 32.5 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -75.89 113.47 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.841 0.857 . . . . 0.0 109.451 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.73 114.82 63.55 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.35 2.2 5.93 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 113.484 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -135.07 114.14 12.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 109.074 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.93 -10.24 59.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.323 -0.861 . . . . 0.0 111.321 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -82.75 -46.46 13.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.008 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.1 m -151.94 164.17 21.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.477 1.111 . . . . 0.0 112.327 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.75 150.98 52.54 Favored 'Cis proline' 0 C--N 1.355 0.904 0 CA-C-N 120.013 1.04 . . . . 0.0 110.231 -3.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.77 97.62 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.429 2.753 . . . . 0.0 113.638 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 tpp -93.77 162.33 13.97 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.758 1.223 . . . . 0.0 108.411 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -146.77 143.4 28.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.654 1.582 . . . . 0.0 108.313 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.98 139.77 41.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.137 0.575 . . . . 0.0 110.036 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.89 71.39 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 126.386 1.946 . . . . 0.0 115.474 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.76 146.15 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.057 1.743 . . . . 0.0 108.345 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 m -91.87 128.25 37.63 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.443 0.64 . . . . 0.0 109.625 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -124.12 172.29 9.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.089 2.556 . . . . 0.0 111.457 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 123.63 46.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 100.791 -3.781 . . . . 0.0 100.791 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.18 114.03 21.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.5 mtm -116.97 113.25 22.12 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.9 -142.49 3.49 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.172 1.844 . . . . 0.0 110.878 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -132.86 176.41 8.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.617 1.209 . . . . 0.0 110.334 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.33 149.29 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.25 114.31 14.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.249 2.22 . . . . 0.0 106.546 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.82 65.62 0.23 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.285 1.834 . . . . 0.0 114.56 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 169.16 -25.84 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 130.701 3.6 . . . . 0.0 111.64 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -112.76 -6.61 13.84 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.648 1.179 . . . . 0.0 113.889 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.67 -151.01 42.35 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 135.56 22.7 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.205 1.936 . . . . 0.0 110.369 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.264 7.4 p -120.4 142.51 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.282 1.4 tm? -129.67 74.1 81.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.04 175.11 5.02 Favored 'Trans proline' 0 CA--C 1.543 0.93 1 C-N-CA 125.497 4.131 . . . . 0.0 113.347 -175.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -58.91 -28.91 88.87 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.283 1.988 . . . . 0.0 113.843 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.25 39.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.7 m -107.66 129.12 55.04 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -82.19 113.74 20.23 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.0 t -133.57 117.86 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 123.812 0.845 . . . . 0.0 109.193 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.75 168.87 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.89 1.276 . . . . 0.0 109.286 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.9 139.29 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.41 0.624 . . . . 0.0 109.415 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -65.55 144.43 56.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.996 1.318 . . . . 0.0 109.203 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -144.34 148.99 43.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.61 -40.5 29.74 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.751 1.634 . . . . 0.0 110.712 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -53.53 -46.43 70.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.801 0.84 . . . . 0.0 110.804 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.91 -40.32 87.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.512 0.725 . . . . 0.0 111.011 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.8 -47.41 82.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.16 0.891 . . . . 0.0 110.009 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -59.31 -39.65 83.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.511 1.524 . . . . 0.0 110.062 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.48 -51.83 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.441 1.019 . . . . 0.0 109.791 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 mt -63.71 -35.07 79.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.129 1.331 . . . . 0.0 109.548 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.0 m -58.67 -49.94 75.7 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.13 -41.47 83.75 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.632 -0.667 . . . . 0.0 112.171 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.84 -28.75 64.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.518 0.727 . . . . 0.0 112.369 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -73.18 -36.64 66.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.865 0.866 . . . . 0.0 108.716 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -75.32 -50.26 16.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.685 1.594 . . . . 0.0 110.37 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 . . . . . 0 CA--C 1.536 0.436 0 O-C-N 120.725 -1.234 . . . . 0.0 111.009 175.904 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.235 0.328 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.42 -42.3 96.13 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.38 -42.64 78.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.013 0.525 . . . . 0.0 112.347 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -64.95 -52.43 56.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.89 -36.46 83.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.339 -0.838 . . . . 0.0 112.092 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -60.3 -38.58 84.12 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.907 1.23 . . . . 0.0 111.236 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 m -70.15 -41.26 74.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.385 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.75 -52.89 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 112.903 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -56.17 138.24 50.3 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.325 1.05 . . . . 0.0 112.222 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -82.66 -14.12 55.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.187 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.1 tp -127.57 122.21 32.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.871 1.268 . . . . 0.0 109.592 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 t -138.2 113.74 9.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.33 171.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.683 1.593 . . . . 0.0 108.875 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.489 ' CG2' ' HD1' ' A' ' 133' ' ' HIS . 34.2 p -130.77 145.22 51.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.17 167.98 21.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.167 -0.958 . . . . 0.0 111.251 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -102.64 130.08 49.43 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.8 t -71.31 113.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -80.15 -42.99 22.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.365 1.466 . . . . 0.0 109.529 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -156.65 166.01 34.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.705 1.202 . . . . 0.0 109.219 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 59.2 mtp -133.23 129.97 38.42 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.07 148.0 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.655 0.782 . . . . 0.0 108.92 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -70.14 155.34 40.76 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.55 1.068 . . . . 0.0 110.252 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -132.24 176.1 3.18 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.811 1.644 . . . . 0.0 111.491 -175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.22 144.27 98.79 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.459 2.773 . . . . 0.0 111.862 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.23 -152.21 51.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.66 3.87 4.58 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.882 -0.776 . . . . 0.0 110.255 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.54 164.28 20.92 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-O 123.691 1.717 . . . . 0.0 116.82 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -147.81 138.14 22.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.794 2.437 . . . . 0.0 106.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.21 143.28 33.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -118.61 123.31 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.9 m -97.1 132.88 42.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.49 175.9 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.896 0.878 . . . . 0.0 112.407 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -135.98 35.17 2.84 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt 38.47 82.09 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 117.8 2.518 . . . . 0.0 117.8 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.1 mm -77.91 -25.89 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.312 1.045 . . . . 0.0 111.095 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.74 162.95 35.98 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 124.955 1.264 . . . . 0.0 110.752 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 150.11 37.02 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.582 1.953 . . . . 0.0 108.323 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -141.5 -27.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.22 1.008 . . . . 0.0 111.079 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -154.93 127.83 8.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.417 1.487 . . . . 0.0 107.317 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -136.48 74.58 1.5 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.303 3.041 . . . . 0.0 105.402 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.24 35.27 2.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.134 1.35 . . . . 0.0 110.355 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.91 -73.33 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 127.551 2.501 . . . . 0.0 110.796 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.0 mt -56.3 134.74 53.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.39 76.07 5.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.757 2.023 . . . . 0.0 108.788 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.7 138.79 97.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.106 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.52 178.15 7.97 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.815 2.343 . . . . 0.0 112.871 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.0 t -49.02 -54.9 23.87 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 117.041 -1.457 . . . . 0.0 110.88 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.16 117.12 4.85 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.72 -152.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 125.03 3.82 . . . . 0.0 111.502 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.6 m -34.06 123.9 0.48 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.856 3.262 . . . . 0.0 112.201 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.16 58.01 0.21 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.64 1.591 . . . . 0.0 109.436 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 161.5 40.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.034 2.534 . . . . 0.0 106.326 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -99.83 151.33 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.4 mt -143.9 165.2 28.38 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.468 1.507 . . . . 0.0 109.813 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -128.65 120.39 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.47 124.45 47.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.347 1.459 . . . . 0.0 107.779 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -80.31 121.21 25.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.835 1.254 . . . . 0.0 110.501 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.74 124.49 30.41 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.04 -1.22 11.17 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.568 2.179 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.5 m -150.58 175.75 11.63 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.495 2.318 . . . . 0.0 108.959 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.95 -4.39 5.72 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -79.21 -51.06 9.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.84 1.655 . . . . 0.0 109.944 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.7 m -133.35 155.37 80.86 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 127.282 2.233 . . . . 0.0 111.352 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.67 156.72 85.94 Favored 'Cis proline' 0 CA--C 1.55 1.29 0 C-N-CA 124.658 -0.976 . . . . 0.0 110.154 -2.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.49 87.23 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.535 3.49 . . . . 0.0 114.873 -175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -99.46 156.91 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.038 2.135 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -150.21 152.67 34.97 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.619 1.568 . . . . 0.0 109.331 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -77.95 136.35 37.98 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.65 43.0 30.67 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.84 0.733 . . . . 0.0 113.371 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.67 153.17 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.667 1.587 . . . . 0.0 107.77 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.2 m -98.94 130.73 45.32 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 110.538 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.99 173.24 11.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.588 1.555 . . . . 0.0 111.893 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tp -108.58 124.77 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 130.113 3.365 . . . . 0.0 102.522 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.72 113.84 24.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -115.0 113.24 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 101.221 -3.622 . . . . 0.0 101.221 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.52 -143.12 3.57 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.013 1.292 . . . . 0.0 111.249 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -133.52 176.92 8.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.118 0.967 . . . . 0.0 109.437 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.37 133.09 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.45 -0.781 . . . . 0.0 111.466 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.47 112.98 25.26 Favored 'General case' 0 C--O 1.242 0.693 1 N-CA-C 96.04 -5.541 . . . . 0.0 96.04 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.24 63.71 8.16 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.802 1.287 . . . . 0.0 109.735 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -169.59 -32.48 0.02 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.802 2.441 . . . . 0.0 109.829 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -113.54 -14.71 12.65 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.203 1.001 . . . . 0.0 111.633 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.55 -172.11 22.66 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.15 135.27 49.91 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.903 1.736 . . . . 0.0 109.351 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -114.18 134.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 1.8 tm? -125.74 78.74 68.89 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 125.221 1.408 . . . . 0.0 108.98 -174.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.23 170.77 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.742 2.961 . . . . 0.0 111.596 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -23.05 75.96 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.517 2.145 . . . . 0.0 112.528 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -83.49 24.0 0.88 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.047 0.939 . . . . 0.0 111.883 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 m -94.43 124.3 38.37 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.925 1.29 . . . . 0.0 108.034 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -77.11 113.79 15.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.5 125.79 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.7 167.85 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.382 1.473 . . . . 0.0 108.246 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.57 138.27 58.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.489 ' HD1' ' CG2' ' A' ' 52' ' ' THR . 50.2 t60 -65.39 131.42 46.39 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -141.12 147.27 46.78 Favored Pre-proline 0 N--CA 1.464 0.249 0 C-N-CA 125.69 1.596 . . . . 0.0 107.281 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.75 -37.12 29.32 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.577 2.185 . . . . 0.0 114.008 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -56.48 -52.74 63.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.818 0.735 . . . . 0.0 110.375 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -58.82 -44.48 90.88 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.542 1.137 . . . . 0.0 110.282 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.59 -45.67 88.61 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.408 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -61.46 -39.53 91.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.523 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.93 -47.79 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 119.649 1.113 . . . . 0.0 109.684 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.03 -40.34 93.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.333 1.424 . . . . 0.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.3 m -59.48 -51.22 70.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 109.0 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -65.31 -33.94 77.16 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.244 1.418 . . . . 0.0 111.018 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.44 -35.96 65.85 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.825 1.25 . . . . 0.0 110.504 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -63.41 -34.9 78.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.063 1.301 . . . . 0.0 109.168 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -74.51 -44.1 52.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.881 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 120.87 1.668 . . . . 0.0 108.104 175.039 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 p . . . . . 0 C--O 1.234 0.271 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.75 -39.14 93.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.62 -50.67 68.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.269 0.628 . . . . 0.0 111.09 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -65.15 -43.23 92.48 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -61.3 -44.75 96.7 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 116.92 -1.514 . . . . 0.0 112.364 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -53.35 -46.7 69.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.787 1.631 . . . . 0.0 110.29 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.3 m -66.04 -37.14 85.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.884 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -51.77 60.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.255 1.022 . . . . 0.0 111.379 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -61.1 147.45 43.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.776 0.83 . . . . 0.0 111.022 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -101.42 -9.49 21.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.736 0.814 . . . . 0.0 109.76 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.0 tp -127.32 119.21 25.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.169 1.788 . . . . 0.0 106.81 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.8 t -137.25 115.52 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -146.57 169.15 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.932 1.293 . . . . 0.0 109.62 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -131.24 143.59 50.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.57 163.96 16.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.903 -1.123 . . . . 0.0 111.383 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.5 m -91.19 129.98 37.12 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.81 113.22 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -84.58 -35.08 23.01 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -160.41 170.49 20.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.06 1.344 . . . . 0.0 109.315 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.5 mtp -140.6 142.03 35.09 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.392 1.877 . . . . 0.0 106.258 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -143.57 147.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.771 0.828 . . . . 0.0 108.803 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.37 150.98 48.06 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.638 1.563 . . . . 0.0 109.709 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -120.89 175.37 2.41 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 127.96 2.504 . . . . 0.0 108.557 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.85 150.31 88.71 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.741 1.628 . . . . 0.0 111.244 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.58 -148.23 50.59 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.919 0.771 . . . . 0.0 112.857 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.5 7.1 2.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 112.341 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.26 170.6 54.83 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 122.737 1.187 . . . . 0.0 114.697 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.32 136.65 18.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.806 2.042 . . . . 0.0 106.36 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.0 136.1 38.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.7 t -115.55 123.17 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -91.46 130.47 37.29 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.61 168.84 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.037 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 t -131.02 37.28 3.78 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.1 mt 38.92 81.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.07 -29.1 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.73 155.74 26.78 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 125.748 1.642 . . . . 0.0 109.076 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.08 135.1 37.19 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.899 2.08 . . . . 0.0 105.728 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -130.57 -28.36 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 124.045 0.841 . . . . 0.0 113.009 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.94 129.91 11.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -145.86 68.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.618 1.967 . . . . 0.0 108.433 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.87 39.32 2.84 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.817 1.199 . . . . 0.0 112.355 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.78 -15.82 0.02 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.431 1.491 . . . . 0.0 115.985 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.16 151.42 23.67 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 120.206 2.003 . . . . 0.0 112.232 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -104.7 64.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.757 2.023 . . . . 0.0 106.255 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.41 148.27 73.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.45 -178.57 3.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.701 1.601 . . . . 0.0 111.285 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -52.25 -58.74 10.41 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.434 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.71 147.41 63.11 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 CA-C-N 121.924 1.723 . . . . 0.0 109.028 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.36 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.083 2.522 . . . . 0.0 112.029 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.8 m -32.34 132.52 0.13 Allowed 'General case' 0 C--O 1.243 0.733 0 C-N-CA 129.303 3.041 . . . . 0.0 112.085 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.7 57.64 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.746 1.641 . . . . 0.0 110.523 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.63 164.53 36.69 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.739 2.016 . . . . 0.0 107.632 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 p -108.09 146.86 32.02 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.365 0.666 . . . . 0.0 112.415 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.1 mt -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.652 1.981 . . . . 0.0 109.856 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -130.94 115.13 16.11 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.076 2.15 . . . . 0.0 105.488 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -94.04 121.4 35.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -75.58 113.7 13.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.653 1.221 . . . . 0.0 108.986 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.79 121.41 46.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.68 -0.79 10.58 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.438 2.092 . . . . 0.0 112.762 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.6 m -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.212 1.805 . . . . 0.0 108.716 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -94.85 -17.98 21.59 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -102.06 -23.23 14.11 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.792 1.178 . . . . 0.0 113.677 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.5 m -135.03 155.51 79.07 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.104 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -69.87 169.49 63.55 Favored 'Cis proline' 0 CA--C 1.546 1.095 0 CA-C-N 119.825 0.973 . . . . 0.0 110.534 -4.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 77.04 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.866 3.044 . . . . 0.0 111.348 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.9 tpp -93.77 154.12 17.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.318 1.447 . . . . 0.0 110.53 -175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -144.5 144.39 31.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.531 0.733 . . . . 0.0 109.797 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -72.2 148.73 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.801 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.51 37.82 94.93 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.024 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.9 t -143.46 152.61 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.661 1.984 . . . . 0.0 106.771 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 m -94.59 129.03 41.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.86 0.838 . . . . 0.0 110.538 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -124.7 172.16 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.33 2.252 . . . . 0.0 111.567 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.51 125.78 52.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.829 3.651 . . . . 0.0 103.493 175.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.28 114.09 21.37 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.713 1.205 . . . . 0.0 107.884 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.4 mtm -117.53 112.91 21.23 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 102.899 -3.001 . . . . 0.0 102.899 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.68 -137.29 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.25 1.881 . . . . 0.0 109.383 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.67 175.68 9.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 108.755 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.57 144.85 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -116.31 113.19 22.61 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -78.31 63.52 3.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 109.842 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 177.59 -24.57 0.0 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.953 3.701 . . . . 0.0 112.21 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -116.33 -33.38 4.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.111 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.37 -167.37 18.81 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.687 1.613 . . . . 0.0 110.464 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.35 137.43 30.92 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.137 1.225 . . . . 0.0 109.218 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.252 14.7 p -121.31 155.96 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.277 1.0 OUTLIER -138.52 74.05 40.96 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -174.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.99 168.8 9.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 124.832 3.688 . . . . 0.0 111.836 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.37 -19.05 55.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.012 1.397 . . . . 0.0 113.429 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -85.37 23.56 1.3 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.521 1.529 . . . . 0.0 111.384 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.3 m -88.45 143.19 27.14 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.109 0.964 . . . . 0.0 110.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -92.67 115.4 28.07 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 t -136.98 125.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -151.03 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.0 109.656 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.03 142.48 58.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.428 1.091 . . . . 0.0 109.796 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -73.82 126.75 31.09 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.984 0.913 . . . . 0.0 109.059 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -139.15 156.52 72.12 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 125.106 1.362 . . . . 0.0 108.4 175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.51 -49.46 11.96 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.234 2.623 . . . . 0.0 114.867 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -58.11 -47.6 82.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.561 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -58.02 -47.02 84.3 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 125.267 1.427 . . . . 0.0 110.439 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -54.37 -51.39 64.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.458 1.503 . . . . 0.0 110.598 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -62.92 -36.24 82.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.252 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.81 -47.27 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.24 1.382 . . . . 0.0 110.183 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.04 -38.7 92.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.061 1.301 . . . . 0.0 109.368 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -44.38 97.34 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.678 -0.638 . . . . 0.0 109.665 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -59.37 -45.93 90.07 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.245 -0.909 . . . . 0.0 109.95 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 -30.43 71.56 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.551 1.141 . . . . 0.0 111.669 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -69.93 -45.77 66.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.824 0.849 . . . . 0.0 110.013 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -75.56 -35.63 60.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 118.956 -0.545 . . . . 0.0 112.131 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 . . . . . 0 N--CA 1.448 -0.537 0 C-N-CA 124.247 1.019 . . . . 0.0 109.974 175.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.238 0.472 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.09 -46.68 83.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -62.6 -48.29 80.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.624 0.769 . . . . 0.0 110.984 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -55.17 -54.61 41.13 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.951 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -62.95 -40.94 99.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.592 -1.194 . . . . 0.0 111.996 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -56.89 -44.22 82.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.9 1.227 . . . . 0.0 110.986 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.8 m -64.01 -44.51 92.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.601 0.637 . . . . 0.0 111.446 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.28 -58.93 5.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.263 1.025 . . . . 0.0 111.209 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -55.74 140.72 40.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.611 1.565 . . . . 0.0 113.094 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -93.45 -8.99 40.05 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.721 0.808 . . . . 0.0 109.467 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.8 tp -124.68 122.86 38.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 108.185 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 t -139.93 113.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.9 m -149.81 171.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.404 1.482 . . . . 0.0 109.116 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 p -133.53 141.89 47.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.03 161.35 22.56 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.955 -1.091 . . . . 0.0 112.192 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -95.83 128.04 42.37 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.39 113.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 29.3 mmmt -85.48 -41.01 15.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.048 0.939 . . . . 0.0 110.431 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -146.53 165.77 28.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 110.144 -175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.6 mtp -142.46 131.15 22.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.751 2.42 . . . . 0.0 105.265 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.69 157.33 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -67.71 150.01 49.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.211 0.604 . . . . 0.0 109.511 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -138.7 171.46 8.17 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 126.768 2.027 . . . . 0.0 109.775 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.14 163.61 22.34 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.569 2.179 . . . . 0.0 112.174 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.26 -151.2 52.25 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.2 9.05 16.17 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.48 171.59 43.59 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 126.58 2.038 . . . . 0.0 117.181 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.95 139.27 17.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.215 2.606 . . . . 0.0 105.171 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.39 124.17 44.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.8 123.17 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -98.5 124.6 43.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.31 174.72 6.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.833 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -137.45 46.05 2.16 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.032 1.287 . . . . 0.0 113.753 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.3 mt 36.14 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.3 mm -75.48 -26.83 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.874 -1.767 . . . . 0.0 109.906 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.72 163.18 36.96 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.58 148.83 41.57 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.55 -51.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -132.37 124.1 28.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -138.16 61.55 1.59 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.696 1.998 . . . . 0.0 107.519 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 28.01 3.98 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.593 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.13 6.88 0.08 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.266 1.889 . . . . 0.0 114.163 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.6 mt -114.43 142.12 46.78 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 120.243 2.022 . . . . 0.0 111.136 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.12 72.82 9.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 111.705 -2.498 . . . . 0.0 105.961 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.35 125.18 81.21 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.78 -174.89 2.21 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.287 2.658 . . . . 0.0 112.48 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -49.73 -55.46 23.12 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.937 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.88 115.31 3.9 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 N-CA-C 108.105 -1.537 . . . . 0.0 108.105 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 88' ' ' THR . 43.3 Cg_endo -74.67 -152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.945 3.763 . . . . 0.0 109.924 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.402 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 51.8 m -34.83 124.38 0.55 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.037 2.135 . . . . 0.0 109.547 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.61 -16.98 5.85 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 128.499 2.952 . . . . 0.0 111.734 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.92 154.6 31.5 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.135 1.467 . . . . 0.0 111.112 -175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 82.2 p -100.11 135.78 41.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -130.6 152.86 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.91 2.084 . . . . 0.0 109.495 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -108.17 114.06 27.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -89.74 119.82 30.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -75.74 113.52 13.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.42 114.28 63.43 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 5.21 1.73 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.619 2.879 . . . . 0.0 114.307 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.6 m -145.53 166.69 24.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.875 2.07 . . . . 0.0 109.044 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -123.57 -22.58 4.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.598 1.159 . . . . 0.0 113.307 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.12 -44.83 87.42 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.368 1.067 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.2 m -143.96 162.96 38.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.602 1.561 . . . . 0.0 109.15 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.36 157.39 68.26 Favored 'Cis proline' 0 CA--C 1.538 0.71 0 CA-C-N 119.671 0.918 . . . . 0.0 110.394 -3.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 80.38 1.14 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.236 2.624 . . . . 0.0 111.897 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.0 tpp -94.09 152.99 18.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.492 2.317 . . . . 0.0 107.943 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -137.27 143.23 42.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.96 142.28 52.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.97 62.61 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.53 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.55 155.33 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.744 1.618 . . . . 0.0 108.266 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m -97.19 131.28 44.08 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.596 0.758 . . . . 0.0 111.393 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -128.48 170.07 13.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.011 2.125 . . . . 0.0 111.594 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.73 126.51 54.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 130.395 3.478 . . . . 0.0 102.996 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.61 113.97 20.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.5 mtm -116.61 113.13 22.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.27 -139.09 2.67 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -134.49 173.04 12.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.41 148.29 30.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -116.49 112.81 21.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 174.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.44 78.68 8.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 177.22 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 130.841 3.656 . . . . 0.0 109.801 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -125.98 -32.1 2.81 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.155 1.782 . . . . 0.0 115.011 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.31 -158.13 14.5 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 139.85 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.803 1.669 . . . . 0.0 111.672 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.34 152.93 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -145.79 74.57 13.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.418 -1.426 . . . . 0.0 111.775 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.52 170.4 15.1 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.288 3.325 . . . . 0.0 111.792 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.03 -9.74 26.1 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.077 1.852 . . . . 0.0 113.727 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.28 25.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 m -105.34 137.84 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.37 2.268 . . . . 0.0 109.154 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.38 113.79 21.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.9 t -134.09 116.63 23.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.74 169.21 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.64 . . . . 0.0 108.874 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.0 mt -64.02 138.44 58.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -64.99 128.15 34.58 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -142.82 147.87 43.64 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.479 1.512 . . . . 0.0 107.767 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.38 -38.04 45.63 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.052 2.501 . . . . 0.0 113.704 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -54.56 -49.41 70.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.669 0.747 . . . . 0.0 110.487 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -66.32 -43.75 85.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.804 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.19 -52.24 46.2 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.109 1.364 . . . . 0.0 111.597 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.62 -47.67 84.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.989 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.9 -48.65 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.711 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mt -63.57 -38.08 89.76 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.969 1.259 . . . . 0.0 109.692 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.4 m -61.5 -46.72 88.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -59.31 -43.32 92.65 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.567 -0.708 . . . . 0.0 110.273 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.66 -26.42 67.79 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.326 1.05 . . . . 0.0 112.192 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 -39.44 71.15 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.281 1.032 . . . . 0.0 109.595 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -70.47 -56.61 6.18 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 . . . . . 0 N--CA 1.452 -0.329 0 C-N-CA 125.111 1.364 . . . . 0.0 108.979 -177.838 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.79 -44.44 93.34 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.081 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -61.48 -43.55 98.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.866 0.757 . . . . 0.0 111.363 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -64.41 -52.33 58.7 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -63.93 -36.03 82.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.958 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -63.65 -33.46 75.67 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.429 1.468 . . . . 0.0 111.317 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.3 -40.65 51.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.315 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -51.17 68.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.388 0.675 . . . . 0.0 110.975 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -60.38 152.73 24.61 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.205 1.402 . . . . 0.0 112.209 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -111.6 -4.02 14.89 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.88 118.47 23.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 t -137.01 113.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.86 172.0 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.186 1.395 . . . . 0.0 109.767 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 p -132.02 140.53 48.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.89 167.23 25.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.097 -1.002 . . . . 0.0 112.355 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.4 m -102.97 126.9 50.33 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 113.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 -44.77 15.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.6 m -146.54 170.9 15.95 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.367 1.067 . . . . 0.0 110.122 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.01 124.57 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.26 2.224 . . . . 0.0 105.667 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.86 148.39 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.294 1.838 . . . . 0.0 107.655 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.84 154.07 38.43 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.849 1.204 . . . . 0.0 109.388 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -138.49 176.24 2.8 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.205 1.402 . . . . 0.0 109.313 -175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.07 139.86 14.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.408 2.739 . . . . 0.0 114.493 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.46 -130.48 40.71 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.54 1.543 . . . . 0.0 110.926 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.15 6.98 26.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.159 0.984 . . . . 0.0 110.342 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.54 163.74 51.37 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 123.203 1.446 . . . . 0.0 113.16 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -153.84 131.27 11.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.398 1.879 . . . . 0.0 106.061 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.98 138.22 39.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.81 122.98 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -91.77 124.25 35.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.9 172.13 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 111.017 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -138.41 35.96 2.27 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.53 0.605 . . . . 0.0 112.191 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.268 25.1 mt 38.71 80.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.51 -20.7 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.228 1.011 . . . . 0.0 109.052 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.17 169.84 41.68 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.079 1.8 . . . . 0.0 110.891 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.38 154.35 42.2 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.199 1.399 . . . . 0.0 108.473 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.33 -41.12 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.29 1.036 . . . . 0.0 109.881 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -144.51 138.24 27.43 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.48 67.39 1.43 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.19 2.996 . . . . 0.0 106.104 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.51 4.58 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.654 2.073 . . . . 0.0 109.695 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.62 -66.4 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 127.462 2.458 . . . . 0.0 111.02 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.25 128.07 34.59 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.269 0.628 . . . . 0.0 111.885 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.29 85.67 7.18 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.1 147.73 90.05 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 121.156 -0.965 . . . . 0.0 108.54 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.28 170.07 18.08 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -46.31 -55.55 13.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.745 1.218 . . . . 0.0 111.396 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.03 138.03 39.11 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 121.086 1.424 . . . . 0.0 109.356 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.79 -154.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.561 3.507 . . . . 0.0 111.909 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -34.15 137.07 0.11 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.492 2.717 . . . . 0.0 112.499 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.2 64.52 0.43 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -175.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.23 162.89 39.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.009 2.524 . . . . 0.0 106.237 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 p -108.82 157.4 18.62 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.211 -0.931 . . . . 0.0 111.986 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -151.69 169.17 22.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.043 2.137 . . . . 0.0 109.757 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -123.22 114.09 19.8 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.71 120.14 32.8 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -73.94 121.92 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.81 1.244 . . . . 0.0 110.12 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.58 123.95 30.67 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.91 -9.56 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.293 1.995 . . . . 0.0 113.885 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -145.39 158.31 43.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.832 1.653 . . . . 0.0 109.759 -176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.24 -16.76 13.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -66.05 -50.79 62.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.776 1.171 . . . . 0.0 110.651 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -134.86 161.39 63.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.93 1.292 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.94 158.71 81.29 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 O-C-N 122.73 0.858 . . . . 0.0 111.463 -3.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.58 90.6 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.483 2.789 . . . . 0.0 110.949 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.91 138.86 39.89 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 127.061 2.144 . . . . 0.0 111.36 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -133.57 137.63 45.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.033 0.921 . . . . 0.0 110.26 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -68.12 144.49 55.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.439 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.06 24.16 69.78 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.6 t -133.94 152.24 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.094 2.157 . . . . 0.0 107.627 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -98.53 130.9 45.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.074 0.95 . . . . 0.0 109.229 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.47 169.38 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.278 2.231 . . . . 0.0 112.882 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.2 tp -115.76 124.21 50.2 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 131.071 3.748 . . . . 0.0 102.017 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.06 113.75 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.7 mtm -115.49 112.91 22.96 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 101.454 -3.536 . . . . 0.0 101.454 175.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.29 -140.89 3.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.473 1.987 . . . . 0.0 110.877 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -138.73 176.89 8.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 t -130.55 132.86 64.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -115.28 114.22 24.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.56 80.12 7.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -173.04 -34.93 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.286 2.635 . . . . 0.0 108.146 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -134.71 -10.95 2.38 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 113.655 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 109.0 -162.66 12.75 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.58 1.086 . . . . 0.0 111.919 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.29 136.83 41.59 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.046 1.83 . . . . 0.0 110.043 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.89 147.87 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.269 1.8 tm? -137.38 73.71 49.21 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -174.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.37 175.09 8.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.493 3.462 . . . . 0.0 111.701 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.6 -17.6 35.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.91 1.74 . . . . 0.0 113.694 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.46 22.37 1.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.567 1.53 . . . . 0.0 111.305 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -98.95 124.54 43.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -76.19 113.87 14.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.3 t -134.23 114.21 18.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.192 0.52 . . . . 0.0 110.168 -175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.29 169.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.972 1.309 . . . . 0.0 108.943 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.17 140.47 58.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.609 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.18 139.79 54.59 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -142.63 148.24 45.77 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 126.045 1.738 . . . . 0.0 106.775 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.3 -36.21 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.239 2.626 . . . . 0.0 111.018 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -58.63 -43.7 89.77 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.276 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -66.81 -43.85 82.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.435 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -51.45 -49.56 61.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.648 1.179 . . . . 0.0 111.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -60.79 -46.84 88.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.176 1.391 . . . . 0.0 111.208 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.3 -50.83 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.467 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.03 -33.82 76.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.489 1.04 . . . . 0.0 109.778 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.4 m -62.8 -40.4 97.25 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.784 -0.573 . . . . 0.0 109.541 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -60.78 -42.59 97.83 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.202 -0.936 . . . . 0.0 109.893 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.67 -30.38 71.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.766 0.826 . . . . 0.0 111.338 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.2 t -65.4 -46.74 78.87 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.324 0.966 . . . . 0.0 108.79 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -67.31 -49.99 61.98 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.871 -0.518 . . . . 0.0 110.414 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 mtm-85 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 123.754 0.821 . . . . 0.0 112.906 -176.014 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.05 -47.41 80.3 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -62.72 -50.07 72.55 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.364 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.4 m -65.97 -40.23 91.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.486 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -63.44 -47.04 83.55 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.142 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.4 ' CD2' HG13 ' A' ' 50' ' ' VAL . 12.1 t80 -52.17 -42.75 63.7 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.51 1.504 . . . . 0.0 110.535 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -63.22 -46.27 87.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.154 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.55 88.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.568 0.747 . . . . 0.0 112.946 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 p -76.15 131.16 39.21 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.884 1.274 . . . . 0.0 111.817 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -88.81 -6.71 57.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.706 0.803 . . . . 0.0 108.929 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.03 114.7 23.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.732 2.413 . . . . 0.0 109.134 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.4 HG13 ' CD2' ' A' ' 44' ' ' PHE . 23.4 t -139.59 113.5 6.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.14 168.52 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.19 1.396 . . . . 0.0 108.524 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.57 ' CG2' ' HD1' ' A' ' 133' ' ' HIS . 2.9 p -134.23 140.99 46.85 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.58 170.58 18.34 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.421 -0.8 . . . . 0.0 111.205 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -109.28 133.94 52.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.51 114.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.314 0.645 . . . . 0.0 109.602 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -77.72 -53.08 7.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -141.22 168.31 20.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.877 1.271 . . . . 0.0 110.739 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.73 141.58 34.89 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 128.02 2.528 . . . . 0.0 105.846 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t -141.87 146.15 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -73.59 139.4 45.51 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 120.203 -1.561 . . . . 0.0 108.921 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -117.74 169.0 8.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 125.662 1.585 . . . . 0.0 108.642 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.39 152.82 24.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.254 2.636 . . . . 0.0 115.548 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.26 -125.91 39.14 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -89.25 9.66 25.03 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.616 0.766 . . . . 0.0 111.274 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.64 171.32 49.25 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.27 139.15 18.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.468 3.107 . . . . 0.0 106.528 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.71 152.16 22.15 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.691 1.196 . . . . 0.0 108.567 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.63 123.43 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -97.67 126.6 43.08 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.36 172.7 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.194 0.998 . . . . 0.0 110.189 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -128.1 36.38 4.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.306 17.4 mt 40.16 80.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.694 2.398 . . . . 0.0 115.511 174.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.9 mm -78.02 -28.43 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 119.077 0.853 . . . . 0.0 109.815 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.1 157.43 28.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.92 138.7 35.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -132.42 -31.74 1.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.301 -175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -151.69 125.82 9.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -143.71 67.29 1.28 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.376 2.27 . . . . 0.0 109.693 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.65 46.01 3.57 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.948 1.261 . . . . 0.0 110.833 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.27 -48.97 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 126.05 1.786 . . . . 0.0 111.072 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.75 124.14 21.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 117.451 0.625 . . . . 0.0 109.336 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -78.47 64.82 3.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 129.108 2.963 . . . . 0.0 108.375 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.7 mt -57.98 123.64 65.36 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.39 -174.74 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.402 2.735 . . . . 0.0 111.55 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -49.46 -53.55 39.31 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.16 -1.4 . . . . 0.0 110.663 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.22 133.49 24.83 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 121.72 1.65 . . . . 0.0 107.965 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.51 -153.82 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.083 3.189 . . . . 0.0 110.96 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.3 m -34.87 131.28 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.584 2.754 . . . . 0.0 111.145 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.7 14.72 1.86 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 125.196 1.379 . . . . 0.0 112.573 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.37 53.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.213 1.506 . . . . 0.0 107.718 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.5 p -76.66 137.21 39.28 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.686 -0.634 . . . . 0.0 110.354 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.91 160.9 36.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.425 0.69 . . . . 0.0 111.194 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -124.17 113.63 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.699 2.0 . . . . 0.0 107.709 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -97.18 121.84 39.51 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -78.06 113.63 16.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.06 114.16 64.68 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.41 6.08 3.34 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.378 2.718 . . . . 0.0 113.119 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.0 m -135.97 151.09 49.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.411 2.284 . . . . 0.0 108.486 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -5.74 11.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.502 0.721 . . . . 0.0 109.707 175.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -71.32 -58.3 3.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.435 2.694 . . . . 0.0 109.354 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -143.91 165.99 21.56 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 129.224 3.01 . . . . 0.0 110.9 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.2 152.52 98.34 Favored 'Cis proline' 0 CA--C 1.544 0.99 0 CA-C-N 119.671 0.918 . . . . 0.0 112.489 -2.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.37 112.32 2.54 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.839 3.026 . . . . 0.0 110.741 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.4 ttp -138.18 163.45 31.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -144.57 150.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.058 0.943 . . . . 0.0 110.047 -176.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.09 146.87 52.21 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.09 33.02 84.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.743 0.687 . . . . 0.0 113.993 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.7 154.87 32.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 119.089 1.445 . . . . 0.0 107.234 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 m -103.32 131.55 50.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.733 1.213 . . . . 0.0 111.704 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.95 175.65 9.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.117 0.967 . . . . 0.0 113.518 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.5 tp -113.01 128.13 56.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 130.799 3.64 . . . . 0.0 103.774 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.13 114.28 22.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.9 mtm -117.76 113.15 21.41 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.53 -137.55 2.39 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.475 1.512 . . . . 0.0 111.005 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -132.3 176.15 8.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.544 1.172 . . . . 0.0 110.9 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.21 139.81 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 121.117 -0.989 . . . . 0.0 109.275 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -103.36 112.84 25.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.58 63.55 6.78 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -157.55 -42.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 129.393 3.077 . . . . 0.0 108.223 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -142.88 -11.53 0.77 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.67 -163.52 13.12 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.589 1.086 . . . . 0.0 111.727 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.32 141.36 51.37 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.273 1.982 . . . . 0.0 113.202 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.94 128.7 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.59 79.65 30.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.53 1.532 . . . . 0.0 110.529 -174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.13 173.63 8.18 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.659 3.573 . . . . 0.0 113.072 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.19 -22.27 73.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.013 1.809 . . . . 0.0 113.249 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -83.6 23.12 0.99 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.258 0.936 . . . . 0.0 111.12 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.5 m -95.92 134.19 39.21 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.632 1.173 . . . . 0.0 110.424 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.32 113.44 17.46 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.1 t -134.81 114.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 123.192 0.597 . . . . 0.0 110.502 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 m -147.26 169.81 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.518 1.527 . . . . 0.0 110.27 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.12 147.28 52.6 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.546 0.738 . . . . 0.0 109.831 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.57 ' HD1' ' CG2' ' A' ' 52' ' ' THR . 26.7 t60 -75.12 137.84 41.66 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -143.61 142.8 21.62 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 107.977 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.55 -38.89 65.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.913 3.075 . . . . 0.0 116.283 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -65.77 -47.68 74.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.792 0.723 . . . . 0.0 110.251 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -58.13 -45.33 87.53 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.84 -0.538 . . . . 0.0 110.013 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -49.63 -55.44 13.63 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.908 1.683 . . . . 0.0 109.632 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -58.19 -43.38 87.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.183 0.993 . . . . 0.0 111.684 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.46 -46.68 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.931 0.787 . . . . 0.0 109.4 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -37.71 85.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.486 1.039 . . . . 0.0 109.079 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 78.9 m -59.99 -38.97 84.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.311 0.96 . . . . 0.0 109.499 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -62.72 -42.73 99.8 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.41 -0.806 . . . . 0.0 110.037 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.8 mt -69.35 -23.56 63.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.683 1.193 . . . . 0.0 112.428 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.4 t -72.63 -33.31 66.54 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.01 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -76.26 -65.59 0.9 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.366 1.466 . . . . 0.0 110.273 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 124.7 1.2 . . . . 0.0 110.831 -175.912 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.6 -49.0 70.37 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -60.9 -46.28 91.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.921 0.488 . . . . 0.0 110.803 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m -62.56 -48.62 78.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.87 0.468 . . . . 0.0 110.319 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.17 -37.27 86.87 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -57.13 -40.78 77.82 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.298 1.408 . . . . 0.0 110.265 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.91 -33.76 66.18 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.513 -0.742 . . . . 0.0 111.861 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.13 66.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.164 0.986 . . . . 0.0 113.043 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -76.05 147.3 38.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 111.133 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.4 t -93.77 -11.51 31.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.299 0.64 . . . . 0.0 109.368 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.8 tp -127.26 120.08 27.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.073 1.349 . . . . 0.0 108.261 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.7 t -138.86 113.89 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -148.11 172.17 2.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.034 1.334 . . . . 0.0 109.326 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.405 ' HB ' ' HD1' ' A' ' 133' ' ' HIS . 5.9 p -130.99 143.21 50.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.87 171.64 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.224 -0.923 . . . . 0.0 111.162 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.4 m -120.69 132.49 55.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 113.68 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 26.4 mmmt -80.98 -51.62 8.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -140.16 168.02 20.78 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 41.6 mtp -137.13 123.78 21.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 100.669 -3.826 . . . . 0.0 100.669 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 t -124.07 145.45 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.52 151.5 37.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.892 0.769 . . . . 0.0 109.446 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.86 173.14 6.01 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 106.726 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.29 136.71 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.379 2.719 . . . . 0.0 115.24 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.5 -123.78 34.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.525 1.536 . . . . 0.0 111.028 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.55 1.88 15.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.931 0.892 . . . . 0.0 112.084 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.88 158.35 51.71 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 122.857 1.254 . . . . 0.0 114.449 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -150.19 137.88 19.94 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.809 2.044 . . . . 0.0 105.827 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.16 123.31 48.08 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.45 123.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.3 m -98.07 124.2 42.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.9 176.16 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.822 0.849 . . . . 0.0 110.072 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -135.34 44.01 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.293 67.4 mt 39.49 81.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.1 mm -79.07 -28.18 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 120.004 1.274 . . . . 0.0 112.6 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.22 158.62 29.06 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.51 140.05 33.4 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.68 1.192 . . . . 0.0 108.332 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -137.13 -30.88 0.84 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.519 0.728 . . . . 0.0 111.391 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -151.85 127.32 10.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.9 p -140.31 59.55 1.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.463 2.705 . . . . 0.0 107.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.92 45.99 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.853 1.216 . . . . 0.0 110.746 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.27 -43.18 0.04 OUTLIER Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.92 3.153 . . . . 0.0 111.459 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.23 128.19 34.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.107 0.956 . . . . 0.0 113.302 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -81.9 75.78 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 mt -58.71 150.23 59.12 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.114 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.58 175.27 4.46 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.114 1.209 . . . . 0.0 109.684 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -49.14 -62.29 2.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.738 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.98 153.2 37.05 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 121.186 1.459 . . . . 0.0 109.99 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.53 -155.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.815 4.343 . . . . 0.0 112.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.3 m -33.26 124.75 0.39 Allowed 'General case' 0 C--O 1.253 1.249 0 C-N-CA 130.149 3.38 . . . . 0.0 114.414 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.42 56.04 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.83 2.157 . . . . 0.0 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.58 154.48 37.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.845 1.258 . . . . 0.0 107.956 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.8 p -86.62 151.82 23.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.627 0.727 . . . . 0.0 111.405 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.3 mt -152.58 152.8 32.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.326 1.851 . . . . 0.0 108.092 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -112.94 113.22 25.18 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -84.95 119.7 25.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -77.14 113.11 14.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.7 113.38 62.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.42 -12.39 25.0 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.708 1.605 . . . . 0.0 113.834 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.5 m -141.83 119.16 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.267 1.427 . . . . 0.0 107.429 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -5.57 47.9 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.04 -1.038 . . . . 0.0 111.192 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -59.46 -58.15 9.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.74 1.216 . . . . 0.0 110.696 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.8 m -152.3 163.78 22.44 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.286 2.234 . . . . 0.0 110.032 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.8 161.7 71.42 Favored 'Cis proline' 0 CA--C 1.545 1.07 0 CA-C-N 119.779 0.957 . . . . 0.0 113.556 1.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.81 133.84 37.96 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.48 2.787 . . . . 0.0 112.206 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.3 ttm -149.65 167.16 27.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.873 0.869 . . . . 0.0 111.613 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -150.73 147.65 27.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.962 2.505 . . . . 0.0 107.386 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -69.22 149.42 48.58 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.24 41.81 99.49 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.08 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.74 149.83 25.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -94.41 136.37 34.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.372 1.069 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.08 175.79 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.763 2.025 . . . . 0.0 112.868 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.11 123.98 43.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 131.07 3.748 . . . . 0.0 101.343 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.83 115.13 22.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.365 1.466 . . . . 0.0 107.979 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 18.1 mtm -117.37 113.17 21.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.96 -139.94 2.99 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.354 1.454 . . . . 0.0 112.079 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -132.6 175.35 9.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.836 -1.391 . . . . 0.0 111.344 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.89 145.45 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -127.76 114.66 17.56 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.28 63.8 0.37 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.388 1.475 . . . . 0.0 114.874 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 170.29 -22.27 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 1 C-N-CA 132.361 4.264 . . . . 0.0 111.81 175.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.22 -4.6 13.72 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.421 1.088 . . . . 0.0 110.718 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.78 -154.75 50.34 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 124.467 1.032 . . . . 0.0 113.162 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 126.59 11.7 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.025 2.483 . . . . 0.0 110.53 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.266 2.7 p -116.78 127.99 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.56 79.52 29.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.412 1.485 . . . . 0.0 109.586 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.96 170.58 13.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.422 3.415 . . . . 0.0 112.708 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.46 -26.31 70.45 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.411 2.074 . . . . 0.0 114.033 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -86.74 23.58 1.66 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.846 1.258 . . . . 0.0 111.208 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -83.37 142.34 31.1 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 108.305 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -82.94 114.05 20.96 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -135.94 119.87 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.16 0.584 . . . . 0.0 110.151 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.3 m -144.75 167.01 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.306 1.443 . . . . 0.0 108.662 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.51 149.31 48.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 110.266 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.405 ' HD1' ' HB ' ' A' ' 52' ' ' THR . 34.1 t60 -69.25 131.5 44.98 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.915 0.886 . . . . 0.0 109.021 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -141.08 147.75 48.93 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.54 -37.85 55.72 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.539 2.826 . . . . 0.0 114.753 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -59.77 -49.23 78.52 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -58.08 -46.89 84.71 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.009 0.923 . . . . 0.0 109.433 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -51.76 -50.45 60.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 109.987 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -63.69 -42.45 97.99 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.634 -0.666 . . . . 0.0 111.847 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.64 -50.76 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.062 0.846 . . . . 0.0 109.347 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.84 -32.17 73.54 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.793 0.724 . . . . 0.0 109.368 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.47 -41.79 88.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.524 0.602 . . . . 0.0 110.121 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.18 -47.16 85.73 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 109.433 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.29 -24.23 66.52 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.491 1.116 . . . . 0.0 112.127 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -69.75 -55.99 8.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 0.0 109.858 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -72.48 -39.51 67.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.858 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 123.587 0.755 . . . . 0.0 110.426 175.123 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.04 -43.97 93.94 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.53 -48.12 80.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.581 0.628 . . . . 0.0 111.059 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.4 m -61.68 -50.61 71.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.502 0.592 . . . . 0.0 110.177 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -59.63 -44.84 93.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.853 -1.546 . . . . 0.0 110.37 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -52.5 -51.22 60.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.098 1.317 . . . . 0.0 111.042 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.4 m -64.42 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.845 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.01 -60.4 2.52 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.007 0.523 . . . . 0.0 111.703 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 p -53.17 124.68 15.13 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.879 0.871 . . . . 0.0 110.931 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -81.99 -4.84 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.383 0.992 . . . . 0.0 109.51 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.1 tp -118.33 120.84 38.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.138 2.175 . . . . 0.0 108.658 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.4 t -144.05 113.59 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -149.38 167.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.365 1.466 . . . . 0.0 108.704 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -127.01 140.61 52.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.83 168.17 27.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.787 -1.196 . . . . 0.0 111.379 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -114.87 130.85 56.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.53 113.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -71.42 -50.49 31.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 m -157.22 168.96 25.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.377 1.471 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.6 mtp -137.33 133.87 35.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.022 2.129 . . . . 0.0 108.033 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -136.66 148.02 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.901 1.28 . . . . 0.0 107.833 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -75.43 145.97 41.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.613 1.097 . . . . 0.0 109.701 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -123.27 171.08 7.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 127.102 2.161 . . . . 0.0 111.726 -175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.3 153.38 34.13 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.181 2.587 . . . . 0.0 113.361 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.89 -124.19 6.91 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.4 23.94 11.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.482 1.113 . . . . 0.0 108.46 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.52 179.57 53.08 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.836 1.798 . . . . 0.0 117.374 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -150.62 136.11 17.99 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.988 2.115 . . . . 0.0 107.037 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.69 123.59 46.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.03 123.22 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -99.78 125.22 45.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.91 174.49 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.369 0.667 . . . . 0.0 109.813 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -132.17 41.56 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt 38.24 80.58 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.242 2.217 . . . . 0.0 115.918 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -77.11 -24.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.406 0.682 . . . . 0.0 112.201 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.07 162.74 34.96 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 126.145 1.831 . . . . 0.0 109.209 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 150.2 32.23 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.535 1.134 . . . . 0.0 108.827 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -143.22 -49.6 0.33 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.139 0.899 . . . . 0.0 111.879 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -131.98 123.68 27.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -141.18 65.37 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.71 2.404 . . . . 0.0 109.253 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.07 42.46 3.15 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.871 1.7 . . . . 0.0 110.929 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.76 -66.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 125.699 1.618 . . . . 0.0 110.601 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 mt -71.04 130.49 41.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.195 0.521 . . . . 0.0 111.728 -175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -84.88 80.04 9.42 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.3 mt -58.91 139.15 87.15 Favored Pre-proline 0 C--O 1.238 0.455 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.46 174.07 12.18 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 120.971 1.114 . . . . 0.0 111.165 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 t -44.92 -59.71 3.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 116.514 -1.707 . . . . 0.0 110.004 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.78 118.59 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.963 1.775 . . . . 0.0 108.836 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.75 -152.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 124.005 3.137 . . . . 0.0 112.803 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.4 m -35.84 124.59 0.71 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.487 2.715 . . . . 0.0 113.206 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.95 30.06 0.44 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.9 1.714 . . . . 0.0 114.174 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.04 158.86 32.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.032 1.333 . . . . 0.0 108.808 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.1 p -98.54 153.68 18.46 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.193 -0.942 . . . . 0.0 112.155 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.0 mt -148.71 162.38 39.86 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.076 1.75 . . . . 0.0 109.458 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -126.11 114.04 17.86 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.906 1.682 . . . . 0.0 107.163 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -96.63 121.2 38.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.451 1.101 . . . . 0.0 110.15 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.31 113.73 18.7 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 124.155 0.909 . . . . 0.0 110.435 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.9 123.75 38.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -6.96 15.54 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.461 2.774 . . . . 0.0 115.536 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.0 m -137.42 121.03 17.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 127.708 2.403 . . . . 0.0 107.051 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.09 61.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -82.49 -30.34 29.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.028 1.285 . . . . 0.0 114.417 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -136.66 155.76 76.56 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.038 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.65 165.88 71.93 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.395 1.177 . . . . 0.0 112.064 2.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.82 104.36 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.934 2.423 . . . . 0.0 109.274 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.2 ttt -139.35 163.74 31.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.529 1.132 . . . . 0.0 109.283 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -143.56 153.89 43.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -75.49 142.08 42.95 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.73 21.98 67.62 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.055 1.312 . . . . 0.0 114.36 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.3 t -134.11 156.69 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.285 1.434 . . . . 0.0 109.485 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 132.71 40.72 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.821 1.648 . . . . 0.0 111.717 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -139.61 168.5 19.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.27 1.828 . . . . 0.0 111.712 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.6 tp -108.31 129.23 55.23 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 129.306 3.042 . . . . 0.0 102.86 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.0 114.07 22.6 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.5 mtm -119.33 113.01 20.16 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.02 -134.05 1.66 Allowed Glycine 0 CA--C 1.526 0.778 0 CA-C-N 120.112 1.323 . . . . 0.0 112.225 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -134.84 172.02 13.57 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.97 0.885 . . . . 0.0 112.015 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.8 t -133.16 140.15 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.397 -0.815 . . . . 0.0 110.337 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -121.57 115.41 22.76 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.869 2.067 . . . . 0.0 111.624 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -71.82 63.69 0.46 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.07 2.548 . . . . 0.0 112.428 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.2 t30 163.39 -22.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 1 C-N-CA 134.041 4.936 . . . . 0.0 114.084 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -113.5 -4.83 13.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.29 1.036 . . . . 0.0 113.023 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.37 -162.38 49.43 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.78 143.32 33.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 118.63 1.215 . . . . 0.0 110.675 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.22 126.83 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -120.28 78.4 26.63 Favored Pre-proline 0 C--N 1.325 -0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 109.972 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.27 164.42 28.18 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.686 2.924 . . . . 0.0 110.946 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.05 -18.06 56.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.094 1.863 . . . . 0.0 114.707 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -84.13 22.85 1.13 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.443 1.019 . . . . 0.0 110.771 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.0 m -88.7 137.43 32.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.519 1.527 . . . . 0.0 107.25 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -78.79 113.62 17.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.76 116.67 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.23 170.21 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.924 1.29 . . . . 0.0 109.615 -175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.08 132.16 49.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.15 0.98 . . . . 0.0 108.825 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 138.19 57.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -133.8 160.02 70.18 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.488 1.915 . . . . 0.0 107.035 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.02 -42.92 2.74 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.928 2.419 . . . . 0.0 110.415 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -58.53 -41.58 85.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.61 0.764 . . . . 0.0 111.252 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.21 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -57.24 -50.01 74.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.284 1.033 . . . . 0.0 110.294 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.3 -34.83 78.54 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.972 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.87 -47.61 75.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.511 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -61.39 -39.06 89.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.501 1.501 . . . . 0.0 108.973 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.5 m -61.09 -47.03 88.2 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -57.33 -46.38 83.31 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.875 0.87 . . . . 0.0 109.466 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.57 -33.78 76.35 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.071 0.948 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -69.38 -49.39 55.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -68.61 -36.6 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.82 0.848 . . . . 0.0 111.564 -175.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 . . . . . 0 C--O 1.234 0.274 0 C-N-CA 127.278 2.231 . . . . 0.0 110.355 175.237 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 C--O 1.235 0.301 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.82 -41.35 97.89 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.41 -43.97 88.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.01 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -66.48 -51.15 59.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.846 0.748 . . . . 0.0 111.033 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -52.34 -44.66 65.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.609 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -52.41 -42.34 63.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.491 0.716 . . . . 0.0 112.704 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.1 m -75.82 -33.81 60.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -38.68 86.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.181 0.9 . . . . 0.0 111.713 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -68.36 130.58 43.31 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.454 0.701 . . . . 0.0 111.066 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -81.95 -8.14 59.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.865 0.866 . . . . 0.0 109.99 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.93 123.37 24.54 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.971 1.708 . . . . 0.0 107.998 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.41 116.97 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.6 169.49 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 110.103 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -128.84 137.65 51.6 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.75 171.01 18.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.834 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -117.59 126.28 52.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.18 113.55 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -80.82 -52.48 7.45 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.472 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 9.6 m -145.11 171.42 14.53 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 125.418 1.487 . . . . 0.0 109.795 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.6 mtp -133.76 134.8 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.79 143.82 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -70.92 137.0 48.89 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.515 -1.365 . . . . 0.0 108.234 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -114.71 168.84 7.41 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.8 1.64 . . . . 0.0 108.86 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.37 161.52 20.01 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.331 2.02 . . . . 0.0 112.273 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -145.01 49.19 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.731 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -88.73 14.2 10.69 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.554 -0.968 . . . . 0.0 110.619 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.19 177.22 53.05 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.106 1.336 . . . . 0.0 115.588 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.76 140.19 19.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.73 2.812 . . . . 0.0 106.17 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.83 145.02 29.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.23 123.25 71.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -101.63 129.86 47.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.22 176.36 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.883 0.873 . . . . 0.0 111.48 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -131.36 39.52 3.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.912 1.285 . . . . 0.0 112.185 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt 36.42 81.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.281 2.232 . . . . 0.0 115.553 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.4 mm -74.52 -32.48 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.504 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.13 161.96 31.92 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.023 1.296 . . . . 0.0 110.242 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.49 152.74 40.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.67 1.588 . . . . 0.0 108.053 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -139.79 -24.42 0.84 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.643 0.589 . . . . 0.0 112.379 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -157.99 138.86 13.11 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.826 2.05 . . . . 0.0 106.117 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -146.85 72.38 1.27 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.214 3.006 . . . . 0.0 105.74 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 50.07 4.34 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 126.618 2.056 . . . . 0.0 109.353 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.19 -70.74 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 126.088 1.804 . . . . 0.0 113.302 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.5 131.73 51.66 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.275 1.03 . . . . 0.0 111.425 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -82.27 89.18 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.32 139.79 96.46 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.24 -175.87 1.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.529 2.153 . . . . 0.0 112.07 -175.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 t -42.83 -58.8 3.51 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.853 1.661 . . . . 0.0 109.215 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.07 147.56 21.04 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 N-CA-C 107.095 -1.925 . . . . 0.0 107.095 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 88' ' ' THR . 95.2 Cg_endo -69.75 -154.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 1 C-N-CA 126.141 4.561 . . . . 0.0 111.665 175.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.4 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 4.4 m -34.01 139.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.953 2.501 . . . . 0.0 113.311 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.52 -1.27 3.98 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.088 2.28 . . . . 0.0 114.496 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.32 148.55 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.351 1.576 . . . . 0.0 108.579 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 p -77.29 149.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.184 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -147.34 161.03 41.83 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.94 0.896 . . . . 0.0 110.034 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -127.42 116.93 21.21 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.93 124.59 42.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.231 1.012 . . . . 0.0 109.499 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -74.06 114.02 11.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.733 1.213 . . . . 0.0 109.775 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.09 115.61 58.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.43 1.24 6.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 95.1 m -132.02 113.63 13.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.744 1.217 . . . . 0.0 109.204 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.98 -12.5 59.37 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.734 -0.604 . . . . 0.0 112.287 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.55 -35.83 24.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 113.753 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -157.16 163.04 26.34 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.564 1.946 . . . . 0.0 110.003 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.37 153.31 81.91 Favored 'Cis proline' 0 CA--C 1.541 0.871 0 O-C-N 122.626 0.803 . . . . 0.0 111.29 -3.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.7 122.47 8.58 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.229 2.619 . . . . 0.0 111.808 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.1 ttp -145.8 160.51 41.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.409 1.883 . . . . 0.0 108.685 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -134.48 145.42 48.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 85.5 tttt -64.02 142.71 58.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.17 35.33 77.4 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.044 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.8 t -140.83 159.3 23.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.926 2.09 . . . . 0.0 107.5 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -101.43 133.65 45.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.38 1.072 . . . . 0.0 111.502 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -137.21 165.4 26.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.629 1.572 . . . . 0.0 111.303 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 124.63 51.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 129.942 3.297 . . . . 0.0 103.522 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.17 119.55 32.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.836 1.654 . . . . 0.0 107.524 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.0 mtm -120.68 113.25 19.94 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.14 -137.7 2.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.109 1.814 . . . . 0.0 111.525 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -136.63 176.49 8.65 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.172 1.389 . . . . 0.0 108.689 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.3 132.01 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.14 113.84 27.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -80.07 63.56 4.62 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.52 -42.47 0.05 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 128.484 2.714 . . . . 0.0 110.452 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -126.24 -4.32 6.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.25 1.02 . . . . 0.0 113.118 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.59 -151.77 18.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.77 137.31 29.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.821 1.681 . . . . 0.0 110.013 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.99 153.06 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.54 80.18 39.26 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -62.15 171.0 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.997 3.798 . . . . 0.0 113.624 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.55 -19.11 64.76 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.756 1.637 . . . . 0.0 113.195 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.6 23.19 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.117 1.367 . . . . 0.0 112.942 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 129.69 35.08 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.821 -0.549 . . . . 0.0 110.135 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -80.57 115.48 20.1 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.5 117.49 35.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 123.735 0.814 . . . . 0.0 109.194 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.8 m -145.49 167.34 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 109.52 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.79 136.54 57.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.444 0.698 . . . . 0.0 110.7 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -67.25 144.35 55.98 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.233 0.613 . . . . 0.0 109.898 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 150.3 29.88 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 127.585 2.354 . . . . 0.0 107.481 175.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.84 -34.26 31.1 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.593 2.195 . . . . 0.0 111.401 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -61.58 -43.09 99.5 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.023 -0.423 . . . . 0.0 111.087 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.32 -41.91 76.05 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.415 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -48.15 -55.93 9.13 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.749 1.22 . . . . 0.0 109.911 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -55.41 -44.11 75.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.687 1.595 . . . . 0.0 111.905 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.54 -49.21 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.004 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.22 -41.03 99.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.012 0.824 . . . . 0.0 108.977 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -59.43 -43.57 93.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.921 0.888 . . . . 0.0 110.639 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.25 -40.54 86.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.81 -33.37 75.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.742 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -66.11 -35.7 81.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.519 1.128 . . . . 0.0 111.028 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -75.88 -40.65 54.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 120.855 -1.153 . . . . 0.0 109.344 175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 . . . . . 0 N--CA 1.445 -0.694 0 CA-C-O 122.605 1.193 . . . . 0.0 109.024 175.4 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -86.93 53.78 2.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.124 1.883 . . . . 0.0 110.007 -169.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.37 33.09 2.08 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 127.891 2.476 . . . . 0.0 111.811 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.34 113.95 64.05 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -79.6 -167.15 0.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.917 3.078 . . . . 0.0 111.117 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.6 m -49.66 160.28 0.3 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.66 1.984 . . . . 0.0 107.166 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.9 t -83.73 121.81 76.28 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 120.056 -1.653 . . . . 0.0 108.663 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.18 171.25 18.38 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 123.719 2.946 . . . . 0.0 110.295 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.12 -18.02 58.23 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.495 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -55.06 129.08 36.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.041 0.937 . . . . 0.0 110.174 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.94 62.19 1.6 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -158.01 161.18 38.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.818 0.847 . . . . 0.0 111.706 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -116.1 156.15 26.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.615 2.366 . . . . 0.0 110.266 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -142.56 175.81 9.51 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.002 2.521 . . . . 0.0 110.663 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.03 -178.88 25.12 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.901 1.715 . . . . 0.0 115.025 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.7 p -92.19 174.47 7.29 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.73 -0.865 . . . . 0.0 110.502 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.33 -47.24 74.14 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.129 -0.938 . . . . 0.0 108.996 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -61.67 -48.11 82.29 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.322 0.965 . . . . 0.0 111.169 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -49.86 -56.75 9.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.719 0.808 . . . . 0.0 110.481 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -68.66 -40.48 80.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.789 -1.577 . . . . 0.0 111.898 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -54.61 -46.4 73.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.435 1.47 . . . . 0.0 110.617 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.7 m -71.88 -24.27 61.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.834 0.854 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.39 18.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -62.93 132.43 52.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 111.993 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -82.93 -8.16 59.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.523 0.729 . . . . 0.0 110.657 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.3 tp -134.83 124.48 25.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.457 1.503 . . . . 0.0 108.122 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.3 t -137.83 115.36 12.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.91 172.2 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.218 1.407 . . . . 0.0 110.303 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -129.24 139.93 51.65 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.88 175.33 13.71 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.746 -1.221 . . . . 0.0 110.918 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.7 m -121.79 134.55 54.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -77.13 114.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -77.48 -54.89 5.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 m -142.61 171.46 14.03 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.72 0.808 . . . . 0.0 110.677 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.2 mtp -138.05 133.15 33.18 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.639 1.976 . . . . 0.0 105.845 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.86 140.84 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.812 1.245 . . . . 0.0 107.798 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -70.24 151.68 45.07 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.393 0.997 . . . . 0.0 110.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -134.77 175.11 3.89 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.854 1.661 . . . . 0.0 108.173 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.62 160.18 18.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.299 3.333 . . . . 0.0 114.095 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 -141.89 43.53 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.66 17.3 3.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.895 0.878 . . . . 0.0 110.313 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.88 166.6 48.94 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-O 123.224 1.458 . . . . 0.0 115.143 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.35 139.83 16.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 106.195 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.04 145.95 31.74 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.04 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -89.84 133.37 34.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.81 173.37 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.082 0.953 . . . . 0.0 111.104 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -132.96 38.01 3.39 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.17 0.988 . . . . 0.0 112.965 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.7 mt 37.49 81.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.297 1.839 . . . . 0.0 115.061 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.04 -33.07 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.981 0.809 . . . . 0.0 110.911 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.84 161.87 33.12 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.028 1.299 . . . . 0.0 110.627 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.24 146.01 31.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.184 1.394 . . . . 0.0 109.513 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -131.02 -41.32 1.13 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.873 0.869 . . . . 0.0 110.991 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -140.3 123.79 17.05 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.42 59.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.077 2.151 . . . . 0.0 107.568 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.04 35.8 2.74 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 124.456 1.027 . . . . 0.0 113.702 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -10.65 0.04 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.511 2.005 . . . . 0.0 114.669 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.17 129.06 47.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.554 1.677 . . . . 0.0 110.515 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.84 67.86 10.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.26 152.54 41.81 Favored Pre-proline 0 CA--C 1.537 0.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.589 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.84 172.1 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.215 1.943 . . . . 0.0 111.523 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t -52.09 -60.12 6.87 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 117.637 -1.173 . . . . 0.0 109.307 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.88 139.6 40.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 N-CA-C 107.164 -1.898 . . . . 0.0 107.164 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.62 -157.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.89 2.393 . . . . 0.0 112.293 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.4 m -34.74 133.63 0.26 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 130.703 3.601 . . . . 0.0 112.42 -176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.47 34.58 0.28 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.776 1.655 . . . . 0.0 110.225 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.79 166.69 20.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.7 2.0 . . . . 0.0 108.572 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.5 p -103.3 149.62 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.003 0.906 . . . . 0.0 112.014 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.3 mt -145.07 170.83 15.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.758 1.223 . . . . 0.0 109.004 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -127.2 115.12 18.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -89.49 120.19 30.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.56 113.64 15.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.54 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.0 113.47 62.51 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.67 -1.31 11.41 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.124 1.883 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.0 m -134.12 113.59 12.23 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 110.083 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -75.54 -5.76 46.87 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.006 -1.059 . . . . 0.0 113.806 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -78.6 -53.27 7.36 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.378 0.671 . . . . 0.0 110.606 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.6 m -154.46 165.5 17.92 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 127.006 2.122 . . . . 0.0 110.282 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -64.66 151.93 74.95 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 119.625 0.902 . . . . 0.0 110.178 -3.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.23 138.79 44.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.405 2.07 . . . . 0.0 111.764 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 ttm -149.43 170.92 17.47 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.918 -1.114 . . . . 0.0 111.444 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.76 138.27 54.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.46 34.65 63.44 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.608 -1.106 . . . . 0.0 113.736 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.07 160.51 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.723 1.761 . . . . 0.0 107.963 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -99.61 136.38 39.62 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 125.354 1.461 . . . . 0.0 110.417 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -139.51 168.05 20.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.304 1.442 . . . . 0.0 112.615 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.94 123.62 50.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.9 113.98 21.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.0 mtm -117.66 113.21 21.57 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.97 -140.19 3.09 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 126.123 1.821 . . . . 0.0 109.687 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -135.38 175.28 9.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.289 1.045 . . . . 0.0 109.548 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -118.89 159.16 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -129.84 112.93 14.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.43 63.64 8.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -177.4 -32.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.202 2.601 . . . . 0.0 110.851 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -127.51 -9.69 5.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.91 -152.83 19.97 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.55 144.05 19.65 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.607 2.204 . . . . 0.0 111.708 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.27 8.5 p -126.7 149.76 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.257 1.6 tm? -137.53 75.23 45.08 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.22 -0.925 . . . . 0.0 108.827 -174.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.9 170.93 9.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.539 3.493 . . . . 0.0 112.91 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.71 -20.15 67.91 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.864 1.709 . . . . 0.0 114.079 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.65 22.99 1.01 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.718 1.207 . . . . 0.0 111.417 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.1 m -91.62 137.24 32.52 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.301 -1.499 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -86.85 114.39 23.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -127.64 126.7 67.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.65 0.738 . . . . 0.0 109.331 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -146.1 163.25 10.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.573 1.949 . . . . 0.0 107.018 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.03 149.33 47.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 123.99 24.47 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -119.99 155.34 55.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-O 117.073 -1.441 . . . . 0.0 107.88 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.07 -42.47 6.01 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.982 2.455 . . . . 0.0 110.452 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -55.05 -53.09 60.21 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 122.957 0.503 . . . . 0.0 110.669 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.85 -44.4 82.12 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.531 0.732 . . . . 0.0 110.612 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -56.52 -53.28 59.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.56 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -59.73 -36.45 76.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.31 1.044 . . . . 0.0 111.523 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.7 mt -65.33 -60.45 2.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 124.478 1.111 . . . . 0.0 108.766 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.81 -34.98 72.11 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.149 1.341 . . . . 0.0 110.949 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.53 -49.58 76.96 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -63.32 -31.58 72.77 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.606 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.1 mt -68.66 -31.38 70.47 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.295 0.952 . . . . 0.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 t -76.7 -34.57 58.17 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.421 0.555 . . . . 0.0 109.67 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -67.07 -58.79 4.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -72.92 159.48 33.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.702 0.801 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -76.88 154.0 34.19 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.2 m -62.59 124.98 85.1 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.405 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.12 93.17 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 119.754 0.948 . . . . 0.0 109.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.1 m -166.4 85.42 0.3 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -123.7 113.06 28.87 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -112.59 -176.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.826 3.017 . . . . 0.0 110.362 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.249 1.061 0 C-N-CA 125.74 1.616 . . . . 0.0 106.924 176.014 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.87 160.74 47.07 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.907 1.738 . . . . 0.0 110.786 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -88.76 62.19 6.32 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.633 1.173 . . . . 0.0 110.78 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.79 134.68 56.73 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 177.5 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.187 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -54.82 148.12 13.69 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.95 1.3 . . . . 0.0 110.348 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -83.64 108.15 12.54 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 127.847 2.459 . . . . 0.0 107.032 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -79.03 171.66 16.07 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.373 2.715 . . . . 0.0 110.673 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -73.75 -22.62 59.8 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 152.74 30.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.019 1.728 . . . . 0.0 109.175 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 t -137.05 102.88 4.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.927 0.891 . . . . 0.0 110.36 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -133.63 166.22 23.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.496 1.519 . . . . 0.0 109.022 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -123.07 146.4 47.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.282 1.833 . . . . 0.0 106.942 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -138.24 172.42 12.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 111.087 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.73 -160.41 47.66 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.953 1.263 . . . . 0.0 113.706 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 p -125.47 171.19 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.71 -44.17 94.42 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.593 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -62.55 -49.22 76.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.278 0.944 . . . . 0.0 111.628 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -56.12 -46.62 79.09 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.428 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -73.8 -44.06 56.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.237 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.415 ' CD2' HG12 ' A' ' 50' ' ' VAL . 7.6 t80 -54.72 -44.29 73.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.843 1.656 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.7 -23.93 61.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.417 -0.802 . . . . 0.0 113.032 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -46.4 28.68 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 110.406 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.5 p -69.14 132.32 46.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.665 1.186 . . . . 0.0 111.181 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -81.32 -12.85 58.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.477 1.035 . . . . 0.0 109.361 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.5 tp -122.75 125.11 44.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.605 1.562 . . . . 0.0 109.93 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.415 HG12 ' CD2' ' A' ' 44' ' ' PHE . 42.2 t -141.01 114.03 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.2 166.76 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.575 1.55 . . . . 0.0 109.222 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 p -124.05 148.91 46.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 175.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.09 171.21 20.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.766 -1.209 . . . . 0.0 110.906 -176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.3 m -124.03 128.08 48.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.41 113.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 20.9 mmmt -84.21 -38.17 20.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.271 1.028 . . . . 0.0 110.042 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 m -151.25 165.86 32.67 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 121.227 -0.921 . . . . 0.0 110.138 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.8 mtp -143.75 124.67 14.31 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.52 146.1 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.56 152.31 44.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.486 -0.759 . . . . 0.0 109.889 -176.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -134.29 169.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.865 2.066 . . . . 0.0 109.481 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -38.59 134.06 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 125.084 3.856 . . . . 0.0 117.492 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.23 -123.61 33.5 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.814 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -88.72 22.55 2.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.364 1.465 . . . . 0.0 110.18 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.44 166.28 45.53 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.676 -1.265 . . . . 0.0 113.997 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -151.86 138.52 18.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.489 1.516 . . . . 0.0 108.349 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.54 128.89 55.52 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.45 123.28 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -93.43 125.14 37.88 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 m -122.89 174.17 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.432 1.493 . . . . 0.0 111.169 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 t -135.25 40.38 2.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.626 0.648 . . . . 0.0 109.91 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.4 mt 38.11 77.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.571 2.748 . . . . 0.0 114.19 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.7 mm -75.54 -23.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.802 1.637 . . . . 0.0 111.133 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.81 159.06 32.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.76 141.33 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.195 0.998 . . . . 0.0 108.527 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -135.31 -33.36 0.9 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.258 0.623 . . . . 0.0 110.823 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -148.99 125.06 10.7 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.26 58.68 1.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.512 2.325 . . . . 0.0 107.782 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.64 36.19 2.82 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.276 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.04 -25.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 116.707 -2.163 . . . . 0.0 116.483 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.5 mt -116.39 155.09 29.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 121.101 2.451 . . . . 0.0 112.555 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.69 94.39 5.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 128.399 2.679 . . . . 0.0 109.047 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.14 131.57 95.04 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.72 -178.69 4.25 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 121.942 1.762 . . . . 0.0 111.103 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 t -53.58 -58.92 10.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.203 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.59 116.02 3.7 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.596 2.197 . . . . 0.0 110.805 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -78.14 -152.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.236 2.624 . . . . 0.0 110.677 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 24.1 m -33.17 123.76 0.39 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 130.625 3.57 . . . . 0.0 111.771 -175.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.16 -16.71 6.33 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.394 2.426 . . . . 0.0 110.986 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.79 150.82 40.82 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.312 1.056 . . . . 0.0 111.363 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -86.01 145.51 27.07 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.4 mt -146.92 164.24 33.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 109.37 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -117.66 113.42 21.87 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.24 119.15 29.47 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -79.76 114.08 18.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.06 1.344 . . . . 0.0 109.94 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.14 114.24 59.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.83 -4.43 14.06 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.108 1.872 . . . . 0.0 113.225 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.7 m -138.17 113.63 9.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.087 1.755 . . . . 0.0 108.823 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -74.29 -7.49 52.98 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.257 -0.902 . . . . 0.0 112.787 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.98 -57.14 3.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.43 1.892 . . . . 0.0 108.97 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.4 m -152.59 160.49 31.11 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.044 1.338 . . . . 0.0 111.829 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.06 161.12 70.29 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.0 1.036 . . . . 0.0 111.887 3.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.42 139.76 91.09 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.163 2.575 . . . . 0.0 112.502 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -153.0 150.95 29.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.864 0.866 . . . . 0.0 110.157 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -144.37 150.8 38.34 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 109.872 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 56' ' ' LYS . 88.4 tttt -79.09 138.68 38.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.31 44.11 76.18 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.2 t -142.6 156.05 18.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 m -102.93 128.64 49.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.589 0.756 . . . . 0.0 110.393 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -126.46 171.3 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.383 1.873 . . . . 0.0 112.314 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.49 123.64 43.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 175.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.36 114.0 22.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 mtm -116.83 113.14 22.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.88 -142.71 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.606 1.098 . . . . 0.0 110.675 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.4 -178.87 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.971 0.891 . . . . 0.0 109.42 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.99 147.2 28.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -125.55 113.65 17.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -79.13 63.55 3.81 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -177.34 -26.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.386 1.875 . . . . 0.0 111.616 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 -7.37 3.17 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.706 0.802 . . . . 0.0 112.978 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.54 -164.19 20.96 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.724 0.693 . . . . 0.0 111.447 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.81 133.9 24.62 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.444 2.096 . . . . 0.0 109.8 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.265 2.9 p -118.83 134.76 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.96 76.11 21.84 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 0.0 109.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.72 172.8 8.92 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.922 3.748 . . . . 0.0 112.69 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -63.86 -34.36 60.97 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.68 2.253 . . . . 0.0 114.632 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.79 23.89 1.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.293 0.951 . . . . 0.0 111.59 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.3 m -85.11 146.93 26.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.469 1.507 . . . . 0.0 109.968 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -91.23 113.74 26.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.2 t -132.18 113.9 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.84 165.58 9.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.373 0.669 . . . . 0.0 109.272 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.04 147.75 52.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.7 149.62 49.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.067 0.947 . . . . 0.0 108.766 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -149.98 152.55 34.31 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 127.961 2.504 . . . . 0.0 105.234 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.01 -35.95 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.009 2.473 . . . . 0.0 112.434 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -61.72 -49.44 76.43 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.773 -0.579 . . . . 0.0 110.176 176.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -54.97 -54.27 44.94 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -44.9 -55.0 5.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.913 2.085 . . . . 0.0 111.8 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -56.24 -43.7 78.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.506 0.722 . . . . 0.0 111.708 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.9 mt -66.34 -40.11 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.709 -0.662 . . . . 0.0 109.479 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.5 mt -58.82 -43.26 90.58 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.7 m -62.08 -41.84 98.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.494 0.718 . . . . 0.0 111.031 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -57.56 -43.41 84.47 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.879 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 mt -76.21 -24.15 54.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.039 1.736 . . . . 0.0 112.819 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -74.24 -35.46 63.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.383 1.473 . . . . 0.0 109.645 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.53 -65.77 0.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.056 0.942 . . . . 0.0 109.1 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -66.22 151.42 47.03 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.415 0.552 . . . . 0.0 110.636 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -72.78 144.4 47.58 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.969 0.508 . . . . 0.0 110.102 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.03 124.69 88.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.49 121.43 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.548 1.499 . . . . 0.0 109.264 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -128.63 65.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.238 1.415 . . . . 0.0 107.194 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -140.17 123.11 10.17 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 121.16 7.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.066 1.844 . . . . 0.0 111.125 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 130.411 3.485 . . . . 0.0 102.367 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 27' ' ' ALA . 73.3 Cg_endo -72.82 165.9 31.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 -155.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -74.64 33.57 0.09 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.671 2.788 . . . . 0.0 112.86 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 25' ' ' PRO . . . -47.65 113.65 2.73 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 127.682 2.393 . . . . 0.0 111.246 -176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.84 74.33 5.56 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.267 3.311 . . . . 0.0 108.495 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -142.7 166.34 24.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.315 1.846 . . . . 0.0 109.022 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.46 109.01 2.03 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.023 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.38 164.0 29.3 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.096 1.864 . . . . 0.0 107.676 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.1 -18.97 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.185 -0.947 . . . . 0.0 112.344 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -48.84 128.34 15.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.643 1.177 . . . . 0.0 110.091 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.9 t -148.25 88.41 1.65 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.14 0.971 . . . . 0.0 108.571 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 164.0 37.62 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -103.8 123.36 46.94 Favored 'General case' 0 C--O 1.235 0.294 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -156.36 176.11 13.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.5 1.045 . . . . 0.0 108.456 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.8 -171.11 17.74 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 122.793 1.218 . . . . 0.0 113.419 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -101.32 164.95 11.53 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.123 2.169 . . . . 0.0 109.03 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -94.24 -54.96 3.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -65.0 -43.17 93.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.288 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -70.63 -47.89 57.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.093 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.94 -36.37 83.21 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.401 -1.285 . . . . 0.0 109.635 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -57.29 -43.69 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.897 1.226 . . . . 0.0 110.69 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.3 m -74.38 -23.58 59.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.52 -34.34 63.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.996 1.271 . . . . 0.0 111.527 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.8 p -76.52 126.69 31.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 t -79.69 -11.71 59.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.922 0.867 . . . . 0.0 108.814 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.3 tp -120.75 114.84 22.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.163 2.185 . . . . 0.0 108.978 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.88 112.89 7.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.62 167.06 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.908 1.683 . . . . 0.0 108.332 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.6 p -131.18 142.54 50.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.96 172.09 15.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.531 -0.731 . . . . 0.0 111.274 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.1 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.67 113.57 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -84.35 -53.77 5.24 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.35 1.06 . . . . 0.0 108.479 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m -140.23 169.09 18.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.167 1.387 . . . . 0.0 109.363 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.94 132.32 38.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 144.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.08 141.91 47.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 47.3 mm-40 -123.64 176.05 2.44 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 128.045 2.538 . . . . 0.0 109.365 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 61' ' ' GLU . 41.4 Cg_endo -60.94 150.53 83.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.681 2.254 . . . . 0.0 112.765 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.91 -123.95 29.53 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.99 23.75 14.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.463 1.105 . . . . 0.0 109.931 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.79 166.73 46.32 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 122.816 1.231 . . . . 0.0 111.874 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -150.38 131.27 14.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.4 137.63 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.5 t -108.38 123.46 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -97.66 126.41 42.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -131.49 176.67 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.168 1.387 . . . . 0.0 111.823 -175.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -135.1 39.21 2.95 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.0 mt 36.07 83.16 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.56 -30.01 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 121.158 -0.964 . . . . 0.0 111.4 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.77 160.73 31.32 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.174 1.368 . . . . 0.0 109.761 176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.84 143.31 26.21 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.299 1.04 . . . . 0.0 108.87 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -126.87 -49.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.59 1.156 . . . . 0.0 108.616 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -142.07 142.06 32.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 107.97 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 p -146.91 72.04 1.25 Allowed 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.298 2.639 . . . . 0.0 105.799 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 38.61 2.77 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 124.263 0.935 . . . . 0.0 112.881 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.63 -11.42 0.03 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.799 2.143 . . . . 0.0 112.91 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -116.35 123.17 46.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 120.623 2.211 . . . . 0.0 108.865 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -80.22 75.34 7.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.845 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -50.58 138.34 22.46 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.47 177.19 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.117 1.878 . . . . 0.0 111.636 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 t -48.74 -55.73 18.45 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.096 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.88 137.55 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.56 1.506 . . . . 0.0 108.634 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.18 -154.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.437 3.425 . . . . 0.0 112.068 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.8 m -33.06 123.9 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.828 3.251 . . . . 0.0 111.415 176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.3 0.49 1.18 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.01 1.767 . . . . 0.0 113.75 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.94 150.07 21.21 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.396 1.598 . . . . 0.0 110.025 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -87.9 142.15 28.02 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.193 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -145.33 161.04 40.58 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.426 1.091 . . . . 0.0 109.85 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -116.39 125.12 51.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.212 2.205 . . . . 0.0 106.937 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.45 123.37 47.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.721 1.609 . . . . 0.0 110.132 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -78.09 114.55 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.743 1.617 . . . . 0.0 111.56 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.92 114.43 61.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -69.97 -9.16 25.38 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.707 2.272 . . . . 0.0 115.555 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 m -148.46 130.79 15.61 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.217 1.407 . . . . 0.0 108.513 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -73.55 -3.94 30.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.843 1.424 . . . . 0.0 114.843 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -73.05 -51.22 18.94 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.091 . . . . 0.0 113.181 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.2 m -140.02 164.39 37.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.833 1.653 . . . . 0.0 111.942 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.03 163.5 76.18 Favored 'Cis proline' 0 CA--C 1.546 1.098 0 CA-C-N 119.381 0.815 . . . . 0.0 111.831 -2.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.27 86.95 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.983 3.122 . . . . 0.0 113.85 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 ttp -114.3 162.83 16.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.44 1.896 . . . . 0.0 109.44 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -146.19 158.24 43.87 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.258 1.023 . . . . 0.0 110.69 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -70.74 139.11 51.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.283 1.433 . . . . 0.0 110.787 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.31 35.45 91.53 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.489 1.042 . . . . 0.0 115.058 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.54 152.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 108.531 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.9 m -96.38 134.66 39.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.95 0.881 . . . . 0.0 110.427 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -139.48 167.69 21.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.155 1.782 . . . . 0.0 112.759 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.9 tp -103.91 132.24 50.35 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 175.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.39 113.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.452 ' HE2' ' CD1' ' A' ' 129' ' ' PHE . 8.6 mtm -117.49 115.78 25.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.04 -143.7 3.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.048 1.308 . . . . 0.0 110.717 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -130.02 178.65 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.253 1.026 . . . . 0.0 108.943 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.8 t -136.1 141.93 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 120.786 -1.196 . . . . 0.0 108.304 175.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -108.22 113.08 25.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -83.06 63.58 7.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -170.01 -40.36 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.956 2.903 . . . . 0.0 109.209 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -126.18 -5.88 6.64 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.74 -164.7 15.33 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.22 137.34 51.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.038 1.419 . . . . 0.0 109.454 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.39 124.68 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 2.2 tm? -114.89 78.98 5.64 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.92 171.26 11.4 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.204 3.27 . . . . 0.0 112.246 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.85 -23.94 76.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.106 1.871 . . . . 0.0 113.126 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.06 23.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.97 1.259 . . . . 0.0 111.46 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.4 m -84.4 128.57 34.66 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.602 -1.311 . . . . 0.0 108.972 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.452 ' CD1' ' HE2' ' A' ' 113' ' ' MET . 40.2 t80 -80.04 113.51 18.26 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.58 116.55 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.96 174.5 7.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.719 0.808 . . . . 0.0 111.01 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.34 123.78 20.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.624 1.57 . . . . 0.0 109.14 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -75.99 142.46 41.91 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.706 -0.621 . . . . 0.0 109.491 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -154.5 156.01 31.22 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 128.124 2.57 . . . . 0.0 106.586 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.01 -35.15 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.614 2.209 . . . . 0.0 113.362 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -56.47 -50.92 70.32 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.952 0.882 . . . . 0.0 110.143 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -64.39 -32.52 74.17 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.673 -0.642 . . . . 0.0 111.651 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.14 -53.11 62.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.005 0.82 . . . . 0.0 110.445 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -62.75 -36.48 83.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.934 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.23 -51.66 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.844 0.747 . . . . 0.0 109.142 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -66.93 -41.72 86.57 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.12 0.568 . . . . 0.0 109.92 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.45 -44.87 95.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.582 0.628 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.48 -31.42 72.62 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.519 -0.738 . . . . 0.0 111.281 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.2 mt -75.82 -27.46 57.9 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 121.532 -0.73 . . . . 0.0 110.254 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -69.24 -45.56 69.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.237 1.415 . . . . 0.0 110.052 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -67.58 -39.33 84.87 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -75.4 177.65 6.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.814 1.645 . . . . 0.0 109.307 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -128.69 152.14 48.73 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 22.4 m -74.82 150.02 85.98 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.91 150.72 49.65 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.765 1.643 . . . . 0.0 108.881 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.4 p -157.49 74.29 0.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.916 1.286 . . . . 0.0 108.374 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -147.33 117.3 4.42 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.256 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.1 145.63 44.84 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.933 1.756 . . . . 0.0 109.517 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.256 1.424 0 C-N-CA 129.093 2.957 . . . . 0.0 105.27 176.23 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -69.13 153.57 71.6 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.409 2.073 . . . . 0.0 110.63 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -82.53 70.77 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.091 1.356 . . . . 0.0 109.181 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.81 148.49 68.39 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.639 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.53 177.5 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.235 2.623 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -49.3 146.71 3.59 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.976 0.91 . . . . 0.0 109.304 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.9 t -81.96 123.14 80.22 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.25 165.97 28.58 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.064 2.509 . . . . 0.0 114.042 -175.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -71.96 -22.03 61.5 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.2 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -58.28 143.18 45.54 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -136.38 121.16 18.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -153.08 164.41 38.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.651 1.581 . . . . 0.0 107.225 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -139.95 133.59 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.4 p -131.11 173.85 10.61 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.224 0.92 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.55 -158.72 49.19 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 121.793 0.663 . . . . 0.0 112.567 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.3 p -129.93 154.1 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.095 1.758 . . . . 0.0 107.109 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.7 -40.03 95.77 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.92 -48.75 79.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.999 0.363 . . . . 0.0 111.195 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.5 m -65.9 -45.83 80.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.58 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.32 -33.38 75.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.497 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -61.34 -40.79 95.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.586 1.084 . . . . 0.0 109.956 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -75.22 -32.49 61.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.55 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.9 73.33 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -76.21 140.9 41.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.53 1.532 . . . . 0.0 110.571 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -85.08 -13.67 49.6 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.427 1.467 . . . . 0.0 110.4 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.3 tp -122.8 127.41 49.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.786 -1.196 . . . . 0.0 110.142 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.1 t -140.57 113.82 5.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.0 m -146.1 171.21 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -133.83 143.16 48.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.77 168.85 20.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.326 -0.859 . . . . 0.0 111.548 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.6 m -106.96 132.94 52.34 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.13 114.85 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -76.59 -57.25 3.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 m -147.35 172.16 14.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.22 1.408 . . . . 0.0 110.187 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 31.1 mtp -135.68 146.57 47.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.81 2.044 . . . . 0.0 107.37 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.16 138.96 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 154.06 42.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 121.646 2.021 . . . . 0.0 109.66 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.11 175.78 3.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 110.974 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -59.18 171.45 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.228 3.285 . . . . 0.0 113.02 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.84 -129.61 45.3 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -112.35 31.8 6.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.0 169.36 40.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 125.046 1.308 . . . . 0.0 113.597 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -156.18 124.33 5.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.748 2.019 . . . . 0.0 106.301 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.11 147.86 27.11 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.68 123.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -92.96 124.41 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -131.43 167.69 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.55 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -128.94 38.06 3.99 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt 40.65 79.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -72.26 -28.84 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.11 161.08 34.48 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.2 144.38 48.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -137.61 -24.04 1.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -156.73 129.46 7.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -137.33 73.45 1.44 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.403 3.081 . . . . 0.0 106.045 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.66 34.88 3.43 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.016 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.25 -69.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 128.122 2.772 . . . . 0.0 109.973 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 mt -45.24 134.51 6.36 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -85.13 65.03 9.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.089 2.155 . . . . 0.0 106.414 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.7 mt -57.98 125.62 74.52 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.46 176.14 8.44 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.891 1.727 . . . . 0.0 113.619 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 t -42.57 -58.89 3.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.118 1.767 . . . . 0.0 110.813 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.56 124.06 10.41 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-N 122.321 1.865 . . . . 0.0 107.731 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.35 -153.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.144 2.562 . . . . 0.0 112.946 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.2 m -34.61 125.19 0.53 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.484 2.714 . . . . 0.0 112.882 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.05 30.98 0.65 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.15 1.357 . . . . 0.0 113.017 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.65 158.81 29.22 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.187 1.795 . . . . 0.0 108.243 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.0 p -107.57 150.71 26.53 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.108 0.867 . . . . 0.0 111.996 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -143.55 163.23 33.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.143 2.177 . . . . 0.0 108.733 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.26 114.21 25.66 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.45 121.46 31.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.77 119.84 17.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.874 1.359 . . . . 0.0 107.563 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.46 113.83 40.61 Favored Pre-proline 0 C--O 1.225 -0.22 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.12 5.59 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.136 2.557 . . . . 0.0 112.956 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.4 m -131.14 113.52 13.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.021 1.329 . . . . 0.0 110.675 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -81.73 -32.78 31.42 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.277 -0.89 . . . . 0.0 111.173 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -59.06 -49.08 79.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.813 1.645 . . . . 0.0 112.82 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.6 m -155.09 165.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 129.006 2.923 . . . . 0.0 108.447 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.04 157.7 70.7 Favored 'Cis proline' 0 CA--C 1.536 0.601 0 CA-C-N 120.794 1.319 . . . . 0.0 111.647 -1.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.89 111.13 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.864 2.376 . . . . 0.0 111.01 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.9 tpp -122.18 141.53 51.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.575 1.95 . . . . 0.0 109.852 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.424 ' HB2' ' HH ' ' A' ' 110' ' ' TYR . 7.2 mttm -141.55 133.85 28.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -69.3 142.5 54.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.42 36.59 69.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.042 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.83 157.92 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.514 1.525 . . . . 0.0 107.449 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 m -100.63 141.0 34.11 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.709 1.203 . . . . 0.0 111.472 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' HH ' ' HB2' ' A' ' 105' ' ' LYS . 92.0 m-85 -135.79 176.37 8.74 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.244 1.818 . . . . 0.0 112.62 -175.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.4 tp -122.92 123.64 41.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 100.916 -3.735 . . . . 0.0 100.916 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.51 113.71 21.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.1 mtm -117.87 113.14 21.31 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 100.566 -3.865 . . . . 0.0 100.566 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.57 -137.45 2.29 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -132.6 177.61 7.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.409 1.1 . . . . 0.0 111.522 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.45 125.32 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -104.84 113.05 26.41 Favored 'General case' 0 C--O 1.237 0.418 1 N-CA-C 96.339 -5.43 . . . . 0.0 96.339 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.257 8.0 tp10 -85.8 95.56 9.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.963 1.363 . . . . 0.0 108.667 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -179.08 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 133.395 4.678 . . . . 0.0 107.597 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -131.38 -8.57 3.73 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 112.768 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.25 -133.99 12.01 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.78 139.4 36.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.14 1.894 . . . . 0.0 114.753 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.55 132.68 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.261 0.4 OUTLIER -115.41 74.31 4.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 125.243 1.417 . . . . 0.0 109.612 -174.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.99 169.05 18.81 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.836 3.691 . . . . 0.0 112.765 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.92 -11.12 29.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 114.85 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -88.82 23.21 2.4 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.621 1.555 . . . . 0.0 110.779 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.1 m -96.69 145.1 26.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.127 1.371 . . . . 0.0 110.593 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -95.72 113.57 25.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 74.5 t -133.45 123.73 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.46 169.28 2.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 0.0 109.031 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.47 150.67 46.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -69.05 142.19 54.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -141.66 137.39 16.24 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.93 -37.97 82.0 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.057 1.838 . . . . 0.0 111.001 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -52.65 -45.46 66.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.21 1.004 . . . . 0.0 111.268 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.0 -42.91 72.41 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.486 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -53.72 -47.38 70.63 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.316 1.047 . . . . 0.0 110.271 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -58.07 -47.55 82.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.84 0.856 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.54 -50.05 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.335 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.42 -35.2 80.13 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.891 1.223 . . . . 0.0 109.744 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 71.7 m -61.04 -47.25 87.26 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -64.54 -38.36 90.75 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 121.717 -0.614 . . . . 0.0 111.064 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.84 -30.07 70.15 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.584 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.7 t -67.1 -40.98 86.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.677 1.126 . . . . 0.0 109.776 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -69.65 -42.78 73.77 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.44 0.696 . . . . 0.0 109.613 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -75.02 176.04 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.66 1.219 . . . . 0.0 109.243 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -138.77 135.95 35.2 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 18.4 m -73.52 157.04 88.31 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.221 0.919 . . . . 0.0 109.487 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.51 113.64 3.4 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.896 2.397 . . . . 0.0 109.317 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.8 p -123.4 74.11 1.22 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -113.19 113.7 48.82 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.32 -153.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 1 C-N-CA 125.536 4.157 . . . . 0.0 108.946 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.251 1.166 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 175.053 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.42 67.28 7.81 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.765 2.31 . . . . 0.0 108.108 164.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -128.6 34.17 4.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.646 1.578 . . . . 0.0 112.06 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.18 142.82 25.34 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.849 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -74.36 164.63 33.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.292 1.995 . . . . 0.0 110.246 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -66.01 162.53 19.18 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.7 t -96.82 104.6 19.02 Favored Pre-proline 0 C--O 1.233 0.217 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.16 160.02 48.35 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.087 1.858 . . . . 0.0 108.886 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.3 -23.41 61.94 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.658 -0.651 . . . . 0.0 110.096 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -64.73 154.6 36.27 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 t -133.39 134.17 43.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -162.22 166.33 25.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.722 2.009 . . . . 0.0 107.037 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -131.12 146.4 52.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -139.69 173.21 11.76 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.601 1.56 . . . . 0.0 110.192 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.3 -163.56 53.06 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 121.807 0.671 . . . . 0.0 112.549 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -129.51 159.16 37.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.002 1.721 . . . . 0.0 108.111 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.9 -47.04 82.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.912 -175.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -59.07 -46.0 89.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 119.393 0.997 . . . . 0.0 110.766 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -67.72 -41.05 84.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.062 0.392 . . . . 0.0 111.209 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.43 -33.16 71.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.741 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -59.51 -31.17 69.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.371 1.441 . . . . 0.0 109.904 175.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 m -71.14 -48.25 53.12 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.57 -50.21 70.38 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.919 0.888 . . . . 0.0 112.074 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -63.5 131.71 48.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.931 0.893 . . . . 0.0 109.811 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -92.87 -7.79 45.21 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.96 115.89 24.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.352 1.461 . . . . 0.0 108.6 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 37.6 t -135.52 114.18 15.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.34 172.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.431 1.493 . . . . 0.0 109.386 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.473 ' CG2' ' HD1' ' A' ' 133' ' ' HIS . 21.1 p -133.51 144.28 49.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.5 166.69 16.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.728 -0.607 . . . . 0.0 111.385 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.1 m -104.21 135.42 45.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.58 115.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.351 1.06 . . . . 0.0 109.56 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -83.53 -49.32 9.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -145.92 171.41 14.87 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 34.9 mtp -134.89 149.39 50.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.77 2.028 . . . . 0.0 106.86 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.95 139.91 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 131.51 41.96 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -113.7 176.25 1.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 124.465 1.106 . . . . 0.0 109.611 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.96 147.61 32.57 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.388 2.059 . . . . 0.0 113.893 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.48 -123.89 33.14 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.159 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -102.91 17.2 24.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.258 1.023 . . . . 0.0 110.582 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.61 170.43 51.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.869 1.26 . . . . 0.0 112.237 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -154.37 142.23 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.239 2.216 . . . . 0.0 105.459 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.28 150.02 35.05 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.28 123.26 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.7 m -90.53 124.57 35.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.74 173.46 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.547 0.739 . . . . 0.0 109.749 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -132.63 41.72 3.16 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.476 ' HB2' ' H ' ' A' ' 90' ' ' ALA 0.331 73.6 mt 39.06 80.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 174.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.5 mm -76.47 -27.64 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 121.859 -0.526 . . . . 0.0 110.169 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.97 156.54 28.12 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 125.226 1.393 . . . . 0.0 109.659 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.48 123.54 13.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -114.4 -29.32 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.817 0.847 . . . . 0.0 112.486 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.83 125.62 11.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.19 71.15 1.34 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.226 2.61 . . . . 0.0 107.589 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.85 46.27 3.62 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.78 -76.79 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 127.119 2.295 . . . . 0.0 110.03 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.85 127.21 11.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.946 1.298 . . . . 0.0 113.419 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -75.97 71.19 2.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.162 2.985 . . . . 0.0 108.319 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.45 132.1 90.69 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.4 179.16 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.525 1.484 . . . . 0.0 110.893 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.0 t -54.0 -55.14 39.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 175.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.24 121.35 8.63 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 N-CA-C 106.915 -1.994 . . . . 0.0 106.915 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.98 -152.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.081 4.521 . . . . 0.0 113.0 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.7 m -33.8 125.76 0.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.837 2.855 . . . . 0.0 112.226 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.14 53.64 0.23 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' H ' ' HB2' ' A' ' 72' ' ' LEU . . . -140.62 158.24 44.28 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.009 2.124 . . . . 0.0 105.741 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 p -87.83 154.33 20.63 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.386 -0.821 . . . . 0.0 111.234 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -147.37 141.16 25.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -108.4 112.54 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.69 123.14 33.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -76.63 113.74 14.6 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.364 1.065 . . . . 0.0 109.129 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.63 114.08 63.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.25 0.89 7.32 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.407 2.071 . . . . 0.0 113.842 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.38 113.33 9.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . 0.29 54.0 pttt -71.94 -4.7 29.89 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -94.15 -38.41 11.1 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -149.09 159.93 36.09 Favored Pre-proline 0 C--N 1.343 0.312 0 C-N-CA 124.014 0.926 . . . . 0.0 112.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.36 150.32 83.05 Favored 'Cis proline' 0 CA--C 1.54 0.819 0 O-C-N 122.722 0.854 . . . . 0.0 112.085 2.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.6 108.39 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 2.873 . . . . 0.0 111.301 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.1 ttp -140.85 149.71 42.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.194 1.798 . . . . 0.0 108.108 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -138.21 161.53 36.61 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.762 0.825 . . . . 0.0 110.858 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -70.09 132.17 45.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.36 25.81 58.44 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.33 152.06 34.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.487 1.515 . . . . 0.0 108.616 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -95.43 133.08 39.81 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.256 1.422 . . . . 0.0 111.365 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.03 175.54 9.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.967 1.307 . . . . 0.0 111.555 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.07 124.62 50.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 131.008 3.723 . . . . 0.0 102.597 175.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.25 114.1 22.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.275 1.03 . . . . 0.0 108.82 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.7 mtm -116.93 113.25 22.16 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 101.652 -3.462 . . . . 0.0 101.652 174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.13 -142.7 3.5 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.788 1.661 . . . . 0.0 109.291 -175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -132.3 174.68 9.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.139 0.97 . . . . 0.0 111.122 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -130.14 138.24 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -120.34 113.08 19.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -76.95 64.85 2.51 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.397 1.479 . . . . 0.0 108.569 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -162.68 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.422 2.689 . . . . 0.0 108.306 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -120.29 -9.34 9.53 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.258 1.023 . . . . 0.0 112.891 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.97 -129.44 9.56 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.93 139.63 22.15 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.976 1.784 . . . . 0.0 112.749 -175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.56 152.76 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -135.05 74.21 63.58 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 174.18 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.987 3.791 . . . . 0.0 113.348 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.26 -21.14 65.53 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.012 1.808 . . . . 0.0 112.175 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.07 22.78 0.92 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 110.742 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.9 m -103.42 129.83 50.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.377 1.071 . . . . 0.0 113.04 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -88.56 120.21 29.73 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.48 123.75 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.52 171.3 4.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.253 1.021 . . . . 0.0 109.693 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.78 145.57 55.53 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.495 1.118 . . . . 0.0 108.454 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.473 ' HD1' ' CG2' ' A' ' 52' ' ' THR . 65.2 t60 -71.94 149.18 45.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 110.42 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -148.73 149.76 31.52 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.64 -39.5 87.5 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.515 2.144 . . . . 0.0 112.301 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -57.75 -49.22 77.29 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.248 0.619 . . . . 0.0 111.286 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -60.11 -43.94 95.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.032 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -54.16 -53.19 56.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.57 0.623 . . . . 0.0 110.598 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -56.69 -45.43 81.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.219 1.408 . . . . 0.0 111.125 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.87 -52.46 61.4 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.122 0.969 . . . . 0.0 109.649 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -37.13 82.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.078 -175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -63.16 -45.71 90.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.244 1.384 . . . . 0.0 108.399 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -57.49 -46.26 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.724 0.693 . . . . 0.0 110.049 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.31 -33.55 75.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.525 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.0 t -62.86 -48.06 80.68 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.707 1.14 . . . . 0.0 110.336 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -62.73 -51.44 67.15 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.908 -0.495 . . . . 0.0 109.942 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -73.12 176.52 5.77 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.764 2.026 . . . . 0.0 111.245 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -106.63 151.52 24.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.21 139.63 55.36 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.42 96.41 0.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 N-CA-C 103.754 -3.21 . . . . 0.0 103.754 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 m -166.27 93.41 0.51 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -115.66 114.27 42.26 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -83.61 118.91 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.725 1.617 . . . . 0.0 109.409 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.251 1.146 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.618 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.53 68.1 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.203 2.602 . . . . 0.0 110.019 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -141.74 33.24 1.61 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.058 1.343 . . . . 0.0 112.611 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.37 109.84 62.57 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 125.072 1.349 . . . . 0.0 110.158 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.06 -179.35 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.558 2.839 . . . . 0.0 110.068 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.2 m -59.11 163.77 3.46 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.8 t -81.56 124.03 80.36 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.641 -175.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.05 175.77 10.42 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.302 2.668 . . . . 0.0 111.538 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -69.47 -20.24 63.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 117.48 -1.248 . . . . 0.0 113.015 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -56.76 121.6 10.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.937 1.244 . . . . 0.0 109.269 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.3 57.35 1.7 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -152.42 153.01 32.7 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.083 1.353 . . . . 0.0 108.004 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 ttp-105 -97.03 152.85 18.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.127 2.171 . . . . 0.0 108.317 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 p -136.05 174.36 10.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.125 1.37 . . . . 0.0 112.111 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 -163.15 54.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.424 1.011 . . . . 0.0 112.219 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -115.49 174.72 5.86 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.983 0.892 . . . . 0.0 109.066 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.14 -50.16 56.38 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -63.08 -48.68 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.697 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -55.76 -46.69 77.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.178 0.445 . . . . 0.0 110.479 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -76.0 -41.42 51.22 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.13 -1.891 . . . . 0.0 112.542 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.421 ' CD2' HG13 ' A' ' 50' ' ' VAL . 10.7 t80 -48.81 -49.05 40.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.035 1.743 . . . . 0.0 109.745 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.07 -32.17 73.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.374 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -56.82 4.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.291 1.036 . . . . 0.0 112.447 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 139.33 41.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.873 1.269 . . . . 0.0 112.729 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -76.97 -24.61 52.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.871 1.268 . . . . 0.0 109.462 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 44.9 tp -120.23 128.04 52.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.219 1.008 . . . . 0.0 110.157 -175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' A' ' 44' ' ' PHE . 35.4 t -141.33 113.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.9 171.12 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.897 1.279 . . . . 0.0 109.487 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -131.33 139.42 49.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.49 168.16 22.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.883 -1.136 . . . . 0.0 111.716 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.3 m -109.82 134.15 52.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.0 114.48 12.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -81.81 -51.66 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 m -148.98 174.25 12.48 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 125.209 1.404 . . . . 0.0 109.696 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 13.6 mtp -135.39 154.88 51.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.957 1.703 . . . . 0.0 107.363 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.87 138.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.697 1.599 . . . . 0.0 106.987 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -70.1 145.69 51.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.058 1.299 . . . . 0.0 108.705 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -131.67 164.7 40.91 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.841 0.857 . . . . 0.0 108.864 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -52.57 155.62 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.751 2.967 . . . . 0.0 115.715 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.42 -124.71 25.27 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.838 1.685 . . . . 0.0 110.854 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -105.02 25.71 10.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.151 1.381 . . . . 0.0 108.316 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.86 176.17 37.53 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.816 1.198 . . . . 0.0 114.255 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -161.82 141.36 9.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.796 2.438 . . . . 0.0 106.817 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.22 152.08 26.53 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 120.851 -1.155 . . . . 0.0 107.889 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.79 123.13 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -89.64 125.91 35.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -123.91 171.76 12.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.758 0.823 . . . . 0.0 109.93 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -132.67 37.19 3.49 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.067 0.947 . . . . 0.0 112.729 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.304 18.6 mt 39.17 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.37 -29.09 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 118.668 0.667 . . . . 0.0 109.625 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 168.48 39.34 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.322 1.439 . . . . 0.0 110.972 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.36 147.62 30.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.899 1.68 . . . . 0.0 109.306 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -141.38 -25.18 0.72 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -156.26 136.88 13.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.301 1.84 . . . . 0.0 106.502 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.0 p -145.31 71.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.614 2.766 . . . . 0.0 109.051 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 43.69 3.19 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.86 1.695 . . . . 0.0 110.088 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.88 -72.45 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 129.497 3.427 . . . . 0.0 109.683 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mt -51.05 132.23 27.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -82.84 76.07 9.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.0 mt -53.19 129.56 50.34 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.36 158.09 46.82 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.593 1.528 . . . . 0.0 112.281 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -52.85 -58.14 13.29 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.22 114.57 3.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 N-CA-C 103.554 -3.287 . . . . 0.0 103.554 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -68.06 -153.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.429 3.419 . . . . 0.0 116.328 -174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.2 m -35.01 134.44 0.24 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 130.76 3.624 . . . . 0.0 111.538 -174.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.69 11.97 3.86 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.733 2.587 . . . . 0.0 110.577 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.6 154.72 20.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.739 1.216 . . . . 0.0 108.182 175.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -104.0 141.26 36.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.437 1.095 . . . . 0.0 111.835 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 mt -147.28 151.6 36.89 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.742 1.217 . . . . 0.0 111.861 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -103.67 114.89 29.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -87.33 122.36 30.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -80.55 114.92 19.79 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.951 1.3 . . . . 0.0 109.8 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.13 114.02 58.41 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 120.817 1.644 . . . . 0.0 107.195 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.15 -7.72 21.52 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.17 1.913 . . . . 0.0 112.43 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.6 m -121.07 113.61 20.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.467 1.907 . . . . 0.0 109.988 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -78.43 -15.85 58.22 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.387 -0.821 . . . . 0.0 112.55 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -83.4 -41.46 18.11 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.683 0.793 . . . . 0.0 112.337 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.7 m -149.63 156.47 38.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.022 1.329 . . . . 0.0 110.36 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.12 159.31 81.0 Favored 'Cis proline' 0 CA--C 1.544 1.008 0 CA-C-N 119.134 0.727 . . . . 0.0 110.802 -3.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.12 142.94 99.89 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.172 2.581 . . . . 0.0 112.848 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 33.0 tpp -149.3 155.15 40.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.513 1.525 . . . . 0.0 109.239 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -150.56 141.1 22.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.555 1.942 . . . . 0.0 106.328 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.65 146.83 54.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.93 45.04 96.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.708 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.7 t -144.07 154.64 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.907 2.083 . . . . 0.0 107.214 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.5 m -102.56 135.29 44.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.591 1.156 . . . . 0.0 111.577 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.8 175.16 9.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.34 1.456 . . . . 0.0 112.851 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.34 124.71 53.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 130.654 3.581 . . . . 0.0 102.554 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.42 114.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.0 mtm -116.42 113.13 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.63 -139.33 2.75 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.047 1.308 . . . . 0.0 111.142 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -131.69 179.05 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.043 0.921 . . . . 0.0 110.336 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.78 145.97 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.651 -0.656 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -111.73 113.42 25.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.46 72.41 6.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -178.18 -39.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 129.186 2.995 . . . . 0.0 111.062 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -130.67 -10.88 3.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.43 -157.82 15.3 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.353 0.979 . . . . 0.0 111.791 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.14 144.53 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.347 2.698 . . . . 0.0 113.464 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.26 2.9 p -127.23 142.13 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.254 1.8 tm? -132.72 79.37 64.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.616 -1.302 . . . . 0.0 109.98 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.65 171.95 8.84 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.349 3.366 . . . . 0.0 112.598 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.01 -33.03 95.72 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.126 1.884 . . . . 0.0 113.268 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -83.96 37.2 0.59 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.42 1.088 . . . . 0.0 112.181 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.6 m -97.32 130.52 44.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.867 1.667 . . . . 0.0 108.898 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.3 113.65 15.29 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.61 123.95 43.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -150.28 171.82 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.28 1.832 . . . . 0.0 109.18 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.14 141.93 58.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.928 1.291 . . . . 0.0 109.504 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -75.72 131.28 39.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.418 0.687 . . . . 0.0 109.913 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -139.16 146.75 50.54 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.072 1.749 . . . . 0.0 107.67 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -57.54 -34.25 97.76 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.006 2.47 . . . . 0.0 113.362 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -54.15 -54.55 38.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.401 0.68 . . . . 0.0 109.679 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.49 -43.19 97.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.884 0.874 . . . . 0.0 109.677 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -51.1 -55.19 18.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.393 1.477 . . . . 0.0 111.166 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -65.53 -30.65 71.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.902 0.481 . . . . 0.0 110.757 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.71 -52.12 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 120.599 -1.313 . . . . 0.0 109.282 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.12 -37.79 81.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.085 1.312 . . . . 0.0 109.432 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.7 m -56.62 -53.62 55.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.693 0.797 . . . . 0.0 108.9 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -61.64 -31.3 71.39 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.595 -0.691 . . . . 0.0 112.201 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.59 -23.9 56.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.134 0.879 . . . . 0.0 111.299 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.8 t -73.67 -38.09 65.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -76.09 -59.59 2.69 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.765 1.226 . . . . 0.0 111.5 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -72.09 151.96 42.7 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 138.01 40.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.93 130.23 72.84 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.353 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.01 92.17 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 107.067 -1.936 . . . . 0.0 107.067 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 t -165.56 73.08 0.18 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.16 111.69 15.59 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -105.16 179.74 0.1 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.491 2.794 . . . . 0.0 110.495 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.256 1.407 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 175.371 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.08 163.13 32.58 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.871 1.714 . . . . 0.0 110.407 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -84.77 67.64 10.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.559 1.544 . . . . 0.0 110.347 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 137.4 77.33 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.938 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.37 -179.19 4.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.053 2.502 . . . . 0.0 111.193 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -56.29 161.96 2.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.159 . . . . 0.0 108.269 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 45.4 t -82.65 124.39 77.51 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.26 164.92 31.96 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.899 2.399 . . . . 0.0 111.115 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -80.31 -34.86 36.41 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.423 -0.799 . . . . 0.0 108.997 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -56.52 132.72 52.27 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.129 0.972 . . . . 0.0 109.827 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.97 145.1 27.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.89 1.276 . . . . 0.0 109.351 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -161.75 158.24 25.5 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -102.67 124.28 47.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.3 p -127.72 176.47 7.51 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.784 1.233 . . . . 0.0 111.684 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.72 -155.22 50.88 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.079 0.847 . . . . 0.0 111.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -137.72 166.65 23.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.35 -40.92 98.63 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -62.22 -54.22 43.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.981 0.809 . . . . 0.0 109.978 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -55.82 -46.39 78.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.92 0.867 . . . . 0.0 111.227 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -69.69 -37.65 76.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.201 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -61.35 -37.18 82.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.592 1.087 . . . . 0.0 109.757 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.7 -57.8 6.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.749 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -29.72 69.69 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -76.25 153.85 35.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.318 0.508 . . . . 0.0 111.895 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -102.85 -6.95 21.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.321 1.048 . . . . 0.0 108.717 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 tp -133.43 123.47 25.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.639 1.576 . . . . 0.0 109.117 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.58 114.55 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.81 172.04 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.807 1.243 . . . . 0.0 109.782 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -134.66 141.24 46.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.82 174.7 13.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 120.626 -1.296 . . . . 0.0 110.987 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.1 m -114.17 130.22 56.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 102.939 -2.985 . . . . 0.0 102.939 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.44 113.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -78.86 -43.33 25.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 108.808 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -152.77 167.76 27.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.248 1.419 . . . . 0.0 109.893 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 57.1 mtp -137.98 125.07 21.47 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.7 t -120.63 146.05 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.485 1.514 . . . . 0.0 107.82 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 -65.73 154.65 38.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.977 1.262 . . . . 0.0 107.877 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -135.13 170.9 9.99 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 124.728 1.211 . . . . 0.0 108.691 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 165.55 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.171 2.581 . . . . 0.0 113.318 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.2 -142.37 45.95 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 125.791 1.663 . . . . 0.0 109.298 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' OE1' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tp10 -97.56 25.19 5.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.917 1.287 . . . . 0.0 107.69 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.68 43.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.383 1.945 . . . . 0.0 114.794 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.48 155.77 35.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.381 2.673 . . . . 0.0 107.309 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.92 146.26 45.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.97 123.15 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 m -92.86 129.15 38.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 170.84 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.887 0.875 . . . . 0.0 111.559 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -135.01 35.38 3.07 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt 37.02 82.38 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.506 2.322 . . . . 0.0 116.003 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.3 mm -75.02 -23.02 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.701 0.8 . . . . 0.0 109.037 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.2 159.66 33.08 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.76 45.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.716 1.607 . . . . 0.0 106.695 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -141.42 -32.01 0.56 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.832 0.707 . . . . 0.0 111.246 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -148.21 129.61 14.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -139.4 70.03 1.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.324 2.249 . . . . 0.0 105.95 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.23 44.47 3.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.295 1.426 . . . . 0.0 109.61 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.77 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 130.075 3.702 . . . . 0.0 107.514 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -44.59 123.52 3.68 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 123.033 1.397 . . . . 0.0 114.408 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.59 64.86 5.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.348 3.059 . . . . 0.0 109.375 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -56.02 131.34 73.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.83 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.06 177.67 7.9 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.428 2.086 . . . . 0.0 112.107 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -48.92 -52.45 46.58 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.938 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.27 116.97 4.32 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 CA-C-N 121.843 1.694 . . . . 0.0 108.538 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.446 ' HB2' ' H ' ' A' ' 88' ' ' THR . 34.4 Cg_endo -78.18 -153.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.343 4.028 . . . . 0.0 111.529 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 75.5 m -33.36 125.44 0.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.838 2.455 . . . . 0.0 110.194 175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.55 2.09 5.89 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.294 1.902 . . . . 0.0 111.42 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.31 150.86 22.9 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.182 1.491 . . . . 0.0 110.112 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.9 p -95.08 150.5 20.11 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 mt -144.29 168.37 20.23 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.195 2.198 . . . . 0.0 109.773 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -127.26 115.01 18.38 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -95.63 124.79 39.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -72.34 139.93 48.19 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.309 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.31 113.64 18.31 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -60.73 -11.83 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.169 3.246 . . . . 0.0 115.451 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.5 m -137.42 118.39 14.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.539 1.535 . . . . 0.0 113.007 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.467 ' HE3' ' OE1' ' A' ' 64' ' ' GLU . 22.0 pttp -73.98 -27.22 60.88 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.665 -0.647 . . . . 0.0 110.188 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -62.73 -52.13 64.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.217 1.407 . . . . 0.0 110.858 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -146.65 159.11 45.09 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 111.673 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.3 160.77 75.3 Favored 'Cis proline' 0 CA--C 1.543 0.928 0 CA-C-N 119.189 0.746 . . . . 0.0 112.554 -0.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.63 95.56 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.957 3.105 . . . . 0.0 111.752 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 34.1 tpp -93.66 160.98 14.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.882 1.673 . . . . 0.0 108.603 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -148.48 136.9 21.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -77.31 145.06 37.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.888 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.16 98.75 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.674 0.67 . . . . 0.0 113.483 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.73 156.96 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 125.915 1.686 . . . . 0.0 107.049 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -89.99 138.72 31.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.991 0.901 . . . . 0.0 110.758 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -136.05 174.66 10.37 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.723 2.409 . . . . 0.0 112.33 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.05 123.62 42.04 Favored 'General case' 0 N--CA 1.448 -0.553 1 C-N-CA 132.504 4.321 . . . . 0.0 101.955 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.9 113.93 19.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.0 mtm -115.56 113.29 23.42 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.55 -136.39 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.46 1.028 . . . . 0.0 112.67 -175.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -135.43 176.12 8.97 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.949 1.3 . . . . 0.0 110.366 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.95 154.4 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -125.02 113.67 18.08 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -74.19 71.01 1.65 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 165.44 -24.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 1 C-N-CA 132.056 4.142 . . . . 0.0 112.134 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -113.78 -4.4 13.37 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.204 0.94 . . . . 0.0 111.628 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.25 -160.29 34.67 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 131.51 19.07 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.307 2.671 . . . . 0.0 111.935 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.76 125.95 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -114.65 84.17 9.78 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 125.973 1.709 . . . . 0.0 109.939 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.27 168.46 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.034 3.156 . . . . 0.0 113.01 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.84 -22.17 73.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.462 2.108 . . . . 0.0 113.318 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.02 23.19 5.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.96 1.304 . . . . 0.0 111.03 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.6 m -83.9 134.59 34.67 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.457 1.503 . . . . 0.0 108.491 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -76.93 113.77 14.98 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.65 116.25 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.8 168.38 7.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.838 0.855 . . . . 0.0 110.082 -175.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.86 145.95 54.87 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.662 0.785 . . . . 0.0 108.916 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -72.45 130.23 40.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.828 0.851 . . . . 0.0 109.702 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -137.21 148.05 60.81 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.889 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -37.8 39.25 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.046 2.497 . . . . 0.0 112.642 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -57.82 -50.98 71.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.018 0.527 . . . . 0.0 110.266 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -59.23 -51.94 67.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.18 -48.13 45.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.519 1.927 . . . . 0.0 111.491 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -44.02 97.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.723 1.209 . . . . 0.0 111.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.7 mt -66.41 -43.67 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.407 -1.282 . . . . 0.0 109.704 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.3 -43.32 96.42 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.651 1.569 . . . . 0.0 109.298 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -57.6 -49.27 76.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.88 -34.92 78.41 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.322 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.4 mt -69.29 -27.76 65.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.978 1.263 . . . . 0.0 111.688 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -71.32 -47.38 57.01 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -71.27 -43.6 66.87 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.634 -0.667 . . . . 0.0 110.81 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -76.54 176.0 8.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.471 1.908 . . . . 0.0 108.657 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.72 145.65 47.27 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 87.0 m -56.7 141.03 74.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 123.804 0.69 . . . . 0.0 111.27 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 94.69 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.114 1.876 . . . . 0.0 107.879 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.4 p -166.15 88.22 0.37 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.246 0.618 . . . . 0.0 111.702 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -116.07 113.54 41.64 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.72 97.55 1.14 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.794 2.329 . . . . 0.0 109.216 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.25 1.125 0 O-C-N 120.958 -1.089 . . . . 0.0 109.848 -179.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.01 72.55 5.8 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.846 3.031 . . . . 0.0 109.195 172.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -142.42 61.76 1.43 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 109.324 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.63 132.6 10.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.635 1.574 . . . . 0.0 110.173 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.71 177.29 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.606 2.871 . . . . 0.0 112.277 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -65.15 160.19 21.82 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.6 t -83.48 113.22 45.28 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 120.843 -1.161 . . . . 0.0 109.255 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -84.41 175.4 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.315 3.344 . . . . 0.0 111.751 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -79.41 -22.29 44.49 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -66.12 161.57 21.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.941 2.096 . . . . 0.0 108.485 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.0 t -152.46 131.87 12.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -158.53 166.29 32.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.502 0.721 . . . . 0.0 110.233 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.56 151.42 49.47 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.787 1.635 . . . . 0.0 109.213 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -146.91 176.06 10.19 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 128.102 2.561 . . . . 0.0 108.812 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.08 179.55 37.09 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.703 1.144 . . . . 0.0 114.903 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -107.03 177.48 4.84 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.271 1.029 . . . . 0.0 108.563 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.2 -50.49 63.68 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.76 -45.26 90.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.883 0.765 . . . . 0.0 111.538 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m -63.62 -44.94 92.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.918 0.326 . . . . 0.0 110.343 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -67.85 -46.19 72.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 117.174 -1.394 . . . . 0.0 110.092 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -48.4 -48.44 36.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.832 1.196 . . . . 0.0 111.331 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.5 m -65.62 -34.29 77.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.882 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -43.41 50.11 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.504 1.122 . . . . 0.0 112.292 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 p -66.75 127.25 31.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.993 0.917 . . . . 0.0 110.352 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.0 t -73.08 -21.43 60.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.955 0.798 . . . . 0.0 110.321 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 tp -117.83 118.78 32.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.552 1.141 . . . . 0.0 109.493 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.8 t -136.62 113.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.41 173.47 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 126.043 1.737 . . . . 0.0 108.061 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.502 ' CG2' ' HD1' ' A' ' 133' ' ' HIS . 35.1 p -136.01 146.36 47.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -167.68 164.59 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.917 0.78 . . . . 0.0 111.991 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 93.0 m -96.44 133.27 41.07 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.42 113.74 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.433 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 27.2 mmmt -72.79 -42.55 63.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.864 0.865 . . . . 0.0 108.979 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -165.56 170.29 14.46 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.069 1.347 . . . . 0.0 110.158 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 42.5 mtp -129.55 134.55 47.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.956 1.702 . . . . 0.0 106.62 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -135.52 144.63 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 159.46 30.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.688 1.585 . . . . 0.0 111.371 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -132.29 172.04 8.07 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 129.372 3.069 . . . . 0.0 110.685 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.91 146.4 16.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.586 2.857 . . . . 0.0 114.013 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.25 -124.43 30.74 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.912 1.244 . . . . 0.0 111.149 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -86.88 -0.52 56.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.855 0.862 . . . . 0.0 112.037 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.62 163.13 40.38 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.704 1.145 . . . . 0.0 114.039 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -148.4 136.22 20.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.27 1.828 . . . . 0.0 106.641 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.73 134.22 45.23 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.61 123.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m -93.23 130.56 38.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -134.71 172.28 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.73 0.812 . . . . 0.0 110.704 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -137.35 41.92 2.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt 38.5 80.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 17.0 mm -72.95 -29.46 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.05 157.56 29.11 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.66 144.97 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.362 1.465 . . . . 0.0 108.077 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -145.08 -25.7 0.48 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -155.36 127.68 7.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -144.56 70.18 1.28 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.564 2.346 . . . . 0.0 108.155 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.2 35.03 2.8 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.13 -81.6 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 127.556 2.503 . . . . 0.0 107.423 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.53 133.1 7.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 117.965 2.58 . . . . 0.0 117.965 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.27 63.79 8.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.011 2.925 . . . . 0.0 108.332 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.78 133.2 47.33 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.07 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.49 175.94 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.363 2.042 . . . . 0.0 112.219 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -50.86 -55.79 24.62 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.582 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.81 126.11 14.8 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.927 1.367 . . . . 0.0 109.137 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.896 2.397 . . . . 0.0 110.89 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.6 m -33.08 127.26 0.32 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 129.378 3.071 . . . . 0.0 112.987 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.74 54.63 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.093 2.282 . . . . 0.0 109.789 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.84 156.55 43.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.126 2.57 . . . . 0.0 107.093 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 p -102.72 155.06 18.57 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.253 -0.904 . . . . 0.0 112.971 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 mt -145.66 163.05 36.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.885 1.674 . . . . 0.0 108.593 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -126.37 113.73 17.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.59 126.35 38.7 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.279 1.031 . . . . 0.0 108.997 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -79.5 113.58 17.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.237 1.015 . . . . 0.0 110.503 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.88 119.03 54.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.56 -13.4 30.05 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.023 1.815 . . . . 0.0 113.292 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.2 126.35 16.45 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.844 1.658 . . . . 0.0 109.402 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -14.14 60.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.863 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -63.77 -58.08 7.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.884 1.22 . . . . 0.0 111.592 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -145.45 158.54 50.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.95 159.73 86.72 Favored 'Cis proline' 0 CA--C 1.548 1.176 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -4.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.89 160.9 27.47 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.729 1.619 . . . . 0.0 111.295 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.4 tpp -152.33 150.84 30.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -139.81 145.98 38.84 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -72.98 138.71 46.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.21 58.83 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.765 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.39 144.44 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 108.62 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 m -92.26 126.99 37.57 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.592 1.157 . . . . 0.0 112.181 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.86 175.66 8.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 112.046 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.17 127.23 54.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.754 3.221 . . . . 0.0 103.359 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.96 114.29 20.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.846 0.858 . . . . 0.0 109.892 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.5 mtm -114.64 111.64 21.64 Favored 'General case' 0 C--N 1.32 -0.69 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.85 -148.32 4.76 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.548 2.023 . . . . 0.0 111.228 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -130.75 178.04 6.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.123 0.969 . . . . 0.0 108.972 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 t -135.71 145.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 121.708 -0.62 . . . . 0.0 109.348 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -114.16 113.85 25.23 Favored 'General case' 0 C--N 1.346 0.414 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.09 72.39 4.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -175.22 -35.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 130.593 3.557 . . . . 0.0 109.141 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -117.37 -16.71 10.24 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.02 -171.36 14.84 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.78 137.81 55.42 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.99 1.793 . . . . 0.0 110.173 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.262 7.2 p -114.65 162.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.289 1.7 tm? -150.9 76.27 8.07 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.9 170.44 11.53 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.973 3.116 . . . . 0.0 112.343 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.38 -19.23 66.61 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.899 1.733 . . . . 0.0 112.214 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -84.41 36.38 0.58 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.446 2.698 . . . . 0.0 109.898 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 m -113.48 133.24 55.32 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.682 1.593 . . . . 0.0 110.804 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -85.01 117.55 24.04 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.19 119.57 31.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.837 0.855 . . . . 0.0 110.134 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.0 m -143.58 168.82 11.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.97 1.708 . . . . 0.0 108.926 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.25 149.39 48.12 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.78 -0.575 . . . . 0.0 110.211 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.502 ' HD1' ' CG2' ' A' ' 52' ' ' THR . 51.6 t60 -72.5 144.34 48.05 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -142.64 149.58 50.96 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.72 -39.76 25.22 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 111.663 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -58.59 -48.04 82.29 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.894 0.316 . . . . 0.0 110.696 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -58.19 -46.88 85.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.763 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.59 -56.51 14.83 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.203 1.401 . . . . 0.0 110.772 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -63.73 -37.88 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.93 -49.77 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.609 1.095 . . . . 0.0 109.837 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.33 -34.2 77.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.575 1.079 . . . . 0.0 108.808 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -60.78 -47.92 84.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -59.11 -49.21 78.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.699 -0.626 . . . . 0.0 110.229 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.6 mt -59.05 -34.53 72.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.682 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 t -56.26 -58.02 9.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.371 0.987 . . . . 0.0 110.526 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -73.13 -38.92 66.12 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.693 0.397 . . . . 0.0 111.693 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -69.81 176.01 3.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.61 1.164 . . . . 0.0 110.211 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -99.57 152.34 20.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.7 m -63.3 150.98 88.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 124.379 1.049 . . . . 0.0 111.342 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.21 93.77 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 104.843 -2.791 . . . . 0.0 104.843 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.51 74.57 0.47 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -143.65 119.32 6.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.59 153.67 75.63 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 121.505 1.47 . . . . 0.0 109.948 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.755 2.022 . . . . 0.0 106.448 176.156 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -84.83 61.61 6.08 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.055 3.17 . . . . 0.0 111.677 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -131.93 33.75 3.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 123.402 1.573 . . . . 0.0 113.118 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.31 124.18 31.93 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 126.018 1.727 . . . . 0.0 110.014 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.85 -166.21 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.856 3.704 . . . . 0.0 112.43 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.8 m -54.36 163.13 0.91 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.177 1.791 . . . . 0.0 107.532 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 t -83.08 143.61 45.92 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 119.721 -1.862 . . . . 0.0 109.802 -174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.93 157.15 62.95 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.611 1.541 . . . . 0.0 110.677 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -73.11 -40.96 64.52 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -66.56 147.67 52.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.243 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.37 151.51 32.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.145 1.378 . . . . 0.0 108.451 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.28 165.82 32.64 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.512 1.525 . . . . 0.0 107.316 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -83.4 166.56 18.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.2 p -111.11 145.39 38.65 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -25.89 -126.52 0.0 OUTLIER Glycine 0 N--CA 1.44 -1.048 1 C-N-CA 133.162 5.172 . . . . 0.0 119.589 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -83.11 144.6 29.75 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.845 -1.178 . . . . 0.0 112.489 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.19 -53.55 10.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.88 1.672 . . . . 0.0 109.274 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -62.14 -31.28 71.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.14 0.882 . . . . 0.0 112.424 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -74.19 -52.39 12.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -59.2 -37.89 78.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.662 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.412 ' CD2' HG13 ' A' ' 50' ' ' VAL . 36.8 t80 -59.1 -41.64 88.59 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.444 1.02 . . . . 0.0 110.777 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -68.35 -41.1 81.17 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.694 -0.629 . . . . 0.0 111.131 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -55.71 11.48 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.698 0.681 . . . . 0.0 112.671 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 p -54.37 148.46 11.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.496 1.118 . . . . 0.0 111.629 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.1 t -99.07 -15.54 18.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.486 0.714 . . . . 0.0 111.551 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.77 115.49 22.77 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' A' ' 44' ' ' PHE . 22.4 t -134.86 113.6 16.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.12 170.36 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.629 1.172 . . . . 0.0 110.947 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -130.97 142.6 50.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.869 2.068 . . . . 0.0 106.953 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -168.56 176.78 5.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.257 -0.902 . . . . 0.0 110.938 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -114.77 136.03 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.69 113.6 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.15 -52.67 7.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -145.93 173.18 12.37 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.856 1.662 . . . . 0.0 109.542 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.5 mtp -139.55 153.29 47.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.149 2.18 . . . . 0.0 106.309 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.2 t -145.49 135.74 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 108.103 -175.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -66.16 147.14 53.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.956 1.707 . . . . 0.0 108.757 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -139.59 169.37 12.36 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 119.331 0.969 . . . . 0.0 112.912 -176.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.97 163.22 7.88 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.573 3.516 . . . . 0.0 114.629 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.58 -123.58 8.3 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -119.84 22.09 11.68 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.31 175.61 45.76 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-O 124.832 2.351 . . . . 0.0 118.934 -174.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -156.42 135.19 11.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.472 2.709 . . . . 0.0 105.387 -175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.75 127.24 54.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.7 123.3 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -86.17 127.17 34.67 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.92 168.13 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.706 0.803 . . . . 0.0 108.933 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 t -129.94 35.9 4.09 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.307 81.7 mt 37.42 80.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.456 2.302 . . . . 0.0 116.273 173.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.58 -40.39 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 110.15 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.37 161.7 29.55 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.46 147.07 42.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.593 1.957 . . . . 0.0 107.637 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.68 -30.1 2.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.707 1.203 . . . . 0.0 110.359 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -150.77 137.43 18.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -142.41 70.17 1.33 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 129.072 2.949 . . . . 0.0 106.434 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.61 32.37 3.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.985 0.802 . . . . 0.0 111.912 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 126.765 2.126 . . . . 0.0 110.983 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.06 132.6 48.91 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.307 1.043 . . . . 0.0 111.199 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -85.72 94.05 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.79 1.636 . . . . 0.0 107.532 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.06 133.0 88.02 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.72 -179.06 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.437 2.758 . . . . 0.0 114.652 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 t -39.58 -60.33 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.371 1.868 . . . . 0.0 110.762 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.17 123.72 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.01 1.806 . . . . 0.0 108.392 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.32 -170.59 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.275 1.983 . . . . 0.0 112.712 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 40.0 m -38.3 127.55 1.38 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.044 2.138 . . . . 0.0 116.458 -175.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.19 14.97 0.09 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 128.392 2.901 . . . . 0.0 110.61 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.38 168.07 9.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.728 1.611 . . . . 0.0 110.728 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.9 p -98.73 153.01 19.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.57 -0.706 . . . . 0.0 112.621 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 24.4 mt -152.37 154.04 34.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.833 1.253 . . . . 0.0 109.612 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -112.51 113.24 25.31 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -89.27 121.27 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.137 0.88 . . . . 0.0 109.106 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -73.76 114.27 11.85 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.038 1.335 . . . . 0.0 110.529 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.5 117.57 55.51 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.95 -4.16 14.26 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.268 2.645 . . . . 0.0 112.982 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.29 120.49 28.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.466 2.306 . . . . 0.0 111.33 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.483 ' HZ2' ' NE2' ' A' ' 100' ' ' GLN . 2.0 pptp? -73.81 -25.92 60.35 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.507 -0.746 . . . . 0.0 110.102 175.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.483 ' NE2' ' HZ2' ' A' ' 99' ' ' LYS . 15.6 mm-40 -69.7 -45.36 68.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.416 1.487 . . . . 0.0 113.059 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.3 m -148.56 163.51 25.83 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -62.57 157.66 62.96 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 O-C-N 122.493 0.733 . . . . 0.0 111.618 -1.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.32 92.71 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.839 3.026 . . . . 0.0 114.268 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.6 tpp -96.03 161.54 13.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.542 1.937 . . . . 0.0 111.563 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -153.48 139.76 18.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.342 1.857 . . . . 0.0 107.896 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.55 146.63 48.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.29 32.27 83.64 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.9 -0.944 . . . . 0.0 114.35 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.7 t -129.63 156.78 42.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.677 1.991 . . . . 0.0 106.636 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.3 m -103.6 136.55 43.1 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.486 0.715 . . . . 0.0 109.726 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.39 176.02 8.9 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.231 1.812 . . . . 0.0 112.773 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.46 123.66 43.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.0 114.24 22.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.142 0.977 . . . . 0.0 108.604 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -117.01 113.34 22.21 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.86 -143.04 3.67 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 126.118 1.818 . . . . 0.0 109.35 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -133.23 177.3 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.527 0.68 . . . . 0.0 110.234 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.98 130.95 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -109.9 113.2 25.73 Favored 'General case' 0 N--CA 1.449 -0.512 1 N-CA-C 98.208 -4.738 . . . . 0.0 98.208 174.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 72.16 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.504 1.621 . . . . 0.0 108.053 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -161.38 -47.38 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.695 2.798 . . . . 0.0 106.579 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.48 -4.49 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.661 1.584 . . . . 0.0 111.245 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.28 -122.72 6.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.267 1.413 . . . . 0.0 109.851 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.82 145.33 28.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.754 2.302 . . . . 0.0 114.931 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.37 151.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -142.6 76.3 18.02 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 120.742 -1.223 . . . . 0.0 108.572 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.73 171.95 6.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.649 3.566 . . . . 0.0 112.428 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.89 -19.13 68.02 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.059 1.414 . . . . 0.0 112.22 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.98 23.21 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.968 2.107 . . . . 0.0 111.773 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.8 m -91.59 132.95 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 110.557 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.85 113.64 18.17 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.59 119.21 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.75 167.77 8.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.102 1.361 . . . . 0.0 108.626 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.22 152.29 41.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -69.94 135.6 49.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -137.36 145.11 48.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.61 -46.24 14.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.926 1.751 . . . . 0.0 112.648 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.85 -38.0 89.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.792 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.72 -41.09 97.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.402 -0.811 . . . . 0.0 109.595 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -54.88 -49.83 70.22 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.381 1.473 . . . . 0.0 109.212 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -62.95 -45.23 93.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.132 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.0 mt -59.21 -47.38 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.804 1.184 . . . . 0.0 109.813 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.96 -38.07 87.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 109.4 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.2 m -61.64 -43.37 98.98 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.718 -0.614 . . . . 0.0 110.099 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -60.3 -52.71 64.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.6 mt -59.27 -32.48 70.05 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.699 0.8 . . . . 0.0 112.016 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.9 t -64.6 -51.24 63.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.081 1.352 . . . . 0.0 110.646 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -71.67 -38.94 70.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -75.21 177.29 6.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.456 1.902 . . . . 0.0 108.928 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -121.18 151.9 39.4 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 82.4 m -58.6 153.18 41.89 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.496 1.118 . . . . 0.0 111.048 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.1 93.83 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.853 2.369 . . . . 0.0 108.832 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.3 m -116.18 55.65 0.8 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.386 1.474 . . . . 0.0 108.735 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -112.91 113.0 50.01 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 101.701 -3.444 . . . . 0.0 101.701 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -111.65 -172.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.078 2.519 . . . . 0.0 112.39 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.257 1.499 0 C-N-CA 129.474 3.109 . . . . 0.0 103.73 175.457 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -87.58 61.7 3.68 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.547 2.831 . . . . 0.0 110.531 168.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -116.47 39.77 3.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.702 1.601 . . . . 0.0 113.041 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.24 97.05 45.75 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.416 1.487 . . . . 0.0 111.119 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.15 -168.39 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 1 C-N-CA 125.459 4.106 . . . . 0.0 110.731 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 m -46.54 145.05 1.95 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.466 1.106 . . . . 0.0 109.022 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.53 126.11 72.14 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.231 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.69 161.63 43.42 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.751 2.3 . . . . 0.0 110.505 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.3 -13.61 60.14 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.844 -1.16 . . . . 0.0 114.116 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -51.14 132.93 28.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.979 1.311 . . . . 0.0 109.236 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.1 t -145.51 94.9 2.57 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.999 1.32 . . . . 0.0 109.313 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.5 ttm-85 -148.44 156.78 42.91 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.358 1.063 . . . . 0.0 110.208 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.3 ttp85 -100.89 133.79 44.84 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 127.837 2.455 . . . . 0.0 107.1 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 p -123.54 167.79 13.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.133 2.173 . . . . 0.0 111.215 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.81 -166.22 1.34 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.687 2.089 . . . . 0.0 113.886 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 p -108.59 169.52 8.6 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -63.93 -40.87 97.44 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.61 -51.84 65.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.221 0.464 . . . . 0.0 110.845 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -53.02 -54.47 34.81 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.199 1.0 . . . . 0.0 110.194 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.91 -35.89 81.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.007 -0.996 . . . . 0.0 111.489 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -57.42 -39.91 77.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.889 1.222 . . . . 0.0 110.315 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.11 -42.67 46.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.865 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.79 78.47 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.106 . . . . 0.0 112.573 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -75.99 145.74 40.06 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.682 0.793 . . . . 0.0 111.459 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -95.12 -5.94 43.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.826 1.25 . . . . 0.0 108.268 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.0 tp -129.09 122.71 30.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.557 2.343 . . . . 0.0 108.272 -176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.3 t -142.56 113.81 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.92 163.34 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.209 1.404 . . . . 0.0 109.019 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 p -126.21 144.76 50.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.67 161.39 20.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.674 -1.266 . . . . 0.0 111.933 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 55.3 m -87.69 132.87 33.96 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.0 t -75.35 113.31 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -82.9 -46.44 12.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.57 1.548 . . . . 0.0 108.13 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -153.03 167.03 30.55 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.491 1.517 . . . . 0.0 108.967 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.3 mtp -135.34 123.98 23.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.943 2.897 . . . . 0.0 105.784 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.73 150.73 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.93 1.292 . . . . 0.0 107.899 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -67.69 154.46 41.43 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.609 -0.682 . . . . 0.0 109.26 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -140.02 168.34 15.21 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.408 1.083 . . . . 0.0 110.776 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.83 162.26 11.29 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.65 2.9 . . . . 0.0 112.915 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.93 -147.48 50.73 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -88.72 20.42 3.49 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.48 169.04 54.9 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-O 123.848 1.804 . . . . 0.0 117.547 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.96 134.11 16.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.735 2.814 . . . . 0.0 104.967 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.55 123.53 42.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.55 123.15 49.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 175.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.0 m -98.72 126.21 44.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.12 175.51 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.221 0.608 . . . . 0.0 111.305 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -133.1 40.84 3.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.278 91.8 mt 38.81 80.97 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.86 -29.5 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.77 0.714 . . . . 0.0 109.42 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.32 159.28 29.03 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.935 1.731 . . . . 0.0 109.408 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.56 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -135.34 -32.04 0.95 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.194 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -157.98 133.58 9.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -145.27 67.85 1.23 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.121 2.168 . . . . 0.0 106.548 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.62 43.83 3.22 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.479 1.514 . . . . 0.0 111.215 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.12 -31.77 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 125.93 1.728 . . . . 0.0 113.16 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.95 144.27 28.43 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.35 1.575 . . . . 0.0 109.993 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -100.55 63.37 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -57.54 141.08 79.37 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.962 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.39 171.51 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.192 1.928 . . . . 0.0 112.961 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.1 t -43.81 -56.13 7.86 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.896 2.078 . . . . 0.0 110.23 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.42 116.79 4.85 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 N-CA-C 106.597 -2.116 . . . . 0.0 106.597 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.46 -152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 1 C-N-CA 125.317 4.011 . . . . 0.0 112.129 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.292 97.5 m -33.77 124.39 0.45 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 129.089 2.956 . . . . 0.0 112.117 -175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.21 -4.05 1.75 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.186 1.85 . . . . 0.0 113.356 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.84 161.04 15.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.034 1.417 . . . . 0.0 109.446 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.2 p -105.32 143.8 32.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.799 0.809 . . . . 0.0 112.231 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -148.25 160.68 42.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.153 1.781 . . . . 0.0 109.48 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.32 121.22 43.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -94.04 122.59 36.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -75.64 113.44 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 124.259 0.974 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.48 114.02 62.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -11.7 29.12 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 111.926 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -117.49 113.25 21.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.993 1.317 . . . . 0.0 111.956 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -82.74 -20.29 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -60.24 -53.59 55.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 109.776 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.3 m -160.58 163.56 21.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 127.483 2.313 . . . . 0.0 108.407 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.13 141.97 41.85 Favored 'Cis proline' 0 CA--C 1.537 0.664 0 CA-C-N 120.678 1.278 . . . . 0.0 111.312 1.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 102.2 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.177 2.585 . . . . 0.0 111.558 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 tpp -93.36 158.41 15.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.045 1.738 . . . . 0.0 108.666 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -142.54 137.22 30.02 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.537 0.684 . . . . 0.0 110.107 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -74.94 144.42 43.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.242 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.11 45.62 55.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -151.13 161.31 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 127.742 2.417 . . . . 0.0 105.513 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.8 m -107.63 131.34 54.48 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -122.77 170.32 10.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.444 1.898 . . . . 0.0 112.622 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.23 123.74 47.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.572 3.549 . . . . 0.0 102.031 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.37 114.13 21.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.5 mtm -119.23 113.33 20.7 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.18 -134.2 1.91 Allowed Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.187 1.375 . . . . 0.0 111.366 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -134.96 -178.5 5.11 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.342 -1.093 . . . . 0.0 109.401 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.9 144.12 33.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 175.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.24 113.43 19.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -75.84 73.95 2.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.388 1.09 . . . . 0.0 108.527 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -168.94 -41.2 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 129.812 3.245 . . . . 0.0 108.343 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -119.2 -6.37 10.39 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.349 1.06 . . . . 0.0 112.682 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -151.32 21.33 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.86 141.95 38.13 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.613 1.542 . . . . 0.0 112.737 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.81 135.62 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.255 1.7 tm? -122.07 74.26 38.16 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 107.486 -174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.86 174.86 6.1 Favored 'Trans proline' 0 CA--C 1.542 0.888 1 C-N-CA 125.728 4.285 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.54 -22.85 61.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.728 2.285 . . . . 0.0 113.463 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -85.17 23.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.355 1.462 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.2 m -97.74 140.1 32.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.922 . . . . 0.0 111.252 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -92.55 117.05 29.56 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.8 117.41 34.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.795 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -147.12 168.68 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.228 1.411 . . . . 0.0 109.117 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.7 141.1 57.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.13 0.967 . . . . 0.0 109.954 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -68.45 136.32 53.06 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.777 1.631 . . . . 0.0 107.877 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -144.65 155.64 56.51 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.112 1.765 . . . . 0.0 106.912 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.44 -40.12 25.77 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.187 1.925 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -56.97 -52.71 64.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.013 0.37 . . . . 0.0 110.945 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -58.09 -44.11 87.45 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 123.091 0.556 . . . . 0.0 110.362 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.96 -50.65 70.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.34 1.056 . . . . 0.0 109.796 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -61.67 -39.57 91.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.275 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.3 mt -63.4 -50.36 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.116 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 mt -62.39 -36.91 83.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.207 1.367 . . . . 0.0 109.088 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.7 m -61.81 -45.36 94.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.15 -38.94 90.93 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.282 -0.886 . . . . 0.0 110.737 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.4 mt -68.65 -24.61 64.55 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.706 0.803 . . . . 0.0 111.582 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 t -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.184 0.902 . . . . 0.0 109.408 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -75.61 -48.88 20.33 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.625 0.77 . . . . 0.0 111.092 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -75.57 157.99 33.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.017 0.826 . . . . 0.0 109.496 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -82.39 150.45 27.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 33.7 m -65.99 123.69 85.7 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.26 159.62 43.52 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.455 2.104 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -162.93 79.77 0.48 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -114.62 113.22 45.2 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.1 153.11 12.66 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 121.654 1.569 . . . . 0.0 108.88 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.257 1.473 1 N-CA-C 98.105 -4.776 . . . . 0.0 98.105 175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 p . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.67 -177.53 2.54 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.113 1.875 . . . . 0.0 109.643 168.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -74.3 43.64 0.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 129.614 3.166 . . . . 0.0 112.082 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.84 115.2 4.29 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.477 2.311 . . . . 0.0 110.572 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -91.29 -169.61 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.571 3.514 . . . . 0.0 112.348 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -57.88 165.6 1.73 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.31 1.444 . . . . 0.0 108.418 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.3 t -84.01 120.91 75.5 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.2 155.83 55.99 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.344 1.363 . . . . 0.0 109.747 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -66.43 -9.45 34.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.884 -1.135 . . . . 0.0 112.937 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.24 128.94 39.53 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.188 1.395 . . . . 0.0 107.521 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -139.41 68.87 1.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -157.35 165.52 35.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.68 2.392 . . . . 0.0 106.156 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -114.68 142.26 46.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.32 2.248 . . . . 0.0 105.508 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.4 p -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.953 1.301 . . . . 0.0 110.872 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.58 -177.02 37.96 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.322 0.963 . . . . 0.0 112.364 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -102.47 165.42 11.11 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.725 -0.868 . . . . 0.0 108.683 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.82 -47.75 76.88 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.05 -48.0 80.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 118.62 0.646 . . . . 0.0 110.593 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 m -59.28 -48.15 82.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.346 0.659 . . . . 0.0 111.077 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -69.0 -33.89 74.41 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.249 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.416 ' CD2' HG13 ' A' ' 50' ' ' VAL . 15.9 t80 -57.52 -36.4 71.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.185 1.357 . . . . 0.0 110.033 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.8 m -69.26 -45.85 68.69 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.39 0.676 . . . . 0.0 111.115 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.28 50.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.511 0.724 . . . . 0.0 112.144 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -62.05 138.49 58.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.78 1.232 . . . . 0.0 109.994 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -94.3 -6.68 43.89 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.061 0.934 . . . . 0.0 109.882 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.6 tp -120.38 120.42 35.92 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 126.75 2.02 . . . . 0.0 107.709 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 HG13 ' CD2' ' A' ' 44' ' ' PHE . 40.1 t -142.88 113.32 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.49 166.8 5.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.776 1.231 . . . . 0.0 108.509 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -130.29 143.66 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -165.58 173.31 11.03 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 110.799 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.8 m -110.82 134.45 52.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.92 113.58 15.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 22.2 mmmt -86.49 -42.38 13.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.424 1.09 . . . . 0.0 110.327 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -147.37 168.99 20.42 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.198 1.399 . . . . 0.0 110.925 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 mtp -138.82 129.25 25.84 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 t -123.72 142.19 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.312 1.045 . . . . 0.0 108.663 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -72.49 139.69 47.78 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -123.62 176.11 2.41 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.339 1.856 . . . . 0.0 108.555 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.81 161.81 34.62 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.929 2.419 . . . . 0.0 112.24 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -154.2 40.17 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -72.2 0.27 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.914 1.285 . . . . 0.0 110.632 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.5 172.56 22.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 126.808 2.147 . . . . 0.0 117.873 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -161.87 141.99 10.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 129.569 3.148 . . . . 0.0 105.44 -176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.29 151.35 27.5 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.93 123.28 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 124.68 43.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.51 169.98 20.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 t -123.8 35.39 4.85 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.26 70.3 mt 36.3 82.58 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 128.071 2.549 . . . . 0.0 116.884 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.7 mm -72.15 -30.99 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.305 -0.872 . . . . 0.0 111.816 175.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.3 160.91 31.7 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.88 49.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -141.32 -25.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.396 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -156.15 125.54 6.23 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -139.57 67.95 1.38 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 127.709 2.404 . . . . 0.0 104.613 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 31.46 3.31 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.58 1.086 . . . . 0.0 111.939 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.58 -62.7 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.247 1.403 . . . . 0.0 111.4 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.12 148.59 30.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 117.147 0.474 . . . . 0.0 111.022 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.11 97.69 11.33 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.2 mt -63.23 147.44 94.81 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.68 178.7 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.539 1.493 . . . . 0.0 111.347 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.3 t -52.31 -61.02 5.06 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.614 1.166 . . . . 0.0 111.245 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 142.36 46.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 N-CA-C 107.36 -1.823 . . . . 0.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.36 -168.94 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.392 1.395 . . . . 0.0 110.846 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.1 m -38.17 130.93 1.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.258 2.223 . . . . 0.0 113.67 -175.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 59.48 0.06 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 105.257 -3.137 . . . . 0.0 105.257 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.63 165.33 31.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 126.501 1.92 . . . . 0.0 106.608 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.9 p -104.0 147.72 27.05 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 120.907 -1.121 . . . . 0.0 111.443 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -147.26 158.77 44.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -125.02 113.84 18.32 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -98.81 121.19 40.45 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.86 0.864 . . . . 0.0 109.57 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.91 113.8 17.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 124.677 1.236 . . . . 0.0 109.994 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.54 120.01 54.31 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.32 0.02 8.0 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.685 2.257 . . . . 0.0 112.458 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 57.7 m -129.83 160.81 32.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.061 2.544 . . . . 0.0 109.121 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -132.01 -8.42 3.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -83.45 -48.03 10.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.482 1.037 . . . . 0.0 108.511 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -127.66 158.22 70.81 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.99 1.316 . . . . 0.0 111.519 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.7 153.26 79.38 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 -4.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.35 96.51 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.403 2.735 . . . . 0.0 112.622 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.5 tpp -94.67 160.94 14.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.135 1.374 . . . . 0.0 110.309 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -152.91 140.02 19.32 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.988 1.715 . . . . 0.0 109.093 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -78.2 147.06 34.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.45 46.6 84.87 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -146.32 147.86 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 126.477 1.911 . . . . 0.0 106.714 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.1 m -93.8 132.13 38.5 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.168 0.587 . . . . 0.0 110.096 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.76 172.38 11.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.631 1.972 . . . . 0.0 111.664 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -115.81 124.15 50.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.21 114.34 23.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.7 mtm -117.89 113.37 21.64 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 103.274 -2.861 . . . . 0.0 103.274 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.74 -134.01 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.802 1.191 . . . . 0.0 111.164 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -135.89 175.98 9.1 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.985 . . . . 0.0 110.991 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -130.21 145.78 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.789 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -123.76 113.7 18.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -81.01 65.32 6.11 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.378 1.085 . . . . 0.0 111.946 -175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -166.82 -39.42 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.982 1.713 . . . . 0.0 110.736 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -113.65 -30.67 6.73 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.96 -168.76 21.21 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.76 160.53 47.75 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.287 1.325 . . . . 0.0 111.342 -177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.47 157.21 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.44 74.73 12.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 120.67 -1.269 . . . . 0.0 108.664 -174.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.05 174.19 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.552 3.501 . . . . 0.0 113.052 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.13 -16.37 50.05 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.847 1.698 . . . . 0.0 111.99 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.81 32.01 0.48 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.038 2.135 . . . . 0.0 110.826 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -113.66 128.73 56.54 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.111 1.364 . . . . 0.0 111.064 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -81.34 113.31 19.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -133.46 123.18 45.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -152.43 173.16 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.362 1.465 . . . . 0.0 110.682 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.91 134.25 54.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.875 1.67 . . . . 0.0 109.323 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -67.74 125.77 27.3 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -140.9 157.64 66.93 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.56 -1.209 . . . . 0.0 109.199 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.52 -44.85 16.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.63 2.887 . . . . 0.0 115.785 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -55.68 -43.42 76.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.542 1.065 . . . . 0.0 110.859 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.35 -44.28 83.66 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.94 -0.553 . . . . 0.0 109.556 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.37 -50.05 65.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.919 0.887 . . . . 0.0 111.657 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.59 -49.77 73.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.592 0.757 . . . . 0.0 109.335 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.73 -52.61 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.861 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.23 -32.82 74.32 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.771 1.169 . . . . 0.0 110.222 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.6 m -65.73 -46.84 77.37 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -60.32 -41.75 94.17 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.685 -0.635 . . . . 0.0 111.267 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.98 -35.64 80.41 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.5 1.12 . . . . 0.0 110.867 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -61.99 -45.61 92.85 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -67.41 -48.88 66.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.53 0.732 . . . . 0.0 110.5 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -68.41 166.43 16.75 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.457 0.646 . . . . 0.0 109.638 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -108.99 123.82 49.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 23.5 m -58.94 158.54 16.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 148.19 31.45 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.381 2.054 . . . . 0.0 110.999 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -142.55 78.4 1.62 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -155.52 113.06 2.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -106.37 45.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.246 3.297 . . . . 0.0 115.388 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.25 1.088 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.067 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 118.157 -0.925 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.98 64.51 8.45 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.861 2.374 . . . . 0.0 109.766 170.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -121.25 57.37 1.0 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 124.065 1.888 . . . . 0.0 110.345 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.24 94.41 6.26 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.171 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.25 -166.93 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 125.178 3.919 . . . . 0.0 110.401 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -50.84 146.07 6.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.323 1.449 . . . . 0.0 107.366 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 t -84.47 144.45 43.16 Favored Pre-proline 0 C--O 1.242 0.704 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.32 153.69 35.83 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.152 2.568 . . . . 0.0 108.715 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -24.18 59.15 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.239 -0.913 . . . . 0.0 112.212 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.1 135.84 55.15 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.1 t -145.92 124.25 12.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.319 1.048 . . . . 0.0 109.118 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -155.52 166.03 34.77 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 128.542 2.737 . . . . 0.0 107.51 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -118.92 150.83 39.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.738 2.015 . . . . 0.0 106.58 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -132.05 176.33 8.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.324 2.249 . . . . 0.0 111.178 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 -158.73 50.96 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.322 1.915 . . . . 0.0 114.439 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -123.06 162.25 22.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.7 -38.31 90.64 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -64.83 -53.75 41.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.474 0.579 . . . . 0.0 111.376 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -59.54 -47.15 86.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.533 0.682 . . . . 0.0 109.183 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.85 -36.2 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.39 -1.29 . . . . 0.0 111.754 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -57.8 -43.43 85.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.55 1.523 . . . . 0.0 111.484 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.91 -34.34 69.02 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.312 0.645 . . . . 0.0 111.495 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.9 96.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.506 0.722 . . . . 0.0 112.261 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -76.08 148.45 37.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.901 1.28 . . . . 0.0 113.831 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 t -90.3 -13.92 34.26 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.643 1.977 . . . . 0.0 109.382 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -131.06 123.99 29.89 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.54 1.536 . . . . 0.0 109.111 -176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.74 114.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.59 168.92 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.516 1.126 . . . . 0.0 109.57 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.0 p -124.31 140.72 52.69 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.61 163.48 24.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.527 -1.358 . . . . 0.0 111.202 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 94.2 m -93.81 127.16 39.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.26 113.32 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -89.78 -47.6 7.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -141.27 166.87 23.58 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.731 0.812 . . . . 0.0 110.208 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.4 mtp -139.06 124.14 18.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.906 1.682 . . . . 0.0 106.83 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.09 146.92 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.249 1.42 . . . . 0.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -72.13 141.1 49.14 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.443 -0.786 . . . . 0.0 109.13 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -132.27 170.25 11.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.767 1.227 . . . . 0.0 109.954 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -62.1 170.32 6.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.028 3.152 . . . . 0.0 114.999 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.5 -123.33 28.96 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -113.94 19.61 16.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 108.255 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.82 171.52 55.15 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 123.37 1.539 . . . . 0.0 115.855 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.73 129.11 8.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.062 2.545 . . . . 0.0 105.264 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.03 123.82 40.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.1 123.17 47.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -95.39 123.73 39.07 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.36 169.04 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.232 1.013 . . . . 0.0 110.539 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -135.75 44.81 2.47 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt 37.8 81.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.746 3.239 . . . . 0.0 119.746 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.4 mm -79.98 -23.14 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.507 1.048 . . . . 0.0 110.305 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.05 160.26 32.58 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.68 35.46 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.632 1.173 . . . . 0.0 109.604 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -138.48 -33.1 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.307 0.643 . . . . 0.0 112.688 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -150.61 133.16 15.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -143.22 77.77 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.091 2.956 . . . . 0.0 103.496 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.61 36.4 2.64 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 125.568 1.556 . . . . 0.0 112.037 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.81 -67.2 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 126.681 2.086 . . . . 0.0 109.736 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.81 125.29 22.89 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 123.755 0.822 . . . . 0.0 108.863 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -78.54 91.28 4.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 124.628 1.205 . . . . 0.0 108.621 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.4 mt -65.84 129.63 94.33 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.64 178.17 7.73 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.45 1.433 . . . . 0.0 112.977 -175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.9 t -43.86 -58.8 4.21 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 116.902 -1.523 . . . . 0.0 109.892 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.77 122.0 9.11 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 N-CA-C 107.623 -1.722 . . . . 0.0 107.623 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -69.83 -153.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 1 C-N-CA 125.909 4.406 . . . . 0.0 110.407 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 54.1 m -31.57 123.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 110.54 -175.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.31 39.21 0.26 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.569 1.081 . . . . 0.0 112.748 -175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.73 164.07 29.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.421 1.488 . . . . 0.0 107.216 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 p -110.38 153.29 25.16 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.874 0.761 . . . . 0.0 112.189 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.5 mt -144.31 159.89 41.94 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.097 1.359 . . . . 0.0 109.165 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -119.67 113.47 20.72 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -95.51 118.59 32.5 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -75.89 113.47 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.841 0.857 . . . . 0.0 109.451 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.73 114.82 63.55 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.35 2.2 5.93 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 113.484 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -135.07 114.14 12.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 109.074 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.93 -10.24 59.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.323 -0.861 . . . . 0.0 111.321 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -82.75 -46.46 13.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.008 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.1 m -151.94 164.17 21.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.477 1.111 . . . . 0.0 112.327 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.75 150.98 52.54 Favored 'Cis proline' 0 C--N 1.355 0.904 0 CA-C-N 120.013 1.04 . . . . 0.0 110.231 -3.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.77 97.62 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.429 2.753 . . . . 0.0 113.638 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 tpp -93.77 162.33 13.97 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.758 1.223 . . . . 0.0 108.411 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -146.77 143.4 28.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.654 1.582 . . . . 0.0 108.313 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.98 139.77 41.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.137 0.575 . . . . 0.0 110.036 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.89 71.39 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 126.386 1.946 . . . . 0.0 115.474 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.76 146.15 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.057 1.743 . . . . 0.0 108.345 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 m -91.87 128.25 37.63 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.443 0.64 . . . . 0.0 109.625 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -124.12 172.29 9.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.089 2.556 . . . . 0.0 111.457 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 123.63 46.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 100.791 -3.781 . . . . 0.0 100.791 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.18 114.03 21.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.5 mtm -116.97 113.25 22.12 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.9 -142.49 3.49 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.172 1.844 . . . . 0.0 110.878 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -132.86 176.41 8.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.617 1.209 . . . . 0.0 110.334 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.33 149.29 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.25 114.31 14.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.249 2.22 . . . . 0.0 106.546 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.82 65.62 0.23 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.285 1.834 . . . . 0.0 114.56 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 169.16 -25.84 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 130.701 3.6 . . . . 0.0 111.64 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -112.76 -6.61 13.84 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.648 1.179 . . . . 0.0 113.889 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.67 -151.01 42.35 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 135.56 22.7 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.205 1.936 . . . . 0.0 110.369 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.264 7.4 p -120.4 142.51 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.282 1.4 tm? -129.67 74.1 81.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -174.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.04 175.11 5.02 Favored 'Trans proline' 0 CA--C 1.543 0.93 1 C-N-CA 125.497 4.131 . . . . 0.0 113.347 -175.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -58.91 -28.91 88.87 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.283 1.988 . . . . 0.0 113.843 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.25 39.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.7 m -107.66 129.12 55.04 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 176.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -82.19 113.74 20.23 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.0 t -133.57 117.86 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 123.812 0.845 . . . . 0.0 109.193 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.75 168.87 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.89 1.276 . . . . 0.0 109.286 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.9 139.29 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.41 0.624 . . . . 0.0 109.415 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -65.55 144.43 56.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.996 1.318 . . . . 0.0 109.203 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -144.34 148.99 43.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.61 -40.5 29.74 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.751 1.634 . . . . 0.0 110.712 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -53.53 -46.43 70.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.801 0.84 . . . . 0.0 110.804 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.91 -40.32 87.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.512 0.725 . . . . 0.0 111.011 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.8 -47.41 82.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.16 0.891 . . . . 0.0 110.009 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -59.31 -39.65 83.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.511 1.524 . . . . 0.0 110.062 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.48 -51.83 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.441 1.019 . . . . 0.0 109.791 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 mt -63.71 -35.07 79.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.129 1.331 . . . . 0.0 109.548 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.0 m -58.67 -49.94 75.7 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.13 -41.47 83.75 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.632 -0.667 . . . . 0.0 112.171 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.84 -28.75 64.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.518 0.727 . . . . 0.0 112.369 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -73.18 -36.64 66.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.865 0.866 . . . . 0.0 108.716 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -75.32 -50.26 16.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.685 1.594 . . . . 0.0 110.37 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.53 166.58 23.2 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.725 -1.234 . . . . 0.0 111.009 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 161.28 24.25 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 22.9 m -79.29 130.74 67.94 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.29 111.84 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.436 2.757 . . . . 0.0 109.279 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 p -160.5 83.21 0.69 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.6 113.24 47.98 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -91.98 -179.0 1.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.667 2.911 . . . . 0.0 110.745 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.255 1.355 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 175.084 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -92.99 55.01 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.004 2.469 . . . . 0.0 111.2 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.87 33.38 3.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.65 148.46 66.87 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 126.592 1.957 . . . . 0.0 109.511 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.05 -178.84 4.03 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.703 2.935 . . . . 0.0 112.701 -176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -65.7 174.35 2.36 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.906 2.083 . . . . 0.0 107.335 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 19.6 t -83.01 116.37 63.86 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.365 -1.46 . . . . 0.0 110.095 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -85.55 176.82 5.33 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.531 2.821 . . . . 0.0 111.705 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -76.21 -9.96 59.04 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -58.9 144.04 45.88 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.803 0.841 . . . . 0.0 109.41 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.8 t -146.23 77.06 1.47 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.5 ttp-105 -151.06 159.5 44.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 129.218 3.007 . . . . 0.0 103.856 175.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -101.25 147.81 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.0 p -137.21 172.3 13.2 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.07 0.548 . . . . 0.0 110.055 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.01 175.65 29.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.392 0.996 . . . . 0.0 112.829 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 p -101.9 168.55 9.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.42 -42.3 96.13 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.38 -42.64 78.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.013 0.525 . . . . 0.0 112.347 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -64.95 -52.43 56.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.89 -36.46 83.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.339 -0.838 . . . . 0.0 112.092 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -60.3 -38.58 84.12 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.907 1.23 . . . . 0.0 111.236 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 m -70.15 -41.26 74.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.385 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.75 -52.89 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 112.903 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -56.17 138.24 50.3 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.325 1.05 . . . . 0.0 112.222 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -82.66 -14.12 55.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.187 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.1 tp -127.57 122.21 32.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.871 1.268 . . . . 0.0 109.592 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.3 t -138.2 113.74 9.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.33 171.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.683 1.593 . . . . 0.0 108.875 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.489 ' CG2' ' HD1' ' A' ' 133' ' ' HIS . 34.2 p -130.77 145.22 51.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.17 167.98 21.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.167 -0.958 . . . . 0.0 111.251 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -102.64 130.08 49.43 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.8 t -71.31 113.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -80.15 -42.99 22.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.365 1.466 . . . . 0.0 109.529 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -156.65 166.01 34.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.705 1.202 . . . . 0.0 109.219 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 59.2 mtp -133.23 129.97 38.42 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.07 148.0 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.655 0.782 . . . . 0.0 108.92 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -70.14 155.34 40.76 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.55 1.068 . . . . 0.0 110.252 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -132.24 176.1 3.18 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.811 1.644 . . . . 0.0 111.491 -175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.22 144.27 98.79 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.459 2.773 . . . . 0.0 111.862 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.23 -152.21 51.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.66 3.87 4.58 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.882 -0.776 . . . . 0.0 110.255 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.54 164.28 20.92 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-O 123.691 1.717 . . . . 0.0 116.82 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -147.81 138.14 22.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.794 2.437 . . . . 0.0 106.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.21 143.28 33.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -118.61 123.31 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.9 m -97.1 132.88 42.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.49 175.9 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.896 0.878 . . . . 0.0 112.407 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -135.98 35.17 2.84 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt 38.47 82.09 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 117.8 2.518 . . . . 0.0 117.8 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.1 mm -77.91 -25.89 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.312 1.045 . . . . 0.0 111.095 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.74 162.95 35.98 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 124.955 1.264 . . . . 0.0 110.752 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 150.11 37.02 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.582 1.953 . . . . 0.0 108.323 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -141.5 -27.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.22 1.008 . . . . 0.0 111.079 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -154.93 127.83 8.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.417 1.487 . . . . 0.0 107.317 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -136.48 74.58 1.5 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.303 3.041 . . . . 0.0 105.402 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.24 35.27 2.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.134 1.35 . . . . 0.0 110.355 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.91 -73.33 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 127.551 2.501 . . . . 0.0 110.796 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.0 mt -56.3 134.74 53.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.39 76.07 5.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.757 2.023 . . . . 0.0 108.788 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.7 138.79 97.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.106 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.52 178.15 7.97 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.815 2.343 . . . . 0.0 112.871 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.0 t -49.02 -54.9 23.87 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 117.041 -1.457 . . . . 0.0 110.88 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.16 117.12 4.85 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -72.72 -152.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 125.03 3.82 . . . . 0.0 111.502 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 41.6 m -34.06 123.9 0.48 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.856 3.262 . . . . 0.0 112.201 -175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.16 58.01 0.21 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.64 1.591 . . . . 0.0 109.436 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 161.5 40.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.034 2.534 . . . . 0.0 106.326 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -99.83 151.33 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.4 mt -143.9 165.2 28.38 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.468 1.507 . . . . 0.0 109.813 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -128.65 120.39 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.47 124.45 47.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.347 1.459 . . . . 0.0 107.779 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -80.31 121.21 25.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.835 1.254 . . . . 0.0 110.501 177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.74 124.49 30.41 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.04 -1.22 11.17 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.568 2.179 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.5 m -150.58 175.75 11.63 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.495 2.318 . . . . 0.0 108.959 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.95 -4.39 5.72 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -79.21 -51.06 9.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.84 1.655 . . . . 0.0 109.944 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.7 m -133.35 155.37 80.86 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 127.282 2.233 . . . . 0.0 111.352 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.67 156.72 85.94 Favored 'Cis proline' 0 CA--C 1.55 1.29 0 C-N-CA 124.658 -0.976 . . . . 0.0 110.154 -2.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.49 87.23 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.535 3.49 . . . . 0.0 114.873 -175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -99.46 156.91 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.038 2.135 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -150.21 152.67 34.97 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.619 1.568 . . . . 0.0 109.331 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -77.95 136.35 37.98 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.65 43.0 30.67 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.84 0.733 . . . . 0.0 113.371 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.67 153.17 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.667 1.587 . . . . 0.0 107.77 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.2 m -98.94 130.73 45.32 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 110.538 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.99 173.24 11.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.588 1.555 . . . . 0.0 111.893 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.0 tp -108.58 124.77 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 130.113 3.365 . . . . 0.0 102.522 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.72 113.84 24.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -115.0 113.24 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 101.221 -3.622 . . . . 0.0 101.221 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.52 -143.12 3.57 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.013 1.292 . . . . 0.0 111.249 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -133.52 176.92 8.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.118 0.967 . . . . 0.0 109.437 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.37 133.09 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.45 -0.781 . . . . 0.0 111.466 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.47 112.98 25.26 Favored 'General case' 0 C--O 1.242 0.693 1 N-CA-C 96.04 -5.541 . . . . 0.0 96.04 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.24 63.71 8.16 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.802 1.287 . . . . 0.0 109.735 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -169.59 -32.48 0.02 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.802 2.441 . . . . 0.0 109.829 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -113.54 -14.71 12.65 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.203 1.001 . . . . 0.0 111.633 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.55 -172.11 22.66 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.15 135.27 49.91 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.903 1.736 . . . . 0.0 109.351 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -114.18 134.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 1.8 tm? -125.74 78.74 68.89 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 125.221 1.408 . . . . 0.0 108.98 -174.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.23 170.77 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.742 2.961 . . . . 0.0 111.596 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -23.05 75.96 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.517 2.145 . . . . 0.0 112.528 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -83.49 24.0 0.88 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.047 0.939 . . . . 0.0 111.883 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 m -94.43 124.3 38.37 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.925 1.29 . . . . 0.0 108.034 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -77.11 113.79 15.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.5 125.79 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.7 167.85 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.382 1.473 . . . . 0.0 108.246 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.57 138.27 58.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.489 ' HD1' ' CG2' ' A' ' 52' ' ' THR . 50.2 t60 -65.39 131.42 46.39 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -141.12 147.27 46.78 Favored Pre-proline 0 N--CA 1.464 0.249 0 C-N-CA 125.69 1.596 . . . . 0.0 107.281 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.75 -37.12 29.32 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.577 2.185 . . . . 0.0 114.008 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -56.48 -52.74 63.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.818 0.735 . . . . 0.0 110.375 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -58.82 -44.48 90.88 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.542 1.137 . . . . 0.0 110.282 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.59 -45.67 88.61 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.408 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -61.46 -39.53 91.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.523 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.93 -47.79 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 119.649 1.113 . . . . 0.0 109.684 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.03 -40.34 93.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.333 1.424 . . . . 0.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.3 m -59.48 -51.22 70.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 109.0 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -65.31 -33.94 77.16 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.244 1.418 . . . . 0.0 111.018 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.44 -35.96 65.85 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.825 1.25 . . . . 0.0 110.504 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -63.41 -34.9 78.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.063 1.301 . . . . 0.0 109.168 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -74.51 -44.1 52.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.881 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -73.09 176.63 5.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.87 1.668 . . . . 0.0 108.104 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.98 146.59 47.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.54 123.7 89.02 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.284 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.62 97.04 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.572 2.181 . . . . 0.0 108.959 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -143.14 76.05 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -114.04 120.53 38.54 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.78 77.63 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.847 2.365 . . . . 0.0 109.937 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.206 -1.378 . . . . 0.0 110.198 -175.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.99 158.88 41.04 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.17 2.58 . . . . 0.0 110.472 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.55 33.85 0.26 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.4 104.8 0.25 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.154 2.182 . . . . 0.0 111.602 -175.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.13 77.8 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.692 3.595 . . . . 0.0 110.214 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -141.92 148.23 38.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.297 2.239 . . . . 0.0 107.032 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 41.3 t -128.52 131.97 24.08 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.874 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.0 159.2 50.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.025 1.817 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -77.19 -47.41 20.35 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.855 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.52 166.2 13.08 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.411 1.484 . . . . 0.0 109.765 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 t -150.12 108.59 3.8 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.249 0.62 . . . . 0.0 110.258 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.12 166.02 23.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.369 1.868 . . . . 0.0 109.184 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttp-105 -131.79 139.85 49.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.904 2.481 . . . . 0.0 105.027 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -147.84 176.67 9.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.803 1.641 . . . . 0.0 112.134 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.43 -157.35 44.21 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.013 0.816 . . . . 0.0 111.255 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 p -120.79 162.73 19.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.75 -39.14 93.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.62 -50.67 68.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.269 0.628 . . . . 0.0 111.09 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -65.15 -43.23 92.48 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -61.3 -44.75 96.7 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 116.92 -1.514 . . . . 0.0 112.364 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -53.35 -46.7 69.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.787 1.631 . . . . 0.0 110.29 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.3 m -66.04 -37.14 85.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.884 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -51.77 60.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.255 1.022 . . . . 0.0 111.379 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -61.1 147.45 43.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.776 0.83 . . . . 0.0 111.022 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -101.42 -9.49 21.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.736 0.814 . . . . 0.0 109.76 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 48.0 tp -127.32 119.21 25.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.169 1.788 . . . . 0.0 106.81 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.8 t -137.25 115.52 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -146.57 169.15 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.932 1.293 . . . . 0.0 109.62 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -131.24 143.59 50.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.57 163.96 16.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.903 -1.123 . . . . 0.0 111.383 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.5 m -91.19 129.98 37.12 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.81 113.22 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -84.58 -35.08 23.01 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -160.41 170.49 20.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.06 1.344 . . . . 0.0 109.315 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.5 mtp -140.6 142.03 35.09 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.392 1.877 . . . . 0.0 106.258 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -143.57 147.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.771 0.828 . . . . 0.0 108.803 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.37 150.98 48.06 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.638 1.563 . . . . 0.0 109.709 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -120.89 175.37 2.41 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 127.96 2.504 . . . . 0.0 108.557 176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.85 150.31 88.71 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.741 1.628 . . . . 0.0 111.244 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.58 -148.23 50.59 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.919 0.771 . . . . 0.0 112.857 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.5 7.1 2.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 112.341 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.26 170.6 54.83 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 122.737 1.187 . . . . 0.0 114.697 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.32 136.65 18.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.806 2.042 . . . . 0.0 106.36 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.0 136.1 38.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.7 t -115.55 123.17 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -91.46 130.47 37.29 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.61 168.84 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.037 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 t -131.02 37.28 3.78 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.1 mt 38.92 81.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.07 -29.1 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.73 155.74 26.78 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 125.748 1.642 . . . . 0.0 109.076 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.08 135.1 37.19 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.899 2.08 . . . . 0.0 105.728 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -130.57 -28.36 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 124.045 0.841 . . . . 0.0 113.009 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.94 129.91 11.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -145.86 68.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.618 1.967 . . . . 0.0 108.433 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.87 39.32 2.84 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.817 1.199 . . . . 0.0 112.355 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.78 -15.82 0.02 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.431 1.491 . . . . 0.0 115.985 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.16 151.42 23.67 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 120.206 2.003 . . . . 0.0 112.232 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -104.7 64.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.757 2.023 . . . . 0.0 106.255 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.41 148.27 73.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.45 -178.57 3.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.701 1.601 . . . . 0.0 111.285 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -52.25 -58.74 10.41 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.434 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.71 147.41 63.11 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 CA-C-N 121.924 1.723 . . . . 0.0 109.028 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.36 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.083 2.522 . . . . 0.0 112.029 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 19.8 m -32.34 132.52 0.13 Allowed 'General case' 0 C--O 1.243 0.733 0 C-N-CA 129.303 3.041 . . . . 0.0 112.085 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.7 57.64 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.746 1.641 . . . . 0.0 110.523 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.63 164.53 36.69 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.739 2.016 . . . . 0.0 107.632 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 p -108.09 146.86 32.02 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.365 0.666 . . . . 0.0 112.415 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.1 mt -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.652 1.981 . . . . 0.0 109.856 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -130.94 115.13 16.11 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.076 2.15 . . . . 0.0 105.488 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -94.04 121.4 35.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -75.58 113.7 13.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.653 1.221 . . . . 0.0 108.986 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.79 121.41 46.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.68 -0.79 10.58 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.438 2.092 . . . . 0.0 112.762 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.6 m -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.212 1.805 . . . . 0.0 108.716 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -94.85 -17.98 21.59 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -102.06 -23.23 14.11 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.792 1.178 . . . . 0.0 113.677 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.5 m -135.03 155.51 79.07 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.104 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -69.87 169.49 63.55 Favored 'Cis proline' 0 CA--C 1.546 1.095 0 CA-C-N 119.825 0.973 . . . . 0.0 110.534 -4.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 77.04 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.866 3.044 . . . . 0.0 111.348 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.9 tpp -93.77 154.12 17.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.318 1.447 . . . . 0.0 110.53 -175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -144.5 144.39 31.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.531 0.733 . . . . 0.0 109.797 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -72.2 148.73 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.801 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.51 37.82 94.93 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.024 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.9 t -143.46 152.61 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.661 1.984 . . . . 0.0 106.771 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 m -94.59 129.03 41.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.86 0.838 . . . . 0.0 110.538 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -124.7 172.16 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.33 2.252 . . . . 0.0 111.567 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.51 125.78 52.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.829 3.651 . . . . 0.0 103.493 175.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.28 114.09 21.37 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.713 1.205 . . . . 0.0 107.884 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 13.4 mtm -117.53 112.91 21.23 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 102.899 -3.001 . . . . 0.0 102.899 174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.68 -137.29 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.25 1.881 . . . . 0.0 109.383 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.67 175.68 9.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 108.755 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.57 144.85 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -116.31 113.19 22.61 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -78.31 63.52 3.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 109.842 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 177.59 -24.57 0.0 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.953 3.701 . . . . 0.0 112.21 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -116.33 -33.38 4.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.111 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.37 -167.37 18.81 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.687 1.613 . . . . 0.0 110.464 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.35 137.43 30.92 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.137 1.225 . . . . 0.0 109.218 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.252 14.7 p -121.31 155.96 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.277 1.0 OUTLIER -138.52 74.05 40.96 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -174.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.99 168.8 9.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 124.832 3.688 . . . . 0.0 111.836 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.37 -19.05 55.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.012 1.397 . . . . 0.0 113.429 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -85.37 23.56 1.3 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.521 1.529 . . . . 0.0 111.384 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.3 m -88.45 143.19 27.14 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.109 0.964 . . . . 0.0 110.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -92.67 115.4 28.07 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 33.3 t -136.98 125.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -151.03 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.0 109.656 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.03 142.48 58.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.428 1.091 . . . . 0.0 109.796 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -73.82 126.75 31.09 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.984 0.913 . . . . 0.0 109.059 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -139.15 156.52 72.12 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 125.106 1.362 . . . . 0.0 108.4 175.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.51 -49.46 11.96 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.234 2.623 . . . . 0.0 114.867 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -58.11 -47.6 82.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.561 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -58.02 -47.02 84.3 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 125.267 1.427 . . . . 0.0 110.439 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -54.37 -51.39 64.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.458 1.503 . . . . 0.0 110.598 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -62.92 -36.24 82.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.252 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.81 -47.27 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.24 1.382 . . . . 0.0 110.183 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.04 -38.7 92.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.061 1.301 . . . . 0.0 109.368 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -44.38 97.34 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.678 -0.638 . . . . 0.0 109.665 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -59.37 -45.93 90.07 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.245 -0.909 . . . . 0.0 109.95 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 -30.43 71.56 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.551 1.141 . . . . 0.0 111.669 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -69.93 -45.77 66.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.824 0.849 . . . . 0.0 110.013 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -75.56 -35.63 60.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 118.956 -0.545 . . . . 0.0 112.131 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -76.19 171.66 14.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.247 1.019 . . . . 0.0 109.974 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -99.13 134.84 41.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 17.6 m -67.11 144.96 98.66 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.57 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 120.2 7.82 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.763 2.309 . . . . 0.0 107.748 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.64 71.49 1.46 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -124.1 113.19 28.18 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.138 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -114.12 -155.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 1 C-N-CA 125.517 4.145 . . . . 0.0 105.338 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.254 1.309 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.126 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -85.64 61.69 5.38 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.048 3.165 . . . . 0.0 110.27 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -138.13 69.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.758 1.266 . . . . 0.0 112.303 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.38 116.16 1.76 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 125.79 1.636 . . . . 0.0 107.585 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.08 158.63 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.794 2.996 . . . . 0.0 112.398 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -73.92 165.56 24.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.072 1.349 . . . . 0.0 110.069 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.4 t -83.82 112.36 39.69 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.179 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.45 175.6 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.714 2.276 . . . . 0.0 110.819 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.38 -16.38 63.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.13 142.18 26.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.806 1.642 . . . . 0.0 110.008 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.64 44.72 2.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.947 0.899 . . . . 0.0 109.052 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -146.06 155.54 42.85 Favored 'General case' 0 C--N 1.338 0.1 0 O-C-N 121.106 -0.996 . . . . 0.0 108.658 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -90.21 145.31 25.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.203 1.801 . . . . 0.0 109.113 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 173.98 11.02 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.818 1.247 . . . . 0.0 110.213 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.43 -172.8 50.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.974 0.797 . . . . 0.0 111.133 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -108.05 170.98 7.67 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.09 -46.68 83.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -62.6 -48.29 80.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.624 0.769 . . . . 0.0 110.984 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -55.17 -54.61 41.13 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.951 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -62.95 -40.94 99.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.592 -1.194 . . . . 0.0 111.996 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -56.89 -44.22 82.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.9 1.227 . . . . 0.0 110.986 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.8 m -64.01 -44.51 92.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.601 0.637 . . . . 0.0 111.446 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.28 -58.93 5.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.263 1.025 . . . . 0.0 111.209 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -55.74 140.72 40.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.611 1.565 . . . . 0.0 113.094 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -93.45 -8.99 40.05 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.721 0.808 . . . . 0.0 109.467 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.8 tp -124.68 122.86 38.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 108.185 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.3 t -139.93 113.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.9 m -149.81 171.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.404 1.482 . . . . 0.0 109.116 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.1 p -133.53 141.89 47.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -164.03 161.35 22.56 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.955 -1.091 . . . . 0.0 112.192 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -95.83 128.04 42.37 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.39 113.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.412 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 29.3 mmmt -85.48 -41.01 15.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.048 0.939 . . . . 0.0 110.431 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -146.53 165.77 28.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 110.144 -175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.6 mtp -142.46 131.15 22.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.751 2.42 . . . . 0.0 105.265 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.69 157.33 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -67.71 150.01 49.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.211 0.604 . . . . 0.0 109.511 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -138.7 171.46 8.17 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 126.768 2.027 . . . . 0.0 109.775 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.14 163.61 22.34 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.569 2.179 . . . . 0.0 112.174 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.26 -151.2 52.25 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.2 9.05 16.17 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.48 171.59 43.59 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 126.58 2.038 . . . . 0.0 117.181 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.95 139.27 17.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.215 2.606 . . . . 0.0 105.171 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.39 124.17 44.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.8 123.17 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -98.5 124.6 43.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.31 174.72 6.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.833 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -137.45 46.05 2.16 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.032 1.287 . . . . 0.0 113.753 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.3 mt 36.14 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.3 mm -75.48 -26.83 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.874 -1.767 . . . . 0.0 109.906 175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.72 163.18 36.96 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.58 148.83 41.57 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.55 -51.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -132.37 124.1 28.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -138.16 61.55 1.59 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.696 1.998 . . . . 0.0 107.519 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 28.01 3.98 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.593 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.13 6.88 0.08 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.266 1.889 . . . . 0.0 114.163 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 77.6 mt -114.43 142.12 46.78 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 120.243 2.022 . . . . 0.0 111.136 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.12 72.82 9.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 111.705 -2.498 . . . . 0.0 105.961 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.35 125.18 81.21 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.78 -174.89 2.21 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.287 2.658 . . . . 0.0 112.48 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -49.73 -55.46 23.12 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.937 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.88 115.31 3.9 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 N-CA-C 108.105 -1.537 . . . . 0.0 108.105 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HB2' ' H ' ' A' ' 88' ' ' THR . 43.3 Cg_endo -74.67 -152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.945 3.763 . . . . 0.0 109.924 177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.402 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 51.8 m -34.83 124.38 0.55 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.037 2.135 . . . . 0.0 109.547 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.61 -16.98 5.85 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 128.499 2.952 . . . . 0.0 111.734 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.92 154.6 31.5 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.135 1.467 . . . . 0.0 111.112 -175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 82.2 p -100.11 135.78 41.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -130.6 152.86 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.91 2.084 . . . . 0.0 109.495 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -108.17 114.06 27.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -89.74 119.82 30.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -75.74 113.52 13.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.42 114.28 63.43 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 5.21 1.73 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.619 2.879 . . . . 0.0 114.307 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.6 m -145.53 166.69 24.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.875 2.07 . . . . 0.0 109.044 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -123.57 -22.58 4.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.598 1.159 . . . . 0.0 113.307 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.12 -44.83 87.42 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.368 1.067 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.2 m -143.96 162.96 38.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.602 1.561 . . . . 0.0 109.15 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.36 157.39 68.26 Favored 'Cis proline' 0 CA--C 1.538 0.71 0 CA-C-N 119.671 0.918 . . . . 0.0 110.394 -3.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 80.38 1.14 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.236 2.624 . . . . 0.0 111.897 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.0 tpp -94.09 152.99 18.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.492 2.317 . . . . 0.0 107.943 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -137.27 143.23 42.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.96 142.28 52.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.97 62.61 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.53 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.55 155.33 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.744 1.618 . . . . 0.0 108.266 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 m -97.19 131.28 44.08 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.596 0.758 . . . . 0.0 111.393 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -128.48 170.07 13.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.011 2.125 . . . . 0.0 111.594 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.73 126.51 54.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 130.395 3.478 . . . . 0.0 102.996 175.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.61 113.97 20.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.5 mtm -116.61 113.13 22.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.27 -139.09 2.67 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -134.49 173.04 12.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -133.41 148.29 30.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -116.49 112.81 21.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 174.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.44 78.68 8.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 177.22 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 130.841 3.656 . . . . 0.0 109.801 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -125.98 -32.1 2.81 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.155 1.782 . . . . 0.0 115.011 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.31 -158.13 14.5 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 139.85 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.803 1.669 . . . . 0.0 111.672 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.34 152.93 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -145.79 74.57 13.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.418 -1.426 . . . . 0.0 111.775 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.52 170.4 15.1 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.288 3.325 . . . . 0.0 111.792 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.03 -9.74 26.1 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.077 1.852 . . . . 0.0 113.727 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.28 25.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 m -105.34 137.84 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.37 2.268 . . . . 0.0 109.154 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.38 113.79 21.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.9 t -134.09 116.63 23.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.74 169.21 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.64 . . . . 0.0 108.874 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.0 mt -64.02 138.44 58.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -64.99 128.15 34.58 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -142.82 147.87 43.64 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.479 1.512 . . . . 0.0 107.767 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.38 -38.04 45.63 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.052 2.501 . . . . 0.0 113.704 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -54.56 -49.41 70.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.669 0.747 . . . . 0.0 110.487 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -66.32 -43.75 85.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.804 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.19 -52.24 46.2 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.109 1.364 . . . . 0.0 111.597 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.62 -47.67 84.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.989 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.9 -48.65 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.711 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mt -63.57 -38.08 89.76 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.969 1.259 . . . . 0.0 109.692 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.4 m -61.5 -46.72 88.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -59.31 -43.32 92.65 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.567 -0.708 . . . . 0.0 110.273 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.66 -26.42 67.79 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.326 1.05 . . . . 0.0 112.192 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 -39.44 71.15 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.281 1.032 . . . . 0.0 109.595 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -70.47 -56.61 6.18 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -62.23 163.22 8.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.111 1.364 . . . . 0.0 108.979 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -100.52 152.02 20.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.236 1.014 . . . . 0.0 108.481 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.25 156.91 89.03 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 122.354 0.262 . . . . 0.0 111.051 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.95 102.82 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.314 2.676 . . . . 0.0 109.785 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -140.18 64.19 1.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -141.26 142.79 28.2 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 176.3 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.829 1.686 . . . . 0.0 109.632 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.257 1.47 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.299 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.236 0.361 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -88.81 53.85 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.131 3.221 . . . . 0.0 109.472 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.48 69.33 0.71 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.327 1.537 . . . . 0.0 107.499 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.9 133.56 12.44 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.753 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.73 179.56 6.39 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.514 2.809 . . . . 0.0 110.531 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -75.25 162.53 28.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.3 t -82.8 119.92 75.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.99 169.5 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.286 2.658 . . . . 0.0 111.561 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -68.62 -15.04 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.836 0.854 . . . . 0.0 111.69 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -60.75 153.77 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.988 1.715 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.1 t -147.7 74.17 1.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.899 0.88 . . . . 0.0 109.074 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -156.92 152.96 27.37 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.975 -1.078 . . . . 0.0 108.668 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -92.29 145.49 24.45 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.323 1.049 . . . . 0.0 108.6 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 p -137.59 163.62 30.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.669 0.747 . . . . 0.0 110.926 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.14 171.06 42.35 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.583 1.087 . . . . 0.0 112.389 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.6 p -94.07 159.1 15.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.79 -44.44 93.34 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.081 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -61.48 -43.55 98.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.866 0.757 . . . . 0.0 111.363 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -64.41 -52.33 58.7 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -63.93 -36.03 82.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.958 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -63.65 -33.46 75.67 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.429 1.468 . . . . 0.0 111.317 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.3 -40.65 51.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.315 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -51.17 68.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.388 0.675 . . . . 0.0 110.975 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -60.38 152.73 24.61 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.205 1.402 . . . . 0.0 112.209 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -111.6 -4.02 14.89 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.88 118.47 23.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 t -137.01 113.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.86 172.0 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.186 1.395 . . . . 0.0 109.767 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 p -132.02 140.53 48.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.89 167.23 25.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.097 -1.002 . . . . 0.0 112.355 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.4 m -102.97 126.9 50.33 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 113.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 -44.77 15.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.6 m -146.54 170.9 15.95 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.367 1.067 . . . . 0.0 110.122 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.01 124.57 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.26 2.224 . . . . 0.0 105.667 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.86 148.39 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.294 1.838 . . . . 0.0 107.655 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.84 154.07 38.43 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.849 1.204 . . . . 0.0 109.388 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -138.49 176.24 2.8 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.205 1.402 . . . . 0.0 109.313 -175.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.07 139.86 14.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.408 2.739 . . . . 0.0 114.493 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.46 -130.48 40.71 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.54 1.543 . . . . 0.0 110.926 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.15 6.98 26.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.159 0.984 . . . . 0.0 110.342 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.54 163.74 51.37 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 123.203 1.446 . . . . 0.0 113.16 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -153.84 131.27 11.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.398 1.879 . . . . 0.0 106.061 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.98 138.22 39.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.81 122.98 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -91.77 124.25 35.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.9 172.13 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 111.017 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -138.41 35.96 2.27 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.53 0.605 . . . . 0.0 112.191 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.268 25.1 mt 38.71 80.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.51 -20.7 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.228 1.011 . . . . 0.0 109.052 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.17 169.84 41.68 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.079 1.8 . . . . 0.0 110.891 175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.38 154.35 42.2 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.199 1.399 . . . . 0.0 108.473 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.33 -41.12 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.29 1.036 . . . . 0.0 109.881 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -144.51 138.24 27.43 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.48 67.39 1.43 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.19 2.996 . . . . 0.0 106.104 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.51 4.58 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.654 2.073 . . . . 0.0 109.695 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.62 -66.4 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 127.462 2.458 . . . . 0.0 111.02 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.25 128.07 34.59 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.269 0.628 . . . . 0.0 111.885 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.29 85.67 7.18 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.1 147.73 90.05 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 121.156 -0.965 . . . . 0.0 108.54 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.28 170.07 18.08 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -46.31 -55.55 13.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.745 1.218 . . . . 0.0 111.396 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.03 138.03 39.11 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 121.086 1.424 . . . . 0.0 109.356 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.79 -154.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.561 3.507 . . . . 0.0 111.909 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.1 m -34.15 137.07 0.11 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.492 2.717 . . . . 0.0 112.499 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.2 64.52 0.43 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -175.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.23 162.89 39.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.009 2.524 . . . . 0.0 106.237 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 p -108.82 157.4 18.62 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.211 -0.931 . . . . 0.0 111.986 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -151.69 169.17 22.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.043 2.137 . . . . 0.0 109.757 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -123.22 114.09 19.8 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.71 120.14 32.8 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -73.94 121.92 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.81 1.244 . . . . 0.0 110.12 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.58 123.95 30.67 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.91 -9.56 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.293 1.995 . . . . 0.0 113.885 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -145.39 158.31 43.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.832 1.653 . . . . 0.0 109.759 -176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.24 -16.76 13.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -66.05 -50.79 62.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.776 1.171 . . . . 0.0 110.651 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -134.86 161.39 63.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.93 1.292 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.94 158.71 81.29 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 O-C-N 122.73 0.858 . . . . 0.0 111.463 -3.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.58 90.6 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.483 2.789 . . . . 0.0 110.949 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.91 138.86 39.89 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 127.061 2.144 . . . . 0.0 111.36 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -133.57 137.63 45.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.033 0.921 . . . . 0.0 110.26 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -68.12 144.49 55.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.439 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.06 24.16 69.78 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.6 t -133.94 152.24 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.094 2.157 . . . . 0.0 107.627 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -98.53 130.9 45.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.074 0.95 . . . . 0.0 109.229 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.47 169.38 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.278 2.231 . . . . 0.0 112.882 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.2 tp -115.76 124.21 50.2 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 131.071 3.748 . . . . 0.0 102.017 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.06 113.75 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.7 mtm -115.49 112.91 22.96 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 101.454 -3.536 . . . . 0.0 101.454 175.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.29 -140.89 3.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.473 1.987 . . . . 0.0 110.877 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -138.73 176.89 8.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 t -130.55 132.86 64.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -115.28 114.22 24.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.56 80.12 7.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -173.04 -34.93 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.286 2.635 . . . . 0.0 108.146 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -134.71 -10.95 2.38 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 113.655 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 109.0 -162.66 12.75 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.58 1.086 . . . . 0.0 111.919 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.29 136.83 41.59 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.046 1.83 . . . . 0.0 110.043 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.89 147.87 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.269 1.8 tm? -137.38 73.71 49.21 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -174.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.37 175.09 8.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.493 3.462 . . . . 0.0 111.701 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.6 -17.6 35.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.91 1.74 . . . . 0.0 113.694 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.46 22.37 1.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.567 1.53 . . . . 0.0 111.305 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -98.95 124.54 43.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -76.19 113.87 14.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 50.3 t -134.23 114.21 18.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.192 0.52 . . . . 0.0 110.168 -175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.29 169.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.972 1.309 . . . . 0.0 108.943 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.17 140.47 58.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.609 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.18 139.79 54.59 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -142.63 148.24 45.77 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 126.045 1.738 . . . . 0.0 106.775 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.3 -36.21 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.239 2.626 . . . . 0.0 111.018 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -58.63 -43.7 89.77 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.276 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -66.81 -43.85 82.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.435 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -51.45 -49.56 61.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.648 1.179 . . . . 0.0 111.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -60.79 -46.84 88.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.176 1.391 . . . . 0.0 111.208 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.3 -50.83 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.467 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.03 -33.82 76.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.489 1.04 . . . . 0.0 109.778 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.4 m -62.8 -40.4 97.25 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.784 -0.573 . . . . 0.0 109.541 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -60.78 -42.59 97.83 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.202 -0.936 . . . . 0.0 109.893 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.67 -30.38 71.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.766 0.826 . . . . 0.0 111.338 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.2 t -65.4 -46.74 78.87 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.324 0.966 . . . . 0.0 108.79 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -67.31 -49.99 61.98 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.871 -0.518 . . . . 0.0 110.414 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 mtm-85 -75.93 162.32 28.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.754 0.821 . . . . 0.0 112.906 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -75.89 155.24 35.41 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.9 m -66.96 145.71 98.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 118.915 -0.564 . . . . 0.0 110.925 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 93.42 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.752 1.634 . . . . 0.0 110.613 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -160.85 83.2 0.66 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.912 2.085 . . . . 0.0 108.646 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -113.97 159.03 37.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.03 43.58 1.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.976 1.784 . . . . 0.0 112.131 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.249 1.031 0 C-N-CA 128.786 2.834 . . . . 0.0 103.4 176.456 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.474 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 4.9 p . . . . . 0 CA--C 1.513 -0.463 0 CA-C-O 119.914 -0.089 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.37 125.17 14.02 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 107.89 -1.619 . . . . 0.0 107.89 159.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -66.76 40.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 1 C-N-CA 133.042 4.537 . . . . 0.0 113.664 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 147.77 96.84 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 126.702 2.001 . . . . 0.0 111.411 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.7 -178.06 4.29 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.183 3.256 . . . . 0.0 112.73 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.2 m -58.45 176.12 0.2 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 126.663 1.985 . . . . 0.0 108.406 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.7 t -83.79 128.49 63.18 Favored Pre-proline 0 C--O 1.241 0.621 0 O-C-N 119.765 -1.835 . . . . 0.0 111.374 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.84 173.34 14.64 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.219 3.279 . . . . 0.0 111.042 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.76 -11.45 59.98 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.667 -0.646 . . . . 0.0 110.914 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -57.46 123.28 14.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -146.64 52.07 1.11 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.55 0.691 . . . . 0.0 109.261 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -144.87 161.44 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.59 1.956 . . . . 0.0 106.169 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -106.56 147.54 29.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.459 2.304 . . . . 0.0 105.882 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -140.79 176.31 8.9 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.686 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.32 169.85 38.36 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.488 1.518 . . . . 0.0 113.954 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -84.06 155.99 22.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 108.525 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.05 -47.41 80.3 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -62.72 -50.07 72.55 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.364 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.4 m -65.97 -40.23 91.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.486 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -63.44 -47.04 83.55 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.142 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.4 ' CD2' HG13 ' A' ' 50' ' ' VAL . 12.1 t80 -52.17 -42.75 63.7 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.51 1.504 . . . . 0.0 110.535 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -63.22 -46.27 87.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.154 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.55 88.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.568 0.747 . . . . 0.0 112.946 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 p -76.15 131.16 39.21 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.884 1.274 . . . . 0.0 111.817 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -88.81 -6.71 57.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.706 0.803 . . . . 0.0 108.929 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.03 114.7 23.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.732 2.413 . . . . 0.0 109.134 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.4 HG13 ' CD2' ' A' ' 44' ' ' PHE . 23.4 t -139.59 113.5 6.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.14 168.52 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.19 1.396 . . . . 0.0 108.524 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.57 ' CG2' ' HD1' ' A' ' 133' ' ' HIS . 2.9 p -134.23 140.99 46.85 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.58 170.58 18.34 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.421 -0.8 . . . . 0.0 111.205 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -109.28 133.94 52.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.51 114.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.314 0.645 . . . . 0.0 109.602 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -77.72 -53.08 7.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -141.22 168.31 20.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.877 1.271 . . . . 0.0 110.739 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.73 141.58 34.89 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 128.02 2.528 . . . . 0.0 105.846 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t -141.87 146.15 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -73.59 139.4 45.51 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 120.203 -1.561 . . . . 0.0 108.921 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -117.74 169.0 8.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 125.662 1.585 . . . . 0.0 108.642 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.39 152.82 24.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.254 2.636 . . . . 0.0 115.548 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.26 -125.91 39.14 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -89.25 9.66 25.03 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.616 0.766 . . . . 0.0 111.274 -176.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.64 171.32 49.25 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.27 139.15 18.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.468 3.107 . . . . 0.0 106.528 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -103.71 152.16 22.15 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.691 1.196 . . . . 0.0 108.567 175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.63 123.43 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -97.67 126.6 43.08 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.36 172.7 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.194 0.998 . . . . 0.0 110.189 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -128.1 36.38 4.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.306 17.4 mt 40.16 80.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.694 2.398 . . . . 0.0 115.511 174.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.9 mm -78.02 -28.43 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 119.077 0.853 . . . . 0.0 109.815 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.1 157.43 28.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.92 138.7 35.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -132.42 -31.74 1.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.301 -175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -151.69 125.82 9.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -143.71 67.29 1.28 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.376 2.27 . . . . 0.0 109.693 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.65 46.01 3.57 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.948 1.261 . . . . 0.0 110.833 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.27 -48.97 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 126.05 1.786 . . . . 0.0 111.072 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.75 124.14 21.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 117.451 0.625 . . . . 0.0 109.336 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -78.47 64.82 3.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 129.108 2.963 . . . . 0.0 108.375 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.7 mt -57.98 123.64 65.36 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.39 -174.74 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.402 2.735 . . . . 0.0 111.55 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -49.46 -53.55 39.31 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.16 -1.4 . . . . 0.0 110.663 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.22 133.49 24.83 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 121.72 1.65 . . . . 0.0 107.965 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.51 -153.82 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.083 3.189 . . . . 0.0 110.96 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.3 m -34.87 131.28 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.584 2.754 . . . . 0.0 111.145 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.7 14.72 1.86 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 125.196 1.379 . . . . 0.0 112.573 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.37 53.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.213 1.506 . . . . 0.0 107.718 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.5 p -76.66 137.21 39.28 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.686 -0.634 . . . . 0.0 110.354 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.91 160.9 36.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.425 0.69 . . . . 0.0 111.194 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -124.17 113.63 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.699 2.0 . . . . 0.0 107.709 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -97.18 121.84 39.51 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -78.06 113.63 16.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.06 114.16 64.68 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.41 6.08 3.34 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.378 2.718 . . . . 0.0 113.119 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.0 m -135.97 151.09 49.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.411 2.284 . . . . 0.0 108.486 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.24 -5.74 11.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.502 0.721 . . . . 0.0 109.707 175.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -71.32 -58.3 3.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.435 2.694 . . . . 0.0 109.354 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -143.91 165.99 21.56 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 129.224 3.01 . . . . 0.0 110.9 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.2 152.52 98.34 Favored 'Cis proline' 0 CA--C 1.544 0.99 0 CA-C-N 119.671 0.918 . . . . 0.0 112.489 -2.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.37 112.32 2.54 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.839 3.026 . . . . 0.0 110.741 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.4 ttp -138.18 163.45 31.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -144.57 150.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.058 0.943 . . . . 0.0 110.047 -176.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.09 146.87 52.21 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.09 33.02 84.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.743 0.687 . . . . 0.0 113.993 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.7 154.87 32.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 119.089 1.445 . . . . 0.0 107.234 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 m -103.32 131.55 50.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.733 1.213 . . . . 0.0 111.704 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.95 175.65 9.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.117 0.967 . . . . 0.0 113.518 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.5 tp -113.01 128.13 56.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 130.799 3.64 . . . . 0.0 103.774 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.13 114.28 22.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.9 mtm -117.76 113.15 21.41 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.53 -137.55 2.39 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.475 1.512 . . . . 0.0 111.005 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -132.3 176.15 8.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.544 1.172 . . . . 0.0 110.9 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.3 t -130.21 139.81 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 121.117 -0.989 . . . . 0.0 109.275 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' OE2' ' HA ' ' A' ' 24' ' ' SER . 19.2 mm-40 -103.36 112.84 25.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.58 63.55 6.78 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -157.55 -42.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 129.393 3.077 . . . . 0.0 108.223 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -142.88 -11.53 0.77 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.67 -163.52 13.12 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.589 1.086 . . . . 0.0 111.727 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.32 141.36 51.37 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.273 1.982 . . . . 0.0 113.202 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.94 128.7 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.59 79.65 30.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.53 1.532 . . . . 0.0 110.529 -174.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.13 173.63 8.18 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.659 3.573 . . . . 0.0 113.072 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.19 -22.27 73.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.013 1.809 . . . . 0.0 113.249 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -83.6 23.12 0.99 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.258 0.936 . . . . 0.0 111.12 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.5 m -95.92 134.19 39.21 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.632 1.173 . . . . 0.0 110.424 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.32 113.44 17.46 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.1 t -134.81 114.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 123.192 0.597 . . . . 0.0 110.502 -175.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 m -147.26 169.81 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.518 1.527 . . . . 0.0 110.27 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.12 147.28 52.6 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.546 0.738 . . . . 0.0 109.831 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.57 ' HD1' ' CG2' ' A' ' 52' ' ' THR . 26.7 t60 -75.12 137.84 41.66 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -143.61 142.8 21.62 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 107.977 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.55 -38.89 65.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.913 3.075 . . . . 0.0 116.283 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -65.77 -47.68 74.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.792 0.723 . . . . 0.0 110.251 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -58.13 -45.33 87.53 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.84 -0.538 . . . . 0.0 110.013 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -49.63 -55.44 13.63 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.908 1.683 . . . . 0.0 109.632 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -58.19 -43.38 87.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.183 0.993 . . . . 0.0 111.684 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.46 -46.68 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.931 0.787 . . . . 0.0 109.4 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -37.71 85.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.486 1.039 . . . . 0.0 109.079 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 78.9 m -59.99 -38.97 84.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.311 0.96 . . . . 0.0 109.499 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -62.72 -42.73 99.8 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.41 -0.806 . . . . 0.0 110.037 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.8 mt -69.35 -23.56 63.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.683 1.193 . . . . 0.0 112.428 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.4 t -72.63 -33.31 66.54 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.01 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -76.26 -65.59 0.9 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.366 1.466 . . . . 0.0 110.273 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -74.97 147.3 40.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.7 1.2 . . . . 0.0 110.831 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -76.86 166.45 23.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 23.3 m -88.47 122.98 69.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.18 93.46 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 N-CA-C 108.195 -1.502 . . . . 0.0 108.195 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.02 84.4 0.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -113.21 132.64 22.33 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.5 172.7 15.82 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.159 2.573 . . . . 0.0 110.434 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--O 1.247 0.942 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 176.15 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.32 164.44 26.58 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.542 2.828 . . . . 0.0 112.189 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -83.1 70.39 10.04 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.385 1.874 . . . . 0.0 111.796 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.52 140.14 96.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.502 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.25 171.38 14.01 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.746 2.297 . . . . 0.0 110.962 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.5 m -58.17 158.95 6.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.248 1.023 . . . . 0.0 110.557 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 t -97.22 102.81 13.35 Favored Pre-proline 0 C--O 1.239 0.544 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.46 166.6 23.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.634 2.223 . . . . 0.0 110.004 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -15.34 59.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -63.57 164.05 10.16 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.624 1.97 . . . . 0.0 110.182 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.6 t -139.54 104.96 5.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.835 1.254 . . . . 0.0 109.125 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -148.08 166.11 28.79 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -135.56 148.48 49.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -134.28 176.58 8.47 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.91 1.684 . . . . 0.0 111.695 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 -158.82 53.72 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 p -123.18 176.37 6.12 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.526 1.13 . . . . 0.0 108.043 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.6 -49.0 70.37 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -60.9 -46.28 91.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.921 0.488 . . . . 0.0 110.803 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m -62.56 -48.62 78.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.87 0.468 . . . . 0.0 110.319 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.17 -37.27 86.87 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -57.13 -40.78 77.82 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.298 1.408 . . . . 0.0 110.265 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.91 -33.76 66.18 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.513 -0.742 . . . . 0.0 111.861 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.13 66.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.164 0.986 . . . . 0.0 113.043 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -76.05 147.3 38.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 111.133 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.4 t -93.77 -11.51 31.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.299 0.64 . . . . 0.0 109.368 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.8 tp -127.26 120.08 27.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.073 1.349 . . . . 0.0 108.261 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.7 t -138.86 113.89 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -148.11 172.17 2.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.034 1.334 . . . . 0.0 109.326 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.405 ' HB ' ' HD1' ' A' ' 133' ' ' HIS . 5.9 p -130.99 143.21 50.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.87 171.64 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.224 -0.923 . . . . 0.0 111.162 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.4 m -120.69 132.49 55.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 113.68 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.418 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 26.4 mmmt -80.98 -51.62 8.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -140.16 168.02 20.78 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 41.6 mtp -137.13 123.78 21.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 100.669 -3.826 . . . . 0.0 100.669 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 t -124.07 145.45 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.52 151.5 37.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.892 0.769 . . . . 0.0 109.446 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.86 173.14 6.01 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 106.726 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.29 136.71 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.379 2.719 . . . . 0.0 115.24 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.5 -123.78 34.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.525 1.536 . . . . 0.0 111.028 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.55 1.88 15.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.931 0.892 . . . . 0.0 112.084 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.88 158.35 51.71 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 122.857 1.254 . . . . 0.0 114.449 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -150.19 137.88 19.94 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.809 2.044 . . . . 0.0 105.827 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.16 123.31 48.08 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.45 123.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.3 m -98.07 124.2 42.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.9 176.16 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.822 0.849 . . . . 0.0 110.072 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -135.34 44.01 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.293 67.4 mt 39.49 81.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.1 mm -79.07 -28.18 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 120.004 1.274 . . . . 0.0 112.6 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.22 158.62 29.06 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.51 140.05 33.4 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.68 1.192 . . . . 0.0 108.332 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -137.13 -30.88 0.84 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.519 0.728 . . . . 0.0 111.391 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -151.85 127.32 10.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.9 p -140.31 59.55 1.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.463 2.705 . . . . 0.0 107.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.92 45.99 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.853 1.216 . . . . 0.0 110.746 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.27 -43.18 0.04 OUTLIER Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.92 3.153 . . . . 0.0 111.459 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.23 128.19 34.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.107 0.956 . . . . 0.0 113.302 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -81.9 75.78 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 mt -58.71 150.23 59.12 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.114 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.58 175.27 4.46 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.114 1.209 . . . . 0.0 109.684 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -49.14 -62.29 2.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.738 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.98 153.2 37.05 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 121.186 1.459 . . . . 0.0 109.99 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.53 -155.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.815 4.343 . . . . 0.0 112.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.3 m -33.26 124.75 0.39 Allowed 'General case' 0 C--O 1.253 1.249 0 C-N-CA 130.149 3.38 . . . . 0.0 114.414 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.42 56.04 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.83 2.157 . . . . 0.0 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.58 154.48 37.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.845 1.258 . . . . 0.0 107.956 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.8 p -86.62 151.82 23.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.627 0.727 . . . . 0.0 111.405 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.3 mt -152.58 152.8 32.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.326 1.851 . . . . 0.0 108.092 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -112.94 113.22 25.18 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -84.95 119.7 25.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -77.14 113.11 14.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.7 113.38 62.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.42 -12.39 25.0 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.708 1.605 . . . . 0.0 113.834 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.5 m -141.83 119.16 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.267 1.427 . . . . 0.0 107.429 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -5.57 47.9 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.04 -1.038 . . . . 0.0 111.192 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -59.46 -58.15 9.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.74 1.216 . . . . 0.0 110.696 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.8 m -152.3 163.78 22.44 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.286 2.234 . . . . 0.0 110.032 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.8 161.7 71.42 Favored 'Cis proline' 0 CA--C 1.545 1.07 0 CA-C-N 119.779 0.957 . . . . 0.0 113.556 1.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.81 133.84 37.96 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.48 2.787 . . . . 0.0 112.206 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.3 ttm -149.65 167.16 27.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.873 0.869 . . . . 0.0 111.613 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -150.73 147.65 27.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.962 2.505 . . . . 0.0 107.386 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -69.22 149.42 48.58 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.24 41.81 99.49 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.08 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.74 149.83 25.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -94.41 136.37 34.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.372 1.069 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.08 175.79 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.763 2.025 . . . . 0.0 112.868 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.11 123.98 43.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 131.07 3.748 . . . . 0.0 101.343 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.83 115.13 22.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.365 1.466 . . . . 0.0 107.979 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 18.1 mtm -117.37 113.17 21.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.96 -139.94 2.99 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.354 1.454 . . . . 0.0 112.079 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -132.6 175.35 9.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.836 -1.391 . . . . 0.0 111.344 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.89 145.45 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -127.76 114.66 17.56 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.28 63.8 0.37 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.388 1.475 . . . . 0.0 114.874 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 170.29 -22.27 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 1 C-N-CA 132.361 4.264 . . . . 0.0 111.81 175.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.22 -4.6 13.72 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.421 1.088 . . . . 0.0 110.718 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.78 -154.75 50.34 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 124.467 1.032 . . . . 0.0 113.162 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 126.59 11.7 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.025 2.483 . . . . 0.0 110.53 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.266 2.7 p -116.78 127.99 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.56 79.52 29.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.412 1.485 . . . . 0.0 109.586 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.96 170.58 13.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.422 3.415 . . . . 0.0 112.708 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.46 -26.31 70.45 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.411 2.074 . . . . 0.0 114.033 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -86.74 23.58 1.66 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.846 1.258 . . . . 0.0 111.208 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -83.37 142.34 31.1 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 108.305 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -82.94 114.05 20.96 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -135.94 119.87 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.16 0.584 . . . . 0.0 110.151 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.3 m -144.75 167.01 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.306 1.443 . . . . 0.0 108.662 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.51 149.31 48.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 110.266 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.405 ' HD1' ' HB ' ' A' ' 52' ' ' THR . 34.1 t60 -69.25 131.5 44.98 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.915 0.886 . . . . 0.0 109.021 -178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -141.08 147.75 48.93 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.54 -37.85 55.72 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.539 2.826 . . . . 0.0 114.753 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -59.77 -49.23 78.52 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -58.08 -46.89 84.71 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.009 0.923 . . . . 0.0 109.433 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -51.76 -50.45 60.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 109.987 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -63.69 -42.45 97.99 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.634 -0.666 . . . . 0.0 111.847 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.64 -50.76 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.062 0.846 . . . . 0.0 109.347 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.84 -32.17 73.54 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.793 0.724 . . . . 0.0 109.368 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.47 -41.79 88.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.524 0.602 . . . . 0.0 110.121 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.18 -47.16 85.73 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 109.433 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.29 -24.23 66.52 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.491 1.116 . . . . 0.0 112.127 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -69.75 -55.99 8.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 0.0 109.858 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -72.48 -39.51 67.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.858 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -75.54 164.15 26.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.587 0.755 . . . . 0.0 110.426 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.41 156.63 19.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 17.8 m -64.05 148.4 95.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 111.761 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.55 97.4 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.009 3.139 . . . . 0.0 109.526 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.1 m -153.13 75.3 1.07 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.591 0.756 . . . . 0.0 110.082 -176.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -117.67 113.91 38.05 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -85.2 174.96 6.77 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.923 3.082 . . . . 0.0 113.884 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 C--O 1.249 1.074 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 175.604 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.27 166.88 19.88 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.57 2.18 . . . . 0.0 111.878 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -84.66 44.53 1.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.759 . . . . 0.0 112.283 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.03 115.68 9.58 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.896 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.64 158.33 35.76 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.262 2.641 . . . . 0.0 114.582 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -64.53 162.5 15.29 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.172 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.28 115.6 59.99 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -70.17 154.29 66.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 N-CA-C 106.571 -2.126 . . . . 0.0 106.571 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -68.3 -46.27 70.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.068 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.55 165.6 16.54 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 t -134.25 117.19 16.17 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.542 -1.349 . . . . 0.0 108.434 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -155.09 166.04 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.468 2.307 . . . . 0.0 111.32 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -116.92 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.796 2.038 . . . . 0.0 106.84 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.5 p -142.19 176.49 8.93 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.458 1.503 . . . . 0.0 107.963 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.58 -164.55 54.64 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -124.9 163.61 21.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.04 -43.97 93.94 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.53 -48.12 80.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.581 0.628 . . . . 0.0 111.059 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.4 m -61.68 -50.61 71.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.502 0.592 . . . . 0.0 110.177 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -59.63 -44.84 93.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.853 -1.546 . . . . 0.0 110.37 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -52.5 -51.22 60.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.098 1.317 . . . . 0.0 111.042 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.4 m -64.42 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.845 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.01 -60.4 2.52 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.007 0.523 . . . . 0.0 111.703 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 p -53.17 124.68 15.13 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.879 0.871 . . . . 0.0 110.931 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -81.99 -4.84 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.383 0.992 . . . . 0.0 109.51 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.1 tp -118.33 120.84 38.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.138 2.175 . . . . 0.0 108.658 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.4 t -144.05 113.59 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -149.38 167.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.365 1.466 . . . . 0.0 108.704 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -127.01 140.61 52.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -157.83 168.17 27.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.787 -1.196 . . . . 0.0 111.379 -178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -114.87 130.85 56.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.53 113.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -71.42 -50.49 31.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 m -157.22 168.96 25.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.377 1.471 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.6 mtp -137.33 133.87 35.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.022 2.129 . . . . 0.0 108.033 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -136.66 148.02 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.901 1.28 . . . . 0.0 107.833 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -75.43 145.97 41.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.613 1.097 . . . . 0.0 109.701 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -123.27 171.08 7.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 127.102 2.161 . . . . 0.0 111.726 -175.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.3 153.38 34.13 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.181 2.587 . . . . 0.0 113.361 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.89 -124.19 6.91 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.4 23.94 11.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.482 1.113 . . . . 0.0 108.46 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.52 179.57 53.08 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.836 1.798 . . . . 0.0 117.374 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -150.62 136.11 17.99 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.988 2.115 . . . . 0.0 107.037 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.69 123.59 46.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.03 123.22 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -99.78 125.22 45.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.6 m -131.91 174.49 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.369 0.667 . . . . 0.0 109.813 -175.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -132.17 41.56 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt 38.24 80.58 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.242 2.217 . . . . 0.0 115.918 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -77.11 -24.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.406 0.682 . . . . 0.0 112.201 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.07 162.74 34.96 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 126.145 1.831 . . . . 0.0 109.209 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 150.2 32.23 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.535 1.134 . . . . 0.0 108.827 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -143.22 -49.6 0.33 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.139 0.899 . . . . 0.0 111.879 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -131.98 123.68 27.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -141.18 65.37 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.71 2.404 . . . . 0.0 109.253 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.07 42.46 3.15 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.871 1.7 . . . . 0.0 110.929 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.76 -66.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 125.699 1.618 . . . . 0.0 110.601 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 mt -71.04 130.49 41.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.195 0.521 . . . . 0.0 111.728 -175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -84.88 80.04 9.42 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.3 mt -58.91 139.15 87.15 Favored Pre-proline 0 C--O 1.238 0.455 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.46 174.07 12.18 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 120.971 1.114 . . . . 0.0 111.165 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 t -44.92 -59.71 3.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 116.514 -1.707 . . . . 0.0 110.004 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.78 118.59 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.963 1.775 . . . . 0.0 108.836 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.75 -152.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 124.005 3.137 . . . . 0.0 112.803 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.4 m -35.84 124.59 0.71 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.487 2.715 . . . . 0.0 113.206 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.95 30.06 0.44 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.9 1.714 . . . . 0.0 114.174 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.04 158.86 32.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.032 1.333 . . . . 0.0 108.808 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.1 p -98.54 153.68 18.46 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.193 -0.942 . . . . 0.0 112.155 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.0 mt -148.71 162.38 39.86 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.076 1.75 . . . . 0.0 109.458 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -126.11 114.04 17.86 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.906 1.682 . . . . 0.0 107.163 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -96.63 121.2 38.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.451 1.101 . . . . 0.0 110.15 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.31 113.73 18.7 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 124.155 0.909 . . . . 0.0 110.435 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.9 123.75 38.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -6.96 15.54 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.461 2.774 . . . . 0.0 115.536 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.0 m -137.42 121.03 17.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 127.708 2.403 . . . . 0.0 107.051 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.09 61.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -82.49 -30.34 29.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.028 1.285 . . . . 0.0 114.417 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -136.66 155.76 76.56 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.038 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.65 165.88 71.93 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.395 1.177 . . . . 0.0 112.064 2.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.82 104.36 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.934 2.423 . . . . 0.0 109.274 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.2 ttt -139.35 163.74 31.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.529 1.132 . . . . 0.0 109.283 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -143.56 153.89 43.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -75.49 142.08 42.95 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.73 21.98 67.62 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.055 1.312 . . . . 0.0 114.36 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.3 t -134.11 156.69 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.285 1.434 . . . . 0.0 109.485 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 132.71 40.72 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.821 1.648 . . . . 0.0 111.717 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -139.61 168.5 19.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.27 1.828 . . . . 0.0 111.712 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.6 tp -108.31 129.23 55.23 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 129.306 3.042 . . . . 0.0 102.86 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.0 114.07 22.6 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.5 mtm -119.33 113.01 20.16 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.02 -134.05 1.66 Allowed Glycine 0 CA--C 1.526 0.778 0 CA-C-N 120.112 1.323 . . . . 0.0 112.225 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -134.84 172.02 13.57 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.97 0.885 . . . . 0.0 112.015 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.8 t -133.16 140.15 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.397 -0.815 . . . . 0.0 110.337 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -121.57 115.41 22.76 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.869 2.067 . . . . 0.0 111.624 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -71.82 63.69 0.46 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.07 2.548 . . . . 0.0 112.428 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.2 t30 163.39 -22.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 1 C-N-CA 134.041 4.936 . . . . 0.0 114.084 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -113.5 -4.83 13.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.29 1.036 . . . . 0.0 113.023 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.37 -162.38 49.43 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -73.78 143.32 33.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 118.63 1.215 . . . . 0.0 110.675 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.22 126.83 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -120.28 78.4 26.63 Favored Pre-proline 0 C--N 1.325 -0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 109.972 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.27 164.42 28.18 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.686 2.924 . . . . 0.0 110.946 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.05 -18.06 56.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.094 1.863 . . . . 0.0 114.707 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -84.13 22.85 1.13 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.443 1.019 . . . . 0.0 110.771 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.0 m -88.7 137.43 32.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.519 1.527 . . . . 0.0 107.25 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -78.79 113.62 17.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.76 116.67 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -175.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.23 170.21 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.924 1.29 . . . . 0.0 109.615 -175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.08 132.16 49.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.15 0.98 . . . . 0.0 108.825 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 138.19 57.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -133.8 160.02 70.18 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.488 1.915 . . . . 0.0 107.035 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.02 -42.92 2.74 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.928 2.419 . . . . 0.0 110.415 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -58.53 -41.58 85.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.61 0.764 . . . . 0.0 111.252 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.21 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -57.24 -50.01 74.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.284 1.033 . . . . 0.0 110.294 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.3 -34.83 78.54 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.972 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.87 -47.61 75.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.511 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -61.39 -39.06 89.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.501 1.501 . . . . 0.0 108.973 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.5 m -61.09 -47.03 88.2 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -57.33 -46.38 83.31 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.875 0.87 . . . . 0.0 109.466 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.57 -33.78 76.35 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.071 0.948 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -69.38 -49.39 55.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -68.61 -36.6 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.82 0.848 . . . . 0.0 111.564 -175.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -76.71 176.51 8.37 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 127.278 2.231 . . . . 0.0 110.355 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -98.11 145.1 26.9 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 33.1 m -69.52 159.05 85.25 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.13 106.19 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.285 2.657 . . . . 0.0 108.736 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 t -146.36 56.09 1.16 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -116.68 113.36 40.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -102.54 145.68 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.944 2.43 . . . . 0.0 108.862 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.261 1.677 0 C-N-CA 128.994 2.918 . . . . 0.0 103.524 175.623 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -85.08 61.02 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.221 2.614 . . . . 0.0 112.608 -171.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -141.54 59.54 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 123.49 1.614 . . . . 0.0 112.23 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.51 6.78 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 108.421 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.56 -172.22 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.967 3.778 . . . . 0.0 110.73 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 m -50.04 153.92 1.26 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.215 1.406 . . . . 0.0 110.201 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.5 t -86.19 127.45 61.52 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.52 174.33 11.81 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.616 2.877 . . . . 0.0 112.959 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -21.04 55.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.094 0.958 . . . . 0.0 112.712 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.59 131.42 50.88 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.645 0.657 . . . . 0.0 109.612 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 t -152.24 79.12 1.24 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.664 0.745 . . . . 0.0 109.697 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -133.71 157.53 45.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.009 1.724 . . . . 0.0 106.576 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -107.56 152.64 23.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -133.84 174.02 10.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.746 0.818 . . . . 0.0 109.236 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.14 -154.2 41.08 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 123.98 0.8 . . . . 0.0 111.366 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.7 p -127.84 168.58 14.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.868 0.867 . . . . 0.0 108.837 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.82 -41.35 97.89 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.41 -43.97 88.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.01 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -66.48 -51.15 59.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.846 0.748 . . . . 0.0 111.033 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -52.34 -44.66 65.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.609 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -52.41 -42.34 63.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.491 0.716 . . . . 0.0 112.704 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.1 m -75.82 -33.81 60.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -38.68 86.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.181 0.9 . . . . 0.0 111.713 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -68.36 130.58 43.31 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.454 0.701 . . . . 0.0 111.066 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -81.95 -8.14 59.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.865 0.866 . . . . 0.0 109.99 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.93 123.37 24.54 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.971 1.708 . . . . 0.0 107.998 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.41 116.97 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.6 169.49 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 110.103 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -128.84 137.65 51.6 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.75 171.01 18.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.834 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -117.59 126.28 52.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.18 113.55 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -80.82 -52.48 7.45 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.472 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 9.6 m -145.11 171.42 14.53 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 125.418 1.487 . . . . 0.0 109.795 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.6 mtp -133.76 134.8 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.79 143.82 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -175.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -70.92 137.0 48.89 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.515 -1.365 . . . . 0.0 108.234 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -114.71 168.84 7.41 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.8 1.64 . . . . 0.0 108.86 178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.37 161.52 20.01 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.331 2.02 . . . . 0.0 112.273 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -145.01 49.19 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.731 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -88.73 14.2 10.69 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.554 -0.968 . . . . 0.0 110.619 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.19 177.22 53.05 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.106 1.336 . . . . 0.0 115.588 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -152.76 140.19 19.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.73 2.812 . . . . 0.0 106.17 -178.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.83 145.02 29.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.23 123.25 71.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -101.63 129.86 47.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.5 m -138.22 176.36 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.883 0.873 . . . . 0.0 111.48 -175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -131.36 39.52 3.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.912 1.285 . . . . 0.0 112.185 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt 36.42 81.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.281 2.232 . . . . 0.0 115.553 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.4 mm -74.52 -32.48 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.504 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.13 161.96 31.92 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.023 1.296 . . . . 0.0 110.242 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.49 152.74 40.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.67 1.588 . . . . 0.0 108.053 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -139.79 -24.42 0.84 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.643 0.589 . . . . 0.0 112.379 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -157.99 138.86 13.11 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.826 2.05 . . . . 0.0 106.117 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -146.85 72.38 1.27 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.214 3.006 . . . . 0.0 105.74 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 50.07 4.34 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 126.618 2.056 . . . . 0.0 109.353 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.19 -70.74 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 126.088 1.804 . . . . 0.0 113.302 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.5 131.73 51.66 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.275 1.03 . . . . 0.0 111.425 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -82.27 89.18 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.32 139.79 96.46 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.24 -175.87 1.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.529 2.153 . . . . 0.0 112.07 -175.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 t -42.83 -58.8 3.51 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.853 1.661 . . . . 0.0 109.215 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.07 147.56 21.04 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 N-CA-C 107.095 -1.925 . . . . 0.0 107.095 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 88' ' ' THR . 95.2 Cg_endo -69.75 -154.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 1 C-N-CA 126.141 4.561 . . . . 0.0 111.665 175.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.4 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 4.4 m -34.01 139.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.953 2.501 . . . . 0.0 113.311 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.52 -1.27 3.98 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.088 2.28 . . . . 0.0 114.496 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.32 148.55 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.351 1.576 . . . . 0.0 108.579 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 p -77.29 149.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.184 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -147.34 161.03 41.83 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.94 0.896 . . . . 0.0 110.034 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -127.42 116.93 21.21 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.93 124.59 42.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.231 1.012 . . . . 0.0 109.499 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -74.06 114.02 11.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.733 1.213 . . . . 0.0 109.775 175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.09 115.61 58.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.43 1.24 6.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 95.1 m -132.02 113.63 13.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.744 1.217 . . . . 0.0 109.204 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.98 -12.5 59.37 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.734 -0.604 . . . . 0.0 112.287 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.55 -35.83 24.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 113.753 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -157.16 163.04 26.34 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.564 1.946 . . . . 0.0 110.003 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.37 153.31 81.91 Favored 'Cis proline' 0 CA--C 1.541 0.871 0 O-C-N 122.626 0.803 . . . . 0.0 111.29 -3.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.7 122.47 8.58 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.229 2.619 . . . . 0.0 111.808 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.1 ttp -145.8 160.51 41.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.409 1.883 . . . . 0.0 108.685 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -134.48 145.42 48.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 85.5 tttt -64.02 142.71 58.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.17 35.33 77.4 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.044 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.8 t -140.83 159.3 23.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.926 2.09 . . . . 0.0 107.5 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -101.43 133.65 45.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.38 1.072 . . . . 0.0 111.502 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -137.21 165.4 26.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.629 1.572 . . . . 0.0 111.303 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 124.63 51.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 129.942 3.297 . . . . 0.0 103.522 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.17 119.55 32.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.836 1.654 . . . . 0.0 107.524 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.0 mtm -120.68 113.25 19.94 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.14 -137.7 2.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.109 1.814 . . . . 0.0 111.525 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -136.63 176.49 8.65 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.172 1.389 . . . . 0.0 108.689 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.3 132.01 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.14 113.84 27.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -80.07 63.56 4.62 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.52 -42.47 0.05 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 128.484 2.714 . . . . 0.0 110.452 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -126.24 -4.32 6.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.25 1.02 . . . . 0.0 113.118 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.59 -151.77 18.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.77 137.31 29.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.821 1.681 . . . . 0.0 110.013 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.99 153.06 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.54 80.18 39.26 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -62.15 171.0 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.997 3.798 . . . . 0.0 113.624 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.55 -19.11 64.76 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.756 1.637 . . . . 0.0 113.195 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.6 23.19 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.117 1.367 . . . . 0.0 112.942 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 129.69 35.08 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.821 -0.549 . . . . 0.0 110.135 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -80.57 115.48 20.1 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.5 117.49 35.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 123.735 0.814 . . . . 0.0 109.194 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.8 m -145.49 167.34 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 109.52 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.79 136.54 57.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.444 0.698 . . . . 0.0 110.7 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -67.25 144.35 55.98 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.233 0.613 . . . . 0.0 109.898 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 150.3 29.88 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 127.585 2.354 . . . . 0.0 107.481 175.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.84 -34.26 31.1 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.593 2.195 . . . . 0.0 111.401 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -61.58 -43.09 99.5 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.023 -0.423 . . . . 0.0 111.087 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.32 -41.91 76.05 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.415 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -48.15 -55.93 9.13 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.749 1.22 . . . . 0.0 109.911 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -55.41 -44.11 75.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.687 1.595 . . . . 0.0 111.905 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.54 -49.21 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.004 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.22 -41.03 99.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.012 0.824 . . . . 0.0 108.977 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -59.43 -43.57 93.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.921 0.888 . . . . 0.0 110.639 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.25 -40.54 86.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.81 -33.37 75.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.742 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -66.11 -35.7 81.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.519 1.128 . . . . 0.0 111.028 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -75.88 -40.65 54.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 120.855 -1.153 . . . . 0.0 109.344 175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -69.35 176.36 3.41 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.605 1.193 . . . . 0.0 109.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -136.0 137.99 41.79 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.811 2.444 . . . . 0.0 104.792 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 18.1 m -68.14 147.58 98.34 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.237 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.27 100.7 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.315 2.677 . . . . 0.0 108.28 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.3 m -145.34 73.11 1.34 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.824 1.249 . . . . 0.0 107.872 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.49 113.1 48.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -101.46 -161.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.172 3.248 . . . . 0.0 108.092 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.246 0.876 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 175.158 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.452 0.644 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.33 -47.24 74.14 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.129 -0.938 . . . . 0.0 108.996 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -61.67 -48.11 82.29 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.322 0.965 . . . . 0.0 111.169 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -49.86 -56.75 9.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.719 0.808 . . . . 0.0 110.481 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -68.66 -40.48 80.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.789 -1.577 . . . . 0.0 111.898 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD2' HG11 ' A' ' 50' ' ' VAL . 42.4 t80 -54.61 -46.4 73.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.435 1.47 . . . . 0.0 110.617 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.7 m -71.88 -24.27 61.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.834 0.854 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.39 18.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -62.93 132.43 52.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 111.993 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -82.93 -8.16 59.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.523 0.729 . . . . 0.0 110.657 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.3 tp -134.83 124.48 25.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.457 1.503 . . . . 0.0 108.122 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG11 ' CD2' ' A' ' 44' ' ' PHE . 17.3 t -137.83 115.36 12.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.91 172.2 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.218 1.407 . . . . 0.0 110.303 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -129.24 139.93 51.65 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.88 175.33 13.71 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.746 -1.221 . . . . 0.0 110.918 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.7 m -121.79 134.55 54.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 68' ' ' VAL . 64.0 t -77.13 114.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -77.48 -54.89 5.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 m -142.61 171.46 14.03 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.72 0.808 . . . . 0.0 110.677 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.2 mtp -138.05 133.15 33.18 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.639 1.976 . . . . 0.0 105.845 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.86 140.84 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.812 1.245 . . . . 0.0 107.798 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -70.24 151.68 45.07 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.393 0.997 . . . . 0.0 110.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -134.77 175.11 3.89 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.854 1.661 . . . . 0.0 108.173 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.62 160.18 18.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.299 3.333 . . . . 0.0 114.095 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 -141.89 43.53 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.66 17.3 3.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.895 0.878 . . . . 0.0 110.313 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.88 166.6 48.94 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-O 123.224 1.458 . . . . 0.0 115.143 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.35 139.83 16.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 106.195 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.04 145.95 31.74 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 55' ' ' VAL . 94.9 t -118.04 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -89.84 133.37 34.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.81 173.37 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.082 0.953 . . . . 0.0 111.104 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -132.96 38.01 3.39 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.17 0.988 . . . . 0.0 112.965 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.7 mt 37.49 81.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.297 1.839 . . . . 0.0 115.061 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.04 -33.07 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.981 0.809 . . . . 0.0 110.911 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.514 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -160.84 161.87 33.12 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.028 1.299 . . . . 0.0 110.627 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.24 146.01 31.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.184 1.394 . . . . 0.0 109.513 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -131.02 -41.32 1.13 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.873 0.869 . . . . 0.0 110.991 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -140.3 123.79 17.05 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.42 59.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.077 2.151 . . . . 0.0 107.568 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.04 35.8 2.74 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 124.456 1.027 . . . . 0.0 113.702 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -10.65 0.04 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.511 2.005 . . . . 0.0 114.669 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.17 129.06 47.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.554 1.677 . . . . 0.0 110.515 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.84 67.86 10.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.26 152.54 41.81 Favored Pre-proline 0 CA--C 1.537 0.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.589 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.84 172.1 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.215 1.943 . . . . 0.0 111.523 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t -52.09 -60.12 6.87 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 117.637 -1.173 . . . . 0.0 109.307 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.88 139.6 40.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 N-CA-C 107.164 -1.898 . . . . 0.0 107.164 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.62 -157.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.89 2.393 . . . . 0.0 112.293 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.514 HG21 ' HA2' ' A' ' 74' ' ' GLY . 40.4 m -34.74 133.63 0.26 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 130.703 3.601 . . . . 0.0 112.42 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.47 34.58 0.28 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.776 1.655 . . . . 0.0 110.225 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.79 166.69 20.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.7 2.0 . . . . 0.0 108.572 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.5 p -103.3 149.62 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.003 0.906 . . . . 0.0 112.014 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.3 mt -145.07 170.83 15.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.758 1.223 . . . . 0.0 109.004 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -127.2 115.12 18.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -89.49 120.19 30.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.56 113.64 15.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.54 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.0 113.47 62.51 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.67 -1.31 11.41 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.124 1.883 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.0 m -134.12 113.59 12.23 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 110.083 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -75.54 -5.76 46.87 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.006 -1.059 . . . . 0.0 113.806 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -78.6 -53.27 7.36 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.378 0.671 . . . . 0.0 110.606 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.6 m -154.46 165.5 17.92 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 127.006 2.122 . . . . 0.0 110.282 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -64.66 151.93 74.95 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 119.625 0.902 . . . . 0.0 110.178 -3.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.23 138.79 44.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.405 2.07 . . . . 0.0 111.764 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 ttm -149.43 170.92 17.47 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.918 -1.114 . . . . 0.0 111.444 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.76 138.27 54.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.46 34.65 63.44 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.608 -1.106 . . . . 0.0 113.736 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.07 160.51 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.723 1.761 . . . . 0.0 107.963 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -99.61 136.38 39.62 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 125.354 1.461 . . . . 0.0 110.417 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -139.51 168.05 20.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.304 1.442 . . . . 0.0 112.615 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.94 123.62 50.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.9 113.98 21.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.539 ' HG2' HG13 ' A' ' 50' ' ' VAL . 27.0 mtm -117.66 113.21 21.57 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.97 -140.19 3.09 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 126.123 1.821 . . . . 0.0 109.687 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -135.38 175.28 9.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.289 1.045 . . . . 0.0 109.548 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -118.89 159.16 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -129.84 112.93 14.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.43 63.64 8.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -177.4 -32.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.202 2.601 . . . . 0.0 110.851 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -127.51 -9.69 5.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.91 -152.83 19.97 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.55 144.05 19.65 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.607 2.204 . . . . 0.0 111.708 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.27 8.5 p -126.7 149.76 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.257 1.6 tm? -137.53 75.23 45.08 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.22 -0.925 . . . . 0.0 108.827 -174.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.9 170.93 9.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.539 3.493 . . . . 0.0 112.91 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.71 -20.15 67.91 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.864 1.709 . . . . 0.0 114.079 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.65 22.99 1.01 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.718 1.207 . . . . 0.0 111.417 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.1 m -91.62 137.24 32.52 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.301 -1.499 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -86.85 114.39 23.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -127.64 126.7 67.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.65 0.738 . . . . 0.0 109.331 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -146.1 163.25 10.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.573 1.949 . . . . 0.0 107.018 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.03 149.33 47.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 123.99 24.47 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -119.99 155.34 55.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-O 117.073 -1.441 . . . . 0.0 107.88 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.07 -42.47 6.01 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.982 2.455 . . . . 0.0 110.452 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -55.05 -53.09 60.21 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 122.957 0.503 . . . . 0.0 110.669 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -56.85 -44.4 82.12 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.531 0.732 . . . . 0.0 110.612 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -56.52 -53.28 59.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.56 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -59.73 -36.45 76.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.31 1.044 . . . . 0.0 111.523 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.7 mt -65.33 -60.45 2.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 124.478 1.111 . . . . 0.0 108.766 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.81 -34.98 72.11 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.149 1.341 . . . . 0.0 110.949 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.53 -49.58 76.96 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -63.32 -31.58 72.77 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.606 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.1 mt -68.66 -31.38 70.47 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.295 0.952 . . . . 0.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 t -76.7 -34.57 58.17 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.421 0.555 . . . . 0.0 109.67 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -67.07 -58.79 4.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 . . . . . 0 N--CA 1.447 -0.601 0 C-N-CA 123.702 0.801 . . . . 0.0 110.489 179.183 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.236 0.391 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD21 HD23 ' A' ' 141' ' ' LEU . 7.1 tt -63.71 -44.17 94.42 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.593 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -62.55 -49.22 76.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.278 0.944 . . . . 0.0 111.628 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -56.12 -46.62 79.09 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.428 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -73.8 -44.06 56.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.237 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.54 ' CD2' HG11 ' A' ' 50' ' ' VAL . 7.6 t80 -54.72 -44.29 73.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.843 1.656 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.7 -23.93 61.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.417 -0.802 . . . . 0.0 113.032 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -46.4 28.68 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 110.406 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.5 p -69.14 132.32 46.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.665 1.186 . . . . 0.0 111.181 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -81.32 -12.85 58.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.477 1.035 . . . . 0.0 109.361 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.5 tp -122.75 125.11 44.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.605 1.562 . . . . 0.0 109.93 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.54 HG11 ' CD2' ' A' ' 44' ' ' PHE . 42.2 t -141.01 114.03 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.2 166.76 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.575 1.55 . . . . 0.0 109.222 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 p -124.05 148.91 46.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -159.09 171.21 20.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.766 -1.209 . . . . 0.0 110.906 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.3 m -124.03 128.08 48.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.41 113.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 20.9 mmmt -84.21 -38.17 20.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.271 1.028 . . . . 0.0 110.042 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 m -151.25 165.86 32.67 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 121.227 -0.921 . . . . 0.0 110.138 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.8 mtp -143.75 124.67 14.31 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.52 146.1 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -65.56 152.31 44.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.486 -0.759 . . . . 0.0 109.889 -176.32 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -134.29 169.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.865 2.066 . . . . 0.0 109.481 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -38.59 134.06 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 125.084 3.856 . . . . 0.0 117.492 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.23 -123.61 33.5 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.814 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -88.72 22.55 2.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.364 1.465 . . . . 0.0 110.18 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.44 166.28 45.53 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.676 -1.265 . . . . 0.0 113.997 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -151.86 138.52 18.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.489 1.516 . . . . 0.0 108.349 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.54 128.89 55.52 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.45 123.28 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -93.43 125.14 37.88 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 11.6 m -122.89 174.17 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.432 1.493 . . . . 0.0 111.169 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 t -135.25 40.38 2.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.626 0.648 . . . . 0.0 109.91 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.4 mt 38.11 77.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.571 2.748 . . . . 0.0 114.19 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 47.7 mm -75.54 -23.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.802 1.637 . . . . 0.0 111.133 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.81 159.06 32.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.76 141.33 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.195 0.998 . . . . 0.0 108.527 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -135.31 -33.36 0.9 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.258 0.623 . . . . 0.0 110.823 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -148.99 125.06 10.7 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.26 58.68 1.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.512 2.325 . . . . 0.0 107.782 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.64 36.19 2.82 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.276 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.04 -25.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 116.707 -2.163 . . . . 0.0 116.483 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.5 mt -116.39 155.09 29.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 121.101 2.451 . . . . 0.0 112.555 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.69 94.39 5.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 128.399 2.679 . . . . 0.0 109.047 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.14 131.57 95.04 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.72 -178.69 4.25 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 121.942 1.762 . . . . 0.0 111.103 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 t -53.58 -58.92 10.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.203 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.59 116.02 3.7 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.596 2.197 . . . . 0.0 110.805 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 88' ' ' THR . 65.5 Cg_endo -78.14 -152.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.236 2.624 . . . . 0.0 110.677 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 24.1 m -33.17 123.76 0.39 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 130.625 3.57 . . . . 0.0 111.771 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.16 -16.71 6.33 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.394 2.426 . . . . 0.0 110.986 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.79 150.82 40.82 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.312 1.056 . . . . 0.0 111.363 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -86.01 145.51 27.07 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.4 mt -146.92 164.24 33.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 109.37 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -117.66 113.42 21.87 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.24 119.15 29.47 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -79.76 114.08 18.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.06 1.344 . . . . 0.0 109.94 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.14 114.24 59.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.83 -4.43 14.06 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.108 1.872 . . . . 0.0 113.225 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.7 m -138.17 113.63 9.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.087 1.755 . . . . 0.0 108.823 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -74.29 -7.49 52.98 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.257 -0.902 . . . . 0.0 112.787 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.98 -57.14 3.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.43 1.892 . . . . 0.0 108.97 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.4 m -152.59 160.49 31.11 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.044 1.338 . . . . 0.0 111.829 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.06 161.12 70.29 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.0 1.036 . . . . 0.0 111.887 3.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.42 139.76 91.09 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.163 2.575 . . . . 0.0 112.502 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -153.0 150.95 29.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.864 0.866 . . . . 0.0 110.157 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -144.37 150.8 38.34 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 109.872 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 56' ' ' LYS . 88.4 tttt -79.09 138.68 38.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.31 44.11 76.18 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.2 t -142.6 156.05 18.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 m -102.93 128.64 49.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.589 0.756 . . . . 0.0 110.393 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -126.46 171.3 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.383 1.873 . . . . 0.0 112.314 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.49 123.64 43.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 175.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.36 114.0 22.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 mtm -116.83 113.14 22.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.88 -142.71 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.606 1.098 . . . . 0.0 110.675 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.4 -178.87 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.971 0.891 . . . . 0.0 109.42 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.99 147.2 28.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -125.55 113.65 17.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -79.13 63.55 3.81 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -177.34 -26.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.386 1.875 . . . . 0.0 111.616 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 -7.37 3.17 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.706 0.802 . . . . 0.0 112.978 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.54 -164.19 20.96 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.724 0.693 . . . . 0.0 111.447 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.81 133.9 24.62 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.444 2.096 . . . . 0.0 109.8 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.265 2.9 p -118.83 134.76 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.96 76.11 21.84 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 0.0 109.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.72 172.8 8.92 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.922 3.748 . . . . 0.0 112.69 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -63.86 -34.36 60.97 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.68 2.253 . . . . 0.0 114.632 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.79 23.89 1.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.293 0.951 . . . . 0.0 111.59 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.3 m -85.11 146.93 26.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.469 1.507 . . . . 0.0 109.968 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -91.23 113.74 26.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.2 t -132.18 113.9 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.84 165.58 9.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.373 0.669 . . . . 0.0 109.272 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.04 147.75 52.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -67.7 149.62 49.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.067 0.947 . . . . 0.0 108.766 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -149.98 152.55 34.31 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 127.961 2.504 . . . . 0.0 105.234 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.01 -35.95 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.009 2.473 . . . . 0.0 112.434 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -61.72 -49.44 76.43 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.773 -0.579 . . . . 0.0 110.176 176.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -54.97 -54.27 44.94 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -44.9 -55.0 5.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.913 2.085 . . . . 0.0 111.8 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -56.24 -43.7 78.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.506 0.722 . . . . 0.0 111.708 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.9 mt -66.34 -40.11 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.709 -0.662 . . . . 0.0 109.479 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.559 HD23 HD21 ' A' ' 40' ' ' LEU . 8.5 mt -58.82 -43.26 90.58 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.7 m -62.08 -41.84 98.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.494 0.718 . . . . 0.0 111.031 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -57.56 -43.41 84.47 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.879 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 mt -76.21 -24.15 54.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.039 1.736 . . . . 0.0 112.819 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -74.24 -35.46 63.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.383 1.473 . . . . 0.0 109.645 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.53 -65.77 0.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.056 0.942 . . . . 0.0 109.1 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 . . . . . 0 CA--C 1.515 -0.392 0 CA-C-N 118.415 0.552 . . . . 0.0 110.636 -176.344 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -94.24 -54.96 3.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -65.0 -43.17 93.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.288 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -70.63 -47.89 57.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.093 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.94 -36.37 83.21 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.401 -1.285 . . . . 0.0 109.635 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' HG11 ' A' ' 50' ' ' VAL . 34.7 t80 -57.29 -43.69 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.897 1.226 . . . . 0.0 110.69 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.3 m -74.38 -23.58 59.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.52 -34.34 63.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.996 1.271 . . . . 0.0 111.527 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.8 p -76.52 126.69 31.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 t -79.69 -11.71 59.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.922 0.867 . . . . 0.0 108.814 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.507 ' HB2' HG23 ' A' ' 116' ' ' VAL . 41.3 tp -120.75 114.84 22.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.163 2.185 . . . . 0.0 108.978 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG11 ' CD1' ' A' ' 44' ' ' PHE . 3.0 t -138.88 112.89 7.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.62 167.06 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.908 1.683 . . . . 0.0 108.332 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 111' ' ' LEU . 3.6 p -131.18 142.54 50.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -162.96 172.09 15.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.531 -0.731 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 28.1 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.67 113.57 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -84.35 -53.77 5.24 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.35 1.06 . . . . 0.0 108.479 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m -140.23 169.09 18.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.167 1.387 . . . . 0.0 109.363 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.94 132.32 38.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 144.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.08 141.91 47.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 47.3 mm-40 -123.64 176.05 2.44 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 128.045 2.538 . . . . 0.0 109.365 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 61' ' ' GLU . 41.4 Cg_endo -60.94 150.53 83.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.681 2.254 . . . . 0.0 112.765 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.91 -123.95 29.53 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.99 23.75 14.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.463 1.105 . . . . 0.0 109.931 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.79 166.73 46.32 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 122.816 1.231 . . . . 0.0 111.874 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -150.38 131.27 14.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.4 137.63 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.5 t -108.38 123.46 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -97.66 126.41 42.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 15.3 m -131.49 176.67 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.168 1.387 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -135.1 39.21 2.95 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.0 mt 36.07 83.16 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.56 -30.01 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 121.158 -0.964 . . . . 0.0 111.4 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.469 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.77 160.73 31.32 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.174 1.368 . . . . 0.0 109.761 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.84 143.31 26.21 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.299 1.04 . . . . 0.0 108.87 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -126.87 -49.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.59 1.156 . . . . 0.0 108.616 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -142.07 142.06 32.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 107.97 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 p -146.91 72.04 1.25 Allowed 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.298 2.639 . . . . 0.0 105.799 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 38.61 2.77 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 124.263 0.935 . . . . 0.0 112.881 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.63 -11.42 0.03 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.799 2.143 . . . . 0.0 112.91 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -116.35 123.17 46.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 120.623 2.211 . . . . 0.0 108.865 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -80.22 75.34 7.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.845 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -50.58 138.34 22.46 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.47 177.19 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.117 1.878 . . . . 0.0 111.636 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 t -48.74 -55.73 18.45 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.096 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.88 137.55 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.56 1.506 . . . . 0.0 108.634 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.18 -154.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.437 3.425 . . . . 0.0 112.068 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.469 HG21 ' HA2' ' A' ' 74' ' ' GLY . 16.8 m -33.06 123.9 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.828 3.251 . . . . 0.0 111.415 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.3 0.49 1.18 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.01 1.767 . . . . 0.0 113.75 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.94 150.07 21.21 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.396 1.598 . . . . 0.0 110.025 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -87.9 142.15 28.02 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.193 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -145.33 161.04 40.58 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.426 1.091 . . . . 0.0 109.85 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -116.39 125.12 51.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.212 2.205 . . . . 0.0 106.937 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.465 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.1 m-85 -106.45 123.37 47.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.721 1.609 . . . . 0.0 110.132 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.416 ' HB3' HG23 ' A' ' 123' ' ' VAL . 44.1 t80 -78.09 114.55 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.743 1.617 . . . . 0.0 111.56 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.92 114.43 61.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -69.97 -9.16 25.38 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.707 2.272 . . . . 0.0 115.555 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 m -148.46 130.79 15.61 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.217 1.407 . . . . 0.0 108.513 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -73.55 -3.94 30.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.843 1.424 . . . . 0.0 114.843 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -73.05 -51.22 18.94 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.091 . . . . 0.0 113.181 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.2 m -140.02 164.39 37.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.833 1.653 . . . . 0.0 111.942 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.03 163.5 76.18 Favored 'Cis proline' 0 CA--C 1.546 1.098 0 CA-C-N 119.381 0.815 . . . . 0.0 111.831 -2.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.27 86.95 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.983 3.122 . . . . 0.0 113.85 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 ttp -114.3 162.83 16.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.44 1.896 . . . . 0.0 109.44 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -146.19 158.24 43.87 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.258 1.023 . . . . 0.0 110.69 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -70.74 139.11 51.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.283 1.433 . . . . 0.0 110.787 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.31 35.45 91.53 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.489 1.042 . . . . 0.0 115.058 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.54 152.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 108.531 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 19.9 m -96.38 134.66 39.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.95 0.881 . . . . 0.0 110.427 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -139.48 167.69 21.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.155 1.782 . . . . 0.0 112.759 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 52' ' ' THR . 15.9 tp -103.91 132.24 50.35 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.39 113.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.471 ' HG2' HG13 ' A' ' 50' ' ' VAL . 8.6 mtm -117.49 115.78 25.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.04 -143.7 3.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.048 1.308 . . . . 0.0 110.717 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -130.02 178.65 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.253 1.026 . . . . 0.0 108.943 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 49' ' ' LEU . 25.8 t -136.1 141.93 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 120.786 -1.196 . . . . 0.0 108.304 175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -108.22 113.08 25.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -83.06 63.58 7.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -170.01 -40.36 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.956 2.903 . . . . 0.0 109.209 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -126.18 -5.88 6.64 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.74 -164.7 15.33 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.22 137.34 51.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.038 1.419 . . . . 0.0 109.454 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 95' ' ' TYR . 3.5 p -120.39 124.68 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 2.2 tm? -114.89 78.98 5.64 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.92 171.26 11.4 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.204 3.27 . . . . 0.0 112.246 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.85 -23.94 76.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.106 1.871 . . . . 0.0 113.126 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.06 23.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.97 1.259 . . . . 0.0 111.46 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.4 m -84.4 128.57 34.66 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.602 -1.311 . . . . 0.0 108.972 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 113' ' ' MET . 40.2 t80 -80.04 113.51 18.26 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.58 116.55 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.96 174.5 7.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.719 0.808 . . . . 0.0 111.01 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.34 123.78 20.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.624 1.57 . . . . 0.0 109.14 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -75.99 142.46 41.91 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.706 -0.621 . . . . 0.0 109.491 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -154.5 156.01 31.22 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 128.124 2.57 . . . . 0.0 106.586 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.01 -35.15 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.614 2.209 . . . . 0.0 113.362 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -56.47 -50.92 70.32 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.952 0.882 . . . . 0.0 110.143 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -64.39 -32.52 74.17 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.673 -0.642 . . . . 0.0 111.651 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.14 -53.11 62.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.005 0.82 . . . . 0.0 110.445 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -62.75 -36.48 83.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.934 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.23 -51.66 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.844 0.747 . . . . 0.0 109.142 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -66.93 -41.72 86.57 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.12 0.568 . . . . 0.0 109.92 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.45 -44.87 95.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.582 0.628 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.48 -31.42 72.62 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.519 -0.738 . . . . 0.0 111.281 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.2 mt -75.82 -27.46 57.9 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 121.532 -0.73 . . . . 0.0 110.254 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -69.24 -45.56 69.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.237 1.415 . . . . 0.0 110.052 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -67.58 -39.33 84.87 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 125.814 1.645 . . . . 0.0 109.307 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.233 0.21 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.7 -40.03 95.77 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.92 -48.75 79.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.999 0.363 . . . . 0.0 111.195 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.5 m -65.9 -45.83 80.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.58 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.32 -33.38 75.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.497 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.526 ' CD2' HG11 ' A' ' 50' ' ' VAL . 18.7 t80 -61.34 -40.79 95.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.586 1.084 . . . . 0.0 109.956 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -75.22 -32.49 61.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.55 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.9 73.33 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -76.21 140.9 41.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.53 1.532 . . . . 0.0 110.571 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -85.08 -13.67 49.6 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.427 1.467 . . . . 0.0 110.4 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.3 tp -122.8 127.41 49.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.786 -1.196 . . . . 0.0 110.142 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 44' ' ' PHE . 33.1 t -140.57 113.82 5.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.0 m -146.1 171.21 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 111' ' ' LEU . 17.8 p -133.83 143.16 48.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 175.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.77 168.85 20.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.326 -0.859 . . . . 0.0 111.548 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.6 m -106.96 132.94 52.34 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.13 114.85 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -76.59 -57.25 3.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 m -147.35 172.16 14.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.22 1.408 . . . . 0.0 110.187 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 31.1 mtp -135.68 146.57 47.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.81 2.044 . . . . 0.0 107.37 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.16 138.96 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 154.06 42.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 121.646 2.021 . . . . 0.0 109.66 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.11 175.78 3.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 110.974 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -59.18 171.45 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.228 3.285 . . . . 0.0 113.02 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.84 -129.61 45.3 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -112.35 31.8 6.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.0 169.36 40.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 125.046 1.308 . . . . 0.0 113.597 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -156.18 124.33 5.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.748 2.019 . . . . 0.0 106.301 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.11 147.86 27.11 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.68 123.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -92.96 124.41 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -131.43 167.69 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.55 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -128.94 38.06 3.99 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt 40.65 79.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -72.26 -28.84 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.11 161.08 34.48 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.2 144.38 48.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -137.61 -24.04 1.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -156.73 129.46 7.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -137.33 73.45 1.44 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.403 3.081 . . . . 0.0 106.045 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.66 34.88 3.43 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.016 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.25 -69.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 128.122 2.772 . . . . 0.0 109.973 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 mt -45.24 134.51 6.36 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -85.13 65.03 9.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.089 2.155 . . . . 0.0 106.414 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.7 mt -57.98 125.62 74.52 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.46 176.14 8.44 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.891 1.727 . . . . 0.0 113.619 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 t -42.57 -58.89 3.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.118 1.767 . . . . 0.0 110.813 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.56 124.06 10.41 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-N 122.321 1.865 . . . . 0.0 107.731 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 88' ' ' THR . 91.5 Cg_endo -73.35 -153.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.144 2.562 . . . . 0.0 112.946 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 51.2 m -34.61 125.19 0.53 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.484 2.714 . . . . 0.0 112.882 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.05 30.98 0.65 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.15 1.357 . . . . 0.0 113.017 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.65 158.81 29.22 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.187 1.795 . . . . 0.0 108.243 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.0 p -107.57 150.71 26.53 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.108 0.867 . . . . 0.0 111.996 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -143.55 163.23 33.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.143 2.177 . . . . 0.0 108.733 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.26 114.21 25.66 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.45 121.46 31.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.77 119.84 17.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.874 1.359 . . . . 0.0 107.563 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.46 113.83 40.61 Favored Pre-proline 0 C--O 1.225 -0.22 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.12 5.59 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.136 2.557 . . . . 0.0 112.956 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.4 m -131.14 113.52 13.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.021 1.329 . . . . 0.0 110.675 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -81.73 -32.78 31.42 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.277 -0.89 . . . . 0.0 111.173 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -59.06 -49.08 79.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.813 1.645 . . . . 0.0 112.82 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.6 m -155.09 165.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 129.006 2.923 . . . . 0.0 108.447 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.04 157.7 70.7 Favored 'Cis proline' 0 CA--C 1.536 0.601 0 CA-C-N 120.794 1.319 . . . . 0.0 111.647 -1.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.89 111.13 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.864 2.376 . . . . 0.0 111.01 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.9 tpp -122.18 141.53 51.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.575 1.95 . . . . 0.0 109.852 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -141.55 133.85 28.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -69.3 142.5 54.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.42 36.59 69.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.042 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.83 157.92 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.514 1.525 . . . . 0.0 107.449 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 m -100.63 141.0 34.11 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.709 1.203 . . . . 0.0 111.472 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -135.79 176.37 8.74 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.244 1.818 . . . . 0.0 112.62 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 52' ' ' THR . 6.4 tp -122.92 123.64 41.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 100.916 -3.735 . . . . 0.0 100.916 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.51 113.71 21.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.1 mtm -117.87 113.14 21.31 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 100.566 -3.865 . . . . 0.0 100.566 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.57 -137.45 2.29 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -132.6 177.61 7.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.409 1.1 . . . . 0.0 111.522 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.45 125.32 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -104.84 113.05 26.41 Favored 'General case' 0 C--O 1.237 0.418 1 N-CA-C 96.339 -5.43 . . . . 0.0 96.339 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.257 8.0 tp10 -85.8 95.56 9.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.963 1.363 . . . . 0.0 108.667 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -179.08 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 133.395 4.678 . . . . 0.0 107.597 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -131.38 -8.57 3.73 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 112.768 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.25 -133.99 12.01 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.78 139.4 36.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.14 1.894 . . . . 0.0 114.753 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.55 132.68 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.261 0.4 OUTLIER -115.41 74.31 4.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 125.243 1.417 . . . . 0.0 109.612 -174.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.99 169.05 18.81 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.836 3.691 . . . . 0.0 112.765 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.92 -11.12 29.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 114.85 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -88.82 23.21 2.4 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.621 1.555 . . . . 0.0 110.779 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.1 m -96.69 145.1 26.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.127 1.371 . . . . 0.0 110.593 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -95.72 113.57 25.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 74.5 t -133.45 123.73 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.46 169.28 2.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 0.0 109.031 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.47 150.67 46.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -69.05 142.19 54.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -141.66 137.39 16.24 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.93 -37.97 82.0 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.057 1.838 . . . . 0.0 111.001 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -52.65 -45.46 66.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.21 1.004 . . . . 0.0 111.268 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.0 -42.91 72.41 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.486 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -53.72 -47.38 70.63 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.316 1.047 . . . . 0.0 110.271 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -58.07 -47.55 82.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.84 0.856 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.54 -50.05 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.335 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.42 -35.2 80.13 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.891 1.223 . . . . 0.0 109.744 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 71.7 m -61.04 -47.25 87.26 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -64.54 -38.36 90.75 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 121.717 -0.614 . . . . 0.0 111.064 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.84 -30.07 70.15 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.584 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.7 t -67.1 -40.98 86.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.677 1.126 . . . . 0.0 109.776 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -69.65 -42.78 73.77 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.44 0.696 . . . . 0.0 109.613 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 122.66 1.219 . . . . 0.0 109.243 176.126 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.9 -47.04 82.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.912 -175.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -59.07 -46.0 89.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 119.393 0.997 . . . . 0.0 110.766 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -67.72 -41.05 84.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.062 0.392 . . . . 0.0 111.209 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.43 -33.16 71.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.741 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 50' ' ' VAL . 42.1 t80 -59.51 -31.17 69.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.371 1.441 . . . . 0.0 109.904 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 m -71.14 -48.25 53.12 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.57 -50.21 70.38 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.919 0.888 . . . . 0.0 112.074 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -63.5 131.71 48.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.931 0.893 . . . . 0.0 109.811 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -92.87 -7.79 45.21 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.96 115.89 24.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.352 1.461 . . . . 0.0 108.6 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' A' ' 113' ' ' MET . 37.6 t -135.52 114.18 15.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.34 172.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.431 1.493 . . . . 0.0 109.386 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 111' ' ' LEU . 21.1 p -133.51 144.28 49.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.5 166.69 16.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.728 -0.607 . . . . 0.0 111.385 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.1 m -104.21 135.42 45.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.58 115.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.351 1.06 . . . . 0.0 109.56 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -83.53 -49.32 9.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -145.92 171.41 14.87 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 34.9 mtp -134.89 149.39 50.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.77 2.028 . . . . 0.0 106.86 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.95 139.91 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 131.51 41.96 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -113.7 176.25 1.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 124.465 1.106 . . . . 0.0 109.611 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.96 147.61 32.57 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.388 2.059 . . . . 0.0 113.893 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.48 -123.89 33.14 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.159 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -102.91 17.2 24.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.258 1.023 . . . . 0.0 110.582 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.61 170.43 51.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.869 1.26 . . . . 0.0 112.237 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -154.37 142.23 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.239 2.216 . . . . 0.0 105.459 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.28 150.02 35.05 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.28 123.26 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.7 m -90.53 124.57 35.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.74 173.46 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.547 0.739 . . . . 0.0 109.749 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -132.63 41.72 3.16 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HB2' ' H ' ' A' ' 90' ' ' ALA 0.331 73.6 mt 39.06 80.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 174.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.5 mm -76.47 -27.64 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 121.859 -0.526 . . . . 0.0 110.169 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.97 156.54 28.12 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 125.226 1.393 . . . . 0.0 109.659 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.48 123.54 13.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -114.4 -29.32 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.817 0.847 . . . . 0.0 112.486 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.83 125.62 11.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.19 71.15 1.34 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.226 2.61 . . . . 0.0 107.589 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.85 46.27 3.62 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.78 -76.79 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 127.119 2.295 . . . . 0.0 110.03 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.85 127.21 11.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.946 1.298 . . . . 0.0 113.419 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -75.97 71.19 2.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.162 2.985 . . . . 0.0 108.319 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.45 132.1 90.69 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.4 179.16 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.525 1.484 . . . . 0.0 110.893 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.0 t -54.0 -55.14 39.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.24 121.35 8.63 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 N-CA-C 106.915 -1.994 . . . . 0.0 106.915 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.98 -152.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.081 4.521 . . . . 0.0 113.0 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.7 m -33.8 125.76 0.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.837 2.855 . . . . 0.0 112.226 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.14 53.64 0.23 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.471 ' H ' ' HB2' ' A' ' 72' ' ' LEU . . . -140.62 158.24 44.28 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.009 2.124 . . . . 0.0 105.741 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 p -87.83 154.33 20.63 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.386 -0.821 . . . . 0.0 111.234 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -147.37 141.16 25.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -108.4 112.54 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.69 123.14 33.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -76.63 113.74 14.6 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.364 1.065 . . . . 0.0 109.129 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.63 114.08 63.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.25 0.89 7.32 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.407 2.071 . . . . 0.0 113.842 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.38 113.33 9.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . 0.29 54.0 pttt -71.94 -4.7 29.89 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -94.15 -38.41 11.1 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -149.09 159.93 36.09 Favored Pre-proline 0 C--N 1.343 0.312 0 C-N-CA 124.014 0.926 . . . . 0.0 112.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.36 150.32 83.05 Favored 'Cis proline' 0 CA--C 1.54 0.819 0 O-C-N 122.722 0.854 . . . . 0.0 112.085 2.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.6 108.39 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 2.873 . . . . 0.0 111.301 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.1 ttp -140.85 149.71 42.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.194 1.798 . . . . 0.0 108.108 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -138.21 161.53 36.61 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.762 0.825 . . . . 0.0 110.858 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -70.09 132.17 45.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.36 25.81 58.44 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.33 152.06 34.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.487 1.515 . . . . 0.0 108.616 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -95.43 133.08 39.81 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.256 1.422 . . . . 0.0 111.365 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.03 175.54 9.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.967 1.307 . . . . 0.0 111.555 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.518 HD11 ' HG3' ' A' ' 113' ' ' MET . 0.6 OUTLIER -116.07 124.62 50.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 131.008 3.723 . . . . 0.0 102.597 175.308 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.25 114.1 22.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.275 1.03 . . . . 0.0 108.82 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 50' ' ' VAL . 22.7 mtm -116.93 113.25 22.16 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 101.652 -3.462 . . . . 0.0 101.652 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.13 -142.7 3.5 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.788 1.661 . . . . 0.0 109.291 -175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -132.3 174.68 9.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.139 0.97 . . . . 0.0 111.122 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -130.14 138.24 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -120.34 113.08 19.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -76.95 64.85 2.51 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.397 1.479 . . . . 0.0 108.569 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -162.68 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.422 2.689 . . . . 0.0 108.306 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -120.29 -9.34 9.53 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.258 1.023 . . . . 0.0 112.891 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.97 -129.44 9.56 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.93 139.63 22.15 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.976 1.784 . . . . 0.0 112.749 -175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.56 152.76 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -135.05 74.21 63.58 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 174.18 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.987 3.791 . . . . 0.0 113.348 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.26 -21.14 65.53 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.012 1.808 . . . . 0.0 112.175 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.07 22.78 0.92 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 110.742 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.9 m -103.42 129.83 50.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.377 1.071 . . . . 0.0 113.04 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -88.56 120.21 29.73 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.48 123.75 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.52 171.3 4.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.253 1.021 . . . . 0.0 109.693 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.78 145.57 55.53 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.495 1.118 . . . . 0.0 108.454 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -71.94 149.18 45.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 110.42 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -148.73 149.76 31.52 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.64 -39.5 87.5 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.515 2.144 . . . . 0.0 112.301 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -57.75 -49.22 77.29 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.248 0.619 . . . . 0.0 111.286 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -60.11 -43.94 95.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.032 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -54.16 -53.19 56.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.57 0.623 . . . . 0.0 110.598 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -56.69 -45.43 81.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.219 1.408 . . . . 0.0 111.125 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.87 -52.46 61.4 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.122 0.969 . . . . 0.0 109.649 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -37.13 82.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.078 -175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -63.16 -45.71 90.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.244 1.384 . . . . 0.0 108.399 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -57.49 -46.26 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.724 0.693 . . . . 0.0 110.049 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.31 -33.55 75.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.525 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.0 t -62.86 -48.06 80.68 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.707 1.14 . . . . 0.0 110.336 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -62.73 -51.44 67.15 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.908 -0.495 . . . . 0.0 109.942 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 126.764 2.026 . . . . 0.0 111.245 -178.528 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.14 -50.16 56.38 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -63.08 -48.68 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.697 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -55.76 -46.69 77.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.178 0.445 . . . . 0.0 110.479 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -76.0 -41.42 51.22 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.13 -1.891 . . . . 0.0 112.542 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.501 ' CD2' HG11 ' A' ' 50' ' ' VAL . 10.7 t80 -48.81 -49.05 40.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.035 1.743 . . . . 0.0 109.745 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.07 -32.17 73.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.374 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -56.82 4.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.291 1.036 . . . . 0.0 112.447 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 139.33 41.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.873 1.269 . . . . 0.0 112.729 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -76.97 -24.61 52.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.871 1.268 . . . . 0.0 109.462 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 94' ' ' PHE . 44.9 tp -120.23 128.04 52.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.219 1.008 . . . . 0.0 110.157 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 44' ' ' PHE . 35.4 t -141.33 113.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.9 171.12 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.897 1.279 . . . . 0.0 109.487 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -131.33 139.42 49.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -162.49 168.16 22.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.883 -1.136 . . . . 0.0 111.716 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.3 m -109.82 134.15 52.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.0 114.48 12.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -81.81 -51.66 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 m -148.98 174.25 12.48 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 125.209 1.404 . . . . 0.0 109.696 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 13.6 mtp -135.39 154.88 51.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.957 1.703 . . . . 0.0 107.363 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.87 138.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.697 1.599 . . . . 0.0 106.987 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -70.1 145.69 51.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.058 1.299 . . . . 0.0 108.705 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 55.9 mm-40 -131.67 164.7 40.91 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.841 0.857 . . . . 0.0 108.864 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -52.57 155.62 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.751 2.967 . . . . 0.0 115.715 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.42 -124.71 25.27 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.838 1.685 . . . . 0.0 110.854 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -105.02 25.71 10.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.151 1.381 . . . . 0.0 108.316 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.86 176.17 37.53 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.816 1.198 . . . . 0.0 114.255 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -161.82 141.36 9.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.796 2.438 . . . . 0.0 106.817 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . . . -110.22 152.08 26.53 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 120.851 -1.155 . . . . 0.0 107.889 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.79 123.13 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -89.64 125.91 35.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 11.4 m -123.91 171.76 12.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.758 0.823 . . . . 0.0 109.93 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -132.67 37.19 3.49 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.067 0.947 . . . . 0.0 112.729 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.304 18.6 mt 39.17 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.37 -29.09 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 118.668 0.667 . . . . 0.0 109.625 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 168.48 39.34 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.322 1.439 . . . . 0.0 110.972 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.36 147.62 30.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.899 1.68 . . . . 0.0 109.306 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -141.38 -25.18 0.72 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -156.26 136.88 13.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.301 1.84 . . . . 0.0 106.502 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.0 p -145.31 71.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.614 2.766 . . . . 0.0 109.051 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 43.69 3.19 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.86 1.695 . . . . 0.0 110.088 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.88 -72.45 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 129.497 3.427 . . . . 0.0 109.683 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mt -51.05 132.23 27.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -82.84 76.07 9.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 83' ' ' LEU . 21.0 mt -53.19 129.56 50.34 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.36 158.09 46.82 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.593 1.528 . . . . 0.0 112.281 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -52.85 -58.14 13.29 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.22 114.57 3.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 N-CA-C 103.554 -3.287 . . . . 0.0 103.554 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 88' ' ' THR . 68.0 Cg_endo -68.06 -153.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.429 3.419 . . . . 0.0 116.328 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 14.2 m -35.01 134.44 0.24 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 130.76 3.624 . . . . 0.0 111.538 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.69 11.97 3.86 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.733 2.587 . . . . 0.0 110.577 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.6 154.72 20.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.739 1.216 . . . . 0.0 108.182 175.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -104.0 141.26 36.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.437 1.095 . . . . 0.0 111.835 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 mt -147.28 151.6 36.89 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.742 1.217 . . . . 0.0 111.861 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -103.67 114.89 29.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.0 m-85 -87.33 122.36 30.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -80.55 114.92 19.79 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.951 1.3 . . . . 0.0 109.8 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.13 114.02 58.41 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 120.817 1.644 . . . . 0.0 107.195 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.15 -7.72 21.52 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.17 1.913 . . . . 0.0 112.43 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.6 m -121.07 113.61 20.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.467 1.907 . . . . 0.0 109.988 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -78.43 -15.85 58.22 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.387 -0.821 . . . . 0.0 112.55 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -83.4 -41.46 18.11 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.683 0.793 . . . . 0.0 112.337 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.7 m -149.63 156.47 38.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.022 1.329 . . . . 0.0 110.36 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.12 159.31 81.0 Favored 'Cis proline' 0 CA--C 1.544 1.008 0 CA-C-N 119.134 0.727 . . . . 0.0 110.802 -3.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.12 142.94 99.89 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.172 2.581 . . . . 0.0 112.848 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 33.0 tpp -149.3 155.15 40.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.513 1.525 . . . . 0.0 109.239 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -150.56 141.1 22.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.555 1.942 . . . . 0.0 106.328 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.65 146.83 54.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.93 45.04 96.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.708 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.7 t -144.07 154.64 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.907 2.083 . . . . 0.0 107.214 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.5 m -102.56 135.29 44.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.591 1.156 . . . . 0.0 111.577 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.8 175.16 9.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.34 1.456 . . . . 0.0 112.851 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.34 124.71 53.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 130.654 3.581 . . . . 0.0 102.554 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.42 114.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.0 mtm -116.42 113.13 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.63 -139.33 2.75 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.047 1.308 . . . . 0.0 111.142 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -131.69 179.05 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.043 0.921 . . . . 0.0 110.336 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.78 145.97 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.651 -0.656 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -111.73 113.42 25.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.46 72.41 6.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -178.18 -39.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 129.186 2.995 . . . . 0.0 111.062 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -130.67 -10.88 3.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.43 -157.82 15.3 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.353 0.979 . . . . 0.0 111.791 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.14 144.53 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.347 2.698 . . . . 0.0 113.464 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.26 2.9 p -127.23 142.13 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.254 1.8 tm? -132.72 79.37 64.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.616 -1.302 . . . . 0.0 109.98 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.65 171.95 8.84 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.349 3.366 . . . . 0.0 112.598 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.01 -33.03 95.72 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.126 1.884 . . . . 0.0 113.268 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -83.96 37.2 0.59 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.42 1.088 . . . . 0.0 112.181 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.6 m -97.32 130.52 44.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.867 1.667 . . . . 0.0 108.898 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.3 113.65 15.29 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.61 123.95 43.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -150.28 171.82 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.28 1.832 . . . . 0.0 109.18 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.14 141.93 58.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.928 1.291 . . . . 0.0 109.504 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -75.72 131.28 39.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.418 0.687 . . . . 0.0 109.913 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -139.16 146.75 50.54 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.072 1.749 . . . . 0.0 107.67 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -57.54 -34.25 97.76 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.006 2.47 . . . . 0.0 113.362 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -54.15 -54.55 38.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.401 0.68 . . . . 0.0 109.679 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.49 -43.19 97.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.884 0.874 . . . . 0.0 109.677 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -51.1 -55.19 18.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.393 1.477 . . . . 0.0 111.166 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -65.53 -30.65 71.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.902 0.481 . . . . 0.0 110.757 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.71 -52.12 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 120.599 -1.313 . . . . 0.0 109.282 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.12 -37.79 81.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.085 1.312 . . . . 0.0 109.432 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.7 m -56.62 -53.62 55.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.693 0.797 . . . . 0.0 108.9 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -61.64 -31.3 71.39 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.595 -0.691 . . . . 0.0 112.201 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.59 -23.9 56.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.134 0.879 . . . . 0.0 111.299 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.8 t -73.67 -38.09 65.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -76.09 -59.59 2.69 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.765 1.226 . . . . 0.0 111.5 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.561 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.35 -40.92 98.63 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -62.22 -54.22 43.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.981 0.809 . . . . 0.0 109.978 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -55.82 -46.39 78.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.92 0.867 . . . . 0.0 111.227 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -69.69 -37.65 76.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.201 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.505 ' CD2' HG11 ' A' ' 50' ' ' VAL . 25.7 t80 -61.35 -37.18 82.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.592 1.087 . . . . 0.0 109.757 175.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.7 -57.8 6.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.749 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -29.72 69.69 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -76.25 153.85 35.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.318 0.508 . . . . 0.0 111.895 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -102.85 -6.95 21.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.321 1.048 . . . . 0.0 108.717 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 94' ' ' PHE . 37.1 tp -133.43 123.47 25.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.639 1.576 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.505 HG11 ' CD2' ' A' ' 44' ' ' PHE . 42.6 t -138.58 114.55 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.81 172.04 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.807 1.243 . . . . 0.0 109.782 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -134.66 141.24 46.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.82 174.7 13.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 120.626 -1.296 . . . . 0.0 110.987 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.1 m -114.17 130.22 56.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 102.939 -2.985 . . . . 0.0 102.939 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.44 113.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -78.86 -43.33 25.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 108.808 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -152.77 167.76 27.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.248 1.419 . . . . 0.0 109.893 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 57.1 mtp -137.98 125.07 21.47 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.7 t -120.63 146.05 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.485 1.514 . . . . 0.0 107.82 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 -65.73 154.65 38.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.977 1.262 . . . . 0.0 107.877 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.594 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 22.5 mm-40 -135.13 170.9 9.99 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 124.728 1.211 . . . . 0.0 108.691 176.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 165.55 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.171 2.581 . . . . 0.0 113.318 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.2 -142.37 45.95 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 125.791 1.663 . . . . 0.0 109.298 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' OE1' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tp10 -97.56 25.19 5.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.917 1.287 . . . . 0.0 107.69 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.68 43.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.383 1.945 . . . . 0.0 114.794 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.48 155.77 35.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.381 2.673 . . . . 0.0 107.309 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.594 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -119.92 146.26 45.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.97 123.15 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 m -92.86 129.15 38.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 170.84 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.887 0.875 . . . . 0.0 111.559 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -135.01 35.38 3.07 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt 37.02 82.38 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.506 2.322 . . . . 0.0 116.003 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.3 mm -75.02 -23.02 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.701 0.8 . . . . 0.0 109.037 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.2 159.66 33.08 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.76 45.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.716 1.607 . . . . 0.0 106.695 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -141.42 -32.01 0.56 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.832 0.707 . . . . 0.0 111.246 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -148.21 129.61 14.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -139.4 70.03 1.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.324 2.249 . . . . 0.0 105.95 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.23 44.47 3.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.295 1.426 . . . . 0.0 109.61 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.77 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 130.075 3.702 . . . . 0.0 107.514 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -44.59 123.52 3.68 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 123.033 1.397 . . . . 0.0 114.408 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.59 64.86 5.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.348 3.059 . . . . 0.0 109.375 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -56.02 131.34 73.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.83 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.06 177.67 7.9 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.428 2.086 . . . . 0.0 112.107 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -48.92 -52.45 46.58 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.938 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.27 116.97 4.32 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 CA-C-N 121.843 1.694 . . . . 0.0 108.538 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.18 -153.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.343 4.028 . . . . 0.0 111.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.5 m -33.36 125.44 0.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.838 2.455 . . . . 0.0 110.194 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.55 2.09 5.89 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.294 1.902 . . . . 0.0 111.42 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.31 150.86 22.9 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.182 1.491 . . . . 0.0 110.112 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.9 p -95.08 150.5 20.11 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 mt -144.29 168.37 20.23 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.195 2.198 . . . . 0.0 109.773 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -127.26 115.01 18.38 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.7 m-85 -95.63 124.79 39.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -72.34 139.93 48.19 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.309 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.31 113.64 18.31 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -60.73 -11.83 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.169 3.246 . . . . 0.0 115.451 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.5 m -137.42 118.39 14.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.539 1.535 . . . . 0.0 113.007 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' OE1' ' A' ' 64' ' ' GLU . 22.0 pttp -73.98 -27.22 60.88 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.665 -0.647 . . . . 0.0 110.188 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -62.73 -52.13 64.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.217 1.407 . . . . 0.0 110.858 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -146.65 159.11 45.09 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 111.673 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.3 160.77 75.3 Favored 'Cis proline' 0 CA--C 1.543 0.928 0 CA-C-N 119.189 0.746 . . . . 0.0 112.554 -0.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.63 95.56 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.957 3.105 . . . . 0.0 111.752 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 34.1 tpp -93.66 160.98 14.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.882 1.673 . . . . 0.0 108.603 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -148.48 136.9 21.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -77.31 145.06 37.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.888 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.16 98.75 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.674 0.67 . . . . 0.0 113.483 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.73 156.96 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 125.915 1.686 . . . . 0.0 107.049 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -89.99 138.72 31.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.991 0.901 . . . . 0.0 110.758 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -136.05 174.66 10.37 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.723 2.409 . . . . 0.0 112.33 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.05 123.62 42.04 Favored 'General case' 0 N--CA 1.448 -0.553 1 C-N-CA 132.504 4.321 . . . . 0.0 101.955 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.9 113.93 19.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.0 mtm -115.56 113.29 23.42 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.55 -136.39 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.46 1.028 . . . . 0.0 112.67 -175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -135.43 176.12 8.97 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.949 1.3 . . . . 0.0 110.366 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.95 154.4 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -125.02 113.67 18.08 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -74.19 71.01 1.65 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 165.44 -24.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 1 C-N-CA 132.056 4.142 . . . . 0.0 112.134 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -113.78 -4.4 13.37 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.204 0.94 . . . . 0.0 111.628 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.25 -160.29 34.67 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 131.51 19.07 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.307 2.671 . . . . 0.0 111.935 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.76 125.95 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -114.65 84.17 9.78 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 125.973 1.709 . . . . 0.0 109.939 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.27 168.46 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.034 3.156 . . . . 0.0 113.01 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.84 -22.17 73.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.462 2.108 . . . . 0.0 113.318 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.02 23.19 5.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.96 1.304 . . . . 0.0 111.03 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.6 m -83.9 134.59 34.67 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.457 1.503 . . . . 0.0 108.491 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -76.93 113.77 14.98 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.65 116.25 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.8 168.38 7.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.838 0.855 . . . . 0.0 110.082 -175.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.86 145.95 54.87 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.662 0.785 . . . . 0.0 108.916 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -72.45 130.23 40.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.828 0.851 . . . . 0.0 109.702 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -137.21 148.05 60.81 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.889 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -37.8 39.25 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.046 2.497 . . . . 0.0 112.642 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -57.82 -50.98 71.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.018 0.527 . . . . 0.0 110.266 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -59.23 -51.94 67.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.18 -48.13 45.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.519 1.927 . . . . 0.0 111.491 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -44.02 97.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.723 1.209 . . . . 0.0 111.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.7 mt -66.41 -43.67 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.407 -1.282 . . . . 0.0 109.704 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.3 -43.32 96.42 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.651 1.569 . . . . 0.0 109.298 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -57.6 -49.27 76.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.88 -34.92 78.41 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.322 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.4 mt -69.29 -27.76 65.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.978 1.263 . . . . 0.0 111.688 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -71.32 -47.38 57.01 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -71.27 -43.6 66.87 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.634 -0.667 . . . . 0.0 110.81 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 N--CA 1.45 -0.447 0 C-N-CA 126.471 1.908 . . . . 0.0 108.657 175.724 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.234 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.2 -50.49 63.68 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.76 -45.26 90.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.883 0.765 . . . . 0.0 111.538 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m -63.62 -44.94 92.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.918 0.326 . . . . 0.0 110.343 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -67.85 -46.19 72.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 117.174 -1.394 . . . . 0.0 110.092 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD2' HG11 ' A' ' 50' ' ' VAL . 54.2 t80 -48.4 -48.44 36.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.832 1.196 . . . . 0.0 111.331 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.5 m -65.62 -34.29 77.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.882 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -43.41 50.11 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.504 1.122 . . . . 0.0 112.292 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 p -66.75 127.25 31.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.993 0.917 . . . . 0.0 110.352 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.0 t -73.08 -21.43 60.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.955 0.798 . . . . 0.0 110.321 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 tp -117.83 118.78 32.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.552 1.141 . . . . 0.0 109.493 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG13 ' HG2' ' A' ' 113' ' ' MET . 19.8 t -136.62 113.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.41 173.47 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 126.043 1.737 . . . . 0.0 108.061 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.715 HG22 ' HA ' ' A' ' 111' ' ' LEU . 35.1 p -136.01 146.36 47.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -167.68 164.59 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.917 0.78 . . . . 0.0 111.991 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 93.0 m -96.44 133.27 41.07 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.42 113.74 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -72.79 -42.55 63.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.864 0.865 . . . . 0.0 108.979 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -165.56 170.29 14.46 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.069 1.347 . . . . 0.0 110.158 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 42.5 mtp -129.55 134.55 47.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.956 1.702 . . . . 0.0 106.62 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -135.52 144.63 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 159.46 30.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.688 1.585 . . . . 0.0 111.371 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -132.29 172.04 8.07 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 129.372 3.069 . . . . 0.0 110.685 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.91 146.4 16.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.586 2.857 . . . . 0.0 114.013 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.25 -124.43 30.74 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.912 1.244 . . . . 0.0 111.149 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -86.88 -0.52 56.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.855 0.862 . . . . 0.0 112.037 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.62 163.13 40.38 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.704 1.145 . . . . 0.0 114.039 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -148.4 136.22 20.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.27 1.828 . . . . 0.0 106.641 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.73 134.22 45.23 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.61 123.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m -93.23 130.56 38.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -134.71 172.28 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.73 0.812 . . . . 0.0 110.704 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -137.35 41.92 2.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt 38.5 80.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.428 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 17.0 mm -72.95 -29.46 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.05 157.56 29.11 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.66 144.97 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.362 1.465 . . . . 0.0 108.077 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -145.08 -25.7 0.48 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -155.36 127.68 7.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -144.56 70.18 1.28 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.564 2.346 . . . . 0.0 108.155 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.2 35.03 2.8 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.13 -81.6 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 127.556 2.503 . . . . 0.0 107.423 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.53 133.1 7.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 117.965 2.58 . . . . 0.0 117.965 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.27 63.79 8.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.011 2.925 . . . . 0.0 108.332 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.78 133.2 47.33 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.07 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.49 175.94 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.363 2.042 . . . . 0.0 112.219 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -50.86 -55.79 24.62 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.582 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.81 126.11 14.8 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.927 1.367 . . . . 0.0 109.137 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.896 2.397 . . . . 0.0 110.89 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.6 m -33.08 127.26 0.32 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 129.378 3.071 . . . . 0.0 112.987 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.74 54.63 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.093 2.282 . . . . 0.0 109.789 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.84 156.55 43.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.126 2.57 . . . . 0.0 107.093 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 p -102.72 155.06 18.57 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.253 -0.904 . . . . 0.0 112.971 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 mt -145.66 163.05 36.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.885 1.674 . . . . 0.0 108.593 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -126.37 113.73 17.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.59 126.35 38.7 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.279 1.031 . . . . 0.0 108.997 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -79.5 113.58 17.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.237 1.015 . . . . 0.0 110.503 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.88 119.03 54.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.56 -13.4 30.05 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.023 1.815 . . . . 0.0 113.292 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.2 126.35 16.45 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.844 1.658 . . . . 0.0 109.402 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -14.14 60.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.863 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -63.77 -58.08 7.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.884 1.22 . . . . 0.0 111.592 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -145.45 158.54 50.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.95 159.73 86.72 Favored 'Cis proline' 0 CA--C 1.548 1.176 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -4.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.89 160.9 27.47 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.729 1.619 . . . . 0.0 111.295 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.4 tpp -152.33 150.84 30.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -139.81 145.98 38.84 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -72.98 138.71 46.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.21 58.83 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.765 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.39 144.44 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 108.62 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.4 m -92.26 126.99 37.57 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.592 1.157 . . . . 0.0 112.181 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.86 175.66 8.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 112.046 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.715 ' HA ' HG22 ' A' ' 52' ' ' THR . 0.1 OUTLIER -116.17 127.23 54.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.754 3.221 . . . . 0.0 103.359 175.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.96 114.29 20.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.846 0.858 . . . . 0.0 109.892 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.64 ' HG2' HG13 ' A' ' 50' ' ' VAL . 10.5 mtm -114.64 111.64 21.64 Favored 'General case' 0 C--N 1.32 -0.69 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 176.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.85 -148.32 4.76 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.548 2.023 . . . . 0.0 111.228 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -130.75 178.04 6.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.123 0.969 . . . . 0.0 108.972 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 t -135.71 145.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 121.708 -0.62 . . . . 0.0 109.348 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -114.16 113.85 25.23 Favored 'General case' 0 C--N 1.346 0.414 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.09 72.39 4.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -175.22 -35.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 130.593 3.557 . . . . 0.0 109.141 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -117.37 -16.71 10.24 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.02 -171.36 14.84 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.78 137.81 55.42 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.99 1.793 . . . . 0.0 110.173 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.262 7.2 p -114.65 162.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.289 1.7 tm? -150.9 76.27 8.07 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.9 170.44 11.53 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.973 3.116 . . . . 0.0 112.343 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.38 -19.23 66.61 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.899 1.733 . . . . 0.0 112.214 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -84.41 36.38 0.58 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.446 2.698 . . . . 0.0 109.898 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 m -113.48 133.24 55.32 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.682 1.593 . . . . 0.0 110.804 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -85.01 117.55 24.04 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.19 119.57 31.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.837 0.855 . . . . 0.0 110.134 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.0 m -143.58 168.82 11.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.97 1.708 . . . . 0.0 108.926 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.25 149.39 48.12 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.78 -0.575 . . . . 0.0 110.211 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -72.5 144.34 48.05 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -142.64 149.58 50.96 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.72 -39.76 25.22 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 111.663 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -58.59 -48.04 82.29 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.894 0.316 . . . . 0.0 110.696 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -58.19 -46.88 85.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.763 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.59 -56.51 14.83 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.203 1.401 . . . . 0.0 110.772 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -63.73 -37.88 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.93 -49.77 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.609 1.095 . . . . 0.0 109.837 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.33 -34.2 77.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.575 1.079 . . . . 0.0 108.808 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -60.78 -47.92 84.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -59.11 -49.21 78.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.699 -0.626 . . . . 0.0 110.229 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.6 mt -59.05 -34.53 72.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.682 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 t -56.26 -58.02 9.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.371 0.987 . . . . 0.0 110.526 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -73.13 -38.92 66.12 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.693 0.397 . . . . 0.0 111.693 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 . . . . . 0 N--CA 1.454 -0.227 0 C-N-CA 124.61 1.164 . . . . 0.0 110.211 176.211 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.798 0.808 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.19 -53.55 10.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.88 1.672 . . . . 0.0 109.274 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -62.14 -31.28 71.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.14 0.882 . . . . 0.0 112.424 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -74.19 -52.39 12.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -59.2 -37.89 78.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.662 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.489 ' CD2' HG11 ' A' ' 50' ' ' VAL . 36.8 t80 -59.1 -41.64 88.59 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.444 1.02 . . . . 0.0 110.777 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -68.35 -41.1 81.17 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.694 -0.629 . . . . 0.0 111.131 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -55.71 11.48 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.698 0.681 . . . . 0.0 112.671 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 p -54.37 148.46 11.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.496 1.118 . . . . 0.0 111.629 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.1 t -99.07 -15.54 18.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.486 0.714 . . . . 0.0 111.551 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.77 115.49 22.77 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' A' ' 44' ' ' PHE . 22.4 t -134.86 113.6 16.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.12 170.36 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.629 1.172 . . . . 0.0 110.947 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -130.97 142.6 50.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.869 2.068 . . . . 0.0 106.953 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -168.56 176.78 5.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.257 -0.902 . . . . 0.0 110.938 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -114.77 136.03 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.69 113.6 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.15 -52.67 7.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -145.93 173.18 12.37 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.856 1.662 . . . . 0.0 109.542 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.5 mtp -139.55 153.29 47.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.149 2.18 . . . . 0.0 106.309 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' O ' HD22 ' A' ' 66' ' ' LEU . 88.2 t -145.49 135.74 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 108.103 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -66.16 147.14 53.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.956 1.707 . . . . 0.0 108.757 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 4.6 mm-40 -139.59 169.37 12.36 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 119.331 0.969 . . . . 0.0 112.912 -176.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.97 163.22 7.88 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.573 3.516 . . . . 0.0 114.629 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.58 -123.58 8.3 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -119.84 22.09 11.68 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.31 175.61 45.76 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-O 124.832 2.351 . . . . 0.0 118.934 -174.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.415 HD22 ' O ' ' A' ' 59' ' ' VAL . 2.8 tm? -156.42 135.19 11.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.472 2.709 . . . . 0.0 105.387 -175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . . . -109.75 127.24 54.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.7 123.3 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -86.17 127.17 34.67 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.92 168.13 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.706 0.803 . . . . 0.0 108.933 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 t -129.94 35.9 4.09 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' HB3' HG23 ' A' ' 88' ' ' THR 0.307 81.7 mt 37.42 80.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.456 2.302 . . . . 0.0 116.273 173.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.58 -40.39 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 110.15 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 88' ' ' THR . . . -152.37 161.7 29.55 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.46 147.07 42.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.593 1.957 . . . . 0.0 107.637 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.68 -30.1 2.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.707 1.203 . . . . 0.0 110.359 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -150.77 137.43 18.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -142.41 70.17 1.33 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 129.072 2.949 . . . . 0.0 106.434 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.61 32.37 3.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.985 0.802 . . . . 0.0 111.912 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 126.765 2.126 . . . . 0.0 110.983 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.06 132.6 48.91 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.307 1.043 . . . . 0.0 111.199 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -85.72 94.05 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.79 1.636 . . . . 0.0 107.532 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.06 133.0 88.02 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.72 -179.06 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.437 2.758 . . . . 0.0 114.652 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 t -39.58 -60.33 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.371 1.868 . . . . 0.0 110.762 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.17 123.72 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.01 1.806 . . . . 0.0 108.392 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.32 -170.59 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.275 1.983 . . . . 0.0 112.712 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.509 HG21 ' CA ' ' A' ' 74' ' ' GLY . 40.0 m -38.3 127.55 1.38 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.044 2.138 . . . . 0.0 116.458 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.19 14.97 0.09 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 128.392 2.901 . . . . 0.0 110.61 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.38 168.07 9.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.728 1.611 . . . . 0.0 110.728 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.9 p -98.73 153.01 19.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.57 -0.706 . . . . 0.0 112.621 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 24.4 mt -152.37 154.04 34.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.833 1.253 . . . . 0.0 109.612 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -112.51 113.24 25.31 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -89.27 121.27 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.137 0.88 . . . . 0.0 109.106 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -73.76 114.27 11.85 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.038 1.335 . . . . 0.0 110.529 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.5 117.57 55.51 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.95 -4.16 14.26 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.268 2.645 . . . . 0.0 112.982 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.29 120.49 28.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.466 2.306 . . . . 0.0 111.33 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -73.81 -25.92 60.35 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.507 -0.746 . . . . 0.0 110.102 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -69.7 -45.36 68.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.416 1.487 . . . . 0.0 113.059 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.416 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 17.3 m -148.56 163.51 25.83 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 101' ' ' CYS . 50.1 Cg_endo -62.57 157.66 62.96 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 O-C-N 122.493 0.733 . . . . 0.0 111.618 -1.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.32 92.71 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.839 3.026 . . . . 0.0 114.268 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.6 tpp -96.03 161.54 13.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.542 1.937 . . . . 0.0 111.563 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -153.48 139.76 18.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.342 1.857 . . . . 0.0 107.896 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.55 146.63 48.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.29 32.27 83.64 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.9 -0.944 . . . . 0.0 114.35 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.7 t -129.63 156.78 42.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.677 1.991 . . . . 0.0 106.636 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.3 m -103.6 136.55 43.1 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.486 0.715 . . . . 0.0 109.726 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.39 176.02 8.9 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.231 1.812 . . . . 0.0 112.773 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.46 123.66 43.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.0 114.24 22.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.142 0.977 . . . . 0.0 108.604 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -117.01 113.34 22.21 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.86 -143.04 3.67 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 126.118 1.818 . . . . 0.0 109.35 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -133.23 177.3 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.527 0.68 . . . . 0.0 110.234 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.98 130.95 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -109.9 113.2 25.73 Favored 'General case' 0 N--CA 1.449 -0.512 1 N-CA-C 98.208 -4.738 . . . . 0.0 98.208 174.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 72.16 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.504 1.621 . . . . 0.0 108.053 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -161.38 -47.38 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.695 2.798 . . . . 0.0 106.579 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.48 -4.49 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.661 1.584 . . . . 0.0 111.245 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.28 -122.72 6.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.267 1.413 . . . . 0.0 109.851 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.82 145.33 28.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.754 2.302 . . . . 0.0 114.931 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.37 151.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 130' ' ' VAL . 1.6 tm? -142.6 76.3 18.02 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 120.742 -1.223 . . . . 0.0 108.572 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.73 171.95 6.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.649 3.566 . . . . 0.0 112.428 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.89 -19.13 68.02 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.059 1.414 . . . . 0.0 112.22 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.98 23.21 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.968 2.107 . . . . 0.0 111.773 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.8 m -91.59 132.95 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 110.557 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.85 113.64 18.17 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 124' ' ' LEU . 55.5 t -136.59 119.21 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.75 167.77 8.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.102 1.361 . . . . 0.0 108.626 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.22 152.29 41.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -69.94 135.6 49.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -137.36 145.11 48.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.61 -46.24 14.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.926 1.751 . . . . 0.0 112.648 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.85 -38.0 89.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.792 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.72 -41.09 97.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.402 -0.811 . . . . 0.0 109.595 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -54.88 -49.83 70.22 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.381 1.473 . . . . 0.0 109.212 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -62.95 -45.23 93.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.132 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.0 mt -59.21 -47.38 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.804 1.184 . . . . 0.0 109.813 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.96 -38.07 87.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 109.4 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.2 m -61.64 -43.37 98.98 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.718 -0.614 . . . . 0.0 110.099 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -60.3 -52.71 64.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.6 mt -59.27 -32.48 70.05 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.699 0.8 . . . . 0.0 112.016 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.9 t -64.6 -51.24 63.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.081 1.352 . . . . 0.0 110.646 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -71.67 -38.94 70.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 126.456 1.902 . . . . 0.0 108.928 176.31 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.236 0.383 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -63.93 -40.87 97.44 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.61 -51.84 65.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.221 0.464 . . . . 0.0 110.845 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -53.02 -54.47 34.81 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.199 1.0 . . . . 0.0 110.194 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.91 -35.89 81.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.007 -0.996 . . . . 0.0 111.489 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 50' ' ' VAL . 30.8 t80 -57.42 -39.91 77.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.889 1.222 . . . . 0.0 110.315 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.11 -42.67 46.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.865 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.79 78.47 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.106 . . . . 0.0 112.573 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -75.99 145.74 40.06 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.682 0.793 . . . . 0.0 111.459 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -95.12 -5.94 43.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.826 1.25 . . . . 0.0 108.268 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD21 ' CE2' ' A' ' 94' ' ' PHE . 26.0 tp -129.09 122.71 30.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.557 2.343 . . . . 0.0 108.272 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 44' ' ' PHE . 23.3 t -142.56 113.81 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.92 163.34 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.209 1.404 . . . . 0.0 109.019 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 p -126.21 144.76 50.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -164.67 161.39 20.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.674 -1.266 . . . . 0.0 111.933 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 55.3 m -87.69 132.87 33.96 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.0 t -75.35 113.31 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -82.9 -46.44 12.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.57 1.548 . . . . 0.0 108.13 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -153.03 167.03 30.55 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.491 1.517 . . . . 0.0 108.967 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.3 mtp -135.34 123.98 23.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.943 2.897 . . . . 0.0 105.784 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.73 150.73 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.93 1.292 . . . . 0.0 107.899 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -67.69 154.46 41.43 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.609 -0.682 . . . . 0.0 109.26 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 23.8 mm-40 -140.02 168.34 15.21 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.408 1.083 . . . . 0.0 110.776 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.83 162.26 11.29 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.65 2.9 . . . . 0.0 112.915 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.93 -147.48 50.73 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -88.72 20.42 3.49 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.48 169.04 54.9 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-O 123.848 1.804 . . . . 0.0 117.547 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.96 134.11 16.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.735 2.814 . . . . 0.0 104.967 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -98.55 123.53 42.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.55 123.15 49.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 175.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.0 m -98.72 126.21 44.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.12 175.51 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.221 0.608 . . . . 0.0 111.305 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -133.1 40.84 3.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.278 91.8 mt 38.81 80.97 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.411 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 26.9 mm -77.86 -29.5 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.77 0.714 . . . . 0.0 109.42 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -155.32 159.28 29.03 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.935 1.731 . . . . 0.0 109.408 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.56 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -135.34 -32.04 0.95 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.194 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -157.98 133.58 9.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -145.27 67.85 1.23 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.121 2.168 . . . . 0.0 106.548 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.62 43.83 3.22 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.479 1.514 . . . . 0.0 111.215 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.12 -31.77 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 125.93 1.728 . . . . 0.0 113.16 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.95 144.27 28.43 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.35 1.575 . . . . 0.0 109.993 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -100.55 63.37 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -57.54 141.08 79.37 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.962 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.39 171.51 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.192 1.928 . . . . 0.0 112.961 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.1 t -43.81 -56.13 7.86 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.896 2.078 . . . . 0.0 110.23 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.42 116.79 4.85 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 N-CA-C 106.597 -2.116 . . . . 0.0 106.597 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.46 -152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 1 C-N-CA 125.317 4.011 . . . . 0.0 112.129 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.456 HG21 ' HA2' ' A' ' 74' ' ' GLY 0.292 97.5 m -33.77 124.39 0.45 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 129.089 2.956 . . . . 0.0 112.117 -175.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.21 -4.05 1.75 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.186 1.85 . . . . 0.0 113.356 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.84 161.04 15.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.034 1.417 . . . . 0.0 109.446 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.2 p -105.32 143.8 32.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.799 0.809 . . . . 0.0 112.231 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -148.25 160.68 42.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.153 1.781 . . . . 0.0 109.48 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.32 121.22 43.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.501 ' CE2' HD21 ' A' ' 49' ' ' LEU . 40.6 m-85 -94.04 122.59 36.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -75.64 113.44 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 124.259 0.974 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.48 114.02 62.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -11.7 29.12 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 111.926 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -117.49 113.25 21.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.993 1.317 . . . . 0.0 111.956 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -82.74 -20.29 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -60.24 -53.59 55.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 109.776 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.3 m -160.58 163.56 21.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 127.483 2.313 . . . . 0.0 108.407 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.13 141.97 41.85 Favored 'Cis proline' 0 CA--C 1.537 0.664 0 CA-C-N 120.678 1.278 . . . . 0.0 111.312 1.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 102.2 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.177 2.585 . . . . 0.0 111.558 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 tpp -93.36 158.41 15.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.045 1.738 . . . . 0.0 108.666 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -142.54 137.22 30.02 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.537 0.684 . . . . 0.0 110.107 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -74.94 144.42 43.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.242 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.11 45.62 55.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -151.13 161.31 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 127.742 2.417 . . . . 0.0 105.513 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.8 m -107.63 131.34 54.48 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -122.77 170.32 10.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.444 1.898 . . . . 0.0 112.622 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.23 123.74 47.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.572 3.549 . . . . 0.0 102.031 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.37 114.13 21.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.5 mtm -119.23 113.33 20.7 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.18 -134.2 1.91 Allowed Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.187 1.375 . . . . 0.0 111.366 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -134.96 -178.5 5.11 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.342 -1.093 . . . . 0.0 109.401 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 49' ' ' LEU . 21.6 t -136.9 144.12 33.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.24 113.43 19.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -75.84 73.95 2.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.388 1.09 . . . . 0.0 108.527 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -168.94 -41.2 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 129.812 3.245 . . . . 0.0 108.343 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -119.2 -6.37 10.39 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.349 1.06 . . . . 0.0 112.682 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -151.32 21.33 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.86 141.95 38.13 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.613 1.542 . . . . 0.0 112.737 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.81 135.62 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 130' ' ' VAL 0.255 1.7 tm? -122.07 74.26 38.16 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 107.486 -174.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.86 174.86 6.1 Favored 'Trans proline' 0 CA--C 1.542 0.888 1 C-N-CA 125.728 4.285 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.54 -22.85 61.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.728 2.285 . . . . 0.0 113.463 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -85.17 23.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.355 1.462 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.2 m -97.74 140.1 32.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.922 . . . . 0.0 111.252 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -92.55 117.05 29.56 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 124' ' ' LEU . 85.3 t -131.8 117.41 34.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.795 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -147.12 168.68 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.228 1.411 . . . . 0.0 109.117 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.7 141.1 57.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.13 0.967 . . . . 0.0 109.954 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -68.45 136.32 53.06 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.777 1.631 . . . . 0.0 107.877 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -144.65 155.64 56.51 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.112 1.765 . . . . 0.0 106.912 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.44 -40.12 25.77 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.187 1.925 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -56.97 -52.71 64.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.013 0.37 . . . . 0.0 110.945 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -58.09 -44.11 87.45 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 123.091 0.556 . . . . 0.0 110.362 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.96 -50.65 70.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.34 1.056 . . . . 0.0 109.796 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -61.67 -39.57 91.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.275 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.3 mt -63.4 -50.36 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.116 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 mt -62.39 -36.91 83.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.207 1.367 . . . . 0.0 109.088 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.7 m -61.81 -45.36 94.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.15 -38.94 90.93 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.282 -0.886 . . . . 0.0 110.737 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.4 mt -68.65 -24.61 64.55 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.706 0.803 . . . . 0.0 111.582 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 t -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.184 0.902 . . . . 0.0 109.408 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -75.61 -48.88 20.33 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.625 0.77 . . . . 0.0 111.092 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 119.017 0.826 . . . . 0.0 109.496 176.51 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.82 -47.75 76.88 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.05 -48.0 80.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 118.62 0.646 . . . . 0.0 110.593 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 m -59.28 -48.15 82.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.346 0.659 . . . . 0.0 111.077 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -69.0 -33.89 74.41 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.249 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.514 ' CD2' HG11 ' A' ' 50' ' ' VAL . 15.9 t80 -57.52 -36.4 71.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.185 1.357 . . . . 0.0 110.033 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.8 m -69.26 -45.85 68.69 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.39 0.676 . . . . 0.0 111.115 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.28 50.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.511 0.724 . . . . 0.0 112.144 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -62.05 138.49 58.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.78 1.232 . . . . 0.0 109.994 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -94.3 -6.68 43.89 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.061 0.934 . . . . 0.0 109.882 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.5 HD21 ' CE2' ' A' ' 94' ' ' PHE . 24.6 tp -120.38 120.42 35.92 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 126.75 2.02 . . . . 0.0 107.709 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 44' ' ' PHE . 40.1 t -142.88 113.32 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.49 166.8 5.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.776 1.231 . . . . 0.0 108.509 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -130.29 143.66 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -165.58 173.31 11.03 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 110.799 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.8 m -110.82 134.45 52.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.92 113.58 15.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 22.2 mmmt -86.49 -42.38 13.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.424 1.09 . . . . 0.0 110.327 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -147.37 168.99 20.42 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.198 1.399 . . . . 0.0 110.925 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 mtp -138.82 129.25 25.84 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.427 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.0 t -123.72 142.19 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.312 1.045 . . . . 0.0 108.663 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -72.49 139.69 47.78 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -123.62 176.11 2.41 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.339 1.856 . . . . 0.0 108.555 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.81 161.81 34.62 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.929 2.419 . . . . 0.0 112.24 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -154.2 40.17 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -72.2 0.27 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.914 1.285 . . . . 0.0 110.632 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.5 172.56 22.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 126.808 2.147 . . . . 0.0 117.873 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 59' ' ' VAL . 1.8 tm? -161.87 141.99 10.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 129.569 3.148 . . . . 0.0 105.44 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.29 151.35 27.5 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.93 123.28 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 124.68 43.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.51 169.98 20.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 t -123.8 35.39 4.85 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.26 70.3 mt 36.3 82.58 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 128.071 2.549 . . . . 0.0 116.884 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 32.7 mm -72.15 -30.99 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.305 -0.872 . . . . 0.0 111.816 175.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.498 ' CA ' HG21 ' A' ' 88' ' ' THR . . . -159.3 160.91 31.7 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.88 49.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -141.32 -25.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.396 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -156.15 125.54 6.23 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -139.57 67.95 1.38 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 127.709 2.404 . . . . 0.0 104.613 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 31.46 3.31 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.58 1.086 . . . . 0.0 111.939 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.58 -62.7 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.247 1.403 . . . . 0.0 111.4 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.12 148.59 30.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 117.147 0.474 . . . . 0.0 111.022 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.11 97.69 11.33 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.2 mt -63.23 147.44 94.81 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.68 178.7 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.539 1.493 . . . . 0.0 111.347 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.3 t -52.31 -61.02 5.06 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.614 1.166 . . . . 0.0 111.245 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 142.36 46.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 N-CA-C 107.36 -1.823 . . . . 0.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.36 -168.94 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.392 1.395 . . . . 0.0 110.846 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.498 HG21 ' CA ' ' A' ' 74' ' ' GLY . 17.1 m -38.17 130.93 1.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.258 2.223 . . . . 0.0 113.67 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 59.48 0.06 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 105.257 -3.137 . . . . 0.0 105.257 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.63 165.33 31.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 126.501 1.92 . . . . 0.0 106.608 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.9 p -104.0 147.72 27.05 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 120.907 -1.121 . . . . 0.0 111.443 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -147.26 158.77 44.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -125.02 113.84 18.32 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.5 ' CE2' HD21 ' A' ' 49' ' ' LEU . 70.8 m-85 -98.81 121.19 40.45 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.86 0.864 . . . . 0.0 109.57 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.91 113.8 17.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 124.677 1.236 . . . . 0.0 109.994 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.54 120.01 54.31 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.32 0.02 8.0 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.685 2.257 . . . . 0.0 112.458 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 57.7 m -129.83 160.81 32.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.061 2.544 . . . . 0.0 109.121 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -132.01 -8.42 3.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -83.45 -48.03 10.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.482 1.037 . . . . 0.0 108.511 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -127.66 158.22 70.81 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.99 1.316 . . . . 0.0 111.519 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.7 153.26 79.38 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 -4.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.35 96.51 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.403 2.735 . . . . 0.0 112.622 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.5 tpp -94.67 160.94 14.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.135 1.374 . . . . 0.0 110.309 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -152.91 140.02 19.32 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.988 1.715 . . . . 0.0 109.093 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -78.2 147.06 34.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.45 46.6 84.87 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -146.32 147.86 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 126.477 1.911 . . . . 0.0 106.714 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.1 m -93.8 132.13 38.5 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.168 0.587 . . . . 0.0 110.096 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.76 172.38 11.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.631 1.972 . . . . 0.0 111.664 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -115.81 124.15 50.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.21 114.34 23.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.7 mtm -117.89 113.37 21.64 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 103.274 -2.861 . . . . 0.0 103.274 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.74 -134.01 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.802 1.191 . . . . 0.0 111.164 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -135.89 175.98 9.1 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.985 . . . . 0.0 110.991 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 6.4 t -130.21 145.78 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.789 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -123.76 113.7 18.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -81.01 65.32 6.11 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.378 1.085 . . . . 0.0 111.946 -175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -166.82 -39.42 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.982 1.713 . . . . 0.0 110.736 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -113.65 -30.67 6.73 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.96 -168.76 21.21 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 Cg_endo -71.76 160.53 47.75 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.287 1.325 . . . . 0.0 111.342 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.47 157.21 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 130' ' ' VAL . 1.7 tm? -146.44 74.73 12.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 120.67 -1.269 . . . . 0.0 108.664 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.05 174.19 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.552 3.501 . . . . 0.0 113.052 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.13 -16.37 50.05 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.847 1.698 . . . . 0.0 111.99 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.81 32.01 0.48 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.038 2.135 . . . . 0.0 110.826 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -113.66 128.73 56.54 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.111 1.364 . . . . 0.0 111.064 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -81.34 113.31 19.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 124' ' ' LEU . 55.6 t -133.46 123.18 45.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -152.43 173.16 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.362 1.465 . . . . 0.0 110.682 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.91 134.25 54.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.875 1.67 . . . . 0.0 109.323 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -67.74 125.77 27.3 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -140.9 157.64 66.93 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.56 -1.209 . . . . 0.0 109.199 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.52 -44.85 16.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.63 2.887 . . . . 0.0 115.785 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -55.68 -43.42 76.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.542 1.065 . . . . 0.0 110.859 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.35 -44.28 83.66 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.94 -0.553 . . . . 0.0 109.556 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.37 -50.05 65.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.919 0.887 . . . . 0.0 111.657 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.59 -49.77 73.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.592 0.757 . . . . 0.0 109.335 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.73 -52.61 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.861 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.23 -32.82 74.32 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.771 1.169 . . . . 0.0 110.222 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.6 m -65.73 -46.84 77.37 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -60.32 -41.75 94.17 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.685 -0.635 . . . . 0.0 111.267 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.98 -35.64 80.41 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.5 1.12 . . . . 0.0 110.867 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -61.99 -45.61 92.85 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -67.41 -48.88 66.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.53 0.732 . . . . 0.0 110.5 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.457 0.646 . . . . 0.0 109.638 178.532 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.236 0.365 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.7 -38.31 90.64 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -64.83 -53.75 41.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.474 0.579 . . . . 0.0 111.376 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -59.54 -47.15 86.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.533 0.682 . . . . 0.0 109.183 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.85 -36.2 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.39 -1.29 . . . . 0.0 111.754 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 50' ' ' VAL . 27.0 t80 -57.8 -43.43 85.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.55 1.523 . . . . 0.0 111.484 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.91 -34.34 69.02 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.312 0.645 . . . . 0.0 111.495 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.9 96.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.506 0.722 . . . . 0.0 112.261 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -76.08 148.45 37.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.901 1.28 . . . . 0.0 113.831 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 t -90.3 -13.92 34.26 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.643 1.977 . . . . 0.0 109.382 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 94' ' ' PHE . 57.9 tp -131.06 123.99 29.89 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.54 1.536 . . . . 0.0 109.111 -176.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 44' ' ' PHE . 22.0 t -141.74 114.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.59 168.92 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.516 1.126 . . . . 0.0 109.57 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.0 p -124.31 140.72 52.69 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.61 163.48 24.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.527 -1.358 . . . . 0.0 111.202 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 94.2 m -93.81 127.16 39.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.26 113.32 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -89.78 -47.6 7.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -141.27 166.87 23.58 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.731 0.812 . . . . 0.0 110.208 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.4 mtp -139.06 124.14 18.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.906 1.682 . . . . 0.0 106.83 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.09 146.92 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.249 1.42 . . . . 0.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -72.13 141.1 49.14 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.443 -0.786 . . . . 0.0 109.13 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 mm-40 -132.27 170.25 11.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.767 1.227 . . . . 0.0 109.954 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -62.1 170.32 6.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.028 3.152 . . . . 0.0 114.999 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.5 -123.33 28.96 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -113.94 19.61 16.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 108.255 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.82 171.52 55.15 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 123.37 1.539 . . . . 0.0 115.855 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.73 129.11 8.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.062 2.545 . . . . 0.0 105.264 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -97.03 123.82 40.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.1 123.17 47.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -95.39 123.73 39.07 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.36 169.04 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.232 1.013 . . . . 0.0 110.539 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -135.75 44.81 2.47 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt 37.8 81.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.746 3.239 . . . . 0.0 119.746 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.4 mm -79.98 -23.14 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.507 1.048 . . . . 0.0 110.305 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.05 160.26 32.58 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.68 35.46 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.632 1.173 . . . . 0.0 109.604 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -138.48 -33.1 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.307 0.643 . . . . 0.0 112.688 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -150.61 133.16 15.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -143.22 77.77 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.091 2.956 . . . . 0.0 103.496 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.61 36.4 2.64 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 125.568 1.556 . . . . 0.0 112.037 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.81 -67.2 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 126.681 2.086 . . . . 0.0 109.736 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.81 125.29 22.89 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 123.755 0.822 . . . . 0.0 108.863 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -78.54 91.28 4.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 124.628 1.205 . . . . 0.0 108.621 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 83' ' ' LEU . 28.4 mt -65.84 129.63 94.33 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.64 178.17 7.73 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.45 1.433 . . . . 0.0 112.977 -175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.9 t -43.86 -58.8 4.21 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 116.902 -1.523 . . . . 0.0 109.892 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.77 122.0 9.11 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 N-CA-C 107.623 -1.722 . . . . 0.0 107.623 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 88' ' ' THR . 84.1 Cg_endo -69.83 -153.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 1 C-N-CA 125.909 4.406 . . . . 0.0 110.407 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 54.1 m -31.57 123.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 110.54 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.31 39.21 0.26 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.569 1.081 . . . . 0.0 112.748 -175.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.73 164.07 29.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.421 1.488 . . . . 0.0 107.216 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 p -110.38 153.29 25.16 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.874 0.761 . . . . 0.0 112.189 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.5 mt -144.31 159.89 41.94 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.097 1.359 . . . . 0.0 109.165 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -119.67 113.47 20.72 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.7 m-85 -95.51 118.59 32.5 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -75.89 113.47 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.841 0.857 . . . . 0.0 109.451 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.73 114.82 63.55 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.35 2.2 5.93 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 113.484 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -135.07 114.14 12.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 109.074 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.93 -10.24 59.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.323 -0.861 . . . . 0.0 111.321 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -82.75 -46.46 13.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.008 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.1 m -151.94 164.17 21.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.477 1.111 . . . . 0.0 112.327 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.75 150.98 52.54 Favored 'Cis proline' 0 C--N 1.355 0.904 0 CA-C-N 120.013 1.04 . . . . 0.0 110.231 -3.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.77 97.62 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.429 2.753 . . . . 0.0 113.638 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 tpp -93.77 162.33 13.97 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.758 1.223 . . . . 0.0 108.411 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -146.77 143.4 28.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.654 1.582 . . . . 0.0 108.313 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.98 139.77 41.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.137 0.575 . . . . 0.0 110.036 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.89 71.39 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 126.386 1.946 . . . . 0.0 115.474 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.76 146.15 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.057 1.743 . . . . 0.0 108.345 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 m -91.87 128.25 37.63 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.443 0.64 . . . . 0.0 109.625 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -124.12 172.29 9.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.089 2.556 . . . . 0.0 111.457 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 123.63 46.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 100.791 -3.781 . . . . 0.0 100.791 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.18 114.03 21.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.5 mtm -116.97 113.25 22.12 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.9 -142.49 3.49 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.172 1.844 . . . . 0.0 110.878 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -132.86 176.41 8.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.617 1.209 . . . . 0.0 110.334 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.33 149.29 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.25 114.31 14.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.249 2.22 . . . . 0.0 106.546 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.82 65.62 0.23 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.285 1.834 . . . . 0.0 114.56 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 169.16 -25.84 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 130.701 3.6 . . . . 0.0 111.64 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -112.76 -6.61 13.84 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.648 1.179 . . . . 0.0 113.889 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.67 -151.01 42.35 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 135.56 22.7 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.205 1.936 . . . . 0.0 110.369 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.264 7.4 p -120.4 142.51 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 130' ' ' VAL 0.282 1.4 tm? -129.67 74.1 81.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -174.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.04 175.11 5.02 Favored 'Trans proline' 0 CA--C 1.543 0.93 1 C-N-CA 125.497 4.131 . . . . 0.0 113.347 -175.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -58.91 -28.91 88.87 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.283 1.988 . . . . 0.0 113.843 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.25 39.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.7 m -107.66 129.12 55.04 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -82.19 113.74 20.23 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 124' ' ' LEU . 50.0 t -133.57 117.86 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 123.812 0.845 . . . . 0.0 109.193 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.75 168.87 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.89 1.276 . . . . 0.0 109.286 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.9 139.29 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.41 0.624 . . . . 0.0 109.415 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -65.55 144.43 56.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.996 1.318 . . . . 0.0 109.203 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -144.34 148.99 43.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.61 -40.5 29.74 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.751 1.634 . . . . 0.0 110.712 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -53.53 -46.43 70.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.801 0.84 . . . . 0.0 110.804 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.91 -40.32 87.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.512 0.725 . . . . 0.0 111.011 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.8 -47.41 82.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.16 0.891 . . . . 0.0 110.009 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -59.31 -39.65 83.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.511 1.524 . . . . 0.0 110.062 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.48 -51.83 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.441 1.019 . . . . 0.0 109.791 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 mt -63.71 -35.07 79.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.129 1.331 . . . . 0.0 109.548 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.0 m -58.67 -49.94 75.7 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.13 -41.47 83.75 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.632 -0.667 . . . . 0.0 112.171 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.84 -28.75 64.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.518 0.727 . . . . 0.0 112.369 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -73.18 -36.64 66.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.865 0.866 . . . . 0.0 108.716 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -75.32 -50.26 16.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.685 1.594 . . . . 0.0 110.37 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 . . . . . 0 CA--C 1.536 0.436 0 O-C-N 120.725 -1.234 . . . . 0.0 111.009 175.904 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.235 0.328 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.42 -42.3 96.13 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.38 -42.64 78.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.013 0.525 . . . . 0.0 112.347 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -64.95 -52.43 56.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.89 -36.46 83.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.339 -0.838 . . . . 0.0 112.092 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 50' ' ' VAL . 35.1 t80 -60.3 -38.58 84.12 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.907 1.23 . . . . 0.0 111.236 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 m -70.15 -41.26 74.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.385 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.75 -52.89 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 112.903 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -56.17 138.24 50.3 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.325 1.05 . . . . 0.0 112.222 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -82.66 -14.12 55.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.187 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.1 tp -127.57 122.21 32.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.871 1.268 . . . . 0.0 109.592 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 44' ' ' PHE . 16.3 t -138.2 113.74 9.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.33 171.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.683 1.593 . . . . 0.0 108.875 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.552 HG22 ' HA ' ' A' ' 111' ' ' LEU . 34.2 p -130.77 145.22 51.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.17 167.98 21.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.167 -0.958 . . . . 0.0 111.251 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -102.64 130.08 49.43 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.8 t -71.31 113.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -80.15 -42.99 22.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.365 1.466 . . . . 0.0 109.529 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -156.65 166.01 34.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.705 1.202 . . . . 0.0 109.219 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 59.2 mtp -133.23 129.97 38.42 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.07 148.0 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.655 0.782 . . . . 0.0 108.92 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -70.14 155.34 40.76 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.55 1.068 . . . . 0.0 110.252 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 5.3 mm-40 -132.24 176.1 3.18 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.811 1.644 . . . . 0.0 111.491 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.22 144.27 98.79 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.459 2.773 . . . . 0.0 111.862 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.23 -152.21 51.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.66 3.87 4.58 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.882 -0.776 . . . . 0.0 110.255 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.54 164.28 20.92 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-O 123.691 1.717 . . . . 0.0 116.82 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -147.81 138.14 22.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.794 2.437 . . . . 0.0 106.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.437 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -105.21 143.28 33.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -118.61 123.31 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.9 m -97.1 132.88 42.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.49 175.9 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.896 0.878 . . . . 0.0 112.407 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -135.98 35.17 2.84 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt 38.47 82.09 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 117.8 2.518 . . . . 0.0 117.8 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.1 mm -77.91 -25.89 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.312 1.045 . . . . 0.0 111.095 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -164.74 162.95 35.98 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 124.955 1.264 . . . . 0.0 110.752 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 150.11 37.02 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.582 1.953 . . . . 0.0 108.323 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.405 ' HD1' HG12 ' A' ' 50' ' ' VAL . 3.6 m-85 -141.5 -27.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.22 1.008 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -154.93 127.83 8.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.417 1.487 . . . . 0.0 107.317 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -136.48 74.58 1.5 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.303 3.041 . . . . 0.0 105.402 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.24 35.27 2.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.134 1.35 . . . . 0.0 110.355 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.91 -73.33 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 127.551 2.501 . . . . 0.0 110.796 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.0 mt -56.3 134.74 53.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.39 76.07 5.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.757 2.023 . . . . 0.0 108.788 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.7 138.79 97.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.106 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.52 178.15 7.97 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.815 2.343 . . . . 0.0 112.871 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.0 t -49.02 -54.9 23.87 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 117.041 -1.457 . . . . 0.0 110.88 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.16 117.12 4.85 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 88' ' ' THR . 79.1 Cg_endo -72.72 -152.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 125.03 3.82 . . . . 0.0 111.502 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 41.6 m -34.06 123.9 0.48 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.856 3.262 . . . . 0.0 112.201 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.16 58.01 0.21 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.64 1.591 . . . . 0.0 109.436 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 161.5 40.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.034 2.534 . . . . 0.0 106.326 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -99.83 151.33 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.4 mt -143.9 165.2 28.38 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.468 1.507 . . . . 0.0 109.813 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -128.65 120.39 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.47 124.45 47.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.347 1.459 . . . . 0.0 107.779 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' A' ' 123' ' ' VAL . 52.7 t80 -80.31 121.21 25.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.835 1.254 . . . . 0.0 110.501 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.74 124.49 30.41 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.04 -1.22 11.17 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.568 2.179 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.5 m -150.58 175.75 11.63 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.495 2.318 . . . . 0.0 108.959 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.95 -4.39 5.72 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -79.21 -51.06 9.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.84 1.655 . . . . 0.0 109.944 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.428 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 15.7 m -133.35 155.37 80.86 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 127.282 2.233 . . . . 0.0 111.352 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 101' ' ' CYS . 63.6 Cg_endo -67.67 156.72 85.94 Favored 'Cis proline' 0 CA--C 1.55 1.29 0 C-N-CA 124.658 -0.976 . . . . 0.0 110.154 -2.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.49 87.23 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.535 3.49 . . . . 0.0 114.873 -175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -99.46 156.91 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.038 2.135 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -150.21 152.67 34.97 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.619 1.568 . . . . 0.0 109.331 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -77.95 136.35 37.98 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.65 43.0 30.67 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.84 0.733 . . . . 0.0 113.371 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.67 153.17 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.667 1.587 . . . . 0.0 107.77 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.2 m -98.94 130.73 45.32 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 110.538 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.99 173.24 11.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.588 1.555 . . . . 0.0 111.893 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.552 ' HA ' HG22 ' A' ' 52' ' ' THR . 7.0 tp -108.58 124.77 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 130.113 3.365 . . . . 0.0 102.522 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.72 113.84 24.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -115.0 113.24 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 101.221 -3.622 . . . . 0.0 101.221 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.52 -143.12 3.57 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.013 1.292 . . . . 0.0 111.249 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -133.52 176.92 8.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.118 0.967 . . . . 0.0 109.437 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.37 133.09 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.45 -0.781 . . . . 0.0 111.466 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.47 112.98 25.26 Favored 'General case' 0 C--O 1.242 0.693 1 N-CA-C 96.04 -5.541 . . . . 0.0 96.04 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.24 63.71 8.16 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.802 1.287 . . . . 0.0 109.735 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -169.59 -32.48 0.02 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.802 2.441 . . . . 0.0 109.829 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -113.54 -14.71 12.65 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.203 1.001 . . . . 0.0 111.633 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.55 -172.11 22.66 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.15 135.27 49.91 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.903 1.736 . . . . 0.0 109.351 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -114.18 134.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 1.8 tm? -125.74 78.74 68.89 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 125.221 1.408 . . . . 0.0 108.98 -174.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.23 170.77 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.742 2.961 . . . . 0.0 111.596 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -23.05 75.96 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.517 2.145 . . . . 0.0 112.528 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -83.49 24.0 0.88 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.047 0.939 . . . . 0.0 111.883 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 m -94.43 124.3 38.37 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.925 1.29 . . . . 0.0 108.034 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -77.11 113.79 15.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.5 125.79 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.7 167.85 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.382 1.473 . . . . 0.0 108.246 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.57 138.27 58.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.39 131.42 46.39 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -141.12 147.27 46.78 Favored Pre-proline 0 N--CA 1.464 0.249 0 C-N-CA 125.69 1.596 . . . . 0.0 107.281 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.75 -37.12 29.32 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.577 2.185 . . . . 0.0 114.008 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -56.48 -52.74 63.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.818 0.735 . . . . 0.0 110.375 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -58.82 -44.48 90.88 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.542 1.137 . . . . 0.0 110.282 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.59 -45.67 88.61 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.408 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -61.46 -39.53 91.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.523 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.93 -47.79 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 119.649 1.113 . . . . 0.0 109.684 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.03 -40.34 93.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.333 1.424 . . . . 0.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.3 m -59.48 -51.22 70.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 109.0 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -65.31 -33.94 77.16 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.244 1.418 . . . . 0.0 111.018 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.44 -35.96 65.85 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.825 1.25 . . . . 0.0 110.504 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -63.41 -34.9 78.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.063 1.301 . . . . 0.0 109.168 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -74.51 -44.1 52.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.881 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 120.87 1.668 . . . . 0.0 108.104 175.039 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 p . . . . . 0 C--O 1.234 0.271 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 141' ' ' LEU . 8.5 tt -63.75 -39.14 93.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.62 -50.67 68.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.269 0.628 . . . . 0.0 111.09 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -65.15 -43.23 92.48 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -61.3 -44.75 96.7 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 116.92 -1.514 . . . . 0.0 112.364 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' A' ' 50' ' ' VAL . 10.2 t80 -53.35 -46.7 69.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.787 1.631 . . . . 0.0 110.29 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.3 m -66.04 -37.14 85.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.884 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -51.77 60.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.255 1.022 . . . . 0.0 111.379 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -61.1 147.45 43.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.776 0.83 . . . . 0.0 111.022 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -101.42 -9.49 21.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.736 0.814 . . . . 0.0 109.76 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 94' ' ' PHE . 48.0 tp -127.32 119.21 25.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.169 1.788 . . . . 0.0 106.81 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 44' ' ' PHE . 48.8 t -137.25 115.52 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -146.57 169.15 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.932 1.293 . . . . 0.0 109.62 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -131.24 143.59 50.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.57 163.96 16.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.903 -1.123 . . . . 0.0 111.383 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.5 m -91.19 129.98 37.12 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.81 113.22 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -84.58 -35.08 23.01 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -160.41 170.49 20.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.06 1.344 . . . . 0.0 109.315 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.5 mtp -140.6 142.03 35.09 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.392 1.877 . . . . 0.0 106.258 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -143.57 147.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.771 0.828 . . . . 0.0 108.803 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.37 150.98 48.06 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.638 1.563 . . . . 0.0 109.709 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 5.7 mm-40 -120.89 175.37 2.41 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 127.96 2.504 . . . . 0.0 108.557 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.85 150.31 88.71 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.741 1.628 . . . . 0.0 111.244 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.58 -148.23 50.59 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.919 0.771 . . . . 0.0 112.857 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.5 7.1 2.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 112.341 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.26 170.6 54.83 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 122.737 1.187 . . . . 0.0 114.697 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.32 136.65 18.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.806 2.042 . . . . 0.0 106.36 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -98.0 136.1 38.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.7 t -115.55 123.17 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -91.46 130.47 37.29 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.61 168.84 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.037 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 t -131.02 37.28 3.78 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.1 mt 38.92 81.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.07 -29.1 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.73 155.74 26.78 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 125.748 1.642 . . . . 0.0 109.076 176.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.08 135.1 37.19 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.899 2.08 . . . . 0.0 105.728 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -130.57 -28.36 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 124.045 0.841 . . . . 0.0 113.009 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.94 129.91 11.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -145.86 68.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.618 1.967 . . . . 0.0 108.433 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.87 39.32 2.84 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.817 1.199 . . . . 0.0 112.355 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.78 -15.82 0.02 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.431 1.491 . . . . 0.0 115.985 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.16 151.42 23.67 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 120.206 2.003 . . . . 0.0 112.232 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -104.7 64.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.757 2.023 . . . . 0.0 106.255 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.41 148.27 73.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.45 -178.57 3.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.701 1.601 . . . . 0.0 111.285 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -52.25 -58.74 10.41 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.434 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.71 147.41 63.11 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 CA-C-N 121.924 1.723 . . . . 0.0 109.028 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.36 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.083 2.522 . . . . 0.0 112.029 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.478 HG21 ' HA2' ' A' ' 74' ' ' GLY . 19.8 m -32.34 132.52 0.13 Allowed 'General case' 0 C--O 1.243 0.733 0 C-N-CA 129.303 3.041 . . . . 0.0 112.085 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.7 57.64 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.746 1.641 . . . . 0.0 110.523 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.63 164.53 36.69 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.739 2.016 . . . . 0.0 107.632 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 p -108.09 146.86 32.02 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.365 0.666 . . . . 0.0 112.415 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.1 mt -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.652 1.981 . . . . 0.0 109.856 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -130.94 115.13 16.11 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.076 2.15 . . . . 0.0 105.488 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.6 m-85 -94.04 121.4 35.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -75.58 113.7 13.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.653 1.221 . . . . 0.0 108.986 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.79 121.41 46.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.68 -0.79 10.58 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.438 2.092 . . . . 0.0 112.762 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.6 m -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.212 1.805 . . . . 0.0 108.716 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -94.85 -17.98 21.59 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -102.06 -23.23 14.11 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.792 1.178 . . . . 0.0 113.677 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.5 m -135.03 155.51 79.07 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.104 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -69.87 169.49 63.55 Favored 'Cis proline' 0 CA--C 1.546 1.095 0 CA-C-N 119.825 0.973 . . . . 0.0 110.534 -4.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 77.04 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.866 3.044 . . . . 0.0 111.348 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.9 tpp -93.77 154.12 17.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.318 1.447 . . . . 0.0 110.53 -175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -144.5 144.39 31.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.531 0.733 . . . . 0.0 109.797 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -72.2 148.73 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.801 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.51 37.82 94.93 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.024 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.9 t -143.46 152.61 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.661 1.984 . . . . 0.0 106.771 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 m -94.59 129.03 41.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.86 0.838 . . . . 0.0 110.538 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -124.7 172.16 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.33 2.252 . . . . 0.0 111.567 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.678 HD11 ' HG3' ' A' ' 113' ' ' MET . 0.6 OUTLIER -116.51 125.78 52.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.829 3.651 . . . . 0.0 103.493 175.565 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.28 114.09 21.37 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.713 1.205 . . . . 0.0 107.884 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.678 ' HG3' HD11 ' A' ' 111' ' ' LEU . 13.4 mtm -117.53 112.91 21.23 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 102.899 -3.001 . . . . 0.0 102.899 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.68 -137.29 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.25 1.881 . . . . 0.0 109.383 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.67 175.68 9.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 108.755 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.57 144.85 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -116.31 113.19 22.61 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -78.31 63.52 3.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 109.842 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 177.59 -24.57 0.0 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.953 3.701 . . . . 0.0 112.21 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -116.33 -33.38 4.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.111 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.37 -167.37 18.81 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.687 1.613 . . . . 0.0 110.464 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.35 137.43 30.92 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.137 1.225 . . . . 0.0 109.218 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.252 14.7 p -121.31 155.96 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 130' ' ' VAL 0.277 1.0 OUTLIER -138.52 74.05 40.96 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -174.861 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.99 168.8 9.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 124.832 3.688 . . . . 0.0 111.836 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.37 -19.05 55.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.012 1.397 . . . . 0.0 113.429 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -85.37 23.56 1.3 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.521 1.529 . . . . 0.0 111.384 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.3 m -88.45 143.19 27.14 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.109 0.964 . . . . 0.0 110.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -92.67 115.4 28.07 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 124' ' ' LEU . 33.3 t -136.98 125.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -151.03 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.0 109.656 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.03 142.48 58.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.428 1.091 . . . . 0.0 109.796 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -73.82 126.75 31.09 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.984 0.913 . . . . 0.0 109.059 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -139.15 156.52 72.12 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 125.106 1.362 . . . . 0.0 108.4 175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.51 -49.46 11.96 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.234 2.623 . . . . 0.0 114.867 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -58.11 -47.6 82.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.561 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -58.02 -47.02 84.3 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 125.267 1.427 . . . . 0.0 110.439 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -54.37 -51.39 64.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.458 1.503 . . . . 0.0 110.598 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -62.92 -36.24 82.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.252 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.81 -47.27 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.24 1.382 . . . . 0.0 110.183 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 40' ' ' LEU . 4.6 mt -63.04 -38.7 92.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.061 1.301 . . . . 0.0 109.368 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -44.38 97.34 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.678 -0.638 . . . . 0.0 109.665 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -59.37 -45.93 90.07 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.245 -0.909 . . . . 0.0 109.95 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 -30.43 71.56 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.551 1.141 . . . . 0.0 111.669 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -69.93 -45.77 66.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.824 0.849 . . . . 0.0 110.013 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -75.56 -35.63 60.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 118.956 -0.545 . . . . 0.0 112.131 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 . . . . . 0 N--CA 1.448 -0.537 0 C-N-CA 124.247 1.019 . . . . 0.0 109.974 175.957 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.238 0.472 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.09 -46.68 83.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -62.6 -48.29 80.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.624 0.769 . . . . 0.0 110.984 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -55.17 -54.61 41.13 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.951 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -62.95 -40.94 99.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.592 -1.194 . . . . 0.0 111.996 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD2' HG11 ' A' ' 50' ' ' VAL . 34.6 t80 -56.89 -44.22 82.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.9 1.227 . . . . 0.0 110.986 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.8 m -64.01 -44.51 92.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.601 0.637 . . . . 0.0 111.446 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.28 -58.93 5.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.263 1.025 . . . . 0.0 111.209 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -55.74 140.72 40.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.611 1.565 . . . . 0.0 113.094 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -93.45 -8.99 40.05 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.721 0.808 . . . . 0.0 109.467 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.8 tp -124.68 122.86 38.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 108.185 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.622 HG11 ' CD2' ' A' ' 44' ' ' PHE . 13.3 t -139.93 113.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.9 m -149.81 171.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.404 1.482 . . . . 0.0 109.116 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 111' ' ' LEU . 3.1 p -133.53 141.89 47.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -164.03 161.35 22.56 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.955 -1.091 . . . . 0.0 112.192 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 32.3 m -95.83 128.04 42.37 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.39 113.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 29.3 mmmt -85.48 -41.01 15.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.048 0.939 . . . . 0.0 110.431 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -146.53 165.77 28.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 110.144 -175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.6 mtp -142.46 131.15 22.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.751 2.42 . . . . 0.0 105.265 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.69 157.33 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -67.71 150.01 49.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.211 0.604 . . . . 0.0 109.511 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.9 mm-40 -138.7 171.46 8.17 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 126.768 2.027 . . . . 0.0 109.775 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.14 163.61 22.34 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.569 2.179 . . . . 0.0 112.174 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.26 -151.2 52.25 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.2 9.05 16.17 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.48 171.59 43.59 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 126.58 2.038 . . . . 0.0 117.181 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.95 139.27 17.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.215 2.606 . . . . 0.0 105.171 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -99.39 124.17 44.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.8 123.17 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -98.5 124.6 43.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.31 174.72 6.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.833 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -137.45 46.05 2.16 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.032 1.287 . . . . 0.0 113.753 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.3 mt 36.14 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.502 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 28.3 mm -75.48 -26.83 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.874 -1.767 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.72 163.18 36.96 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.58 148.83 41.57 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.55 -51.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -132.37 124.1 28.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -138.16 61.55 1.59 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.696 1.998 . . . . 0.0 107.519 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 28.01 3.98 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.593 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.13 6.88 0.08 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.266 1.889 . . . . 0.0 114.163 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' HG ' HG11 ' A' ' 116' ' ' VAL . 77.6 mt -114.43 142.12 46.78 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 120.243 2.022 . . . . 0.0 111.136 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.12 72.82 9.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 111.705 -2.498 . . . . 0.0 105.961 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.35 125.18 81.21 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.78 -174.89 2.21 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.287 2.658 . . . . 0.0 112.48 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -49.73 -55.46 23.12 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.937 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.88 115.31 3.9 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 N-CA-C 108.105 -1.537 . . . . 0.0 108.105 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.67 -152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.945 3.763 . . . . 0.0 109.924 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -34.83 124.38 0.55 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.037 2.135 . . . . 0.0 109.547 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.61 -16.98 5.85 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 128.499 2.952 . . . . 0.0 111.734 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.92 154.6 31.5 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.135 1.467 . . . . 0.0 111.112 -175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 82.2 p -100.11 135.78 41.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -130.6 152.86 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.91 2.084 . . . . 0.0 109.495 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -108.17 114.06 27.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -89.74 119.82 30.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -75.74 113.52 13.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.42 114.28 63.43 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 5.21 1.73 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.619 2.879 . . . . 0.0 114.307 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.6 m -145.53 166.69 24.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.875 2.07 . . . . 0.0 109.044 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -123.57 -22.58 4.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.598 1.159 . . . . 0.0 113.307 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.12 -44.83 87.42 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.368 1.067 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.2 m -143.96 162.96 38.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.602 1.561 . . . . 0.0 109.15 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.36 157.39 68.26 Favored 'Cis proline' 0 CA--C 1.538 0.71 0 CA-C-N 119.671 0.918 . . . . 0.0 110.394 -3.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 80.38 1.14 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.236 2.624 . . . . 0.0 111.897 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.0 tpp -94.09 152.99 18.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.492 2.317 . . . . 0.0 107.943 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -137.27 143.23 42.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.96 142.28 52.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.97 62.61 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.53 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.55 155.33 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.744 1.618 . . . . 0.0 108.266 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 8.6 m -97.19 131.28 44.08 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.596 0.758 . . . . 0.0 111.393 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -128.48 170.07 13.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.011 2.125 . . . . 0.0 111.594 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HA ' HG22 ' A' ' 52' ' ' THR . 0.2 OUTLIER -114.73 126.51 54.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 130.395 3.478 . . . . 0.0 102.996 175.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.61 113.97 20.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.524 ' HG2' HG13 ' A' ' 50' ' ' VAL . 5.5 mtm -116.61 113.13 22.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.27 -139.09 2.67 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -134.49 173.04 12.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.451 HG11 ' HG ' ' A' ' 81' ' ' LEU . 2.4 t -133.41 148.29 30.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -116.49 112.81 21.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 174.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.44 78.68 8.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 177.22 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 130.841 3.656 . . . . 0.0 109.801 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -125.98 -32.1 2.81 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.155 1.782 . . . . 0.0 115.011 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.31 -158.13 14.5 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 139.85 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.803 1.669 . . . . 0.0 111.672 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.34 152.93 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.611 HD11 HG21 ' A' ' 130' ' ' VAL . 1.6 tm? -145.79 74.57 13.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.418 -1.426 . . . . 0.0 111.775 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.52 170.4 15.1 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.288 3.325 . . . . 0.0 111.792 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.03 -9.74 26.1 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.077 1.852 . . . . 0.0 113.727 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.28 25.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 m -105.34 137.84 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.37 2.268 . . . . 0.0 109.154 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.38 113.79 21.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.611 HG21 HD11 ' A' ' 124' ' ' LEU . 78.9 t -134.09 116.63 23.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.74 169.21 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.64 . . . . 0.0 108.874 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.0 mt -64.02 138.44 58.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -64.99 128.15 34.58 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -142.82 147.87 43.64 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.479 1.512 . . . . 0.0 107.767 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.38 -38.04 45.63 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.052 2.501 . . . . 0.0 113.704 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -54.56 -49.41 70.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.669 0.747 . . . . 0.0 110.487 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -66.32 -43.75 85.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.804 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.19 -52.24 46.2 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.109 1.364 . . . . 0.0 111.597 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.62 -47.67 84.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.989 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.9 -48.65 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.711 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mt -63.57 -38.08 89.76 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.969 1.259 . . . . 0.0 109.692 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.4 m -61.5 -46.72 88.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -59.31 -43.32 92.65 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.567 -0.708 . . . . 0.0 110.273 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.66 -26.42 67.79 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.326 1.05 . . . . 0.0 112.192 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 -39.44 71.15 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.281 1.032 . . . . 0.0 109.595 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -70.47 -56.61 6.18 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 . . . . . 0 N--CA 1.452 -0.329 0 C-N-CA 125.111 1.364 . . . . 0.0 108.979 -177.838 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.79 -44.44 93.34 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.081 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -61.48 -43.55 98.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.866 0.757 . . . . 0.0 111.363 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -64.41 -52.33 58.7 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -63.93 -36.03 82.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.958 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' A' ' 50' ' ' VAL . 51.9 t80 -63.65 -33.46 75.67 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.429 1.468 . . . . 0.0 111.317 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.3 -40.65 51.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.315 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -51.17 68.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.388 0.675 . . . . 0.0 110.975 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -60.38 152.73 24.61 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.205 1.402 . . . . 0.0 112.209 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -111.6 -4.02 14.89 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.88 118.47 23.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 44' ' ' PHE . 10.8 t -137.01 113.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.86 172.0 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.186 1.395 . . . . 0.0 109.767 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 111' ' ' LEU . 4.1 p -132.02 140.53 48.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.89 167.23 25.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.097 -1.002 . . . . 0.0 112.355 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.4 m -102.97 126.9 50.33 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 113.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 -44.77 15.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.6 m -146.54 170.9 15.95 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.367 1.067 . . . . 0.0 110.122 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.01 124.57 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.26 2.224 . . . . 0.0 105.667 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.86 148.39 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.294 1.838 . . . . 0.0 107.655 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.84 154.07 38.43 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.849 1.204 . . . . 0.0 109.388 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 72.0 mm-40 -138.49 176.24 2.8 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.205 1.402 . . . . 0.0 109.313 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.07 139.86 14.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.408 2.739 . . . . 0.0 114.493 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.46 -130.48 40.71 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.54 1.543 . . . . 0.0 110.926 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.15 6.98 26.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.159 0.984 . . . . 0.0 110.342 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.54 163.74 51.37 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 123.203 1.446 . . . . 0.0 113.16 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -153.84 131.27 11.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.398 1.879 . . . . 0.0 106.061 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -101.98 138.22 39.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.81 122.98 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -91.77 124.25 35.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.9 172.13 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 111.017 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -138.41 35.96 2.27 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.53 0.605 . . . . 0.0 112.191 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.268 25.1 mt 38.71 80.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.51 -20.7 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.228 1.011 . . . . 0.0 109.052 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -168.17 169.84 41.68 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.079 1.8 . . . . 0.0 110.891 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.38 154.35 42.2 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.199 1.399 . . . . 0.0 108.473 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.545 ' HD2' HG12 ' A' ' 50' ' ' VAL . 26.4 m-85 -136.33 -41.12 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.29 1.036 . . . . 0.0 109.881 175.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -144.51 138.24 27.43 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.48 67.39 1.43 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.19 2.996 . . . . 0.0 106.104 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.51 4.58 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.654 2.073 . . . . 0.0 109.695 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.62 -66.4 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 127.462 2.458 . . . . 0.0 111.02 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.25 128.07 34.59 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.269 0.628 . . . . 0.0 111.885 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.29 85.67 7.18 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.1 147.73 90.05 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 121.156 -0.965 . . . . 0.0 108.54 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.28 170.07 18.08 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -46.31 -55.55 13.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.745 1.218 . . . . 0.0 111.396 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.03 138.03 39.11 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 121.086 1.424 . . . . 0.0 109.356 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.79 -154.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.561 3.507 . . . . 0.0 111.909 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.456 HG21 ' HA2' ' A' ' 74' ' ' GLY . 87.1 m -34.15 137.07 0.11 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.492 2.717 . . . . 0.0 112.499 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.2 64.52 0.43 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -175.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.23 162.89 39.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.009 2.524 . . . . 0.0 106.237 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 p -108.82 157.4 18.62 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.211 -0.931 . . . . 0.0 111.986 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -151.69 169.17 22.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.043 2.137 . . . . 0.0 109.757 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -123.22 114.09 19.8 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.71 120.14 32.8 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -73.94 121.92 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.81 1.244 . . . . 0.0 110.12 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.58 123.95 30.67 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.91 -9.56 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.293 1.995 . . . . 0.0 113.885 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -145.39 158.31 43.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.832 1.653 . . . . 0.0 109.759 -176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.24 -16.76 13.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -66.05 -50.79 62.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.776 1.171 . . . . 0.0 110.651 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -134.86 161.39 63.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.93 1.292 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.94 158.71 81.29 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 O-C-N 122.73 0.858 . . . . 0.0 111.463 -3.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.58 90.6 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.483 2.789 . . . . 0.0 110.949 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.91 138.86 39.89 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 127.061 2.144 . . . . 0.0 111.36 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -133.57 137.63 45.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.033 0.921 . . . . 0.0 110.26 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -68.12 144.49 55.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.439 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.06 24.16 69.78 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.6 t -133.94 152.24 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.094 2.157 . . . . 0.0 107.627 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -98.53 130.9 45.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.074 0.95 . . . . 0.0 109.229 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.47 169.38 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.278 2.231 . . . . 0.0 112.882 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HA ' HG22 ' A' ' 52' ' ' THR . 13.2 tp -115.76 124.21 50.2 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 131.071 3.748 . . . . 0.0 102.017 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.06 113.75 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.482 ' HG2' HG13 ' A' ' 50' ' ' VAL . 11.7 mtm -115.49 112.91 22.96 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 101.454 -3.536 . . . . 0.0 101.454 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.29 -140.89 3.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.473 1.987 . . . . 0.0 110.877 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -138.73 176.89 8.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 t -130.55 132.86 64.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -115.28 114.22 24.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.56 80.12 7.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -173.04 -34.93 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.286 2.635 . . . . 0.0 108.146 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -134.71 -10.95 2.38 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 113.655 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 109.0 -162.66 12.75 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.58 1.086 . . . . 0.0 111.919 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.29 136.83 41.59 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.046 1.83 . . . . 0.0 110.043 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.89 147.87 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 130' ' ' VAL 0.269 1.8 tm? -137.38 73.71 49.21 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -174.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.37 175.09 8.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.493 3.462 . . . . 0.0 111.701 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.6 -17.6 35.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.91 1.74 . . . . 0.0 113.694 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.46 22.37 1.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.567 1.53 . . . . 0.0 111.305 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -98.95 124.54 43.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -76.19 113.87 14.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 124' ' ' LEU . 50.3 t -134.23 114.21 18.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.192 0.52 . . . . 0.0 110.168 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.29 169.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.972 1.309 . . . . 0.0 108.943 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.17 140.47 58.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.609 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.18 139.79 54.59 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -142.63 148.24 45.77 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 126.045 1.738 . . . . 0.0 106.775 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.3 -36.21 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.239 2.626 . . . . 0.0 111.018 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -58.63 -43.7 89.77 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.276 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -66.81 -43.85 82.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.435 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -51.45 -49.56 61.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.648 1.179 . . . . 0.0 111.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -60.79 -46.84 88.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.176 1.391 . . . . 0.0 111.208 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.3 -50.83 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.467 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.03 -33.82 76.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.489 1.04 . . . . 0.0 109.778 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.4 m -62.8 -40.4 97.25 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.784 -0.573 . . . . 0.0 109.541 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -60.78 -42.59 97.83 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.202 -0.936 . . . . 0.0 109.893 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.67 -30.38 71.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.766 0.826 . . . . 0.0 111.338 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.2 t -65.4 -46.74 78.87 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.324 0.966 . . . . 0.0 108.79 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -67.31 -49.99 61.98 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.871 -0.518 . . . . 0.0 110.414 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 mtm-85 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 123.754 0.821 . . . . 0.0 112.906 -176.014 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.05 -47.41 80.3 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -62.72 -50.07 72.55 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.364 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.4 m -65.97 -40.23 91.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.486 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -63.44 -47.04 83.55 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.142 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.564 ' CD2' HG11 ' A' ' 50' ' ' VAL . 12.1 t80 -52.17 -42.75 63.7 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.51 1.504 . . . . 0.0 110.535 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -63.22 -46.27 87.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.154 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.55 88.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.568 0.747 . . . . 0.0 112.946 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 p -76.15 131.16 39.21 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.884 1.274 . . . . 0.0 111.817 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -88.81 -6.71 57.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.706 0.803 . . . . 0.0 108.929 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.486 ' HB2' HG23 ' A' ' 116' ' ' VAL . 27.8 tp -118.03 114.7 23.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.732 2.413 . . . . 0.0 109.134 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 44' ' ' PHE . 23.4 t -139.59 113.5 6.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.14 168.52 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.19 1.396 . . . . 0.0 108.524 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 111' ' ' LEU . 2.9 p -134.23 140.99 46.85 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.58 170.58 18.34 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.421 -0.8 . . . . 0.0 111.205 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -109.28 133.94 52.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.51 114.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.314 0.645 . . . . 0.0 109.602 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -77.72 -53.08 7.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -141.22 168.31 20.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.877 1.271 . . . . 0.0 110.739 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.73 141.58 34.89 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 128.02 2.528 . . . . 0.0 105.846 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t -141.87 146.15 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -73.59 139.4 45.51 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 120.203 -1.561 . . . . 0.0 108.921 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 45.4 mm-40 -117.74 169.0 8.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 125.662 1.585 . . . . 0.0 108.642 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.39 152.82 24.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.254 2.636 . . . . 0.0 115.548 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.26 -125.91 39.14 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.0 tp10 -89.25 9.66 25.03 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.616 0.766 . . . . 0.0 111.274 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.64 171.32 49.25 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.27 139.15 18.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.468 3.107 . . . . 0.0 106.528 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -103.71 152.16 22.15 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.691 1.196 . . . . 0.0 108.567 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.63 123.43 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -97.67 126.6 43.08 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.36 172.7 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.194 0.998 . . . . 0.0 110.189 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -128.1 36.38 4.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.306 17.4 mt 40.16 80.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.694 2.398 . . . . 0.0 115.511 174.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.9 mm -78.02 -28.43 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 119.077 0.853 . . . . 0.0 109.815 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -159.1 157.43 28.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.92 138.7 35.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -132.42 -31.74 1.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.301 -175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -151.69 125.82 9.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -143.71 67.29 1.28 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.376 2.27 . . . . 0.0 109.693 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.65 46.01 3.57 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.948 1.261 . . . . 0.0 110.833 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.27 -48.97 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 126.05 1.786 . . . . 0.0 111.072 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.75 124.14 21.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 117.451 0.625 . . . . 0.0 109.336 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -78.47 64.82 3.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 129.108 2.963 . . . . 0.0 108.375 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.7 mt -57.98 123.64 65.36 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.39 -174.74 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.402 2.735 . . . . 0.0 111.55 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -49.46 -53.55 39.31 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.16 -1.4 . . . . 0.0 110.663 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.22 133.49 24.83 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 121.72 1.65 . . . . 0.0 107.965 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.51 -153.82 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.083 3.189 . . . . 0.0 110.96 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.411 HG21 ' HA2' ' A' ' 74' ' ' GLY . 52.3 m -34.87 131.28 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.584 2.754 . . . . 0.0 111.145 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.7 14.72 1.86 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 125.196 1.379 . . . . 0.0 112.573 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.37 53.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.213 1.506 . . . . 0.0 107.718 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.5 p -76.66 137.21 39.28 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.686 -0.634 . . . . 0.0 110.354 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.91 160.9 36.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.425 0.69 . . . . 0.0 111.194 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -124.17 113.63 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.699 2.0 . . . . 0.0 107.709 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -97.18 121.84 39.51 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.404 ' HB3' HG23 ' A' ' 123' ' ' VAL . 43.3 t80 -78.06 113.63 16.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.06 114.16 64.68 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.41 6.08 3.34 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.378 2.718 . . . . 0.0 113.119 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.0 m -135.97 151.09 49.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.411 2.284 . . . . 0.0 108.486 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -117.24 -5.74 11.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.502 0.721 . . . . 0.0 109.707 175.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -71.32 -58.3 3.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.435 2.694 . . . . 0.0 109.354 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -143.91 165.99 21.56 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 129.224 3.01 . . . . 0.0 110.9 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.2 152.52 98.34 Favored 'Cis proline' 0 CA--C 1.544 0.99 0 CA-C-N 119.671 0.918 . . . . 0.0 112.489 -2.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.37 112.32 2.54 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.839 3.026 . . . . 0.0 110.741 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.4 ttp -138.18 163.45 31.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -144.57 150.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.058 0.943 . . . . 0.0 110.047 -176.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.09 146.87 52.21 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.09 33.02 84.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.743 0.687 . . . . 0.0 113.993 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.7 154.87 32.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 119.089 1.445 . . . . 0.0 107.234 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 m -103.32 131.55 50.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.733 1.213 . . . . 0.0 111.704 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.95 175.65 9.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.117 0.967 . . . . 0.0 113.518 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 52' ' ' THR . 11.5 tp -113.01 128.13 56.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 130.799 3.64 . . . . 0.0 103.774 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.13 114.28 22.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.9 mtm -117.76 113.15 21.41 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.53 -137.55 2.39 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.475 1.512 . . . . 0.0 111.005 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -132.3 176.15 8.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.544 1.172 . . . . 0.0 110.9 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 49' ' ' LEU . 21.3 t -130.21 139.81 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 121.117 -0.989 . . . . 0.0 109.275 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -103.36 112.84 25.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.58 63.55 6.78 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -157.55 -42.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 129.393 3.077 . . . . 0.0 108.223 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -142.88 -11.53 0.77 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.67 -163.52 13.12 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.589 1.086 . . . . 0.0 111.727 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.32 141.36 51.37 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.273 1.982 . . . . 0.0 113.202 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -122.94 128.7 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.423 HD11 HG21 ' A' ' 130' ' ' VAL . 2.0 tm? -120.59 79.65 30.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.53 1.532 . . . . 0.0 110.529 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.13 173.63 8.18 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.659 3.573 . . . . 0.0 113.072 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.19 -22.27 73.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.013 1.809 . . . . 0.0 113.249 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -83.6 23.12 0.99 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.258 0.936 . . . . 0.0 111.12 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.5 m -95.92 134.19 39.21 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.632 1.173 . . . . 0.0 110.424 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.32 113.44 17.46 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.423 HG21 HD11 ' A' ' 124' ' ' LEU . 79.1 t -134.81 114.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 123.192 0.597 . . . . 0.0 110.502 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 m -147.26 169.81 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.518 1.527 . . . . 0.0 110.27 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.12 147.28 52.6 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.546 0.738 . . . . 0.0 109.831 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -75.12 137.84 41.66 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -143.61 142.8 21.62 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 107.977 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.55 -38.89 65.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.913 3.075 . . . . 0.0 116.283 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -65.77 -47.68 74.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.792 0.723 . . . . 0.0 110.251 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -58.13 -45.33 87.53 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.84 -0.538 . . . . 0.0 110.013 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -49.63 -55.44 13.63 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.908 1.683 . . . . 0.0 109.632 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -58.19 -43.38 87.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.183 0.993 . . . . 0.0 111.684 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.46 -46.68 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.931 0.787 . . . . 0.0 109.4 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -37.71 85.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.486 1.039 . . . . 0.0 109.079 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 78.9 m -59.99 -38.97 84.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.311 0.96 . . . . 0.0 109.499 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -62.72 -42.73 99.8 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.41 -0.806 . . . . 0.0 110.037 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.8 mt -69.35 -23.56 63.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.683 1.193 . . . . 0.0 112.428 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.4 t -72.63 -33.31 66.54 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.01 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -76.26 -65.59 0.9 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.366 1.466 . . . . 0.0 110.273 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 124.7 1.2 . . . . 0.0 110.831 -175.912 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.6 -49.0 70.37 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -60.9 -46.28 91.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.921 0.488 . . . . 0.0 110.803 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m -62.56 -48.62 78.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.87 0.468 . . . . 0.0 110.319 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.17 -37.27 86.87 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.591 ' CD2' HG11 ' A' ' 50' ' ' VAL . 24.2 t80 -57.13 -40.78 77.82 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.298 1.408 . . . . 0.0 110.265 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.91 -33.76 66.18 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.513 -0.742 . . . . 0.0 111.861 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.13 66.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.164 0.986 . . . . 0.0 113.043 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -76.05 147.3 38.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 111.133 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.4 t -93.77 -11.51 31.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.299 0.64 . . . . 0.0 109.368 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.422 HD21 ' CE2' ' A' ' 94' ' ' PHE . 28.8 tp -127.26 120.08 27.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.073 1.349 . . . . 0.0 108.261 -175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 44' ' ' PHE . 26.7 t -138.86 113.89 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -148.11 172.17 2.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.034 1.334 . . . . 0.0 109.326 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.9 p -130.99 143.21 50.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.627 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -159.87 171.64 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.224 -0.923 . . . . 0.0 111.162 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.4 m -120.69 132.49 55.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 113.68 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 26.4 mmmt -80.98 -51.62 8.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -140.16 168.02 20.78 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 41.6 mtp -137.13 123.78 21.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 100.669 -3.826 . . . . 0.0 100.669 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 t -124.07 145.45 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.52 151.5 37.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.892 0.769 . . . . 0.0 109.446 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 6.1 mm-40 -135.86 173.14 6.01 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 106.726 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.29 136.71 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.379 2.719 . . . . 0.0 115.24 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.5 -123.78 34.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.525 1.536 . . . . 0.0 111.028 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.55 1.88 15.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.931 0.892 . . . . 0.0 112.084 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.88 158.35 51.71 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 122.857 1.254 . . . . 0.0 114.449 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -150.19 137.88 19.94 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.809 2.044 . . . . 0.0 105.827 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -107.16 123.31 48.08 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.45 123.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.3 m -98.07 124.2 42.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.627 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 17.8 m -126.9 176.16 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.822 0.849 . . . . 0.0 110.072 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -135.34 44.01 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.293 67.4 mt 39.49 81.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.1 mm -79.07 -28.18 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 120.004 1.274 . . . . 0.0 112.6 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -157.22 158.62 29.06 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 176.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.51 140.05 33.4 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.68 1.192 . . . . 0.0 108.332 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -137.13 -30.88 0.84 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.519 0.728 . . . . 0.0 111.391 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -151.85 127.32 10.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.9 p -140.31 59.55 1.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.463 2.705 . . . . 0.0 107.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.92 45.99 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.853 1.216 . . . . 0.0 110.746 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.27 -43.18 0.04 OUTLIER Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.92 3.153 . . . . 0.0 111.459 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.23 128.19 34.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.107 0.956 . . . . 0.0 113.302 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -81.9 75.78 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 mt -58.71 150.23 59.12 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.114 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.58 175.27 4.46 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.114 1.209 . . . . 0.0 109.684 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -49.14 -62.29 2.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.738 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.98 153.2 37.05 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 121.186 1.459 . . . . 0.0 109.99 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.53 -155.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.815 4.343 . . . . 0.0 112.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.416 HG21 ' HA2' ' A' ' 74' ' ' GLY . 85.3 m -33.26 124.75 0.39 Allowed 'General case' 0 C--O 1.253 1.249 0 C-N-CA 130.149 3.38 . . . . 0.0 114.414 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.42 56.04 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.83 2.157 . . . . 0.0 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.58 154.48 37.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.845 1.258 . . . . 0.0 107.956 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.8 p -86.62 151.82 23.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.627 0.727 . . . . 0.0 111.405 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.3 mt -152.58 152.8 32.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.326 1.851 . . . . 0.0 108.092 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -112.94 113.22 25.18 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.3 m-85 -84.95 119.7 25.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -77.14 113.11 14.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.7 113.38 62.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.42 -12.39 25.0 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.708 1.605 . . . . 0.0 113.834 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.5 m -141.83 119.16 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.267 1.427 . . . . 0.0 107.429 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -5.57 47.9 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.04 -1.038 . . . . 0.0 111.192 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -59.46 -58.15 9.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.74 1.216 . . . . 0.0 110.696 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.8 m -152.3 163.78 22.44 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.286 2.234 . . . . 0.0 110.032 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.8 161.7 71.42 Favored 'Cis proline' 0 CA--C 1.545 1.07 0 CA-C-N 119.779 0.957 . . . . 0.0 113.556 1.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.81 133.84 37.96 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.48 2.787 . . . . 0.0 112.206 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.3 ttm -149.65 167.16 27.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.873 0.869 . . . . 0.0 111.613 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -150.73 147.65 27.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.962 2.505 . . . . 0.0 107.386 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -69.22 149.42 48.58 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.24 41.81 99.49 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.08 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.74 149.83 25.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -94.41 136.37 34.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.372 1.069 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.08 175.79 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.763 2.025 . . . . 0.0 112.868 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.11 123.98 43.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 131.07 3.748 . . . . 0.0 101.343 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.83 115.13 22.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.365 1.466 . . . . 0.0 107.979 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.496 ' HG2' HG13 ' A' ' 50' ' ' VAL . 18.1 mtm -117.37 113.17 21.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 175.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.96 -139.94 2.99 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.354 1.454 . . . . 0.0 112.079 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -132.6 175.35 9.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.836 -1.391 . . . . 0.0 111.344 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.89 145.45 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -127.76 114.66 17.56 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.28 63.8 0.37 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.388 1.475 . . . . 0.0 114.874 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 170.29 -22.27 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 1 C-N-CA 132.361 4.264 . . . . 0.0 111.81 175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.22 -4.6 13.72 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.421 1.088 . . . . 0.0 110.718 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.78 -154.75 50.34 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 124.467 1.032 . . . . 0.0 113.162 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 126.59 11.7 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.025 2.483 . . . . 0.0 110.53 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.266 2.7 p -116.78 127.99 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.56 79.52 29.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.412 1.485 . . . . 0.0 109.586 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.96 170.58 13.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.422 3.415 . . . . 0.0 112.708 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.46 -26.31 70.45 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.411 2.074 . . . . 0.0 114.033 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -86.74 23.58 1.66 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.846 1.258 . . . . 0.0 111.208 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -83.37 142.34 31.1 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 108.305 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -82.94 114.05 20.96 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -135.94 119.87 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.16 0.584 . . . . 0.0 110.151 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.3 m -144.75 167.01 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.306 1.443 . . . . 0.0 108.662 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.51 149.31 48.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 110.266 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -69.25 131.5 44.98 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.915 0.886 . . . . 0.0 109.021 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -141.08 147.75 48.93 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.54 -37.85 55.72 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.539 2.826 . . . . 0.0 114.753 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -59.77 -49.23 78.52 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -58.08 -46.89 84.71 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.009 0.923 . . . . 0.0 109.433 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -51.76 -50.45 60.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 109.987 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -63.69 -42.45 97.99 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.634 -0.666 . . . . 0.0 111.847 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.64 -50.76 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.062 0.846 . . . . 0.0 109.347 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.84 -32.17 73.54 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.793 0.724 . . . . 0.0 109.368 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.47 -41.79 88.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.524 0.602 . . . . 0.0 110.121 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.18 -47.16 85.73 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 109.433 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.29 -24.23 66.52 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.491 1.116 . . . . 0.0 112.127 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -69.75 -55.99 8.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 0.0 109.858 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -72.48 -39.51 67.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.858 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 123.587 0.755 . . . . 0.0 110.426 175.123 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.04 -43.97 93.94 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.53 -48.12 80.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.581 0.628 . . . . 0.0 111.059 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.4 m -61.68 -50.61 71.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.502 0.592 . . . . 0.0 110.177 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -59.63 -44.84 93.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.853 -1.546 . . . . 0.0 110.37 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 50' ' ' VAL . 22.4 t80 -52.5 -51.22 60.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.098 1.317 . . . . 0.0 111.042 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.4 m -64.42 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.845 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.01 -60.4 2.52 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.007 0.523 . . . . 0.0 111.703 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 p -53.17 124.68 15.13 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.879 0.871 . . . . 0.0 110.931 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -81.99 -4.84 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.383 0.992 . . . . 0.0 109.51 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.455 HD21 ' HE2' ' A' ' 94' ' ' PHE . 34.1 tp -118.33 120.84 38.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.138 2.175 . . . . 0.0 108.658 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 44' ' ' PHE . 38.4 t -144.05 113.59 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -149.38 167.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.365 1.466 . . . . 0.0 108.704 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -127.01 140.61 52.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -157.83 168.17 27.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.787 -1.196 . . . . 0.0 111.379 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -114.87 130.85 56.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.53 113.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -71.42 -50.49 31.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 m -157.22 168.96 25.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.377 1.471 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.6 mtp -137.33 133.87 35.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.022 2.129 . . . . 0.0 108.033 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -136.66 148.02 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.901 1.28 . . . . 0.0 107.833 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -75.43 145.97 41.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.613 1.097 . . . . 0.0 109.701 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.506 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.2 mm-40 -123.27 171.08 7.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 127.102 2.161 . . . . 0.0 111.726 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.3 153.38 34.13 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.181 2.587 . . . . 0.0 113.361 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.89 -124.19 6.91 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.4 23.94 11.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.482 1.113 . . . . 0.0 108.46 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.52 179.57 53.08 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.836 1.798 . . . . 0.0 117.374 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -150.62 136.11 17.99 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.988 2.115 . . . . 0.0 107.037 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.506 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -102.69 123.59 46.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 175.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.03 123.22 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -99.78 125.22 45.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 3.6 m -131.91 174.49 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.369 0.667 . . . . 0.0 109.813 -175.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -132.17 41.56 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt 38.24 80.58 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.242 2.217 . . . . 0.0 115.918 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -77.11 -24.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.406 0.682 . . . . 0.0 112.201 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.07 162.74 34.96 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 126.145 1.831 . . . . 0.0 109.209 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 150.2 32.23 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.535 1.134 . . . . 0.0 108.827 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -143.22 -49.6 0.33 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.139 0.899 . . . . 0.0 111.879 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -131.98 123.68 27.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -141.18 65.37 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.71 2.404 . . . . 0.0 109.253 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.07 42.46 3.15 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.871 1.7 . . . . 0.0 110.929 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.76 -66.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 125.699 1.618 . . . . 0.0 110.601 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 mt -71.04 130.49 41.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.195 0.521 . . . . 0.0 111.728 -175.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -84.88 80.04 9.42 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.3 mt -58.91 139.15 87.15 Favored Pre-proline 0 C--O 1.238 0.455 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.46 174.07 12.18 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 120.971 1.114 . . . . 0.0 111.165 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 t -44.92 -59.71 3.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 116.514 -1.707 . . . . 0.0 110.004 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.78 118.59 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.963 1.775 . . . . 0.0 108.836 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.75 -152.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 124.005 3.137 . . . . 0.0 112.803 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.4 m -35.84 124.59 0.71 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.487 2.715 . . . . 0.0 113.206 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.95 30.06 0.44 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.9 1.714 . . . . 0.0 114.174 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.04 158.86 32.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.032 1.333 . . . . 0.0 108.808 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.1 p -98.54 153.68 18.46 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.193 -0.942 . . . . 0.0 112.155 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.0 mt -148.71 162.38 39.86 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.076 1.75 . . . . 0.0 109.458 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -126.11 114.04 17.86 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.906 1.682 . . . . 0.0 107.163 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HE2' HD21 ' A' ' 49' ' ' LEU . 32.9 m-85 -96.63 121.2 38.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.451 1.101 . . . . 0.0 110.15 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.31 113.73 18.7 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 124.155 0.909 . . . . 0.0 110.435 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.9 123.75 38.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -6.96 15.54 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.461 2.774 . . . . 0.0 115.536 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.0 m -137.42 121.03 17.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 127.708 2.403 . . . . 0.0 107.051 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.09 61.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -82.49 -30.34 29.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.028 1.285 . . . . 0.0 114.417 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -136.66 155.76 76.56 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.038 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.65 165.88 71.93 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.395 1.177 . . . . 0.0 112.064 2.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.82 104.36 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.934 2.423 . . . . 0.0 109.274 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.2 ttt -139.35 163.74 31.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.529 1.132 . . . . 0.0 109.283 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -143.56 153.89 43.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -75.49 142.08 42.95 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.73 21.98 67.62 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.055 1.312 . . . . 0.0 114.36 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.3 t -134.11 156.69 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.285 1.434 . . . . 0.0 109.485 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 132.71 40.72 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.821 1.648 . . . . 0.0 111.717 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -139.61 168.5 19.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.27 1.828 . . . . 0.0 111.712 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.6 tp -108.31 129.23 55.23 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 129.306 3.042 . . . . 0.0 102.86 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.0 114.07 22.6 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.5 mtm -119.33 113.01 20.16 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.02 -134.05 1.66 Allowed Glycine 0 CA--C 1.526 0.778 0 CA-C-N 120.112 1.323 . . . . 0.0 112.225 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -134.84 172.02 13.57 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.97 0.885 . . . . 0.0 112.015 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 49' ' ' LEU . 4.8 t -133.16 140.15 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.397 -0.815 . . . . 0.0 110.337 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -121.57 115.41 22.76 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.869 2.067 . . . . 0.0 111.624 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -71.82 63.69 0.46 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.07 2.548 . . . . 0.0 112.428 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.2 t30 163.39 -22.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 1 C-N-CA 134.041 4.936 . . . . 0.0 114.084 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -113.5 -4.83 13.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.29 1.036 . . . . 0.0 113.023 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.37 -162.38 49.43 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 91.3 Cg_endo -73.78 143.32 33.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 118.63 1.215 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.22 126.83 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 130' ' ' VAL . 2.2 tm? -120.28 78.4 26.63 Favored Pre-proline 0 C--N 1.325 -0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 109.972 -174.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.27 164.42 28.18 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.686 2.924 . . . . 0.0 110.946 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.05 -18.06 56.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.094 1.863 . . . . 0.0 114.707 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -84.13 22.85 1.13 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.443 1.019 . . . . 0.0 110.771 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.0 m -88.7 137.43 32.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.519 1.527 . . . . 0.0 107.25 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -78.79 113.62 17.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 124' ' ' LEU . 99.3 t -136.76 116.67 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.23 170.21 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.924 1.29 . . . . 0.0 109.615 -175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.08 132.16 49.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.15 0.98 . . . . 0.0 108.825 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 138.19 57.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -133.8 160.02 70.18 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.488 1.915 . . . . 0.0 107.035 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.02 -42.92 2.74 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.928 2.419 . . . . 0.0 110.415 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -58.53 -41.58 85.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.61 0.764 . . . . 0.0 111.252 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.21 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -57.24 -50.01 74.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.284 1.033 . . . . 0.0 110.294 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.3 -34.83 78.54 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.972 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.87 -47.61 75.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.511 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -61.39 -39.06 89.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.501 1.501 . . . . 0.0 108.973 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.5 m -61.09 -47.03 88.2 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -57.33 -46.38 83.31 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.875 0.87 . . . . 0.0 109.466 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.57 -33.78 76.35 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.071 0.948 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -69.38 -49.39 55.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -68.61 -36.6 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.82 0.848 . . . . 0.0 111.564 -175.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 . . . . . 0 C--O 1.234 0.274 0 C-N-CA 127.278 2.231 . . . . 0.0 110.355 175.237 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 C--O 1.235 0.301 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.82 -41.35 97.89 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.41 -43.97 88.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.01 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -66.48 -51.15 59.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.846 0.748 . . . . 0.0 111.033 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -52.34 -44.66 65.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.609 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 50' ' ' VAL . 23.9 t80 -52.41 -42.34 63.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.491 0.716 . . . . 0.0 112.704 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.1 m -75.82 -33.81 60.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -38.68 86.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.181 0.9 . . . . 0.0 111.713 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -68.36 130.58 43.31 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.454 0.701 . . . . 0.0 111.066 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -81.95 -8.14 59.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.865 0.866 . . . . 0.0 109.99 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.93 123.37 24.54 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.971 1.708 . . . . 0.0 107.998 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 44' ' ' PHE . 39.4 t -136.41 116.97 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.6 169.49 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 110.103 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -128.84 137.65 51.6 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -151.75 171.01 18.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.834 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -117.59 126.28 52.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.18 113.55 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -80.82 -52.48 7.45 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 9.6 m -145.11 171.42 14.53 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 125.418 1.487 . . . . 0.0 109.795 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.406 ' HB3' HD21 ' A' ' 66' ' ' LEU . 24.6 mtp -133.76 134.8 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.79 143.82 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -70.92 137.0 48.89 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.515 -1.365 . . . . 0.0 108.234 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.545 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.5 mm-40 -114.71 168.84 7.41 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.8 1.64 . . . . 0.0 108.86 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.37 161.52 20.01 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.331 2.02 . . . . 0.0 112.273 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -145.01 49.19 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.731 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -88.73 14.2 10.69 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.554 -0.968 . . . . 0.0 110.619 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.19 177.22 53.05 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.106 1.336 . . . . 0.0 115.588 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 58' ' ' MET . 2.2 tm? -152.76 140.19 19.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.73 2.812 . . . . 0.0 106.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.545 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -100.83 145.02 29.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.23 123.25 71.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -101.63 129.86 47.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.697 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 30.5 m -138.22 176.36 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.883 0.873 . . . . 0.0 111.48 -175.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -131.36 39.52 3.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.912 1.285 . . . . 0.0 112.185 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt 36.42 81.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.281 2.232 . . . . 0.0 115.553 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.4 mm -74.52 -32.48 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.504 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.13 161.96 31.92 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.023 1.296 . . . . 0.0 110.242 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.49 152.74 40.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.67 1.588 . . . . 0.0 108.053 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -139.79 -24.42 0.84 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.643 0.589 . . . . 0.0 112.379 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -157.99 138.86 13.11 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.826 2.05 . . . . 0.0 106.117 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -146.85 72.38 1.27 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.214 3.006 . . . . 0.0 105.74 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 50.07 4.34 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 126.618 2.056 . . . . 0.0 109.353 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.19 -70.74 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 126.088 1.804 . . . . 0.0 113.302 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.5 131.73 51.66 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.275 1.03 . . . . 0.0 111.425 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -82.27 89.18 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.32 139.79 96.46 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.24 -175.87 1.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.529 2.153 . . . . 0.0 112.07 -175.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 t -42.83 -58.8 3.51 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.853 1.661 . . . . 0.0 109.215 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.07 147.56 21.04 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 N-CA-C 107.095 -1.925 . . . . 0.0 107.095 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.75 -154.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 1 C-N-CA 126.141 4.561 . . . . 0.0 111.665 175.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.565 HG21 ' HA2' ' A' ' 74' ' ' GLY . 4.4 m -34.01 139.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.953 2.501 . . . . 0.0 113.311 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.52 -1.27 3.98 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.088 2.28 . . . . 0.0 114.496 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.32 148.55 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.351 1.576 . . . . 0.0 108.579 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 p -77.29 149.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.184 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -147.34 161.03 41.83 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.94 0.896 . . . . 0.0 110.034 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -127.42 116.93 21.21 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.93 124.59 42.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.231 1.012 . . . . 0.0 109.499 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.452 ' HB3' HG23 ' A' ' 123' ' ' VAL . 28.5 t80 -74.06 114.02 11.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.733 1.213 . . . . 0.0 109.775 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.09 115.61 58.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.43 1.24 6.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 95.1 m -132.02 113.63 13.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.744 1.217 . . . . 0.0 109.204 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.98 -12.5 59.37 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.734 -0.604 . . . . 0.0 112.287 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.55 -35.83 24.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 113.753 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -157.16 163.04 26.34 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.564 1.946 . . . . 0.0 110.003 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.37 153.31 81.91 Favored 'Cis proline' 0 CA--C 1.541 0.871 0 O-C-N 122.626 0.803 . . . . 0.0 111.29 -3.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.7 122.47 8.58 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.229 2.619 . . . . 0.0 111.808 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 13.1 ttp -145.8 160.51 41.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.409 1.883 . . . . 0.0 108.685 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -134.48 145.42 48.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 85.5 tttt -64.02 142.71 58.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.17 35.33 77.4 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.044 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.8 t -140.83 159.3 23.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.926 2.09 . . . . 0.0 107.5 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -101.43 133.65 45.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.38 1.072 . . . . 0.0 111.502 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 104' ' ' MET . 45.7 m-85 -137.21 165.4 26.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.629 1.572 . . . . 0.0 111.303 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 124.63 51.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 129.942 3.297 . . . . 0.0 103.522 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.17 119.55 32.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.836 1.654 . . . . 0.0 107.524 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.0 mtm -120.68 113.25 19.94 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.14 -137.7 2.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.109 1.814 . . . . 0.0 111.525 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -136.63 176.49 8.65 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.172 1.389 . . . . 0.0 108.689 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.3 132.01 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.14 113.84 27.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -80.07 63.56 4.62 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.52 -42.47 0.05 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 128.484 2.714 . . . . 0.0 110.452 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -126.24 -4.32 6.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.25 1.02 . . . . 0.0 113.118 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.59 -151.77 18.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.77 137.31 29.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.821 1.681 . . . . 0.0 110.013 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.6 p -119.99 153.06 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.54 80.18 39.26 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -62.15 171.0 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.997 3.798 . . . . 0.0 113.624 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.55 -19.11 64.76 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.756 1.637 . . . . 0.0 113.195 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.6 23.19 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.117 1.367 . . . . 0.0 112.942 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 129.69 35.08 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.821 -0.549 . . . . 0.0 110.135 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -80.57 115.48 20.1 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.5 117.49 35.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 123.735 0.814 . . . . 0.0 109.194 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.8 m -145.49 167.34 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 109.52 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.79 136.54 57.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.444 0.698 . . . . 0.0 110.7 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -67.25 144.35 55.98 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.233 0.613 . . . . 0.0 109.898 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 150.3 29.88 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 127.585 2.354 . . . . 0.0 107.481 175.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.84 -34.26 31.1 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.593 2.195 . . . . 0.0 111.401 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -61.58 -43.09 99.5 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.023 -0.423 . . . . 0.0 111.087 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.32 -41.91 76.05 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.415 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -48.15 -55.93 9.13 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.749 1.22 . . . . 0.0 109.911 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -55.41 -44.11 75.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.687 1.595 . . . . 0.0 111.905 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.54 -49.21 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.004 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.22 -41.03 99.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.012 0.824 . . . . 0.0 108.977 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -59.43 -43.57 93.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.921 0.888 . . . . 0.0 110.639 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.25 -40.54 86.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.81 -33.37 75.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.742 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -66.11 -35.7 81.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.519 1.128 . . . . 0.0 111.028 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -75.88 -40.65 54.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 120.855 -1.153 . . . . 0.0 109.344 175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 . . . . . 0 N--CA 1.445 -0.694 0 CA-C-O 122.605 1.193 . . . . 0.0 109.024 175.4 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -86.93 53.78 2.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.124 1.883 . . . . 0.0 110.007 -169.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.37 33.09 2.08 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 127.891 2.476 . . . . 0.0 111.811 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.34 113.95 64.05 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -79.6 -167.15 0.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.917 3.078 . . . . 0.0 111.117 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.6 m -49.66 160.28 0.3 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.66 1.984 . . . . 0.0 107.166 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.9 t -83.73 121.81 76.28 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 120.056 -1.653 . . . . 0.0 108.663 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.18 171.25 18.38 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 123.719 2.946 . . . . 0.0 110.295 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.12 -18.02 58.23 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.495 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -55.06 129.08 36.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.041 0.937 . . . . 0.0 110.174 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.94 62.19 1.6 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -158.01 161.18 38.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.818 0.847 . . . . 0.0 111.706 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -116.1 156.15 26.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.615 2.366 . . . . 0.0 110.266 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -142.56 175.81 9.51 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.002 2.521 . . . . 0.0 110.663 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.03 -178.88 25.12 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.901 1.715 . . . . 0.0 115.025 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.7 p -92.19 174.47 7.29 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.73 -0.865 . . . . 0.0 110.502 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.33 -47.24 74.14 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.129 -0.938 . . . . 0.0 108.996 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -61.67 -48.11 82.29 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.322 0.965 . . . . 0.0 111.169 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -49.86 -56.75 9.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.719 0.808 . . . . 0.0 110.481 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -68.66 -40.48 80.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.789 -1.577 . . . . 0.0 111.898 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD2' HG11 ' A' ' 50' ' ' VAL . 42.4 t80 -54.61 -46.4 73.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.435 1.47 . . . . 0.0 110.617 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.7 m -71.88 -24.27 61.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.834 0.854 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.39 18.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -62.93 132.43 52.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 111.993 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -82.93 -8.16 59.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.523 0.729 . . . . 0.0 110.657 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.3 tp -134.83 124.48 25.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.457 1.503 . . . . 0.0 108.122 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG11 ' CD2' ' A' ' 44' ' ' PHE . 17.3 t -137.83 115.36 12.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.91 172.2 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.218 1.407 . . . . 0.0 110.303 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -129.24 139.93 51.65 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.88 175.33 13.71 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.746 -1.221 . . . . 0.0 110.918 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.7 m -121.79 134.55 54.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 68' ' ' VAL . 64.0 t -77.13 114.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -77.48 -54.89 5.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 m -142.61 171.46 14.03 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.72 0.808 . . . . 0.0 110.677 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.2 mtp -138.05 133.15 33.18 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.639 1.976 . . . . 0.0 105.845 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.86 140.84 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.812 1.245 . . . . 0.0 107.798 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -70.24 151.68 45.07 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.393 0.997 . . . . 0.0 110.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -134.77 175.11 3.89 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.854 1.661 . . . . 0.0 108.173 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.62 160.18 18.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.299 3.333 . . . . 0.0 114.095 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 -141.89 43.53 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.66 17.3 3.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.895 0.878 . . . . 0.0 110.313 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.88 166.6 48.94 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-O 123.224 1.458 . . . . 0.0 115.143 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.35 139.83 16.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 106.195 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.04 145.95 31.74 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 55' ' ' VAL . 94.9 t -118.04 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -89.84 133.37 34.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.81 173.37 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.082 0.953 . . . . 0.0 111.104 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -132.96 38.01 3.39 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.17 0.988 . . . . 0.0 112.965 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.7 mt 37.49 81.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.297 1.839 . . . . 0.0 115.061 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.04 -33.07 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.981 0.809 . . . . 0.0 110.911 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.514 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -160.84 161.87 33.12 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.028 1.299 . . . . 0.0 110.627 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.24 146.01 31.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.184 1.394 . . . . 0.0 109.513 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -131.02 -41.32 1.13 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.873 0.869 . . . . 0.0 110.991 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -140.3 123.79 17.05 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.42 59.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.077 2.151 . . . . 0.0 107.568 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.04 35.8 2.74 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 124.456 1.027 . . . . 0.0 113.702 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -10.65 0.04 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.511 2.005 . . . . 0.0 114.669 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.17 129.06 47.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.554 1.677 . . . . 0.0 110.515 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.84 67.86 10.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.26 152.54 41.81 Favored Pre-proline 0 CA--C 1.537 0.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.589 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.84 172.1 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.215 1.943 . . . . 0.0 111.523 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t -52.09 -60.12 6.87 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 117.637 -1.173 . . . . 0.0 109.307 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.88 139.6 40.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 N-CA-C 107.164 -1.898 . . . . 0.0 107.164 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.62 -157.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.89 2.393 . . . . 0.0 112.293 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.514 HG21 ' HA2' ' A' ' 74' ' ' GLY . 40.4 m -34.74 133.63 0.26 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 130.703 3.601 . . . . 0.0 112.42 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.47 34.58 0.28 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.776 1.655 . . . . 0.0 110.225 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.79 166.69 20.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.7 2.0 . . . . 0.0 108.572 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.5 p -103.3 149.62 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.003 0.906 . . . . 0.0 112.014 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.3 mt -145.07 170.83 15.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.758 1.223 . . . . 0.0 109.004 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -127.2 115.12 18.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -89.49 120.19 30.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.56 113.64 15.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.54 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.0 113.47 62.51 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.67 -1.31 11.41 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.124 1.883 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.0 m -134.12 113.59 12.23 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 110.083 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -75.54 -5.76 46.87 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.006 -1.059 . . . . 0.0 113.806 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -78.6 -53.27 7.36 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.378 0.671 . . . . 0.0 110.606 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.6 m -154.46 165.5 17.92 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 127.006 2.122 . . . . 0.0 110.282 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -64.66 151.93 74.95 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 119.625 0.902 . . . . 0.0 110.178 -3.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.23 138.79 44.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.405 2.07 . . . . 0.0 111.764 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 ttm -149.43 170.92 17.47 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.918 -1.114 . . . . 0.0 111.444 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.76 138.27 54.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.46 34.65 63.44 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.608 -1.106 . . . . 0.0 113.736 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.07 160.51 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.723 1.761 . . . . 0.0 107.963 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -99.61 136.38 39.62 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 125.354 1.461 . . . . 0.0 110.417 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -139.51 168.05 20.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.304 1.442 . . . . 0.0 112.615 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.94 123.62 50.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.9 113.98 21.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.539 ' HG2' HG13 ' A' ' 50' ' ' VAL . 27.0 mtm -117.66 113.21 21.57 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.97 -140.19 3.09 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 126.123 1.821 . . . . 0.0 109.687 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -135.38 175.28 9.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.289 1.045 . . . . 0.0 109.548 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -118.89 159.16 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -129.84 112.93 14.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.43 63.64 8.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -177.4 -32.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.202 2.601 . . . . 0.0 110.851 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -127.51 -9.69 5.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.91 -152.83 19.97 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.55 144.05 19.65 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.607 2.204 . . . . 0.0 111.708 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.27 8.5 p -126.7 149.76 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.257 1.6 tm? -137.53 75.23 45.08 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.22 -0.925 . . . . 0.0 108.827 -174.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.9 170.93 9.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.539 3.493 . . . . 0.0 112.91 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.71 -20.15 67.91 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.864 1.709 . . . . 0.0 114.079 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.65 22.99 1.01 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.718 1.207 . . . . 0.0 111.417 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.1 m -91.62 137.24 32.52 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.301 -1.499 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -86.85 114.39 23.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -127.64 126.7 67.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.65 0.738 . . . . 0.0 109.331 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -146.1 163.25 10.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.573 1.949 . . . . 0.0 107.018 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.03 149.33 47.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 123.99 24.47 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -119.99 155.34 55.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-O 117.073 -1.441 . . . . 0.0 107.88 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.07 -42.47 6.01 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.982 2.455 . . . . 0.0 110.452 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -55.05 -53.09 60.21 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 122.957 0.503 . . . . 0.0 110.669 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -56.85 -44.4 82.12 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.531 0.732 . . . . 0.0 110.612 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -56.52 -53.28 59.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.56 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -59.73 -36.45 76.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.31 1.044 . . . . 0.0 111.523 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.7 mt -65.33 -60.45 2.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 124.478 1.111 . . . . 0.0 108.766 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.81 -34.98 72.11 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.149 1.341 . . . . 0.0 110.949 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.53 -49.58 76.96 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -63.32 -31.58 72.77 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.606 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.1 mt -68.66 -31.38 70.47 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.295 0.952 . . . . 0.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 t -76.7 -34.57 58.17 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.421 0.555 . . . . 0.0 109.67 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -67.07 -58.79 4.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -72.92 159.48 33.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.702 0.801 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -76.88 154.0 34.19 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.2 m -62.59 124.98 85.1 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.405 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.12 93.17 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 119.754 0.948 . . . . 0.0 109.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.1 m -166.4 85.42 0.3 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -123.7 113.06 28.87 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -112.59 -176.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.826 3.017 . . . . 0.0 110.362 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.249 1.061 0 C-N-CA 125.74 1.616 . . . . 0.0 106.924 176.014 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.87 160.74 47.07 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.907 1.738 . . . . 0.0 110.786 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -88.76 62.19 6.32 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.633 1.173 . . . . 0.0 110.78 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.79 134.68 56.73 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 177.5 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.187 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -54.82 148.12 13.69 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.95 1.3 . . . . 0.0 110.348 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -83.64 108.15 12.54 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 127.847 2.459 . . . . 0.0 107.032 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -79.03 171.66 16.07 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.373 2.715 . . . . 0.0 110.673 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -73.75 -22.62 59.8 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 152.74 30.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.019 1.728 . . . . 0.0 109.175 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 t -137.05 102.88 4.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.927 0.891 . . . . 0.0 110.36 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -133.63 166.22 23.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.496 1.519 . . . . 0.0 109.022 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -123.07 146.4 47.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.282 1.833 . . . . 0.0 106.942 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -138.24 172.42 12.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 111.087 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.73 -160.41 47.66 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.953 1.263 . . . . 0.0 113.706 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 p -125.47 171.19 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD21 HD23 ' A' ' 141' ' ' LEU . 7.1 tt -63.71 -44.17 94.42 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.593 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -62.55 -49.22 76.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.278 0.944 . . . . 0.0 111.628 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -56.12 -46.62 79.09 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.428 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -73.8 -44.06 56.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.237 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.54 ' CD2' HG11 ' A' ' 50' ' ' VAL . 7.6 t80 -54.72 -44.29 73.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.843 1.656 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.7 -23.93 61.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.417 -0.802 . . . . 0.0 113.032 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -46.4 28.68 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 110.406 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.5 p -69.14 132.32 46.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.665 1.186 . . . . 0.0 111.181 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -81.32 -12.85 58.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.477 1.035 . . . . 0.0 109.361 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.5 tp -122.75 125.11 44.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.605 1.562 . . . . 0.0 109.93 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.54 HG11 ' CD2' ' A' ' 44' ' ' PHE . 42.2 t -141.01 114.03 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.2 166.76 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.575 1.55 . . . . 0.0 109.222 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 p -124.05 148.91 46.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 175.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -159.09 171.21 20.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.766 -1.209 . . . . 0.0 110.906 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.3 m -124.03 128.08 48.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.41 113.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 20.9 mmmt -84.21 -38.17 20.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.271 1.028 . . . . 0.0 110.042 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 m -151.25 165.86 32.67 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 121.227 -0.921 . . . . 0.0 110.138 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.8 mtp -143.75 124.67 14.31 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.52 146.1 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -65.56 152.31 44.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.486 -0.759 . . . . 0.0 109.889 -176.32 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -134.29 169.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.865 2.066 . . . . 0.0 109.481 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -38.59 134.06 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 125.084 3.856 . . . . 0.0 117.492 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.23 -123.61 33.5 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.814 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -88.72 22.55 2.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.364 1.465 . . . . 0.0 110.18 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.44 166.28 45.53 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.676 -1.265 . . . . 0.0 113.997 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -151.86 138.52 18.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.489 1.516 . . . . 0.0 108.349 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.54 128.89 55.52 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.45 123.28 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -93.43 125.14 37.88 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 11.6 m -122.89 174.17 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.432 1.493 . . . . 0.0 111.169 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 t -135.25 40.38 2.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.626 0.648 . . . . 0.0 109.91 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.4 mt 38.11 77.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.571 2.748 . . . . 0.0 114.19 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 47.7 mm -75.54 -23.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.802 1.637 . . . . 0.0 111.133 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.81 159.06 32.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.76 141.33 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.195 0.998 . . . . 0.0 108.527 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -135.31 -33.36 0.9 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.258 0.623 . . . . 0.0 110.823 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -148.99 125.06 10.7 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.26 58.68 1.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.512 2.325 . . . . 0.0 107.782 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.64 36.19 2.82 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.276 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.04 -25.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 116.707 -2.163 . . . . 0.0 116.483 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.5 mt -116.39 155.09 29.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 121.101 2.451 . . . . 0.0 112.555 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.69 94.39 5.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 128.399 2.679 . . . . 0.0 109.047 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.14 131.57 95.04 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.72 -178.69 4.25 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 121.942 1.762 . . . . 0.0 111.103 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 t -53.58 -58.92 10.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.203 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.59 116.02 3.7 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.596 2.197 . . . . 0.0 110.805 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 88' ' ' THR . 65.5 Cg_endo -78.14 -152.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.236 2.624 . . . . 0.0 110.677 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 24.1 m -33.17 123.76 0.39 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 130.625 3.57 . . . . 0.0 111.771 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.16 -16.71 6.33 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.394 2.426 . . . . 0.0 110.986 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.79 150.82 40.82 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.312 1.056 . . . . 0.0 111.363 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -86.01 145.51 27.07 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.4 mt -146.92 164.24 33.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 109.37 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -117.66 113.42 21.87 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.24 119.15 29.47 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -79.76 114.08 18.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.06 1.344 . . . . 0.0 109.94 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.14 114.24 59.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.83 -4.43 14.06 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.108 1.872 . . . . 0.0 113.225 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.7 m -138.17 113.63 9.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.087 1.755 . . . . 0.0 108.823 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -74.29 -7.49 52.98 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.257 -0.902 . . . . 0.0 112.787 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.98 -57.14 3.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.43 1.892 . . . . 0.0 108.97 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.4 m -152.59 160.49 31.11 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.044 1.338 . . . . 0.0 111.829 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.06 161.12 70.29 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.0 1.036 . . . . 0.0 111.887 3.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.42 139.76 91.09 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.163 2.575 . . . . 0.0 112.502 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -153.0 150.95 29.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.864 0.866 . . . . 0.0 110.157 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -144.37 150.8 38.34 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 109.872 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 56' ' ' LYS . 88.4 tttt -79.09 138.68 38.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.31 44.11 76.18 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.2 t -142.6 156.05 18.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 m -102.93 128.64 49.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.589 0.756 . . . . 0.0 110.393 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -126.46 171.3 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.383 1.873 . . . . 0.0 112.314 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.49 123.64 43.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 175.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.36 114.0 22.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 mtm -116.83 113.14 22.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.88 -142.71 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.606 1.098 . . . . 0.0 110.675 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.4 -178.87 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.971 0.891 . . . . 0.0 109.42 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.99 147.2 28.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -125.55 113.65 17.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -79.13 63.55 3.81 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -177.34 -26.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.386 1.875 . . . . 0.0 111.616 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 -7.37 3.17 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.706 0.802 . . . . 0.0 112.978 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.54 -164.19 20.96 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.724 0.693 . . . . 0.0 111.447 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.81 133.9 24.62 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.444 2.096 . . . . 0.0 109.8 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.265 2.9 p -118.83 134.76 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.96 76.11 21.84 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 0.0 109.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.72 172.8 8.92 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.922 3.748 . . . . 0.0 112.69 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -63.86 -34.36 60.97 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.68 2.253 . . . . 0.0 114.632 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.79 23.89 1.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.293 0.951 . . . . 0.0 111.59 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.3 m -85.11 146.93 26.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.469 1.507 . . . . 0.0 109.968 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -91.23 113.74 26.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.2 t -132.18 113.9 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.84 165.58 9.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.373 0.669 . . . . 0.0 109.272 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.04 147.75 52.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -67.7 149.62 49.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.067 0.947 . . . . 0.0 108.766 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -149.98 152.55 34.31 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 127.961 2.504 . . . . 0.0 105.234 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.01 -35.95 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.009 2.473 . . . . 0.0 112.434 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -61.72 -49.44 76.43 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.773 -0.579 . . . . 0.0 110.176 176.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -54.97 -54.27 44.94 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -44.9 -55.0 5.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.913 2.085 . . . . 0.0 111.8 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -56.24 -43.7 78.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.506 0.722 . . . . 0.0 111.708 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.9 mt -66.34 -40.11 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.709 -0.662 . . . . 0.0 109.479 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.559 HD23 HD21 ' A' ' 40' ' ' LEU . 8.5 mt -58.82 -43.26 90.58 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.7 m -62.08 -41.84 98.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.494 0.718 . . . . 0.0 111.031 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -57.56 -43.41 84.47 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.879 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 mt -76.21 -24.15 54.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.039 1.736 . . . . 0.0 112.819 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -74.24 -35.46 63.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.383 1.473 . . . . 0.0 109.645 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.53 -65.77 0.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.056 0.942 . . . . 0.0 109.1 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -66.22 151.42 47.03 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.415 0.552 . . . . 0.0 110.636 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -72.78 144.4 47.58 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.969 0.508 . . . . 0.0 110.102 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.03 124.69 88.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.49 121.43 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.548 1.499 . . . . 0.0 109.264 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -128.63 65.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.238 1.415 . . . . 0.0 107.194 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -140.17 123.11 10.17 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 121.16 7.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.066 1.844 . . . . 0.0 111.125 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 130.411 3.485 . . . . 0.0 102.367 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.82 165.9 31.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 -155.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -74.64 33.57 0.09 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.671 2.788 . . . . 0.0 112.86 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.65 113.65 2.73 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 127.682 2.393 . . . . 0.0 111.246 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.84 74.33 5.56 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.267 3.311 . . . . 0.0 108.495 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -142.7 166.34 24.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.315 1.846 . . . . 0.0 109.022 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.46 109.01 2.03 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.023 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.38 164.0 29.3 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.096 1.864 . . . . 0.0 107.676 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.1 -18.97 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.185 -0.947 . . . . 0.0 112.344 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -48.84 128.34 15.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.643 1.177 . . . . 0.0 110.091 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.9 t -148.25 88.41 1.65 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.14 0.971 . . . . 0.0 108.571 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 164.0 37.62 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -103.8 123.36 46.94 Favored 'General case' 0 C--O 1.235 0.294 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -156.36 176.11 13.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.5 1.045 . . . . 0.0 108.456 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.8 -171.11 17.74 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 122.793 1.218 . . . . 0.0 113.419 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -101.32 164.95 11.53 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.123 2.169 . . . . 0.0 109.03 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -94.24 -54.96 3.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -65.0 -43.17 93.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.288 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -70.63 -47.89 57.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.093 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.94 -36.37 83.21 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.401 -1.285 . . . . 0.0 109.635 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' HG11 ' A' ' 50' ' ' VAL . 34.7 t80 -57.29 -43.69 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.897 1.226 . . . . 0.0 110.69 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.3 m -74.38 -23.58 59.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.52 -34.34 63.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.996 1.271 . . . . 0.0 111.527 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.8 p -76.52 126.69 31.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 t -79.69 -11.71 59.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.922 0.867 . . . . 0.0 108.814 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.507 ' HB2' HG23 ' A' ' 116' ' ' VAL . 41.3 tp -120.75 114.84 22.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.163 2.185 . . . . 0.0 108.978 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG11 ' CD1' ' A' ' 44' ' ' PHE . 3.0 t -138.88 112.89 7.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.62 167.06 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.908 1.683 . . . . 0.0 108.332 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 111' ' ' LEU . 3.6 p -131.18 142.54 50.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -162.96 172.09 15.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.531 -0.731 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 28.1 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.67 113.57 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -84.35 -53.77 5.24 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.35 1.06 . . . . 0.0 108.479 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m -140.23 169.09 18.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.167 1.387 . . . . 0.0 109.363 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.94 132.32 38.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 144.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.08 141.91 47.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 47.3 mm-40 -123.64 176.05 2.44 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 128.045 2.538 . . . . 0.0 109.365 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 61' ' ' GLU . 41.4 Cg_endo -60.94 150.53 83.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.681 2.254 . . . . 0.0 112.765 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.91 -123.95 29.53 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.99 23.75 14.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.463 1.105 . . . . 0.0 109.931 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.79 166.73 46.32 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 122.816 1.231 . . . . 0.0 111.874 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -150.38 131.27 14.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.4 137.63 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.5 t -108.38 123.46 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -97.66 126.41 42.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 15.3 m -131.49 176.67 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.168 1.387 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -135.1 39.21 2.95 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.0 mt 36.07 83.16 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.56 -30.01 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 121.158 -0.964 . . . . 0.0 111.4 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.469 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.77 160.73 31.32 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.174 1.368 . . . . 0.0 109.761 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.84 143.31 26.21 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.299 1.04 . . . . 0.0 108.87 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -126.87 -49.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.59 1.156 . . . . 0.0 108.616 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -142.07 142.06 32.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 107.97 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 p -146.91 72.04 1.25 Allowed 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.298 2.639 . . . . 0.0 105.799 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 38.61 2.77 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 124.263 0.935 . . . . 0.0 112.881 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.63 -11.42 0.03 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.799 2.143 . . . . 0.0 112.91 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -116.35 123.17 46.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 120.623 2.211 . . . . 0.0 108.865 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -80.22 75.34 7.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.845 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -50.58 138.34 22.46 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.47 177.19 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.117 1.878 . . . . 0.0 111.636 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 t -48.74 -55.73 18.45 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.096 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.88 137.55 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.56 1.506 . . . . 0.0 108.634 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.18 -154.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.437 3.425 . . . . 0.0 112.068 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.469 HG21 ' HA2' ' A' ' 74' ' ' GLY . 16.8 m -33.06 123.9 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.828 3.251 . . . . 0.0 111.415 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.3 0.49 1.18 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.01 1.767 . . . . 0.0 113.75 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.94 150.07 21.21 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.396 1.598 . . . . 0.0 110.025 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -87.9 142.15 28.02 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.193 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -145.33 161.04 40.58 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.426 1.091 . . . . 0.0 109.85 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -116.39 125.12 51.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.212 2.205 . . . . 0.0 106.937 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.465 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.1 m-85 -106.45 123.37 47.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.721 1.609 . . . . 0.0 110.132 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.416 ' HB3' HG23 ' A' ' 123' ' ' VAL . 44.1 t80 -78.09 114.55 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.743 1.617 . . . . 0.0 111.56 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.92 114.43 61.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -69.97 -9.16 25.38 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.707 2.272 . . . . 0.0 115.555 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 m -148.46 130.79 15.61 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.217 1.407 . . . . 0.0 108.513 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -73.55 -3.94 30.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.843 1.424 . . . . 0.0 114.843 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -73.05 -51.22 18.94 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.091 . . . . 0.0 113.181 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.2 m -140.02 164.39 37.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.833 1.653 . . . . 0.0 111.942 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.03 163.5 76.18 Favored 'Cis proline' 0 CA--C 1.546 1.098 0 CA-C-N 119.381 0.815 . . . . 0.0 111.831 -2.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.27 86.95 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.983 3.122 . . . . 0.0 113.85 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 ttp -114.3 162.83 16.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.44 1.896 . . . . 0.0 109.44 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -146.19 158.24 43.87 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.258 1.023 . . . . 0.0 110.69 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -70.74 139.11 51.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.283 1.433 . . . . 0.0 110.787 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.31 35.45 91.53 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.489 1.042 . . . . 0.0 115.058 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.54 152.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 108.531 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 19.9 m -96.38 134.66 39.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.95 0.881 . . . . 0.0 110.427 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -139.48 167.69 21.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.155 1.782 . . . . 0.0 112.759 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 52' ' ' THR . 15.9 tp -103.91 132.24 50.35 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 175.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.39 113.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.471 ' HG2' HG13 ' A' ' 50' ' ' VAL . 8.6 mtm -117.49 115.78 25.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.04 -143.7 3.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.048 1.308 . . . . 0.0 110.717 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -130.02 178.65 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.253 1.026 . . . . 0.0 108.943 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 49' ' ' LEU . 25.8 t -136.1 141.93 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 120.786 -1.196 . . . . 0.0 108.304 175.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -108.22 113.08 25.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -83.06 63.58 7.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -170.01 -40.36 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.956 2.903 . . . . 0.0 109.209 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -126.18 -5.88 6.64 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.74 -164.7 15.33 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.22 137.34 51.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.038 1.419 . . . . 0.0 109.454 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 95' ' ' TYR . 3.5 p -120.39 124.68 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 2.2 tm? -114.89 78.98 5.64 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.92 171.26 11.4 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.204 3.27 . . . . 0.0 112.246 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.85 -23.94 76.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.106 1.871 . . . . 0.0 113.126 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.06 23.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.97 1.259 . . . . 0.0 111.46 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.4 m -84.4 128.57 34.66 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.602 -1.311 . . . . 0.0 108.972 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 113' ' ' MET . 40.2 t80 -80.04 113.51 18.26 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.58 116.55 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.96 174.5 7.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.719 0.808 . . . . 0.0 111.01 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.34 123.78 20.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.624 1.57 . . . . 0.0 109.14 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -75.99 142.46 41.91 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.706 -0.621 . . . . 0.0 109.491 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -154.5 156.01 31.22 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 128.124 2.57 . . . . 0.0 106.586 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.01 -35.15 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.614 2.209 . . . . 0.0 113.362 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -56.47 -50.92 70.32 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.952 0.882 . . . . 0.0 110.143 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -64.39 -32.52 74.17 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.673 -0.642 . . . . 0.0 111.651 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.14 -53.11 62.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.005 0.82 . . . . 0.0 110.445 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -62.75 -36.48 83.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.934 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.23 -51.66 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.844 0.747 . . . . 0.0 109.142 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -66.93 -41.72 86.57 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.12 0.568 . . . . 0.0 109.92 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.45 -44.87 95.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.582 0.628 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.48 -31.42 72.62 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.519 -0.738 . . . . 0.0 111.281 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 51.2 mt -75.82 -27.46 57.9 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 121.532 -0.73 . . . . 0.0 110.254 175.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -69.24 -45.56 69.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.237 1.415 . . . . 0.0 110.052 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -67.58 -39.33 84.87 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -75.4 177.65 6.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.814 1.645 . . . . 0.0 109.307 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -128.69 152.14 48.73 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 22.4 m -74.82 150.02 85.98 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.91 150.72 49.65 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.765 1.643 . . . . 0.0 108.881 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.4 p -157.49 74.29 0.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.916 1.286 . . . . 0.0 108.374 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -147.33 117.3 4.42 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.256 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.1 145.63 44.84 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.933 1.756 . . . . 0.0 109.517 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.256 1.424 0 C-N-CA 129.093 2.957 . . . . 0.0 105.27 176.23 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -69.13 153.57 71.6 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.409 2.073 . . . . 0.0 110.63 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -82.53 70.77 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.091 1.356 . . . . 0.0 109.181 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.81 148.49 68.39 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.639 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.53 177.5 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.235 2.623 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -49.3 146.71 3.59 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.976 0.91 . . . . 0.0 109.304 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.9 t -81.96 123.14 80.22 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.25 165.97 28.58 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.064 2.509 . . . . 0.0 114.042 -175.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -71.96 -22.03 61.5 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.2 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -58.28 143.18 45.54 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -136.38 121.16 18.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -153.08 164.41 38.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.651 1.581 . . . . 0.0 107.225 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -139.95 133.59 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.4 p -131.11 173.85 10.61 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.224 0.92 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.55 -158.72 49.19 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 121.793 0.663 . . . . 0.0 112.567 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.3 p -129.93 154.1 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.095 1.758 . . . . 0.0 107.109 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.7 -40.03 95.77 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.92 -48.75 79.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.999 0.363 . . . . 0.0 111.195 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.5 m -65.9 -45.83 80.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.58 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.32 -33.38 75.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.497 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.526 ' CD2' HG11 ' A' ' 50' ' ' VAL . 18.7 t80 -61.34 -40.79 95.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.586 1.084 . . . . 0.0 109.956 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -75.22 -32.49 61.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.55 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.9 73.33 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -76.21 140.9 41.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.53 1.532 . . . . 0.0 110.571 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -85.08 -13.67 49.6 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.427 1.467 . . . . 0.0 110.4 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.3 tp -122.8 127.41 49.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.786 -1.196 . . . . 0.0 110.142 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 44' ' ' PHE . 33.1 t -140.57 113.82 5.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.0 m -146.1 171.21 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 111' ' ' LEU . 17.8 p -133.83 143.16 48.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 175.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.77 168.85 20.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.326 -0.859 . . . . 0.0 111.548 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.6 m -106.96 132.94 52.34 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.13 114.85 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -76.59 -57.25 3.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 m -147.35 172.16 14.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.22 1.408 . . . . 0.0 110.187 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 31.1 mtp -135.68 146.57 47.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.81 2.044 . . . . 0.0 107.37 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.16 138.96 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 154.06 42.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 121.646 2.021 . . . . 0.0 109.66 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.11 175.78 3.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 110.974 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -59.18 171.45 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.228 3.285 . . . . 0.0 113.02 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.84 -129.61 45.3 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -112.35 31.8 6.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.0 169.36 40.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 125.046 1.308 . . . . 0.0 113.597 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -156.18 124.33 5.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.748 2.019 . . . . 0.0 106.301 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.11 147.86 27.11 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.68 123.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -92.96 124.41 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -131.43 167.69 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.55 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -128.94 38.06 3.99 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt 40.65 79.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -72.26 -28.84 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.11 161.08 34.48 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.2 144.38 48.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -137.61 -24.04 1.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -156.73 129.46 7.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -137.33 73.45 1.44 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.403 3.081 . . . . 0.0 106.045 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.66 34.88 3.43 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.016 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.25 -69.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 128.122 2.772 . . . . 0.0 109.973 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 mt -45.24 134.51 6.36 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -85.13 65.03 9.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.089 2.155 . . . . 0.0 106.414 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.7 mt -57.98 125.62 74.52 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.46 176.14 8.44 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.891 1.727 . . . . 0.0 113.619 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 t -42.57 -58.89 3.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.118 1.767 . . . . 0.0 110.813 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.56 124.06 10.41 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-N 122.321 1.865 . . . . 0.0 107.731 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 88' ' ' THR . 91.5 Cg_endo -73.35 -153.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.144 2.562 . . . . 0.0 112.946 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 51.2 m -34.61 125.19 0.53 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.484 2.714 . . . . 0.0 112.882 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.05 30.98 0.65 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.15 1.357 . . . . 0.0 113.017 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.65 158.81 29.22 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.187 1.795 . . . . 0.0 108.243 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.0 p -107.57 150.71 26.53 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.108 0.867 . . . . 0.0 111.996 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -143.55 163.23 33.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.143 2.177 . . . . 0.0 108.733 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.26 114.21 25.66 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.45 121.46 31.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.77 119.84 17.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.874 1.359 . . . . 0.0 107.563 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.46 113.83 40.61 Favored Pre-proline 0 C--O 1.225 -0.22 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.12 5.59 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.136 2.557 . . . . 0.0 112.956 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.4 m -131.14 113.52 13.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.021 1.329 . . . . 0.0 110.675 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -81.73 -32.78 31.42 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.277 -0.89 . . . . 0.0 111.173 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -59.06 -49.08 79.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.813 1.645 . . . . 0.0 112.82 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.6 m -155.09 165.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 129.006 2.923 . . . . 0.0 108.447 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.04 157.7 70.7 Favored 'Cis proline' 0 CA--C 1.536 0.601 0 CA-C-N 120.794 1.319 . . . . 0.0 111.647 -1.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.89 111.13 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.864 2.376 . . . . 0.0 111.01 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.9 tpp -122.18 141.53 51.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.575 1.95 . . . . 0.0 109.852 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -141.55 133.85 28.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -69.3 142.5 54.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.42 36.59 69.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.042 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.83 157.92 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.514 1.525 . . . . 0.0 107.449 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 m -100.63 141.0 34.11 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.709 1.203 . . . . 0.0 111.472 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -135.79 176.37 8.74 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.244 1.818 . . . . 0.0 112.62 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 52' ' ' THR . 6.4 tp -122.92 123.64 41.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 100.916 -3.735 . . . . 0.0 100.916 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.51 113.71 21.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.1 mtm -117.87 113.14 21.31 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 100.566 -3.865 . . . . 0.0 100.566 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.57 -137.45 2.29 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -132.6 177.61 7.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.409 1.1 . . . . 0.0 111.522 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.45 125.32 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -104.84 113.05 26.41 Favored 'General case' 0 C--O 1.237 0.418 1 N-CA-C 96.339 -5.43 . . . . 0.0 96.339 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.257 8.0 tp10 -85.8 95.56 9.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.963 1.363 . . . . 0.0 108.667 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -179.08 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 133.395 4.678 . . . . 0.0 107.597 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -131.38 -8.57 3.73 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 112.768 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.25 -133.99 12.01 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.78 139.4 36.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.14 1.894 . . . . 0.0 114.753 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.55 132.68 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.261 0.4 OUTLIER -115.41 74.31 4.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 125.243 1.417 . . . . 0.0 109.612 -174.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.99 169.05 18.81 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.836 3.691 . . . . 0.0 112.765 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.92 -11.12 29.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 114.85 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -88.82 23.21 2.4 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.621 1.555 . . . . 0.0 110.779 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.1 m -96.69 145.1 26.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.127 1.371 . . . . 0.0 110.593 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -95.72 113.57 25.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 74.5 t -133.45 123.73 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.46 169.28 2.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 0.0 109.031 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.47 150.67 46.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -69.05 142.19 54.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -141.66 137.39 16.24 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.93 -37.97 82.0 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.057 1.838 . . . . 0.0 111.001 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -52.65 -45.46 66.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.21 1.004 . . . . 0.0 111.268 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.0 -42.91 72.41 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.486 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -53.72 -47.38 70.63 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.316 1.047 . . . . 0.0 110.271 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -58.07 -47.55 82.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.84 0.856 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.54 -50.05 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.335 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.42 -35.2 80.13 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.891 1.223 . . . . 0.0 109.744 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 71.7 m -61.04 -47.25 87.26 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -64.54 -38.36 90.75 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 121.717 -0.614 . . . . 0.0 111.064 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.84 -30.07 70.15 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.584 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.7 t -67.1 -40.98 86.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.677 1.126 . . . . 0.0 109.776 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -69.65 -42.78 73.77 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.44 0.696 . . . . 0.0 109.613 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -75.02 176.04 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.66 1.219 . . . . 0.0 109.243 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -138.77 135.95 35.2 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 18.4 m -73.52 157.04 88.31 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.221 0.919 . . . . 0.0 109.487 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.51 113.64 3.4 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.896 2.397 . . . . 0.0 109.317 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.8 p -123.4 74.11 1.22 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -113.19 113.7 48.82 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.32 -153.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 1 C-N-CA 125.536 4.157 . . . . 0.0 108.946 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.251 1.166 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 175.053 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.42 67.28 7.81 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.765 2.31 . . . . 0.0 108.108 164.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -128.6 34.17 4.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.646 1.578 . . . . 0.0 112.06 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.18 142.82 25.34 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.849 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -74.36 164.63 33.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.292 1.995 . . . . 0.0 110.246 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -66.01 162.53 19.18 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.7 t -96.82 104.6 19.02 Favored Pre-proline 0 C--O 1.233 0.217 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.16 160.02 48.35 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.087 1.858 . . . . 0.0 108.886 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.3 -23.41 61.94 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.658 -0.651 . . . . 0.0 110.096 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -64.73 154.6 36.27 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 t -133.39 134.17 43.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -175.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -162.22 166.33 25.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.722 2.009 . . . . 0.0 107.037 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -131.12 146.4 52.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -139.69 173.21 11.76 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.601 1.56 . . . . 0.0 110.192 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.3 -163.56 53.06 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 121.807 0.671 . . . . 0.0 112.549 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -129.51 159.16 37.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.002 1.721 . . . . 0.0 108.111 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.9 -47.04 82.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.912 -175.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -59.07 -46.0 89.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 119.393 0.997 . . . . 0.0 110.766 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -67.72 -41.05 84.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.062 0.392 . . . . 0.0 111.209 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.43 -33.16 71.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.741 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 50' ' ' VAL . 42.1 t80 -59.51 -31.17 69.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.371 1.441 . . . . 0.0 109.904 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 m -71.14 -48.25 53.12 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.57 -50.21 70.38 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.919 0.888 . . . . 0.0 112.074 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -63.5 131.71 48.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.931 0.893 . . . . 0.0 109.811 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -92.87 -7.79 45.21 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.96 115.89 24.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.352 1.461 . . . . 0.0 108.6 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' A' ' 113' ' ' MET . 37.6 t -135.52 114.18 15.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.34 172.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.431 1.493 . . . . 0.0 109.386 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 111' ' ' LEU . 21.1 p -133.51 144.28 49.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.5 166.69 16.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.728 -0.607 . . . . 0.0 111.385 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.1 m -104.21 135.42 45.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.58 115.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.351 1.06 . . . . 0.0 109.56 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -83.53 -49.32 9.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -145.92 171.41 14.87 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 34.9 mtp -134.89 149.39 50.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.77 2.028 . . . . 0.0 106.86 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.95 139.91 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 131.51 41.96 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -113.7 176.25 1.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 124.465 1.106 . . . . 0.0 109.611 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.96 147.61 32.57 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.388 2.059 . . . . 0.0 113.893 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.48 -123.89 33.14 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.159 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -102.91 17.2 24.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.258 1.023 . . . . 0.0 110.582 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.61 170.43 51.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.869 1.26 . . . . 0.0 112.237 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -154.37 142.23 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.239 2.216 . . . . 0.0 105.459 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.28 150.02 35.05 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.28 123.26 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.7 m -90.53 124.57 35.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.74 173.46 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.547 0.739 . . . . 0.0 109.749 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -132.63 41.72 3.16 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HB2' ' H ' ' A' ' 90' ' ' ALA 0.331 73.6 mt 39.06 80.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 174.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.5 mm -76.47 -27.64 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 121.859 -0.526 . . . . 0.0 110.169 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.97 156.54 28.12 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 125.226 1.393 . . . . 0.0 109.659 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.48 123.54 13.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -114.4 -29.32 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.817 0.847 . . . . 0.0 112.486 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.83 125.62 11.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.19 71.15 1.34 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.226 2.61 . . . . 0.0 107.589 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.85 46.27 3.62 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.78 -76.79 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 127.119 2.295 . . . . 0.0 110.03 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.85 127.21 11.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.946 1.298 . . . . 0.0 113.419 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -75.97 71.19 2.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.162 2.985 . . . . 0.0 108.319 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.45 132.1 90.69 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.4 179.16 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.525 1.484 . . . . 0.0 110.893 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.0 t -54.0 -55.14 39.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.24 121.35 8.63 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 N-CA-C 106.915 -1.994 . . . . 0.0 106.915 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.98 -152.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.081 4.521 . . . . 0.0 113.0 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.7 m -33.8 125.76 0.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.837 2.855 . . . . 0.0 112.226 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.14 53.64 0.23 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.471 ' H ' ' HB2' ' A' ' 72' ' ' LEU . . . -140.62 158.24 44.28 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.009 2.124 . . . . 0.0 105.741 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 p -87.83 154.33 20.63 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.386 -0.821 . . . . 0.0 111.234 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -147.37 141.16 25.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -108.4 112.54 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.69 123.14 33.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -76.63 113.74 14.6 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.364 1.065 . . . . 0.0 109.129 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.63 114.08 63.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.25 0.89 7.32 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.407 2.071 . . . . 0.0 113.842 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.38 113.33 9.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . 0.29 54.0 pttt -71.94 -4.7 29.89 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -94.15 -38.41 11.1 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -149.09 159.93 36.09 Favored Pre-proline 0 C--N 1.343 0.312 0 C-N-CA 124.014 0.926 . . . . 0.0 112.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.36 150.32 83.05 Favored 'Cis proline' 0 CA--C 1.54 0.819 0 O-C-N 122.722 0.854 . . . . 0.0 112.085 2.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.6 108.39 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 2.873 . . . . 0.0 111.301 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.1 ttp -140.85 149.71 42.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.194 1.798 . . . . 0.0 108.108 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -138.21 161.53 36.61 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.762 0.825 . . . . 0.0 110.858 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -70.09 132.17 45.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.36 25.81 58.44 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.33 152.06 34.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.487 1.515 . . . . 0.0 108.616 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -95.43 133.08 39.81 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.256 1.422 . . . . 0.0 111.365 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.03 175.54 9.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.967 1.307 . . . . 0.0 111.555 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.518 HD11 ' HG3' ' A' ' 113' ' ' MET . 0.6 OUTLIER -116.07 124.62 50.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 131.008 3.723 . . . . 0.0 102.597 175.308 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.25 114.1 22.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.275 1.03 . . . . 0.0 108.82 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 50' ' ' VAL . 22.7 mtm -116.93 113.25 22.16 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 101.652 -3.462 . . . . 0.0 101.652 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.13 -142.7 3.5 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.788 1.661 . . . . 0.0 109.291 -175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -132.3 174.68 9.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.139 0.97 . . . . 0.0 111.122 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -130.14 138.24 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -120.34 113.08 19.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -76.95 64.85 2.51 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.397 1.479 . . . . 0.0 108.569 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -162.68 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.422 2.689 . . . . 0.0 108.306 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -120.29 -9.34 9.53 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.258 1.023 . . . . 0.0 112.891 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.97 -129.44 9.56 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.93 139.63 22.15 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.976 1.784 . . . . 0.0 112.749 -175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.56 152.76 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -135.05 74.21 63.58 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 174.18 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.987 3.791 . . . . 0.0 113.348 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.26 -21.14 65.53 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.012 1.808 . . . . 0.0 112.175 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.07 22.78 0.92 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 110.742 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.9 m -103.42 129.83 50.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.377 1.071 . . . . 0.0 113.04 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -88.56 120.21 29.73 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.48 123.75 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.52 171.3 4.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.253 1.021 . . . . 0.0 109.693 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.78 145.57 55.53 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.495 1.118 . . . . 0.0 108.454 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -71.94 149.18 45.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 110.42 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -148.73 149.76 31.52 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.64 -39.5 87.5 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.515 2.144 . . . . 0.0 112.301 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -57.75 -49.22 77.29 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.248 0.619 . . . . 0.0 111.286 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -60.11 -43.94 95.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.032 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -54.16 -53.19 56.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.57 0.623 . . . . 0.0 110.598 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -56.69 -45.43 81.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.219 1.408 . . . . 0.0 111.125 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.87 -52.46 61.4 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.122 0.969 . . . . 0.0 109.649 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -37.13 82.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.078 -175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -63.16 -45.71 90.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.244 1.384 . . . . 0.0 108.399 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -57.49 -46.26 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.724 0.693 . . . . 0.0 110.049 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.31 -33.55 75.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.525 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.0 t -62.86 -48.06 80.68 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.707 1.14 . . . . 0.0 110.336 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -62.73 -51.44 67.15 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.908 -0.495 . . . . 0.0 109.942 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -73.12 176.52 5.77 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.764 2.026 . . . . 0.0 111.245 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -106.63 151.52 24.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.21 139.63 55.36 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.42 96.41 0.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 N-CA-C 103.754 -3.21 . . . . 0.0 103.754 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 m -166.27 93.41 0.51 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -115.66 114.27 42.26 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -83.61 118.91 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.725 1.617 . . . . 0.0 109.409 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.251 1.146 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.618 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.53 68.1 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.203 2.602 . . . . 0.0 110.019 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -141.74 33.24 1.61 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.058 1.343 . . . . 0.0 112.611 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.37 109.84 62.57 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 125.072 1.349 . . . . 0.0 110.158 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.06 -179.35 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.558 2.839 . . . . 0.0 110.068 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.2 m -59.11 163.77 3.46 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.8 t -81.56 124.03 80.36 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.641 -175.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.05 175.77 10.42 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.302 2.668 . . . . 0.0 111.538 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -69.47 -20.24 63.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 117.48 -1.248 . . . . 0.0 113.015 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -56.76 121.6 10.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.937 1.244 . . . . 0.0 109.269 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.3 57.35 1.7 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -152.42 153.01 32.7 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.083 1.353 . . . . 0.0 108.004 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 ttp-105 -97.03 152.85 18.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.127 2.171 . . . . 0.0 108.317 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 p -136.05 174.36 10.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.125 1.37 . . . . 0.0 112.111 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 -163.15 54.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.424 1.011 . . . . 0.0 112.219 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -115.49 174.72 5.86 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.983 0.892 . . . . 0.0 109.066 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.14 -50.16 56.38 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -63.08 -48.68 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.697 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -55.76 -46.69 77.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.178 0.445 . . . . 0.0 110.479 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -76.0 -41.42 51.22 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.13 -1.891 . . . . 0.0 112.542 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.501 ' CD2' HG11 ' A' ' 50' ' ' VAL . 10.7 t80 -48.81 -49.05 40.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.035 1.743 . . . . 0.0 109.745 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.07 -32.17 73.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.374 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -56.82 4.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.291 1.036 . . . . 0.0 112.447 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 139.33 41.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.873 1.269 . . . . 0.0 112.729 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -76.97 -24.61 52.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.871 1.268 . . . . 0.0 109.462 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 94' ' ' PHE . 44.9 tp -120.23 128.04 52.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.219 1.008 . . . . 0.0 110.157 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 44' ' ' PHE . 35.4 t -141.33 113.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.9 171.12 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.897 1.279 . . . . 0.0 109.487 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -131.33 139.42 49.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -162.49 168.16 22.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.883 -1.136 . . . . 0.0 111.716 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.3 m -109.82 134.15 52.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.0 114.48 12.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -81.81 -51.66 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 m -148.98 174.25 12.48 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 125.209 1.404 . . . . 0.0 109.696 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 13.6 mtp -135.39 154.88 51.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.957 1.703 . . . . 0.0 107.363 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.87 138.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.697 1.599 . . . . 0.0 106.987 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -70.1 145.69 51.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.058 1.299 . . . . 0.0 108.705 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 55.9 mm-40 -131.67 164.7 40.91 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.841 0.857 . . . . 0.0 108.864 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -52.57 155.62 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.751 2.967 . . . . 0.0 115.715 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.42 -124.71 25.27 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.838 1.685 . . . . 0.0 110.854 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -105.02 25.71 10.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.151 1.381 . . . . 0.0 108.316 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.86 176.17 37.53 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.816 1.198 . . . . 0.0 114.255 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -161.82 141.36 9.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.796 2.438 . . . . 0.0 106.817 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . . . -110.22 152.08 26.53 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 120.851 -1.155 . . . . 0.0 107.889 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.79 123.13 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -89.64 125.91 35.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 11.4 m -123.91 171.76 12.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.758 0.823 . . . . 0.0 109.93 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -132.67 37.19 3.49 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.067 0.947 . . . . 0.0 112.729 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.304 18.6 mt 39.17 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.37 -29.09 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 118.668 0.667 . . . . 0.0 109.625 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 168.48 39.34 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.322 1.439 . . . . 0.0 110.972 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.36 147.62 30.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.899 1.68 . . . . 0.0 109.306 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -141.38 -25.18 0.72 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -156.26 136.88 13.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.301 1.84 . . . . 0.0 106.502 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.0 p -145.31 71.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.614 2.766 . . . . 0.0 109.051 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 43.69 3.19 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.86 1.695 . . . . 0.0 110.088 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.88 -72.45 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 129.497 3.427 . . . . 0.0 109.683 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mt -51.05 132.23 27.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -82.84 76.07 9.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 83' ' ' LEU . 21.0 mt -53.19 129.56 50.34 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.36 158.09 46.82 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.593 1.528 . . . . 0.0 112.281 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -52.85 -58.14 13.29 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.22 114.57 3.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 N-CA-C 103.554 -3.287 . . . . 0.0 103.554 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 88' ' ' THR . 68.0 Cg_endo -68.06 -153.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.429 3.419 . . . . 0.0 116.328 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 14.2 m -35.01 134.44 0.24 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 130.76 3.624 . . . . 0.0 111.538 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.69 11.97 3.86 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.733 2.587 . . . . 0.0 110.577 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.6 154.72 20.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.739 1.216 . . . . 0.0 108.182 175.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -104.0 141.26 36.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.437 1.095 . . . . 0.0 111.835 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 mt -147.28 151.6 36.89 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.742 1.217 . . . . 0.0 111.861 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -103.67 114.89 29.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.0 m-85 -87.33 122.36 30.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -80.55 114.92 19.79 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.951 1.3 . . . . 0.0 109.8 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.13 114.02 58.41 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 120.817 1.644 . . . . 0.0 107.195 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.15 -7.72 21.52 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.17 1.913 . . . . 0.0 112.43 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.6 m -121.07 113.61 20.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.467 1.907 . . . . 0.0 109.988 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -78.43 -15.85 58.22 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.387 -0.821 . . . . 0.0 112.55 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -83.4 -41.46 18.11 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.683 0.793 . . . . 0.0 112.337 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.7 m -149.63 156.47 38.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.022 1.329 . . . . 0.0 110.36 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.12 159.31 81.0 Favored 'Cis proline' 0 CA--C 1.544 1.008 0 CA-C-N 119.134 0.727 . . . . 0.0 110.802 -3.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.12 142.94 99.89 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.172 2.581 . . . . 0.0 112.848 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 33.0 tpp -149.3 155.15 40.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.513 1.525 . . . . 0.0 109.239 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -150.56 141.1 22.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.555 1.942 . . . . 0.0 106.328 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.65 146.83 54.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.93 45.04 96.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.708 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.7 t -144.07 154.64 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.907 2.083 . . . . 0.0 107.214 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.5 m -102.56 135.29 44.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.591 1.156 . . . . 0.0 111.577 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.8 175.16 9.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.34 1.456 . . . . 0.0 112.851 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.34 124.71 53.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 130.654 3.581 . . . . 0.0 102.554 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.42 114.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.0 mtm -116.42 113.13 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.63 -139.33 2.75 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.047 1.308 . . . . 0.0 111.142 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -131.69 179.05 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.043 0.921 . . . . 0.0 110.336 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.78 145.97 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.651 -0.656 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -111.73 113.42 25.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.46 72.41 6.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -178.18 -39.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 129.186 2.995 . . . . 0.0 111.062 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -130.67 -10.88 3.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.43 -157.82 15.3 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.353 0.979 . . . . 0.0 111.791 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.14 144.53 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.347 2.698 . . . . 0.0 113.464 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.26 2.9 p -127.23 142.13 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.254 1.8 tm? -132.72 79.37 64.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.616 -1.302 . . . . 0.0 109.98 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.65 171.95 8.84 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.349 3.366 . . . . 0.0 112.598 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.01 -33.03 95.72 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.126 1.884 . . . . 0.0 113.268 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -83.96 37.2 0.59 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.42 1.088 . . . . 0.0 112.181 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.6 m -97.32 130.52 44.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.867 1.667 . . . . 0.0 108.898 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.3 113.65 15.29 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.61 123.95 43.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -150.28 171.82 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.28 1.832 . . . . 0.0 109.18 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.14 141.93 58.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.928 1.291 . . . . 0.0 109.504 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -75.72 131.28 39.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.418 0.687 . . . . 0.0 109.913 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -139.16 146.75 50.54 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.072 1.749 . . . . 0.0 107.67 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -57.54 -34.25 97.76 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.006 2.47 . . . . 0.0 113.362 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -54.15 -54.55 38.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.401 0.68 . . . . 0.0 109.679 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.49 -43.19 97.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.884 0.874 . . . . 0.0 109.677 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -51.1 -55.19 18.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.393 1.477 . . . . 0.0 111.166 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -65.53 -30.65 71.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.902 0.481 . . . . 0.0 110.757 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.71 -52.12 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 120.599 -1.313 . . . . 0.0 109.282 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.12 -37.79 81.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.085 1.312 . . . . 0.0 109.432 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.7 m -56.62 -53.62 55.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.693 0.797 . . . . 0.0 108.9 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -61.64 -31.3 71.39 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.595 -0.691 . . . . 0.0 112.201 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.59 -23.9 56.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.134 0.879 . . . . 0.0 111.299 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.8 t -73.67 -38.09 65.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -76.09 -59.59 2.69 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.765 1.226 . . . . 0.0 111.5 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -72.09 151.96 42.7 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 138.01 40.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.93 130.23 72.84 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.353 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.01 92.17 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 107.067 -1.936 . . . . 0.0 107.067 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 t -165.56 73.08 0.18 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.16 111.69 15.59 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -105.16 179.74 0.1 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.491 2.794 . . . . 0.0 110.495 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.256 1.407 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 175.371 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.08 163.13 32.58 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.871 1.714 . . . . 0.0 110.407 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -84.77 67.64 10.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.559 1.544 . . . . 0.0 110.347 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 137.4 77.33 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.938 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.37 -179.19 4.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.053 2.502 . . . . 0.0 111.193 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -56.29 161.96 2.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.159 . . . . 0.0 108.269 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 45.4 t -82.65 124.39 77.51 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.26 164.92 31.96 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.899 2.399 . . . . 0.0 111.115 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -80.31 -34.86 36.41 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.423 -0.799 . . . . 0.0 108.997 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -56.52 132.72 52.27 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.129 0.972 . . . . 0.0 109.827 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.97 145.1 27.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.89 1.276 . . . . 0.0 109.351 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -161.75 158.24 25.5 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -102.67 124.28 47.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.3 p -127.72 176.47 7.51 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.784 1.233 . . . . 0.0 111.684 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.72 -155.22 50.88 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.079 0.847 . . . . 0.0 111.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -137.72 166.65 23.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.35 -40.92 98.63 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -62.22 -54.22 43.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.981 0.809 . . . . 0.0 109.978 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -55.82 -46.39 78.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.92 0.867 . . . . 0.0 111.227 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -69.69 -37.65 76.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.201 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.505 ' CD2' HG11 ' A' ' 50' ' ' VAL . 25.7 t80 -61.35 -37.18 82.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.592 1.087 . . . . 0.0 109.757 175.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.7 -57.8 6.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.749 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -29.72 69.69 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -76.25 153.85 35.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.318 0.508 . . . . 0.0 111.895 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -102.85 -6.95 21.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.321 1.048 . . . . 0.0 108.717 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 94' ' ' PHE . 37.1 tp -133.43 123.47 25.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.639 1.576 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.505 HG11 ' CD2' ' A' ' 44' ' ' PHE . 42.6 t -138.58 114.55 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.81 172.04 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.807 1.243 . . . . 0.0 109.782 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -134.66 141.24 46.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.82 174.7 13.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 120.626 -1.296 . . . . 0.0 110.987 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.1 m -114.17 130.22 56.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 102.939 -2.985 . . . . 0.0 102.939 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.44 113.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -78.86 -43.33 25.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 108.808 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -152.77 167.76 27.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.248 1.419 . . . . 0.0 109.893 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 57.1 mtp -137.98 125.07 21.47 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.7 t -120.63 146.05 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.485 1.514 . . . . 0.0 107.82 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 -65.73 154.65 38.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.977 1.262 . . . . 0.0 107.877 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.594 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 22.5 mm-40 -135.13 170.9 9.99 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 124.728 1.211 . . . . 0.0 108.691 176.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 165.55 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.171 2.581 . . . . 0.0 113.318 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.2 -142.37 45.95 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 125.791 1.663 . . . . 0.0 109.298 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' OE1' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tp10 -97.56 25.19 5.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.917 1.287 . . . . 0.0 107.69 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.68 43.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.383 1.945 . . . . 0.0 114.794 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.48 155.77 35.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.381 2.673 . . . . 0.0 107.309 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.594 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -119.92 146.26 45.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.97 123.15 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 m -92.86 129.15 38.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 170.84 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.887 0.875 . . . . 0.0 111.559 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -135.01 35.38 3.07 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt 37.02 82.38 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.506 2.322 . . . . 0.0 116.003 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.3 mm -75.02 -23.02 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.701 0.8 . . . . 0.0 109.037 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.2 159.66 33.08 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.76 45.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.716 1.607 . . . . 0.0 106.695 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -141.42 -32.01 0.56 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.832 0.707 . . . . 0.0 111.246 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -148.21 129.61 14.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -139.4 70.03 1.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.324 2.249 . . . . 0.0 105.95 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.23 44.47 3.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.295 1.426 . . . . 0.0 109.61 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.77 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 130.075 3.702 . . . . 0.0 107.514 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -44.59 123.52 3.68 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 123.033 1.397 . . . . 0.0 114.408 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.59 64.86 5.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.348 3.059 . . . . 0.0 109.375 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -56.02 131.34 73.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.83 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.06 177.67 7.9 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.428 2.086 . . . . 0.0 112.107 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -48.92 -52.45 46.58 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.938 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.27 116.97 4.32 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 CA-C-N 121.843 1.694 . . . . 0.0 108.538 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.18 -153.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.343 4.028 . . . . 0.0 111.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.5 m -33.36 125.44 0.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.838 2.455 . . . . 0.0 110.194 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.55 2.09 5.89 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.294 1.902 . . . . 0.0 111.42 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.31 150.86 22.9 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.182 1.491 . . . . 0.0 110.112 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.9 p -95.08 150.5 20.11 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 mt -144.29 168.37 20.23 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.195 2.198 . . . . 0.0 109.773 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -127.26 115.01 18.38 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.7 m-85 -95.63 124.79 39.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -72.34 139.93 48.19 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.309 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.31 113.64 18.31 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -60.73 -11.83 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.169 3.246 . . . . 0.0 115.451 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.5 m -137.42 118.39 14.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.539 1.535 . . . . 0.0 113.007 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' OE1' ' A' ' 64' ' ' GLU . 22.0 pttp -73.98 -27.22 60.88 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.665 -0.647 . . . . 0.0 110.188 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -62.73 -52.13 64.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.217 1.407 . . . . 0.0 110.858 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -146.65 159.11 45.09 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 111.673 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.3 160.77 75.3 Favored 'Cis proline' 0 CA--C 1.543 0.928 0 CA-C-N 119.189 0.746 . . . . 0.0 112.554 -0.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.63 95.56 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.957 3.105 . . . . 0.0 111.752 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 34.1 tpp -93.66 160.98 14.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.882 1.673 . . . . 0.0 108.603 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -148.48 136.9 21.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -77.31 145.06 37.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.888 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.16 98.75 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.674 0.67 . . . . 0.0 113.483 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.73 156.96 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 125.915 1.686 . . . . 0.0 107.049 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -89.99 138.72 31.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.991 0.901 . . . . 0.0 110.758 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -136.05 174.66 10.37 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.723 2.409 . . . . 0.0 112.33 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.05 123.62 42.04 Favored 'General case' 0 N--CA 1.448 -0.553 1 C-N-CA 132.504 4.321 . . . . 0.0 101.955 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.9 113.93 19.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.0 mtm -115.56 113.29 23.42 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.55 -136.39 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.46 1.028 . . . . 0.0 112.67 -175.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -135.43 176.12 8.97 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.949 1.3 . . . . 0.0 110.366 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.95 154.4 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -125.02 113.67 18.08 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -74.19 71.01 1.65 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 165.44 -24.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 1 C-N-CA 132.056 4.142 . . . . 0.0 112.134 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -113.78 -4.4 13.37 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.204 0.94 . . . . 0.0 111.628 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.25 -160.29 34.67 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 131.51 19.07 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.307 2.671 . . . . 0.0 111.935 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.76 125.95 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -114.65 84.17 9.78 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 125.973 1.709 . . . . 0.0 109.939 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.27 168.46 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.034 3.156 . . . . 0.0 113.01 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.84 -22.17 73.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.462 2.108 . . . . 0.0 113.318 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.02 23.19 5.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.96 1.304 . . . . 0.0 111.03 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.6 m -83.9 134.59 34.67 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.457 1.503 . . . . 0.0 108.491 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -76.93 113.77 14.98 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.65 116.25 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.8 168.38 7.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.838 0.855 . . . . 0.0 110.082 -175.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.86 145.95 54.87 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.662 0.785 . . . . 0.0 108.916 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -72.45 130.23 40.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.828 0.851 . . . . 0.0 109.702 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -137.21 148.05 60.81 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.889 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -37.8 39.25 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.046 2.497 . . . . 0.0 112.642 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -57.82 -50.98 71.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.018 0.527 . . . . 0.0 110.266 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -59.23 -51.94 67.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.18 -48.13 45.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.519 1.927 . . . . 0.0 111.491 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -44.02 97.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.723 1.209 . . . . 0.0 111.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.7 mt -66.41 -43.67 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.407 -1.282 . . . . 0.0 109.704 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.3 -43.32 96.42 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.651 1.569 . . . . 0.0 109.298 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -57.6 -49.27 76.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.88 -34.92 78.41 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.322 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.4 mt -69.29 -27.76 65.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.978 1.263 . . . . 0.0 111.688 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -71.32 -47.38 57.01 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -71.27 -43.6 66.87 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.634 -0.667 . . . . 0.0 110.81 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -76.54 176.0 8.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.471 1.908 . . . . 0.0 108.657 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.72 145.65 47.27 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 87.0 m -56.7 141.03 74.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 123.804 0.69 . . . . 0.0 111.27 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 94.69 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.114 1.876 . . . . 0.0 107.879 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.4 p -166.15 88.22 0.37 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.246 0.618 . . . . 0.0 111.702 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -116.07 113.54 41.64 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.72 97.55 1.14 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.794 2.329 . . . . 0.0 109.216 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.25 1.125 0 O-C-N 120.958 -1.089 . . . . 0.0 109.848 -179.698 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.01 72.55 5.8 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.846 3.031 . . . . 0.0 109.195 172.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -142.42 61.76 1.43 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 109.324 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.63 132.6 10.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.635 1.574 . . . . 0.0 110.173 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.71 177.29 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.606 2.871 . . . . 0.0 112.277 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -65.15 160.19 21.82 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.6 t -83.48 113.22 45.28 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 120.843 -1.161 . . . . 0.0 109.255 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -84.41 175.4 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.315 3.344 . . . . 0.0 111.751 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -79.41 -22.29 44.49 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -66.12 161.57 21.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.941 2.096 . . . . 0.0 108.485 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.0 t -152.46 131.87 12.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -158.53 166.29 32.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.502 0.721 . . . . 0.0 110.233 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.56 151.42 49.47 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.787 1.635 . . . . 0.0 109.213 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -146.91 176.06 10.19 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 128.102 2.561 . . . . 0.0 108.812 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.08 179.55 37.09 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.703 1.144 . . . . 0.0 114.903 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -107.03 177.48 4.84 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.271 1.029 . . . . 0.0 108.563 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.2 -50.49 63.68 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.76 -45.26 90.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.883 0.765 . . . . 0.0 111.538 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m -63.62 -44.94 92.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.918 0.326 . . . . 0.0 110.343 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -67.85 -46.19 72.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 117.174 -1.394 . . . . 0.0 110.092 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD2' HG11 ' A' ' 50' ' ' VAL . 54.2 t80 -48.4 -48.44 36.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.832 1.196 . . . . 0.0 111.331 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.5 m -65.62 -34.29 77.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.882 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -43.41 50.11 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.504 1.122 . . . . 0.0 112.292 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 p -66.75 127.25 31.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.993 0.917 . . . . 0.0 110.352 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.0 t -73.08 -21.43 60.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.955 0.798 . . . . 0.0 110.321 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 tp -117.83 118.78 32.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.552 1.141 . . . . 0.0 109.493 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG13 ' HG2' ' A' ' 113' ' ' MET . 19.8 t -136.62 113.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.41 173.47 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 126.043 1.737 . . . . 0.0 108.061 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.715 HG22 ' HA ' ' A' ' 111' ' ' LEU . 35.1 p -136.01 146.36 47.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -167.68 164.59 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.917 0.78 . . . . 0.0 111.991 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 93.0 m -96.44 133.27 41.07 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.42 113.74 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -72.79 -42.55 63.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.864 0.865 . . . . 0.0 108.979 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -165.56 170.29 14.46 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.069 1.347 . . . . 0.0 110.158 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 42.5 mtp -129.55 134.55 47.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.956 1.702 . . . . 0.0 106.62 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -135.52 144.63 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 159.46 30.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.688 1.585 . . . . 0.0 111.371 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -132.29 172.04 8.07 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 129.372 3.069 . . . . 0.0 110.685 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.91 146.4 16.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.586 2.857 . . . . 0.0 114.013 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.25 -124.43 30.74 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.912 1.244 . . . . 0.0 111.149 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -86.88 -0.52 56.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.855 0.862 . . . . 0.0 112.037 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.62 163.13 40.38 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.704 1.145 . . . . 0.0 114.039 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -148.4 136.22 20.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.27 1.828 . . . . 0.0 106.641 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.73 134.22 45.23 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.61 123.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m -93.23 130.56 38.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -134.71 172.28 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.73 0.812 . . . . 0.0 110.704 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -137.35 41.92 2.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt 38.5 80.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.428 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 17.0 mm -72.95 -29.46 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.05 157.56 29.11 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.66 144.97 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.362 1.465 . . . . 0.0 108.077 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -145.08 -25.7 0.48 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -155.36 127.68 7.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -144.56 70.18 1.28 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.564 2.346 . . . . 0.0 108.155 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.2 35.03 2.8 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.13 -81.6 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 127.556 2.503 . . . . 0.0 107.423 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.53 133.1 7.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 117.965 2.58 . . . . 0.0 117.965 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.27 63.79 8.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.011 2.925 . . . . 0.0 108.332 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.78 133.2 47.33 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.07 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.49 175.94 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.363 2.042 . . . . 0.0 112.219 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -50.86 -55.79 24.62 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.582 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.81 126.11 14.8 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.927 1.367 . . . . 0.0 109.137 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.896 2.397 . . . . 0.0 110.89 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.6 m -33.08 127.26 0.32 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 129.378 3.071 . . . . 0.0 112.987 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.74 54.63 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.093 2.282 . . . . 0.0 109.789 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.84 156.55 43.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.126 2.57 . . . . 0.0 107.093 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 p -102.72 155.06 18.57 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.253 -0.904 . . . . 0.0 112.971 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 mt -145.66 163.05 36.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.885 1.674 . . . . 0.0 108.593 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -126.37 113.73 17.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.59 126.35 38.7 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.279 1.031 . . . . 0.0 108.997 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -79.5 113.58 17.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.237 1.015 . . . . 0.0 110.503 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.88 119.03 54.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.56 -13.4 30.05 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.023 1.815 . . . . 0.0 113.292 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.2 126.35 16.45 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.844 1.658 . . . . 0.0 109.402 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -14.14 60.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.863 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -63.77 -58.08 7.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.884 1.22 . . . . 0.0 111.592 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -145.45 158.54 50.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.95 159.73 86.72 Favored 'Cis proline' 0 CA--C 1.548 1.176 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -4.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.89 160.9 27.47 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.729 1.619 . . . . 0.0 111.295 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.4 tpp -152.33 150.84 30.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -139.81 145.98 38.84 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -72.98 138.71 46.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.21 58.83 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.765 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.39 144.44 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 108.62 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.4 m -92.26 126.99 37.57 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.592 1.157 . . . . 0.0 112.181 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.86 175.66 8.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 112.046 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.715 ' HA ' HG22 ' A' ' 52' ' ' THR . 0.1 OUTLIER -116.17 127.23 54.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.754 3.221 . . . . 0.0 103.359 175.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.96 114.29 20.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.846 0.858 . . . . 0.0 109.892 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.64 ' HG2' HG13 ' A' ' 50' ' ' VAL . 10.5 mtm -114.64 111.64 21.64 Favored 'General case' 0 C--N 1.32 -0.69 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 176.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.85 -148.32 4.76 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.548 2.023 . . . . 0.0 111.228 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -130.75 178.04 6.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.123 0.969 . . . . 0.0 108.972 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 t -135.71 145.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 121.708 -0.62 . . . . 0.0 109.348 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -114.16 113.85 25.23 Favored 'General case' 0 C--N 1.346 0.414 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.09 72.39 4.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -175.22 -35.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 130.593 3.557 . . . . 0.0 109.141 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -117.37 -16.71 10.24 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.02 -171.36 14.84 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.78 137.81 55.42 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.99 1.793 . . . . 0.0 110.173 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.262 7.2 p -114.65 162.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.289 1.7 tm? -150.9 76.27 8.07 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.9 170.44 11.53 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.973 3.116 . . . . 0.0 112.343 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.38 -19.23 66.61 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.899 1.733 . . . . 0.0 112.214 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -84.41 36.38 0.58 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.446 2.698 . . . . 0.0 109.898 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 m -113.48 133.24 55.32 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.682 1.593 . . . . 0.0 110.804 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -85.01 117.55 24.04 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.19 119.57 31.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.837 0.855 . . . . 0.0 110.134 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.0 m -143.58 168.82 11.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.97 1.708 . . . . 0.0 108.926 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.25 149.39 48.12 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.78 -0.575 . . . . 0.0 110.211 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -72.5 144.34 48.05 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -142.64 149.58 50.96 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.72 -39.76 25.22 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 111.663 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -58.59 -48.04 82.29 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.894 0.316 . . . . 0.0 110.696 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -58.19 -46.88 85.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.763 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.59 -56.51 14.83 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.203 1.401 . . . . 0.0 110.772 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -63.73 -37.88 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.93 -49.77 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.609 1.095 . . . . 0.0 109.837 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.33 -34.2 77.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.575 1.079 . . . . 0.0 108.808 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -60.78 -47.92 84.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -59.11 -49.21 78.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.699 -0.626 . . . . 0.0 110.229 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.6 mt -59.05 -34.53 72.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.682 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 t -56.26 -58.02 9.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.371 0.987 . . . . 0.0 110.526 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -73.13 -38.92 66.12 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.693 0.397 . . . . 0.0 111.693 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -69.81 176.01 3.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.61 1.164 . . . . 0.0 110.211 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -99.57 152.34 20.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.7 m -63.3 150.98 88.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 124.379 1.049 . . . . 0.0 111.342 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.21 93.77 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 104.843 -2.791 . . . . 0.0 104.843 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.51 74.57 0.47 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -143.65 119.32 6.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.59 153.67 75.63 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 121.505 1.47 . . . . 0.0 109.948 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.755 2.022 . . . . 0.0 106.448 176.156 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -84.83 61.61 6.08 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.055 3.17 . . . . 0.0 111.677 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -131.93 33.75 3.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 123.402 1.573 . . . . 0.0 113.118 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.31 124.18 31.93 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 126.018 1.727 . . . . 0.0 110.014 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.85 -166.21 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.856 3.704 . . . . 0.0 112.43 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.8 m -54.36 163.13 0.91 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.177 1.791 . . . . 0.0 107.532 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 t -83.08 143.61 45.92 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 119.721 -1.862 . . . . 0.0 109.802 -174.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.93 157.15 62.95 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.611 1.541 . . . . 0.0 110.677 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -73.11 -40.96 64.52 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -66.56 147.67 52.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.243 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.37 151.51 32.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.145 1.378 . . . . 0.0 108.451 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.28 165.82 32.64 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.512 1.525 . . . . 0.0 107.316 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -83.4 166.56 18.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.2 p -111.11 145.39 38.65 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -25.89 -126.52 0.0 OUTLIER Glycine 0 N--CA 1.44 -1.048 1 C-N-CA 133.162 5.172 . . . . 0.0 119.589 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -83.11 144.6 29.75 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.845 -1.178 . . . . 0.0 112.489 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.19 -53.55 10.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.88 1.672 . . . . 0.0 109.274 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -62.14 -31.28 71.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.14 0.882 . . . . 0.0 112.424 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -74.19 -52.39 12.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -59.2 -37.89 78.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.662 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.489 ' CD2' HG11 ' A' ' 50' ' ' VAL . 36.8 t80 -59.1 -41.64 88.59 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.444 1.02 . . . . 0.0 110.777 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -68.35 -41.1 81.17 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.694 -0.629 . . . . 0.0 111.131 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -55.71 11.48 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.698 0.681 . . . . 0.0 112.671 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 p -54.37 148.46 11.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.496 1.118 . . . . 0.0 111.629 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.1 t -99.07 -15.54 18.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.486 0.714 . . . . 0.0 111.551 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.77 115.49 22.77 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' A' ' 44' ' ' PHE . 22.4 t -134.86 113.6 16.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.12 170.36 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.629 1.172 . . . . 0.0 110.947 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -130.97 142.6 50.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.869 2.068 . . . . 0.0 106.953 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -168.56 176.78 5.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.257 -0.902 . . . . 0.0 110.938 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -114.77 136.03 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.69 113.6 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.15 -52.67 7.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -145.93 173.18 12.37 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.856 1.662 . . . . 0.0 109.542 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.5 mtp -139.55 153.29 47.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.149 2.18 . . . . 0.0 106.309 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' O ' HD22 ' A' ' 66' ' ' LEU . 88.2 t -145.49 135.74 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 108.103 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -66.16 147.14 53.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.956 1.707 . . . . 0.0 108.757 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 4.6 mm-40 -139.59 169.37 12.36 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 119.331 0.969 . . . . 0.0 112.912 -176.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.97 163.22 7.88 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.573 3.516 . . . . 0.0 114.629 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.58 -123.58 8.3 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -119.84 22.09 11.68 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.31 175.61 45.76 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-O 124.832 2.351 . . . . 0.0 118.934 -174.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.415 HD22 ' O ' ' A' ' 59' ' ' VAL . 2.8 tm? -156.42 135.19 11.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.472 2.709 . . . . 0.0 105.387 -175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . . . -109.75 127.24 54.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.7 123.3 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -86.17 127.17 34.67 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.92 168.13 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.706 0.803 . . . . 0.0 108.933 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 t -129.94 35.9 4.09 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' HB3' HG23 ' A' ' 88' ' ' THR 0.307 81.7 mt 37.42 80.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.456 2.302 . . . . 0.0 116.273 173.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.58 -40.39 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 110.15 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 88' ' ' THR . . . -152.37 161.7 29.55 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.46 147.07 42.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.593 1.957 . . . . 0.0 107.637 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.68 -30.1 2.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.707 1.203 . . . . 0.0 110.359 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -150.77 137.43 18.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -142.41 70.17 1.33 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 129.072 2.949 . . . . 0.0 106.434 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.61 32.37 3.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.985 0.802 . . . . 0.0 111.912 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 126.765 2.126 . . . . 0.0 110.983 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.06 132.6 48.91 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.307 1.043 . . . . 0.0 111.199 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -85.72 94.05 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.79 1.636 . . . . 0.0 107.532 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.06 133.0 88.02 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.72 -179.06 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.437 2.758 . . . . 0.0 114.652 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 t -39.58 -60.33 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.371 1.868 . . . . 0.0 110.762 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.17 123.72 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.01 1.806 . . . . 0.0 108.392 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.32 -170.59 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.275 1.983 . . . . 0.0 112.712 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.509 HG21 ' CA ' ' A' ' 74' ' ' GLY . 40.0 m -38.3 127.55 1.38 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.044 2.138 . . . . 0.0 116.458 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.19 14.97 0.09 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 128.392 2.901 . . . . 0.0 110.61 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.38 168.07 9.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.728 1.611 . . . . 0.0 110.728 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.9 p -98.73 153.01 19.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.57 -0.706 . . . . 0.0 112.621 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 24.4 mt -152.37 154.04 34.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.833 1.253 . . . . 0.0 109.612 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -112.51 113.24 25.31 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -89.27 121.27 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.137 0.88 . . . . 0.0 109.106 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -73.76 114.27 11.85 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.038 1.335 . . . . 0.0 110.529 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.5 117.57 55.51 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.95 -4.16 14.26 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.268 2.645 . . . . 0.0 112.982 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.29 120.49 28.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.466 2.306 . . . . 0.0 111.33 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -73.81 -25.92 60.35 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.507 -0.746 . . . . 0.0 110.102 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -69.7 -45.36 68.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.416 1.487 . . . . 0.0 113.059 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.416 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 17.3 m -148.56 163.51 25.83 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 101' ' ' CYS . 50.1 Cg_endo -62.57 157.66 62.96 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 O-C-N 122.493 0.733 . . . . 0.0 111.618 -1.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.32 92.71 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.839 3.026 . . . . 0.0 114.268 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.6 tpp -96.03 161.54 13.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.542 1.937 . . . . 0.0 111.563 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -153.48 139.76 18.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.342 1.857 . . . . 0.0 107.896 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.55 146.63 48.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.29 32.27 83.64 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.9 -0.944 . . . . 0.0 114.35 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.7 t -129.63 156.78 42.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.677 1.991 . . . . 0.0 106.636 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.3 m -103.6 136.55 43.1 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.486 0.715 . . . . 0.0 109.726 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.39 176.02 8.9 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.231 1.812 . . . . 0.0 112.773 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.46 123.66 43.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.0 114.24 22.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.142 0.977 . . . . 0.0 108.604 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -117.01 113.34 22.21 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.86 -143.04 3.67 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 126.118 1.818 . . . . 0.0 109.35 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -133.23 177.3 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.527 0.68 . . . . 0.0 110.234 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.98 130.95 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -109.9 113.2 25.73 Favored 'General case' 0 N--CA 1.449 -0.512 1 N-CA-C 98.208 -4.738 . . . . 0.0 98.208 174.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 72.16 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.504 1.621 . . . . 0.0 108.053 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -161.38 -47.38 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.695 2.798 . . . . 0.0 106.579 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.48 -4.49 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.661 1.584 . . . . 0.0 111.245 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.28 -122.72 6.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.267 1.413 . . . . 0.0 109.851 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.82 145.33 28.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.754 2.302 . . . . 0.0 114.931 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.37 151.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 130' ' ' VAL . 1.6 tm? -142.6 76.3 18.02 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 120.742 -1.223 . . . . 0.0 108.572 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.73 171.95 6.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.649 3.566 . . . . 0.0 112.428 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.89 -19.13 68.02 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.059 1.414 . . . . 0.0 112.22 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.98 23.21 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.968 2.107 . . . . 0.0 111.773 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.8 m -91.59 132.95 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 110.557 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.85 113.64 18.17 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 124' ' ' LEU . 55.5 t -136.59 119.21 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.75 167.77 8.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.102 1.361 . . . . 0.0 108.626 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.22 152.29 41.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -69.94 135.6 49.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -137.36 145.11 48.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.61 -46.24 14.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.926 1.751 . . . . 0.0 112.648 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.85 -38.0 89.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.792 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.72 -41.09 97.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.402 -0.811 . . . . 0.0 109.595 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -54.88 -49.83 70.22 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.381 1.473 . . . . 0.0 109.212 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -62.95 -45.23 93.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.132 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.0 mt -59.21 -47.38 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.804 1.184 . . . . 0.0 109.813 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.96 -38.07 87.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 109.4 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.2 m -61.64 -43.37 98.98 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.718 -0.614 . . . . 0.0 110.099 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -60.3 -52.71 64.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.6 mt -59.27 -32.48 70.05 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.699 0.8 . . . . 0.0 112.016 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.9 t -64.6 -51.24 63.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.081 1.352 . . . . 0.0 110.646 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -71.67 -38.94 70.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -75.21 177.29 6.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.456 1.902 . . . . 0.0 108.928 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -121.18 151.9 39.4 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 82.4 m -58.6 153.18 41.89 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.496 1.118 . . . . 0.0 111.048 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.1 93.83 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.853 2.369 . . . . 0.0 108.832 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.3 m -116.18 55.65 0.8 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.386 1.474 . . . . 0.0 108.735 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -112.91 113.0 50.01 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 101.701 -3.444 . . . . 0.0 101.701 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -111.65 -172.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.078 2.519 . . . . 0.0 112.39 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.257 1.499 0 C-N-CA 129.474 3.109 . . . . 0.0 103.73 175.457 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -87.58 61.7 3.68 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.547 2.831 . . . . 0.0 110.531 168.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -116.47 39.77 3.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.702 1.601 . . . . 0.0 113.041 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.24 97.05 45.75 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.416 1.487 . . . . 0.0 111.119 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.15 -168.39 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 1 C-N-CA 125.459 4.106 . . . . 0.0 110.731 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 m -46.54 145.05 1.95 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.466 1.106 . . . . 0.0 109.022 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.53 126.11 72.14 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.231 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.69 161.63 43.42 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.751 2.3 . . . . 0.0 110.505 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.3 -13.61 60.14 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.844 -1.16 . . . . 0.0 114.116 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -51.14 132.93 28.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.979 1.311 . . . . 0.0 109.236 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.1 t -145.51 94.9 2.57 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.999 1.32 . . . . 0.0 109.313 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.5 ttm-85 -148.44 156.78 42.91 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.358 1.063 . . . . 0.0 110.208 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.3 ttp85 -100.89 133.79 44.84 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 127.837 2.455 . . . . 0.0 107.1 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 p -123.54 167.79 13.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.133 2.173 . . . . 0.0 111.215 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.81 -166.22 1.34 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.687 2.089 . . . . 0.0 113.886 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 p -108.59 169.52 8.6 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -63.93 -40.87 97.44 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.61 -51.84 65.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.221 0.464 . . . . 0.0 110.845 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -53.02 -54.47 34.81 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.199 1.0 . . . . 0.0 110.194 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.91 -35.89 81.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.007 -0.996 . . . . 0.0 111.489 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 50' ' ' VAL . 30.8 t80 -57.42 -39.91 77.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.889 1.222 . . . . 0.0 110.315 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.11 -42.67 46.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.865 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.79 78.47 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.106 . . . . 0.0 112.573 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -75.99 145.74 40.06 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.682 0.793 . . . . 0.0 111.459 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -95.12 -5.94 43.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.826 1.25 . . . . 0.0 108.268 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD21 ' CE2' ' A' ' 94' ' ' PHE . 26.0 tp -129.09 122.71 30.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.557 2.343 . . . . 0.0 108.272 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 44' ' ' PHE . 23.3 t -142.56 113.81 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.92 163.34 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.209 1.404 . . . . 0.0 109.019 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 p -126.21 144.76 50.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -164.67 161.39 20.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.674 -1.266 . . . . 0.0 111.933 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 55.3 m -87.69 132.87 33.96 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.0 t -75.35 113.31 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -82.9 -46.44 12.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.57 1.548 . . . . 0.0 108.13 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -153.03 167.03 30.55 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.491 1.517 . . . . 0.0 108.967 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.3 mtp -135.34 123.98 23.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.943 2.897 . . . . 0.0 105.784 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.73 150.73 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.93 1.292 . . . . 0.0 107.899 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -67.69 154.46 41.43 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.609 -0.682 . . . . 0.0 109.26 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 23.8 mm-40 -140.02 168.34 15.21 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.408 1.083 . . . . 0.0 110.776 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.83 162.26 11.29 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.65 2.9 . . . . 0.0 112.915 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.93 -147.48 50.73 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -88.72 20.42 3.49 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.48 169.04 54.9 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-O 123.848 1.804 . . . . 0.0 117.547 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.96 134.11 16.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.735 2.814 . . . . 0.0 104.967 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -98.55 123.53 42.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.55 123.15 49.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 175.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.0 m -98.72 126.21 44.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.12 175.51 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.221 0.608 . . . . 0.0 111.305 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -133.1 40.84 3.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.278 91.8 mt 38.81 80.97 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.411 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 26.9 mm -77.86 -29.5 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.77 0.714 . . . . 0.0 109.42 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -155.32 159.28 29.03 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.935 1.731 . . . . 0.0 109.408 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.56 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -135.34 -32.04 0.95 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.194 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -157.98 133.58 9.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -145.27 67.85 1.23 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.121 2.168 . . . . 0.0 106.548 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.62 43.83 3.22 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.479 1.514 . . . . 0.0 111.215 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.12 -31.77 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 125.93 1.728 . . . . 0.0 113.16 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.95 144.27 28.43 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.35 1.575 . . . . 0.0 109.993 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -100.55 63.37 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -57.54 141.08 79.37 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.962 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.39 171.51 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.192 1.928 . . . . 0.0 112.961 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.1 t -43.81 -56.13 7.86 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.896 2.078 . . . . 0.0 110.23 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.42 116.79 4.85 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 N-CA-C 106.597 -2.116 . . . . 0.0 106.597 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.46 -152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 1 C-N-CA 125.317 4.011 . . . . 0.0 112.129 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.456 HG21 ' HA2' ' A' ' 74' ' ' GLY 0.292 97.5 m -33.77 124.39 0.45 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 129.089 2.956 . . . . 0.0 112.117 -175.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.21 -4.05 1.75 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.186 1.85 . . . . 0.0 113.356 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.84 161.04 15.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.034 1.417 . . . . 0.0 109.446 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.2 p -105.32 143.8 32.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.799 0.809 . . . . 0.0 112.231 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -148.25 160.68 42.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.153 1.781 . . . . 0.0 109.48 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.32 121.22 43.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.501 ' CE2' HD21 ' A' ' 49' ' ' LEU . 40.6 m-85 -94.04 122.59 36.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -75.64 113.44 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 124.259 0.974 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.48 114.02 62.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -11.7 29.12 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 111.926 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -117.49 113.25 21.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.993 1.317 . . . . 0.0 111.956 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -82.74 -20.29 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -60.24 -53.59 55.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 109.776 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.3 m -160.58 163.56 21.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 127.483 2.313 . . . . 0.0 108.407 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.13 141.97 41.85 Favored 'Cis proline' 0 CA--C 1.537 0.664 0 CA-C-N 120.678 1.278 . . . . 0.0 111.312 1.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 102.2 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.177 2.585 . . . . 0.0 111.558 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 tpp -93.36 158.41 15.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.045 1.738 . . . . 0.0 108.666 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -142.54 137.22 30.02 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.537 0.684 . . . . 0.0 110.107 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -74.94 144.42 43.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.242 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.11 45.62 55.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -151.13 161.31 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 127.742 2.417 . . . . 0.0 105.513 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.8 m -107.63 131.34 54.48 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -122.77 170.32 10.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.444 1.898 . . . . 0.0 112.622 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.23 123.74 47.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.572 3.549 . . . . 0.0 102.031 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.37 114.13 21.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.5 mtm -119.23 113.33 20.7 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.18 -134.2 1.91 Allowed Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.187 1.375 . . . . 0.0 111.366 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -134.96 -178.5 5.11 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.342 -1.093 . . . . 0.0 109.401 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 49' ' ' LEU . 21.6 t -136.9 144.12 33.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.24 113.43 19.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -75.84 73.95 2.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.388 1.09 . . . . 0.0 108.527 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -168.94 -41.2 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 129.812 3.245 . . . . 0.0 108.343 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -119.2 -6.37 10.39 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.349 1.06 . . . . 0.0 112.682 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -151.32 21.33 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.86 141.95 38.13 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.613 1.542 . . . . 0.0 112.737 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.81 135.62 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 130' ' ' VAL 0.255 1.7 tm? -122.07 74.26 38.16 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 107.486 -174.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.86 174.86 6.1 Favored 'Trans proline' 0 CA--C 1.542 0.888 1 C-N-CA 125.728 4.285 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.54 -22.85 61.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.728 2.285 . . . . 0.0 113.463 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -85.17 23.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.355 1.462 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.2 m -97.74 140.1 32.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.922 . . . . 0.0 111.252 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -92.55 117.05 29.56 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 124' ' ' LEU . 85.3 t -131.8 117.41 34.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.795 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -147.12 168.68 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.228 1.411 . . . . 0.0 109.117 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.7 141.1 57.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.13 0.967 . . . . 0.0 109.954 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -68.45 136.32 53.06 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.777 1.631 . . . . 0.0 107.877 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -144.65 155.64 56.51 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.112 1.765 . . . . 0.0 106.912 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.44 -40.12 25.77 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.187 1.925 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -56.97 -52.71 64.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.013 0.37 . . . . 0.0 110.945 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -58.09 -44.11 87.45 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 123.091 0.556 . . . . 0.0 110.362 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.96 -50.65 70.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.34 1.056 . . . . 0.0 109.796 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -61.67 -39.57 91.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.275 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.3 mt -63.4 -50.36 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.116 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 mt -62.39 -36.91 83.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.207 1.367 . . . . 0.0 109.088 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.7 m -61.81 -45.36 94.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.15 -38.94 90.93 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.282 -0.886 . . . . 0.0 110.737 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.4 mt -68.65 -24.61 64.55 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.706 0.803 . . . . 0.0 111.582 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 t -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.184 0.902 . . . . 0.0 109.408 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -75.61 -48.88 20.33 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.625 0.77 . . . . 0.0 111.092 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -75.57 157.99 33.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.017 0.826 . . . . 0.0 109.496 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -82.39 150.45 27.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 33.7 m -65.99 123.69 85.7 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.26 159.62 43.52 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.455 2.104 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -162.93 79.77 0.48 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -114.62 113.22 45.2 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.1 153.11 12.66 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 121.654 1.569 . . . . 0.0 108.88 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.257 1.473 1 N-CA-C 98.105 -4.776 . . . . 0.0 98.105 175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 p . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.67 -177.53 2.54 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.113 1.875 . . . . 0.0 109.643 168.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -74.3 43.64 0.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 129.614 3.166 . . . . 0.0 112.082 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.84 115.2 4.29 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.477 2.311 . . . . 0.0 110.572 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -91.29 -169.61 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.571 3.514 . . . . 0.0 112.348 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -57.88 165.6 1.73 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.31 1.444 . . . . 0.0 108.418 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.3 t -84.01 120.91 75.5 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.2 155.83 55.99 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.344 1.363 . . . . 0.0 109.747 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -66.43 -9.45 34.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.884 -1.135 . . . . 0.0 112.937 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.24 128.94 39.53 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.188 1.395 . . . . 0.0 107.521 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -139.41 68.87 1.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -157.35 165.52 35.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.68 2.392 . . . . 0.0 106.156 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -114.68 142.26 46.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.32 2.248 . . . . 0.0 105.508 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.4 p -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.953 1.301 . . . . 0.0 110.872 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.58 -177.02 37.96 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.322 0.963 . . . . 0.0 112.364 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -102.47 165.42 11.11 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.725 -0.868 . . . . 0.0 108.683 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.82 -47.75 76.88 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.05 -48.0 80.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 118.62 0.646 . . . . 0.0 110.593 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 m -59.28 -48.15 82.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.346 0.659 . . . . 0.0 111.077 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -69.0 -33.89 74.41 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.249 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.514 ' CD2' HG11 ' A' ' 50' ' ' VAL . 15.9 t80 -57.52 -36.4 71.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.185 1.357 . . . . 0.0 110.033 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.8 m -69.26 -45.85 68.69 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.39 0.676 . . . . 0.0 111.115 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.28 50.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.511 0.724 . . . . 0.0 112.144 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -62.05 138.49 58.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.78 1.232 . . . . 0.0 109.994 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -94.3 -6.68 43.89 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.061 0.934 . . . . 0.0 109.882 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.5 HD21 ' CE2' ' A' ' 94' ' ' PHE . 24.6 tp -120.38 120.42 35.92 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 126.75 2.02 . . . . 0.0 107.709 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 44' ' ' PHE . 40.1 t -142.88 113.32 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.49 166.8 5.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.776 1.231 . . . . 0.0 108.509 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -130.29 143.66 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -165.58 173.31 11.03 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 110.799 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.8 m -110.82 134.45 52.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.92 113.58 15.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 22.2 mmmt -86.49 -42.38 13.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.424 1.09 . . . . 0.0 110.327 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -147.37 168.99 20.42 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.198 1.399 . . . . 0.0 110.925 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 mtp -138.82 129.25 25.84 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.0 t -123.72 142.19 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.312 1.045 . . . . 0.0 108.663 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -72.49 139.69 47.78 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -123.62 176.11 2.41 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.339 1.856 . . . . 0.0 108.555 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.81 161.81 34.62 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.929 2.419 . . . . 0.0 112.24 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -154.2 40.17 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -72.2 0.27 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.914 1.285 . . . . 0.0 110.632 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.5 172.56 22.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 126.808 2.147 . . . . 0.0 117.873 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 59' ' ' VAL . 1.8 tm? -161.87 141.99 10.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 129.569 3.148 . . . . 0.0 105.44 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.29 151.35 27.5 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.93 123.28 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 124.68 43.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.51 169.98 20.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 t -123.8 35.39 4.85 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.26 70.3 mt 36.3 82.58 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 128.071 2.549 . . . . 0.0 116.884 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 32.7 mm -72.15 -30.99 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.305 -0.872 . . . . 0.0 111.816 175.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.498 ' CA ' HG21 ' A' ' 88' ' ' THR . . . -159.3 160.91 31.7 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.88 49.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -141.32 -25.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.396 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -156.15 125.54 6.23 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -139.57 67.95 1.38 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 127.709 2.404 . . . . 0.0 104.613 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 31.46 3.31 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.58 1.086 . . . . 0.0 111.939 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.58 -62.7 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.247 1.403 . . . . 0.0 111.4 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.12 148.59 30.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 117.147 0.474 . . . . 0.0 111.022 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.11 97.69 11.33 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.2 mt -63.23 147.44 94.81 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.68 178.7 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.539 1.493 . . . . 0.0 111.347 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.3 t -52.31 -61.02 5.06 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.614 1.166 . . . . 0.0 111.245 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 142.36 46.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 N-CA-C 107.36 -1.823 . . . . 0.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.36 -168.94 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.392 1.395 . . . . 0.0 110.846 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.498 HG21 ' CA ' ' A' ' 74' ' ' GLY . 17.1 m -38.17 130.93 1.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.258 2.223 . . . . 0.0 113.67 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 59.48 0.06 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 105.257 -3.137 . . . . 0.0 105.257 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.63 165.33 31.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 126.501 1.92 . . . . 0.0 106.608 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.9 p -104.0 147.72 27.05 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 120.907 -1.121 . . . . 0.0 111.443 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -147.26 158.77 44.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -125.02 113.84 18.32 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.5 ' CE2' HD21 ' A' ' 49' ' ' LEU . 70.8 m-85 -98.81 121.19 40.45 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.86 0.864 . . . . 0.0 109.57 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.91 113.8 17.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 124.677 1.236 . . . . 0.0 109.994 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.54 120.01 54.31 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.32 0.02 8.0 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.685 2.257 . . . . 0.0 112.458 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 57.7 m -129.83 160.81 32.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.061 2.544 . . . . 0.0 109.121 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -132.01 -8.42 3.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -83.45 -48.03 10.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.482 1.037 . . . . 0.0 108.511 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -127.66 158.22 70.81 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.99 1.316 . . . . 0.0 111.519 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.7 153.26 79.38 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 -4.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.35 96.51 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.403 2.735 . . . . 0.0 112.622 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.5 tpp -94.67 160.94 14.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.135 1.374 . . . . 0.0 110.309 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -152.91 140.02 19.32 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.988 1.715 . . . . 0.0 109.093 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -78.2 147.06 34.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.45 46.6 84.87 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -146.32 147.86 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 126.477 1.911 . . . . 0.0 106.714 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.1 m -93.8 132.13 38.5 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.168 0.587 . . . . 0.0 110.096 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.76 172.38 11.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.631 1.972 . . . . 0.0 111.664 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -115.81 124.15 50.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.21 114.34 23.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.7 mtm -117.89 113.37 21.64 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 103.274 -2.861 . . . . 0.0 103.274 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.74 -134.01 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.802 1.191 . . . . 0.0 111.164 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -135.89 175.98 9.1 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.985 . . . . 0.0 110.991 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 6.4 t -130.21 145.78 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.789 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -123.76 113.7 18.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -81.01 65.32 6.11 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.378 1.085 . . . . 0.0 111.946 -175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -166.82 -39.42 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.982 1.713 . . . . 0.0 110.736 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -113.65 -30.67 6.73 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.96 -168.76 21.21 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 Cg_endo -71.76 160.53 47.75 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.287 1.325 . . . . 0.0 111.342 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.47 157.21 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 130' ' ' VAL . 1.7 tm? -146.44 74.73 12.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 120.67 -1.269 . . . . 0.0 108.664 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.05 174.19 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.552 3.501 . . . . 0.0 113.052 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.13 -16.37 50.05 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.847 1.698 . . . . 0.0 111.99 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.81 32.01 0.48 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.038 2.135 . . . . 0.0 110.826 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -113.66 128.73 56.54 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.111 1.364 . . . . 0.0 111.064 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -81.34 113.31 19.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 124' ' ' LEU . 55.6 t -133.46 123.18 45.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -152.43 173.16 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.362 1.465 . . . . 0.0 110.682 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.91 134.25 54.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.875 1.67 . . . . 0.0 109.323 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -67.74 125.77 27.3 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -140.9 157.64 66.93 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.56 -1.209 . . . . 0.0 109.199 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.52 -44.85 16.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.63 2.887 . . . . 0.0 115.785 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -55.68 -43.42 76.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.542 1.065 . . . . 0.0 110.859 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.35 -44.28 83.66 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.94 -0.553 . . . . 0.0 109.556 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.37 -50.05 65.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.919 0.887 . . . . 0.0 111.657 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.59 -49.77 73.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.592 0.757 . . . . 0.0 109.335 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.73 -52.61 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.861 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.23 -32.82 74.32 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.771 1.169 . . . . 0.0 110.222 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.6 m -65.73 -46.84 77.37 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -60.32 -41.75 94.17 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.685 -0.635 . . . . 0.0 111.267 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.98 -35.64 80.41 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.5 1.12 . . . . 0.0 110.867 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -61.99 -45.61 92.85 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -67.41 -48.88 66.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.53 0.732 . . . . 0.0 110.5 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -68.41 166.43 16.75 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.457 0.646 . . . . 0.0 109.638 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -108.99 123.82 49.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 23.5 m -58.94 158.54 16.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 148.19 31.45 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.381 2.054 . . . . 0.0 110.999 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -142.55 78.4 1.62 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -155.52 113.06 2.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -106.37 45.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.246 3.297 . . . . 0.0 115.388 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.25 1.088 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.067 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 118.157 -0.925 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.98 64.51 8.45 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.861 2.374 . . . . 0.0 109.766 170.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -121.25 57.37 1.0 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 124.065 1.888 . . . . 0.0 110.345 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.24 94.41 6.26 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.171 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.25 -166.93 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 125.178 3.919 . . . . 0.0 110.401 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -50.84 146.07 6.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.323 1.449 . . . . 0.0 107.366 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 t -84.47 144.45 43.16 Favored Pre-proline 0 C--O 1.242 0.704 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.32 153.69 35.83 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.152 2.568 . . . . 0.0 108.715 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -24.18 59.15 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.239 -0.913 . . . . 0.0 112.212 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.1 135.84 55.15 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.1 t -145.92 124.25 12.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.319 1.048 . . . . 0.0 109.118 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -155.52 166.03 34.77 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 128.542 2.737 . . . . 0.0 107.51 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -118.92 150.83 39.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.738 2.015 . . . . 0.0 106.58 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -132.05 176.33 8.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.324 2.249 . . . . 0.0 111.178 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 -158.73 50.96 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.322 1.915 . . . . 0.0 114.439 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -123.06 162.25 22.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.7 -38.31 90.64 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -64.83 -53.75 41.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.474 0.579 . . . . 0.0 111.376 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -59.54 -47.15 86.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.533 0.682 . . . . 0.0 109.183 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.85 -36.2 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.39 -1.29 . . . . 0.0 111.754 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 50' ' ' VAL . 27.0 t80 -57.8 -43.43 85.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.55 1.523 . . . . 0.0 111.484 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.91 -34.34 69.02 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.312 0.645 . . . . 0.0 111.495 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.9 96.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.506 0.722 . . . . 0.0 112.261 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -76.08 148.45 37.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.901 1.28 . . . . 0.0 113.831 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 t -90.3 -13.92 34.26 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.643 1.977 . . . . 0.0 109.382 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 94' ' ' PHE . 57.9 tp -131.06 123.99 29.89 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.54 1.536 . . . . 0.0 109.111 -176.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 44' ' ' PHE . 22.0 t -141.74 114.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.59 168.92 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.516 1.126 . . . . 0.0 109.57 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.0 p -124.31 140.72 52.69 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.61 163.48 24.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.527 -1.358 . . . . 0.0 111.202 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 94.2 m -93.81 127.16 39.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.26 113.32 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -89.78 -47.6 7.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -141.27 166.87 23.58 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.731 0.812 . . . . 0.0 110.208 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.4 mtp -139.06 124.14 18.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.906 1.682 . . . . 0.0 106.83 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.09 146.92 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.249 1.42 . . . . 0.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -72.13 141.1 49.14 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.443 -0.786 . . . . 0.0 109.13 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 mm-40 -132.27 170.25 11.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.767 1.227 . . . . 0.0 109.954 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -62.1 170.32 6.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.028 3.152 . . . . 0.0 114.999 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.5 -123.33 28.96 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -113.94 19.61 16.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 108.255 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.82 171.52 55.15 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 123.37 1.539 . . . . 0.0 115.855 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.73 129.11 8.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.062 2.545 . . . . 0.0 105.264 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -97.03 123.82 40.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.1 123.17 47.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -95.39 123.73 39.07 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.36 169.04 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.232 1.013 . . . . 0.0 110.539 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -135.75 44.81 2.47 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt 37.8 81.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.746 3.239 . . . . 0.0 119.746 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.4 mm -79.98 -23.14 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.507 1.048 . . . . 0.0 110.305 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.05 160.26 32.58 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.68 35.46 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.632 1.173 . . . . 0.0 109.604 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -138.48 -33.1 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.307 0.643 . . . . 0.0 112.688 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -150.61 133.16 15.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -143.22 77.77 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.091 2.956 . . . . 0.0 103.496 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.61 36.4 2.64 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 125.568 1.556 . . . . 0.0 112.037 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.81 -67.2 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 126.681 2.086 . . . . 0.0 109.736 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.81 125.29 22.89 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 123.755 0.822 . . . . 0.0 108.863 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -78.54 91.28 4.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 124.628 1.205 . . . . 0.0 108.621 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 83' ' ' LEU . 28.4 mt -65.84 129.63 94.33 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.64 178.17 7.73 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.45 1.433 . . . . 0.0 112.977 -175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.9 t -43.86 -58.8 4.21 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 116.902 -1.523 . . . . 0.0 109.892 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.77 122.0 9.11 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 N-CA-C 107.623 -1.722 . . . . 0.0 107.623 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 88' ' ' THR . 84.1 Cg_endo -69.83 -153.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 1 C-N-CA 125.909 4.406 . . . . 0.0 110.407 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 54.1 m -31.57 123.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 110.54 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.31 39.21 0.26 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.569 1.081 . . . . 0.0 112.748 -175.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.73 164.07 29.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.421 1.488 . . . . 0.0 107.216 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 p -110.38 153.29 25.16 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.874 0.761 . . . . 0.0 112.189 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.5 mt -144.31 159.89 41.94 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.097 1.359 . . . . 0.0 109.165 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -119.67 113.47 20.72 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.7 m-85 -95.51 118.59 32.5 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -75.89 113.47 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.841 0.857 . . . . 0.0 109.451 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.73 114.82 63.55 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.35 2.2 5.93 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 113.484 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -135.07 114.14 12.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 109.074 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.93 -10.24 59.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.323 -0.861 . . . . 0.0 111.321 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -82.75 -46.46 13.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.008 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.1 m -151.94 164.17 21.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.477 1.111 . . . . 0.0 112.327 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.75 150.98 52.54 Favored 'Cis proline' 0 C--N 1.355 0.904 0 CA-C-N 120.013 1.04 . . . . 0.0 110.231 -3.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.77 97.62 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.429 2.753 . . . . 0.0 113.638 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 tpp -93.77 162.33 13.97 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.758 1.223 . . . . 0.0 108.411 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -146.77 143.4 28.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.654 1.582 . . . . 0.0 108.313 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.98 139.77 41.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.137 0.575 . . . . 0.0 110.036 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.89 71.39 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 126.386 1.946 . . . . 0.0 115.474 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.76 146.15 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.057 1.743 . . . . 0.0 108.345 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 m -91.87 128.25 37.63 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.443 0.64 . . . . 0.0 109.625 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -124.12 172.29 9.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.089 2.556 . . . . 0.0 111.457 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 123.63 46.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 100.791 -3.781 . . . . 0.0 100.791 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.18 114.03 21.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.5 mtm -116.97 113.25 22.12 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.9 -142.49 3.49 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.172 1.844 . . . . 0.0 110.878 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -132.86 176.41 8.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.617 1.209 . . . . 0.0 110.334 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.33 149.29 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.25 114.31 14.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.249 2.22 . . . . 0.0 106.546 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.82 65.62 0.23 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.285 1.834 . . . . 0.0 114.56 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 169.16 -25.84 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 130.701 3.6 . . . . 0.0 111.64 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -112.76 -6.61 13.84 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.648 1.179 . . . . 0.0 113.889 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.67 -151.01 42.35 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 135.56 22.7 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.205 1.936 . . . . 0.0 110.369 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.264 7.4 p -120.4 142.51 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 130' ' ' VAL 0.282 1.4 tm? -129.67 74.1 81.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -174.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.04 175.11 5.02 Favored 'Trans proline' 0 CA--C 1.543 0.93 1 C-N-CA 125.497 4.131 . . . . 0.0 113.347 -175.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -58.91 -28.91 88.87 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.283 1.988 . . . . 0.0 113.843 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.25 39.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.7 m -107.66 129.12 55.04 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 176.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -82.19 113.74 20.23 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 124' ' ' LEU . 50.0 t -133.57 117.86 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 123.812 0.845 . . . . 0.0 109.193 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.75 168.87 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.89 1.276 . . . . 0.0 109.286 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.9 139.29 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.41 0.624 . . . . 0.0 109.415 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -65.55 144.43 56.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.996 1.318 . . . . 0.0 109.203 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -144.34 148.99 43.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.61 -40.5 29.74 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.751 1.634 . . . . 0.0 110.712 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -53.53 -46.43 70.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.801 0.84 . . . . 0.0 110.804 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.91 -40.32 87.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.512 0.725 . . . . 0.0 111.011 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.8 -47.41 82.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.16 0.891 . . . . 0.0 110.009 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -59.31 -39.65 83.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.511 1.524 . . . . 0.0 110.062 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.48 -51.83 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.441 1.019 . . . . 0.0 109.791 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 mt -63.71 -35.07 79.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.129 1.331 . . . . 0.0 109.548 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.0 m -58.67 -49.94 75.7 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.13 -41.47 83.75 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.632 -0.667 . . . . 0.0 112.171 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.84 -28.75 64.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.518 0.727 . . . . 0.0 112.369 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -73.18 -36.64 66.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.865 0.866 . . . . 0.0 108.716 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -75.32 -50.26 16.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.685 1.594 . . . . 0.0 110.37 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.53 166.58 23.2 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.725 -1.234 . . . . 0.0 111.009 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 161.28 24.25 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 22.9 m -79.29 130.74 67.94 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.29 111.84 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.436 2.757 . . . . 0.0 109.279 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 p -160.5 83.21 0.69 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.6 113.24 47.98 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -91.98 -179.0 1.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.667 2.911 . . . . 0.0 110.745 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.255 1.355 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 175.084 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -92.99 55.01 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.004 2.469 . . . . 0.0 111.2 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.87 33.38 3.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.65 148.46 66.87 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 126.592 1.957 . . . . 0.0 109.511 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.05 -178.84 4.03 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.703 2.935 . . . . 0.0 112.701 -176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -65.7 174.35 2.36 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.906 2.083 . . . . 0.0 107.335 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 19.6 t -83.01 116.37 63.86 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.365 -1.46 . . . . 0.0 110.095 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -85.55 176.82 5.33 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.531 2.821 . . . . 0.0 111.705 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -76.21 -9.96 59.04 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.421 HE22 ' NH1' ' A' ' 35' ' ' ARG . 3.3 tp-100 -58.9 144.04 45.88 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.803 0.841 . . . . 0.0 109.41 176.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.8 t -146.23 77.06 1.47 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' NH1' HE22 ' A' ' 33' ' ' GLN . 36.5 ttp-105 -151.06 159.5 44.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 129.218 3.007 . . . . 0.0 103.856 175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -101.25 147.81 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.0 p -137.21 172.3 13.2 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.07 0.548 . . . . 0.0 110.055 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.01 175.65 29.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.392 0.996 . . . . 0.0 112.829 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 p -101.9 168.55 9.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.42 -42.3 96.13 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.38 -42.64 78.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.013 0.525 . . . . 0.0 112.347 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -64.95 -52.43 56.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.89 -36.46 83.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.339 -0.838 . . . . 0.0 112.092 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 50' ' ' VAL . 35.1 t80 -60.3 -38.58 84.12 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.907 1.23 . . . . 0.0 111.236 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 m -70.15 -41.26 74.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.385 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.75 -52.89 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 112.903 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -56.17 138.24 50.3 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.325 1.05 . . . . 0.0 112.222 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -82.66 -14.12 55.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.187 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.1 tp -127.57 122.21 32.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.871 1.268 . . . . 0.0 109.592 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 44' ' ' PHE . 16.3 t -138.2 113.74 9.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.33 171.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.683 1.593 . . . . 0.0 108.875 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.552 HG22 ' HA ' ' A' ' 111' ' ' LEU . 34.2 p -130.77 145.22 51.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.17 167.98 21.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.167 -0.958 . . . . 0.0 111.251 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -102.64 130.08 49.43 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.8 t -71.31 113.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -80.15 -42.99 22.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.365 1.466 . . . . 0.0 109.529 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -156.65 166.01 34.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.705 1.202 . . . . 0.0 109.219 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 59.2 mtp -133.23 129.97 38.42 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.07 148.0 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.655 0.782 . . . . 0.0 108.92 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -70.14 155.34 40.76 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.55 1.068 . . . . 0.0 110.252 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 5.3 mm-40 -132.24 176.1 3.18 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.811 1.644 . . . . 0.0 111.491 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.22 144.27 98.79 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.459 2.773 . . . . 0.0 111.862 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.23 -152.21 51.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.66 3.87 4.58 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.882 -0.776 . . . . 0.0 110.255 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.54 164.28 20.92 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-O 123.691 1.717 . . . . 0.0 116.82 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -147.81 138.14 22.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.794 2.437 . . . . 0.0 106.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -105.21 143.28 33.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -118.61 123.31 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.9 m -97.1 132.88 42.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.49 175.9 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.896 0.878 . . . . 0.0 112.407 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -135.98 35.17 2.84 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt 38.47 82.09 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 117.8 2.518 . . . . 0.0 117.8 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.1 mm -77.91 -25.89 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.312 1.045 . . . . 0.0 111.095 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -164.74 162.95 35.98 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 124.955 1.264 . . . . 0.0 110.752 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 150.11 37.02 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.582 1.953 . . . . 0.0 108.323 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.405 ' HD1' HG12 ' A' ' 50' ' ' VAL . 3.6 m-85 -141.5 -27.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.22 1.008 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -154.93 127.83 8.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.417 1.487 . . . . 0.0 107.317 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -136.48 74.58 1.5 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.303 3.041 . . . . 0.0 105.402 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.24 35.27 2.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.134 1.35 . . . . 0.0 110.355 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.91 -73.33 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 127.551 2.501 . . . . 0.0 110.796 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.0 mt -56.3 134.74 53.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.39 76.07 5.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.757 2.023 . . . . 0.0 108.788 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.7 138.79 97.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.106 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.52 178.15 7.97 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.815 2.343 . . . . 0.0 112.871 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.0 t -49.02 -54.9 23.87 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 117.041 -1.457 . . . . 0.0 110.88 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.16 117.12 4.85 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 88' ' ' THR . 79.1 Cg_endo -72.72 -152.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 125.03 3.82 . . . . 0.0 111.502 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 41.6 m -34.06 123.9 0.48 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.856 3.262 . . . . 0.0 112.201 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.16 58.01 0.21 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.64 1.591 . . . . 0.0 109.436 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 161.5 40.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.034 2.534 . . . . 0.0 106.326 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -99.83 151.33 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.4 mt -143.9 165.2 28.38 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.468 1.507 . . . . 0.0 109.813 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -128.65 120.39 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.47 124.45 47.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.347 1.459 . . . . 0.0 107.779 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' A' ' 123' ' ' VAL . 52.7 t80 -80.31 121.21 25.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.835 1.254 . . . . 0.0 110.501 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.74 124.49 30.41 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.04 -1.22 11.17 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.568 2.179 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.5 m -150.58 175.75 11.63 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.495 2.318 . . . . 0.0 108.959 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.95 -4.39 5.72 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -79.21 -51.06 9.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.84 1.655 . . . . 0.0 109.944 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.428 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 15.7 m -133.35 155.37 80.86 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 127.282 2.233 . . . . 0.0 111.352 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 101' ' ' CYS . 63.6 Cg_endo -67.67 156.72 85.94 Favored 'Cis proline' 0 CA--C 1.55 1.29 0 C-N-CA 124.658 -0.976 . . . . 0.0 110.154 -2.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.49 87.23 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.535 3.49 . . . . 0.0 114.873 -175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -99.46 156.91 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.038 2.135 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -150.21 152.67 34.97 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.619 1.568 . . . . 0.0 109.331 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -77.95 136.35 37.98 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.65 43.0 30.67 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.84 0.733 . . . . 0.0 113.371 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.67 153.17 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.667 1.587 . . . . 0.0 107.77 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.2 m -98.94 130.73 45.32 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 110.538 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.99 173.24 11.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.588 1.555 . . . . 0.0 111.893 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.552 ' HA ' HG22 ' A' ' 52' ' ' THR . 7.0 tp -108.58 124.77 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 130.113 3.365 . . . . 0.0 102.522 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.72 113.84 24.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -115.0 113.24 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 101.221 -3.622 . . . . 0.0 101.221 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.52 -143.12 3.57 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.013 1.292 . . . . 0.0 111.249 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -133.52 176.92 8.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.118 0.967 . . . . 0.0 109.437 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.37 133.09 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.45 -0.781 . . . . 0.0 111.466 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.47 112.98 25.26 Favored 'General case' 0 C--O 1.242 0.693 1 N-CA-C 96.04 -5.541 . . . . 0.0 96.04 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.24 63.71 8.16 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.802 1.287 . . . . 0.0 109.735 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -169.59 -32.48 0.02 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.802 2.441 . . . . 0.0 109.829 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -113.54 -14.71 12.65 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.203 1.001 . . . . 0.0 111.633 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.55 -172.11 22.66 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.15 135.27 49.91 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.903 1.736 . . . . 0.0 109.351 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -114.18 134.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 1.8 tm? -125.74 78.74 68.89 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 125.221 1.408 . . . . 0.0 108.98 -174.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.23 170.77 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.742 2.961 . . . . 0.0 111.596 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -23.05 75.96 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.517 2.145 . . . . 0.0 112.528 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -83.49 24.0 0.88 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.047 0.939 . . . . 0.0 111.883 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 m -94.43 124.3 38.37 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.925 1.29 . . . . 0.0 108.034 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -77.11 113.79 15.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.5 125.79 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.7 167.85 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.382 1.473 . . . . 0.0 108.246 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.57 138.27 58.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.39 131.42 46.39 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -141.12 147.27 46.78 Favored Pre-proline 0 N--CA 1.464 0.249 0 C-N-CA 125.69 1.596 . . . . 0.0 107.281 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.75 -37.12 29.32 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.577 2.185 . . . . 0.0 114.008 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -56.48 -52.74 63.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.818 0.735 . . . . 0.0 110.375 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -58.82 -44.48 90.88 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.542 1.137 . . . . 0.0 110.282 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.59 -45.67 88.61 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.408 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -61.46 -39.53 91.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.523 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.93 -47.79 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 119.649 1.113 . . . . 0.0 109.684 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.03 -40.34 93.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.333 1.424 . . . . 0.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.3 m -59.48 -51.22 70.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 109.0 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -65.31 -33.94 77.16 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.244 1.418 . . . . 0.0 111.018 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.44 -35.96 65.85 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.825 1.25 . . . . 0.0 110.504 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -63.41 -34.9 78.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.063 1.301 . . . . 0.0 109.168 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -74.51 -44.1 52.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.881 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -73.09 176.63 5.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.87 1.668 . . . . 0.0 108.104 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.98 146.59 47.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.54 123.7 89.02 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.284 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.62 97.04 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.572 2.181 . . . . 0.0 108.959 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -143.14 76.05 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -114.04 120.53 38.54 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.78 77.63 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.847 2.365 . . . . 0.0 109.937 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.206 -1.378 . . . . 0.0 110.198 -175.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.99 158.88 41.04 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.17 2.58 . . . . 0.0 110.472 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.55 33.85 0.26 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.4 104.8 0.25 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.154 2.182 . . . . 0.0 111.602 -175.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.13 77.8 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.692 3.595 . . . . 0.0 110.214 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -141.92 148.23 38.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.297 2.239 . . . . 0.0 107.032 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 41.3 t -128.52 131.97 24.08 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.874 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.0 159.2 50.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.025 1.817 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -77.19 -47.41 20.35 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.855 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.52 166.2 13.08 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.411 1.484 . . . . 0.0 109.765 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 t -150.12 108.59 3.8 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.249 0.62 . . . . 0.0 110.258 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' ' HE ' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -134.12 166.02 23.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.369 1.868 . . . . 0.0 109.184 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttp-105 -131.79 139.85 49.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.904 2.481 . . . . 0.0 105.027 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -147.84 176.67 9.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.803 1.641 . . . . 0.0 112.134 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.43 -157.35 44.21 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.013 0.816 . . . . 0.0 111.255 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 p -120.79 162.73 19.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 141' ' ' LEU . 8.5 tt -63.75 -39.14 93.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.62 -50.67 68.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.269 0.628 . . . . 0.0 111.09 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -65.15 -43.23 92.48 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -61.3 -44.75 96.7 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 116.92 -1.514 . . . . 0.0 112.364 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' A' ' 50' ' ' VAL . 10.2 t80 -53.35 -46.7 69.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.787 1.631 . . . . 0.0 110.29 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.3 m -66.04 -37.14 85.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.884 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -51.77 60.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.255 1.022 . . . . 0.0 111.379 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -61.1 147.45 43.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.776 0.83 . . . . 0.0 111.022 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -101.42 -9.49 21.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.736 0.814 . . . . 0.0 109.76 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 94' ' ' PHE . 48.0 tp -127.32 119.21 25.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.169 1.788 . . . . 0.0 106.81 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 44' ' ' PHE . 48.8 t -137.25 115.52 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -146.57 169.15 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.932 1.293 . . . . 0.0 109.62 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -131.24 143.59 50.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.57 163.96 16.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.903 -1.123 . . . . 0.0 111.383 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.5 m -91.19 129.98 37.12 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.81 113.22 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -84.58 -35.08 23.01 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -160.41 170.49 20.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.06 1.344 . . . . 0.0 109.315 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.5 mtp -140.6 142.03 35.09 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.392 1.877 . . . . 0.0 106.258 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -143.57 147.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.771 0.828 . . . . 0.0 108.803 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.37 150.98 48.06 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.638 1.563 . . . . 0.0 109.709 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 5.7 mm-40 -120.89 175.37 2.41 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 127.96 2.504 . . . . 0.0 108.557 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.85 150.31 88.71 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.741 1.628 . . . . 0.0 111.244 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.58 -148.23 50.59 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.919 0.771 . . . . 0.0 112.857 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.5 7.1 2.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 112.341 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.26 170.6 54.83 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 122.737 1.187 . . . . 0.0 114.697 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.32 136.65 18.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.806 2.042 . . . . 0.0 106.36 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.454 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -98.0 136.1 38.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.7 t -115.55 123.17 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -91.46 130.47 37.29 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.61 168.84 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.037 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 t -131.02 37.28 3.78 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.1 mt 38.92 81.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.07 -29.1 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.73 155.74 26.78 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 125.748 1.642 . . . . 0.0 109.076 176.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.08 135.1 37.19 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.899 2.08 . . . . 0.0 105.728 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -130.57 -28.36 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 124.045 0.841 . . . . 0.0 113.009 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.94 129.91 11.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -145.86 68.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.618 1.967 . . . . 0.0 108.433 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.87 39.32 2.84 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.817 1.199 . . . . 0.0 112.355 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.78 -15.82 0.02 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.431 1.491 . . . . 0.0 115.985 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.16 151.42 23.67 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 120.206 2.003 . . . . 0.0 112.232 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -104.7 64.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.757 2.023 . . . . 0.0 106.255 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.41 148.27 73.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.45 -178.57 3.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.701 1.601 . . . . 0.0 111.285 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -52.25 -58.74 10.41 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.434 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.71 147.41 63.11 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 CA-C-N 121.924 1.723 . . . . 0.0 109.028 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.36 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.083 2.522 . . . . 0.0 112.029 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.478 HG21 ' HA2' ' A' ' 74' ' ' GLY . 19.8 m -32.34 132.52 0.13 Allowed 'General case' 0 C--O 1.243 0.733 0 C-N-CA 129.303 3.041 . . . . 0.0 112.085 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.7 57.64 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.746 1.641 . . . . 0.0 110.523 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.63 164.53 36.69 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.739 2.016 . . . . 0.0 107.632 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 p -108.09 146.86 32.02 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.365 0.666 . . . . 0.0 112.415 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.1 mt -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.652 1.981 . . . . 0.0 109.856 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -130.94 115.13 16.11 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.076 2.15 . . . . 0.0 105.488 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.6 m-85 -94.04 121.4 35.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -75.58 113.7 13.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.653 1.221 . . . . 0.0 108.986 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.79 121.41 46.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.68 -0.79 10.58 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.438 2.092 . . . . 0.0 112.762 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.6 m -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.212 1.805 . . . . 0.0 108.716 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -94.85 -17.98 21.59 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -102.06 -23.23 14.11 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.792 1.178 . . . . 0.0 113.677 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.5 m -135.03 155.51 79.07 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.104 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -69.87 169.49 63.55 Favored 'Cis proline' 0 CA--C 1.546 1.095 0 CA-C-N 119.825 0.973 . . . . 0.0 110.534 -4.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 77.04 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.866 3.044 . . . . 0.0 111.348 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.9 tpp -93.77 154.12 17.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.318 1.447 . . . . 0.0 110.53 -175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -144.5 144.39 31.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.531 0.733 . . . . 0.0 109.797 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -72.2 148.73 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.801 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.51 37.82 94.93 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.024 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.9 t -143.46 152.61 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.661 1.984 . . . . 0.0 106.771 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 m -94.59 129.03 41.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.86 0.838 . . . . 0.0 110.538 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -124.7 172.16 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.33 2.252 . . . . 0.0 111.567 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.678 HD11 ' HG3' ' A' ' 113' ' ' MET . 0.6 OUTLIER -116.51 125.78 52.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.829 3.651 . . . . 0.0 103.493 175.565 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.28 114.09 21.37 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.713 1.205 . . . . 0.0 107.884 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.678 ' HG3' HD11 ' A' ' 111' ' ' LEU . 13.4 mtm -117.53 112.91 21.23 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 102.899 -3.001 . . . . 0.0 102.899 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.68 -137.29 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.25 1.881 . . . . 0.0 109.383 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.67 175.68 9.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 108.755 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.57 144.85 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -116.31 113.19 22.61 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -78.31 63.52 3.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 109.842 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 177.59 -24.57 0.0 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.953 3.701 . . . . 0.0 112.21 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -116.33 -33.38 4.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.111 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.37 -167.37 18.81 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.687 1.613 . . . . 0.0 110.464 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.35 137.43 30.92 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.137 1.225 . . . . 0.0 109.218 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.252 14.7 p -121.31 155.96 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 130' ' ' VAL 0.277 1.0 OUTLIER -138.52 74.05 40.96 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -174.861 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.99 168.8 9.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 124.832 3.688 . . . . 0.0 111.836 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.37 -19.05 55.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.012 1.397 . . . . 0.0 113.429 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -85.37 23.56 1.3 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.521 1.529 . . . . 0.0 111.384 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.3 m -88.45 143.19 27.14 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.109 0.964 . . . . 0.0 110.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -92.67 115.4 28.07 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 124' ' ' LEU . 33.3 t -136.98 125.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -151.03 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.0 109.656 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.03 142.48 58.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.428 1.091 . . . . 0.0 109.796 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -73.82 126.75 31.09 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.984 0.913 . . . . 0.0 109.059 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -139.15 156.52 72.12 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 125.106 1.362 . . . . 0.0 108.4 175.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.51 -49.46 11.96 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.234 2.623 . . . . 0.0 114.867 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -58.11 -47.6 82.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.561 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -58.02 -47.02 84.3 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 125.267 1.427 . . . . 0.0 110.439 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -54.37 -51.39 64.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.458 1.503 . . . . 0.0 110.598 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -62.92 -36.24 82.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.252 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.81 -47.27 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.24 1.382 . . . . 0.0 110.183 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 40' ' ' LEU . 4.6 mt -63.04 -38.7 92.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.061 1.301 . . . . 0.0 109.368 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -44.38 97.34 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.678 -0.638 . . . . 0.0 109.665 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -59.37 -45.93 90.07 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.245 -0.909 . . . . 0.0 109.95 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 -30.43 71.56 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.551 1.141 . . . . 0.0 111.669 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -69.93 -45.77 66.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.824 0.849 . . . . 0.0 110.013 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -75.56 -35.63 60.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 118.956 -0.545 . . . . 0.0 112.131 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -76.19 171.66 14.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.247 1.019 . . . . 0.0 109.974 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -99.13 134.84 41.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 17.6 m -67.11 144.96 98.66 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.57 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 120.2 7.82 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.763 2.309 . . . . 0.0 107.748 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.64 71.49 1.46 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -124.1 113.19 28.18 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.138 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -114.12 -155.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 1 C-N-CA 125.517 4.145 . . . . 0.0 105.338 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.254 1.309 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.126 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -85.64 61.69 5.38 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.048 3.165 . . . . 0.0 110.27 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -138.13 69.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.758 1.266 . . . . 0.0 112.303 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.38 116.16 1.76 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 125.79 1.636 . . . . 0.0 107.585 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.08 158.63 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.794 2.996 . . . . 0.0 112.398 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -73.92 165.56 24.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.072 1.349 . . . . 0.0 110.069 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.4 t -83.82 112.36 39.69 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.179 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.45 175.6 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.714 2.276 . . . . 0.0 110.819 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.38 -16.38 63.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.13 142.18 26.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.806 1.642 . . . . 0.0 110.008 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.64 44.72 2.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.947 0.899 . . . . 0.0 109.052 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -146.06 155.54 42.85 Favored 'General case' 0 C--N 1.338 0.1 0 O-C-N 121.106 -0.996 . . . . 0.0 108.658 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -90.21 145.31 25.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.203 1.801 . . . . 0.0 109.113 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 173.98 11.02 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.818 1.247 . . . . 0.0 110.213 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.43 -172.8 50.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.974 0.797 . . . . 0.0 111.133 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -108.05 170.98 7.67 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.09 -46.68 83.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -62.6 -48.29 80.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.624 0.769 . . . . 0.0 110.984 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -55.17 -54.61 41.13 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.951 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -62.95 -40.94 99.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.592 -1.194 . . . . 0.0 111.996 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD2' HG11 ' A' ' 50' ' ' VAL . 34.6 t80 -56.89 -44.22 82.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.9 1.227 . . . . 0.0 110.986 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.8 m -64.01 -44.51 92.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.601 0.637 . . . . 0.0 111.446 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.28 -58.93 5.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.263 1.025 . . . . 0.0 111.209 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -55.74 140.72 40.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.611 1.565 . . . . 0.0 113.094 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -93.45 -8.99 40.05 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.721 0.808 . . . . 0.0 109.467 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.8 tp -124.68 122.86 38.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 108.185 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.622 HG11 ' CD2' ' A' ' 44' ' ' PHE . 13.3 t -139.93 113.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.9 m -149.81 171.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.404 1.482 . . . . 0.0 109.116 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 111' ' ' LEU . 3.1 p -133.53 141.89 47.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -164.03 161.35 22.56 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.955 -1.091 . . . . 0.0 112.192 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 32.3 m -95.83 128.04 42.37 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.39 113.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 29.3 mmmt -85.48 -41.01 15.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.048 0.939 . . . . 0.0 110.431 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -146.53 165.77 28.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 110.144 -175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.6 mtp -142.46 131.15 22.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.751 2.42 . . . . 0.0 105.265 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.69 157.33 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -67.71 150.01 49.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.211 0.604 . . . . 0.0 109.511 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.9 mm-40 -138.7 171.46 8.17 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 126.768 2.027 . . . . 0.0 109.775 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.14 163.61 22.34 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.569 2.179 . . . . 0.0 112.174 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.26 -151.2 52.25 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.2 9.05 16.17 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.48 171.59 43.59 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 126.58 2.038 . . . . 0.0 117.181 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.95 139.27 17.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.215 2.606 . . . . 0.0 105.171 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -99.39 124.17 44.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.8 123.17 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -98.5 124.6 43.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.31 174.72 6.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.833 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -137.45 46.05 2.16 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.032 1.287 . . . . 0.0 113.753 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.3 mt 36.14 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.502 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 28.3 mm -75.48 -26.83 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.874 -1.767 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.72 163.18 36.96 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.58 148.83 41.57 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.55 -51.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -132.37 124.1 28.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -138.16 61.55 1.59 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.696 1.998 . . . . 0.0 107.519 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 28.01 3.98 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.593 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.13 6.88 0.08 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.266 1.889 . . . . 0.0 114.163 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' HG ' HG11 ' A' ' 116' ' ' VAL . 77.6 mt -114.43 142.12 46.78 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 120.243 2.022 . . . . 0.0 111.136 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.12 72.82 9.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 111.705 -2.498 . . . . 0.0 105.961 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.35 125.18 81.21 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.78 -174.89 2.21 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.287 2.658 . . . . 0.0 112.48 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -49.73 -55.46 23.12 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.937 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.88 115.31 3.9 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 N-CA-C 108.105 -1.537 . . . . 0.0 108.105 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.67 -152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.945 3.763 . . . . 0.0 109.924 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -34.83 124.38 0.55 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.037 2.135 . . . . 0.0 109.547 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.61 -16.98 5.85 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 128.499 2.952 . . . . 0.0 111.734 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.92 154.6 31.5 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.135 1.467 . . . . 0.0 111.112 -175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 82.2 p -100.11 135.78 41.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -130.6 152.86 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.91 2.084 . . . . 0.0 109.495 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -108.17 114.06 27.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -89.74 119.82 30.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -75.74 113.52 13.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.42 114.28 63.43 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 5.21 1.73 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.619 2.879 . . . . 0.0 114.307 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.6 m -145.53 166.69 24.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.875 2.07 . . . . 0.0 109.044 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -123.57 -22.58 4.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.598 1.159 . . . . 0.0 113.307 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.12 -44.83 87.42 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.368 1.067 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.2 m -143.96 162.96 38.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.602 1.561 . . . . 0.0 109.15 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.36 157.39 68.26 Favored 'Cis proline' 0 CA--C 1.538 0.71 0 CA-C-N 119.671 0.918 . . . . 0.0 110.394 -3.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 80.38 1.14 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.236 2.624 . . . . 0.0 111.897 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.0 tpp -94.09 152.99 18.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.492 2.317 . . . . 0.0 107.943 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -137.27 143.23 42.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.96 142.28 52.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.97 62.61 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.53 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.55 155.33 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.744 1.618 . . . . 0.0 108.266 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 8.6 m -97.19 131.28 44.08 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.596 0.758 . . . . 0.0 111.393 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -128.48 170.07 13.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.011 2.125 . . . . 0.0 111.594 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HA ' HG22 ' A' ' 52' ' ' THR . 0.2 OUTLIER -114.73 126.51 54.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 130.395 3.478 . . . . 0.0 102.996 175.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.61 113.97 20.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.524 ' HG2' HG13 ' A' ' 50' ' ' VAL . 5.5 mtm -116.61 113.13 22.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.27 -139.09 2.67 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -134.49 173.04 12.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.451 HG11 ' HG ' ' A' ' 81' ' ' LEU . 2.4 t -133.41 148.29 30.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -116.49 112.81 21.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 174.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.44 78.68 8.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 177.22 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 130.841 3.656 . . . . 0.0 109.801 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -125.98 -32.1 2.81 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.155 1.782 . . . . 0.0 115.011 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.31 -158.13 14.5 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 139.85 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.803 1.669 . . . . 0.0 111.672 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.34 152.93 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.611 HD11 HG21 ' A' ' 130' ' ' VAL . 1.6 tm? -145.79 74.57 13.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.418 -1.426 . . . . 0.0 111.775 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.52 170.4 15.1 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.288 3.325 . . . . 0.0 111.792 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.03 -9.74 26.1 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.077 1.852 . . . . 0.0 113.727 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.28 25.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 m -105.34 137.84 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.37 2.268 . . . . 0.0 109.154 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.38 113.79 21.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.611 HG21 HD11 ' A' ' 124' ' ' LEU . 78.9 t -134.09 116.63 23.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.74 169.21 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.64 . . . . 0.0 108.874 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.0 mt -64.02 138.44 58.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -64.99 128.15 34.58 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -142.82 147.87 43.64 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.479 1.512 . . . . 0.0 107.767 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.38 -38.04 45.63 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.052 2.501 . . . . 0.0 113.704 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -54.56 -49.41 70.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.669 0.747 . . . . 0.0 110.487 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -66.32 -43.75 85.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.804 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.19 -52.24 46.2 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.109 1.364 . . . . 0.0 111.597 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.62 -47.67 84.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.989 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.9 -48.65 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.711 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mt -63.57 -38.08 89.76 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.969 1.259 . . . . 0.0 109.692 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.4 m -61.5 -46.72 88.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -59.31 -43.32 92.65 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.567 -0.708 . . . . 0.0 110.273 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.66 -26.42 67.79 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.326 1.05 . . . . 0.0 112.192 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 -39.44 71.15 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.281 1.032 . . . . 0.0 109.595 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -70.47 -56.61 6.18 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -62.23 163.22 8.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.111 1.364 . . . . 0.0 108.979 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -100.52 152.02 20.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.236 1.014 . . . . 0.0 108.481 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.25 156.91 89.03 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 122.354 0.262 . . . . 0.0 111.051 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.95 102.82 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.314 2.676 . . . . 0.0 109.785 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -140.18 64.19 1.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -141.26 142.79 28.2 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 176.3 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.829 1.686 . . . . 0.0 109.632 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.257 1.47 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.299 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.236 0.361 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -88.81 53.85 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.131 3.221 . . . . 0.0 109.472 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.48 69.33 0.71 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.327 1.537 . . . . 0.0 107.499 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.9 133.56 12.44 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.753 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.73 179.56 6.39 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.514 2.809 . . . . 0.0 110.531 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -75.25 162.53 28.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.3 t -82.8 119.92 75.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.99 169.5 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.286 2.658 . . . . 0.0 111.561 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -68.62 -15.04 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.836 0.854 . . . . 0.0 111.69 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -60.75 153.77 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.988 1.715 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.1 t -147.7 74.17 1.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.899 0.88 . . . . 0.0 109.074 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -156.92 152.96 27.37 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.975 -1.078 . . . . 0.0 108.668 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -92.29 145.49 24.45 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.323 1.049 . . . . 0.0 108.6 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 p -137.59 163.62 30.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.669 0.747 . . . . 0.0 110.926 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.14 171.06 42.35 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.583 1.087 . . . . 0.0 112.389 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.6 p -94.07 159.1 15.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.79 -44.44 93.34 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.081 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -61.48 -43.55 98.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.866 0.757 . . . . 0.0 111.363 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -64.41 -52.33 58.7 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -63.93 -36.03 82.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.958 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' A' ' 50' ' ' VAL . 51.9 t80 -63.65 -33.46 75.67 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.429 1.468 . . . . 0.0 111.317 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.3 -40.65 51.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.315 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -51.17 68.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.388 0.675 . . . . 0.0 110.975 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -60.38 152.73 24.61 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.205 1.402 . . . . 0.0 112.209 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -111.6 -4.02 14.89 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.88 118.47 23.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 44' ' ' PHE . 10.8 t -137.01 113.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.86 172.0 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.186 1.395 . . . . 0.0 109.767 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 111' ' ' LEU . 4.1 p -132.02 140.53 48.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.89 167.23 25.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.097 -1.002 . . . . 0.0 112.355 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.4 m -102.97 126.9 50.33 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 113.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 -44.77 15.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.6 m -146.54 170.9 15.95 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.367 1.067 . . . . 0.0 110.122 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.01 124.57 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.26 2.224 . . . . 0.0 105.667 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.86 148.39 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.294 1.838 . . . . 0.0 107.655 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.84 154.07 38.43 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.849 1.204 . . . . 0.0 109.388 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 72.0 mm-40 -138.49 176.24 2.8 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.205 1.402 . . . . 0.0 109.313 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.07 139.86 14.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.408 2.739 . . . . 0.0 114.493 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.46 -130.48 40.71 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.54 1.543 . . . . 0.0 110.926 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.15 6.98 26.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.159 0.984 . . . . 0.0 110.342 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.54 163.74 51.37 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 123.203 1.446 . . . . 0.0 113.16 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -153.84 131.27 11.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.398 1.879 . . . . 0.0 106.061 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -101.98 138.22 39.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.81 122.98 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -91.77 124.25 35.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.9 172.13 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 111.017 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -138.41 35.96 2.27 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.53 0.605 . . . . 0.0 112.191 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.268 25.1 mt 38.71 80.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.51 -20.7 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.228 1.011 . . . . 0.0 109.052 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -168.17 169.84 41.68 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.079 1.8 . . . . 0.0 110.891 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.38 154.35 42.2 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.199 1.399 . . . . 0.0 108.473 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.545 ' HD2' HG12 ' A' ' 50' ' ' VAL . 26.4 m-85 -136.33 -41.12 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.29 1.036 . . . . 0.0 109.881 175.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -144.51 138.24 27.43 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.48 67.39 1.43 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.19 2.996 . . . . 0.0 106.104 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.51 4.58 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.654 2.073 . . . . 0.0 109.695 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.62 -66.4 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 127.462 2.458 . . . . 0.0 111.02 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.25 128.07 34.59 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.269 0.628 . . . . 0.0 111.885 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.29 85.67 7.18 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.1 147.73 90.05 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 121.156 -0.965 . . . . 0.0 108.54 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.28 170.07 18.08 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -46.31 -55.55 13.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.745 1.218 . . . . 0.0 111.396 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.03 138.03 39.11 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 121.086 1.424 . . . . 0.0 109.356 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.79 -154.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.561 3.507 . . . . 0.0 111.909 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.456 HG21 ' HA2' ' A' ' 74' ' ' GLY . 87.1 m -34.15 137.07 0.11 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.492 2.717 . . . . 0.0 112.499 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.2 64.52 0.43 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -175.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.23 162.89 39.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.009 2.524 . . . . 0.0 106.237 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 p -108.82 157.4 18.62 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.211 -0.931 . . . . 0.0 111.986 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -151.69 169.17 22.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.043 2.137 . . . . 0.0 109.757 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -123.22 114.09 19.8 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.71 120.14 32.8 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -73.94 121.92 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.81 1.244 . . . . 0.0 110.12 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.58 123.95 30.67 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.91 -9.56 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.293 1.995 . . . . 0.0 113.885 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -145.39 158.31 43.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.832 1.653 . . . . 0.0 109.759 -176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.24 -16.76 13.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -66.05 -50.79 62.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.776 1.171 . . . . 0.0 110.651 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -134.86 161.39 63.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.93 1.292 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.94 158.71 81.29 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 O-C-N 122.73 0.858 . . . . 0.0 111.463 -3.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.58 90.6 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.483 2.789 . . . . 0.0 110.949 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.91 138.86 39.89 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 127.061 2.144 . . . . 0.0 111.36 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -133.57 137.63 45.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.033 0.921 . . . . 0.0 110.26 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -68.12 144.49 55.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.439 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.06 24.16 69.78 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.6 t -133.94 152.24 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.094 2.157 . . . . 0.0 107.627 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -98.53 130.9 45.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.074 0.95 . . . . 0.0 109.229 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.47 169.38 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.278 2.231 . . . . 0.0 112.882 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HA ' HG22 ' A' ' 52' ' ' THR . 13.2 tp -115.76 124.21 50.2 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 131.071 3.748 . . . . 0.0 102.017 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.06 113.75 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.482 ' HG2' HG13 ' A' ' 50' ' ' VAL . 11.7 mtm -115.49 112.91 22.96 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 101.454 -3.536 . . . . 0.0 101.454 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.29 -140.89 3.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.473 1.987 . . . . 0.0 110.877 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -138.73 176.89 8.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 t -130.55 132.86 64.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -115.28 114.22 24.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.56 80.12 7.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -173.04 -34.93 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.286 2.635 . . . . 0.0 108.146 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -134.71 -10.95 2.38 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 113.655 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 109.0 -162.66 12.75 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.58 1.086 . . . . 0.0 111.919 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.29 136.83 41.59 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.046 1.83 . . . . 0.0 110.043 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.89 147.87 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 130' ' ' VAL 0.269 1.8 tm? -137.38 73.71 49.21 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -174.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.37 175.09 8.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.493 3.462 . . . . 0.0 111.701 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.6 -17.6 35.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.91 1.74 . . . . 0.0 113.694 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.46 22.37 1.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.567 1.53 . . . . 0.0 111.305 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -98.95 124.54 43.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -76.19 113.87 14.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 124' ' ' LEU . 50.3 t -134.23 114.21 18.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.192 0.52 . . . . 0.0 110.168 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.29 169.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.972 1.309 . . . . 0.0 108.943 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.17 140.47 58.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.609 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.18 139.79 54.59 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -142.63 148.24 45.77 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 126.045 1.738 . . . . 0.0 106.775 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.3 -36.21 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.239 2.626 . . . . 0.0 111.018 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -58.63 -43.7 89.77 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.276 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -66.81 -43.85 82.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.435 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -51.45 -49.56 61.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.648 1.179 . . . . 0.0 111.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -60.79 -46.84 88.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.176 1.391 . . . . 0.0 111.208 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.3 -50.83 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.467 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.03 -33.82 76.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.489 1.04 . . . . 0.0 109.778 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.4 m -62.8 -40.4 97.25 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.784 -0.573 . . . . 0.0 109.541 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -60.78 -42.59 97.83 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.202 -0.936 . . . . 0.0 109.893 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.67 -30.38 71.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.766 0.826 . . . . 0.0 111.338 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.2 t -65.4 -46.74 78.87 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.324 0.966 . . . . 0.0 108.79 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -67.31 -49.99 61.98 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.871 -0.518 . . . . 0.0 110.414 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 mtm-85 -75.93 162.32 28.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.754 0.821 . . . . 0.0 112.906 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -75.89 155.24 35.41 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.9 m -66.96 145.71 98.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 118.915 -0.564 . . . . 0.0 110.925 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 93.42 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.752 1.634 . . . . 0.0 110.613 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -160.85 83.2 0.66 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.912 2.085 . . . . 0.0 108.646 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -113.97 159.03 37.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.03 43.58 1.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.976 1.784 . . . . 0.0 112.131 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.249 1.031 0 C-N-CA 128.786 2.834 . . . . 0.0 103.4 176.456 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.478 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 4.9 p . . . . . 0 CA--C 1.513 -0.463 0 CA-C-O 119.914 -0.089 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.37 125.17 14.02 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 107.89 -1.619 . . . . 0.0 107.89 159.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -66.76 40.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 1 C-N-CA 133.042 4.537 . . . . 0.0 113.664 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 147.77 96.84 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 126.702 2.001 . . . . 0.0 111.411 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.7 -178.06 4.29 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.183 3.256 . . . . 0.0 112.73 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.2 m -58.45 176.12 0.2 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 126.663 1.985 . . . . 0.0 108.406 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.7 t -83.79 128.49 63.18 Favored Pre-proline 0 C--O 1.241 0.621 0 O-C-N 119.765 -1.835 . . . . 0.0 111.374 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.84 173.34 14.64 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.219 3.279 . . . . 0.0 111.042 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.76 -11.45 59.98 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.667 -0.646 . . . . 0.0 110.914 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -57.46 123.28 14.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -146.64 52.07 1.11 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.55 0.691 . . . . 0.0 109.261 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -144.87 161.44 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.59 1.956 . . . . 0.0 106.169 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -106.56 147.54 29.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.459 2.304 . . . . 0.0 105.882 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -140.79 176.31 8.9 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.686 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.32 169.85 38.36 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.488 1.518 . . . . 0.0 113.954 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -84.06 155.99 22.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 108.525 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.05 -47.41 80.3 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -62.72 -50.07 72.55 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.364 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.4 m -65.97 -40.23 91.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.486 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -63.44 -47.04 83.55 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.142 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.564 ' CD2' HG11 ' A' ' 50' ' ' VAL . 12.1 t80 -52.17 -42.75 63.7 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.51 1.504 . . . . 0.0 110.535 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -63.22 -46.27 87.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.154 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.55 88.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.568 0.747 . . . . 0.0 112.946 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 p -76.15 131.16 39.21 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.884 1.274 . . . . 0.0 111.817 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -88.81 -6.71 57.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.706 0.803 . . . . 0.0 108.929 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.486 ' HB2' HG23 ' A' ' 116' ' ' VAL . 27.8 tp -118.03 114.7 23.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.732 2.413 . . . . 0.0 109.134 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 44' ' ' PHE . 23.4 t -139.59 113.5 6.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.14 168.52 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.19 1.396 . . . . 0.0 108.524 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 111' ' ' LEU . 2.9 p -134.23 140.99 46.85 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.58 170.58 18.34 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.421 -0.8 . . . . 0.0 111.205 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -109.28 133.94 52.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.51 114.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.314 0.645 . . . . 0.0 109.602 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -77.72 -53.08 7.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -141.22 168.31 20.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.877 1.271 . . . . 0.0 110.739 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.73 141.58 34.89 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 128.02 2.528 . . . . 0.0 105.846 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t -141.87 146.15 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -73.59 139.4 45.51 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 120.203 -1.561 . . . . 0.0 108.921 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 45.4 mm-40 -117.74 169.0 8.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 125.662 1.585 . . . . 0.0 108.642 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.39 152.82 24.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.254 2.636 . . . . 0.0 115.548 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.26 -125.91 39.14 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.0 tp10 -89.25 9.66 25.03 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.616 0.766 . . . . 0.0 111.274 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.64 171.32 49.25 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.27 139.15 18.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.468 3.107 . . . . 0.0 106.528 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -103.71 152.16 22.15 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.691 1.196 . . . . 0.0 108.567 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.63 123.43 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -97.67 126.6 43.08 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.36 172.7 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.194 0.998 . . . . 0.0 110.189 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -128.1 36.38 4.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.306 17.4 mt 40.16 80.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.694 2.398 . . . . 0.0 115.511 174.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.9 mm -78.02 -28.43 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 119.077 0.853 . . . . 0.0 109.815 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -159.1 157.43 28.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.92 138.7 35.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -132.42 -31.74 1.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.301 -175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -151.69 125.82 9.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -143.71 67.29 1.28 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.376 2.27 . . . . 0.0 109.693 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.65 46.01 3.57 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.948 1.261 . . . . 0.0 110.833 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.27 -48.97 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 126.05 1.786 . . . . 0.0 111.072 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.75 124.14 21.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 117.451 0.625 . . . . 0.0 109.336 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -78.47 64.82 3.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 129.108 2.963 . . . . 0.0 108.375 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.7 mt -57.98 123.64 65.36 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.39 -174.74 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.402 2.735 . . . . 0.0 111.55 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -49.46 -53.55 39.31 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.16 -1.4 . . . . 0.0 110.663 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.22 133.49 24.83 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 121.72 1.65 . . . . 0.0 107.965 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.51 -153.82 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.083 3.189 . . . . 0.0 110.96 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.411 HG21 ' HA2' ' A' ' 74' ' ' GLY . 52.3 m -34.87 131.28 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.584 2.754 . . . . 0.0 111.145 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.7 14.72 1.86 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 125.196 1.379 . . . . 0.0 112.573 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.37 53.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.213 1.506 . . . . 0.0 107.718 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.5 p -76.66 137.21 39.28 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.686 -0.634 . . . . 0.0 110.354 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.91 160.9 36.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.425 0.69 . . . . 0.0 111.194 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -124.17 113.63 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.699 2.0 . . . . 0.0 107.709 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -97.18 121.84 39.51 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.404 ' HB3' HG23 ' A' ' 123' ' ' VAL . 43.3 t80 -78.06 113.63 16.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.06 114.16 64.68 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.41 6.08 3.34 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.378 2.718 . . . . 0.0 113.119 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.0 m -135.97 151.09 49.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.411 2.284 . . . . 0.0 108.486 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -117.24 -5.74 11.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.502 0.721 . . . . 0.0 109.707 175.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -71.32 -58.3 3.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.435 2.694 . . . . 0.0 109.354 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -143.91 165.99 21.56 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 129.224 3.01 . . . . 0.0 110.9 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.2 152.52 98.34 Favored 'Cis proline' 0 CA--C 1.544 0.99 0 CA-C-N 119.671 0.918 . . . . 0.0 112.489 -2.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.37 112.32 2.54 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.839 3.026 . . . . 0.0 110.741 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.4 ttp -138.18 163.45 31.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -144.57 150.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.058 0.943 . . . . 0.0 110.047 -176.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.09 146.87 52.21 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.09 33.02 84.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.743 0.687 . . . . 0.0 113.993 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.7 154.87 32.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 119.089 1.445 . . . . 0.0 107.234 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 m -103.32 131.55 50.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.733 1.213 . . . . 0.0 111.704 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.95 175.65 9.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.117 0.967 . . . . 0.0 113.518 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 52' ' ' THR . 11.5 tp -113.01 128.13 56.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 130.799 3.64 . . . . 0.0 103.774 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.13 114.28 22.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.9 mtm -117.76 113.15 21.41 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.53 -137.55 2.39 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.475 1.512 . . . . 0.0 111.005 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -132.3 176.15 8.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.544 1.172 . . . . 0.0 110.9 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 49' ' ' LEU . 21.3 t -130.21 139.81 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 121.117 -0.989 . . . . 0.0 109.275 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' OE2' ' HA ' ' A' ' 24' ' ' SER . 19.2 mm-40 -103.36 112.84 25.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.58 63.55 6.78 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -157.55 -42.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 129.393 3.077 . . . . 0.0 108.223 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -142.88 -11.53 0.77 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.67 -163.52 13.12 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.589 1.086 . . . . 0.0 111.727 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.32 141.36 51.37 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.273 1.982 . . . . 0.0 113.202 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -122.94 128.7 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.423 HD11 HG21 ' A' ' 130' ' ' VAL . 2.0 tm? -120.59 79.65 30.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.53 1.532 . . . . 0.0 110.529 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.13 173.63 8.18 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.659 3.573 . . . . 0.0 113.072 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.19 -22.27 73.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.013 1.809 . . . . 0.0 113.249 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -83.6 23.12 0.99 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.258 0.936 . . . . 0.0 111.12 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.5 m -95.92 134.19 39.21 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.632 1.173 . . . . 0.0 110.424 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.32 113.44 17.46 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.423 HG21 HD11 ' A' ' 124' ' ' LEU . 79.1 t -134.81 114.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 123.192 0.597 . . . . 0.0 110.502 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 m -147.26 169.81 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.518 1.527 . . . . 0.0 110.27 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.12 147.28 52.6 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.546 0.738 . . . . 0.0 109.831 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -75.12 137.84 41.66 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -143.61 142.8 21.62 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 107.977 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.55 -38.89 65.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.913 3.075 . . . . 0.0 116.283 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -65.77 -47.68 74.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.792 0.723 . . . . 0.0 110.251 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -58.13 -45.33 87.53 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.84 -0.538 . . . . 0.0 110.013 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -49.63 -55.44 13.63 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.908 1.683 . . . . 0.0 109.632 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -58.19 -43.38 87.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.183 0.993 . . . . 0.0 111.684 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.46 -46.68 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.931 0.787 . . . . 0.0 109.4 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -37.71 85.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.486 1.039 . . . . 0.0 109.079 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 78.9 m -59.99 -38.97 84.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.311 0.96 . . . . 0.0 109.499 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -62.72 -42.73 99.8 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.41 -0.806 . . . . 0.0 110.037 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.8 mt -69.35 -23.56 63.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.683 1.193 . . . . 0.0 112.428 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.4 t -72.63 -33.31 66.54 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.01 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -76.26 -65.59 0.9 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.366 1.466 . . . . 0.0 110.273 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -74.97 147.3 40.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.7 1.2 . . . . 0.0 110.831 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -76.86 166.45 23.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 23.3 m -88.47 122.98 69.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.18 93.46 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 N-CA-C 108.195 -1.502 . . . . 0.0 108.195 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.02 84.4 0.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -113.21 132.64 22.33 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.5 172.7 15.82 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.159 2.573 . . . . 0.0 110.434 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--O 1.247 0.942 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 176.15 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.32 164.44 26.58 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.542 2.828 . . . . 0.0 112.189 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -83.1 70.39 10.04 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.385 1.874 . . . . 0.0 111.796 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.52 140.14 96.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.502 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.25 171.38 14.01 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.746 2.297 . . . . 0.0 110.962 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.5 m -58.17 158.95 6.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.248 1.023 . . . . 0.0 110.557 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 t -97.22 102.81 13.35 Favored Pre-proline 0 C--O 1.239 0.544 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.46 166.6 23.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.634 2.223 . . . . 0.0 110.004 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -15.34 59.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -63.57 164.05 10.16 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.624 1.97 . . . . 0.0 110.182 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.6 t -139.54 104.96 5.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.835 1.254 . . . . 0.0 109.125 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -148.08 166.11 28.79 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -135.56 148.48 49.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -134.28 176.58 8.47 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.91 1.684 . . . . 0.0 111.695 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 -158.82 53.72 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 p -123.18 176.37 6.12 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.526 1.13 . . . . 0.0 108.043 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.6 -49.0 70.37 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -60.9 -46.28 91.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.921 0.488 . . . . 0.0 110.803 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m -62.56 -48.62 78.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.87 0.468 . . . . 0.0 110.319 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.17 -37.27 86.87 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.591 ' CD2' HG11 ' A' ' 50' ' ' VAL . 24.2 t80 -57.13 -40.78 77.82 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.298 1.408 . . . . 0.0 110.265 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.91 -33.76 66.18 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.513 -0.742 . . . . 0.0 111.861 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.13 66.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.164 0.986 . . . . 0.0 113.043 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -76.05 147.3 38.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 111.133 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.4 t -93.77 -11.51 31.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.299 0.64 . . . . 0.0 109.368 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.422 HD21 ' CE2' ' A' ' 94' ' ' PHE . 28.8 tp -127.26 120.08 27.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.073 1.349 . . . . 0.0 108.261 -175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 44' ' ' PHE . 26.7 t -138.86 113.89 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -148.11 172.17 2.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.034 1.334 . . . . 0.0 109.326 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.9 p -130.99 143.21 50.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.627 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -159.87 171.64 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.224 -0.923 . . . . 0.0 111.162 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.4 m -120.69 132.49 55.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 113.68 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 26.4 mmmt -80.98 -51.62 8.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -140.16 168.02 20.78 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 41.6 mtp -137.13 123.78 21.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 100.669 -3.826 . . . . 0.0 100.669 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 t -124.07 145.45 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.52 151.5 37.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.892 0.769 . . . . 0.0 109.446 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 6.1 mm-40 -135.86 173.14 6.01 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 106.726 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.29 136.71 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.379 2.719 . . . . 0.0 115.24 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.5 -123.78 34.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.525 1.536 . . . . 0.0 111.028 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.55 1.88 15.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.931 0.892 . . . . 0.0 112.084 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.88 158.35 51.71 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 122.857 1.254 . . . . 0.0 114.449 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -150.19 137.88 19.94 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.809 2.044 . . . . 0.0 105.827 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -107.16 123.31 48.08 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.45 123.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.3 m -98.07 124.2 42.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.627 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 17.8 m -126.9 176.16 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.822 0.849 . . . . 0.0 110.072 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -135.34 44.01 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.293 67.4 mt 39.49 81.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.1 mm -79.07 -28.18 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 120.004 1.274 . . . . 0.0 112.6 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -157.22 158.62 29.06 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 176.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.51 140.05 33.4 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.68 1.192 . . . . 0.0 108.332 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -137.13 -30.88 0.84 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.519 0.728 . . . . 0.0 111.391 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -151.85 127.32 10.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.9 p -140.31 59.55 1.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.463 2.705 . . . . 0.0 107.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.92 45.99 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.853 1.216 . . . . 0.0 110.746 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.27 -43.18 0.04 OUTLIER Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.92 3.153 . . . . 0.0 111.459 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.23 128.19 34.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.107 0.956 . . . . 0.0 113.302 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -81.9 75.78 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 mt -58.71 150.23 59.12 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.114 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.58 175.27 4.46 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.114 1.209 . . . . 0.0 109.684 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -49.14 -62.29 2.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.738 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.98 153.2 37.05 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 121.186 1.459 . . . . 0.0 109.99 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.53 -155.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.815 4.343 . . . . 0.0 112.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.416 HG21 ' HA2' ' A' ' 74' ' ' GLY . 85.3 m -33.26 124.75 0.39 Allowed 'General case' 0 C--O 1.253 1.249 0 C-N-CA 130.149 3.38 . . . . 0.0 114.414 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.42 56.04 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.83 2.157 . . . . 0.0 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.58 154.48 37.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.845 1.258 . . . . 0.0 107.956 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.8 p -86.62 151.82 23.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.627 0.727 . . . . 0.0 111.405 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.3 mt -152.58 152.8 32.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.326 1.851 . . . . 0.0 108.092 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -112.94 113.22 25.18 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.3 m-85 -84.95 119.7 25.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -77.14 113.11 14.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.7 113.38 62.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.42 -12.39 25.0 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.708 1.605 . . . . 0.0 113.834 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.5 m -141.83 119.16 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.267 1.427 . . . . 0.0 107.429 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -5.57 47.9 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.04 -1.038 . . . . 0.0 111.192 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -59.46 -58.15 9.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.74 1.216 . . . . 0.0 110.696 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.8 m -152.3 163.78 22.44 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.286 2.234 . . . . 0.0 110.032 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.8 161.7 71.42 Favored 'Cis proline' 0 CA--C 1.545 1.07 0 CA-C-N 119.779 0.957 . . . . 0.0 113.556 1.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.81 133.84 37.96 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.48 2.787 . . . . 0.0 112.206 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.3 ttm -149.65 167.16 27.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.873 0.869 . . . . 0.0 111.613 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -150.73 147.65 27.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.962 2.505 . . . . 0.0 107.386 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -69.22 149.42 48.58 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.24 41.81 99.49 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.08 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.74 149.83 25.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -94.41 136.37 34.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.372 1.069 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.08 175.79 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.763 2.025 . . . . 0.0 112.868 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.11 123.98 43.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 131.07 3.748 . . . . 0.0 101.343 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.83 115.13 22.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.365 1.466 . . . . 0.0 107.979 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.496 ' HG2' HG13 ' A' ' 50' ' ' VAL . 18.1 mtm -117.37 113.17 21.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 175.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.96 -139.94 2.99 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.354 1.454 . . . . 0.0 112.079 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -132.6 175.35 9.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.836 -1.391 . . . . 0.0 111.344 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.89 145.45 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -127.76 114.66 17.56 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.28 63.8 0.37 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.388 1.475 . . . . 0.0 114.874 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 170.29 -22.27 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 1 C-N-CA 132.361 4.264 . . . . 0.0 111.81 175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.22 -4.6 13.72 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.421 1.088 . . . . 0.0 110.718 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.78 -154.75 50.34 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 124.467 1.032 . . . . 0.0 113.162 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 126.59 11.7 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.025 2.483 . . . . 0.0 110.53 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.266 2.7 p -116.78 127.99 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.56 79.52 29.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.412 1.485 . . . . 0.0 109.586 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.96 170.58 13.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.422 3.415 . . . . 0.0 112.708 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.46 -26.31 70.45 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.411 2.074 . . . . 0.0 114.033 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -86.74 23.58 1.66 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.846 1.258 . . . . 0.0 111.208 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -83.37 142.34 31.1 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 108.305 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -82.94 114.05 20.96 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -135.94 119.87 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.16 0.584 . . . . 0.0 110.151 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.3 m -144.75 167.01 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.306 1.443 . . . . 0.0 108.662 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.51 149.31 48.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 110.266 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -69.25 131.5 44.98 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.915 0.886 . . . . 0.0 109.021 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -141.08 147.75 48.93 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.54 -37.85 55.72 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.539 2.826 . . . . 0.0 114.753 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -59.77 -49.23 78.52 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -58.08 -46.89 84.71 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.009 0.923 . . . . 0.0 109.433 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -51.76 -50.45 60.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 109.987 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -63.69 -42.45 97.99 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.634 -0.666 . . . . 0.0 111.847 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.64 -50.76 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.062 0.846 . . . . 0.0 109.347 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.84 -32.17 73.54 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.793 0.724 . . . . 0.0 109.368 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.47 -41.79 88.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.524 0.602 . . . . 0.0 110.121 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.18 -47.16 85.73 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 109.433 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.29 -24.23 66.52 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.491 1.116 . . . . 0.0 112.127 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -69.75 -55.99 8.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 0.0 109.858 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -72.48 -39.51 67.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.858 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -75.54 164.15 26.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.587 0.755 . . . . 0.0 110.426 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.41 156.63 19.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 17.8 m -64.05 148.4 95.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 111.761 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.55 97.4 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.009 3.139 . . . . 0.0 109.526 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.1 m -153.13 75.3 1.07 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.591 0.756 . . . . 0.0 110.082 -176.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -117.67 113.91 38.05 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -85.2 174.96 6.77 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.923 3.082 . . . . 0.0 113.884 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 C--O 1.249 1.074 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 175.604 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.27 166.88 19.88 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.57 2.18 . . . . 0.0 111.878 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -84.66 44.53 1.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.759 . . . . 0.0 112.283 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.03 115.68 9.58 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.896 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.64 158.33 35.76 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.262 2.641 . . . . 0.0 114.582 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -64.53 162.5 15.29 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.172 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.28 115.6 59.99 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -70.17 154.29 66.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 N-CA-C 106.571 -2.126 . . . . 0.0 106.571 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -68.3 -46.27 70.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.068 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.55 165.6 16.54 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 t -134.25 117.19 16.17 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.542 -1.349 . . . . 0.0 108.434 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -155.09 166.04 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.468 2.307 . . . . 0.0 111.32 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -116.92 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.796 2.038 . . . . 0.0 106.84 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.5 p -142.19 176.49 8.93 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.458 1.503 . . . . 0.0 107.963 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.58 -164.55 54.64 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -124.9 163.61 21.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.04 -43.97 93.94 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.53 -48.12 80.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.581 0.628 . . . . 0.0 111.059 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.4 m -61.68 -50.61 71.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.502 0.592 . . . . 0.0 110.177 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -59.63 -44.84 93.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.853 -1.546 . . . . 0.0 110.37 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 50' ' ' VAL . 22.4 t80 -52.5 -51.22 60.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.098 1.317 . . . . 0.0 111.042 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.4 m -64.42 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.845 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.01 -60.4 2.52 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.007 0.523 . . . . 0.0 111.703 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 p -53.17 124.68 15.13 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.879 0.871 . . . . 0.0 110.931 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -81.99 -4.84 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.383 0.992 . . . . 0.0 109.51 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.455 HD21 ' HE2' ' A' ' 94' ' ' PHE . 34.1 tp -118.33 120.84 38.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.138 2.175 . . . . 0.0 108.658 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 44' ' ' PHE . 38.4 t -144.05 113.59 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -149.38 167.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.365 1.466 . . . . 0.0 108.704 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -127.01 140.61 52.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -157.83 168.17 27.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.787 -1.196 . . . . 0.0 111.379 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -114.87 130.85 56.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.53 113.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -71.42 -50.49 31.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 m -157.22 168.96 25.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.377 1.471 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.6 mtp -137.33 133.87 35.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.022 2.129 . . . . 0.0 108.033 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -136.66 148.02 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.901 1.28 . . . . 0.0 107.833 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -75.43 145.97 41.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.613 1.097 . . . . 0.0 109.701 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.506 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.2 mm-40 -123.27 171.08 7.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 127.102 2.161 . . . . 0.0 111.726 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.3 153.38 34.13 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.181 2.587 . . . . 0.0 113.361 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.89 -124.19 6.91 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.4 23.94 11.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.482 1.113 . . . . 0.0 108.46 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.52 179.57 53.08 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.836 1.798 . . . . 0.0 117.374 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -150.62 136.11 17.99 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.988 2.115 . . . . 0.0 107.037 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.506 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -102.69 123.59 46.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 175.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.03 123.22 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -99.78 125.22 45.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 3.6 m -131.91 174.49 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.369 0.667 . . . . 0.0 109.813 -175.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -132.17 41.56 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt 38.24 80.58 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.242 2.217 . . . . 0.0 115.918 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -77.11 -24.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.406 0.682 . . . . 0.0 112.201 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.07 162.74 34.96 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 126.145 1.831 . . . . 0.0 109.209 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 150.2 32.23 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.535 1.134 . . . . 0.0 108.827 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -143.22 -49.6 0.33 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.139 0.899 . . . . 0.0 111.879 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -131.98 123.68 27.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -141.18 65.37 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.71 2.404 . . . . 0.0 109.253 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.07 42.46 3.15 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.871 1.7 . . . . 0.0 110.929 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.76 -66.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 125.699 1.618 . . . . 0.0 110.601 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 mt -71.04 130.49 41.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.195 0.521 . . . . 0.0 111.728 -175.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -84.88 80.04 9.42 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.3 mt -58.91 139.15 87.15 Favored Pre-proline 0 C--O 1.238 0.455 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.46 174.07 12.18 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 120.971 1.114 . . . . 0.0 111.165 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 t -44.92 -59.71 3.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 116.514 -1.707 . . . . 0.0 110.004 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.78 118.59 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.963 1.775 . . . . 0.0 108.836 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.75 -152.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 124.005 3.137 . . . . 0.0 112.803 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.4 m -35.84 124.59 0.71 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.487 2.715 . . . . 0.0 113.206 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.95 30.06 0.44 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.9 1.714 . . . . 0.0 114.174 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.04 158.86 32.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.032 1.333 . . . . 0.0 108.808 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.1 p -98.54 153.68 18.46 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.193 -0.942 . . . . 0.0 112.155 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.0 mt -148.71 162.38 39.86 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.076 1.75 . . . . 0.0 109.458 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -126.11 114.04 17.86 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.906 1.682 . . . . 0.0 107.163 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HE2' HD21 ' A' ' 49' ' ' LEU . 32.9 m-85 -96.63 121.2 38.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.451 1.101 . . . . 0.0 110.15 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.31 113.73 18.7 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 124.155 0.909 . . . . 0.0 110.435 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.9 123.75 38.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -6.96 15.54 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.461 2.774 . . . . 0.0 115.536 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.0 m -137.42 121.03 17.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 127.708 2.403 . . . . 0.0 107.051 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.09 61.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -82.49 -30.34 29.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.028 1.285 . . . . 0.0 114.417 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -136.66 155.76 76.56 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.038 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.65 165.88 71.93 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.395 1.177 . . . . 0.0 112.064 2.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.82 104.36 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.934 2.423 . . . . 0.0 109.274 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.2 ttt -139.35 163.74 31.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.529 1.132 . . . . 0.0 109.283 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -143.56 153.89 43.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -75.49 142.08 42.95 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.73 21.98 67.62 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.055 1.312 . . . . 0.0 114.36 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.3 t -134.11 156.69 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.285 1.434 . . . . 0.0 109.485 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 132.71 40.72 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.821 1.648 . . . . 0.0 111.717 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -139.61 168.5 19.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.27 1.828 . . . . 0.0 111.712 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.6 tp -108.31 129.23 55.23 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 129.306 3.042 . . . . 0.0 102.86 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.0 114.07 22.6 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.5 mtm -119.33 113.01 20.16 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.02 -134.05 1.66 Allowed Glycine 0 CA--C 1.526 0.778 0 CA-C-N 120.112 1.323 . . . . 0.0 112.225 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -134.84 172.02 13.57 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.97 0.885 . . . . 0.0 112.015 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 49' ' ' LEU . 4.8 t -133.16 140.15 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.397 -0.815 . . . . 0.0 110.337 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -121.57 115.41 22.76 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.869 2.067 . . . . 0.0 111.624 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -71.82 63.69 0.46 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.07 2.548 . . . . 0.0 112.428 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.2 t30 163.39 -22.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 1 C-N-CA 134.041 4.936 . . . . 0.0 114.084 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -113.5 -4.83 13.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.29 1.036 . . . . 0.0 113.023 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.37 -162.38 49.43 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 91.3 Cg_endo -73.78 143.32 33.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 118.63 1.215 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.22 126.83 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 130' ' ' VAL . 2.2 tm? -120.28 78.4 26.63 Favored Pre-proline 0 C--N 1.325 -0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 109.972 -174.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.27 164.42 28.18 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.686 2.924 . . . . 0.0 110.946 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.05 -18.06 56.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.094 1.863 . . . . 0.0 114.707 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -84.13 22.85 1.13 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.443 1.019 . . . . 0.0 110.771 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.0 m -88.7 137.43 32.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.519 1.527 . . . . 0.0 107.25 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -78.79 113.62 17.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 124' ' ' LEU . 99.3 t -136.76 116.67 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.23 170.21 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.924 1.29 . . . . 0.0 109.615 -175.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.08 132.16 49.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.15 0.98 . . . . 0.0 108.825 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 138.19 57.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -133.8 160.02 70.18 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.488 1.915 . . . . 0.0 107.035 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.02 -42.92 2.74 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.928 2.419 . . . . 0.0 110.415 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -58.53 -41.58 85.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.61 0.764 . . . . 0.0 111.252 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.21 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -57.24 -50.01 74.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.284 1.033 . . . . 0.0 110.294 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.3 -34.83 78.54 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.972 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.87 -47.61 75.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.511 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -61.39 -39.06 89.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.501 1.501 . . . . 0.0 108.973 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.5 m -61.09 -47.03 88.2 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -57.33 -46.38 83.31 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.875 0.87 . . . . 0.0 109.466 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.57 -33.78 76.35 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.071 0.948 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -69.38 -49.39 55.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -68.61 -36.6 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.82 0.848 . . . . 0.0 111.564 -175.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -76.71 176.51 8.37 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 127.278 2.231 . . . . 0.0 110.355 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -98.11 145.1 26.9 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 33.1 m -69.52 159.05 85.25 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.13 106.19 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.285 2.657 . . . . 0.0 108.736 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 t -146.36 56.09 1.16 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -116.68 113.36 40.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -102.54 145.68 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.944 2.43 . . . . 0.0 108.862 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.261 1.677 0 C-N-CA 128.994 2.918 . . . . 0.0 103.524 175.623 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -85.08 61.02 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.221 2.614 . . . . 0.0 112.608 -171.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -141.54 59.54 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 123.49 1.614 . . . . 0.0 112.23 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.51 6.78 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 108.421 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.56 -172.22 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.967 3.778 . . . . 0.0 110.73 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 m -50.04 153.92 1.26 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.215 1.406 . . . . 0.0 110.201 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.5 t -86.19 127.45 61.52 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.52 174.33 11.81 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.616 2.877 . . . . 0.0 112.959 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -21.04 55.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.094 0.958 . . . . 0.0 112.712 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.59 131.42 50.88 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.645 0.657 . . . . 0.0 109.612 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 t -152.24 79.12 1.24 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.664 0.745 . . . . 0.0 109.697 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -133.71 157.53 45.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.009 1.724 . . . . 0.0 106.576 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -107.56 152.64 23.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -133.84 174.02 10.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.746 0.818 . . . . 0.0 109.236 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.14 -154.2 41.08 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 123.98 0.8 . . . . 0.0 111.366 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.7 p -127.84 168.58 14.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.868 0.867 . . . . 0.0 108.837 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.82 -41.35 97.89 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.41 -43.97 88.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.01 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -66.48 -51.15 59.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.846 0.748 . . . . 0.0 111.033 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -52.34 -44.66 65.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.609 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 50' ' ' VAL . 23.9 t80 -52.41 -42.34 63.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.491 0.716 . . . . 0.0 112.704 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.1 m -75.82 -33.81 60.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -38.68 86.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.181 0.9 . . . . 0.0 111.713 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -68.36 130.58 43.31 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.454 0.701 . . . . 0.0 111.066 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -81.95 -8.14 59.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.865 0.866 . . . . 0.0 109.99 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.93 123.37 24.54 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.971 1.708 . . . . 0.0 107.998 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 44' ' ' PHE . 39.4 t -136.41 116.97 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.6 169.49 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 110.103 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -128.84 137.65 51.6 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -151.75 171.01 18.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.834 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -117.59 126.28 52.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.18 113.55 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -80.82 -52.48 7.45 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 9.6 m -145.11 171.42 14.53 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 125.418 1.487 . . . . 0.0 109.795 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.406 ' HB3' HD21 ' A' ' 66' ' ' LEU . 24.6 mtp -133.76 134.8 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.79 143.82 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -175.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -70.92 137.0 48.89 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.515 -1.365 . . . . 0.0 108.234 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.545 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.5 mm-40 -114.71 168.84 7.41 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.8 1.64 . . . . 0.0 108.86 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.37 161.52 20.01 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.331 2.02 . . . . 0.0 112.273 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -145.01 49.19 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.731 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -88.73 14.2 10.69 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.554 -0.968 . . . . 0.0 110.619 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.19 177.22 53.05 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.106 1.336 . . . . 0.0 115.588 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 58' ' ' MET . 2.2 tm? -152.76 140.19 19.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.73 2.812 . . . . 0.0 106.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.545 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -100.83 145.02 29.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.23 123.25 71.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -101.63 129.86 47.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.697 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 30.5 m -138.22 176.36 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.883 0.873 . . . . 0.0 111.48 -175.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -131.36 39.52 3.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.912 1.285 . . . . 0.0 112.185 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt 36.42 81.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.281 2.232 . . . . 0.0 115.553 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.4 mm -74.52 -32.48 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.504 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.13 161.96 31.92 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.023 1.296 . . . . 0.0 110.242 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.49 152.74 40.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.67 1.588 . . . . 0.0 108.053 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -139.79 -24.42 0.84 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.643 0.589 . . . . 0.0 112.379 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -157.99 138.86 13.11 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.826 2.05 . . . . 0.0 106.117 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -146.85 72.38 1.27 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.214 3.006 . . . . 0.0 105.74 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 50.07 4.34 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 126.618 2.056 . . . . 0.0 109.353 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.19 -70.74 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 126.088 1.804 . . . . 0.0 113.302 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.5 131.73 51.66 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.275 1.03 . . . . 0.0 111.425 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -82.27 89.18 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.32 139.79 96.46 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.24 -175.87 1.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.529 2.153 . . . . 0.0 112.07 -175.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 t -42.83 -58.8 3.51 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.853 1.661 . . . . 0.0 109.215 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.07 147.56 21.04 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 N-CA-C 107.095 -1.925 . . . . 0.0 107.095 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.75 -154.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 1 C-N-CA 126.141 4.561 . . . . 0.0 111.665 175.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.565 HG21 ' HA2' ' A' ' 74' ' ' GLY . 4.4 m -34.01 139.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.953 2.501 . . . . 0.0 113.311 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.52 -1.27 3.98 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.088 2.28 . . . . 0.0 114.496 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.32 148.55 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.351 1.576 . . . . 0.0 108.579 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 p -77.29 149.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.184 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -147.34 161.03 41.83 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.94 0.896 . . . . 0.0 110.034 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -127.42 116.93 21.21 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.93 124.59 42.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.231 1.012 . . . . 0.0 109.499 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.452 ' HB3' HG23 ' A' ' 123' ' ' VAL . 28.5 t80 -74.06 114.02 11.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.733 1.213 . . . . 0.0 109.775 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.09 115.61 58.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.43 1.24 6.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 95.1 m -132.02 113.63 13.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.744 1.217 . . . . 0.0 109.204 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.98 -12.5 59.37 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.734 -0.604 . . . . 0.0 112.287 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.55 -35.83 24.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 113.753 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -157.16 163.04 26.34 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.564 1.946 . . . . 0.0 110.003 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.37 153.31 81.91 Favored 'Cis proline' 0 CA--C 1.541 0.871 0 O-C-N 122.626 0.803 . . . . 0.0 111.29 -3.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.7 122.47 8.58 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.229 2.619 . . . . 0.0 111.808 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 13.1 ttp -145.8 160.51 41.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.409 1.883 . . . . 0.0 108.685 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -134.48 145.42 48.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 85.5 tttt -64.02 142.71 58.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.17 35.33 77.4 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.044 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.8 t -140.83 159.3 23.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.926 2.09 . . . . 0.0 107.5 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -101.43 133.65 45.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.38 1.072 . . . . 0.0 111.502 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 104' ' ' MET . 45.7 m-85 -137.21 165.4 26.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.629 1.572 . . . . 0.0 111.303 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 124.63 51.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 129.942 3.297 . . . . 0.0 103.522 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.17 119.55 32.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.836 1.654 . . . . 0.0 107.524 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.0 mtm -120.68 113.25 19.94 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.14 -137.7 2.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.109 1.814 . . . . 0.0 111.525 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -136.63 176.49 8.65 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.172 1.389 . . . . 0.0 108.689 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.3 132.01 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.14 113.84 27.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -80.07 63.56 4.62 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.52 -42.47 0.05 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 128.484 2.714 . . . . 0.0 110.452 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -126.24 -4.32 6.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.25 1.02 . . . . 0.0 113.118 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.59 -151.77 18.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.77 137.31 29.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.821 1.681 . . . . 0.0 110.013 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.6 p -119.99 153.06 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.54 80.18 39.26 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -62.15 171.0 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.997 3.798 . . . . 0.0 113.624 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.55 -19.11 64.76 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.756 1.637 . . . . 0.0 113.195 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.6 23.19 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.117 1.367 . . . . 0.0 112.942 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 129.69 35.08 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.821 -0.549 . . . . 0.0 110.135 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -80.57 115.48 20.1 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.5 117.49 35.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 123.735 0.814 . . . . 0.0 109.194 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.8 m -145.49 167.34 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 109.52 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.79 136.54 57.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.444 0.698 . . . . 0.0 110.7 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -67.25 144.35 55.98 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.233 0.613 . . . . 0.0 109.898 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 150.3 29.88 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 127.585 2.354 . . . . 0.0 107.481 175.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.84 -34.26 31.1 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.593 2.195 . . . . 0.0 111.401 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -61.58 -43.09 99.5 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.023 -0.423 . . . . 0.0 111.087 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.32 -41.91 76.05 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.415 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -48.15 -55.93 9.13 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.749 1.22 . . . . 0.0 109.911 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -55.41 -44.11 75.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.687 1.595 . . . . 0.0 111.905 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.54 -49.21 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.004 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.22 -41.03 99.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.012 0.824 . . . . 0.0 108.977 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -59.43 -43.57 93.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.921 0.888 . . . . 0.0 110.639 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.25 -40.54 86.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.81 -33.37 75.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.742 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -66.11 -35.7 81.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.519 1.128 . . . . 0.0 111.028 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -75.88 -40.65 54.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 120.855 -1.153 . . . . 0.0 109.344 175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -69.35 176.36 3.41 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.605 1.193 . . . . 0.0 109.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -136.0 137.99 41.79 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.811 2.444 . . . . 0.0 104.792 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 18.1 m -68.14 147.58 98.34 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.237 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.27 100.7 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.315 2.677 . . . . 0.0 108.28 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.3 m -145.34 73.11 1.34 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.824 1.249 . . . . 0.0 107.872 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.49 113.1 48.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -101.46 -161.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.172 3.248 . . . . 0.0 108.092 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.246 0.876 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 175.158 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.7 p . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.452 0.644 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.33 -47.24 74.14 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.129 -0.938 . . . . 0.0 108.996 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -61.67 -48.11 82.29 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.322 0.965 . . . . 0.0 111.169 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -49.86 -56.75 9.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.719 0.808 . . . . 0.0 110.481 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -68.66 -40.48 80.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.789 -1.577 . . . . 0.0 111.898 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD2' HG11 ' A' ' 50' ' ' VAL . 42.4 t80 -54.61 -46.4 73.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.435 1.47 . . . . 0.0 110.617 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.7 m -71.88 -24.27 61.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.834 0.854 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.39 18.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -62.93 132.43 52.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 111.993 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -82.93 -8.16 59.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.523 0.729 . . . . 0.0 110.657 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.3 tp -134.83 124.48 25.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.457 1.503 . . . . 0.0 108.122 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG11 ' CD2' ' A' ' 44' ' ' PHE . 17.3 t -137.83 115.36 12.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.91 172.2 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.218 1.407 . . . . 0.0 110.303 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -129.24 139.93 51.65 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.88 175.33 13.71 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.746 -1.221 . . . . 0.0 110.918 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.7 m -121.79 134.55 54.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 68' ' ' VAL . 64.0 t -77.13 114.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -77.48 -54.89 5.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 m -142.61 171.46 14.03 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.72 0.808 . . . . 0.0 110.677 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.2 mtp -138.05 133.15 33.18 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.639 1.976 . . . . 0.0 105.845 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.86 140.84 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.812 1.245 . . . . 0.0 107.798 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -70.24 151.68 45.07 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.393 0.997 . . . . 0.0 110.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -134.77 175.11 3.89 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.854 1.661 . . . . 0.0 108.173 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.62 160.18 18.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.299 3.333 . . . . 0.0 114.095 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 -141.89 43.53 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.66 17.3 3.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.895 0.878 . . . . 0.0 110.313 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.88 166.6 48.94 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-O 123.224 1.458 . . . . 0.0 115.143 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.35 139.83 16.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 106.195 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.04 145.95 31.74 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 55' ' ' VAL . 94.9 t -118.04 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -89.84 133.37 34.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.81 173.37 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.082 0.953 . . . . 0.0 111.104 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -132.96 38.01 3.39 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.17 0.988 . . . . 0.0 112.965 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.7 mt 37.49 81.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.297 1.839 . . . . 0.0 115.061 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.04 -33.07 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.981 0.809 . . . . 0.0 110.911 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.514 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -160.84 161.87 33.12 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.028 1.299 . . . . 0.0 110.627 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.24 146.01 31.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.184 1.394 . . . . 0.0 109.513 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -131.02 -41.32 1.13 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.873 0.869 . . . . 0.0 110.991 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -140.3 123.79 17.05 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.42 59.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.077 2.151 . . . . 0.0 107.568 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.04 35.8 2.74 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 124.456 1.027 . . . . 0.0 113.702 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -10.65 0.04 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.511 2.005 . . . . 0.0 114.669 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.17 129.06 47.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.554 1.677 . . . . 0.0 110.515 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.84 67.86 10.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.26 152.54 41.81 Favored Pre-proline 0 CA--C 1.537 0.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.589 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.84 172.1 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.215 1.943 . . . . 0.0 111.523 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t -52.09 -60.12 6.87 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 117.637 -1.173 . . . . 0.0 109.307 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.88 139.6 40.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 N-CA-C 107.164 -1.898 . . . . 0.0 107.164 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.62 -157.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.89 2.393 . . . . 0.0 112.293 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.514 HG21 ' HA2' ' A' ' 74' ' ' GLY . 40.4 m -34.74 133.63 0.26 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 130.703 3.601 . . . . 0.0 112.42 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.47 34.58 0.28 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.776 1.655 . . . . 0.0 110.225 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.79 166.69 20.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.7 2.0 . . . . 0.0 108.572 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.5 p -103.3 149.62 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.003 0.906 . . . . 0.0 112.014 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.3 mt -145.07 170.83 15.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.758 1.223 . . . . 0.0 109.004 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -127.2 115.12 18.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -89.49 120.19 30.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.56 113.64 15.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.54 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.0 113.47 62.51 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.67 -1.31 11.41 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.124 1.883 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.0 m -134.12 113.59 12.23 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 110.083 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -75.54 -5.76 46.87 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.006 -1.059 . . . . 0.0 113.806 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -78.6 -53.27 7.36 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.378 0.671 . . . . 0.0 110.606 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.6 m -154.46 165.5 17.92 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 127.006 2.122 . . . . 0.0 110.282 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -64.66 151.93 74.95 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 119.625 0.902 . . . . 0.0 110.178 -3.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.23 138.79 44.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.405 2.07 . . . . 0.0 111.764 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 ttm -149.43 170.92 17.47 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.918 -1.114 . . . . 0.0 111.444 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.76 138.27 54.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.46 34.65 63.44 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.608 -1.106 . . . . 0.0 113.736 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.07 160.51 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.723 1.761 . . . . 0.0 107.963 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -99.61 136.38 39.62 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 125.354 1.461 . . . . 0.0 110.417 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -139.51 168.05 20.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.304 1.442 . . . . 0.0 112.615 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.94 123.62 50.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.9 113.98 21.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.539 ' HG2' HG13 ' A' ' 50' ' ' VAL . 27.0 mtm -117.66 113.21 21.57 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.97 -140.19 3.09 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 126.123 1.821 . . . . 0.0 109.687 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -135.38 175.28 9.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.289 1.045 . . . . 0.0 109.548 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -118.89 159.16 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -129.84 112.93 14.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.43 63.64 8.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -177.4 -32.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.202 2.601 . . . . 0.0 110.851 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -127.51 -9.69 5.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.91 -152.83 19.97 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.55 144.05 19.65 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.607 2.204 . . . . 0.0 111.708 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.27 8.5 p -126.7 149.76 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.257 1.6 tm? -137.53 75.23 45.08 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.22 -0.925 . . . . 0.0 108.827 -174.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.9 170.93 9.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.539 3.493 . . . . 0.0 112.91 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.71 -20.15 67.91 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.864 1.709 . . . . 0.0 114.079 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.65 22.99 1.01 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.718 1.207 . . . . 0.0 111.417 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.1 m -91.62 137.24 32.52 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.301 -1.499 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -86.85 114.39 23.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -127.64 126.7 67.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.65 0.738 . . . . 0.0 109.331 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -146.1 163.25 10.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.573 1.949 . . . . 0.0 107.018 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.03 149.33 47.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 123.99 24.47 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -119.99 155.34 55.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-O 117.073 -1.441 . . . . 0.0 107.88 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.07 -42.47 6.01 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.982 2.455 . . . . 0.0 110.452 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -55.05 -53.09 60.21 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 122.957 0.503 . . . . 0.0 110.669 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.85 -44.4 82.12 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.531 0.732 . . . . 0.0 110.612 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -56.52 -53.28 59.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.56 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -59.73 -36.45 76.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.31 1.044 . . . . 0.0 111.523 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.7 mt -65.33 -60.45 2.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 124.478 1.111 . . . . 0.0 108.766 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.81 -34.98 72.11 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.149 1.341 . . . . 0.0 110.949 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.53 -49.58 76.96 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -63.32 -31.58 72.77 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.606 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.1 mt -68.66 -31.38 70.47 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.295 0.952 . . . . 0.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 t -76.7 -34.57 58.17 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.421 0.555 . . . . 0.0 109.67 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -67.07 -58.79 4.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 . . . . . 0 N--CA 1.447 -0.601 0 C-N-CA 123.702 0.801 . . . . 0.0 110.489 179.183 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 C--O 1.236 0.391 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.559 HD21 HD23 ' A' ' 141' ' ' LEU . 7.1 tt -63.71 -44.17 94.42 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.593 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -62.55 -49.22 76.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.278 0.944 . . . . 0.0 111.628 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -56.12 -46.62 79.09 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.428 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -73.8 -44.06 56.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.237 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.54 ' CD2' HG11 ' A' ' 50' ' ' VAL . 7.6 t80 -54.72 -44.29 73.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.843 1.656 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.7 -23.93 61.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.417 -0.802 . . . . 0.0 113.032 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -46.4 28.68 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 110.406 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.5 p -69.14 132.32 46.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.665 1.186 . . . . 0.0 111.181 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -81.32 -12.85 58.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.477 1.035 . . . . 0.0 109.361 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.5 tp -122.75 125.11 44.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.605 1.562 . . . . 0.0 109.93 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.54 HG11 ' CD2' ' A' ' 44' ' ' PHE . 42.2 t -141.01 114.03 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.2 166.76 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.575 1.55 . . . . 0.0 109.222 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 p -124.05 148.91 46.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -159.09 171.21 20.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.766 -1.209 . . . . 0.0 110.906 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.3 m -124.03 128.08 48.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.41 113.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.415 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 20.9 mmmt -84.21 -38.17 20.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.271 1.028 . . . . 0.0 110.042 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 m -151.25 165.86 32.67 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 121.227 -0.921 . . . . 0.0 110.138 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.8 mtp -143.75 124.67 14.31 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.52 146.1 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -65.56 152.31 44.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.486 -0.759 . . . . 0.0 109.889 -176.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -134.29 169.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.865 2.066 . . . . 0.0 109.481 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -38.59 134.06 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 125.084 3.856 . . . . 0.0 117.492 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.23 -123.61 33.5 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.814 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -88.72 22.55 2.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.364 1.465 . . . . 0.0 110.18 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.44 166.28 45.53 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.676 -1.265 . . . . 0.0 113.997 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -151.86 138.52 18.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.489 1.516 . . . . 0.0 108.349 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.54 128.89 55.52 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.45 123.28 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -93.43 125.14 37.88 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 11.6 m -122.89 174.17 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.432 1.493 . . . . 0.0 111.169 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 t -135.25 40.38 2.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.626 0.648 . . . . 0.0 109.91 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.4 mt 38.11 77.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.571 2.748 . . . . 0.0 114.19 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 47.7 mm -75.54 -23.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.802 1.637 . . . . 0.0 111.133 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.81 159.06 32.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.76 141.33 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.195 0.998 . . . . 0.0 108.527 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -135.31 -33.36 0.9 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.258 0.623 . . . . 0.0 110.823 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -148.99 125.06 10.7 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.26 58.68 1.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.512 2.325 . . . . 0.0 107.782 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.64 36.19 2.82 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.276 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.04 -25.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 116.707 -2.163 . . . . 0.0 116.483 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.5 mt -116.39 155.09 29.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 121.101 2.451 . . . . 0.0 112.555 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.69 94.39 5.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 128.399 2.679 . . . . 0.0 109.047 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.14 131.57 95.04 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.72 -178.69 4.25 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 121.942 1.762 . . . . 0.0 111.103 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 t -53.58 -58.92 10.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.203 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.59 116.02 3.7 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.596 2.197 . . . . 0.0 110.805 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 88' ' ' THR . 65.5 Cg_endo -78.14 -152.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.236 2.624 . . . . 0.0 110.677 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 24.1 m -33.17 123.76 0.39 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 130.625 3.57 . . . . 0.0 111.771 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.16 -16.71 6.33 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.394 2.426 . . . . 0.0 110.986 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.79 150.82 40.82 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.312 1.056 . . . . 0.0 111.363 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -86.01 145.51 27.07 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.4 mt -146.92 164.24 33.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 109.37 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -117.66 113.42 21.87 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.24 119.15 29.47 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -79.76 114.08 18.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.06 1.344 . . . . 0.0 109.94 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.14 114.24 59.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.83 -4.43 14.06 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.108 1.872 . . . . 0.0 113.225 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.7 m -138.17 113.63 9.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.087 1.755 . . . . 0.0 108.823 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -74.29 -7.49 52.98 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.257 -0.902 . . . . 0.0 112.787 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.98 -57.14 3.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.43 1.892 . . . . 0.0 108.97 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.4 m -152.59 160.49 31.11 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.044 1.338 . . . . 0.0 111.829 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.06 161.12 70.29 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.0 1.036 . . . . 0.0 111.887 3.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.42 139.76 91.09 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.163 2.575 . . . . 0.0 112.502 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -153.0 150.95 29.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.864 0.866 . . . . 0.0 110.157 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -144.37 150.8 38.34 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 109.872 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 56' ' ' LYS . 88.4 tttt -79.09 138.68 38.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.31 44.11 76.18 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.2 t -142.6 156.05 18.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 m -102.93 128.64 49.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.589 0.756 . . . . 0.0 110.393 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -126.46 171.3 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.383 1.873 . . . . 0.0 112.314 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.49 123.64 43.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 175.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.36 114.0 22.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 mtm -116.83 113.14 22.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.88 -142.71 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.606 1.098 . . . . 0.0 110.675 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.4 -178.87 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.971 0.891 . . . . 0.0 109.42 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.99 147.2 28.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -125.55 113.65 17.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -79.13 63.55 3.81 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -177.34 -26.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.386 1.875 . . . . 0.0 111.616 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 -7.37 3.17 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.706 0.802 . . . . 0.0 112.978 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.54 -164.19 20.96 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.724 0.693 . . . . 0.0 111.447 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.81 133.9 24.62 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.444 2.096 . . . . 0.0 109.8 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.265 2.9 p -118.83 134.76 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.96 76.11 21.84 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 0.0 109.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.72 172.8 8.92 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.922 3.748 . . . . 0.0 112.69 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -63.86 -34.36 60.97 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.68 2.253 . . . . 0.0 114.632 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.79 23.89 1.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.293 0.951 . . . . 0.0 111.59 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.3 m -85.11 146.93 26.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.469 1.507 . . . . 0.0 109.968 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -91.23 113.74 26.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.2 t -132.18 113.9 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.84 165.58 9.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.373 0.669 . . . . 0.0 109.272 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.04 147.75 52.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.7 149.62 49.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.067 0.947 . . . . 0.0 108.766 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -149.98 152.55 34.31 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 127.961 2.504 . . . . 0.0 105.234 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.01 -35.95 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.009 2.473 . . . . 0.0 112.434 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -61.72 -49.44 76.43 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.773 -0.579 . . . . 0.0 110.176 176.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -54.97 -54.27 44.94 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -44.9 -55.0 5.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.913 2.085 . . . . 0.0 111.8 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -56.24 -43.7 78.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.506 0.722 . . . . 0.0 111.708 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.9 mt -66.34 -40.11 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.709 -0.662 . . . . 0.0 109.479 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.559 HD23 HD21 ' A' ' 40' ' ' LEU . 8.5 mt -58.82 -43.26 90.58 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.7 m -62.08 -41.84 98.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.494 0.718 . . . . 0.0 111.031 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -57.56 -43.41 84.47 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.879 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 mt -76.21 -24.15 54.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.039 1.736 . . . . 0.0 112.819 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -74.24 -35.46 63.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.383 1.473 . . . . 0.0 109.645 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.53 -65.77 0.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.056 0.942 . . . . 0.0 109.1 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 . . . . . 0 CA--C 1.515 -0.392 0 CA-C-N 118.415 0.552 . . . . 0.0 110.636 -176.344 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -94.24 -54.96 3.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.449 HE21 HD21 ' A' ' 144' ' ' LEU . 47.3 mt-30 -65.0 -43.17 93.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.288 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -70.63 -47.89 57.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.093 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.94 -36.37 83.21 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.401 -1.285 . . . . 0.0 109.635 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' HG11 ' A' ' 50' ' ' VAL . 34.7 t80 -57.29 -43.69 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.897 1.226 . . . . 0.0 110.69 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.3 m -74.38 -23.58 59.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.52 -34.34 63.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.996 1.271 . . . . 0.0 111.527 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.8 p -76.52 126.69 31.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 t -79.69 -11.71 59.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.922 0.867 . . . . 0.0 108.814 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.507 ' HB2' HG23 ' A' ' 116' ' ' VAL . 41.3 tp -120.75 114.84 22.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.163 2.185 . . . . 0.0 108.978 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG11 ' CD1' ' A' ' 44' ' ' PHE . 3.0 t -138.88 112.89 7.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.62 167.06 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.908 1.683 . . . . 0.0 108.332 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 111' ' ' LEU . 3.6 p -131.18 142.54 50.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -162.96 172.09 15.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.531 -0.731 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 28.1 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.67 113.57 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -84.35 -53.77 5.24 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.35 1.06 . . . . 0.0 108.479 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m -140.23 169.09 18.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.167 1.387 . . . . 0.0 109.363 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.94 132.32 38.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 144.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.08 141.91 47.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 47.3 mm-40 -123.64 176.05 2.44 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 128.045 2.538 . . . . 0.0 109.365 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 61' ' ' GLU . 41.4 Cg_endo -60.94 150.53 83.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.681 2.254 . . . . 0.0 112.765 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.91 -123.95 29.53 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.99 23.75 14.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.463 1.105 . . . . 0.0 109.931 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.79 166.73 46.32 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 122.816 1.231 . . . . 0.0 111.874 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -150.38 131.27 14.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.4 137.63 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.5 t -108.38 123.46 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -97.66 126.41 42.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 15.3 m -131.49 176.67 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.168 1.387 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -135.1 39.21 2.95 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.0 mt 36.07 83.16 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.56 -30.01 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 121.158 -0.964 . . . . 0.0 111.4 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.469 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.77 160.73 31.32 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.174 1.368 . . . . 0.0 109.761 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.84 143.31 26.21 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.299 1.04 . . . . 0.0 108.87 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -126.87 -49.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.59 1.156 . . . . 0.0 108.616 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -142.07 142.06 32.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 107.97 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 p -146.91 72.04 1.25 Allowed 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.298 2.639 . . . . 0.0 105.799 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 38.61 2.77 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 124.263 0.935 . . . . 0.0 112.881 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.63 -11.42 0.03 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.799 2.143 . . . . 0.0 112.91 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -116.35 123.17 46.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 120.623 2.211 . . . . 0.0 108.865 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -80.22 75.34 7.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.845 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -50.58 138.34 22.46 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.47 177.19 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.117 1.878 . . . . 0.0 111.636 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 t -48.74 -55.73 18.45 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.096 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.88 137.55 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.56 1.506 . . . . 0.0 108.634 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.18 -154.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.437 3.425 . . . . 0.0 112.068 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.469 HG21 ' HA2' ' A' ' 74' ' ' GLY . 16.8 m -33.06 123.9 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.828 3.251 . . . . 0.0 111.415 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.3 0.49 1.18 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.01 1.767 . . . . 0.0 113.75 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.94 150.07 21.21 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.396 1.598 . . . . 0.0 110.025 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -87.9 142.15 28.02 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.193 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -145.33 161.04 40.58 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.426 1.091 . . . . 0.0 109.85 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -116.39 125.12 51.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.212 2.205 . . . . 0.0 106.937 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.465 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.1 m-85 -106.45 123.37 47.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.721 1.609 . . . . 0.0 110.132 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.416 ' HB3' HG23 ' A' ' 123' ' ' VAL . 44.1 t80 -78.09 114.55 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.743 1.617 . . . . 0.0 111.56 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.92 114.43 61.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -69.97 -9.16 25.38 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.707 2.272 . . . . 0.0 115.555 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 m -148.46 130.79 15.61 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.217 1.407 . . . . 0.0 108.513 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -73.55 -3.94 30.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.843 1.424 . . . . 0.0 114.843 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -73.05 -51.22 18.94 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.091 . . . . 0.0 113.181 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.2 m -140.02 164.39 37.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.833 1.653 . . . . 0.0 111.942 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.03 163.5 76.18 Favored 'Cis proline' 0 CA--C 1.546 1.098 0 CA-C-N 119.381 0.815 . . . . 0.0 111.831 -2.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.27 86.95 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.983 3.122 . . . . 0.0 113.85 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 ttp -114.3 162.83 16.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.44 1.896 . . . . 0.0 109.44 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -146.19 158.24 43.87 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.258 1.023 . . . . 0.0 110.69 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -70.74 139.11 51.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.283 1.433 . . . . 0.0 110.787 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.31 35.45 91.53 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.489 1.042 . . . . 0.0 115.058 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.54 152.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 108.531 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 19.9 m -96.38 134.66 39.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.95 0.881 . . . . 0.0 110.427 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -139.48 167.69 21.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.155 1.782 . . . . 0.0 112.759 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 52' ' ' THR . 15.9 tp -103.91 132.24 50.35 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.39 113.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.471 ' HG2' HG13 ' A' ' 50' ' ' VAL . 8.6 mtm -117.49 115.78 25.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.04 -143.7 3.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.048 1.308 . . . . 0.0 110.717 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -130.02 178.65 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.253 1.026 . . . . 0.0 108.943 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 49' ' ' LEU . 25.8 t -136.1 141.93 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 120.786 -1.196 . . . . 0.0 108.304 175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -108.22 113.08 25.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -83.06 63.58 7.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -170.01 -40.36 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.956 2.903 . . . . 0.0 109.209 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -126.18 -5.88 6.64 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.74 -164.7 15.33 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.22 137.34 51.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.038 1.419 . . . . 0.0 109.454 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 95' ' ' TYR . 3.5 p -120.39 124.68 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 2.2 tm? -114.89 78.98 5.64 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.92 171.26 11.4 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.204 3.27 . . . . 0.0 112.246 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.85 -23.94 76.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.106 1.871 . . . . 0.0 113.126 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.06 23.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.97 1.259 . . . . 0.0 111.46 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.4 m -84.4 128.57 34.66 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.602 -1.311 . . . . 0.0 108.972 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 113' ' ' MET . 40.2 t80 -80.04 113.51 18.26 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.58 116.55 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.96 174.5 7.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.719 0.808 . . . . 0.0 111.01 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.34 123.78 20.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.624 1.57 . . . . 0.0 109.14 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -75.99 142.46 41.91 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.706 -0.621 . . . . 0.0 109.491 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -154.5 156.01 31.22 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 128.124 2.57 . . . . 0.0 106.586 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.01 -35.15 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.614 2.209 . . . . 0.0 113.362 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -56.47 -50.92 70.32 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.952 0.882 . . . . 0.0 110.143 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -64.39 -32.52 74.17 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.673 -0.642 . . . . 0.0 111.651 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.14 -53.11 62.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.005 0.82 . . . . 0.0 110.445 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -62.75 -36.48 83.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.934 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.23 -51.66 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.844 0.747 . . . . 0.0 109.142 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -66.93 -41.72 86.57 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.12 0.568 . . . . 0.0 109.92 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.45 -44.87 95.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.582 0.628 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.48 -31.42 72.62 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.519 -0.738 . . . . 0.0 111.281 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.449 HD21 HE21 ' A' ' 41' ' ' GLN . 51.2 mt -75.82 -27.46 57.9 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 121.532 -0.73 . . . . 0.0 110.254 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -69.24 -45.56 69.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.237 1.415 . . . . 0.0 110.052 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -67.58 -39.33 84.87 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 . . . . . 0 CA--C 1.547 0.851 0 C-N-CA 125.814 1.645 . . . . 0.0 109.307 176.07 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.233 0.21 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.7 -40.03 95.77 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.92 -48.75 79.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.999 0.363 . . . . 0.0 111.195 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.5 m -65.9 -45.83 80.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.58 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.32 -33.38 75.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.497 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.526 ' CD2' HG11 ' A' ' 50' ' ' VAL . 18.7 t80 -61.34 -40.79 95.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.586 1.084 . . . . 0.0 109.956 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -75.22 -32.49 61.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.55 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.9 73.33 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -76.21 140.9 41.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.53 1.532 . . . . 0.0 110.571 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -85.08 -13.67 49.6 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.427 1.467 . . . . 0.0 110.4 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.3 tp -122.8 127.41 49.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.786 -1.196 . . . . 0.0 110.142 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 44' ' ' PHE . 33.1 t -140.57 113.82 5.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.0 m -146.1 171.21 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 111' ' ' LEU . 17.8 p -133.83 143.16 48.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 175.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.77 168.85 20.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.326 -0.859 . . . . 0.0 111.548 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.6 m -106.96 132.94 52.34 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.13 114.85 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -76.59 -57.25 3.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 m -147.35 172.16 14.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.22 1.408 . . . . 0.0 110.187 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 31.1 mtp -135.68 146.57 47.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.81 2.044 . . . . 0.0 107.37 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.16 138.96 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 154.06 42.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 121.646 2.021 . . . . 0.0 109.66 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.11 175.78 3.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 110.974 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -59.18 171.45 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.228 3.285 . . . . 0.0 113.02 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.84 -129.61 45.3 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -112.35 31.8 6.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.0 169.36 40.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 125.046 1.308 . . . . 0.0 113.597 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -156.18 124.33 5.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.748 2.019 . . . . 0.0 106.301 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.11 147.86 27.11 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.68 123.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -92.96 124.41 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -131.43 167.69 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.55 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -128.94 38.06 3.99 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt 40.65 79.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -72.26 -28.84 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.11 161.08 34.48 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.2 144.38 48.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -137.61 -24.04 1.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -156.73 129.46 7.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -137.33 73.45 1.44 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.403 3.081 . . . . 0.0 106.045 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.66 34.88 3.43 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.016 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.25 -69.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 128.122 2.772 . . . . 0.0 109.973 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 mt -45.24 134.51 6.36 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -85.13 65.03 9.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.089 2.155 . . . . 0.0 106.414 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.7 mt -57.98 125.62 74.52 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.46 176.14 8.44 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.891 1.727 . . . . 0.0 113.619 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 t -42.57 -58.89 3.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.118 1.767 . . . . 0.0 110.813 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.56 124.06 10.41 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-N 122.321 1.865 . . . . 0.0 107.731 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 88' ' ' THR . 91.5 Cg_endo -73.35 -153.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.144 2.562 . . . . 0.0 112.946 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 51.2 m -34.61 125.19 0.53 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.484 2.714 . . . . 0.0 112.882 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.05 30.98 0.65 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.15 1.357 . . . . 0.0 113.017 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.65 158.81 29.22 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.187 1.795 . . . . 0.0 108.243 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.0 p -107.57 150.71 26.53 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.108 0.867 . . . . 0.0 111.996 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -143.55 163.23 33.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.143 2.177 . . . . 0.0 108.733 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.26 114.21 25.66 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.45 121.46 31.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.77 119.84 17.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.874 1.359 . . . . 0.0 107.563 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.46 113.83 40.61 Favored Pre-proline 0 C--O 1.225 -0.22 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.12 5.59 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.136 2.557 . . . . 0.0 112.956 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.4 m -131.14 113.52 13.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.021 1.329 . . . . 0.0 110.675 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -81.73 -32.78 31.42 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.277 -0.89 . . . . 0.0 111.173 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -59.06 -49.08 79.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.813 1.645 . . . . 0.0 112.82 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.6 m -155.09 165.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 129.006 2.923 . . . . 0.0 108.447 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.04 157.7 70.7 Favored 'Cis proline' 0 CA--C 1.536 0.601 0 CA-C-N 120.794 1.319 . . . . 0.0 111.647 -1.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.89 111.13 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.864 2.376 . . . . 0.0 111.01 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.9 tpp -122.18 141.53 51.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.575 1.95 . . . . 0.0 109.852 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -141.55 133.85 28.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -69.3 142.5 54.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.42 36.59 69.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.042 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.83 157.92 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.514 1.525 . . . . 0.0 107.449 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 m -100.63 141.0 34.11 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.709 1.203 . . . . 0.0 111.472 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -135.79 176.37 8.74 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.244 1.818 . . . . 0.0 112.62 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 52' ' ' THR . 6.4 tp -122.92 123.64 41.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 100.916 -3.735 . . . . 0.0 100.916 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.51 113.71 21.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.1 mtm -117.87 113.14 21.31 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 100.566 -3.865 . . . . 0.0 100.566 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.57 -137.45 2.29 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -132.6 177.61 7.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.409 1.1 . . . . 0.0 111.522 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.45 125.32 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -104.84 113.05 26.41 Favored 'General case' 0 C--O 1.237 0.418 1 N-CA-C 96.339 -5.43 . . . . 0.0 96.339 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.257 8.0 tp10 -85.8 95.56 9.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.963 1.363 . . . . 0.0 108.667 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -179.08 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 133.395 4.678 . . . . 0.0 107.597 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -131.38 -8.57 3.73 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 112.768 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.25 -133.99 12.01 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.78 139.4 36.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.14 1.894 . . . . 0.0 114.753 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.55 132.68 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.261 0.4 OUTLIER -115.41 74.31 4.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 125.243 1.417 . . . . 0.0 109.612 -174.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.99 169.05 18.81 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.836 3.691 . . . . 0.0 112.765 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.92 -11.12 29.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 114.85 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -88.82 23.21 2.4 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.621 1.555 . . . . 0.0 110.779 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.1 m -96.69 145.1 26.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.127 1.371 . . . . 0.0 110.593 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -95.72 113.57 25.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 74.5 t -133.45 123.73 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.46 169.28 2.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 0.0 109.031 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.47 150.67 46.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -69.05 142.19 54.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -141.66 137.39 16.24 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.93 -37.97 82.0 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.057 1.838 . . . . 0.0 111.001 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -52.65 -45.46 66.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.21 1.004 . . . . 0.0 111.268 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.0 -42.91 72.41 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.486 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -53.72 -47.38 70.63 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.316 1.047 . . . . 0.0 110.271 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -58.07 -47.55 82.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.84 0.856 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.54 -50.05 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.335 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.42 -35.2 80.13 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.891 1.223 . . . . 0.0 109.744 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 71.7 m -61.04 -47.25 87.26 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -64.54 -38.36 90.75 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 121.717 -0.614 . . . . 0.0 111.064 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.84 -30.07 70.15 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.584 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.7 t -67.1 -40.98 86.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.677 1.126 . . . . 0.0 109.776 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -69.65 -42.78 73.77 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.44 0.696 . . . . 0.0 109.613 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 . . . . . 0 N--CA 1.447 -0.577 0 CA-C-O 122.66 1.219 . . . . 0.0 109.243 176.126 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.9 -47.04 82.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.912 -175.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -59.07 -46.0 89.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 119.393 0.997 . . . . 0.0 110.766 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -67.72 -41.05 84.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.062 0.392 . . . . 0.0 111.209 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.43 -33.16 71.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.741 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 50' ' ' VAL . 42.1 t80 -59.51 -31.17 69.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.371 1.441 . . . . 0.0 109.904 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 m -71.14 -48.25 53.12 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.57 -50.21 70.38 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.919 0.888 . . . . 0.0 112.074 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -63.5 131.71 48.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.931 0.893 . . . . 0.0 109.811 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -92.87 -7.79 45.21 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.96 115.89 24.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.352 1.461 . . . . 0.0 108.6 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' A' ' 113' ' ' MET . 37.6 t -135.52 114.18 15.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.34 172.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.431 1.493 . . . . 0.0 109.386 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 111' ' ' LEU . 21.1 p -133.51 144.28 49.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.5 166.69 16.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.728 -0.607 . . . . 0.0 111.385 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.1 m -104.21 135.42 45.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.58 115.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.351 1.06 . . . . 0.0 109.56 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -83.53 -49.32 9.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -145.92 171.41 14.87 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 34.9 mtp -134.89 149.39 50.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.77 2.028 . . . . 0.0 106.86 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.95 139.91 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 131.51 41.96 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -113.7 176.25 1.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 124.465 1.106 . . . . 0.0 109.611 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.96 147.61 32.57 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.388 2.059 . . . . 0.0 113.893 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.48 -123.89 33.14 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.159 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -102.91 17.2 24.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.258 1.023 . . . . 0.0 110.582 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.61 170.43 51.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.869 1.26 . . . . 0.0 112.237 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -154.37 142.23 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.239 2.216 . . . . 0.0 105.459 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.28 150.02 35.05 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.28 123.26 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.7 m -90.53 124.57 35.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.74 173.46 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.547 0.739 . . . . 0.0 109.749 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -132.63 41.72 3.16 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HB2' ' H ' ' A' ' 90' ' ' ALA 0.331 73.6 mt 39.06 80.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 174.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.5 mm -76.47 -27.64 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 121.859 -0.526 . . . . 0.0 110.169 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.97 156.54 28.12 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 125.226 1.393 . . . . 0.0 109.659 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.48 123.54 13.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -114.4 -29.32 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.817 0.847 . . . . 0.0 112.486 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.83 125.62 11.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.19 71.15 1.34 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.226 2.61 . . . . 0.0 107.589 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.85 46.27 3.62 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.78 -76.79 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 127.119 2.295 . . . . 0.0 110.03 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.85 127.21 11.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.946 1.298 . . . . 0.0 113.419 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -75.97 71.19 2.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.162 2.985 . . . . 0.0 108.319 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.45 132.1 90.69 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.4 179.16 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.525 1.484 . . . . 0.0 110.893 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.0 t -54.0 -55.14 39.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 175.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.24 121.35 8.63 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 N-CA-C 106.915 -1.994 . . . . 0.0 106.915 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.98 -152.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.081 4.521 . . . . 0.0 113.0 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.7 m -33.8 125.76 0.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.837 2.855 . . . . 0.0 112.226 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.14 53.64 0.23 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.471 ' H ' ' HB2' ' A' ' 72' ' ' LEU . . . -140.62 158.24 44.28 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.009 2.124 . . . . 0.0 105.741 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 p -87.83 154.33 20.63 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.386 -0.821 . . . . 0.0 111.234 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -147.37 141.16 25.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -108.4 112.54 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.69 123.14 33.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -76.63 113.74 14.6 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.364 1.065 . . . . 0.0 109.129 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.63 114.08 63.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.25 0.89 7.32 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.407 2.071 . . . . 0.0 113.842 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.38 113.33 9.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . 0.29 54.0 pttt -71.94 -4.7 29.89 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -94.15 -38.41 11.1 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -149.09 159.93 36.09 Favored Pre-proline 0 C--N 1.343 0.312 0 C-N-CA 124.014 0.926 . . . . 0.0 112.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.36 150.32 83.05 Favored 'Cis proline' 0 CA--C 1.54 0.819 0 O-C-N 122.722 0.854 . . . . 0.0 112.085 2.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.6 108.39 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 2.873 . . . . 0.0 111.301 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.1 ttp -140.85 149.71 42.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.194 1.798 . . . . 0.0 108.108 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -138.21 161.53 36.61 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.762 0.825 . . . . 0.0 110.858 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -70.09 132.17 45.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.36 25.81 58.44 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.33 152.06 34.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.487 1.515 . . . . 0.0 108.616 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -95.43 133.08 39.81 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.256 1.422 . . . . 0.0 111.365 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.03 175.54 9.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.967 1.307 . . . . 0.0 111.555 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.518 HD11 ' HG3' ' A' ' 113' ' ' MET . 0.6 OUTLIER -116.07 124.62 50.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 131.008 3.723 . . . . 0.0 102.597 175.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.25 114.1 22.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.275 1.03 . . . . 0.0 108.82 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 50' ' ' VAL . 22.7 mtm -116.93 113.25 22.16 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 101.652 -3.462 . . . . 0.0 101.652 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.13 -142.7 3.5 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.788 1.661 . . . . 0.0 109.291 -175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -132.3 174.68 9.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.139 0.97 . . . . 0.0 111.122 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -130.14 138.24 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -120.34 113.08 19.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -76.95 64.85 2.51 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.397 1.479 . . . . 0.0 108.569 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -162.68 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.422 2.689 . . . . 0.0 108.306 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -120.29 -9.34 9.53 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.258 1.023 . . . . 0.0 112.891 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.97 -129.44 9.56 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.93 139.63 22.15 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.976 1.784 . . . . 0.0 112.749 -175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.56 152.76 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -135.05 74.21 63.58 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 174.18 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.987 3.791 . . . . 0.0 113.348 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.26 -21.14 65.53 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.012 1.808 . . . . 0.0 112.175 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.07 22.78 0.92 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 110.742 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.9 m -103.42 129.83 50.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.377 1.071 . . . . 0.0 113.04 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -88.56 120.21 29.73 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.48 123.75 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.52 171.3 4.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.253 1.021 . . . . 0.0 109.693 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.78 145.57 55.53 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.495 1.118 . . . . 0.0 108.454 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -71.94 149.18 45.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 110.42 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -148.73 149.76 31.52 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.64 -39.5 87.5 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.515 2.144 . . . . 0.0 112.301 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -57.75 -49.22 77.29 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.248 0.619 . . . . 0.0 111.286 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -60.11 -43.94 95.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.032 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -54.16 -53.19 56.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.57 0.623 . . . . 0.0 110.598 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -56.69 -45.43 81.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.219 1.408 . . . . 0.0 111.125 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.87 -52.46 61.4 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.122 0.969 . . . . 0.0 109.649 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -37.13 82.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.078 -175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -63.16 -45.71 90.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.244 1.384 . . . . 0.0 108.399 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -57.49 -46.26 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.724 0.693 . . . . 0.0 110.049 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.31 -33.55 75.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.525 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.0 t -62.86 -48.06 80.68 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.707 1.14 . . . . 0.0 110.336 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -62.73 -51.44 67.15 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.908 -0.495 . . . . 0.0 109.942 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 N--CA 1.455 -0.218 0 C-N-CA 126.764 2.026 . . . . 0.0 111.245 -178.528 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.468 0.431 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.14 -50.16 56.38 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -63.08 -48.68 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.697 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -55.76 -46.69 77.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.178 0.445 . . . . 0.0 110.479 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -76.0 -41.42 51.22 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.13 -1.891 . . . . 0.0 112.542 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.501 ' CD2' HG11 ' A' ' 50' ' ' VAL . 10.7 t80 -48.81 -49.05 40.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.035 1.743 . . . . 0.0 109.745 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.07 -32.17 73.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.374 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -56.82 4.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.291 1.036 . . . . 0.0 112.447 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 139.33 41.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.873 1.269 . . . . 0.0 112.729 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -76.97 -24.61 52.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.871 1.268 . . . . 0.0 109.462 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 94' ' ' PHE . 44.9 tp -120.23 128.04 52.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.219 1.008 . . . . 0.0 110.157 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 44' ' ' PHE . 35.4 t -141.33 113.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.9 171.12 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.897 1.279 . . . . 0.0 109.487 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -131.33 139.42 49.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -162.49 168.16 22.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.883 -1.136 . . . . 0.0 111.716 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.3 m -109.82 134.15 52.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.0 114.48 12.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -81.81 -51.66 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 m -148.98 174.25 12.48 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 125.209 1.404 . . . . 0.0 109.696 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 13.6 mtp -135.39 154.88 51.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.957 1.703 . . . . 0.0 107.363 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.87 138.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.697 1.599 . . . . 0.0 106.987 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -70.1 145.69 51.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.058 1.299 . . . . 0.0 108.705 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 55.9 mm-40 -131.67 164.7 40.91 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.841 0.857 . . . . 0.0 108.864 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -52.57 155.62 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.751 2.967 . . . . 0.0 115.715 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.42 -124.71 25.27 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.838 1.685 . . . . 0.0 110.854 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -105.02 25.71 10.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.151 1.381 . . . . 0.0 108.316 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.86 176.17 37.53 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.816 1.198 . . . . 0.0 114.255 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -161.82 141.36 9.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.796 2.438 . . . . 0.0 106.817 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . . . -110.22 152.08 26.53 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 120.851 -1.155 . . . . 0.0 107.889 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.79 123.13 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -89.64 125.91 35.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 11.4 m -123.91 171.76 12.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.758 0.823 . . . . 0.0 109.93 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -132.67 37.19 3.49 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.067 0.947 . . . . 0.0 112.729 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.304 18.6 mt 39.17 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.37 -29.09 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 118.668 0.667 . . . . 0.0 109.625 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 168.48 39.34 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.322 1.439 . . . . 0.0 110.972 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.36 147.62 30.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.899 1.68 . . . . 0.0 109.306 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -141.38 -25.18 0.72 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -156.26 136.88 13.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.301 1.84 . . . . 0.0 106.502 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.0 p -145.31 71.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.614 2.766 . . . . 0.0 109.051 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 43.69 3.19 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.86 1.695 . . . . 0.0 110.088 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.88 -72.45 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 129.497 3.427 . . . . 0.0 109.683 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mt -51.05 132.23 27.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -82.84 76.07 9.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 83' ' ' LEU . 21.0 mt -53.19 129.56 50.34 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.36 158.09 46.82 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.593 1.528 . . . . 0.0 112.281 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -52.85 -58.14 13.29 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.22 114.57 3.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 N-CA-C 103.554 -3.287 . . . . 0.0 103.554 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 88' ' ' THR . 68.0 Cg_endo -68.06 -153.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.429 3.419 . . . . 0.0 116.328 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 14.2 m -35.01 134.44 0.24 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 130.76 3.624 . . . . 0.0 111.538 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.69 11.97 3.86 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.733 2.587 . . . . 0.0 110.577 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.6 154.72 20.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.739 1.216 . . . . 0.0 108.182 175.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -104.0 141.26 36.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.437 1.095 . . . . 0.0 111.835 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 mt -147.28 151.6 36.89 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.742 1.217 . . . . 0.0 111.861 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -103.67 114.89 29.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.0 m-85 -87.33 122.36 30.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -80.55 114.92 19.79 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.951 1.3 . . . . 0.0 109.8 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.13 114.02 58.41 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 120.817 1.644 . . . . 0.0 107.195 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.15 -7.72 21.52 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.17 1.913 . . . . 0.0 112.43 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.6 m -121.07 113.61 20.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.467 1.907 . . . . 0.0 109.988 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -78.43 -15.85 58.22 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.387 -0.821 . . . . 0.0 112.55 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -83.4 -41.46 18.11 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.683 0.793 . . . . 0.0 112.337 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.7 m -149.63 156.47 38.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.022 1.329 . . . . 0.0 110.36 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.12 159.31 81.0 Favored 'Cis proline' 0 CA--C 1.544 1.008 0 CA-C-N 119.134 0.727 . . . . 0.0 110.802 -3.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.12 142.94 99.89 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.172 2.581 . . . . 0.0 112.848 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 33.0 tpp -149.3 155.15 40.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.513 1.525 . . . . 0.0 109.239 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -150.56 141.1 22.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.555 1.942 . . . . 0.0 106.328 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.65 146.83 54.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.93 45.04 96.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.708 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.7 t -144.07 154.64 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.907 2.083 . . . . 0.0 107.214 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.5 m -102.56 135.29 44.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.591 1.156 . . . . 0.0 111.577 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.8 175.16 9.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.34 1.456 . . . . 0.0 112.851 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.34 124.71 53.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 130.654 3.581 . . . . 0.0 102.554 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.42 114.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.0 mtm -116.42 113.13 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.63 -139.33 2.75 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.047 1.308 . . . . 0.0 111.142 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -131.69 179.05 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.043 0.921 . . . . 0.0 110.336 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.78 145.97 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.651 -0.656 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -111.73 113.42 25.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.46 72.41 6.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -178.18 -39.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 129.186 2.995 . . . . 0.0 111.062 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -130.67 -10.88 3.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.43 -157.82 15.3 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.353 0.979 . . . . 0.0 111.791 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.14 144.53 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.347 2.698 . . . . 0.0 113.464 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.26 2.9 p -127.23 142.13 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.254 1.8 tm? -132.72 79.37 64.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.616 -1.302 . . . . 0.0 109.98 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.65 171.95 8.84 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.349 3.366 . . . . 0.0 112.598 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.01 -33.03 95.72 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.126 1.884 . . . . 0.0 113.268 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -83.96 37.2 0.59 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.42 1.088 . . . . 0.0 112.181 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.6 m -97.32 130.52 44.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.867 1.667 . . . . 0.0 108.898 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.3 113.65 15.29 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.61 123.95 43.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -150.28 171.82 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.28 1.832 . . . . 0.0 109.18 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.14 141.93 58.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.928 1.291 . . . . 0.0 109.504 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -75.72 131.28 39.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.418 0.687 . . . . 0.0 109.913 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -139.16 146.75 50.54 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.072 1.749 . . . . 0.0 107.67 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -57.54 -34.25 97.76 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.006 2.47 . . . . 0.0 113.362 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -54.15 -54.55 38.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.401 0.68 . . . . 0.0 109.679 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.49 -43.19 97.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.884 0.874 . . . . 0.0 109.677 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -51.1 -55.19 18.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.393 1.477 . . . . 0.0 111.166 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -65.53 -30.65 71.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.902 0.481 . . . . 0.0 110.757 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.71 -52.12 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 120.599 -1.313 . . . . 0.0 109.282 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.12 -37.79 81.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.085 1.312 . . . . 0.0 109.432 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.7 m -56.62 -53.62 55.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.693 0.797 . . . . 0.0 108.9 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -61.64 -31.3 71.39 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.595 -0.691 . . . . 0.0 112.201 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.59 -23.9 56.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.134 0.879 . . . . 0.0 111.299 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.8 t -73.67 -38.09 65.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -76.09 -59.59 2.69 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.765 1.226 . . . . 0.0 111.5 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.561 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.231 0.128 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.35 -40.92 98.63 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -62.22 -54.22 43.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.981 0.809 . . . . 0.0 109.978 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -55.82 -46.39 78.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.92 0.867 . . . . 0.0 111.227 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -69.69 -37.65 76.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.201 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.505 ' CD2' HG11 ' A' ' 50' ' ' VAL . 25.7 t80 -61.35 -37.18 82.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.592 1.087 . . . . 0.0 109.757 175.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.7 -57.8 6.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.749 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -29.72 69.69 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -76.25 153.85 35.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.318 0.508 . . . . 0.0 111.895 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -102.85 -6.95 21.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.321 1.048 . . . . 0.0 108.717 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 94' ' ' PHE . 37.1 tp -133.43 123.47 25.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.639 1.576 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.505 HG11 ' CD2' ' A' ' 44' ' ' PHE . 42.6 t -138.58 114.55 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.81 172.04 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.807 1.243 . . . . 0.0 109.782 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -134.66 141.24 46.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.82 174.7 13.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 120.626 -1.296 . . . . 0.0 110.987 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.1 m -114.17 130.22 56.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 102.939 -2.985 . . . . 0.0 102.939 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.44 113.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -78.86 -43.33 25.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 108.808 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -152.77 167.76 27.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.248 1.419 . . . . 0.0 109.893 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 57.1 mtp -137.98 125.07 21.47 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.7 t -120.63 146.05 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.485 1.514 . . . . 0.0 107.82 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 -65.73 154.65 38.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.977 1.262 . . . . 0.0 107.877 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.594 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 22.5 mm-40 -135.13 170.9 9.99 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 124.728 1.211 . . . . 0.0 108.691 176.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 165.55 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.171 2.581 . . . . 0.0 113.318 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.2 -142.37 45.95 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 125.791 1.663 . . . . 0.0 109.298 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' OE1' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tp10 -97.56 25.19 5.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.917 1.287 . . . . 0.0 107.69 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.68 43.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.383 1.945 . . . . 0.0 114.794 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.48 155.77 35.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.381 2.673 . . . . 0.0 107.309 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.594 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -119.92 146.26 45.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.97 123.15 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 m -92.86 129.15 38.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 170.84 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.887 0.875 . . . . 0.0 111.559 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -135.01 35.38 3.07 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt 37.02 82.38 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.506 2.322 . . . . 0.0 116.003 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.3 mm -75.02 -23.02 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.701 0.8 . . . . 0.0 109.037 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.2 159.66 33.08 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.76 45.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.716 1.607 . . . . 0.0 106.695 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -141.42 -32.01 0.56 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.832 0.707 . . . . 0.0 111.246 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -148.21 129.61 14.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -139.4 70.03 1.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.324 2.249 . . . . 0.0 105.95 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.23 44.47 3.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.295 1.426 . . . . 0.0 109.61 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.77 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 130.075 3.702 . . . . 0.0 107.514 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -44.59 123.52 3.68 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 123.033 1.397 . . . . 0.0 114.408 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.59 64.86 5.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.348 3.059 . . . . 0.0 109.375 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -56.02 131.34 73.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.83 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.06 177.67 7.9 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.428 2.086 . . . . 0.0 112.107 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -48.92 -52.45 46.58 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.938 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.27 116.97 4.32 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 CA-C-N 121.843 1.694 . . . . 0.0 108.538 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.18 -153.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.343 4.028 . . . . 0.0 111.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.5 m -33.36 125.44 0.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.838 2.455 . . . . 0.0 110.194 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.55 2.09 5.89 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.294 1.902 . . . . 0.0 111.42 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.31 150.86 22.9 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.182 1.491 . . . . 0.0 110.112 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.9 p -95.08 150.5 20.11 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 mt -144.29 168.37 20.23 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.195 2.198 . . . . 0.0 109.773 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -127.26 115.01 18.38 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.7 m-85 -95.63 124.79 39.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -72.34 139.93 48.19 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.309 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.31 113.64 18.31 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -60.73 -11.83 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.169 3.246 . . . . 0.0 115.451 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.5 m -137.42 118.39 14.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.539 1.535 . . . . 0.0 113.007 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' OE1' ' A' ' 64' ' ' GLU . 22.0 pttp -73.98 -27.22 60.88 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.665 -0.647 . . . . 0.0 110.188 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -62.73 -52.13 64.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.217 1.407 . . . . 0.0 110.858 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -146.65 159.11 45.09 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 111.673 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.3 160.77 75.3 Favored 'Cis proline' 0 CA--C 1.543 0.928 0 CA-C-N 119.189 0.746 . . . . 0.0 112.554 -0.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.63 95.56 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.957 3.105 . . . . 0.0 111.752 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 34.1 tpp -93.66 160.98 14.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.882 1.673 . . . . 0.0 108.603 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -148.48 136.9 21.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -77.31 145.06 37.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.888 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.16 98.75 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.674 0.67 . . . . 0.0 113.483 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.73 156.96 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 125.915 1.686 . . . . 0.0 107.049 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -89.99 138.72 31.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.991 0.901 . . . . 0.0 110.758 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -136.05 174.66 10.37 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.723 2.409 . . . . 0.0 112.33 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.05 123.62 42.04 Favored 'General case' 0 N--CA 1.448 -0.553 1 C-N-CA 132.504 4.321 . . . . 0.0 101.955 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.9 113.93 19.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.0 mtm -115.56 113.29 23.42 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.55 -136.39 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.46 1.028 . . . . 0.0 112.67 -175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -135.43 176.12 8.97 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.949 1.3 . . . . 0.0 110.366 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.95 154.4 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -125.02 113.67 18.08 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -74.19 71.01 1.65 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 165.44 -24.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 1 C-N-CA 132.056 4.142 . . . . 0.0 112.134 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -113.78 -4.4 13.37 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.204 0.94 . . . . 0.0 111.628 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.25 -160.29 34.67 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 131.51 19.07 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.307 2.671 . . . . 0.0 111.935 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.76 125.95 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -114.65 84.17 9.78 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 125.973 1.709 . . . . 0.0 109.939 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.27 168.46 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.034 3.156 . . . . 0.0 113.01 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.84 -22.17 73.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.462 2.108 . . . . 0.0 113.318 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.02 23.19 5.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.96 1.304 . . . . 0.0 111.03 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.6 m -83.9 134.59 34.67 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.457 1.503 . . . . 0.0 108.491 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -76.93 113.77 14.98 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.65 116.25 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.8 168.38 7.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.838 0.855 . . . . 0.0 110.082 -175.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.86 145.95 54.87 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.662 0.785 . . . . 0.0 108.916 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -72.45 130.23 40.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.828 0.851 . . . . 0.0 109.702 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -137.21 148.05 60.81 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.889 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -37.8 39.25 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.046 2.497 . . . . 0.0 112.642 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -57.82 -50.98 71.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.018 0.527 . . . . 0.0 110.266 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -59.23 -51.94 67.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.18 -48.13 45.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.519 1.927 . . . . 0.0 111.491 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -44.02 97.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.723 1.209 . . . . 0.0 111.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.7 mt -66.41 -43.67 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.407 -1.282 . . . . 0.0 109.704 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.3 -43.32 96.42 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.651 1.569 . . . . 0.0 109.298 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -57.6 -49.27 76.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.88 -34.92 78.41 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.322 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.4 mt -69.29 -27.76 65.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.978 1.263 . . . . 0.0 111.688 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -71.32 -47.38 57.01 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -71.27 -43.6 66.87 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.634 -0.667 . . . . 0.0 110.81 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 N--CA 1.45 -0.447 0 C-N-CA 126.471 1.908 . . . . 0.0 108.657 175.724 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 C--O 1.234 0.259 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.2 -50.49 63.68 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.76 -45.26 90.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.883 0.765 . . . . 0.0 111.538 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m -63.62 -44.94 92.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.918 0.326 . . . . 0.0 110.343 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -67.85 -46.19 72.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 117.174 -1.394 . . . . 0.0 110.092 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD2' HG11 ' A' ' 50' ' ' VAL . 54.2 t80 -48.4 -48.44 36.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.832 1.196 . . . . 0.0 111.331 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.5 m -65.62 -34.29 77.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.882 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -43.41 50.11 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.504 1.122 . . . . 0.0 112.292 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 p -66.75 127.25 31.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.993 0.917 . . . . 0.0 110.352 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.0 t -73.08 -21.43 60.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.955 0.798 . . . . 0.0 110.321 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 tp -117.83 118.78 32.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.552 1.141 . . . . 0.0 109.493 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.64 HG13 ' HG2' ' A' ' 113' ' ' MET . 19.8 t -136.62 113.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.41 173.47 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 126.043 1.737 . . . . 0.0 108.061 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.715 HG22 ' HA ' ' A' ' 111' ' ' LEU . 35.1 p -136.01 146.36 47.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -167.68 164.59 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.917 0.78 . . . . 0.0 111.991 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 93.0 m -96.44 133.27 41.07 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.42 113.74 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -72.79 -42.55 63.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.864 0.865 . . . . 0.0 108.979 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -165.56 170.29 14.46 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.069 1.347 . . . . 0.0 110.158 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 42.5 mtp -129.55 134.55 47.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.956 1.702 . . . . 0.0 106.62 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -135.52 144.63 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 159.46 30.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.688 1.585 . . . . 0.0 111.371 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -132.29 172.04 8.07 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 129.372 3.069 . . . . 0.0 110.685 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.91 146.4 16.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.586 2.857 . . . . 0.0 114.013 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.25 -124.43 30.74 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.912 1.244 . . . . 0.0 111.149 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -86.88 -0.52 56.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.855 0.862 . . . . 0.0 112.037 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.62 163.13 40.38 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.704 1.145 . . . . 0.0 114.039 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -148.4 136.22 20.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.27 1.828 . . . . 0.0 106.641 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.73 134.22 45.23 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.61 123.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m -93.23 130.56 38.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -134.71 172.28 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.73 0.812 . . . . 0.0 110.704 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -137.35 41.92 2.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt 38.5 80.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.428 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 17.0 mm -72.95 -29.46 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.05 157.56 29.11 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.66 144.97 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.362 1.465 . . . . 0.0 108.077 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -145.08 -25.7 0.48 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -155.36 127.68 7.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -144.56 70.18 1.28 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.564 2.346 . . . . 0.0 108.155 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.2 35.03 2.8 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.13 -81.6 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 127.556 2.503 . . . . 0.0 107.423 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.53 133.1 7.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 117.965 2.58 . . . . 0.0 117.965 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.27 63.79 8.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.011 2.925 . . . . 0.0 108.332 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.78 133.2 47.33 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.07 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.49 175.94 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.363 2.042 . . . . 0.0 112.219 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -50.86 -55.79 24.62 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.582 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.81 126.11 14.8 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.927 1.367 . . . . 0.0 109.137 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.896 2.397 . . . . 0.0 110.89 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.6 m -33.08 127.26 0.32 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 129.378 3.071 . . . . 0.0 112.987 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.74 54.63 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.093 2.282 . . . . 0.0 109.789 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.84 156.55 43.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.126 2.57 . . . . 0.0 107.093 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 p -102.72 155.06 18.57 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.253 -0.904 . . . . 0.0 112.971 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 mt -145.66 163.05 36.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.885 1.674 . . . . 0.0 108.593 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -126.37 113.73 17.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.59 126.35 38.7 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.279 1.031 . . . . 0.0 108.997 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -79.5 113.58 17.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.237 1.015 . . . . 0.0 110.503 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.88 119.03 54.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.56 -13.4 30.05 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.023 1.815 . . . . 0.0 113.292 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.2 126.35 16.45 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.844 1.658 . . . . 0.0 109.402 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -14.14 60.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.863 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -63.77 -58.08 7.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.884 1.22 . . . . 0.0 111.592 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -145.45 158.54 50.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.95 159.73 86.72 Favored 'Cis proline' 0 CA--C 1.548 1.176 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -4.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.89 160.9 27.47 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.729 1.619 . . . . 0.0 111.295 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.4 tpp -152.33 150.84 30.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -139.81 145.98 38.84 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -72.98 138.71 46.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.21 58.83 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.765 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.39 144.44 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 108.62 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.4 m -92.26 126.99 37.57 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.592 1.157 . . . . 0.0 112.181 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.86 175.66 8.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 112.046 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.715 ' HA ' HG22 ' A' ' 52' ' ' THR . 0.1 OUTLIER -116.17 127.23 54.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.754 3.221 . . . . 0.0 103.359 175.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.96 114.29 20.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.846 0.858 . . . . 0.0 109.892 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.64 ' HG2' HG13 ' A' ' 50' ' ' VAL . 10.5 mtm -114.64 111.64 21.64 Favored 'General case' 0 C--N 1.32 -0.69 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 176.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.85 -148.32 4.76 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.548 2.023 . . . . 0.0 111.228 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -130.75 178.04 6.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.123 0.969 . . . . 0.0 108.972 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 t -135.71 145.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 121.708 -0.62 . . . . 0.0 109.348 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -114.16 113.85 25.23 Favored 'General case' 0 C--N 1.346 0.414 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.09 72.39 4.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -175.22 -35.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 130.593 3.557 . . . . 0.0 109.141 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -117.37 -16.71 10.24 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.02 -171.36 14.84 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.78 137.81 55.42 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.99 1.793 . . . . 0.0 110.173 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.262 7.2 p -114.65 162.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.289 1.7 tm? -150.9 76.27 8.07 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.9 170.44 11.53 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.973 3.116 . . . . 0.0 112.343 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.38 -19.23 66.61 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.899 1.733 . . . . 0.0 112.214 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -84.41 36.38 0.58 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.446 2.698 . . . . 0.0 109.898 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 m -113.48 133.24 55.32 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.682 1.593 . . . . 0.0 110.804 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -85.01 117.55 24.04 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.19 119.57 31.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.837 0.855 . . . . 0.0 110.134 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.0 m -143.58 168.82 11.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.97 1.708 . . . . 0.0 108.926 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.25 149.39 48.12 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.78 -0.575 . . . . 0.0 110.211 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -72.5 144.34 48.05 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -142.64 149.58 50.96 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.72 -39.76 25.22 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 111.663 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -58.59 -48.04 82.29 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.894 0.316 . . . . 0.0 110.696 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -58.19 -46.88 85.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.763 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.59 -56.51 14.83 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.203 1.401 . . . . 0.0 110.772 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -63.73 -37.88 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.93 -49.77 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.609 1.095 . . . . 0.0 109.837 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.33 -34.2 77.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.575 1.079 . . . . 0.0 108.808 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -60.78 -47.92 84.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -59.11 -49.21 78.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.699 -0.626 . . . . 0.0 110.229 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.6 mt -59.05 -34.53 72.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.682 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 t -56.26 -58.02 9.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.371 0.987 . . . . 0.0 110.526 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -73.13 -38.92 66.12 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.693 0.397 . . . . 0.0 111.693 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 . . . . . 0 N--CA 1.454 -0.227 0 C-N-CA 124.61 1.164 . . . . 0.0 110.211 176.211 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.798 0.808 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.19 -53.55 10.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.88 1.672 . . . . 0.0 109.274 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -62.14 -31.28 71.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.14 0.882 . . . . 0.0 112.424 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -74.19 -52.39 12.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -59.2 -37.89 78.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.662 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.489 ' CD2' HG11 ' A' ' 50' ' ' VAL . 36.8 t80 -59.1 -41.64 88.59 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.444 1.02 . . . . 0.0 110.777 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -68.35 -41.1 81.17 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.694 -0.629 . . . . 0.0 111.131 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -55.71 11.48 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.698 0.681 . . . . 0.0 112.671 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 p -54.37 148.46 11.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.496 1.118 . . . . 0.0 111.629 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.1 t -99.07 -15.54 18.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.486 0.714 . . . . 0.0 111.551 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.77 115.49 22.77 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' A' ' 44' ' ' PHE . 22.4 t -134.86 113.6 16.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.12 170.36 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.629 1.172 . . . . 0.0 110.947 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -130.97 142.6 50.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.869 2.068 . . . . 0.0 106.953 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -168.56 176.78 5.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.257 -0.902 . . . . 0.0 110.938 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -114.77 136.03 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.69 113.6 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.15 -52.67 7.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -145.93 173.18 12.37 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.856 1.662 . . . . 0.0 109.542 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.5 mtp -139.55 153.29 47.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.149 2.18 . . . . 0.0 106.309 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' O ' HD22 ' A' ' 66' ' ' LEU . 88.2 t -145.49 135.74 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 108.103 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -66.16 147.14 53.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.956 1.707 . . . . 0.0 108.757 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 4.6 mm-40 -139.59 169.37 12.36 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 119.331 0.969 . . . . 0.0 112.912 -176.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.97 163.22 7.88 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.573 3.516 . . . . 0.0 114.629 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.58 -123.58 8.3 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -119.84 22.09 11.68 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.31 175.61 45.76 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-O 124.832 2.351 . . . . 0.0 118.934 -174.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.415 HD22 ' O ' ' A' ' 59' ' ' VAL . 2.8 tm? -156.42 135.19 11.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.472 2.709 . . . . 0.0 105.387 -175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . . . -109.75 127.24 54.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.7 123.3 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -86.17 127.17 34.67 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.92 168.13 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.706 0.803 . . . . 0.0 108.933 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 t -129.94 35.9 4.09 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' HB3' HG23 ' A' ' 88' ' ' THR 0.307 81.7 mt 37.42 80.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.456 2.302 . . . . 0.0 116.273 173.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.58 -40.39 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 110.15 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 88' ' ' THR . . . -152.37 161.7 29.55 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.46 147.07 42.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.593 1.957 . . . . 0.0 107.637 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.68 -30.1 2.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.707 1.203 . . . . 0.0 110.359 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -150.77 137.43 18.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -142.41 70.17 1.33 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 129.072 2.949 . . . . 0.0 106.434 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.61 32.37 3.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.985 0.802 . . . . 0.0 111.912 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 126.765 2.126 . . . . 0.0 110.983 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.06 132.6 48.91 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.307 1.043 . . . . 0.0 111.199 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -85.72 94.05 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.79 1.636 . . . . 0.0 107.532 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.06 133.0 88.02 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.72 -179.06 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.437 2.758 . . . . 0.0 114.652 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 t -39.58 -60.33 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.371 1.868 . . . . 0.0 110.762 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.17 123.72 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.01 1.806 . . . . 0.0 108.392 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.32 -170.59 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.275 1.983 . . . . 0.0 112.712 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.509 HG21 ' CA ' ' A' ' 74' ' ' GLY . 40.0 m -38.3 127.55 1.38 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.044 2.138 . . . . 0.0 116.458 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.19 14.97 0.09 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 128.392 2.901 . . . . 0.0 110.61 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.38 168.07 9.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.728 1.611 . . . . 0.0 110.728 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.9 p -98.73 153.01 19.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.57 -0.706 . . . . 0.0 112.621 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 24.4 mt -152.37 154.04 34.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.833 1.253 . . . . 0.0 109.612 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -112.51 113.24 25.31 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -89.27 121.27 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.137 0.88 . . . . 0.0 109.106 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -73.76 114.27 11.85 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.038 1.335 . . . . 0.0 110.529 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.5 117.57 55.51 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.95 -4.16 14.26 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.268 2.645 . . . . 0.0 112.982 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.29 120.49 28.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.466 2.306 . . . . 0.0 111.33 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -73.81 -25.92 60.35 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.507 -0.746 . . . . 0.0 110.102 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -69.7 -45.36 68.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.416 1.487 . . . . 0.0 113.059 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.416 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 17.3 m -148.56 163.51 25.83 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 101' ' ' CYS . 50.1 Cg_endo -62.57 157.66 62.96 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 O-C-N 122.493 0.733 . . . . 0.0 111.618 -1.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.32 92.71 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.839 3.026 . . . . 0.0 114.268 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.6 tpp -96.03 161.54 13.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.542 1.937 . . . . 0.0 111.563 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -153.48 139.76 18.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.342 1.857 . . . . 0.0 107.896 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.55 146.63 48.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.29 32.27 83.64 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.9 -0.944 . . . . 0.0 114.35 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.7 t -129.63 156.78 42.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.677 1.991 . . . . 0.0 106.636 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.3 m -103.6 136.55 43.1 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.486 0.715 . . . . 0.0 109.726 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.39 176.02 8.9 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.231 1.812 . . . . 0.0 112.773 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.46 123.66 43.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.0 114.24 22.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.142 0.977 . . . . 0.0 108.604 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -117.01 113.34 22.21 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.86 -143.04 3.67 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 126.118 1.818 . . . . 0.0 109.35 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -133.23 177.3 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.527 0.68 . . . . 0.0 110.234 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.98 130.95 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -109.9 113.2 25.73 Favored 'General case' 0 N--CA 1.449 -0.512 1 N-CA-C 98.208 -4.738 . . . . 0.0 98.208 174.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 72.16 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.504 1.621 . . . . 0.0 108.053 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -161.38 -47.38 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.695 2.798 . . . . 0.0 106.579 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.48 -4.49 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.661 1.584 . . . . 0.0 111.245 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.28 -122.72 6.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.267 1.413 . . . . 0.0 109.851 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.82 145.33 28.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.754 2.302 . . . . 0.0 114.931 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.37 151.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 130' ' ' VAL . 1.6 tm? -142.6 76.3 18.02 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 120.742 -1.223 . . . . 0.0 108.572 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.73 171.95 6.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.649 3.566 . . . . 0.0 112.428 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.89 -19.13 68.02 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.059 1.414 . . . . 0.0 112.22 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.98 23.21 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.968 2.107 . . . . 0.0 111.773 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.8 m -91.59 132.95 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 110.557 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.85 113.64 18.17 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 124' ' ' LEU . 55.5 t -136.59 119.21 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.75 167.77 8.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.102 1.361 . . . . 0.0 108.626 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.22 152.29 41.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -69.94 135.6 49.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -137.36 145.11 48.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.61 -46.24 14.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.926 1.751 . . . . 0.0 112.648 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.85 -38.0 89.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.792 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.72 -41.09 97.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.402 -0.811 . . . . 0.0 109.595 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -54.88 -49.83 70.22 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.381 1.473 . . . . 0.0 109.212 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -62.95 -45.23 93.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.132 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.0 mt -59.21 -47.38 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.804 1.184 . . . . 0.0 109.813 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.96 -38.07 87.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 109.4 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.2 m -61.64 -43.37 98.98 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.718 -0.614 . . . . 0.0 110.099 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -60.3 -52.71 64.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.6 mt -59.27 -32.48 70.05 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.699 0.8 . . . . 0.0 112.016 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.9 t -64.6 -51.24 63.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.081 1.352 . . . . 0.0 110.646 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -71.67 -38.94 70.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 126.456 1.902 . . . . 0.0 108.928 176.31 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.236 0.383 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -63.93 -40.87 97.44 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.61 -51.84 65.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.221 0.464 . . . . 0.0 110.845 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -53.02 -54.47 34.81 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.199 1.0 . . . . 0.0 110.194 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.91 -35.89 81.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.007 -0.996 . . . . 0.0 111.489 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 50' ' ' VAL . 30.8 t80 -57.42 -39.91 77.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.889 1.222 . . . . 0.0 110.315 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.11 -42.67 46.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.865 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.79 78.47 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.106 . . . . 0.0 112.573 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -75.99 145.74 40.06 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.682 0.793 . . . . 0.0 111.459 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -95.12 -5.94 43.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.826 1.25 . . . . 0.0 108.268 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD21 ' CE2' ' A' ' 94' ' ' PHE . 26.0 tp -129.09 122.71 30.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.557 2.343 . . . . 0.0 108.272 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 44' ' ' PHE . 23.3 t -142.56 113.81 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.92 163.34 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.209 1.404 . . . . 0.0 109.019 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 p -126.21 144.76 50.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -164.67 161.39 20.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.674 -1.266 . . . . 0.0 111.933 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 55.3 m -87.69 132.87 33.96 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.0 t -75.35 113.31 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -82.9 -46.44 12.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.57 1.548 . . . . 0.0 108.13 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -153.03 167.03 30.55 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.491 1.517 . . . . 0.0 108.967 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.3 mtp -135.34 123.98 23.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.943 2.897 . . . . 0.0 105.784 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.73 150.73 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.93 1.292 . . . . 0.0 107.899 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -67.69 154.46 41.43 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.609 -0.682 . . . . 0.0 109.26 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.461 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 23.8 mm-40 -140.02 168.34 15.21 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.408 1.083 . . . . 0.0 110.776 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.83 162.26 11.29 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.65 2.9 . . . . 0.0 112.915 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.93 -147.48 50.73 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -88.72 20.42 3.49 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.48 169.04 54.9 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-O 123.848 1.804 . . . . 0.0 117.547 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.96 134.11 16.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.735 2.814 . . . . 0.0 104.967 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -98.55 123.53 42.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.55 123.15 49.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 175.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.0 m -98.72 126.21 44.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.12 175.51 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.221 0.608 . . . . 0.0 111.305 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -133.1 40.84 3.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.278 91.8 mt 38.81 80.97 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.411 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 26.9 mm -77.86 -29.5 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.77 0.714 . . . . 0.0 109.42 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -155.32 159.28 29.03 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.935 1.731 . . . . 0.0 109.408 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.56 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -135.34 -32.04 0.95 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.194 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -157.98 133.58 9.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -145.27 67.85 1.23 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.121 2.168 . . . . 0.0 106.548 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.62 43.83 3.22 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.479 1.514 . . . . 0.0 111.215 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.12 -31.77 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 125.93 1.728 . . . . 0.0 113.16 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.95 144.27 28.43 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.35 1.575 . . . . 0.0 109.993 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -100.55 63.37 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -57.54 141.08 79.37 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.962 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.39 171.51 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.192 1.928 . . . . 0.0 112.961 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.1 t -43.81 -56.13 7.86 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.896 2.078 . . . . 0.0 110.23 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.42 116.79 4.85 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 N-CA-C 106.597 -2.116 . . . . 0.0 106.597 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.46 -152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 1 C-N-CA 125.317 4.011 . . . . 0.0 112.129 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.456 HG21 ' HA2' ' A' ' 74' ' ' GLY 0.292 97.5 m -33.77 124.39 0.45 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 129.089 2.956 . . . . 0.0 112.117 -175.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.21 -4.05 1.75 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.186 1.85 . . . . 0.0 113.356 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.84 161.04 15.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.034 1.417 . . . . 0.0 109.446 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.2 p -105.32 143.8 32.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.799 0.809 . . . . 0.0 112.231 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -148.25 160.68 42.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.153 1.781 . . . . 0.0 109.48 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.32 121.22 43.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.501 ' CE2' HD21 ' A' ' 49' ' ' LEU . 40.6 m-85 -94.04 122.59 36.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -75.64 113.44 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 124.259 0.974 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.48 114.02 62.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -11.7 29.12 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 111.926 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -117.49 113.25 21.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.993 1.317 . . . . 0.0 111.956 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -82.74 -20.29 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -60.24 -53.59 55.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 109.776 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.3 m -160.58 163.56 21.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 127.483 2.313 . . . . 0.0 108.407 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.13 141.97 41.85 Favored 'Cis proline' 0 CA--C 1.537 0.664 0 CA-C-N 120.678 1.278 . . . . 0.0 111.312 1.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 102.2 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.177 2.585 . . . . 0.0 111.558 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 tpp -93.36 158.41 15.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.045 1.738 . . . . 0.0 108.666 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -142.54 137.22 30.02 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.537 0.684 . . . . 0.0 110.107 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -74.94 144.42 43.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.242 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.11 45.62 55.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -151.13 161.31 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 127.742 2.417 . . . . 0.0 105.513 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.8 m -107.63 131.34 54.48 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -122.77 170.32 10.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.444 1.898 . . . . 0.0 112.622 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.23 123.74 47.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.572 3.549 . . . . 0.0 102.031 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.37 114.13 21.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.5 mtm -119.23 113.33 20.7 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.18 -134.2 1.91 Allowed Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.187 1.375 . . . . 0.0 111.366 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -134.96 -178.5 5.11 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.342 -1.093 . . . . 0.0 109.401 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 49' ' ' LEU . 21.6 t -136.9 144.12 33.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.24 113.43 19.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -75.84 73.95 2.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.388 1.09 . . . . 0.0 108.527 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -168.94 -41.2 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 129.812 3.245 . . . . 0.0 108.343 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -119.2 -6.37 10.39 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.349 1.06 . . . . 0.0 112.682 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -151.32 21.33 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.86 141.95 38.13 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.613 1.542 . . . . 0.0 112.737 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.81 135.62 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 130' ' ' VAL 0.255 1.7 tm? -122.07 74.26 38.16 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 107.486 -174.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.86 174.86 6.1 Favored 'Trans proline' 0 CA--C 1.542 0.888 1 C-N-CA 125.728 4.285 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.54 -22.85 61.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.728 2.285 . . . . 0.0 113.463 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -85.17 23.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.355 1.462 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.2 m -97.74 140.1 32.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.922 . . . . 0.0 111.252 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -92.55 117.05 29.56 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 124' ' ' LEU . 85.3 t -131.8 117.41 34.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.795 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -147.12 168.68 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.228 1.411 . . . . 0.0 109.117 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.7 141.1 57.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.13 0.967 . . . . 0.0 109.954 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -68.45 136.32 53.06 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.777 1.631 . . . . 0.0 107.877 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -144.65 155.64 56.51 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.112 1.765 . . . . 0.0 106.912 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.44 -40.12 25.77 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.187 1.925 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -56.97 -52.71 64.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.013 0.37 . . . . 0.0 110.945 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -58.09 -44.11 87.45 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 123.091 0.556 . . . . 0.0 110.362 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.96 -50.65 70.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.34 1.056 . . . . 0.0 109.796 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -61.67 -39.57 91.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.275 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.3 mt -63.4 -50.36 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.116 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 mt -62.39 -36.91 83.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.207 1.367 . . . . 0.0 109.088 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.7 m -61.81 -45.36 94.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.15 -38.94 90.93 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.282 -0.886 . . . . 0.0 110.737 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.4 mt -68.65 -24.61 64.55 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.706 0.803 . . . . 0.0 111.582 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 t -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.184 0.902 . . . . 0.0 109.408 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -75.61 -48.88 20.33 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.625 0.77 . . . . 0.0 111.092 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 119.017 0.826 . . . . 0.0 109.496 176.51 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.463 0.216 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.82 -47.75 76.88 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.05 -48.0 80.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 118.62 0.646 . . . . 0.0 110.593 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 m -59.28 -48.15 82.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.346 0.659 . . . . 0.0 111.077 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -69.0 -33.89 74.41 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.249 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.514 ' CD2' HG11 ' A' ' 50' ' ' VAL . 15.9 t80 -57.52 -36.4 71.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.185 1.357 . . . . 0.0 110.033 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.8 m -69.26 -45.85 68.69 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.39 0.676 . . . . 0.0 111.115 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.28 50.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.511 0.724 . . . . 0.0 112.144 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -62.05 138.49 58.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.78 1.232 . . . . 0.0 109.994 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -94.3 -6.68 43.89 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.061 0.934 . . . . 0.0 109.882 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.5 HD21 ' CE2' ' A' ' 94' ' ' PHE . 24.6 tp -120.38 120.42 35.92 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 126.75 2.02 . . . . 0.0 107.709 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 44' ' ' PHE . 40.1 t -142.88 113.32 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.49 166.8 5.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.776 1.231 . . . . 0.0 108.509 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -130.29 143.66 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -165.58 173.31 11.03 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 110.799 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.8 m -110.82 134.45 52.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.92 113.58 15.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 22.2 mmmt -86.49 -42.38 13.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.424 1.09 . . . . 0.0 110.327 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -147.37 168.99 20.42 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.198 1.399 . . . . 0.0 110.925 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 mtp -138.82 129.25 25.84 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.427 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.0 t -123.72 142.19 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.312 1.045 . . . . 0.0 108.663 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -72.49 139.69 47.78 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -123.62 176.11 2.41 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.339 1.856 . . . . 0.0 108.555 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.81 161.81 34.62 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.929 2.419 . . . . 0.0 112.24 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -154.2 40.17 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -72.2 0.27 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.914 1.285 . . . . 0.0 110.632 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.5 172.56 22.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 126.808 2.147 . . . . 0.0 117.873 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 59' ' ' VAL . 1.8 tm? -161.87 141.99 10.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 129.569 3.148 . . . . 0.0 105.44 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.29 151.35 27.5 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.93 123.28 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 124.68 43.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.51 169.98 20.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 t -123.8 35.39 4.85 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.26 70.3 mt 36.3 82.58 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 128.071 2.549 . . . . 0.0 116.884 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 32.7 mm -72.15 -30.99 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.305 -0.872 . . . . 0.0 111.816 175.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.498 ' CA ' HG21 ' A' ' 88' ' ' THR . . . -159.3 160.91 31.7 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.88 49.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -141.32 -25.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.396 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -156.15 125.54 6.23 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -139.57 67.95 1.38 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 127.709 2.404 . . . . 0.0 104.613 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 31.46 3.31 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.58 1.086 . . . . 0.0 111.939 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.58 -62.7 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.247 1.403 . . . . 0.0 111.4 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.12 148.59 30.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 117.147 0.474 . . . . 0.0 111.022 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.11 97.69 11.33 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.2 mt -63.23 147.44 94.81 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.68 178.7 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.539 1.493 . . . . 0.0 111.347 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.3 t -52.31 -61.02 5.06 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.614 1.166 . . . . 0.0 111.245 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 142.36 46.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 N-CA-C 107.36 -1.823 . . . . 0.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.36 -168.94 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.392 1.395 . . . . 0.0 110.846 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.498 HG21 ' CA ' ' A' ' 74' ' ' GLY . 17.1 m -38.17 130.93 1.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.258 2.223 . . . . 0.0 113.67 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 59.48 0.06 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 105.257 -3.137 . . . . 0.0 105.257 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.63 165.33 31.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 126.501 1.92 . . . . 0.0 106.608 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.9 p -104.0 147.72 27.05 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 120.907 -1.121 . . . . 0.0 111.443 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -147.26 158.77 44.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -125.02 113.84 18.32 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.5 ' CE2' HD21 ' A' ' 49' ' ' LEU . 70.8 m-85 -98.81 121.19 40.45 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.86 0.864 . . . . 0.0 109.57 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.91 113.8 17.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 124.677 1.236 . . . . 0.0 109.994 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.54 120.01 54.31 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.32 0.02 8.0 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.685 2.257 . . . . 0.0 112.458 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 57.7 m -129.83 160.81 32.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.061 2.544 . . . . 0.0 109.121 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -132.01 -8.42 3.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -83.45 -48.03 10.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.482 1.037 . . . . 0.0 108.511 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -127.66 158.22 70.81 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.99 1.316 . . . . 0.0 111.519 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.7 153.26 79.38 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 -4.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.35 96.51 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.403 2.735 . . . . 0.0 112.622 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.5 tpp -94.67 160.94 14.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.135 1.374 . . . . 0.0 110.309 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -152.91 140.02 19.32 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.988 1.715 . . . . 0.0 109.093 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -78.2 147.06 34.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.45 46.6 84.87 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -146.32 147.86 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 126.477 1.911 . . . . 0.0 106.714 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.1 m -93.8 132.13 38.5 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.168 0.587 . . . . 0.0 110.096 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.76 172.38 11.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.631 1.972 . . . . 0.0 111.664 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -115.81 124.15 50.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.21 114.34 23.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.7 mtm -117.89 113.37 21.64 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 103.274 -2.861 . . . . 0.0 103.274 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.74 -134.01 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.802 1.191 . . . . 0.0 111.164 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -135.89 175.98 9.1 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.985 . . . . 0.0 110.991 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 6.4 t -130.21 145.78 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.789 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -123.76 113.7 18.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -81.01 65.32 6.11 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.378 1.085 . . . . 0.0 111.946 -175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -166.82 -39.42 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.982 1.713 . . . . 0.0 110.736 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -113.65 -30.67 6.73 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.96 -168.76 21.21 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 Cg_endo -71.76 160.53 47.75 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.287 1.325 . . . . 0.0 111.342 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.47 157.21 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 130' ' ' VAL . 1.7 tm? -146.44 74.73 12.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 120.67 -1.269 . . . . 0.0 108.664 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.05 174.19 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.552 3.501 . . . . 0.0 113.052 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.13 -16.37 50.05 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.847 1.698 . . . . 0.0 111.99 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.81 32.01 0.48 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.038 2.135 . . . . 0.0 110.826 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -113.66 128.73 56.54 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.111 1.364 . . . . 0.0 111.064 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -81.34 113.31 19.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 124' ' ' LEU . 55.6 t -133.46 123.18 45.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -152.43 173.16 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.362 1.465 . . . . 0.0 110.682 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.91 134.25 54.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.875 1.67 . . . . 0.0 109.323 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -67.74 125.77 27.3 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -140.9 157.64 66.93 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.56 -1.209 . . . . 0.0 109.199 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.52 -44.85 16.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.63 2.887 . . . . 0.0 115.785 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -55.68 -43.42 76.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.542 1.065 . . . . 0.0 110.859 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.35 -44.28 83.66 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.94 -0.553 . . . . 0.0 109.556 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.37 -50.05 65.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.919 0.887 . . . . 0.0 111.657 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.59 -49.77 73.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.592 0.757 . . . . 0.0 109.335 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.73 -52.61 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.861 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.23 -32.82 74.32 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.771 1.169 . . . . 0.0 110.222 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.6 m -65.73 -46.84 77.37 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -60.32 -41.75 94.17 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.685 -0.635 . . . . 0.0 111.267 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.98 -35.64 80.41 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.5 1.12 . . . . 0.0 110.867 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -61.99 -45.61 92.85 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -67.41 -48.88 66.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.53 0.732 . . . . 0.0 110.5 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.457 0.646 . . . . 0.0 109.638 178.532 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.236 0.365 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.7 -38.31 90.64 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -64.83 -53.75 41.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.474 0.579 . . . . 0.0 111.376 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -59.54 -47.15 86.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.533 0.682 . . . . 0.0 109.183 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.85 -36.2 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.39 -1.29 . . . . 0.0 111.754 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 50' ' ' VAL . 27.0 t80 -57.8 -43.43 85.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.55 1.523 . . . . 0.0 111.484 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.91 -34.34 69.02 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.312 0.645 . . . . 0.0 111.495 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.9 96.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.506 0.722 . . . . 0.0 112.261 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -76.08 148.45 37.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.901 1.28 . . . . 0.0 113.831 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 t -90.3 -13.92 34.26 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.643 1.977 . . . . 0.0 109.382 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 94' ' ' PHE . 57.9 tp -131.06 123.99 29.89 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.54 1.536 . . . . 0.0 109.111 -176.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 44' ' ' PHE . 22.0 t -141.74 114.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.59 168.92 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.516 1.126 . . . . 0.0 109.57 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.0 p -124.31 140.72 52.69 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.61 163.48 24.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.527 -1.358 . . . . 0.0 111.202 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 94.2 m -93.81 127.16 39.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.26 113.32 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -89.78 -47.6 7.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -141.27 166.87 23.58 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.731 0.812 . . . . 0.0 110.208 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.4 mtp -139.06 124.14 18.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.906 1.682 . . . . 0.0 106.83 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.09 146.92 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.249 1.42 . . . . 0.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -72.13 141.1 49.14 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.443 -0.786 . . . . 0.0 109.13 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 mm-40 -132.27 170.25 11.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.767 1.227 . . . . 0.0 109.954 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -62.1 170.32 6.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.028 3.152 . . . . 0.0 114.999 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.5 -123.33 28.96 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -113.94 19.61 16.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 108.255 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.82 171.52 55.15 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 123.37 1.539 . . . . 0.0 115.855 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.73 129.11 8.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.062 2.545 . . . . 0.0 105.264 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -97.03 123.82 40.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.1 123.17 47.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -95.39 123.73 39.07 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.36 169.04 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.232 1.013 . . . . 0.0 110.539 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -135.75 44.81 2.47 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt 37.8 81.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.746 3.239 . . . . 0.0 119.746 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.4 mm -79.98 -23.14 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.507 1.048 . . . . 0.0 110.305 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.05 160.26 32.58 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.68 35.46 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.632 1.173 . . . . 0.0 109.604 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -138.48 -33.1 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.307 0.643 . . . . 0.0 112.688 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -150.61 133.16 15.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -143.22 77.77 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.091 2.956 . . . . 0.0 103.496 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.61 36.4 2.64 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 125.568 1.556 . . . . 0.0 112.037 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.81 -67.2 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 126.681 2.086 . . . . 0.0 109.736 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.81 125.29 22.89 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 123.755 0.822 . . . . 0.0 108.863 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -78.54 91.28 4.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 124.628 1.205 . . . . 0.0 108.621 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 83' ' ' LEU . 28.4 mt -65.84 129.63 94.33 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.64 178.17 7.73 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.45 1.433 . . . . 0.0 112.977 -175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.9 t -43.86 -58.8 4.21 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 116.902 -1.523 . . . . 0.0 109.892 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.77 122.0 9.11 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 N-CA-C 107.623 -1.722 . . . . 0.0 107.623 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 88' ' ' THR . 84.1 Cg_endo -69.83 -153.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 1 C-N-CA 125.909 4.406 . . . . 0.0 110.407 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 54.1 m -31.57 123.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 110.54 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.31 39.21 0.26 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.569 1.081 . . . . 0.0 112.748 -175.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.73 164.07 29.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.421 1.488 . . . . 0.0 107.216 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 p -110.38 153.29 25.16 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.874 0.761 . . . . 0.0 112.189 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.5 mt -144.31 159.89 41.94 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.097 1.359 . . . . 0.0 109.165 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -119.67 113.47 20.72 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.7 m-85 -95.51 118.59 32.5 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -75.89 113.47 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.841 0.857 . . . . 0.0 109.451 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.73 114.82 63.55 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.35 2.2 5.93 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 113.484 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -135.07 114.14 12.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 109.074 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.93 -10.24 59.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.323 -0.861 . . . . 0.0 111.321 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -82.75 -46.46 13.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.008 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.1 m -151.94 164.17 21.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.477 1.111 . . . . 0.0 112.327 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.75 150.98 52.54 Favored 'Cis proline' 0 C--N 1.355 0.904 0 CA-C-N 120.013 1.04 . . . . 0.0 110.231 -3.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.77 97.62 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.429 2.753 . . . . 0.0 113.638 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 tpp -93.77 162.33 13.97 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.758 1.223 . . . . 0.0 108.411 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -146.77 143.4 28.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.654 1.582 . . . . 0.0 108.313 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.98 139.77 41.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.137 0.575 . . . . 0.0 110.036 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.89 71.39 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 126.386 1.946 . . . . 0.0 115.474 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.76 146.15 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.057 1.743 . . . . 0.0 108.345 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 m -91.87 128.25 37.63 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.443 0.64 . . . . 0.0 109.625 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -124.12 172.29 9.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.089 2.556 . . . . 0.0 111.457 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 123.63 46.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 100.791 -3.781 . . . . 0.0 100.791 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.18 114.03 21.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.5 mtm -116.97 113.25 22.12 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.9 -142.49 3.49 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.172 1.844 . . . . 0.0 110.878 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -132.86 176.41 8.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.617 1.209 . . . . 0.0 110.334 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.33 149.29 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.25 114.31 14.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.249 2.22 . . . . 0.0 106.546 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.82 65.62 0.23 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.285 1.834 . . . . 0.0 114.56 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 169.16 -25.84 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 130.701 3.6 . . . . 0.0 111.64 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -112.76 -6.61 13.84 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.648 1.179 . . . . 0.0 113.889 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.67 -151.01 42.35 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 135.56 22.7 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.205 1.936 . . . . 0.0 110.369 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.264 7.4 p -120.4 142.51 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 130' ' ' VAL 0.282 1.4 tm? -129.67 74.1 81.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -174.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.04 175.11 5.02 Favored 'Trans proline' 0 CA--C 1.543 0.93 1 C-N-CA 125.497 4.131 . . . . 0.0 113.347 -175.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -58.91 -28.91 88.87 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.283 1.988 . . . . 0.0 113.843 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.25 39.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.7 m -107.66 129.12 55.04 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -82.19 113.74 20.23 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 124' ' ' LEU . 50.0 t -133.57 117.86 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 123.812 0.845 . . . . 0.0 109.193 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.75 168.87 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.89 1.276 . . . . 0.0 109.286 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.9 139.29 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.41 0.624 . . . . 0.0 109.415 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -65.55 144.43 56.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.996 1.318 . . . . 0.0 109.203 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -144.34 148.99 43.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.61 -40.5 29.74 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.751 1.634 . . . . 0.0 110.712 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -53.53 -46.43 70.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.801 0.84 . . . . 0.0 110.804 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.91 -40.32 87.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.512 0.725 . . . . 0.0 111.011 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.8 -47.41 82.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.16 0.891 . . . . 0.0 110.009 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -59.31 -39.65 83.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.511 1.524 . . . . 0.0 110.062 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.48 -51.83 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.441 1.019 . . . . 0.0 109.791 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 mt -63.71 -35.07 79.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.129 1.331 . . . . 0.0 109.548 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.0 m -58.67 -49.94 75.7 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.13 -41.47 83.75 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.632 -0.667 . . . . 0.0 112.171 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.84 -28.75 64.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.518 0.727 . . . . 0.0 112.369 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -73.18 -36.64 66.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.865 0.866 . . . . 0.0 108.716 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -75.32 -50.26 16.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.685 1.594 . . . . 0.0 110.37 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 . . . . . 0 CA--C 1.536 0.436 0 O-C-N 120.725 -1.234 . . . . 0.0 111.009 175.904 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.235 0.328 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.42 -42.3 96.13 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.38 -42.64 78.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.013 0.525 . . . . 0.0 112.347 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -64.95 -52.43 56.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.89 -36.46 83.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.339 -0.838 . . . . 0.0 112.092 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 50' ' ' VAL . 35.1 t80 -60.3 -38.58 84.12 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.907 1.23 . . . . 0.0 111.236 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 m -70.15 -41.26 74.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.385 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.75 -52.89 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 112.903 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -56.17 138.24 50.3 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.325 1.05 . . . . 0.0 112.222 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -82.66 -14.12 55.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.187 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.1 tp -127.57 122.21 32.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.871 1.268 . . . . 0.0 109.592 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 44' ' ' PHE . 16.3 t -138.2 113.74 9.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.33 171.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.683 1.593 . . . . 0.0 108.875 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.552 HG22 ' HA ' ' A' ' 111' ' ' LEU . 34.2 p -130.77 145.22 51.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.17 167.98 21.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.167 -0.958 . . . . 0.0 111.251 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -102.64 130.08 49.43 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.8 t -71.31 113.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -80.15 -42.99 22.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.365 1.466 . . . . 0.0 109.529 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -156.65 166.01 34.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.705 1.202 . . . . 0.0 109.219 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 59.2 mtp -133.23 129.97 38.42 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.07 148.0 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.655 0.782 . . . . 0.0 108.92 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -70.14 155.34 40.76 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.55 1.068 . . . . 0.0 110.252 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 5.3 mm-40 -132.24 176.1 3.18 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.811 1.644 . . . . 0.0 111.491 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.22 144.27 98.79 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.459 2.773 . . . . 0.0 111.862 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.23 -152.21 51.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.66 3.87 4.58 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.882 -0.776 . . . . 0.0 110.255 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.54 164.28 20.92 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-O 123.691 1.717 . . . . 0.0 116.82 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -147.81 138.14 22.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.794 2.437 . . . . 0.0 106.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.437 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -105.21 143.28 33.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -118.61 123.31 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.9 m -97.1 132.88 42.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.49 175.9 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.896 0.878 . . . . 0.0 112.407 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -135.98 35.17 2.84 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt 38.47 82.09 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 117.8 2.518 . . . . 0.0 117.8 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.1 mm -77.91 -25.89 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.312 1.045 . . . . 0.0 111.095 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -164.74 162.95 35.98 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 124.955 1.264 . . . . 0.0 110.752 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 150.11 37.02 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.582 1.953 . . . . 0.0 108.323 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.405 ' HD1' HG12 ' A' ' 50' ' ' VAL . 3.6 m-85 -141.5 -27.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.22 1.008 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -154.93 127.83 8.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.417 1.487 . . . . 0.0 107.317 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -136.48 74.58 1.5 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.303 3.041 . . . . 0.0 105.402 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.24 35.27 2.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.134 1.35 . . . . 0.0 110.355 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.91 -73.33 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 127.551 2.501 . . . . 0.0 110.796 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.0 mt -56.3 134.74 53.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.39 76.07 5.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.757 2.023 . . . . 0.0 108.788 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.7 138.79 97.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.106 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.52 178.15 7.97 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.815 2.343 . . . . 0.0 112.871 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.0 t -49.02 -54.9 23.87 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 117.041 -1.457 . . . . 0.0 110.88 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.16 117.12 4.85 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 88' ' ' THR . 79.1 Cg_endo -72.72 -152.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 125.03 3.82 . . . . 0.0 111.502 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 41.6 m -34.06 123.9 0.48 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.856 3.262 . . . . 0.0 112.201 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.16 58.01 0.21 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.64 1.591 . . . . 0.0 109.436 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 161.5 40.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.034 2.534 . . . . 0.0 106.326 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -99.83 151.33 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.4 mt -143.9 165.2 28.38 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.468 1.507 . . . . 0.0 109.813 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -128.65 120.39 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.47 124.45 47.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.347 1.459 . . . . 0.0 107.779 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' A' ' 123' ' ' VAL . 52.7 t80 -80.31 121.21 25.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.835 1.254 . . . . 0.0 110.501 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.74 124.49 30.41 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.04 -1.22 11.17 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.568 2.179 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.5 m -150.58 175.75 11.63 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.495 2.318 . . . . 0.0 108.959 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.95 -4.39 5.72 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -79.21 -51.06 9.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.84 1.655 . . . . 0.0 109.944 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.428 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 15.7 m -133.35 155.37 80.86 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 127.282 2.233 . . . . 0.0 111.352 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 101' ' ' CYS . 63.6 Cg_endo -67.67 156.72 85.94 Favored 'Cis proline' 0 CA--C 1.55 1.29 0 C-N-CA 124.658 -0.976 . . . . 0.0 110.154 -2.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.49 87.23 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.535 3.49 . . . . 0.0 114.873 -175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -99.46 156.91 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.038 2.135 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -150.21 152.67 34.97 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.619 1.568 . . . . 0.0 109.331 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -77.95 136.35 37.98 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.65 43.0 30.67 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.84 0.733 . . . . 0.0 113.371 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.67 153.17 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.667 1.587 . . . . 0.0 107.77 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.2 m -98.94 130.73 45.32 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 110.538 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.99 173.24 11.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.588 1.555 . . . . 0.0 111.893 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.552 ' HA ' HG22 ' A' ' 52' ' ' THR . 7.0 tp -108.58 124.77 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 130.113 3.365 . . . . 0.0 102.522 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.72 113.84 24.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -115.0 113.24 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 101.221 -3.622 . . . . 0.0 101.221 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.52 -143.12 3.57 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.013 1.292 . . . . 0.0 111.249 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -133.52 176.92 8.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.118 0.967 . . . . 0.0 109.437 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.37 133.09 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.45 -0.781 . . . . 0.0 111.466 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.47 112.98 25.26 Favored 'General case' 0 C--O 1.242 0.693 1 N-CA-C 96.04 -5.541 . . . . 0.0 96.04 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.24 63.71 8.16 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.802 1.287 . . . . 0.0 109.735 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -169.59 -32.48 0.02 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.802 2.441 . . . . 0.0 109.829 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -113.54 -14.71 12.65 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.203 1.001 . . . . 0.0 111.633 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.55 -172.11 22.66 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.15 135.27 49.91 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.903 1.736 . . . . 0.0 109.351 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -114.18 134.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 1.8 tm? -125.74 78.74 68.89 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 125.221 1.408 . . . . 0.0 108.98 -174.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.23 170.77 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.742 2.961 . . . . 0.0 111.596 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -23.05 75.96 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.517 2.145 . . . . 0.0 112.528 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -83.49 24.0 0.88 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.047 0.939 . . . . 0.0 111.883 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 m -94.43 124.3 38.37 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.925 1.29 . . . . 0.0 108.034 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -77.11 113.79 15.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.5 125.79 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.7 167.85 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.382 1.473 . . . . 0.0 108.246 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.57 138.27 58.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.39 131.42 46.39 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -141.12 147.27 46.78 Favored Pre-proline 0 N--CA 1.464 0.249 0 C-N-CA 125.69 1.596 . . . . 0.0 107.281 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.75 -37.12 29.32 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.577 2.185 . . . . 0.0 114.008 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -56.48 -52.74 63.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.818 0.735 . . . . 0.0 110.375 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -58.82 -44.48 90.88 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.542 1.137 . . . . 0.0 110.282 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.59 -45.67 88.61 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.408 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -61.46 -39.53 91.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.523 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.93 -47.79 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 119.649 1.113 . . . . 0.0 109.684 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.03 -40.34 93.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.333 1.424 . . . . 0.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.3 m -59.48 -51.22 70.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 109.0 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -65.31 -33.94 77.16 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.244 1.418 . . . . 0.0 111.018 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.44 -35.96 65.85 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.825 1.25 . . . . 0.0 110.504 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -63.41 -34.9 78.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.063 1.301 . . . . 0.0 109.168 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -74.51 -44.1 52.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.881 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 120.87 1.668 . . . . 0.0 108.104 175.039 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 p . . . . . 0 C--O 1.234 0.271 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 141' ' ' LEU . 8.5 tt -63.75 -39.14 93.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.62 -50.67 68.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.269 0.628 . . . . 0.0 111.09 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -65.15 -43.23 92.48 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -61.3 -44.75 96.7 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 116.92 -1.514 . . . . 0.0 112.364 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' A' ' 50' ' ' VAL . 10.2 t80 -53.35 -46.7 69.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.787 1.631 . . . . 0.0 110.29 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.3 m -66.04 -37.14 85.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.884 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -51.77 60.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.255 1.022 . . . . 0.0 111.379 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -61.1 147.45 43.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.776 0.83 . . . . 0.0 111.022 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -101.42 -9.49 21.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.736 0.814 . . . . 0.0 109.76 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 94' ' ' PHE . 48.0 tp -127.32 119.21 25.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.169 1.788 . . . . 0.0 106.81 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 44' ' ' PHE . 48.8 t -137.25 115.52 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -146.57 169.15 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.932 1.293 . . . . 0.0 109.62 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -131.24 143.59 50.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.57 163.96 16.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.903 -1.123 . . . . 0.0 111.383 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.5 m -91.19 129.98 37.12 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.81 113.22 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -84.58 -35.08 23.01 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -160.41 170.49 20.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.06 1.344 . . . . 0.0 109.315 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.5 mtp -140.6 142.03 35.09 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.392 1.877 . . . . 0.0 106.258 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -143.57 147.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.771 0.828 . . . . 0.0 108.803 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.37 150.98 48.06 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.638 1.563 . . . . 0.0 109.709 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 5.7 mm-40 -120.89 175.37 2.41 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 127.96 2.504 . . . . 0.0 108.557 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.85 150.31 88.71 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.741 1.628 . . . . 0.0 111.244 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.58 -148.23 50.59 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.919 0.771 . . . . 0.0 112.857 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.5 7.1 2.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 112.341 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.26 170.6 54.83 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 122.737 1.187 . . . . 0.0 114.697 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.32 136.65 18.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.806 2.042 . . . . 0.0 106.36 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -98.0 136.1 38.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.7 t -115.55 123.17 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -91.46 130.47 37.29 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.61 168.84 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.037 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 t -131.02 37.28 3.78 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.1 mt 38.92 81.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.07 -29.1 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.73 155.74 26.78 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 125.748 1.642 . . . . 0.0 109.076 176.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.08 135.1 37.19 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.899 2.08 . . . . 0.0 105.728 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -130.57 -28.36 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 124.045 0.841 . . . . 0.0 113.009 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.94 129.91 11.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -145.86 68.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.618 1.967 . . . . 0.0 108.433 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.87 39.32 2.84 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.817 1.199 . . . . 0.0 112.355 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.78 -15.82 0.02 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.431 1.491 . . . . 0.0 115.985 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.16 151.42 23.67 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 120.206 2.003 . . . . 0.0 112.232 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -104.7 64.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.757 2.023 . . . . 0.0 106.255 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.41 148.27 73.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.45 -178.57 3.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.701 1.601 . . . . 0.0 111.285 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -52.25 -58.74 10.41 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.434 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.71 147.41 63.11 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 CA-C-N 121.924 1.723 . . . . 0.0 109.028 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.36 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.083 2.522 . . . . 0.0 112.029 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.478 HG21 ' HA2' ' A' ' 74' ' ' GLY . 19.8 m -32.34 132.52 0.13 Allowed 'General case' 0 C--O 1.243 0.733 0 C-N-CA 129.303 3.041 . . . . 0.0 112.085 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.7 57.64 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.746 1.641 . . . . 0.0 110.523 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.63 164.53 36.69 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.739 2.016 . . . . 0.0 107.632 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 p -108.09 146.86 32.02 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.365 0.666 . . . . 0.0 112.415 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.1 mt -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.652 1.981 . . . . 0.0 109.856 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -130.94 115.13 16.11 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.076 2.15 . . . . 0.0 105.488 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.6 m-85 -94.04 121.4 35.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -75.58 113.7 13.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.653 1.221 . . . . 0.0 108.986 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.79 121.41 46.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.68 -0.79 10.58 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.438 2.092 . . . . 0.0 112.762 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.6 m -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.212 1.805 . . . . 0.0 108.716 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -94.85 -17.98 21.59 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -102.06 -23.23 14.11 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.792 1.178 . . . . 0.0 113.677 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.5 m -135.03 155.51 79.07 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.104 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -69.87 169.49 63.55 Favored 'Cis proline' 0 CA--C 1.546 1.095 0 CA-C-N 119.825 0.973 . . . . 0.0 110.534 -4.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 77.04 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.866 3.044 . . . . 0.0 111.348 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.9 tpp -93.77 154.12 17.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.318 1.447 . . . . 0.0 110.53 -175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -144.5 144.39 31.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.531 0.733 . . . . 0.0 109.797 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -72.2 148.73 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.801 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.51 37.82 94.93 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.024 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.9 t -143.46 152.61 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.661 1.984 . . . . 0.0 106.771 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 m -94.59 129.03 41.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.86 0.838 . . . . 0.0 110.538 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -124.7 172.16 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.33 2.252 . . . . 0.0 111.567 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.678 HD11 ' HG3' ' A' ' 113' ' ' MET . 0.6 OUTLIER -116.51 125.78 52.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.829 3.651 . . . . 0.0 103.493 175.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.28 114.09 21.37 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.713 1.205 . . . . 0.0 107.884 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.678 ' HG3' HD11 ' A' ' 111' ' ' LEU . 13.4 mtm -117.53 112.91 21.23 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 102.899 -3.001 . . . . 0.0 102.899 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.68 -137.29 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.25 1.881 . . . . 0.0 109.383 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.67 175.68 9.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 108.755 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.57 144.85 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -116.31 113.19 22.61 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -78.31 63.52 3.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 109.842 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 177.59 -24.57 0.0 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.953 3.701 . . . . 0.0 112.21 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -116.33 -33.38 4.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.111 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.37 -167.37 18.81 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.687 1.613 . . . . 0.0 110.464 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.35 137.43 30.92 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.137 1.225 . . . . 0.0 109.218 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.252 14.7 p -121.31 155.96 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 130' ' ' VAL 0.277 1.0 OUTLIER -138.52 74.05 40.96 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -174.861 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.99 168.8 9.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 124.832 3.688 . . . . 0.0 111.836 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.37 -19.05 55.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.012 1.397 . . . . 0.0 113.429 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -85.37 23.56 1.3 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.521 1.529 . . . . 0.0 111.384 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.3 m -88.45 143.19 27.14 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.109 0.964 . . . . 0.0 110.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -92.67 115.4 28.07 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 124' ' ' LEU . 33.3 t -136.98 125.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -151.03 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.0 109.656 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.03 142.48 58.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.428 1.091 . . . . 0.0 109.796 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -73.82 126.75 31.09 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.984 0.913 . . . . 0.0 109.059 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -139.15 156.52 72.12 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 125.106 1.362 . . . . 0.0 108.4 175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.51 -49.46 11.96 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.234 2.623 . . . . 0.0 114.867 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -58.11 -47.6 82.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.561 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -58.02 -47.02 84.3 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 125.267 1.427 . . . . 0.0 110.439 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -54.37 -51.39 64.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.458 1.503 . . . . 0.0 110.598 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -62.92 -36.24 82.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.252 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.81 -47.27 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.24 1.382 . . . . 0.0 110.183 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 40' ' ' LEU . 4.6 mt -63.04 -38.7 92.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.061 1.301 . . . . 0.0 109.368 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -44.38 97.34 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.678 -0.638 . . . . 0.0 109.665 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -59.37 -45.93 90.07 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.245 -0.909 . . . . 0.0 109.95 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 -30.43 71.56 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.551 1.141 . . . . 0.0 111.669 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -69.93 -45.77 66.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.824 0.849 . . . . 0.0 110.013 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -75.56 -35.63 60.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 118.956 -0.545 . . . . 0.0 112.131 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 . . . . . 0 N--CA 1.448 -0.537 0 C-N-CA 124.247 1.019 . . . . 0.0 109.974 175.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.238 0.472 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.09 -46.68 83.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -62.6 -48.29 80.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.624 0.769 . . . . 0.0 110.984 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -55.17 -54.61 41.13 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.951 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -62.95 -40.94 99.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.592 -1.194 . . . . 0.0 111.996 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD2' HG11 ' A' ' 50' ' ' VAL . 34.6 t80 -56.89 -44.22 82.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.9 1.227 . . . . 0.0 110.986 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.8 m -64.01 -44.51 92.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.601 0.637 . . . . 0.0 111.446 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.28 -58.93 5.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.263 1.025 . . . . 0.0 111.209 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -55.74 140.72 40.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.611 1.565 . . . . 0.0 113.094 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -93.45 -8.99 40.05 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.721 0.808 . . . . 0.0 109.467 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.8 tp -124.68 122.86 38.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 108.185 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.622 HG11 ' CD2' ' A' ' 44' ' ' PHE . 13.3 t -139.93 113.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.9 m -149.81 171.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.404 1.482 . . . . 0.0 109.116 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 111' ' ' LEU . 3.1 p -133.53 141.89 47.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -164.03 161.35 22.56 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.955 -1.091 . . . . 0.0 112.192 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 32.3 m -95.83 128.04 42.37 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.39 113.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 29.3 mmmt -85.48 -41.01 15.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.048 0.939 . . . . 0.0 110.431 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -146.53 165.77 28.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 110.144 -175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.6 mtp -142.46 131.15 22.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.751 2.42 . . . . 0.0 105.265 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.69 157.33 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -67.71 150.01 49.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.211 0.604 . . . . 0.0 109.511 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.9 mm-40 -138.7 171.46 8.17 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 126.768 2.027 . . . . 0.0 109.775 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.14 163.61 22.34 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.569 2.179 . . . . 0.0 112.174 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.26 -151.2 52.25 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.2 9.05 16.17 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.48 171.59 43.59 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 126.58 2.038 . . . . 0.0 117.181 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.95 139.27 17.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.215 2.606 . . . . 0.0 105.171 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -99.39 124.17 44.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.8 123.17 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -98.5 124.6 43.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.31 174.72 6.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.833 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -137.45 46.05 2.16 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.032 1.287 . . . . 0.0 113.753 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.3 mt 36.14 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.502 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 28.3 mm -75.48 -26.83 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.874 -1.767 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.72 163.18 36.96 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.58 148.83 41.57 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.55 -51.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -132.37 124.1 28.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -138.16 61.55 1.59 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.696 1.998 . . . . 0.0 107.519 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 28.01 3.98 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.593 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.13 6.88 0.08 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.266 1.889 . . . . 0.0 114.163 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' HG ' HG11 ' A' ' 116' ' ' VAL . 77.6 mt -114.43 142.12 46.78 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 120.243 2.022 . . . . 0.0 111.136 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.12 72.82 9.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 111.705 -2.498 . . . . 0.0 105.961 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.35 125.18 81.21 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.78 -174.89 2.21 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.287 2.658 . . . . 0.0 112.48 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -49.73 -55.46 23.12 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.937 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.88 115.31 3.9 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 N-CA-C 108.105 -1.537 . . . . 0.0 108.105 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.67 -152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.945 3.763 . . . . 0.0 109.924 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -34.83 124.38 0.55 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.037 2.135 . . . . 0.0 109.547 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.61 -16.98 5.85 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 128.499 2.952 . . . . 0.0 111.734 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.92 154.6 31.5 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.135 1.467 . . . . 0.0 111.112 -175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 82.2 p -100.11 135.78 41.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -130.6 152.86 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.91 2.084 . . . . 0.0 109.495 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -108.17 114.06 27.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -89.74 119.82 30.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -75.74 113.52 13.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.42 114.28 63.43 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 5.21 1.73 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.619 2.879 . . . . 0.0 114.307 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.6 m -145.53 166.69 24.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.875 2.07 . . . . 0.0 109.044 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -123.57 -22.58 4.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.598 1.159 . . . . 0.0 113.307 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.12 -44.83 87.42 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.368 1.067 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.2 m -143.96 162.96 38.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.602 1.561 . . . . 0.0 109.15 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.36 157.39 68.26 Favored 'Cis proline' 0 CA--C 1.538 0.71 0 CA-C-N 119.671 0.918 . . . . 0.0 110.394 -3.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 80.38 1.14 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.236 2.624 . . . . 0.0 111.897 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.0 tpp -94.09 152.99 18.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.492 2.317 . . . . 0.0 107.943 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -137.27 143.23 42.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.96 142.28 52.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.97 62.61 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.53 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.55 155.33 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.744 1.618 . . . . 0.0 108.266 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 8.6 m -97.19 131.28 44.08 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.596 0.758 . . . . 0.0 111.393 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -128.48 170.07 13.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.011 2.125 . . . . 0.0 111.594 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HA ' HG22 ' A' ' 52' ' ' THR . 0.2 OUTLIER -114.73 126.51 54.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 130.395 3.478 . . . . 0.0 102.996 175.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.61 113.97 20.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.524 ' HG2' HG13 ' A' ' 50' ' ' VAL . 5.5 mtm -116.61 113.13 22.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.27 -139.09 2.67 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -134.49 173.04 12.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.451 HG11 ' HG ' ' A' ' 81' ' ' LEU . 2.4 t -133.41 148.29 30.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -116.49 112.81 21.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 174.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.44 78.68 8.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 177.22 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 130.841 3.656 . . . . 0.0 109.801 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -125.98 -32.1 2.81 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.155 1.782 . . . . 0.0 115.011 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.31 -158.13 14.5 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 139.85 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.803 1.669 . . . . 0.0 111.672 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.34 152.93 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.611 HD11 HG21 ' A' ' 130' ' ' VAL . 1.6 tm? -145.79 74.57 13.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.418 -1.426 . . . . 0.0 111.775 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.52 170.4 15.1 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.288 3.325 . . . . 0.0 111.792 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.03 -9.74 26.1 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.077 1.852 . . . . 0.0 113.727 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.28 25.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 m -105.34 137.84 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.37 2.268 . . . . 0.0 109.154 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.38 113.79 21.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.611 HG21 HD11 ' A' ' 124' ' ' LEU . 78.9 t -134.09 116.63 23.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.74 169.21 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.64 . . . . 0.0 108.874 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.0 mt -64.02 138.44 58.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -64.99 128.15 34.58 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -142.82 147.87 43.64 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.479 1.512 . . . . 0.0 107.767 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.38 -38.04 45.63 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.052 2.501 . . . . 0.0 113.704 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -54.56 -49.41 70.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.669 0.747 . . . . 0.0 110.487 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -66.32 -43.75 85.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.804 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.19 -52.24 46.2 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.109 1.364 . . . . 0.0 111.597 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.62 -47.67 84.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.989 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.9 -48.65 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.711 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mt -63.57 -38.08 89.76 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.969 1.259 . . . . 0.0 109.692 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.4 m -61.5 -46.72 88.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -59.31 -43.32 92.65 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.567 -0.708 . . . . 0.0 110.273 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.66 -26.42 67.79 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.326 1.05 . . . . 0.0 112.192 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 -39.44 71.15 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.281 1.032 . . . . 0.0 109.595 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -70.47 -56.61 6.18 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 . . . . . 0 N--CA 1.452 -0.329 0 C-N-CA 125.111 1.364 . . . . 0.0 108.979 -177.838 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.79 -44.44 93.34 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.081 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -61.48 -43.55 98.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.866 0.757 . . . . 0.0 111.363 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -64.41 -52.33 58.7 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -63.93 -36.03 82.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.958 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' A' ' 50' ' ' VAL . 51.9 t80 -63.65 -33.46 75.67 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.429 1.468 . . . . 0.0 111.317 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.3 -40.65 51.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.315 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -51.17 68.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.388 0.675 . . . . 0.0 110.975 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -60.38 152.73 24.61 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.205 1.402 . . . . 0.0 112.209 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -111.6 -4.02 14.89 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.88 118.47 23.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 44' ' ' PHE . 10.8 t -137.01 113.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.86 172.0 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.186 1.395 . . . . 0.0 109.767 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 111' ' ' LEU . 4.1 p -132.02 140.53 48.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.89 167.23 25.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.097 -1.002 . . . . 0.0 112.355 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.4 m -102.97 126.9 50.33 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 113.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 -44.77 15.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.6 m -146.54 170.9 15.95 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.367 1.067 . . . . 0.0 110.122 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.01 124.57 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.26 2.224 . . . . 0.0 105.667 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.86 148.39 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.294 1.838 . . . . 0.0 107.655 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.84 154.07 38.43 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.849 1.204 . . . . 0.0 109.388 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 72.0 mm-40 -138.49 176.24 2.8 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.205 1.402 . . . . 0.0 109.313 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.07 139.86 14.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.408 2.739 . . . . 0.0 114.493 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.46 -130.48 40.71 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.54 1.543 . . . . 0.0 110.926 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.15 6.98 26.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.159 0.984 . . . . 0.0 110.342 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.54 163.74 51.37 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 123.203 1.446 . . . . 0.0 113.16 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -153.84 131.27 11.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.398 1.879 . . . . 0.0 106.061 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -101.98 138.22 39.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.81 122.98 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -91.77 124.25 35.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.9 172.13 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 111.017 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -138.41 35.96 2.27 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.53 0.605 . . . . 0.0 112.191 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.268 25.1 mt 38.71 80.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.51 -20.7 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.228 1.011 . . . . 0.0 109.052 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -168.17 169.84 41.68 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.079 1.8 . . . . 0.0 110.891 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.38 154.35 42.2 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.199 1.399 . . . . 0.0 108.473 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.545 ' HD2' HG12 ' A' ' 50' ' ' VAL . 26.4 m-85 -136.33 -41.12 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.29 1.036 . . . . 0.0 109.881 175.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -144.51 138.24 27.43 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.48 67.39 1.43 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.19 2.996 . . . . 0.0 106.104 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.51 4.58 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.654 2.073 . . . . 0.0 109.695 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.62 -66.4 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 127.462 2.458 . . . . 0.0 111.02 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.25 128.07 34.59 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.269 0.628 . . . . 0.0 111.885 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.29 85.67 7.18 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.1 147.73 90.05 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 121.156 -0.965 . . . . 0.0 108.54 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.28 170.07 18.08 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -46.31 -55.55 13.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.745 1.218 . . . . 0.0 111.396 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.03 138.03 39.11 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 121.086 1.424 . . . . 0.0 109.356 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.79 -154.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.561 3.507 . . . . 0.0 111.909 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.456 HG21 ' HA2' ' A' ' 74' ' ' GLY . 87.1 m -34.15 137.07 0.11 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.492 2.717 . . . . 0.0 112.499 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.2 64.52 0.43 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -175.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.23 162.89 39.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.009 2.524 . . . . 0.0 106.237 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 p -108.82 157.4 18.62 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.211 -0.931 . . . . 0.0 111.986 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -151.69 169.17 22.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.043 2.137 . . . . 0.0 109.757 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -123.22 114.09 19.8 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.71 120.14 32.8 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -73.94 121.92 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.81 1.244 . . . . 0.0 110.12 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.58 123.95 30.67 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.91 -9.56 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.293 1.995 . . . . 0.0 113.885 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -145.39 158.31 43.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.832 1.653 . . . . 0.0 109.759 -176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.24 -16.76 13.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -66.05 -50.79 62.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.776 1.171 . . . . 0.0 110.651 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -134.86 161.39 63.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.93 1.292 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.94 158.71 81.29 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 O-C-N 122.73 0.858 . . . . 0.0 111.463 -3.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.58 90.6 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.483 2.789 . . . . 0.0 110.949 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.91 138.86 39.89 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 127.061 2.144 . . . . 0.0 111.36 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -133.57 137.63 45.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.033 0.921 . . . . 0.0 110.26 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -68.12 144.49 55.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.439 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.06 24.16 69.78 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.6 t -133.94 152.24 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.094 2.157 . . . . 0.0 107.627 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -98.53 130.9 45.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.074 0.95 . . . . 0.0 109.229 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.47 169.38 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.278 2.231 . . . . 0.0 112.882 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HA ' HG22 ' A' ' 52' ' ' THR . 13.2 tp -115.76 124.21 50.2 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 131.071 3.748 . . . . 0.0 102.017 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.06 113.75 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.482 ' HG2' HG13 ' A' ' 50' ' ' VAL . 11.7 mtm -115.49 112.91 22.96 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 101.454 -3.536 . . . . 0.0 101.454 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.29 -140.89 3.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.473 1.987 . . . . 0.0 110.877 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -138.73 176.89 8.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 t -130.55 132.86 64.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -115.28 114.22 24.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.56 80.12 7.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -173.04 -34.93 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.286 2.635 . . . . 0.0 108.146 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -134.71 -10.95 2.38 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 113.655 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 109.0 -162.66 12.75 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.58 1.086 . . . . 0.0 111.919 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.29 136.83 41.59 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.046 1.83 . . . . 0.0 110.043 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.89 147.87 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 130' ' ' VAL 0.269 1.8 tm? -137.38 73.71 49.21 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -174.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.37 175.09 8.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.493 3.462 . . . . 0.0 111.701 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.6 -17.6 35.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.91 1.74 . . . . 0.0 113.694 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.46 22.37 1.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.567 1.53 . . . . 0.0 111.305 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -98.95 124.54 43.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -76.19 113.87 14.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 124' ' ' LEU . 50.3 t -134.23 114.21 18.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.192 0.52 . . . . 0.0 110.168 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.29 169.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.972 1.309 . . . . 0.0 108.943 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.17 140.47 58.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.609 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.18 139.79 54.59 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -142.63 148.24 45.77 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 126.045 1.738 . . . . 0.0 106.775 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.3 -36.21 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.239 2.626 . . . . 0.0 111.018 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -58.63 -43.7 89.77 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.276 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -66.81 -43.85 82.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.435 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -51.45 -49.56 61.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.648 1.179 . . . . 0.0 111.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -60.79 -46.84 88.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.176 1.391 . . . . 0.0 111.208 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.3 -50.83 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.467 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.03 -33.82 76.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.489 1.04 . . . . 0.0 109.778 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.4 m -62.8 -40.4 97.25 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.784 -0.573 . . . . 0.0 109.541 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -60.78 -42.59 97.83 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.202 -0.936 . . . . 0.0 109.893 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.67 -30.38 71.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.766 0.826 . . . . 0.0 111.338 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.2 t -65.4 -46.74 78.87 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.324 0.966 . . . . 0.0 108.79 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -67.31 -49.99 61.98 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.871 -0.518 . . . . 0.0 110.414 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 mtm-85 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 123.754 0.821 . . . . 0.0 112.906 -176.014 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.05 -47.41 80.3 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -62.72 -50.07 72.55 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.364 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.4 m -65.97 -40.23 91.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.486 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -63.44 -47.04 83.55 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.142 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.564 ' CD2' HG11 ' A' ' 50' ' ' VAL . 12.1 t80 -52.17 -42.75 63.7 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.51 1.504 . . . . 0.0 110.535 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -63.22 -46.27 87.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.154 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.55 88.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.568 0.747 . . . . 0.0 112.946 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 p -76.15 131.16 39.21 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.884 1.274 . . . . 0.0 111.817 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -88.81 -6.71 57.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.706 0.803 . . . . 0.0 108.929 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.486 ' HB2' HG23 ' A' ' 116' ' ' VAL . 27.8 tp -118.03 114.7 23.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.732 2.413 . . . . 0.0 109.134 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 44' ' ' PHE . 23.4 t -139.59 113.5 6.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.14 168.52 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.19 1.396 . . . . 0.0 108.524 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 111' ' ' LEU . 2.9 p -134.23 140.99 46.85 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.58 170.58 18.34 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.421 -0.8 . . . . 0.0 111.205 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -109.28 133.94 52.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.51 114.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.314 0.645 . . . . 0.0 109.602 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -77.72 -53.08 7.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -141.22 168.31 20.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.877 1.271 . . . . 0.0 110.739 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.73 141.58 34.89 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 128.02 2.528 . . . . 0.0 105.846 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t -141.87 146.15 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -73.59 139.4 45.51 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 120.203 -1.561 . . . . 0.0 108.921 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 45.4 mm-40 -117.74 169.0 8.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 125.662 1.585 . . . . 0.0 108.642 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.39 152.82 24.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.254 2.636 . . . . 0.0 115.548 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.26 -125.91 39.14 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.0 tp10 -89.25 9.66 25.03 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.616 0.766 . . . . 0.0 111.274 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.64 171.32 49.25 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.27 139.15 18.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.468 3.107 . . . . 0.0 106.528 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -103.71 152.16 22.15 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.691 1.196 . . . . 0.0 108.567 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.63 123.43 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -97.67 126.6 43.08 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.36 172.7 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.194 0.998 . . . . 0.0 110.189 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -128.1 36.38 4.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.306 17.4 mt 40.16 80.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.694 2.398 . . . . 0.0 115.511 174.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.9 mm -78.02 -28.43 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 119.077 0.853 . . . . 0.0 109.815 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -159.1 157.43 28.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.92 138.7 35.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -132.42 -31.74 1.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.301 -175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -151.69 125.82 9.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -143.71 67.29 1.28 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.376 2.27 . . . . 0.0 109.693 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.65 46.01 3.57 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.948 1.261 . . . . 0.0 110.833 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.27 -48.97 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 126.05 1.786 . . . . 0.0 111.072 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.75 124.14 21.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 117.451 0.625 . . . . 0.0 109.336 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -78.47 64.82 3.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 129.108 2.963 . . . . 0.0 108.375 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.7 mt -57.98 123.64 65.36 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.39 -174.74 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.402 2.735 . . . . 0.0 111.55 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -49.46 -53.55 39.31 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.16 -1.4 . . . . 0.0 110.663 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.22 133.49 24.83 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 121.72 1.65 . . . . 0.0 107.965 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.51 -153.82 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.083 3.189 . . . . 0.0 110.96 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.411 HG21 ' HA2' ' A' ' 74' ' ' GLY . 52.3 m -34.87 131.28 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.584 2.754 . . . . 0.0 111.145 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.7 14.72 1.86 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 125.196 1.379 . . . . 0.0 112.573 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.37 53.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.213 1.506 . . . . 0.0 107.718 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.5 p -76.66 137.21 39.28 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.686 -0.634 . . . . 0.0 110.354 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.91 160.9 36.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.425 0.69 . . . . 0.0 111.194 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -124.17 113.63 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.699 2.0 . . . . 0.0 107.709 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -97.18 121.84 39.51 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.404 ' HB3' HG23 ' A' ' 123' ' ' VAL . 43.3 t80 -78.06 113.63 16.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.06 114.16 64.68 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.41 6.08 3.34 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.378 2.718 . . . . 0.0 113.119 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.0 m -135.97 151.09 49.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.411 2.284 . . . . 0.0 108.486 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -117.24 -5.74 11.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.502 0.721 . . . . 0.0 109.707 175.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -71.32 -58.3 3.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.435 2.694 . . . . 0.0 109.354 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -143.91 165.99 21.56 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 129.224 3.01 . . . . 0.0 110.9 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.2 152.52 98.34 Favored 'Cis proline' 0 CA--C 1.544 0.99 0 CA-C-N 119.671 0.918 . . . . 0.0 112.489 -2.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.37 112.32 2.54 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.839 3.026 . . . . 0.0 110.741 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.4 ttp -138.18 163.45 31.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -144.57 150.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.058 0.943 . . . . 0.0 110.047 -176.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.09 146.87 52.21 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.09 33.02 84.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.743 0.687 . . . . 0.0 113.993 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.7 154.87 32.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 119.089 1.445 . . . . 0.0 107.234 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 m -103.32 131.55 50.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.733 1.213 . . . . 0.0 111.704 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.95 175.65 9.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.117 0.967 . . . . 0.0 113.518 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 52' ' ' THR . 11.5 tp -113.01 128.13 56.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 130.799 3.64 . . . . 0.0 103.774 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.13 114.28 22.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.9 mtm -117.76 113.15 21.41 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.53 -137.55 2.39 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.475 1.512 . . . . 0.0 111.005 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -132.3 176.15 8.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.544 1.172 . . . . 0.0 110.9 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 49' ' ' LEU . 21.3 t -130.21 139.81 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 121.117 -0.989 . . . . 0.0 109.275 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -103.36 112.84 25.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.58 63.55 6.78 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -157.55 -42.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 129.393 3.077 . . . . 0.0 108.223 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -142.88 -11.53 0.77 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.67 -163.52 13.12 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.589 1.086 . . . . 0.0 111.727 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.32 141.36 51.37 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.273 1.982 . . . . 0.0 113.202 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -122.94 128.7 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.423 HD11 HG21 ' A' ' 130' ' ' VAL . 2.0 tm? -120.59 79.65 30.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.53 1.532 . . . . 0.0 110.529 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.13 173.63 8.18 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.659 3.573 . . . . 0.0 113.072 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.19 -22.27 73.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.013 1.809 . . . . 0.0 113.249 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -83.6 23.12 0.99 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.258 0.936 . . . . 0.0 111.12 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.5 m -95.92 134.19 39.21 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.632 1.173 . . . . 0.0 110.424 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.32 113.44 17.46 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.423 HG21 HD11 ' A' ' 124' ' ' LEU . 79.1 t -134.81 114.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 123.192 0.597 . . . . 0.0 110.502 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 m -147.26 169.81 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.518 1.527 . . . . 0.0 110.27 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.12 147.28 52.6 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.546 0.738 . . . . 0.0 109.831 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -75.12 137.84 41.66 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -143.61 142.8 21.62 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 107.977 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.55 -38.89 65.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.913 3.075 . . . . 0.0 116.283 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -65.77 -47.68 74.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.792 0.723 . . . . 0.0 110.251 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -58.13 -45.33 87.53 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.84 -0.538 . . . . 0.0 110.013 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -49.63 -55.44 13.63 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.908 1.683 . . . . 0.0 109.632 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -58.19 -43.38 87.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.183 0.993 . . . . 0.0 111.684 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.46 -46.68 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.931 0.787 . . . . 0.0 109.4 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -37.71 85.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.486 1.039 . . . . 0.0 109.079 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 78.9 m -59.99 -38.97 84.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.311 0.96 . . . . 0.0 109.499 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -62.72 -42.73 99.8 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.41 -0.806 . . . . 0.0 110.037 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.8 mt -69.35 -23.56 63.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.683 1.193 . . . . 0.0 112.428 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.4 t -72.63 -33.31 66.54 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.01 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -76.26 -65.59 0.9 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.366 1.466 . . . . 0.0 110.273 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 . . . . . 0 N--CA 1.45 -0.473 0 C-N-CA 124.7 1.2 . . . . 0.0 110.831 -175.912 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.6 -49.0 70.37 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -60.9 -46.28 91.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.921 0.488 . . . . 0.0 110.803 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m -62.56 -48.62 78.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.87 0.468 . . . . 0.0 110.319 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.17 -37.27 86.87 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.591 ' CD2' HG11 ' A' ' 50' ' ' VAL . 24.2 t80 -57.13 -40.78 77.82 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.298 1.408 . . . . 0.0 110.265 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.91 -33.76 66.18 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.513 -0.742 . . . . 0.0 111.861 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.13 66.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.164 0.986 . . . . 0.0 113.043 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -76.05 147.3 38.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 111.133 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.4 t -93.77 -11.51 31.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.299 0.64 . . . . 0.0 109.368 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.422 HD21 ' CE2' ' A' ' 94' ' ' PHE . 28.8 tp -127.26 120.08 27.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.073 1.349 . . . . 0.0 108.261 -175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 44' ' ' PHE . 26.7 t -138.86 113.89 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -148.11 172.17 2.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.034 1.334 . . . . 0.0 109.326 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.9 p -130.99 143.21 50.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.627 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -159.87 171.64 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.224 -0.923 . . . . 0.0 111.162 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.4 m -120.69 132.49 55.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 113.68 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 26.4 mmmt -80.98 -51.62 8.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -140.16 168.02 20.78 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 41.6 mtp -137.13 123.78 21.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 100.669 -3.826 . . . . 0.0 100.669 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 t -124.07 145.45 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.52 151.5 37.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.892 0.769 . . . . 0.0 109.446 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 6.1 mm-40 -135.86 173.14 6.01 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 106.726 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.29 136.71 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.379 2.719 . . . . 0.0 115.24 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.5 -123.78 34.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.525 1.536 . . . . 0.0 111.028 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.55 1.88 15.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.931 0.892 . . . . 0.0 112.084 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.88 158.35 51.71 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 122.857 1.254 . . . . 0.0 114.449 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -150.19 137.88 19.94 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.809 2.044 . . . . 0.0 105.827 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -107.16 123.31 48.08 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.45 123.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.3 m -98.07 124.2 42.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.627 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 17.8 m -126.9 176.16 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.822 0.849 . . . . 0.0 110.072 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -135.34 44.01 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.293 67.4 mt 39.49 81.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.1 mm -79.07 -28.18 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 120.004 1.274 . . . . 0.0 112.6 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -157.22 158.62 29.06 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 176.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.51 140.05 33.4 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.68 1.192 . . . . 0.0 108.332 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -137.13 -30.88 0.84 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.519 0.728 . . . . 0.0 111.391 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -151.85 127.32 10.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.9 p -140.31 59.55 1.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.463 2.705 . . . . 0.0 107.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.92 45.99 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.853 1.216 . . . . 0.0 110.746 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.27 -43.18 0.04 OUTLIER Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.92 3.153 . . . . 0.0 111.459 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.23 128.19 34.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.107 0.956 . . . . 0.0 113.302 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -81.9 75.78 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 mt -58.71 150.23 59.12 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.114 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.58 175.27 4.46 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.114 1.209 . . . . 0.0 109.684 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -49.14 -62.29 2.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.738 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.98 153.2 37.05 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 121.186 1.459 . . . . 0.0 109.99 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.53 -155.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.815 4.343 . . . . 0.0 112.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.416 HG21 ' HA2' ' A' ' 74' ' ' GLY . 85.3 m -33.26 124.75 0.39 Allowed 'General case' 0 C--O 1.253 1.249 0 C-N-CA 130.149 3.38 . . . . 0.0 114.414 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.42 56.04 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.83 2.157 . . . . 0.0 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.58 154.48 37.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.845 1.258 . . . . 0.0 107.956 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.8 p -86.62 151.82 23.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.627 0.727 . . . . 0.0 111.405 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.3 mt -152.58 152.8 32.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.326 1.851 . . . . 0.0 108.092 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -112.94 113.22 25.18 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.3 m-85 -84.95 119.7 25.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -77.14 113.11 14.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.7 113.38 62.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.42 -12.39 25.0 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.708 1.605 . . . . 0.0 113.834 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.5 m -141.83 119.16 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.267 1.427 . . . . 0.0 107.429 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -5.57 47.9 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.04 -1.038 . . . . 0.0 111.192 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -59.46 -58.15 9.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.74 1.216 . . . . 0.0 110.696 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.8 m -152.3 163.78 22.44 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.286 2.234 . . . . 0.0 110.032 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.8 161.7 71.42 Favored 'Cis proline' 0 CA--C 1.545 1.07 0 CA-C-N 119.779 0.957 . . . . 0.0 113.556 1.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.81 133.84 37.96 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.48 2.787 . . . . 0.0 112.206 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.3 ttm -149.65 167.16 27.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.873 0.869 . . . . 0.0 111.613 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -150.73 147.65 27.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.962 2.505 . . . . 0.0 107.386 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -69.22 149.42 48.58 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.24 41.81 99.49 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.08 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.74 149.83 25.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -94.41 136.37 34.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.372 1.069 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.08 175.79 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.763 2.025 . . . . 0.0 112.868 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.11 123.98 43.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 131.07 3.748 . . . . 0.0 101.343 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.83 115.13 22.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.365 1.466 . . . . 0.0 107.979 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.496 ' HG2' HG13 ' A' ' 50' ' ' VAL . 18.1 mtm -117.37 113.17 21.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 175.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.96 -139.94 2.99 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.354 1.454 . . . . 0.0 112.079 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -132.6 175.35 9.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.836 -1.391 . . . . 0.0 111.344 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.89 145.45 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -127.76 114.66 17.56 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.28 63.8 0.37 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.388 1.475 . . . . 0.0 114.874 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 170.29 -22.27 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 1 C-N-CA 132.361 4.264 . . . . 0.0 111.81 175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.22 -4.6 13.72 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.421 1.088 . . . . 0.0 110.718 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.78 -154.75 50.34 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 124.467 1.032 . . . . 0.0 113.162 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 126.59 11.7 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.025 2.483 . . . . 0.0 110.53 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.266 2.7 p -116.78 127.99 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.56 79.52 29.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.412 1.485 . . . . 0.0 109.586 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.96 170.58 13.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.422 3.415 . . . . 0.0 112.708 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.46 -26.31 70.45 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.411 2.074 . . . . 0.0 114.033 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -86.74 23.58 1.66 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.846 1.258 . . . . 0.0 111.208 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -83.37 142.34 31.1 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 108.305 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -82.94 114.05 20.96 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -135.94 119.87 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.16 0.584 . . . . 0.0 110.151 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.3 m -144.75 167.01 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.306 1.443 . . . . 0.0 108.662 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.51 149.31 48.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 110.266 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -69.25 131.5 44.98 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.915 0.886 . . . . 0.0 109.021 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -141.08 147.75 48.93 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.54 -37.85 55.72 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.539 2.826 . . . . 0.0 114.753 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -59.77 -49.23 78.52 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -58.08 -46.89 84.71 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.009 0.923 . . . . 0.0 109.433 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -51.76 -50.45 60.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 109.987 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -63.69 -42.45 97.99 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.634 -0.666 . . . . 0.0 111.847 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.64 -50.76 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.062 0.846 . . . . 0.0 109.347 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.84 -32.17 73.54 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.793 0.724 . . . . 0.0 109.368 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.47 -41.79 88.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.524 0.602 . . . . 0.0 110.121 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.18 -47.16 85.73 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 109.433 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.29 -24.23 66.52 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.491 1.116 . . . . 0.0 112.127 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -69.75 -55.99 8.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 0.0 109.858 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -72.48 -39.51 67.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.858 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 123.587 0.755 . . . . 0.0 110.426 175.123 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.04 -43.97 93.94 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.53 -48.12 80.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.581 0.628 . . . . 0.0 111.059 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.4 m -61.68 -50.61 71.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.502 0.592 . . . . 0.0 110.177 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -59.63 -44.84 93.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.853 -1.546 . . . . 0.0 110.37 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 50' ' ' VAL . 22.4 t80 -52.5 -51.22 60.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.098 1.317 . . . . 0.0 111.042 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.4 m -64.42 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.845 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.01 -60.4 2.52 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.007 0.523 . . . . 0.0 111.703 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 p -53.17 124.68 15.13 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.879 0.871 . . . . 0.0 110.931 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -81.99 -4.84 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.383 0.992 . . . . 0.0 109.51 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.455 HD21 ' HE2' ' A' ' 94' ' ' PHE . 34.1 tp -118.33 120.84 38.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.138 2.175 . . . . 0.0 108.658 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 44' ' ' PHE . 38.4 t -144.05 113.59 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -149.38 167.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.365 1.466 . . . . 0.0 108.704 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -127.01 140.61 52.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -157.83 168.17 27.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.787 -1.196 . . . . 0.0 111.379 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -114.87 130.85 56.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.53 113.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -71.42 -50.49 31.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 m -157.22 168.96 25.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.377 1.471 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.6 mtp -137.33 133.87 35.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.022 2.129 . . . . 0.0 108.033 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -136.66 148.02 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.901 1.28 . . . . 0.0 107.833 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -75.43 145.97 41.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.613 1.097 . . . . 0.0 109.701 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.506 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.2 mm-40 -123.27 171.08 7.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 127.102 2.161 . . . . 0.0 111.726 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.3 153.38 34.13 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.181 2.587 . . . . 0.0 113.361 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.89 -124.19 6.91 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.4 23.94 11.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.482 1.113 . . . . 0.0 108.46 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.52 179.57 53.08 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.836 1.798 . . . . 0.0 117.374 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -150.62 136.11 17.99 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.988 2.115 . . . . 0.0 107.037 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.506 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -102.69 123.59 46.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 175.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.03 123.22 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -99.78 125.22 45.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 3.6 m -131.91 174.49 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.369 0.667 . . . . 0.0 109.813 -175.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -132.17 41.56 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt 38.24 80.58 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.242 2.217 . . . . 0.0 115.918 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -77.11 -24.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.406 0.682 . . . . 0.0 112.201 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.07 162.74 34.96 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 126.145 1.831 . . . . 0.0 109.209 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 150.2 32.23 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.535 1.134 . . . . 0.0 108.827 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -143.22 -49.6 0.33 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.139 0.899 . . . . 0.0 111.879 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -131.98 123.68 27.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -141.18 65.37 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.71 2.404 . . . . 0.0 109.253 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.07 42.46 3.15 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.871 1.7 . . . . 0.0 110.929 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.76 -66.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 125.699 1.618 . . . . 0.0 110.601 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 mt -71.04 130.49 41.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.195 0.521 . . . . 0.0 111.728 -175.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -84.88 80.04 9.42 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.3 mt -58.91 139.15 87.15 Favored Pre-proline 0 C--O 1.238 0.455 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.46 174.07 12.18 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 120.971 1.114 . . . . 0.0 111.165 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 t -44.92 -59.71 3.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 116.514 -1.707 . . . . 0.0 110.004 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.78 118.59 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.963 1.775 . . . . 0.0 108.836 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.75 -152.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 124.005 3.137 . . . . 0.0 112.803 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.4 m -35.84 124.59 0.71 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.487 2.715 . . . . 0.0 113.206 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.95 30.06 0.44 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.9 1.714 . . . . 0.0 114.174 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.04 158.86 32.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.032 1.333 . . . . 0.0 108.808 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.1 p -98.54 153.68 18.46 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.193 -0.942 . . . . 0.0 112.155 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.0 mt -148.71 162.38 39.86 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.076 1.75 . . . . 0.0 109.458 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -126.11 114.04 17.86 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.906 1.682 . . . . 0.0 107.163 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HE2' HD21 ' A' ' 49' ' ' LEU . 32.9 m-85 -96.63 121.2 38.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.451 1.101 . . . . 0.0 110.15 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.31 113.73 18.7 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 124.155 0.909 . . . . 0.0 110.435 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.9 123.75 38.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -6.96 15.54 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.461 2.774 . . . . 0.0 115.536 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.0 m -137.42 121.03 17.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 127.708 2.403 . . . . 0.0 107.051 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.09 61.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -82.49 -30.34 29.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.028 1.285 . . . . 0.0 114.417 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -136.66 155.76 76.56 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.038 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.65 165.88 71.93 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.395 1.177 . . . . 0.0 112.064 2.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.82 104.36 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.934 2.423 . . . . 0.0 109.274 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.2 ttt -139.35 163.74 31.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.529 1.132 . . . . 0.0 109.283 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -143.56 153.89 43.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -75.49 142.08 42.95 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.73 21.98 67.62 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.055 1.312 . . . . 0.0 114.36 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.3 t -134.11 156.69 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.285 1.434 . . . . 0.0 109.485 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 132.71 40.72 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.821 1.648 . . . . 0.0 111.717 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -139.61 168.5 19.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.27 1.828 . . . . 0.0 111.712 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.6 tp -108.31 129.23 55.23 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 129.306 3.042 . . . . 0.0 102.86 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.0 114.07 22.6 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.5 mtm -119.33 113.01 20.16 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.02 -134.05 1.66 Allowed Glycine 0 CA--C 1.526 0.778 0 CA-C-N 120.112 1.323 . . . . 0.0 112.225 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -134.84 172.02 13.57 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.97 0.885 . . . . 0.0 112.015 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 49' ' ' LEU . 4.8 t -133.16 140.15 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.397 -0.815 . . . . 0.0 110.337 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -121.57 115.41 22.76 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.869 2.067 . . . . 0.0 111.624 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -71.82 63.69 0.46 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.07 2.548 . . . . 0.0 112.428 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.2 t30 163.39 -22.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 1 C-N-CA 134.041 4.936 . . . . 0.0 114.084 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -113.5 -4.83 13.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.29 1.036 . . . . 0.0 113.023 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.37 -162.38 49.43 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 91.3 Cg_endo -73.78 143.32 33.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 118.63 1.215 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.22 126.83 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 130' ' ' VAL . 2.2 tm? -120.28 78.4 26.63 Favored Pre-proline 0 C--N 1.325 -0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 109.972 -174.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.27 164.42 28.18 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.686 2.924 . . . . 0.0 110.946 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.05 -18.06 56.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.094 1.863 . . . . 0.0 114.707 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -84.13 22.85 1.13 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.443 1.019 . . . . 0.0 110.771 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.0 m -88.7 137.43 32.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.519 1.527 . . . . 0.0 107.25 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -78.79 113.62 17.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 124' ' ' LEU . 99.3 t -136.76 116.67 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.23 170.21 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.924 1.29 . . . . 0.0 109.615 -175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.08 132.16 49.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.15 0.98 . . . . 0.0 108.825 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 138.19 57.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -133.8 160.02 70.18 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.488 1.915 . . . . 0.0 107.035 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.02 -42.92 2.74 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.928 2.419 . . . . 0.0 110.415 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -58.53 -41.58 85.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.61 0.764 . . . . 0.0 111.252 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.21 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -57.24 -50.01 74.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.284 1.033 . . . . 0.0 110.294 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.3 -34.83 78.54 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.972 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.87 -47.61 75.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.511 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -61.39 -39.06 89.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.501 1.501 . . . . 0.0 108.973 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.5 m -61.09 -47.03 88.2 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -57.33 -46.38 83.31 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.875 0.87 . . . . 0.0 109.466 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.57 -33.78 76.35 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.071 0.948 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -69.38 -49.39 55.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -68.61 -36.6 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.82 0.848 . . . . 0.0 111.564 -175.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 . . . . . 0 C--O 1.234 0.274 0 C-N-CA 127.278 2.231 . . . . 0.0 110.355 175.237 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 C--O 1.235 0.301 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.82 -41.35 97.89 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.41 -43.97 88.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.01 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -66.48 -51.15 59.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.846 0.748 . . . . 0.0 111.033 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -52.34 -44.66 65.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.609 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 50' ' ' VAL . 23.9 t80 -52.41 -42.34 63.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.491 0.716 . . . . 0.0 112.704 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.1 m -75.82 -33.81 60.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -38.68 86.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.181 0.9 . . . . 0.0 111.713 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -68.36 130.58 43.31 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.454 0.701 . . . . 0.0 111.066 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -81.95 -8.14 59.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.865 0.866 . . . . 0.0 109.99 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.93 123.37 24.54 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.971 1.708 . . . . 0.0 107.998 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 44' ' ' PHE . 39.4 t -136.41 116.97 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.6 169.49 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 110.103 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -128.84 137.65 51.6 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -151.75 171.01 18.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.834 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -117.59 126.28 52.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.18 113.55 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -80.82 -52.48 7.45 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 9.6 m -145.11 171.42 14.53 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 125.418 1.487 . . . . 0.0 109.795 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.406 ' HB3' HD21 ' A' ' 66' ' ' LEU . 24.6 mtp -133.76 134.8 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.79 143.82 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -70.92 137.0 48.89 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.515 -1.365 . . . . 0.0 108.234 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.545 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.5 mm-40 -114.71 168.84 7.41 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.8 1.64 . . . . 0.0 108.86 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.37 161.52 20.01 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.331 2.02 . . . . 0.0 112.273 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -145.01 49.19 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.731 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -88.73 14.2 10.69 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.554 -0.968 . . . . 0.0 110.619 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.19 177.22 53.05 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.106 1.336 . . . . 0.0 115.588 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 58' ' ' MET . 2.2 tm? -152.76 140.19 19.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.73 2.812 . . . . 0.0 106.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.545 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -100.83 145.02 29.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.23 123.25 71.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -101.63 129.86 47.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.697 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 30.5 m -138.22 176.36 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.883 0.873 . . . . 0.0 111.48 -175.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -131.36 39.52 3.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.912 1.285 . . . . 0.0 112.185 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt 36.42 81.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.281 2.232 . . . . 0.0 115.553 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.4 mm -74.52 -32.48 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.504 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.13 161.96 31.92 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.023 1.296 . . . . 0.0 110.242 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.49 152.74 40.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.67 1.588 . . . . 0.0 108.053 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -139.79 -24.42 0.84 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.643 0.589 . . . . 0.0 112.379 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -157.99 138.86 13.11 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.826 2.05 . . . . 0.0 106.117 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -146.85 72.38 1.27 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.214 3.006 . . . . 0.0 105.74 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 50.07 4.34 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 126.618 2.056 . . . . 0.0 109.353 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.19 -70.74 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 126.088 1.804 . . . . 0.0 113.302 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.5 131.73 51.66 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.275 1.03 . . . . 0.0 111.425 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -82.27 89.18 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.32 139.79 96.46 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.24 -175.87 1.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.529 2.153 . . . . 0.0 112.07 -175.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 t -42.83 -58.8 3.51 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.853 1.661 . . . . 0.0 109.215 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.07 147.56 21.04 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 N-CA-C 107.095 -1.925 . . . . 0.0 107.095 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.75 -154.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 1 C-N-CA 126.141 4.561 . . . . 0.0 111.665 175.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.565 HG21 ' HA2' ' A' ' 74' ' ' GLY . 4.4 m -34.01 139.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.953 2.501 . . . . 0.0 113.311 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.52 -1.27 3.98 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.088 2.28 . . . . 0.0 114.496 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.32 148.55 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.351 1.576 . . . . 0.0 108.579 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 p -77.29 149.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.184 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -147.34 161.03 41.83 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.94 0.896 . . . . 0.0 110.034 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -127.42 116.93 21.21 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.93 124.59 42.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.231 1.012 . . . . 0.0 109.499 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.452 ' HB3' HG23 ' A' ' 123' ' ' VAL . 28.5 t80 -74.06 114.02 11.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.733 1.213 . . . . 0.0 109.775 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.09 115.61 58.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.43 1.24 6.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 95.1 m -132.02 113.63 13.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.744 1.217 . . . . 0.0 109.204 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.98 -12.5 59.37 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.734 -0.604 . . . . 0.0 112.287 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.55 -35.83 24.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 113.753 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -157.16 163.04 26.34 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.564 1.946 . . . . 0.0 110.003 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.37 153.31 81.91 Favored 'Cis proline' 0 CA--C 1.541 0.871 0 O-C-N 122.626 0.803 . . . . 0.0 111.29 -3.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.7 122.47 8.58 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.229 2.619 . . . . 0.0 111.808 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 13.1 ttp -145.8 160.51 41.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.409 1.883 . . . . 0.0 108.685 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -134.48 145.42 48.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 85.5 tttt -64.02 142.71 58.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.17 35.33 77.4 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.044 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.8 t -140.83 159.3 23.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.926 2.09 . . . . 0.0 107.5 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -101.43 133.65 45.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.38 1.072 . . . . 0.0 111.502 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 104' ' ' MET . 45.7 m-85 -137.21 165.4 26.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.629 1.572 . . . . 0.0 111.303 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 124.63 51.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 129.942 3.297 . . . . 0.0 103.522 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.17 119.55 32.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.836 1.654 . . . . 0.0 107.524 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.0 mtm -120.68 113.25 19.94 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.14 -137.7 2.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.109 1.814 . . . . 0.0 111.525 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -136.63 176.49 8.65 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.172 1.389 . . . . 0.0 108.689 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.3 132.01 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.14 113.84 27.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -80.07 63.56 4.62 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.52 -42.47 0.05 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 128.484 2.714 . . . . 0.0 110.452 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -126.24 -4.32 6.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.25 1.02 . . . . 0.0 113.118 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.59 -151.77 18.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.77 137.31 29.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.821 1.681 . . . . 0.0 110.013 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.6 p -119.99 153.06 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.54 80.18 39.26 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -62.15 171.0 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.997 3.798 . . . . 0.0 113.624 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.55 -19.11 64.76 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.756 1.637 . . . . 0.0 113.195 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.6 23.19 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.117 1.367 . . . . 0.0 112.942 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 129.69 35.08 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.821 -0.549 . . . . 0.0 110.135 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -80.57 115.48 20.1 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.5 117.49 35.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 123.735 0.814 . . . . 0.0 109.194 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.8 m -145.49 167.34 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 109.52 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.79 136.54 57.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.444 0.698 . . . . 0.0 110.7 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -67.25 144.35 55.98 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.233 0.613 . . . . 0.0 109.898 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 150.3 29.88 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 127.585 2.354 . . . . 0.0 107.481 175.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.84 -34.26 31.1 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.593 2.195 . . . . 0.0 111.401 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -61.58 -43.09 99.5 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.023 -0.423 . . . . 0.0 111.087 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.32 -41.91 76.05 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.415 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -48.15 -55.93 9.13 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.749 1.22 . . . . 0.0 109.911 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -55.41 -44.11 75.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.687 1.595 . . . . 0.0 111.905 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.54 -49.21 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.004 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.22 -41.03 99.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.012 0.824 . . . . 0.0 108.977 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -59.43 -43.57 93.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.921 0.888 . . . . 0.0 110.639 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.25 -40.54 86.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.81 -33.37 75.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.742 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -66.11 -35.7 81.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.519 1.128 . . . . 0.0 111.028 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -75.88 -40.65 54.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 120.855 -1.153 . . . . 0.0 109.344 175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 . . . . . 0 N--CA 1.445 -0.694 0 CA-C-O 122.605 1.193 . . . . 0.0 109.024 175.4 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -86.93 53.78 2.86 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.124 1.883 . . . . 0.0 110.007 -169.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.37 33.09 2.08 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 127.891 2.476 . . . . 0.0 111.811 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -97.34 113.95 64.05 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 104.149 -2.537 . . . . 0.0 104.149 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -79.6 -167.15 0.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.917 3.078 . . . . 0.0 111.117 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.6 m -49.66 160.28 0.3 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.66 1.984 . . . . 0.0 107.166 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.9 t -83.73 121.81 76.28 Favored Pre-proline 0 C--O 1.235 0.306 0 O-C-N 120.056 -1.653 . . . . 0.0 108.663 -175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -74.18 171.25 18.38 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 123.719 2.946 . . . . 0.0 110.295 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -77.12 -18.02 58.23 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-O 118.771 -0.633 . . . . 0.0 111.495 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -55.06 129.08 36.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.041 0.937 . . . . 0.0 110.174 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.94 62.19 1.6 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.0 ttt85 -158.01 161.18 38.07 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.818 0.847 . . . . 0.0 111.706 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -116.1 156.15 26.91 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 127.615 2.366 . . . . 0.0 110.266 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -142.56 175.81 9.51 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.002 2.521 . . . . 0.0 110.663 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.03 -178.88 25.12 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.901 1.715 . . . . 0.0 115.025 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.7 p -92.19 174.47 7.29 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.73 -0.865 . . . . 0.0 110.502 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.33 -47.24 74.14 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 118.129 -0.938 . . . . 0.0 108.996 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -61.67 -48.11 82.29 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.322 0.965 . . . . 0.0 111.169 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -49.86 -56.75 9.25 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.719 0.808 . . . . 0.0 110.481 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -68.66 -40.48 80.17 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 116.789 -1.577 . . . . 0.0 111.898 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD2' HG11 ' A' ' 50' ' ' VAL . 42.4 t80 -54.61 -46.4 73.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.435 1.47 . . . . 0.0 110.617 176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.7 m -71.88 -24.27 61.64 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.834 0.854 . . . . 0.0 112.496 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.39 18.65 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -62.93 132.43 52.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.91 1.284 . . . . 0.0 111.993 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -82.93 -8.16 59.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.523 0.729 . . . . 0.0 110.657 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 41.3 tp -134.83 124.48 25.14 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 125.457 1.503 . . . . 0.0 108.122 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG11 ' CD2' ' A' ' 44' ' ' PHE . 17.3 t -137.83 115.36 12.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.91 172.2 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.218 1.407 . . . . 0.0 110.303 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.0 p -129.24 139.93 51.65 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -158.88 175.33 13.71 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.746 -1.221 . . . . 0.0 110.918 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.7 m -121.79 134.55 54.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 68' ' ' VAL . 64.0 t -77.13 114.02 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -77.48 -54.89 5.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.6 m -142.61 171.46 14.03 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.72 0.808 . . . . 0.0 110.677 -175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.2 mtp -138.05 133.15 33.18 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.639 1.976 . . . . 0.0 105.845 175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -136.86 140.84 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.812 1.245 . . . . 0.0 107.798 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -70.24 151.68 45.07 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 119.393 0.997 . . . . 0.0 110.006 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -134.77 175.11 3.89 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.854 1.661 . . . . 0.0 108.173 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -58.62 160.18 18.12 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 124.299 3.333 . . . . 0.0 114.095 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 57.4 -141.89 43.53 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.66 17.3 3.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.895 0.878 . . . . 0.0 110.313 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.88 166.6 48.94 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-O 123.224 1.458 . . . . 0.0 115.143 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -155.35 139.83 16.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.465 2.706 . . . . 0.0 106.195 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.04 145.95 31.74 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG13 HG13 ' A' ' 55' ' ' VAL . 94.9 t -118.04 123.08 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -89.84 133.37 34.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.5 m -135.81 173.37 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.082 0.953 . . . . 0.0 111.104 -175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 t -132.96 38.01 3.39 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 124.17 0.988 . . . . 0.0 112.965 -176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.7 mt 37.49 81.23 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.297 1.839 . . . . 0.0 115.061 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -76.04 -33.07 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 118.981 0.809 . . . . 0.0 110.911 176.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.514 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -160.84 161.87 33.12 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.028 1.299 . . . . 0.0 110.627 177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.24 146.01 31.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.184 1.394 . . . . 0.0 109.513 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -131.02 -41.32 1.13 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.873 0.869 . . . . 0.0 110.991 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -140.3 123.79 17.05 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.42 59.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.077 2.151 . . . . 0.0 107.568 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.04 35.8 2.74 Favored Glycine 0 N--CA 1.464 0.536 0 C-N-CA 124.456 1.027 . . . . 0.0 113.702 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -10.65 0.04 OUTLIER Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.511 2.005 . . . . 0.0 114.669 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mt -101.17 129.06 47.01 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 119.554 1.677 . . . . 0.0 110.515 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -85.84 67.86 10.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.8 mt -58.26 152.54 41.81 Favored Pre-proline 0 CA--C 1.537 0.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.589 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -64.84 172.1 7.59 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.215 1.943 . . . . 0.0 111.523 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.3 t -52.09 -60.12 6.87 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-O 117.637 -1.173 . . . . 0.0 109.307 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.88 139.6 40.2 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 N-CA-C 107.164 -1.898 . . . . 0.0 107.164 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.62 -157.1 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.89 2.393 . . . . 0.0 112.293 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.514 HG21 ' HA2' ' A' ' 74' ' ' GLY . 40.4 m -34.74 133.63 0.26 Allowed 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 130.703 3.601 . . . . 0.0 112.42 -176.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.47 34.58 0.28 Allowed Glycine 0 C--N 1.339 0.741 0 C-N-CA 125.776 1.655 . . . . 0.0 110.225 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.79 166.69 20.99 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.7 2.0 . . . . 0.0 108.572 -175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 93.5 p -103.3 149.62 24.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 122.003 0.906 . . . . 0.0 112.014 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 56.3 mt -145.07 170.83 15.44 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.758 1.223 . . . . 0.0 109.004 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -127.2 115.12 18.59 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 103.467 -2.79 . . . . 0.0 103.467 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -89.49 120.19 30.59 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -77.56 113.64 15.59 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.057 0.943 . . . . 0.0 108.54 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.0 113.47 62.51 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -76.67 -1.31 11.41 Favored 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.124 1.883 . . . . 0.0 112.998 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.0 m -134.12 113.59 12.23 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.605 1.562 . . . . 0.0 110.083 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -75.54 -5.76 46.87 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.006 -1.059 . . . . 0.0 113.806 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -78.6 -53.27 7.36 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.378 0.671 . . . . 0.0 110.606 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.6 m -154.46 165.5 17.92 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 127.006 2.122 . . . . 0.0 110.282 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -64.66 151.93 74.95 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 119.625 0.902 . . . . 0.0 110.178 -3.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.23 138.79 44.15 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.405 2.07 . . . . 0.0 111.764 -175.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 ttm -149.43 170.92 17.47 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 120.918 -1.114 . . . . 0.0 111.444 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.76 138.27 54.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.46 34.65 63.44 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 118.608 -1.106 . . . . 0.0 113.736 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.07 160.51 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.723 1.761 . . . . 0.0 107.963 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -99.61 136.38 39.62 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 125.354 1.461 . . . . 0.0 110.417 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -139.51 168.05 20.7 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.304 1.442 . . . . 0.0 112.615 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.94 123.62 50.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 101.034 -3.691 . . . . 0.0 101.034 175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.9 113.98 21.88 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.539 ' HG2' HG13 ' A' ' 50' ' ' VAL . 27.0 mtm -117.66 113.21 21.57 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 175.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.97 -140.19 3.09 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 126.123 1.821 . . . . 0.0 109.687 -175.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -135.38 175.28 9.73 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.289 1.045 . . . . 0.0 109.548 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -118.89 159.16 19.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -129.84 112.93 14.06 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -85.43 63.64 8.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -177.4 -32.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.202 2.601 . . . . 0.0 110.851 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -127.51 -9.69 5.69 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.91 -152.83 19.97 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.55 144.05 19.65 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.607 2.204 . . . . 0.0 111.708 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.27 8.5 p -126.7 149.76 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.257 1.6 tm? -137.53 75.23 45.08 Favored Pre-proline 0 CA--C 1.542 0.646 0 O-C-N 121.22 -0.925 . . . . 0.0 108.827 -174.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -64.9 170.93 9.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.539 3.493 . . . . 0.0 112.91 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.71 -20.15 67.91 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 121.864 1.709 . . . . 0.0 114.079 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -83.65 22.99 1.01 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.718 1.207 . . . . 0.0 111.417 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.1 m -91.62 137.24 32.52 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 120.301 -1.499 . . . . 0.0 110.641 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -86.85 114.39 23.45 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -127.64 126.7 67.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.65 0.738 . . . . 0.0 109.331 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.8 m -146.1 163.25 10.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.573 1.949 . . . . 0.0 107.018 176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.03 149.33 47.68 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.196 0.522 . . . . 0.0 110.063 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.81 123.99 24.47 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -119.99 155.34 55.46 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-O 117.073 -1.441 . . . . 0.0 107.88 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.07 -42.47 6.01 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.982 2.455 . . . . 0.0 110.452 175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -55.05 -53.09 60.21 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 122.957 0.503 . . . . 0.0 110.669 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.85 -44.4 82.12 Favored 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.531 0.732 . . . . 0.0 110.612 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -56.52 -53.28 59.33 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.198 0.999 . . . . 0.0 110.56 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -59.73 -36.45 76.6 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.31 1.044 . . . . 0.0 111.523 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 61.7 mt -65.33 -60.45 2.67 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 C-N-CA 124.478 1.111 . . . . 0.0 108.766 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -58.81 -34.98 72.11 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.149 1.341 . . . . 0.0 110.949 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.53 -49.58 76.96 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -63.32 -31.58 72.77 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-O 117.904 -1.046 . . . . 0.0 112.606 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 50.1 mt -68.66 -31.38 70.47 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 119.295 0.952 . . . . 0.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 11.0 t -76.7 -34.57 58.17 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.421 0.555 . . . . 0.0 109.67 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -67.07 -58.79 4.23 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.8 mtm180 -72.92 159.48 33.64 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.702 0.801 . . . . 0.0 110.489 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -76.88 154.0 34.19 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 14.2 m -62.59 124.98 85.1 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.405 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.12 93.17 1.1 Allowed 'Trans proline' 0 N--CA 1.45 -1.083 0 CA-C-N 119.754 0.948 . . . . 0.0 109.666 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.1 m -166.4 85.42 0.3 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -123.7 113.06 28.87 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -112.59 -176.66 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.826 3.017 . . . . 0.0 110.362 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.249 1.061 0 C-N-CA 125.74 1.616 . . . . 0.0 106.924 176.014 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.87 160.74 47.07 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.907 1.738 . . . . 0.0 110.786 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -88.76 62.19 6.32 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 124.633 1.173 . . . . 0.0 110.78 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.79 134.68 56.73 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.75 177.5 6.2 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.079 2.519 . . . . 0.0 113.187 -175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.0 m -54.82 148.12 13.69 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.95 1.3 . . . . 0.0 110.348 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.6 t -83.64 108.15 12.54 Favored Pre-proline 0 N--CA 1.449 -0.512 0 C-N-CA 127.847 2.459 . . . . 0.0 107.032 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -79.03 171.66 16.07 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.373 2.715 . . . . 0.0 110.673 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.2 mtmm -73.75 -22.62 59.8 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 152.74 30.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.019 1.728 . . . . 0.0 109.175 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.5 t -137.05 102.88 4.97 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.927 0.891 . . . . 0.0 110.36 -175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -133.63 166.22 23.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.496 1.519 . . . . 0.0 109.022 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 58.9 ttp85 -123.07 146.4 47.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 126.282 1.833 . . . . 0.0 106.942 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -138.24 172.42 12.94 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.122 1.369 . . . . 0.0 111.087 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.73 -160.41 47.66 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.953 1.263 . . . . 0.0 113.706 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 p -125.47 171.19 10.69 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.559 HD21 HD23 ' A' ' 141' ' ' LEU . 7.1 tt -63.71 -44.17 94.42 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.593 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -62.55 -49.22 76.16 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.278 0.944 . . . . 0.0 111.628 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.3 m -56.12 -46.62 79.09 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 122.992 0.517 . . . . 0.0 110.428 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -73.8 -44.06 56.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.237 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.54 ' CD2' HG11 ' A' ' 50' ' ' VAL . 7.6 t80 -54.72 -44.29 73.35 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.843 1.656 . . . . 0.0 110.15 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.7 -23.93 61.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.417 -0.802 . . . . 0.0 113.032 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.18 -46.4 28.68 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.496 1.044 . . . . 0.0 110.406 175.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.5 p -69.14 132.32 46.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.665 1.186 . . . . 0.0 111.181 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -81.32 -12.85 58.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.477 1.035 . . . . 0.0 109.361 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.5 tp -122.75 125.11 44.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.605 1.562 . . . . 0.0 109.93 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.54 HG11 ' CD2' ' A' ' 44' ' ' PHE . 42.2 t -141.01 114.03 4.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.2 m -147.2 166.76 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 125.575 1.55 . . . . 0.0 109.222 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 p -124.05 148.91 46.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 175.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -159.09 171.21 20.38 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 120.766 -1.209 . . . . 0.0 110.906 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.3 m -124.03 128.08 48.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.41 113.65 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.415 ' O ' ' HE3' ' A' ' 106' ' ' LYS . 20.9 mmmt -84.21 -38.17 20.92 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.271 1.028 . . . . 0.0 110.042 176.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 m -151.25 165.86 32.67 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 121.227 -0.921 . . . . 0.0 110.138 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.8 mtp -143.75 124.67 14.31 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 175.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.52 146.1 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' H ' ' HD2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -65.56 152.31 44.37 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.486 -0.759 . . . . 0.0 109.889 -176.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -134.29 169.76 13.06 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 126.865 2.066 . . . . 0.0 109.481 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -38.59 134.06 0.89 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 125.084 3.856 . . . . 0.0 117.492 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.23 -123.61 33.5 Favored Glycine 0 CA--C 1.522 0.521 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.814 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -88.72 22.55 2.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.364 1.465 . . . . 0.0 110.18 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.44 166.28 45.53 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 120.676 -1.265 . . . . 0.0 113.997 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -151.86 138.52 18.77 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.489 1.516 . . . . 0.0 108.349 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.54 128.89 55.52 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.45 123.28 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 104.369 -2.456 . . . . 0.0 104.369 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -93.43 125.14 37.88 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 11.6 m -122.89 174.17 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.432 1.493 . . . . 0.0 111.169 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.1 t -135.25 40.38 2.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.626 0.648 . . . . 0.0 109.91 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 36.4 mt 38.11 77.9 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.571 2.748 . . . . 0.0 114.19 176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 47.7 mm -75.54 -23.34 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 120.802 1.637 . . . . 0.0 111.133 -177.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.81 159.06 32.05 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.76 141.33 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 124.195 0.998 . . . . 0.0 108.527 -177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -135.31 -33.36 0.9 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.258 0.623 . . . . 0.0 110.823 -175.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -148.99 125.06 10.7 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.26 58.68 1.7 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.512 2.325 . . . . 0.0 107.782 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.64 36.19 2.82 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-O 119.077 -0.846 . . . . 0.0 113.276 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.04 -25.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.825 0 CA-C-O 116.707 -2.163 . . . . 0.0 116.483 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.5 mt -116.39 155.09 29.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 121.101 2.451 . . . . 0.0 112.555 175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -78.69 94.39 5.07 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 128.399 2.679 . . . . 0.0 109.047 176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.2 mt -64.14 131.57 95.04 Favored Pre-proline 0 C--O 1.235 0.341 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.72 -178.69 4.25 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 121.942 1.762 . . . . 0.0 111.103 -175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.8 t -53.58 -58.92 10.9 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 117.508 -1.234 . . . . 0.0 108.203 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -65.59 116.02 3.7 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.596 2.197 . . . . 0.0 110.805 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.427 ' HB2' ' H ' ' A' ' 88' ' ' THR . 65.5 Cg_endo -78.14 -152.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.236 2.624 . . . . 0.0 110.677 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.427 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 24.1 m -33.17 123.76 0.39 Allowed 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 130.625 3.57 . . . . 0.0 111.771 -175.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.16 -16.71 6.33 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.394 2.426 . . . . 0.0 110.986 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.79 150.82 40.82 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 118.312 1.056 . . . . 0.0 111.363 -175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.6 p -86.01 145.51 27.07 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.4 mt -146.92 164.24 33.55 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.243 1.817 . . . . 0.0 109.37 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.9 mtmm -117.66 113.42 21.87 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -89.24 119.15 29.47 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -79.76 114.08 18.41 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.06 1.344 . . . . 0.0 109.94 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.14 114.24 59.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.83 -4.43 14.06 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.108 1.872 . . . . 0.0 113.225 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.7 m -138.17 113.63 9.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.087 1.755 . . . . 0.0 108.823 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -74.29 -7.49 52.98 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.257 -0.902 . . . . 0.0 112.787 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.98 -57.14 3.67 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 126.43 1.892 . . . . 0.0 108.97 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.4 m -152.59 160.49 31.11 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 125.044 1.338 . . . . 0.0 111.829 -175.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.06 161.12 70.29 Favored 'Cis proline' 0 CA--C 1.54 0.82 0 CA-C-N 120.0 1.036 . . . . 0.0 111.887 3.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -59.42 139.76 91.09 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.163 2.575 . . . . 0.0 112.502 -175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -153.0 150.95 29.73 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.864 0.866 . . . . 0.0 110.157 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -144.37 150.8 38.34 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 109.872 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 56' ' ' LYS . 88.4 tttt -79.09 138.68 38.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.31 44.11 76.18 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 176.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 75.2 t -142.6 156.05 18.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.8 m -102.93 128.64 49.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.589 0.756 . . . . 0.0 110.393 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -126.46 171.3 11.16 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.383 1.873 . . . . 0.0 112.314 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.49 123.64 43.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 175.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.36 114.0 22.27 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.9 mtm -116.83 113.14 22.1 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 102.334 -3.21 . . . . 0.0 102.334 175.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.88 -142.71 3.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.606 1.098 . . . . 0.0 110.675 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -128.4 -178.87 4.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.971 0.891 . . . . 0.0 109.42 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.99 147.2 28.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -125.55 113.65 17.71 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 174.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -79.13 63.55 3.81 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -177.34 -26.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.386 1.875 . . . . 0.0 111.616 -175.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 -7.37 3.17 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.706 0.802 . . . . 0.0 112.978 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 98.54 -164.19 20.96 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 118.724 0.693 . . . . 0.0 111.447 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -70.81 133.9 24.62 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.444 2.096 . . . . 0.0 109.8 -176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.265 2.9 p -118.83 134.76 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.96 76.11 21.84 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 0.0 109.082 -174.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -66.72 172.8 8.92 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 124.922 3.748 . . . . 0.0 112.69 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -63.86 -34.36 60.97 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.68 2.253 . . . . 0.0 114.632 -176.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.79 23.89 1.12 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 119.293 0.951 . . . . 0.0 111.59 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 71.3 m -85.11 146.93 26.89 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.469 1.507 . . . . 0.0 109.968 176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -91.23 113.74 26.08 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.2 t -132.18 113.9 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.84 165.58 9.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 123.373 0.669 . . . . 0.0 109.272 -176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.04 147.75 52.91 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -67.7 149.62 49.75 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.067 0.947 . . . . 0.0 108.766 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -149.98 152.55 34.31 Favored Pre-proline 0 N--CA 1.472 0.633 0 C-N-CA 127.961 2.504 . . . . 0.0 105.234 175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -70.01 -35.95 11.01 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.009 2.473 . . . . 0.0 112.434 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -61.72 -49.44 76.43 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.773 -0.579 . . . . 0.0 110.176 176.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -54.97 -54.27 44.94 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -44.9 -55.0 5.84 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.913 2.085 . . . . 0.0 111.8 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 64.4 tp60 -56.24 -43.7 78.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.506 0.722 . . . . 0.0 111.708 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.9 mt -66.34 -40.11 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 118.709 -0.662 . . . . 0.0 109.479 -176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.559 HD23 HD21 ' A' ' 40' ' ' LEU . 8.5 mt -58.82 -43.26 90.58 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.7 m -62.08 -41.84 98.59 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.494 0.718 . . . . 0.0 111.031 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -57.56 -43.41 84.47 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.879 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 mt -76.21 -24.15 54.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.039 1.736 . . . . 0.0 112.819 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -74.24 -35.46 63.85 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.383 1.473 . . . . 0.0 109.645 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -76.53 -65.77 0.89 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.056 0.942 . . . . 0.0 109.1 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -66.22 151.42 47.03 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 118.415 0.552 . . . . 0.0 110.636 -176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -72.78 144.4 47.58 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 122.969 0.508 . . . . 0.0 110.102 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 35.1 m -76.03 124.69 88.49 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -65.49 121.43 8.83 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 121.548 1.499 . . . . 0.0 109.264 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.2 p -128.63 65.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.238 1.415 . . . . 0.0 107.194 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -140.17 123.11 10.17 Favored Pre-proline 0 C--O 1.237 0.42 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.33 121.16 7.51 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.066 1.844 . . . . 0.0 111.125 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.256 1.412 0 C-N-CA 130.411 3.485 . . . . 0.0 102.367 175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m . . . . . 0 N--CA 1.469 0.518 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.82 165.9 31.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.394 2.063 . . . . 0.0 112.151 -155.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -74.64 33.57 0.09 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 128.671 2.788 . . . . 0.0 112.86 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.65 113.65 2.73 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 127.682 2.393 . . . . 0.0 111.246 -176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.84 74.33 5.56 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.267 3.311 . . . . 0.0 108.495 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.5 m -142.7 166.34 24.92 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.315 1.846 . . . . 0.0 109.022 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.0 t -156.46 109.01 2.03 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.649 1.579 . . . . 0.0 109.023 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.38 164.0 29.3 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.096 1.864 . . . . 0.0 107.676 175.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.1 -18.97 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.185 -0.947 . . . . 0.0 112.344 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -48.84 128.34 15.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.643 1.177 . . . . 0.0 110.091 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 48.9 t -148.25 88.41 1.65 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.14 0.971 . . . . 0.0 108.571 -177.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.68 164.0 37.62 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -103.8 123.36 46.94 Favored 'General case' 0 C--O 1.235 0.294 1 N-CA-C 100.144 -4.021 . . . . 0.0 100.144 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -156.36 176.11 13.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 119.5 1.045 . . . . 0.0 108.456 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.8 -171.11 17.74 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 122.793 1.218 . . . . 0.0 113.419 175.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -101.32 164.95 11.53 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.123 2.169 . . . . 0.0 109.03 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -94.24 -54.96 3.36 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.449 HE21 HD21 ' A' ' 144' ' ' LEU . 47.3 mt-30 -65.0 -43.17 93.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 118.474 -0.774 . . . . 0.0 111.288 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -70.63 -47.89 57.8 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 118.402 -1.319 . . . . 0.0 109.093 -176.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.94 -36.37 83.21 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-O 117.401 -1.285 . . . . 0.0 109.635 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.624 ' CD1' HG11 ' A' ' 50' ' ' VAL . 34.7 t80 -57.29 -43.69 83.42 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.897 1.226 . . . . 0.0 110.69 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.3 m -74.38 -23.58 59.01 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.52 -34.34 63.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 119.996 1.271 . . . . 0.0 111.527 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.8 p -76.52 126.69 31.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.4 t -79.69 -11.71 59.84 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 121.922 0.867 . . . . 0.0 108.814 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.507 ' HB2' HG23 ' A' ' 116' ' ' VAL . 41.3 tp -120.75 114.84 22.23 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 127.163 2.185 . . . . 0.0 108.978 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG11 ' CD1' ' A' ' 44' ' ' PHE . 3.0 t -138.88 112.89 7.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 175.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.62 167.06 2.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 125.908 1.683 . . . . 0.0 108.332 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 111' ' ' LEU . 3.6 p -131.18 142.54 50.21 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -162.96 172.09 15.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.531 -0.731 . . . . 0.0 111.274 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 28.1 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 175.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.7 t -75.67 113.57 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -84.35 -53.77 5.24 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.35 1.06 . . . . 0.0 108.479 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 m -140.23 169.09 18.33 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.167 1.387 . . . . 0.0 109.363 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.94 132.32 38.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.24 144.73 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -73.08 141.91 47.57 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.577 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 47.3 mm-40 -123.64 176.05 2.44 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 128.045 2.538 . . . . 0.0 109.365 -175.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 61' ' ' GLU . 41.4 Cg_endo -60.94 150.53 83.35 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.681 2.254 . . . . 0.0 112.765 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.91 -123.95 29.53 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 -175.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.99 23.75 14.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.463 1.105 . . . . 0.0 109.931 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.79 166.73 46.32 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-O 122.816 1.231 . . . . 0.0 111.874 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -150.38 131.27 14.2 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.4 137.63 39.48 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.5 t -108.38 123.46 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -97.66 126.41 42.97 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 15.3 m -131.49 176.67 8.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 125.168 1.387 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -135.1 39.21 2.95 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.0 mt 36.07 83.16 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.5 mm -78.56 -30.01 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 121.158 -0.964 . . . . 0.0 111.4 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.469 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.77 160.73 31.32 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 125.174 1.368 . . . . 0.0 109.761 176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.84 143.31 26.21 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.299 1.04 . . . . 0.0 108.87 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -126.87 -49.22 1.48 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.59 1.156 . . . . 0.0 108.616 -176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -142.07 142.06 32.81 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.743 1.217 . . . . 0.0 107.97 176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.5 p -146.91 72.04 1.25 Allowed 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.298 2.639 . . . . 0.0 105.799 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 38.61 2.77 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 124.263 0.935 . . . . 0.0 112.881 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.63 -11.42 0.03 OUTLIER Glycine 0 CA--C 1.535 1.293 0 C-N-CA 126.799 2.143 . . . . 0.0 112.91 175.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -116.35 123.17 46.95 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 120.623 2.211 . . . . 0.0 108.865 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -80.22 75.34 7.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.585 -2.098 . . . . 0.0 106.845 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.9 mt -50.58 138.34 22.46 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.47 177.19 2.83 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.117 1.878 . . . . 0.0 111.636 -175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.3 t -48.74 -55.73 18.45 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.096 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.88 137.55 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.56 1.506 . . . . 0.0 108.634 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.18 -154.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.437 3.425 . . . . 0.0 112.068 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.469 HG21 ' HA2' ' A' ' 74' ' ' GLY . 16.8 m -33.06 123.9 0.38 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 129.828 3.251 . . . . 0.0 111.415 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.3 0.49 1.18 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.01 1.767 . . . . 0.0 113.75 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -91.94 150.07 21.21 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.396 1.598 . . . . 0.0 110.025 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.0 p -87.9 142.15 28.02 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.692 -0.63 . . . . 0.0 110.193 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 mt -145.33 161.04 40.58 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.426 1.091 . . . . 0.0 109.85 -176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -116.39 125.12 51.61 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.212 2.205 . . . . 0.0 106.937 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.465 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.1 m-85 -106.45 123.37 47.97 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.721 1.609 . . . . 0.0 110.132 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.416 ' HB3' HG23 ' A' ' 123' ' ' VAL . 44.1 t80 -78.09 114.55 17.07 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.743 1.617 . . . . 0.0 111.56 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.92 114.43 61.59 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -69.97 -9.16 25.38 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.707 2.272 . . . . 0.0 115.555 -175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.7 m -148.46 130.79 15.61 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 125.217 1.407 . . . . 0.0 108.513 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -73.55 -3.94 30.89 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.843 1.424 . . . . 0.0 114.843 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -73.05 -51.22 18.94 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.599 1.091 . . . . 0.0 113.181 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.2 m -140.02 164.39 37.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 125.833 1.653 . . . . 0.0 111.942 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.03 163.5 76.18 Favored 'Cis proline' 0 CA--C 1.546 1.098 0 CA-C-N 119.381 0.815 . . . . 0.0 111.831 -2.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.27 86.95 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.983 3.122 . . . . 0.0 113.85 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 ttp -114.3 162.83 16.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.44 1.896 . . . . 0.0 109.44 179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -146.19 158.24 43.87 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.258 1.023 . . . . 0.0 110.69 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -70.74 139.11 51.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 125.283 1.433 . . . . 0.0 110.787 175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.31 35.45 91.53 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 124.489 1.042 . . . . 0.0 115.058 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.3 t -134.54 152.03 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 108.531 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 19.9 m -96.38 134.66 39.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.95 0.881 . . . . 0.0 110.427 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -139.48 167.69 21.52 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.155 1.782 . . . . 0.0 112.759 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.601 ' HA ' HG22 ' A' ' 52' ' ' THR . 15.9 tp -103.91 132.24 50.35 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 175.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.39 113.42 20.77 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.471 ' HG2' HG13 ' A' ' 50' ' ' VAL . 8.6 mtm -117.49 115.78 25.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 100.503 -3.888 . . . . 0.0 100.503 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.04 -143.7 3.74 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 125.048 1.308 . . . . 0.0 110.717 -175.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -130.02 178.65 6.38 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.253 1.026 . . . . 0.0 108.943 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 49' ' ' LEU . 25.8 t -136.1 141.93 40.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 120.786 -1.196 . . . . 0.0 108.304 175.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -108.22 113.08 25.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -83.06 63.58 7.19 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -170.01 -40.36 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 128.956 2.903 . . . . 0.0 109.209 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -126.18 -5.88 6.64 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 103.74 -164.7 15.33 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -65.22 137.34 51.37 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.038 1.419 . . . . 0.0 109.454 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 95' ' ' TYR . 3.5 p -120.39 124.68 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 2.2 tm? -114.89 78.98 5.64 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -175.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.92 171.26 11.4 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.204 3.27 . . . . 0.0 112.246 -175.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.85 -23.94 76.62 Favored 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.106 1.871 . . . . 0.0 113.126 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -86.06 23.93 1.41 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.97 1.259 . . . . 0.0 111.46 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 69.4 m -84.4 128.57 34.66 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.602 -1.311 . . . . 0.0 108.972 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.461 ' CD1' ' HE2' ' A' ' 113' ' ' MET . 40.2 t80 -80.04 113.51 18.26 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 175.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.58 116.55 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 m -140.96 174.5 7.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 123.719 0.808 . . . . 0.0 111.01 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.34 123.78 20.04 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.624 1.57 . . . . 0.0 109.14 -176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -75.99 142.46 41.91 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 121.706 -0.621 . . . . 0.0 109.491 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -154.5 156.01 31.22 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 128.124 2.57 . . . . 0.0 106.586 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.01 -35.15 21.07 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.614 2.209 . . . . 0.0 113.362 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -56.47 -50.92 70.32 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.952 0.882 . . . . 0.0 110.143 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -64.39 -32.52 74.17 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.673 -0.642 . . . . 0.0 111.651 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -59.14 -53.11 62.0 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.005 0.82 . . . . 0.0 110.445 176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -62.75 -36.48 83.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.934 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 74.2 mt -57.23 -51.66 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.844 0.747 . . . . 0.0 109.142 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mt -66.93 -41.72 86.57 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.12 0.568 . . . . 0.0 109.92 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 30.6 m -60.45 -44.87 95.4 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.582 0.628 . . . . 0.0 110.089 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.48 -31.42 72.62 Favored 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.519 -0.738 . . . . 0.0 111.281 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.449 HD21 HE21 ' A' ' 41' ' ' GLN . 51.2 mt -75.82 -27.46 57.9 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 121.532 -0.73 . . . . 0.0 110.254 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -69.24 -45.56 69.46 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.237 1.415 . . . . 0.0 110.052 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -67.58 -39.33 84.87 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -75.4 177.65 6.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.814 1.645 . . . . 0.0 109.307 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -128.69 152.14 48.73 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 104.713 -2.328 . . . . 0.0 104.713 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 22.4 m -74.82 150.02 85.98 Favored Pre-proline 0 C--O 1.238 0.483 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.91 150.72 49.65 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 121.765 1.643 . . . . 0.0 108.881 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.4 p -157.49 74.29 0.75 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.916 1.286 . . . . 0.0 108.374 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -147.33 117.3 4.42 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.256 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.1 145.63 44.84 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.933 1.756 . . . . 0.0 109.517 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.256 1.424 0 C-N-CA 129.093 2.957 . . . . 0.0 105.27 176.23 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.466 0.367 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -69.13 153.57 71.6 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.409 2.073 . . . . 0.0 110.63 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -82.53 70.77 9.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.091 1.356 . . . . 0.0 109.181 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.81 148.49 68.39 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.639 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.53 177.5 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.235 2.623 . . . . 0.0 111.668 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -49.3 146.71 3.59 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.976 0.91 . . . . 0.0 109.304 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.9 t -81.96 123.14 80.22 Favored Pre-proline 0 C--O 1.236 0.354 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -69.25 165.97 28.58 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.064 2.509 . . . . 0.0 114.042 -175.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -71.96 -22.03 61.5 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.2 175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.544 ' HA ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -58.28 143.18 45.54 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -178.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -136.38 121.16 18.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttm105 -153.08 164.41 38.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.651 1.581 . . . . 0.0 107.225 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -139.95 133.59 30.36 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 104.327 -2.471 . . . . 0.0 104.327 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.4 p -131.11 173.85 10.61 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.224 0.92 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.55 -158.72 49.19 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 121.793 0.663 . . . . 0.0 112.567 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.3 p -129.93 154.1 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.095 1.758 . . . . 0.0 107.109 -176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.7 -40.03 95.77 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.92 -48.75 79.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.999 0.363 . . . . 0.0 111.195 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.5 m -65.9 -45.83 80.55 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 120.197 -0.601 . . . . 0.0 109.58 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -65.32 -33.38 75.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.497 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.526 ' CD2' HG11 ' A' ' 50' ' ' VAL . 18.7 t80 -61.34 -40.79 95.54 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.586 1.084 . . . . 0.0 109.956 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 82.3 m -75.22 -32.49 61.18 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 118.232 -0.889 . . . . 0.0 111.55 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.9 73.33 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 p -76.21 140.9 41.86 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.53 1.532 . . . . 0.0 110.571 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -85.08 -13.67 49.6 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 120.427 1.467 . . . . 0.0 110.4 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.3 tp -122.8 127.41 49.07 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 120.786 -1.196 . . . . 0.0 110.142 177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 44' ' ' PHE . 33.1 t -140.57 113.82 5.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.0 m -146.1 171.21 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 125.273 1.429 . . . . 0.0 108.966 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 111' ' ' LEU . 17.8 p -133.83 143.16 48.17 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 175.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.77 168.85 20.85 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.326 -0.859 . . . . 0.0 111.548 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 97.6 m -106.96 132.94 52.34 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 175.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -72.13 114.85 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -76.59 -57.25 3.97 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.1 m -147.35 172.16 14.32 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.22 1.408 . . . . 0.0 110.187 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 31.1 mtp -135.68 146.57 47.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.81 2.044 . . . . 0.0 107.37 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 t -139.16 138.96 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 154.06 42.61 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 121.646 2.021 . . . . 0.0 109.66 176.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.11 175.78 3.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 110.974 -175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -59.18 171.45 2.3 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.228 3.285 . . . . 0.0 113.02 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.84 -129.61 45.3 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -112.35 31.8 6.03 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.0 169.36 40.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 125.046 1.308 . . . . 0.0 113.597 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -156.18 124.33 5.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.748 2.019 . . . . 0.0 106.301 -176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.11 147.86 27.11 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.6 t -126.68 123.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 m -92.96 124.41 36.92 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -131.43 167.69 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 118.192 -0.909 . . . . 0.0 109.55 -176.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 t -128.94 38.06 3.99 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 116.281 1.956 . . . . 0.0 116.281 -175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.6 mt 40.65 79.94 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.4 mm -72.26 -28.84 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.11 161.08 34.48 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.2 144.38 48.42 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -137.61 -24.04 1.06 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 -175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -156.73 129.46 7.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 175.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -137.33 73.45 1.44 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.403 3.081 . . . . 0.0 106.045 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.66 34.88 3.43 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.016 -175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.25 -69.04 0.02 OUTLIER Glycine 0 CA--C 1.529 0.944 0 C-N-CA 128.122 2.772 . . . . 0.0 109.973 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 mt -45.24 134.51 6.36 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 -175.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -85.13 65.03 9.02 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 127.089 2.155 . . . . 0.0 106.414 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.7 mt -57.98 125.62 74.52 Favored Pre-proline 0 C--O 1.237 0.412 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.46 176.14 8.44 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.891 1.727 . . . . 0.0 113.619 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.8 t -42.57 -58.89 3.28 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 126.118 1.767 . . . . 0.0 110.813 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -70.56 124.06 10.41 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 CA-C-N 122.321 1.865 . . . . 0.0 107.731 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 88' ' ' THR . 91.5 Cg_endo -73.35 -153.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.144 2.562 . . . . 0.0 112.946 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 51.2 m -34.61 125.19 0.53 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.484 2.714 . . . . 0.0 112.882 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.05 30.98 0.65 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.15 1.357 . . . . 0.0 113.017 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.65 158.81 29.22 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.187 1.795 . . . . 0.0 108.243 176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 95.0 p -107.57 150.71 26.53 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.108 0.867 . . . . 0.0 111.996 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 25.3 mt -143.55 163.23 33.77 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.143 2.177 . . . . 0.0 108.733 -175.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.26 114.21 25.66 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 175.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.45 121.46 31.71 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -72.77 119.84 17.56 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.874 1.359 . . . . 0.0 107.563 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.46 113.83 40.61 Favored Pre-proline 0 C--O 1.225 -0.22 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.12 5.59 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.136 2.557 . . . . 0.0 112.956 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 34.4 m -131.14 113.52 13.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.021 1.329 . . . . 0.0 110.675 -175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -81.73 -32.78 31.42 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 121.277 -0.89 . . . . 0.0 111.173 175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 67.7 mm-40 -59.06 -49.08 79.24 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.813 1.645 . . . . 0.0 112.82 -175.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.6 m -155.09 165.45 18.21 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 129.006 2.923 . . . . 0.0 108.447 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -64.04 157.7 70.7 Favored 'Cis proline' 0 CA--C 1.536 0.601 0 CA-C-N 120.794 1.319 . . . . 0.0 111.647 -1.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.89 111.13 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.864 2.376 . . . . 0.0 111.01 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.9 tpp -122.18 141.53 51.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.575 1.95 . . . . 0.0 109.852 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -141.55 133.85 28.02 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -69.3 142.5 54.07 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.42 36.59 69.45 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-O 118.812 -0.993 . . . . 0.0 112.042 177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.83 157.92 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.514 1.525 . . . . 0.0 107.449 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.4 m -100.63 141.0 34.11 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.709 1.203 . . . . 0.0 111.472 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -135.79 176.37 8.74 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.244 1.818 . . . . 0.0 112.62 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.404 ' HA ' HG22 ' A' ' 52' ' ' THR . 6.4 tp -122.92 123.64 41.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 100.916 -3.735 . . . . 0.0 100.916 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.51 113.71 21.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.1 mtm -117.87 113.14 21.31 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 100.566 -3.865 . . . . 0.0 100.566 175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.57 -137.45 2.29 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -175.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -132.6 177.61 7.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.409 1.1 . . . . 0.0 111.522 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.45 125.32 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 105.149 -2.167 . . . . 0.0 105.149 175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -104.84 113.05 26.41 Favored 'General case' 0 C--O 1.237 0.418 1 N-CA-C 96.339 -5.43 . . . . 0.0 96.339 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . 0.257 8.0 tp10 -85.8 95.56 9.46 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 122.963 1.363 . . . . 0.0 108.667 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -179.08 -35.87 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.93 1 C-N-CA 133.395 4.678 . . . . 0.0 107.597 -175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtt-85 -131.38 -8.57 3.73 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.643 1.177 . . . . 0.0 112.768 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.25 -133.99 12.01 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.78 139.4 36.61 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.14 1.894 . . . . 0.0 114.753 -175.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.55 132.68 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 N-CA-C 102.973 -2.973 . . . . 0.0 102.973 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.261 0.4 OUTLIER -115.41 74.31 4.21 Favored Pre-proline 0 C--N 1.323 -0.559 0 C-N-CA 125.243 1.417 . . . . 0.0 109.612 -174.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -68.99 169.05 18.81 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 124.836 3.691 . . . . 0.0 112.765 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.92 -11.12 29.54 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 114.85 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -88.82 23.21 2.4 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 120.621 1.555 . . . . 0.0 110.779 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.1 m -96.69 145.1 26.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.127 1.371 . . . . 0.0 110.593 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -95.72 113.57 25.22 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 104.257 -2.497 . . . . 0.0 104.257 175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 74.5 t -133.45 123.73 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.9 m -149.46 169.28 2.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 125.882 1.673 . . . . 0.0 109.031 -176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 68.9 mt -64.47 150.67 46.11 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -69.05 142.19 54.61 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -141.66 137.39 16.24 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.93 -37.97 82.0 Favored 'Trans proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.057 1.838 . . . . 0.0 111.001 176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -52.65 -45.46 66.71 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.21 1.004 . . . . 0.0 111.268 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -70.0 -42.91 72.41 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.486 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -53.72 -47.38 70.63 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.316 1.047 . . . . 0.0 110.271 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -58.07 -47.55 82.84 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.84 0.856 . . . . 0.0 110.406 175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 72.4 mt -60.54 -50.05 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 118.613 -0.708 . . . . 0.0 109.335 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.42 -35.2 80.13 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.891 1.223 . . . . 0.0 109.744 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 71.7 m -61.04 -47.25 87.26 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -64.54 -38.36 90.75 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 121.717 -0.614 . . . . 0.0 111.064 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.1 mt -66.84 -30.07 70.15 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.584 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.7 t -67.1 -40.98 86.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 119.677 1.126 . . . . 0.0 109.776 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -69.65 -42.78 73.77 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.44 0.696 . . . . 0.0 109.613 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -75.02 176.04 7.59 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 122.66 1.219 . . . . 0.0 109.243 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.0 pttt -138.77 135.95 35.2 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 18.4 m -73.52 157.04 88.31 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.221 0.919 . . . . 0.0 109.487 175.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.51 113.64 3.4 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.896 2.397 . . . . 0.0 109.317 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 53.8 p -123.4 74.11 1.22 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -113.19 113.7 48.82 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.32 -153.91 0.05 OUTLIER 'Trans proline' 0 CA--C 1.536 0.602 1 C-N-CA 125.536 4.157 . . . . 0.0 108.946 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.251 1.166 0 N-CA-C 102.427 -3.175 . . . . 0.0 102.427 175.053 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.236 0.344 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -77.42 67.28 7.81 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.765 2.31 . . . . 0.0 108.108 164.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -128.6 34.17 4.55 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 125.646 1.578 . . . . 0.0 112.06 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.18 142.82 25.34 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.849 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -74.36 164.63 33.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.292 1.995 . . . . 0.0 110.246 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.1 m -66.01 162.53 19.18 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 42.7 t -96.82 104.6 19.02 Favored Pre-proline 0 C--O 1.233 0.217 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 175.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.16 160.02 48.35 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.087 1.858 . . . . 0.0 108.886 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -71.3 -23.41 61.94 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 121.658 -0.651 . . . . 0.0 110.096 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -64.73 154.6 36.27 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.7 t -133.39 134.17 43.34 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 -175.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -162.22 166.33 25.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.722 2.009 . . . . 0.0 107.037 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -131.12 146.4 52.34 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.0 p -139.69 173.21 11.76 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.601 1.56 . . . . 0.0 110.192 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.3 -163.56 53.06 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 121.807 0.671 . . . . 0.0 112.549 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 p -129.51 159.16 37.18 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 126.002 1.721 . . . . 0.0 108.111 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.9 -47.04 82.17 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.912 -175.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -59.07 -46.0 89.39 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 119.393 0.997 . . . . 0.0 110.766 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 m -67.72 -41.05 84.1 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.062 0.392 . . . . 0.0 111.209 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -70.43 -33.16 71.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 117.807 -1.092 . . . . 0.0 109.741 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.588 ' CD2' HG11 ' A' ' 50' ' ' VAL . 42.1 t80 -59.51 -31.17 69.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 120.371 1.441 . . . . 0.0 109.904 175.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 m -71.14 -48.25 53.12 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.299 -0.876 . . . . 0.0 110.842 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.57 -50.21 70.38 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.919 0.888 . . . . 0.0 112.074 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -63.5 131.71 48.99 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.931 0.893 . . . . 0.0 109.811 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 t -92.87 -7.79 45.21 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.96 115.89 24.05 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.352 1.461 . . . . 0.0 108.6 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' A' ' 113' ' ' MET . 37.6 t -135.52 114.18 15.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.8 m -147.34 172.14 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.431 1.493 . . . . 0.0 109.386 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 111' ' ' LEU . 21.1 p -133.51 144.28 49.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 174.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.5 166.69 16.15 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 121.728 -0.607 . . . . 0.0 111.385 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.1 m -104.21 135.42 45.71 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -75.58 115.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.351 1.06 . . . . 0.0 109.56 -177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -83.53 -49.32 9.36 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 73.2 m -145.92 171.41 14.87 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 -176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 34.9 mtp -134.89 149.39 50.29 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.77 2.028 . . . . 0.0 106.86 175.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.95 139.91 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.35 131.51 41.96 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -113.7 176.25 1.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 124.465 1.106 . . . . 0.0 109.611 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.96 147.61 32.57 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.388 2.059 . . . . 0.0 113.893 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.48 -123.89 33.14 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.159 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -102.91 17.2 24.55 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.258 1.023 . . . . 0.0 110.582 -176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.61 170.43 51.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.869 1.26 . . . . 0.0 112.237 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -154.37 142.23 20.08 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 127.239 2.216 . . . . 0.0 105.459 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -114.28 150.02 35.05 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.28 123.26 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.7 m -90.53 124.57 35.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.74 173.46 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.547 0.739 . . . . 0.0 109.749 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -132.63 41.72 3.16 Favored 'General case' 0 CA--C 1.558 1.277 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' HB2' ' H ' ' A' ' 90' ' ' ALA 0.331 73.6 mt 39.06 80.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 174.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.5 mm -76.47 -27.64 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 O-C-N 121.859 -0.526 . . . . 0.0 110.169 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.97 156.54 28.12 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 125.226 1.393 . . . . 0.0 109.659 175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.48 123.54 13.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -114.4 -29.32 6.92 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.817 0.847 . . . . 0.0 112.486 -175.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -148.83 125.62 11.18 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -142.19 71.15 1.34 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.226 2.61 . . . . 0.0 107.589 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.85 46.27 3.62 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.78 -76.79 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 127.119 2.295 . . . . 0.0 110.03 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.2 mt -47.85 127.21 11.6 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.946 1.298 . . . . 0.0 113.419 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -75.97 71.19 2.75 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.162 2.985 . . . . 0.0 108.319 175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.45 132.1 90.69 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -70.4 179.16 4.26 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.525 1.484 . . . . 0.0 110.893 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.0 t -54.0 -55.14 39.42 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 175.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.24 121.35 8.63 Favored 'Trans proline' 0 CA--C 1.549 1.243 0 N-CA-C 106.915 -1.994 . . . . 0.0 106.915 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -73.98 -152.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.081 4.521 . . . . 0.0 113.0 -175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 98.7 m -33.8 125.76 0.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 128.837 2.855 . . . . 0.0 112.226 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.14 53.64 0.23 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.471 ' H ' ' HB2' ' A' ' 72' ' ' LEU . . . -140.62 158.24 44.28 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.009 2.124 . . . . 0.0 105.741 176.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.1 p -87.83 154.33 20.63 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.386 -0.821 . . . . 0.0 111.234 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.6 mt -147.37 141.16 25.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -108.4 112.54 25.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.69 123.14 33.46 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -76.63 113.74 14.6 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.364 1.065 . . . . 0.0 109.129 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.63 114.08 63.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -73.25 0.89 7.32 Favored 'Trans proline' 0 C--O 1.242 0.685 0 C-N-CA 122.407 2.071 . . . . 0.0 113.842 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 3.5 m -138.38 113.33 9.18 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . 0.29 54.0 pttt -71.94 -4.7 29.89 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -94.15 -38.41 11.1 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -149.09 159.93 36.09 Favored Pre-proline 0 C--N 1.343 0.312 0 C-N-CA 124.014 0.926 . . . . 0.0 112.98 -175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -67.36 150.32 83.05 Favored 'Cis proline' 0 CA--C 1.54 0.819 0 O-C-N 122.722 0.854 . . . . 0.0 112.085 2.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -64.6 108.39 1.03 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.609 2.873 . . . . 0.0 111.301 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.1 ttp -140.85 149.71 42.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.194 1.798 . . . . 0.0 108.108 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 mtmt -138.21 161.53 36.61 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.762 0.825 . . . . 0.0 110.858 -176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -70.09 132.17 45.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.409 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.36 25.81 58.44 Favored Glycine 0 C--N 1.332 0.325 0 N-CA-C 116.585 1.394 . . . . 0.0 116.585 175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 66.3 t -127.33 152.06 34.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 125.487 1.515 . . . . 0.0 108.616 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.7 m -95.43 133.08 39.81 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.256 1.422 . . . . 0.0 111.365 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.03 175.54 9.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.967 1.307 . . . . 0.0 111.555 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.518 HD11 ' HG3' ' A' ' 113' ' ' MET . 0.6 OUTLIER -116.07 124.62 50.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 131.008 3.723 . . . . 0.0 102.597 175.308 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.25 114.1 22.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.275 1.03 . . . . 0.0 108.82 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 50' ' ' VAL . 22.7 mtm -116.93 113.25 22.16 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 101.652 -3.462 . . . . 0.0 101.652 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.13 -142.7 3.5 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.788 1.661 . . . . 0.0 109.291 -175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -132.3 174.68 9.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.139 0.97 . . . . 0.0 111.122 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -130.14 138.24 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -120.34 113.08 19.84 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -76.95 64.85 2.51 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.397 1.479 . . . . 0.0 108.569 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -162.68 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.422 2.689 . . . . 0.0 108.306 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -120.29 -9.34 9.53 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.258 1.023 . . . . 0.0 112.891 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 87.97 -129.44 9.56 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.93 139.63 22.15 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.976 1.784 . . . . 0.0 112.749 -175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.56 152.76 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 104.191 -2.522 . . . . 0.0 104.191 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -135.05 74.21 63.58 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.36 174.18 5.47 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.987 3.791 . . . . 0.0 113.348 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.26 -21.14 65.53 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.012 1.808 . . . . 0.0 112.175 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.07 22.78 0.92 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.56 1.544 . . . . 0.0 110.742 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.9 m -103.42 129.83 50.62 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.377 1.071 . . . . 0.0 113.04 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -88.56 120.21 29.73 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.8 t -139.48 123.75 19.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.52 171.3 4.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.253 1.021 . . . . 0.0 109.693 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.78 145.57 55.53 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.495 1.118 . . . . 0.0 108.454 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -71.94 149.18 45.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.326 0.65 . . . . 0.0 110.42 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -148.73 149.76 31.52 Favored Pre-proline 0 N--CA 1.469 0.507 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.64 -39.5 87.5 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.515 2.144 . . . . 0.0 112.301 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -57.75 -49.22 77.29 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.248 0.619 . . . . 0.0 111.286 175.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -60.11 -43.94 95.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.032 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -54.16 -53.19 56.7 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 118.57 0.623 . . . . 0.0 110.598 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -56.69 -45.43 81.76 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.219 1.408 . . . . 0.0 111.125 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 54.5 mt -60.87 -52.46 61.4 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 124.122 0.969 . . . . 0.0 109.649 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.57 -37.13 82.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.078 -175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 55.2 m -63.16 -45.71 90.55 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 120.244 1.384 . . . . 0.0 108.399 175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -57.49 -46.26 83.93 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.724 0.693 . . . . 0.0 110.049 178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.31 -33.55 75.75 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.525 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 14.0 t -62.86 -48.06 80.68 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.707 1.14 . . . . 0.0 110.336 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -62.73 -51.44 67.15 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 121.908 -0.495 . . . . 0.0 109.942 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -73.12 176.52 5.77 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.764 2.026 . . . . 0.0 111.245 -178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -106.63 151.52 24.96 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.5 m -54.21 139.63 55.36 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.42 96.41 0.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 N-CA-C 103.754 -3.21 . . . . 0.0 103.754 175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.8 m -166.27 93.41 0.51 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -115.66 114.27 42.26 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -83.61 118.91 2.55 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.725 1.617 . . . . 0.0 109.409 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.251 1.146 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.618 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.53 68.1 6.24 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.203 2.602 . . . . 0.0 110.019 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.0 p30 -141.74 33.24 1.61 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.058 1.343 . . . . 0.0 112.611 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.37 109.84 62.57 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 125.072 1.349 . . . . 0.0 110.158 176.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -79.06 -179.35 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.558 2.839 . . . . 0.0 110.068 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 87.2 m -59.11 163.77 3.46 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 175.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.8 t -81.56 124.03 80.36 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.641 -175.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.05 175.77 10.42 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.302 2.668 . . . . 0.0 111.538 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -69.47 -20.24 63.75 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 117.48 -1.248 . . . . 0.0 113.015 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -56.76 121.6 10.2 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.937 1.244 . . . . 0.0 109.269 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.3 57.35 1.7 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -152.42 153.01 32.7 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.083 1.353 . . . . 0.0 108.004 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 ttp-105 -97.03 152.85 18.34 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.127 2.171 . . . . 0.0 108.317 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.8 p -136.05 174.36 10.7 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.125 1.37 . . . . 0.0 112.111 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 -163.15 54.2 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.424 1.011 . . . . 0.0 112.219 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -115.49 174.72 5.86 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 117.983 0.892 . . . . 0.0 109.066 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.9 tt -68.14 -50.16 56.38 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -63.08 -48.68 77.56 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 118.966 -0.54 . . . . 0.0 110.697 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.0 m -55.76 -46.69 77.83 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.178 0.445 . . . . 0.0 110.479 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -76.0 -41.42 51.22 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.13 -1.891 . . . . 0.0 112.542 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.501 ' CD2' HG11 ' A' ' 50' ' ' VAL . 10.7 t80 -48.81 -49.05 40.79 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.035 1.743 . . . . 0.0 109.745 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.07 -32.17 73.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.374 -178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -56.82 4.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.291 1.036 . . . . 0.0 112.447 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -55.0 139.33 41.37 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.873 1.269 . . . . 0.0 112.729 -175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.7 t -76.97 -24.61 52.3 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.871 1.268 . . . . 0.0 109.462 175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.407 HD21 ' CE2' ' A' ' 94' ' ' PHE . 44.9 tp -120.23 128.04 52.98 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.219 1.008 . . . . 0.0 110.157 -175.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 44' ' ' PHE . 35.4 t -141.33 113.93 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.9 171.12 6.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 124.897 1.279 . . . . 0.0 109.487 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 p -131.33 139.42 49.53 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -162.49 168.16 22.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.883 -1.136 . . . . 0.0 111.716 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.3 m -109.82 134.15 52.35 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.0 114.48 12.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -81.81 -51.66 7.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.8 m -148.98 174.25 12.48 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 125.209 1.404 . . . . 0.0 109.696 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 13.6 mtp -135.39 154.88 51.33 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.957 1.703 . . . . 0.0 107.363 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.87 138.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 125.697 1.599 . . . . 0.0 106.987 -175.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -70.1 145.69 51.43 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 120.058 1.299 . . . . 0.0 108.705 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 55.9 mm-40 -131.67 164.7 40.91 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.841 0.857 . . . . 0.0 108.864 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -52.57 155.62 9.9 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.751 2.967 . . . . 0.0 115.715 -177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.42 -124.71 25.27 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.838 1.685 . . . . 0.0 110.854 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -105.02 25.71 10.18 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.151 1.381 . . . . 0.0 108.316 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.86 176.17 37.53 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.816 1.198 . . . . 0.0 114.255 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -161.82 141.36 9.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 127.796 2.438 . . . . 0.0 106.817 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . . . -110.22 152.08 26.53 Favored 'General case' 0 CA--C 1.517 -0.304 0 O-C-N 120.851 -1.155 . . . . 0.0 107.889 175.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.79 123.13 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.2 m -89.64 125.91 35.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.472 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 11.4 m -123.91 171.76 12.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.758 0.823 . . . . 0.0 109.93 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -132.67 37.19 3.49 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.067 0.947 . . . . 0.0 112.729 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.304 18.6 mt 39.17 81.09 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.5 mm -74.37 -29.09 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 118.668 0.667 . . . . 0.0 109.625 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 168.48 39.34 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.322 1.439 . . . . 0.0 110.972 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -147.36 147.62 30.5 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.899 1.68 . . . . 0.0 109.306 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -141.38 -25.18 0.72 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -156.26 136.88 13.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.301 1.84 . . . . 0.0 106.502 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.0 p -145.31 71.89 1.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 128.614 2.766 . . . . 0.0 109.051 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.52 43.69 3.19 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.86 1.695 . . . . 0.0 110.088 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.88 -72.45 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 129.497 3.427 . . . . 0.0 109.683 176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mt -51.05 132.23 27.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -175.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -82.84 76.07 9.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 83' ' ' LEU . 21.0 mt -53.19 129.56 50.34 Favored Pre-proline 0 C--O 1.234 0.27 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.36 158.09 46.82 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.593 1.528 . . . . 0.0 112.281 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.8 t -52.85 -58.14 13.29 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.22 114.57 3.66 Favored 'Trans proline' 0 C--N 1.35 0.624 0 N-CA-C 103.554 -3.287 . . . . 0.0 103.554 174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 88' ' ' THR . 68.0 Cg_endo -68.06 -153.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.429 3.419 . . . . 0.0 116.328 -174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 14.2 m -35.01 134.44 0.24 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 130.76 3.624 . . . . 0.0 111.538 -174.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 125.69 11.97 3.86 Favored Glycine 0 CA--C 1.542 1.73 0 C-N-CA 127.733 2.587 . . . . 0.0 110.577 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -88.6 154.72 20.1 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.739 1.216 . . . . 0.0 108.182 175.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 60.9 p -104.0 141.26 36.5 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.437 1.095 . . . . 0.0 111.835 178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.9 mt -147.28 151.6 36.89 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.742 1.217 . . . . 0.0 111.861 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -103.67 114.89 29.5 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.407 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.0 m-85 -87.33 122.36 30.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -80.55 114.92 19.79 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.951 1.3 . . . . 0.0 109.8 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.13 114.02 58.41 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 120.817 1.644 . . . . 0.0 107.195 176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.15 -7.72 21.52 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.17 1.913 . . . . 0.0 112.43 177.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.6 m -121.07 113.61 20.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 126.467 1.907 . . . . 0.0 109.988 175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -78.43 -15.85 58.22 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.387 -0.821 . . . . 0.0 112.55 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -83.4 -41.46 18.11 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.683 0.793 . . . . 0.0 112.337 -175.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.7 m -149.63 156.47 38.91 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 125.022 1.329 . . . . 0.0 110.36 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -67.12 159.31 81.0 Favored 'Cis proline' 0 CA--C 1.544 1.008 0 CA-C-N 119.134 0.727 . . . . 0.0 110.802 -3.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.12 142.94 99.89 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.172 2.581 . . . . 0.0 112.848 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 33.0 tpp -149.3 155.15 40.09 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.513 1.525 . . . . 0.0 109.239 178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -150.56 141.1 22.52 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.555 1.942 . . . . 0.0 106.328 175.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -65.65 146.83 54.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.93 45.04 96.49 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 119.059 -0.856 . . . . 0.0 113.708 175.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 92.7 t -144.07 154.64 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.907 2.083 . . . . 0.0 107.214 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.5 m -102.56 135.29 44.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.591 1.156 . . . . 0.0 111.577 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.8 175.16 9.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 125.34 1.456 . . . . 0.0 112.851 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.5 tp -113.34 124.71 53.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 130.654 3.581 . . . . 0.0 102.554 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -117.42 114.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.0 mtm -116.42 113.13 22.44 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 102.769 -3.048 . . . . 0.0 102.769 175.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.63 -139.33 2.75 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.047 1.308 . . . . 0.0 111.142 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -131.69 179.05 6.29 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 118.043 0.921 . . . . 0.0 110.336 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.3 t -135.78 145.97 30.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 O-C-N 121.651 -0.656 . . . . 0.0 110.354 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -111.73 113.42 25.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 102.35 -3.204 . . . . 0.0 102.35 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -79.46 72.41 6.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -178.18 -39.29 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 129.186 2.995 . . . . 0.0 111.062 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -130.67 -10.88 3.95 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.43 -157.82 15.3 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.353 0.979 . . . . 0.0 111.791 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -71.14 144.53 47.0 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.347 2.698 . . . . 0.0 113.464 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.26 2.9 p -127.23 142.13 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.254 1.8 tm? -132.72 79.37 64.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 O-C-N 120.616 -1.302 . . . . 0.0 109.98 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.65 171.95 8.84 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.349 3.366 . . . . 0.0 112.598 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.01 -33.03 95.72 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.126 1.884 . . . . 0.0 113.268 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -83.96 37.2 0.59 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.42 1.088 . . . . 0.0 112.181 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.6 m -97.32 130.52 44.48 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.867 1.667 . . . . 0.0 108.898 175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.3 113.65 15.29 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 106.635 -1.616 . . . . 0.0 106.635 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.0 t -134.61 123.95 43.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.7 m -150.28 171.82 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.28 1.832 . . . . 0.0 109.18 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 62.1 mt -64.14 141.93 58.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.928 1.291 . . . . 0.0 109.504 175.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -75.72 131.28 39.75 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.418 0.687 . . . . 0.0 109.913 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -139.16 146.75 50.54 Favored Pre-proline 0 C--O 1.238 0.497 0 C-N-CA 126.072 1.749 . . . . 0.0 107.67 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -57.54 -34.25 97.76 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.006 2.47 . . . . 0.0 113.362 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -54.15 -54.55 38.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.401 0.68 . . . . 0.0 109.679 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -63.49 -43.19 97.99 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.884 0.874 . . . . 0.0 109.677 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -51.1 -55.19 18.94 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.393 1.477 . . . . 0.0 111.166 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -65.53 -30.65 71.43 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 122.902 0.481 . . . . 0.0 110.757 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.8 mt -65.71 -52.12 54.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 120.599 -1.313 . . . . 0.0 109.282 175.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mt -60.12 -37.79 81.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.085 1.312 . . . . 0.0 109.432 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 96.7 m -56.62 -53.62 55.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.693 0.797 . . . . 0.0 108.9 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -61.64 -31.3 71.39 Favored 'General case' 0 CA--C 1.522 -0.097 0 O-C-N 121.595 -0.691 . . . . 0.0 112.201 177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.59 -23.9 56.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.134 0.879 . . . . 0.0 111.299 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.8 t -73.67 -38.09 65.04 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -76.09 -59.59 2.69 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 124.765 1.226 . . . . 0.0 111.5 -176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -72.09 151.96 42.7 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.97 138.01 40.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 174.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.93 130.23 72.84 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 118.378 -0.82 . . . . 0.0 110.353 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.01 92.17 1.13 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 107.067 -1.936 . . . . 0.0 107.067 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 t -165.56 73.08 0.18 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -131.16 111.69 15.59 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 103.986 -2.598 . . . . 0.0 103.986 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -105.16 179.74 0.1 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.491 2.794 . . . . 0.0 110.495 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.256 1.407 0 N-CA-C 102.835 -3.024 . . . . 0.0 102.835 175.371 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.08 163.13 32.58 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 121.871 1.714 . . . . 0.0 110.407 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -84.77 67.64 10.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.559 1.544 . . . . 0.0 110.347 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 137.4 77.33 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.938 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.37 -179.19 4.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.053 2.502 . . . . 0.0 111.193 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.5 m -56.29 161.96 2.28 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.599 1.159 . . . . 0.0 108.269 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 45.4 t -82.65 124.39 77.51 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.26 164.92 31.96 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.899 2.399 . . . . 0.0 111.115 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -80.31 -34.86 36.41 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.423 -0.799 . . . . 0.0 108.997 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -56.52 132.72 52.27 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.129 0.972 . . . . 0.0 109.827 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -148.97 145.1 27.19 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.89 1.276 . . . . 0.0 109.351 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -161.75 158.24 25.5 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 ttp180 -102.67 124.28 47.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.3 p -127.72 176.47 7.51 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.784 1.233 . . . . 0.0 111.684 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.72 -155.22 50.88 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 124.079 0.847 . . . . 0.0 111.04 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -137.72 166.65 23.46 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 tt -63.35 -40.92 98.63 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.316 -0.865 . . . . 0.0 109.471 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -62.22 -54.22 43.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.981 0.809 . . . . 0.0 109.978 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -55.82 -46.39 78.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.92 0.867 . . . . 0.0 111.227 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -69.69 -37.65 76.71 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 117.944 -1.026 . . . . 0.0 110.201 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.505 ' CD2' HG11 ' A' ' 50' ' ' VAL . 25.7 t80 -61.35 -37.18 82.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.592 1.087 . . . . 0.0 109.757 175.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.9 m -66.7 -57.8 6.4 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.474 0.579 . . . . 0.0 110.749 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.85 -29.72 69.69 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -76.25 153.85 35.68 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.318 0.508 . . . . 0.0 111.895 177.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.4 t -102.85 -6.95 21.98 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.321 1.048 . . . . 0.0 108.717 175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 94' ' ' PHE . 37.1 tp -133.43 123.47 25.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.639 1.576 . . . . 0.0 109.117 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.505 HG11 ' CD2' ' A' ' 44' ' ' PHE . 42.6 t -138.58 114.55 9.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.4 m -144.81 172.04 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.807 1.243 . . . . 0.0 109.782 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 p -134.66 141.24 46.51 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -160.82 174.7 13.49 Favored 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 120.626 -1.296 . . . . 0.0 110.987 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.1 m -114.17 130.22 56.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 102.939 -2.985 . . . . 0.0 102.939 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -73.44 113.06 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -78.86 -43.33 25.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 124.147 0.979 . . . . 0.0 108.808 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -152.77 167.76 27.95 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.248 1.419 . . . . 0.0 109.893 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 57.1 mtp -137.98 125.07 21.47 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 175.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.7 t -120.63 146.05 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.485 1.514 . . . . 0.0 107.82 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 mtt85 -65.73 154.65 38.4 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.977 1.262 . . . . 0.0 107.877 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.594 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 22.5 mm-40 -135.13 170.9 9.99 Favored Pre-proline 0 C--O 1.237 0.414 0 C-N-CA 124.728 1.211 . . . . 0.0 108.691 176.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.79 165.55 8.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.171 2.581 . . . . 0.0 113.318 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.2 -142.37 45.95 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 125.791 1.663 . . . . 0.0 109.298 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' OE1' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tp10 -97.56 25.19 5.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.917 1.287 . . . . 0.0 107.69 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -90.45 -179.68 43.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 126.383 1.945 . . . . 0.0 114.794 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -154.48 155.77 35.5 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 128.381 2.673 . . . . 0.0 107.309 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.594 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -119.92 146.26 45.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.2 t -120.97 123.15 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.0 m -92.86 129.15 38.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.83 170.84 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.887 0.875 . . . . 0.0 111.559 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -135.01 35.38 3.07 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt 37.02 82.38 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.506 2.322 . . . . 0.0 116.003 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 30.3 mm -75.02 -23.02 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.701 0.8 . . . . 0.0 109.037 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.2 159.66 33.08 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.78 150.76 45.14 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.716 1.607 . . . . 0.0 106.695 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -141.42 -32.01 0.56 Allowed 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.832 0.707 . . . . 0.0 111.246 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.1 ttmm -148.21 129.61 14.81 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -139.4 70.03 1.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.324 2.249 . . . . 0.0 105.95 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.23 44.47 3.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 125.295 1.426 . . . . 0.0 109.61 178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -168.77 -80.92 0.05 OUTLIER Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 130.075 3.702 . . . . 0.0 107.514 176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -44.59 123.52 3.68 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 123.033 1.397 . . . . 0.0 114.408 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.59 64.86 5.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.348 3.059 . . . . 0.0 109.375 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -56.02 131.34 73.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 O-C-N 121.128 -0.983 . . . . 0.0 109.83 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.06 177.67 7.9 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.428 2.086 . . . . 0.0 112.107 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.1 t -48.92 -52.45 46.58 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.938 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -66.27 116.97 4.32 Favored 'Trans proline' 0 CA--C 1.548 1.187 0 CA-C-N 121.843 1.694 . . . . 0.0 108.538 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -78.18 -153.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.756 1 C-N-CA 125.343 4.028 . . . . 0.0 111.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 75.5 m -33.36 125.44 0.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.838 2.455 . . . . 0.0 110.194 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.55 2.09 5.89 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.294 1.902 . . . . 0.0 111.42 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.31 150.86 22.9 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.182 1.491 . . . . 0.0 110.112 -175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.9 p -95.08 150.5 20.11 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 mt -144.29 168.37 20.23 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.195 2.198 . . . . 0.0 109.773 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -127.26 115.01 18.38 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.7 m-85 -95.63 124.79 39.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -177.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -72.34 139.93 48.19 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 117.703 -1.141 . . . . 0.0 108.309 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 t -129.31 113.64 18.31 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -60.73 -11.83 19.17 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 124.169 3.246 . . . . 0.0 115.451 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.5 m -137.42 118.39 14.3 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.539 1.535 . . . . 0.0 113.007 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' OE1' ' A' ' 64' ' ' GLU . 22.0 pttp -73.98 -27.22 60.88 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.665 -0.647 . . . . 0.0 110.188 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -62.73 -52.13 64.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.217 1.407 . . . . 0.0 110.858 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -146.65 159.11 45.09 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 125.248 1.419 . . . . 0.0 111.673 -175.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.3 160.77 75.3 Favored 'Cis proline' 0 CA--C 1.543 0.928 0 CA-C-N 119.189 0.746 . . . . 0.0 112.554 -0.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.63 95.56 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.957 3.105 . . . . 0.0 111.752 -175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 34.1 tpp -93.66 160.98 14.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.882 1.673 . . . . 0.0 108.603 -176.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.9 mmmt -148.48 136.9 21.3 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -77.31 145.06 37.63 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.122 -0.944 . . . . 0.0 108.888 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.51 40.16 98.75 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 118.674 0.67 . . . . 0.0 113.483 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.73 156.96 23.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 125.915 1.686 . . . . 0.0 107.049 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -89.99 138.72 31.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.991 0.901 . . . . 0.0 110.758 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -136.05 174.66 10.37 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.723 2.409 . . . . 0.0 112.33 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.5 tp -122.05 123.62 42.04 Favored 'General case' 0 N--CA 1.448 -0.553 1 C-N-CA 132.504 4.321 . . . . 0.0 101.955 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.9 113.93 19.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.0 mtm -115.56 113.29 23.42 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.55 -136.39 2.53 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.46 1.028 . . . . 0.0 112.67 -175.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -135.43 176.12 8.97 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.949 1.3 . . . . 0.0 110.366 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.95 154.4 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 175.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -125.02 113.67 18.08 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -74.19 71.01 1.65 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -174.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 165.44 -24.94 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.221 1 C-N-CA 132.056 4.142 . . . . 0.0 112.134 177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mmt85 -113.78 -4.4 13.37 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.204 0.94 . . . . 0.0 111.628 -174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.25 -160.29 34.67 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 131.51 19.07 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.307 2.671 . . . . 0.0 111.935 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.76 125.95 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -114.65 84.17 9.78 Favored Pre-proline 0 C--N 1.321 -0.642 0 C-N-CA 125.973 1.709 . . . . 0.0 109.939 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -62.27 168.46 9.39 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 124.034 3.156 . . . . 0.0 113.01 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.84 -22.17 73.66 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.462 2.108 . . . . 0.0 113.318 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -95.02 23.19 5.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.96 1.304 . . . . 0.0 111.03 -177.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 75.6 m -83.9 134.59 34.67 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.457 1.503 . . . . 0.0 108.491 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -76.93 113.77 14.98 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 105.31 -2.108 . . . . 0.0 105.31 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.5 t -132.65 116.25 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.8 168.38 7.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.838 0.855 . . . . 0.0 110.082 -175.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.1 mp -63.86 145.95 54.87 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.662 0.785 . . . . 0.0 108.916 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -72.45 130.23 40.2 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.828 0.851 . . . . 0.0 109.702 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -137.21 148.05 60.81 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-O 116.977 -1.487 . . . . 0.0 108.889 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.21 -37.8 39.25 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.046 2.497 . . . . 0.0 112.642 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -57.82 -50.98 71.45 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.018 0.527 . . . . 0.0 110.266 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -59.23 -51.94 67.81 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -49.18 -48.13 45.4 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.519 1.927 . . . . 0.0 111.491 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.35 -44.02 97.45 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.723 1.209 . . . . 0.0 111.447 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.7 mt -66.41 -43.67 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 117.407 -1.282 . . . . 0.0 109.704 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.3 -43.32 96.42 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 120.651 1.569 . . . . 0.0 109.298 175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 99.5 m -57.6 -49.27 76.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -62.88 -34.92 78.41 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.095 -0.955 . . . . 0.0 111.322 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.4 mt -69.29 -27.76 65.68 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 119.978 1.263 . . . . 0.0 111.688 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -71.32 -47.38 57.01 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -71.27 -43.6 66.87 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 121.634 -0.667 . . . . 0.0 110.81 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -76.54 176.0 8.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.471 1.908 . . . . 0.0 108.657 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.72 145.65 47.27 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 175.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 87.0 m -56.7 141.03 74.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 123.804 0.69 . . . . 0.0 111.27 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 94.69 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 122.114 1.876 . . . . 0.0 107.879 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.4 p -166.15 88.22 0.37 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.246 0.618 . . . . 0.0 111.702 -176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -116.07 113.54 41.64 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 105.059 -2.201 . . . . 0.0 105.059 174.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.72 97.55 1.14 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.794 2.329 . . . . 0.0 109.216 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.25 1.125 0 O-C-N 120.958 -1.089 . . . . 0.0 109.848 -179.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.8 m . . . . . 0 N--CA 1.468 0.429 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.01 72.55 5.8 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.846 3.031 . . . . 0.0 109.195 172.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -142.42 61.76 1.43 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 109.324 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.63 132.6 10.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.635 1.574 . . . . 0.0 110.173 -176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -83.71 177.29 6.34 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.606 2.871 . . . . 0.0 112.277 -176.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 m -65.15 160.19 21.82 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 25.6 t -83.48 113.22 45.28 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 120.843 -1.161 . . . . 0.0 109.255 -175.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -84.41 175.4 7.22 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.315 3.344 . . . . 0.0 111.751 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -79.41 -22.29 44.49 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -66.12 161.57 21.54 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.941 2.096 . . . . 0.0 108.485 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.0 t -152.46 131.87 12.92 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 18.7 tpt180 -158.53 166.29 32.49 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.502 0.721 . . . . 0.0 110.233 -177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.56 151.42 49.47 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.787 1.635 . . . . 0.0 109.213 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -146.91 176.06 10.19 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 128.102 2.561 . . . . 0.0 108.812 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.08 179.55 37.09 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.703 1.144 . . . . 0.0 114.903 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 p -107.03 177.48 4.84 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.271 1.029 . . . . 0.0 108.563 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tt -66.2 -50.49 63.68 Favored 'General case' 0 C--O 1.225 -0.199 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 -63.76 -45.26 90.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.883 0.765 . . . . 0.0 111.538 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m -63.62 -44.94 92.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 117.918 0.326 . . . . 0.0 110.343 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -67.85 -46.19 72.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 117.174 -1.394 . . . . 0.0 110.092 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD2' HG11 ' A' ' 50' ' ' VAL . 54.2 t80 -48.4 -48.44 36.99 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.832 1.196 . . . . 0.0 111.331 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 96.5 m -65.62 -34.29 77.89 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.284 -0.865 . . . . 0.0 112.882 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.41 -43.41 50.11 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.504 1.122 . . . . 0.0 112.292 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 p -66.75 127.25 31.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.993 0.917 . . . . 0.0 110.352 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.0 t -73.08 -21.43 60.77 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.955 0.798 . . . . 0.0 110.321 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 tp -117.83 118.78 32.96 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.552 1.141 . . . . 0.0 109.493 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.64 HG13 ' HG2' ' A' ' 113' ' ' MET . 19.8 t -136.62 113.96 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 175.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.41 173.47 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 126.043 1.737 . . . . 0.0 108.061 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.715 HG22 ' HA ' ' A' ' 111' ' ' LEU . 35.1 p -136.01 146.36 47.08 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 175.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -167.68 164.59 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.917 0.78 . . . . 0.0 111.991 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 93.0 m -96.44 133.27 41.07 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.7 t -72.42 113.74 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -72.79 -42.55 63.81 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.864 0.865 . . . . 0.0 108.979 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 m -165.56 170.29 14.46 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.069 1.347 . . . . 0.0 110.158 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 42.5 mtp -129.55 134.55 47.81 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.956 1.702 . . . . 0.0 106.62 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.3 t -135.52 144.63 33.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.96 159.46 30.59 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.688 1.585 . . . . 0.0 111.371 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -132.29 172.04 8.07 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 129.372 3.069 . . . . 0.0 110.685 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -49.91 146.4 16.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.586 2.857 . . . . 0.0 114.013 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.25 -124.43 30.74 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.912 1.244 . . . . 0.0 111.149 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -86.88 -0.52 56.63 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.855 0.862 . . . . 0.0 112.037 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.62 163.13 40.38 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 124.704 1.145 . . . . 0.0 114.039 -175.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -148.4 136.22 20.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 126.27 1.828 . . . . 0.0 106.641 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.73 134.22 45.23 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.61 123.2 67.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.87 -2.27 . . . . 0.0 104.87 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m -93.23 130.56 38.89 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -134.71 172.28 16.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 123.73 0.812 . . . . 0.0 110.704 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -137.35 41.92 2.39 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt 38.5 80.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 118.129 2.64 . . . . 0.0 118.129 174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.428 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 17.0 mm -72.95 -29.46 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -161.05 157.56 29.11 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.66 144.97 48.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.362 1.465 . . . . 0.0 108.077 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -145.08 -25.7 0.48 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 -175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -155.36 127.68 7.77 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -144.56 70.18 1.28 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 127.564 2.346 . . . . 0.0 108.155 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.2 35.03 2.8 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.13 -81.6 0.03 OUTLIER Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 127.556 2.503 . . . . 0.0 107.423 176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.6 mt -45.53 133.1 7.88 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 117.965 2.58 . . . . 0.0 117.965 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.27 63.79 8.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 129.011 2.925 . . . . 0.0 108.332 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.1 mt -52.78 133.2 47.33 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 117.492 -1.242 . . . . 0.0 109.07 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.49 175.94 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.363 2.042 . . . . 0.0 112.219 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.5 t -50.86 -55.79 24.62 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 117.785 -1.103 . . . . 0.0 109.582 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.81 126.11 14.8 Favored 'Trans proline' 0 CA--C 1.548 1.203 0 CA-C-N 120.927 1.367 . . . . 0.0 109.137 175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.49 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.896 2.397 . . . . 0.0 110.89 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.6 m -33.08 127.26 0.32 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 129.378 3.071 . . . . 0.0 112.987 -175.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.74 54.63 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 127.093 2.282 . . . . 0.0 109.789 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.84 156.55 43.2 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 128.126 2.57 . . . . 0.0 107.093 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.2 p -102.72 155.06 18.57 Favored 'General case' 0 C--N 1.332 -0.158 0 O-C-N 121.253 -0.904 . . . . 0.0 112.971 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 mt -145.66 163.05 36.09 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.885 1.674 . . . . 0.0 108.593 -176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -126.37 113.73 17.28 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -93.59 126.35 38.7 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.279 1.031 . . . . 0.0 108.997 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -79.5 113.58 17.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.237 1.015 . . . . 0.0 110.503 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.88 119.03 54.73 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.56 -13.4 30.05 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.023 1.815 . . . . 0.0 113.292 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.2 126.35 16.45 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.844 1.658 . . . . 0.0 109.402 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.96 -14.14 60.99 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 117.668 -1.158 . . . . 0.0 113.863 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -63.77 -58.08 7.96 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 119.884 1.22 . . . . 0.0 111.592 -176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -145.45 158.54 50.54 Favored Pre-proline 0 CA--C 1.53 0.181 0 N-CA-C 115.219 1.562 . . . . 0.0 115.219 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -68.95 159.73 86.72 Favored 'Cis proline' 0 CA--C 1.548 1.176 0 N-CA-C 108.387 -1.428 . . . . 0.0 108.387 -4.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.89 160.9 27.47 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.729 1.619 . . . . 0.0 111.295 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.4 tpp -152.33 150.84 30.17 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -139.81 145.98 38.84 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -72.98 138.71 46.22 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 73.47 33.21 58.83 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.765 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 52.9 t -133.39 144.44 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.958 1.303 . . . . 0.0 108.62 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.4 m -92.26 126.99 37.57 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.592 1.157 . . . . 0.0 112.181 176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.86 175.66 8.17 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 112.046 -176.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.715 ' HA ' HG22 ' A' ' 52' ' ' THR . 0.1 OUTLIER -116.17 127.23 54.63 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 129.754 3.221 . . . . 0.0 103.359 175.662 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -122.96 114.29 20.22 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.846 0.858 . . . . 0.0 109.892 -178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.64 ' HG2' HG13 ' A' ' 50' ' ' VAL . 10.5 mtm -114.64 111.64 21.64 Favored 'General case' 0 C--N 1.32 -0.69 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 176.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -150.85 -148.32 4.76 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.548 2.023 . . . . 0.0 111.228 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.7 mm-40 -130.75 178.04 6.95 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.123 0.969 . . . . 0.0 108.972 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 13.1 t -135.71 145.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 121.708 -0.62 . . . . 0.0 109.348 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -114.16 113.85 25.23 Favored 'General case' 0 C--N 1.346 0.414 1 N-CA-C 96.011 -5.552 . . . . 0.0 96.011 174.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -93.09 72.39 4.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -175.22 -35.47 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 130.593 3.557 . . . . 0.0 109.141 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -117.37 -16.71 10.24 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.02 -171.36 14.84 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.78 137.81 55.42 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.99 1.793 . . . . 0.0 110.173 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.262 7.2 p -114.65 162.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.289 1.7 tm? -150.9 76.27 8.07 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.9 170.44 11.53 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.973 3.116 . . . . 0.0 112.343 -176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.38 -19.23 66.61 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.899 1.733 . . . . 0.0 112.214 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -84.41 36.38 0.58 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 128.446 2.698 . . . . 0.0 109.898 175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.3 m -113.48 133.24 55.32 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.682 1.593 . . . . 0.0 110.804 176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -85.01 117.55 24.04 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.7 t -134.19 119.57 31.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 123.837 0.855 . . . . 0.0 110.134 -176.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.0 m -143.58 168.82 11.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.97 1.708 . . . . 0.0 108.926 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.25 149.39 48.12 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 121.78 -0.575 . . . . 0.0 110.211 176.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -72.5 144.34 48.05 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -142.64 149.58 50.96 Favored Pre-proline 0 N--CA 1.464 0.229 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.72 -39.76 25.22 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.508 2.139 . . . . 0.0 111.663 -178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -58.59 -48.04 82.29 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.894 0.316 . . . . 0.0 110.696 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -58.19 -46.88 85.02 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 118.913 -0.565 . . . . 0.0 109.763 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -52.59 -56.51 14.83 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.203 1.401 . . . . 0.0 110.772 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -63.73 -37.88 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.147 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.8 mt -62.93 -49.77 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 119.609 1.095 . . . . 0.0 109.837 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.3 mt -65.33 -34.2 77.77 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.575 1.079 . . . . 0.0 108.808 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.4 m -60.78 -47.92 84.14 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -59.11 -49.21 78.72 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.699 -0.626 . . . . 0.0 110.229 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.6 mt -59.05 -34.53 72.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.682 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 t -56.26 -58.02 9.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.371 0.987 . . . . 0.0 110.526 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -73.13 -38.92 66.12 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 122.693 0.397 . . . . 0.0 111.693 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -69.81 176.01 3.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.61 1.164 . . . . 0.0 110.211 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -99.57 152.34 20.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.7 m -63.3 150.98 88.18 Favored Pre-proline 0 N--CA 1.449 -0.496 0 O-C-N 124.379 1.049 . . . . 0.0 111.342 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -76.21 93.77 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.271 0 N-CA-C 104.843 -2.791 . . . . 0.0 104.843 175.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.51 74.57 0.47 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -143.65 119.32 6.35 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.59 153.67 75.63 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 121.505 1.47 . . . . 0.0 109.948 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.755 2.022 . . . . 0.0 106.448 176.156 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.2 m . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -84.83 61.61 6.08 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.055 3.17 . . . . 0.0 111.677 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -131.93 33.75 3.91 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 123.402 1.573 . . . . 0.0 113.118 -176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.31 124.18 31.93 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 126.018 1.727 . . . . 0.0 110.014 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.85 -166.21 0.35 Allowed 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 124.856 3.704 . . . . 0.0 112.43 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 50.8 m -54.36 163.13 0.91 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.177 1.791 . . . . 0.0 107.532 175.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 t -83.08 143.61 45.92 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 119.721 -1.862 . . . . 0.0 109.802 -174.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.93 157.15 62.95 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.611 1.541 . . . . 0.0 110.677 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -73.11 -40.96 64.52 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -66.56 147.67 52.95 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.243 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.37 151.51 32.95 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.145 1.378 . . . . 0.0 108.451 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.1 ttt180 -159.28 165.82 32.64 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.512 1.525 . . . . 0.0 107.316 176.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -83.4 166.56 18.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.2 p -111.11 145.39 38.65 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -25.89 -126.52 0.0 OUTLIER Glycine 0 N--CA 1.44 -1.048 1 C-N-CA 133.162 5.172 . . . . 0.0 119.589 -176.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -83.11 144.6 29.75 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.845 -1.178 . . . . 0.0 112.489 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -73.19 -53.55 10.65 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.88 1.672 . . . . 0.0 109.274 -178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -62.14 -31.28 71.74 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.14 0.882 . . . . 0.0 112.424 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.6 m -74.19 -52.39 12.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -59.2 -37.89 78.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.662 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.489 ' CD2' HG11 ' A' ' 50' ' ' VAL . 36.8 t80 -59.1 -41.64 88.59 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.444 1.02 . . . . 0.0 110.777 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.4 m -68.35 -41.1 81.17 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.694 -0.629 . . . . 0.0 111.131 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.11 -55.71 11.48 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.698 0.681 . . . . 0.0 112.671 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.6 p -54.37 148.46 11.76 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.496 1.118 . . . . 0.0 111.629 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.1 t -99.07 -15.54 18.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.486 0.714 . . . . 0.0 111.551 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.1 tp -121.77 115.49 22.77 Favored 'General case' 0 CA--C 1.512 -0.511 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' A' ' 44' ' ' PHE . 22.4 t -134.86 113.6 16.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.12 170.36 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.629 1.172 . . . . 0.0 110.947 -175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -130.97 142.6 50.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 126.869 2.068 . . . . 0.0 106.953 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -168.56 176.78 5.54 Favored 'General case' 0 CA--C 1.518 -0.265 0 O-C-N 121.257 -0.902 . . . . 0.0 110.938 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.9 m -114.77 136.03 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -71.69 113.6 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -81.15 -52.67 7.12 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.7 m -145.93 173.18 12.37 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 125.856 1.662 . . . . 0.0 109.542 -177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.5 mtp -139.55 153.29 47.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 127.149 2.18 . . . . 0.0 106.309 175.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' O ' HD22 ' A' ' 66' ' ' LEU . 88.2 t -145.49 135.74 18.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 108.103 -175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -66.16 147.14 53.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.956 1.707 . . . . 0.0 108.757 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 4.6 mm-40 -139.59 169.37 12.36 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 119.331 0.969 . . . . 0.0 112.912 -176.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.97 163.22 7.88 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 124.573 3.516 . . . . 0.0 114.629 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.58 -123.58 8.3 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 104.323 -3.511 . . . . 0.0 104.323 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -119.84 22.09 11.68 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.31 175.61 45.76 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-O 124.832 2.351 . . . . 0.0 118.934 -174.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.415 HD22 ' O ' ' A' ' 59' ' ' VAL . 2.8 tm? -156.42 135.19 11.75 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 128.472 2.709 . . . . 0.0 105.387 -175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.66 ' HB2' ' HG3' ' A' ' 61' ' ' GLU . . . -109.75 127.24 54.49 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.6 t -98.7 123.3 51.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 m -86.17 127.17 34.67 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 m -130.92 168.13 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.706 0.803 . . . . 0.0 108.933 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.5 t -129.94 35.9 4.09 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -177.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' HB3' HG23 ' A' ' 88' ' ' THR 0.307 81.7 mt 37.42 80.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.456 2.302 . . . . 0.0 116.273 173.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 40.4 mm -67.58 -40.39 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.367 0.985 . . . . 0.0 110.15 175.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 88' ' ' THR . . . -152.37 161.7 29.55 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.46 147.07 42.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.593 1.957 . . . . 0.0 107.637 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -128.68 -30.1 2.33 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.707 1.203 . . . . 0.0 110.359 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -150.77 137.43 18.89 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -142.41 70.17 1.33 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 129.072 2.949 . . . . 0.0 106.434 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.61 32.37 3.15 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 123.985 0.802 . . . . 0.0 111.912 -176.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -59.33 0.01 OUTLIER Glycine 0 N--CA 1.437 -1.253 0 C-N-CA 126.765 2.126 . . . . 0.0 110.983 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mt -66.06 132.6 48.91 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.307 1.043 . . . . 0.0 111.199 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -85.72 94.05 9.01 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.79 1.636 . . . . 0.0 107.532 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.5 mt -70.06 133.0 88.02 Favored Pre-proline 0 C--O 1.24 0.555 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.72 -179.06 3.84 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 123.437 2.758 . . . . 0.0 114.652 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 t -39.58 -60.33 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.371 1.868 . . . . 0.0 110.762 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -73.17 123.72 9.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.01 1.806 . . . . 0.0 108.392 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.32 -170.59 0.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.275 1.983 . . . . 0.0 112.712 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.509 HG21 ' CA ' ' A' ' 74' ' ' GLY . 40.0 m -38.3 127.55 1.38 Allowed 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.044 2.138 . . . . 0.0 116.458 -175.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.19 14.97 0.09 OUTLIER Glycine 0 CA--C 1.529 0.919 0 C-N-CA 128.392 2.901 . . . . 0.0 110.61 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.38 168.07 9.55 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 125.728 1.611 . . . . 0.0 110.728 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.9 p -98.73 153.01 19.05 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 121.57 -0.706 . . . . 0.0 112.621 -177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 24.4 mt -152.37 154.04 34.83 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.833 1.253 . . . . 0.0 109.612 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -112.51 113.24 25.31 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -89.27 121.27 31.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 119.137 0.88 . . . . 0.0 109.106 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -73.76 114.27 11.85 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 125.038 1.335 . . . . 0.0 110.529 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.5 117.57 55.51 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.95 -4.16 14.26 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.268 2.645 . . . . 0.0 112.982 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 16.4 m -127.29 120.49 28.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 127.466 2.306 . . . . 0.0 111.33 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 pptp? -73.81 -25.92 60.35 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.507 -0.746 . . . . 0.0 110.102 175.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -69.7 -45.36 68.44 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.416 1.487 . . . . 0.0 113.059 -175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.416 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 17.3 m -148.56 163.51 25.83 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 101' ' ' CYS . 50.1 Cg_endo -62.57 157.66 62.96 Favored 'Cis proline' 0 CA--C 1.54 0.799 0 O-C-N 122.493 0.733 . . . . 0.0 111.618 -1.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.32 92.71 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.839 3.026 . . . . 0.0 114.268 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.6 tpp -96.03 161.54 13.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.542 1.937 . . . . 0.0 111.563 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -153.48 139.76 18.52 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.342 1.857 . . . . 0.0 107.896 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 57.4 tttt -71.55 146.63 48.34 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.29 32.27 83.64 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 118.9 -0.944 . . . . 0.0 114.35 175.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 56.7 t -129.63 156.78 42.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 126.677 1.991 . . . . 0.0 106.636 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.3 m -103.6 136.55 43.1 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.486 0.715 . . . . 0.0 109.726 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -133.39 176.02 8.9 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.231 1.812 . . . . 0.0 112.773 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.46 123.66 43.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 100.736 -3.802 . . . . 0.0 100.736 175.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -118.0 114.24 22.86 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 124.142 0.977 . . . . 0.0 108.604 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -117.01 113.34 22.21 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.86 -143.04 3.67 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 126.118 1.818 . . . . 0.0 109.35 -175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -133.23 177.3 7.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.527 0.68 . . . . 0.0 110.234 -175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.9 t -132.98 130.95 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -109.9 113.2 25.73 Favored 'General case' 0 N--CA 1.449 -0.512 1 N-CA-C 98.208 -4.738 . . . . 0.0 98.208 174.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 72.16 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 123.504 1.621 . . . . 0.0 108.053 -174.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -161.38 -47.38 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.695 2.798 . . . . 0.0 106.579 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.48 -4.49 13.56 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.661 1.584 . . . . 0.0 111.245 -176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.28 -122.72 6.16 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.267 1.413 . . . . 0.0 109.851 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -75.82 145.33 28.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.754 2.302 . . . . 0.0 114.931 -175.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 p -140.37 151.67 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 130' ' ' VAL . 1.6 tm? -142.6 76.3 18.02 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 120.742 -1.223 . . . . 0.0 108.572 -174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.73 171.95 6.42 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.649 3.566 . . . . 0.0 112.428 -176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -62.89 -19.13 68.02 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.059 1.414 . . . . 0.0 112.22 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.98 23.21 2.13 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.968 2.107 . . . . 0.0 111.773 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 67.8 m -91.59 132.95 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.645 1.178 . . . . 0.0 110.557 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -79.85 113.64 18.17 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 124' ' ' LEU . 55.5 t -136.59 119.21 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -175.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.75 167.77 8.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 125.102 1.361 . . . . 0.0 108.626 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.22 152.29 41.25 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -69.94 135.6 49.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -137.36 145.11 48.19 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.61 -46.24 14.94 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.926 1.751 . . . . 0.0 112.648 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.85 -38.0 89.51 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.792 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -61.72 -41.09 97.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.402 -0.811 . . . . 0.0 109.595 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -54.88 -49.83 70.22 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.381 1.473 . . . . 0.0 109.212 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -62.95 -45.23 93.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.132 176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 68.0 mt -59.21 -47.38 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 119.804 1.184 . . . . 0.0 109.813 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 mt -65.96 -38.07 87.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 109.4 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 59.2 m -61.64 -43.37 98.98 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.718 -0.614 . . . . 0.0 110.099 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -60.3 -52.71 64.11 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.6 mt -59.27 -32.48 70.05 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.699 0.8 . . . . 0.0 112.016 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.9 t -64.6 -51.24 63.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.081 1.352 . . . . 0.0 110.646 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -71.67 -38.94 70.58 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -75.21 177.29 6.6 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.456 1.902 . . . . 0.0 108.928 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.2 pttm -121.18 151.9 39.4 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 82.4 m -58.6 153.18 41.89 Favored Pre-proline 0 C--O 1.238 0.454 0 C-N-CA 124.496 1.118 . . . . 0.0 111.048 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.1 93.83 0.96 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.853 2.369 . . . . 0.0 108.832 176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.3 m -116.18 55.65 0.8 Allowed 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.386 1.474 . . . . 0.0 108.735 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -112.91 113.0 50.01 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 101.701 -3.444 . . . . 0.0 101.701 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -111.65 -172.85 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.078 2.519 . . . . 0.0 112.39 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.257 1.499 0 C-N-CA 129.474 3.109 . . . . 0.0 103.73 175.457 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.474 0.725 0 CA-C-O 119.62 -0.228 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -87.58 61.7 3.68 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.547 2.831 . . . . 0.0 110.531 168.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -116.47 39.77 3.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.702 1.601 . . . . 0.0 113.041 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -122.24 97.05 45.75 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.416 1.487 . . . . 0.0 111.119 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.15 -168.39 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 1 C-N-CA 125.459 4.106 . . . . 0.0 110.731 176.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.6 m -46.54 145.05 1.95 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.466 1.106 . . . . 0.0 109.022 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.53 126.11 72.14 Favored Pre-proline 0 C--O 1.243 0.74 0 CA-C-O 119.27 -0.395 . . . . 0.0 111.231 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.69 161.63 43.42 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.751 2.3 . . . . 0.0 110.505 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.3 -13.61 60.14 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.844 -1.16 . . . . 0.0 114.116 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -51.14 132.93 28.36 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.979 1.311 . . . . 0.0 109.236 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.1 t -145.51 94.9 2.57 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.999 1.32 . . . . 0.0 109.313 -175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 41.5 ttm-85 -148.44 156.78 42.91 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.358 1.063 . . . . 0.0 110.208 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.3 ttp85 -100.89 133.79 44.84 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 127.837 2.455 . . . . 0.0 107.1 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 p -123.54 167.79 13.44 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.133 2.173 . . . . 0.0 111.215 -175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 52.81 -166.22 1.34 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 126.687 2.089 . . . . 0.0 113.886 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 p -108.59 169.52 8.6 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 tt -63.93 -40.87 97.44 Favored 'General case' 0 C--O 1.222 -0.357 0 O-C-N 121.119 -0.988 . . . . 0.0 109.073 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.61 -51.84 65.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.221 0.464 . . . . 0.0 110.845 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.8 m -53.02 -54.47 34.81 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.199 1.0 . . . . 0.0 110.194 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -66.91 -35.89 81.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.007 -0.996 . . . . 0.0 111.489 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 50' ' ' VAL . 30.8 t80 -57.42 -39.91 77.18 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.889 1.222 . . . . 0.0 110.315 175.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -76.11 -42.67 46.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.936 -1.03 . . . . 0.0 111.865 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.79 78.47 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.464 1.106 . . . . 0.0 112.573 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -75.99 145.74 40.06 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.682 0.793 . . . . 0.0 111.459 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.4 t -95.12 -5.94 43.04 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.826 1.25 . . . . 0.0 108.268 175.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD21 ' CE2' ' A' ' 94' ' ' PHE . 26.0 tp -129.09 122.71 30.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.557 2.343 . . . . 0.0 108.272 -176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 44' ' ' PHE . 23.3 t -142.56 113.81 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 175.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -148.92 163.34 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.209 1.404 . . . . 0.0 109.019 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 p -126.21 144.76 50.65 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -164.67 161.39 20.76 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 120.674 -1.266 . . . . 0.0 111.933 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 55.3 m -87.69 132.87 33.96 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.0 t -75.35 113.31 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -82.9 -46.44 12.98 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.57 1.548 . . . . 0.0 108.13 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -153.03 167.03 30.55 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.491 1.517 . . . . 0.0 108.967 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.3 mtp -135.34 123.98 23.68 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.943 2.897 . . . . 0.0 105.784 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.8 t -124.73 150.73 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 124.93 1.292 . . . . 0.0 107.899 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -67.69 154.46 41.43 Favored 'General case' 0 C--O 1.223 -0.314 0 O-C-N 121.609 -0.682 . . . . 0.0 109.26 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 23.8 mm-40 -140.02 168.34 15.21 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.408 1.083 . . . . 0.0 110.776 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.83 162.26 11.29 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.65 2.9 . . . . 0.0 112.915 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.93 -147.48 50.73 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 -175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -88.72 20.42 3.49 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.48 169.04 54.9 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-O 123.848 1.804 . . . . 0.0 117.547 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -150.96 134.11 16.04 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.735 2.814 . . . . 0.0 104.967 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -98.55 123.53 42.77 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.55 123.15 49.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 175.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.0 m -98.72 126.21 44.28 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -134.12 175.51 11.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.221 0.608 . . . . 0.0 111.305 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 t -133.1 40.84 3.18 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -176.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.278 91.8 mt 38.81 80.97 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.819 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 177.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.411 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 26.9 mm -77.86 -29.5 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 118.77 0.714 . . . . 0.0 109.42 175.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -155.32 159.28 29.03 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 125.935 1.731 . . . . 0.0 109.408 176.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.49 143.56 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -135.34 -32.04 0.95 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 119.139 -0.458 . . . . 0.0 111.194 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -157.98 133.58 9.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -145.27 67.85 1.23 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.121 2.168 . . . . 0.0 106.548 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.62 43.83 3.22 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 125.479 1.514 . . . . 0.0 111.215 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.12 -31.77 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 125.93 1.728 . . . . 0.0 113.16 176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.4 mt -84.95 144.27 28.43 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 119.35 1.575 . . . . 0.0 109.993 175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -100.55 63.37 1.08 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -57.54 141.08 79.37 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-O 119.02 -0.514 . . . . 0.0 109.962 -177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.39 171.51 16.87 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.192 1.928 . . . . 0.0 112.961 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.1 t -43.81 -56.13 7.86 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.896 2.078 . . . . 0.0 110.23 177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -72.42 116.79 4.85 Favored 'Trans proline' 0 CA--C 1.551 1.35 0 N-CA-C 106.597 -2.116 . . . . 0.0 106.597 175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.46 -152.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 1 C-N-CA 125.317 4.011 . . . . 0.0 112.129 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.456 HG21 ' HA2' ' A' ' 74' ' ' GLY 0.292 97.5 m -33.77 124.39 0.45 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 129.089 2.956 . . . . 0.0 112.117 -175.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.21 -4.05 1.75 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 126.186 1.85 . . . . 0.0 113.356 -176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -90.84 161.04 15.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.034 1.417 . . . . 0.0 109.446 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 77.2 p -105.32 143.8 32.99 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.799 0.809 . . . . 0.0 112.231 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 mt -148.25 160.68 42.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.153 1.781 . . . . 0.0 109.48 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -113.32 121.22 43.74 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.501 ' CE2' HD21 ' A' ' 49' ' ' LEU . 40.6 m-85 -94.04 122.59 36.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -75.64 113.44 13.09 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 124.259 0.974 . . . . 0.0 109.001 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.48 114.02 62.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.22 -11.7 29.12 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 111.926 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -117.49 113.25 21.76 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.993 1.317 . . . . 0.0 111.956 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -82.74 -20.29 36.25 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 175.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -60.24 -53.59 55.84 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.448 1.499 . . . . 0.0 109.776 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.3 m -160.58 163.56 21.16 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 127.483 2.313 . . . . 0.0 108.407 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -63.13 141.97 41.85 Favored 'Cis proline' 0 CA--C 1.537 0.664 0 CA-C-N 120.678 1.278 . . . . 0.0 111.312 1.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.51 102.2 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.177 2.585 . . . . 0.0 111.558 -175.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 tpp -93.36 158.41 15.75 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.045 1.738 . . . . 0.0 108.666 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -142.54 137.22 30.02 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.537 0.684 . . . . 0.0 110.107 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -74.94 144.42 43.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.134 -1.393 . . . . 0.0 107.242 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 70.11 45.62 55.3 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -151.13 161.31 3.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 127.742 2.417 . . . . 0.0 105.513 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 2.8 m -107.63 131.34 54.48 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -122.77 170.32 10.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.444 1.898 . . . . 0.0 112.622 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.23 123.74 47.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.572 3.549 . . . . 0.0 102.031 175.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.37 114.13 21.87 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.5 mtm -119.23 113.33 20.7 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.18 -134.2 1.91 Allowed Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.187 1.375 . . . . 0.0 111.366 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -134.96 -178.5 5.11 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.342 -1.093 . . . . 0.0 109.401 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 49' ' ' LEU . 21.6 t -136.9 144.12 33.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 175.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.24 113.43 19.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -75.84 73.95 2.77 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 122.388 1.09 . . . . 0.0 108.527 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -168.94 -41.2 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 129.812 3.245 . . . . 0.0 108.343 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 29.8 mtt-85 -119.2 -6.37 10.39 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.349 1.06 . . . . 0.0 112.682 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 90.44 -151.32 21.33 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.86 141.95 38.13 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.613 1.542 . . . . 0.0 112.737 -175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.0 p -126.81 135.62 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 130' ' ' VAL 0.255 1.7 tm? -122.07 74.26 38.16 Favored Pre-proline 0 C--N 1.32 -0.68 0 C-N-CA 125.433 1.493 . . . . 0.0 107.486 -174.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.86 174.86 6.1 Favored 'Trans proline' 0 CA--C 1.542 0.888 1 C-N-CA 125.728 4.285 . . . . 0.0 114.237 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.54 -22.85 61.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.728 2.285 . . . . 0.0 113.463 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -85.17 23.61 1.24 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.355 1.462 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.2 m -97.74 140.1 32.64 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.006 0.922 . . . . 0.0 111.252 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -92.55 117.05 29.56 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 124' ' ' LEU . 85.3 t -131.8 117.41 34.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.537 0.735 . . . . 0.0 109.795 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -147.12 168.68 4.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 125.228 1.411 . . . . 0.0 109.117 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.6 mp -66.7 141.1 57.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 122.13 0.967 . . . . 0.0 109.954 175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -68.45 136.32 53.06 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.777 1.631 . . . . 0.0 107.877 175.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 -144.65 155.64 56.51 Favored Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 126.112 1.765 . . . . 0.0 106.912 176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.44 -40.12 25.77 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.187 1.925 . . . . 0.0 112.862 -175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -56.97 -52.71 64.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.013 0.37 . . . . 0.0 110.945 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -58.09 -44.11 87.45 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 123.091 0.556 . . . . 0.0 110.362 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -55.96 -50.65 70.2 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.34 1.056 . . . . 0.0 109.796 -177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -61.67 -39.57 91.86 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.275 176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.3 mt -63.4 -50.36 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-O 118.154 -0.927 . . . . 0.0 110.116 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 mt -62.39 -36.91 83.78 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 120.207 1.367 . . . . 0.0 109.088 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.7 m -61.81 -45.36 94.17 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -62.15 -38.94 90.93 Favored 'General case' 0 N--CA 1.462 0.132 0 O-C-N 121.282 -0.886 . . . . 0.0 110.737 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 82.4 mt -68.65 -24.61 64.55 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.706 0.803 . . . . 0.0 111.582 176.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.9 t -76.09 -34.66 59.54 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.184 0.902 . . . . 0.0 109.408 175.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -75.61 -48.88 20.33 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.625 0.77 . . . . 0.0 111.092 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -75.57 157.99 33.1 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.017 0.826 . . . . 0.0 109.496 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -82.39 150.45 27.12 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 33.7 m -65.99 123.69 85.7 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.26 159.62 43.52 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.455 2.104 . . . . 0.0 111.182 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -162.93 79.77 0.48 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.254 -3.61 . . . . 0.0 101.254 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -114.62 113.22 45.2 Favored Pre-proline 0 N--CA 1.452 -0.365 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.1 153.11 12.66 Favored 'Trans proline' 0 N--CA 1.446 -1.276 0 C-N-CA 121.654 1.569 . . . . 0.0 108.88 175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.257 1.473 1 N-CA-C 98.105 -4.776 . . . . 0.0 98.105 175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.1 p . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.67 -177.53 2.54 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.113 1.875 . . . . 0.0 109.643 168.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 -74.3 43.64 0.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 129.614 3.166 . . . . 0.0 112.082 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.84 115.2 4.29 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 127.477 2.311 . . . . 0.0 110.572 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -91.29 -169.61 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.571 3.514 . . . . 0.0 112.348 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 m -57.88 165.6 1.73 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.31 1.444 . . . . 0.0 108.418 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.3 t -84.01 120.91 75.5 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -72.2 155.83 55.99 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.344 1.363 . . . . 0.0 109.747 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -66.43 -9.45 34.18 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.884 -1.135 . . . . 0.0 112.937 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -57.24 128.94 39.53 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 125.188 1.395 . . . . 0.0 107.521 175.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -139.41 68.87 1.37 Allowed 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -157.35 165.52 35.57 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.68 2.392 . . . . 0.0 106.156 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -114.68 142.26 46.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.32 2.248 . . . . 0.0 105.508 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.4 p -127.87 174.41 9.18 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.953 1.301 . . . . 0.0 110.872 -175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.58 -177.02 37.96 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.322 0.963 . . . . 0.0 112.364 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -102.47 165.42 11.11 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 121.725 -0.868 . . . . 0.0 108.683 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.82 -47.75 76.88 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -63.05 -48.0 80.59 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 118.62 0.646 . . . . 0.0 110.593 -176.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.8 m -59.28 -48.15 82.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.346 0.659 . . . . 0.0 111.077 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -69.0 -33.89 74.41 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-O 117.744 -1.122 . . . . 0.0 111.249 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.514 ' CD2' HG11 ' A' ' 50' ' ' VAL . 15.9 t80 -57.52 -36.4 71.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 120.185 1.357 . . . . 0.0 110.033 175.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 62.8 m -69.26 -45.85 68.69 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.39 0.676 . . . . 0.0 111.115 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -52.28 50.85 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.511 0.724 . . . . 0.0 112.144 -177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -62.05 138.49 58.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.78 1.232 . . . . 0.0 109.994 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -94.3 -6.68 43.89 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 122.061 0.934 . . . . 0.0 109.882 175.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.5 HD21 ' CE2' ' A' ' 94' ' ' PHE . 24.6 tp -120.38 120.42 35.92 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 126.75 2.02 . . . . 0.0 107.709 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.514 HG11 ' CD2' ' A' ' 44' ' ' PHE . 40.1 t -142.88 113.32 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.1 m -147.49 166.8 5.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.776 1.231 . . . . 0.0 108.509 -176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -130.29 143.66 50.91 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -165.58 173.31 11.03 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.155 -0.966 . . . . 0.0 110.799 -179.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 46.8 m -110.82 134.45 52.5 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -75.92 113.58 15.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -176.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 22.2 mmmt -86.49 -42.38 13.61 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.424 1.09 . . . . 0.0 110.327 177.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.4 m -147.37 168.99 20.42 Favored 'General case' 0 C--N 1.334 -0.084 0 C-N-CA 125.198 1.399 . . . . 0.0 110.925 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 50.1 mtp -138.82 129.25 25.84 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' O ' HD22 ' A' ' 66' ' ' LEU . 6.0 t -123.72 142.19 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 124.312 1.045 . . . . 0.0 108.663 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -72.49 139.69 47.78 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -123.62 176.11 2.41 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.339 1.856 . . . . 0.0 108.555 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.81 161.81 34.62 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.929 2.419 . . . . 0.0 112.24 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -154.2 40.17 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -72.2 0.27 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.914 1.285 . . . . 0.0 110.632 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -65.5 172.56 22.86 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 126.808 2.147 . . . . 0.0 117.873 -175.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.427 HD22 ' O ' ' A' ' 59' ' ' VAL . 1.8 tm? -161.87 141.99 10.28 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 129.569 3.148 . . . . 0.0 105.44 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -110.29 151.35 27.5 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.9 t -120.93 123.28 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.2 m -98.58 124.68 43.49 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.51 169.98 20.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 43.9 t -123.8 35.39 4.85 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.26 70.3 mt 36.3 82.58 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 128.071 2.549 . . . . 0.0 116.884 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 32.7 mm -72.15 -30.99 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.305 -0.872 . . . . 0.0 111.816 175.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.498 ' CA ' HG21 ' A' ' 88' ' ' THR . . . -159.3 160.91 31.7 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.88 49.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -141.32 -25.12 0.72 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.396 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -156.15 125.54 6.23 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 p -139.57 67.95 1.38 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 127.709 2.404 . . . . 0.0 104.613 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 31.46 3.31 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.58 1.086 . . . . 0.0 111.939 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.58 -62.7 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 125.247 1.403 . . . . 0.0 111.4 -176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.12 148.59 30.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 117.147 0.474 . . . . 0.0 111.022 -177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.11 97.69 11.33 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.636 -1.986 . . . . 0.0 105.636 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 35.2 mt -63.23 147.44 94.81 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.68 178.7 4.27 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.539 1.493 . . . . 0.0 111.347 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.3 t -52.31 -61.02 5.06 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 124.614 1.166 . . . . 0.0 111.245 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.98 142.36 46.74 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 N-CA-C 107.36 -1.823 . . . . 0.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.36 -168.94 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.392 1.395 . . . . 0.0 110.846 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.498 HG21 ' CA ' ' A' ' 74' ' ' GLY . 17.1 m -38.17 130.93 1.18 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.258 2.223 . . . . 0.0 113.67 -175.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.98 59.48 0.06 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 105.257 -3.137 . . . . 0.0 105.257 -175.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -148.63 165.33 31.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 126.501 1.92 . . . . 0.0 106.608 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.9 p -104.0 147.72 27.05 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 120.907 -1.121 . . . . 0.0 111.443 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -147.26 158.77 44.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.348 1.459 . . . . 0.0 109.068 175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -125.02 113.84 18.32 Favored 'General case' 0 C--O 1.227 -0.082 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.5 ' CE2' HD21 ' A' ' 49' ' ' LEU . 70.8 m-85 -98.81 121.19 40.45 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 123.86 0.864 . . . . 0.0 109.57 -175.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -78.91 113.8 17.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 124.677 1.236 . . . . 0.0 109.994 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.54 120.01 54.31 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.32 0.02 8.0 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.685 2.257 . . . . 0.0 112.458 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 57.7 m -129.83 160.81 32.35 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.061 2.544 . . . . 0.0 109.121 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.1 pttm -132.01 -8.42 3.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -83.45 -48.03 10.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.482 1.037 . . . . 0.0 108.511 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.1 m -127.66 158.22 70.81 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 124.99 1.316 . . . . 0.0 111.519 176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.7 153.26 79.38 Favored 'Cis proline' 0 CA--C 1.543 0.964 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 -4.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -63.35 96.51 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.403 2.735 . . . . 0.0 112.622 -175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 32.5 tpp -94.67 160.94 14.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.135 1.374 . . . . 0.0 110.309 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -152.91 140.02 19.32 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.988 1.715 . . . . 0.0 109.093 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -78.2 147.06 34.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 175.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.45 46.6 84.87 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.4 t -146.32 147.86 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 126.477 1.911 . . . . 0.0 106.714 176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.1 m -93.8 132.13 38.5 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.168 0.587 . . . . 0.0 110.096 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -129.76 172.38 11.7 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.631 1.972 . . . . 0.0 111.664 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 tp -115.81 124.15 50.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 101.381 -3.563 . . . . 0.0 101.381 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.21 114.34 23.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.7 mtm -117.89 113.37 21.64 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 103.274 -2.861 . . . . 0.0 103.274 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.74 -134.01 1.72 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.802 1.191 . . . . 0.0 111.164 -175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -135.89 175.98 9.1 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.525 -0.985 . . . . 0.0 110.991 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 122' ' ' PRO . 6.4 t -130.21 145.78 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.789 176.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -123.76 113.7 18.93 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -81.01 65.32 6.11 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 122.378 1.085 . . . . 0.0 111.946 -175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -166.82 -39.42 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.982 1.713 . . . . 0.0 110.736 175.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -113.65 -30.67 6.73 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 -175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.96 -168.76 21.21 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 Cg_endo -71.76 160.53 47.75 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 121.287 1.325 . . . . 0.0 111.342 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.3 p -132.47 157.21 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 130' ' ' VAL . 1.7 tm? -146.44 74.73 12.64 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 120.67 -1.269 . . . . 0.0 108.664 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.05 174.19 7.27 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.552 3.501 . . . . 0.0 113.052 -175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.13 -16.37 50.05 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.847 1.698 . . . . 0.0 111.99 175.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.81 32.01 0.48 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.038 2.135 . . . . 0.0 110.826 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 48.1 m -113.66 128.73 56.54 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.111 1.364 . . . . 0.0 111.064 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -81.34 113.31 19.36 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 124' ' ' LEU . 55.6 t -133.46 123.18 45.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.6 m -152.43 173.16 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.362 1.465 . . . . 0.0 110.682 -176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.91 134.25 54.77 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.875 1.67 . . . . 0.0 109.323 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -67.74 125.77 27.3 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -140.9 157.64 66.93 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 117.56 -1.209 . . . . 0.0 109.199 176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.52 -44.85 16.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.63 2.887 . . . . 0.0 115.785 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -55.68 -43.42 76.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 119.542 1.065 . . . . 0.0 110.859 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -66.35 -44.28 83.66 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.94 -0.553 . . . . 0.0 109.556 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -53.37 -50.05 65.9 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.919 0.887 . . . . 0.0 111.657 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -56.59 -49.77 73.92 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.592 0.757 . . . . 0.0 109.335 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.73 -52.61 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 118.324 -0.846 . . . . 0.0 109.861 -175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 mt -63.23 -32.82 74.32 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.771 1.169 . . . . 0.0 110.222 -176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 20.6 m -65.73 -46.84 77.37 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -60.32 -41.75 94.17 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.685 -0.635 . . . . 0.0 111.267 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 93.1 mt -66.98 -35.64 80.41 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.5 1.12 . . . . 0.0 110.867 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -61.99 -45.61 92.85 Favored 'General case' 0 C--O 1.231 0.087 0 C-N-CA 124.056 0.943 . . . . 0.0 108.491 175.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -67.41 -48.88 66.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.53 0.732 . . . . 0.0 110.5 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -68.41 166.43 16.75 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.457 0.646 . . . . 0.0 109.638 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -108.99 123.82 49.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 175.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 23.5 m -58.94 158.54 16.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.94 148.19 31.45 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.381 2.054 . . . . 0.0 110.999 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.2 m -142.55 78.4 1.62 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -155.52 113.06 2.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -106.37 45.41 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.246 3.297 . . . . 0.0 115.388 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 C--O 1.25 1.088 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 176.067 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.7 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 118.157 -0.925 . . . . 0.0 109.851 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -81.98 64.51 8.45 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.861 2.374 . . . . 0.0 109.766 170.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -121.25 57.37 1.0 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 124.065 1.888 . . . . 0.0 110.345 -177.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.24 94.41 6.26 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 113.676 -1.602 . . . . 0.0 110.171 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -83.25 -166.93 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 125.178 3.919 . . . . 0.0 110.401 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.6 m -50.84 146.07 6.37 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.323 1.449 . . . . 0.0 107.366 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 6.2 t -84.47 144.45 43.16 Favored Pre-proline 0 C--O 1.242 0.704 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.32 153.69 35.83 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.152 2.568 . . . . 0.0 108.715 175.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -24.18 59.15 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 121.239 -0.913 . . . . 0.0 112.212 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.1 135.84 55.15 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.1 t -145.92 124.25 12.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.319 1.048 . . . . 0.0 109.118 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 tpt85 -155.52 166.03 34.77 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 128.542 2.737 . . . . 0.0 107.51 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -118.92 150.83 39.23 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.738 2.015 . . . . 0.0 106.58 175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -132.05 176.33 8.47 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.324 2.249 . . . . 0.0 111.178 -176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 -158.73 50.96 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 126.322 1.915 . . . . 0.0 114.439 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -123.06 162.25 22.78 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 175.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 tt -63.7 -38.31 90.64 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -64.83 -53.75 41.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 118.474 0.579 . . . . 0.0 111.376 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -59.54 -47.15 86.65 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.533 0.682 . . . . 0.0 109.183 -177.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -67.85 -36.2 79.9 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.39 -1.29 . . . . 0.0 111.754 -175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.623 ' CD2' HG11 ' A' ' 50' ' ' VAL . 27.0 t80 -57.8 -43.43 85.64 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 120.55 1.523 . . . . 0.0 111.484 176.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.91 -34.34 69.02 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.312 0.645 . . . . 0.0 111.495 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.9 96.32 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.506 0.722 . . . . 0.0 112.261 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 p -76.08 148.45 37.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.901 1.28 . . . . 0.0 113.831 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 t -90.3 -13.92 34.26 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.643 1.977 . . . . 0.0 109.382 175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 94' ' ' PHE . 57.9 tp -131.06 123.99 29.89 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.54 1.536 . . . . 0.0 109.111 -176.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 44' ' ' PHE . 22.0 t -141.74 114.8 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.2 m -147.59 168.92 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.516 1.126 . . . . 0.0 109.57 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.0 p -124.31 140.72 52.69 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 174.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.61 163.48 24.42 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.527 -1.358 . . . . 0.0 111.202 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 94.2 m -93.81 127.16 39.4 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -72.26 113.32 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -89.78 -47.6 7.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -141.27 166.87 23.58 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.731 0.812 . . . . 0.0 110.208 -175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 40.4 mtp -139.06 124.14 18.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.906 1.682 . . . . 0.0 106.83 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -118.09 146.92 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.249 1.42 . . . . 0.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -72.13 141.1 49.14 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 121.443 -0.786 . . . . 0.0 109.13 -179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 61.6 mm-40 -132.27 170.25 11.82 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.767 1.227 . . . . 0.0 109.954 -176.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -62.1 170.32 6.45 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 124.028 3.152 . . . . 0.0 114.999 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.5 -123.33 28.96 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 108.003 -2.039 . . . . 0.0 108.003 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -113.94 19.61 16.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.183 1.393 . . . . 0.0 108.255 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -77.82 171.52 55.15 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 123.37 1.539 . . . . 0.0 115.855 -175.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -155.73 129.11 8.28 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.062 2.545 . . . . 0.0 105.264 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -97.03 123.82 40.86 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 76.0 t -95.1 123.17 47.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.1 m -95.39 123.73 39.07 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.36 169.04 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 124.232 1.013 . . . . 0.0 110.539 -175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -135.75 44.81 2.47 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt 37.8 81.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.746 3.239 . . . . 0.0 119.746 175.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 18.4 mm -79.98 -23.14 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.507 1.048 . . . . 0.0 110.305 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.05 160.26 32.58 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 175.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.22 146.68 35.46 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.632 1.173 . . . . 0.0 109.604 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -138.48 -33.1 0.68 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.307 0.643 . . . . 0.0 112.688 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -150.61 133.16 15.69 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -143.22 77.77 1.58 Allowed 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.091 2.956 . . . . 0.0 103.496 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.61 36.4 2.64 Favored Glycine 0 N--CA 1.466 0.649 0 C-N-CA 125.568 1.556 . . . . 0.0 112.037 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.81 -67.2 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 126.681 2.086 . . . . 0.0 109.736 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.81 125.29 22.89 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 123.755 0.822 . . . . 0.0 108.863 -176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -78.54 91.28 4.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 124.628 1.205 . . . . 0.0 108.621 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 83' ' ' LEU . 28.4 mt -65.84 129.63 94.33 Favored Pre-proline 0 C--O 1.235 0.296 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 175.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.64 178.17 7.73 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.45 1.433 . . . . 0.0 112.977 -175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.9 t -43.86 -58.8 4.21 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-O 116.902 -1.523 . . . . 0.0 109.892 175.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.77 122.0 9.11 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 N-CA-C 107.623 -1.722 . . . . 0.0 107.623 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 88' ' ' THR . 84.1 Cg_endo -69.83 -153.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.688 1 C-N-CA 125.909 4.406 . . . . 0.0 110.407 175.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 54.1 m -31.57 123.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 129.103 2.961 . . . . 0.0 110.54 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.31 39.21 0.26 Allowed Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.569 1.081 . . . . 0.0 112.748 -175.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.73 164.07 29.11 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.421 1.488 . . . . 0.0 107.216 175.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.2 p -110.38 153.29 25.16 Favored 'General case' 0 C--O 1.227 -0.088 0 CA-C-N 118.874 0.761 . . . . 0.0 112.189 -176.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.5 mt -144.31 159.89 41.94 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.097 1.359 . . . . 0.0 109.165 -175.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -119.67 113.47 20.72 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 49' ' ' LEU . 2.7 m-85 -95.51 118.59 32.5 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -75.89 113.47 13.42 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.841 0.857 . . . . 0.0 109.451 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.73 114.82 63.55 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -73.35 2.2 5.93 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.392 2.728 . . . . 0.0 113.484 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.3 m -135.07 114.14 12.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.503 1.921 . . . . 0.0 109.074 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -73.93 -10.24 59.45 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.323 -0.861 . . . . 0.0 111.321 175.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -82.75 -46.46 13.12 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.53 -0.748 . . . . 0.0 112.008 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.1 m -151.94 164.17 21.15 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.477 1.111 . . . . 0.0 112.327 -175.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.75 150.98 52.54 Favored 'Cis proline' 0 C--N 1.355 0.904 0 CA-C-N 120.013 1.04 . . . . 0.0 110.231 -3.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.77 97.62 0.39 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.429 2.753 . . . . 0.0 113.638 -175.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 tpp -93.77 162.33 13.97 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.758 1.223 . . . . 0.0 108.411 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -146.77 143.4 28.63 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.654 1.582 . . . . 0.0 108.313 175.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -75.98 139.77 41.69 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.137 0.575 . . . . 0.0 110.036 175.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.51 21.89 71.39 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 126.386 1.946 . . . . 0.0 115.474 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 54.8 t -123.76 146.15 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.057 1.743 . . . . 0.0 108.345 -176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 5.1 m -91.87 128.25 37.63 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.443 0.64 . . . . 0.0 109.625 175.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -124.12 172.29 9.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.089 2.556 . . . . 0.0 111.457 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.62 123.63 46.65 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 100.791 -3.781 . . . . 0.0 100.791 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.18 114.03 21.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 11.5 mtm -116.97 113.25 22.12 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 103.729 -2.693 . . . . 0.0 103.729 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.9 -142.49 3.49 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.172 1.844 . . . . 0.0 110.878 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -132.86 176.41 8.5 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 118.617 1.209 . . . . 0.0 110.334 -176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.33 149.29 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -132.25 114.31 14.28 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.249 2.22 . . . . 0.0 106.546 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.82 65.62 0.23 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.285 1.834 . . . . 0.0 114.56 -175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 169.16 -25.84 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 130.701 3.6 . . . . 0.0 111.64 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -112.76 -6.61 13.84 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.648 1.179 . . . . 0.0 113.889 -176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.67 -151.01 42.35 Favored Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.33 135.56 22.7 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.205 1.936 . . . . 0.0 110.369 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.264 7.4 p -120.4 142.51 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 130' ' ' VAL 0.282 1.4 tm? -129.67 74.1 81.02 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -174.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.04 175.11 5.02 Favored 'Trans proline' 0 CA--C 1.543 0.93 1 C-N-CA 125.497 4.131 . . . . 0.0 113.347 -175.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -58.91 -28.91 88.87 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.283 1.988 . . . . 0.0 113.843 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -84.25 39.44 0.72 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.7 m -107.66 129.12 55.04 Favored 'General case' 0 C--O 1.24 0.582 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 176.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -82.19 113.74 20.23 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 124' ' ' LEU . 50.0 t -133.57 117.86 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 C-N-CA 123.812 0.845 . . . . 0.0 109.193 -175.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.75 168.87 3.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 C-N-CA 124.89 1.276 . . . . 0.0 109.286 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.6 mp -63.9 139.29 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.41 0.624 . . . . 0.0 109.415 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -65.55 144.43 56.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.996 1.318 . . . . 0.0 109.203 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 -144.34 148.99 43.01 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.61 -40.5 29.74 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 121.751 1.634 . . . . 0.0 110.712 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -53.53 -46.43 70.15 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.801 0.84 . . . . 0.0 110.804 176.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.91 -40.32 87.65 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.512 0.725 . . . . 0.0 111.011 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.8 -47.41 82.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.16 0.891 . . . . 0.0 110.009 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -59.31 -39.65 83.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.511 1.524 . . . . 0.0 110.062 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 64.9 mt -63.48 -51.83 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.441 1.019 . . . . 0.0 109.791 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.3 mt -63.71 -35.07 79.37 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 120.129 1.331 . . . . 0.0 109.548 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.0 m -58.67 -49.94 75.7 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -58.13 -41.47 83.75 Favored 'General case' 0 N--CA 1.462 0.171 0 O-C-N 121.632 -0.667 . . . . 0.0 112.171 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.84 -28.75 64.83 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.518 0.727 . . . . 0.0 112.369 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 t -73.18 -36.64 66.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.865 0.866 . . . . 0.0 108.716 175.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -75.32 -50.26 16.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.685 1.594 . . . . 0.0 110.37 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -76.53 166.58 23.2 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 120.725 -1.234 . . . . 0.0 111.009 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.05 161.28 24.25 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 22.9 m -79.29 130.74 67.94 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.29 111.84 3.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.436 2.757 . . . . 0.0 109.279 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.6 p -160.5 83.21 0.69 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.6 113.24 47.98 Favored Pre-proline 0 C--O 1.234 0.265 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -91.98 -179.0 1.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.667 2.911 . . . . 0.0 110.745 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.255 1.355 0 N-CA-C 101.059 -3.682 . . . . 0.0 101.059 175.084 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -92.99 55.01 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.004 2.469 . . . . 0.0 111.2 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -105.87 33.38 3.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.65 148.46 66.87 Favored Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 126.592 1.957 . . . . 0.0 109.511 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.05 -178.84 4.03 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.703 2.935 . . . . 0.0 112.701 -176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 m -65.7 174.35 2.36 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.906 2.083 . . . . 0.0 107.335 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 19.6 t -83.01 116.37 63.86 Favored Pre-proline 0 CA--C 1.551 0.992 0 O-C-N 120.365 -1.46 . . . . 0.0 110.095 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -85.55 176.82 5.33 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.531 2.821 . . . . 0.0 111.705 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -76.21 -9.96 59.04 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.421 HE22 ' NH1' ' A' ' 35' ' ' ARG . 3.3 tp-100 -58.9 144.04 45.88 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.803 0.841 . . . . 0.0 109.41 176.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 49.8 t -146.23 77.06 1.47 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.792 1.637 . . . . 0.0 108.436 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' NH1' HE22 ' A' ' 33' ' ' GLN . 36.5 ttp-105 -151.06 159.5 44.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 129.218 3.007 . . . . 0.0 103.856 175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -101.25 147.81 25.85 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.0 p -137.21 172.3 13.2 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.07 0.548 . . . . 0.0 110.055 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.01 175.65 29.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.392 0.996 . . . . 0.0 112.829 -176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.1 p -101.9 168.55 9.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.42 -42.3 96.13 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -68.38 -42.64 78.81 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.013 0.525 . . . . 0.0 112.347 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -64.95 -52.43 56.37 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.89 -36.46 83.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.339 -0.838 . . . . 0.0 112.092 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.576 ' CD2' HG11 ' A' ' 50' ' ' VAL . 35.1 t80 -60.3 -38.58 84.12 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.907 1.23 . . . . 0.0 111.236 177.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.8 m -70.15 -41.26 74.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 118.667 -0.682 . . . . 0.0 111.385 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.75 -52.89 25.73 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.39 1.076 . . . . 0.0 112.903 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -56.17 138.24 50.3 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.325 1.05 . . . . 0.0 112.222 -175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -82.66 -14.12 55.23 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.06 -1.025 . . . . 0.0 110.187 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.1 tp -127.57 122.21 32.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.871 1.268 . . . . 0.0 109.592 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG11 ' CD2' ' A' ' 44' ' ' PHE . 16.3 t -138.2 113.74 9.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 m -149.33 171.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.683 1.593 . . . . 0.0 108.875 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.552 HG22 ' HA ' ' A' ' 111' ' ' LEU . 34.2 p -130.77 145.22 51.9 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -163.17 167.98 21.38 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.167 -0.958 . . . . 0.0 111.251 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.8 m -102.64 130.08 49.43 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 66.8 t -71.31 113.5 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -80.15 -42.99 22.4 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.365 1.466 . . . . 0.0 109.529 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -156.65 166.01 34.63 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.705 1.202 . . . . 0.0 109.219 176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 59.2 mtp -133.23 129.97 38.42 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.334 -2.099 . . . . 0.0 105.334 175.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -135.07 148.0 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.655 0.782 . . . . 0.0 108.92 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -70.14 155.34 40.76 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.55 1.068 . . . . 0.0 110.252 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 5.3 mm-40 -132.24 176.1 3.18 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 125.811 1.644 . . . . 0.0 111.491 -175.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -61.22 144.27 98.79 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 123.459 2.773 . . . . 0.0 111.862 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.23 -152.21 51.81 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.66 3.87 4.58 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.882 -0.776 . . . . 0.0 110.255 175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.54 164.28 20.92 Favored Glycine 0 N--CA 1.444 -0.785 0 CA-C-O 123.691 1.717 . . . . 0.0 116.82 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -147.81 138.14 22.97 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.794 2.437 . . . . 0.0 106.934 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.437 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -105.21 143.28 33.61 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 176.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.5 t -118.61 123.31 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.9 m -97.1 132.88 42.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.5 m -134.49 175.9 10.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.896 0.878 . . . . 0.0 112.407 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -135.98 35.17 2.84 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt 38.47 82.09 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 117.8 2.518 . . . . 0.0 117.8 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.1 mm -77.91 -25.89 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 124.312 1.045 . . . . 0.0 111.095 175.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -164.74 162.95 35.98 Favored Glycine 0 N--CA 1.464 0.553 0 C-N-CA 124.955 1.264 . . . . 0.0 110.752 177.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -144.51 150.11 37.02 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 126.582 1.953 . . . . 0.0 108.323 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.405 ' HD1' HG12 ' A' ' 50' ' ' VAL . 3.6 m-85 -141.5 -27.84 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.22 1.008 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -154.93 127.83 8.16 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.417 1.487 . . . . 0.0 107.317 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -136.48 74.58 1.5 Allowed 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 129.303 3.041 . . . . 0.0 105.402 175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.24 35.27 2.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.134 1.35 . . . . 0.0 110.355 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.91 -73.33 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 127.551 2.501 . . . . 0.0 110.796 -177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.0 mt -56.3 134.74 53.63 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -91.39 76.07 5.96 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.757 2.023 . . . . 0.0 108.788 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.7 138.79 97.48 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.106 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.52 178.15 7.97 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.815 2.343 . . . . 0.0 112.871 -175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.0 t -49.02 -54.9 23.87 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-O 117.041 -1.457 . . . . 0.0 110.88 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.16 117.12 4.85 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 N-CA-C 107.969 -1.589 . . . . 0.0 107.969 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 88' ' ' THR . 79.1 Cg_endo -72.72 -152.83 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 125.03 3.82 . . . . 0.0 111.502 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.42 ' H ' ' HB2' ' A' ' 87' ' ' PRO . 41.6 m -34.06 123.9 0.48 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 129.856 3.262 . . . . 0.0 112.201 -175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.16 58.01 0.21 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.64 1.591 . . . . 0.0 109.436 -175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.76 161.5 40.51 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 128.034 2.534 . . . . 0.0 106.326 175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.2 p -99.83 151.33 21.4 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.4 mt -143.9 165.2 28.38 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 125.468 1.507 . . . . 0.0 109.813 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -128.65 120.39 26.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -101.47 124.45 47.16 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.347 1.459 . . . . 0.0 107.779 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' A' ' 123' ' ' VAL . 52.7 t80 -80.31 121.21 25.38 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.835 1.254 . . . . 0.0 110.501 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.74 124.49 30.41 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.04 -1.22 11.17 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 122.568 2.179 . . . . 0.0 114.246 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 61.5 m -150.58 175.75 11.63 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.495 2.318 . . . . 0.0 108.959 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.95 -4.39 5.72 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -79.21 -51.06 9.99 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.84 1.655 . . . . 0.0 109.944 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.428 ' HA ' ' C ' ' A' ' 102' ' ' PRO . 15.7 m -133.35 155.37 80.86 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 127.282 2.233 . . . . 0.0 111.352 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 101' ' ' CYS . 63.6 Cg_endo -67.67 156.72 85.94 Favored 'Cis proline' 0 CA--C 1.55 1.29 0 C-N-CA 124.658 -0.976 . . . . 0.0 110.154 -2.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -63.49 87.23 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.535 3.49 . . . . 0.0 114.873 -175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 tpp -99.46 156.91 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.038 2.135 . . . . 0.0 110.395 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -150.21 152.67 34.97 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.619 1.568 . . . . 0.0 109.331 175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -77.95 136.35 37.98 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.65 43.0 30.67 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.84 0.733 . . . . 0.0 113.371 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.8 t -142.67 153.17 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 125.667 1.587 . . . . 0.0 107.77 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.2 m -98.94 130.73 45.32 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.135 0.974 . . . . 0.0 110.538 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -132.99 173.24 11.63 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.588 1.555 . . . . 0.0 111.893 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.552 ' HA ' HG22 ' A' ' 52' ' ' THR . 7.0 tp -108.58 124.77 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 130.113 3.365 . . . . 0.0 102.522 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -114.72 113.84 24.83 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.8 mtm -115.0 113.24 23.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 101.221 -3.622 . . . . 0.0 101.221 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.52 -143.12 3.57 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.013 1.292 . . . . 0.0 111.249 -175.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -133.52 176.92 8.11 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.118 0.967 . . . . 0.0 109.437 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.37 133.09 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 121.45 -0.781 . . . . 0.0 111.466 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.47 112.98 25.26 Favored 'General case' 0 C--O 1.242 0.693 1 N-CA-C 96.04 -5.541 . . . . 0.0 96.04 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -86.24 63.71 8.16 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 122.802 1.287 . . . . 0.0 109.735 -175.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -169.59 -32.48 0.02 OUTLIER 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.802 2.441 . . . . 0.0 109.829 -176.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -113.54 -14.71 12.65 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.203 1.001 . . . . 0.0 111.633 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.55 -172.11 22.66 Favored Glycine 0 CA--C 1.531 1.078 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.15 135.27 49.91 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.903 1.736 . . . . 0.0 109.351 176.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -114.18 134.27 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 102.89 -3.004 . . . . 0.0 102.89 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.253 1.8 tm? -125.74 78.74 68.89 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 125.221 1.408 . . . . 0.0 108.98 -174.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.23 170.77 7.33 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.742 2.961 . . . . 0.0 111.596 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -61.55 -23.05 75.96 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.517 2.145 . . . . 0.0 112.528 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -83.49 24.0 0.88 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.047 0.939 . . . . 0.0 111.883 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.9 m -94.43 124.3 38.37 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.925 1.29 . . . . 0.0 108.034 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -77.11 113.79 15.22 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -128.5 125.79 64.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.8 m -144.7 167.85 10.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.382 1.473 . . . . 0.0 108.246 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.4 mp -63.57 138.27 58.44 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -65.39 131.42 46.39 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -141.12 147.27 46.78 Favored Pre-proline 0 N--CA 1.464 0.249 0 C-N-CA 125.69 1.596 . . . . 0.0 107.281 175.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.75 -37.12 29.32 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.577 2.185 . . . . 0.0 114.008 -175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -56.48 -52.74 63.58 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.818 0.735 . . . . 0.0 110.375 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -58.82 -44.48 90.88 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.542 1.137 . . . . 0.0 110.282 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -58.59 -45.67 88.61 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.996 0.919 . . . . 0.0 111.408 -175.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -61.46 -39.53 91.22 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.523 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.93 -47.79 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 119.649 1.113 . . . . 0.0 109.684 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.03 -40.34 93.24 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 120.333 1.424 . . . . 0.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 11.3 m -59.48 -51.22 70.82 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.017 0.927 . . . . 0.0 109.0 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -65.31 -33.94 77.16 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.244 1.418 . . . . 0.0 111.018 -176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 80.4 mt -73.44 -35.96 65.85 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.825 1.25 . . . . 0.0 110.504 176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.4 t -63.41 -34.9 78.75 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.063 1.301 . . . . 0.0 109.168 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -74.51 -44.1 52.82 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.881 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -73.09 176.63 5.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.87 1.668 . . . . 0.0 108.104 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.98 146.59 47.49 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 81.7 m -69.54 123.7 89.02 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.284 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.62 97.04 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.572 2.181 . . . . 0.0 108.959 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -143.14 76.05 1.51 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -114.04 120.53 38.54 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.78 77.63 3.33 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.847 2.365 . . . . 0.0 109.937 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.206 -1.378 . . . . 0.0 110.198 -175.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.513 -0.756 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -62.99 158.88 41.04 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.17 2.58 . . . . 0.0 110.472 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.55 33.85 0.26 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.4 104.8 0.25 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 127.154 2.182 . . . . 0.0 111.602 -175.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.13 77.8 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.692 3.595 . . . . 0.0 110.214 -175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.6 m -141.92 148.23 38.35 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 127.297 2.239 . . . . 0.0 107.032 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 41.3 t -128.52 131.97 24.08 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.874 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.0 159.2 50.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.025 1.817 . . . . 0.0 109.562 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -77.19 -47.41 20.35 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 118.602 -1.239 . . . . 0.0 108.855 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -66.52 166.2 13.08 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.411 1.484 . . . . 0.0 109.765 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.9 t -150.12 108.59 3.8 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.249 0.62 . . . . 0.0 110.258 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' HA ' ' HE ' ' A' ' 35' ' ' ARG . 0.6 OUTLIER -134.12 166.02 23.72 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.369 1.868 . . . . 0.0 109.184 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 24.8 ttp-105 -131.79 139.85 49.03 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 127.904 2.481 . . . . 0.0 105.027 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -147.84 176.67 9.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.803 1.641 . . . . 0.0 112.134 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.43 -157.35 44.21 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.013 0.816 . . . . 0.0 111.255 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.7 p -120.79 162.73 19.28 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 141' ' ' LEU . 8.5 tt -63.75 -39.14 93.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -63.62 -50.67 68.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.269 0.628 . . . . 0.0 111.09 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.7 m -65.15 -43.23 92.48 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -177.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -61.3 -44.75 96.7 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-O 116.92 -1.514 . . . . 0.0 112.364 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' A' ' 50' ' ' VAL . 10.2 t80 -53.35 -46.7 69.64 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.787 1.631 . . . . 0.0 110.29 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 74.3 m -66.04 -37.14 85.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.735 -0.65 . . . . 0.0 111.884 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.89 -51.77 60.16 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.255 1.022 . . . . 0.0 111.379 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.4 p -61.1 147.45 43.87 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.776 0.83 . . . . 0.0 111.022 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.4 t -101.42 -9.49 21.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.736 0.814 . . . . 0.0 109.76 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 94' ' ' PHE . 48.0 tp -127.32 119.21 25.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.169 1.788 . . . . 0.0 106.81 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 44' ' ' PHE . 48.8 t -137.25 115.52 14.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 176.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -146.57 169.15 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.932 1.293 . . . . 0.0 109.62 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.9 p -131.24 143.59 50.68 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 103.896 -2.631 . . . . 0.0 103.896 174.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.57 163.96 16.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 120.903 -1.123 . . . . 0.0 111.383 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.5 m -91.19 129.98 37.12 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.81 113.22 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mmmt -84.58 -35.08 23.01 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.755 1.222 . . . . 0.0 111.309 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -160.41 170.49 20.89 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.06 1.344 . . . . 0.0 109.315 -176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 23.5 mtp -140.6 142.03 35.09 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 126.392 1.877 . . . . 0.0 106.258 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.1 t -143.57 147.09 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.771 0.828 . . . . 0.0 108.803 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -66.37 150.98 48.06 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.638 1.563 . . . . 0.0 109.709 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 5.7 mm-40 -120.89 175.37 2.41 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 127.96 2.504 . . . . 0.0 108.557 176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.85 150.31 88.71 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.741 1.628 . . . . 0.0 111.244 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.58 -148.23 50.59 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.919 0.771 . . . . 0.0 112.857 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -73.5 7.1 2.54 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.3 1.04 . . . . 0.0 112.341 176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.26 170.6 54.83 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-O 122.737 1.187 . . . . 0.0 114.697 -176.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -150.32 136.65 18.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.806 2.042 . . . . 0.0 106.36 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.454 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -98.0 136.1 38.74 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 176.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.7 t -115.55 123.17 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 175.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 m -91.46 130.47 37.29 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.2 m -133.61 168.84 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.037 -176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.5 t -131.02 37.28 3.78 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.1 mt 38.92 81.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 117.613 2.449 . . . . 0.0 117.613 175.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.1 mm -79.07 -29.1 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.478 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.73 155.74 26.78 Favored Glycine 0 C--N 1.337 0.615 0 C-N-CA 125.748 1.642 . . . . 0.0 109.076 176.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.08 135.1 37.19 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 126.899 2.08 . . . . 0.0 105.728 175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -130.57 -28.36 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 124.045 0.841 . . . . 0.0 113.009 -175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -152.94 129.91 11.04 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.2 p -145.86 68.99 1.21 Allowed 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.618 1.967 . . . . 0.0 108.433 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.87 39.32 2.84 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 124.817 1.199 . . . . 0.0 112.355 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.78 -15.82 0.02 OUTLIER Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.431 1.491 . . . . 0.0 115.985 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 26.3 mt -86.16 151.42 23.67 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 120.206 2.003 . . . . 0.0 112.232 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.9 p-10 -104.7 64.04 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.757 2.023 . . . . 0.0 106.255 175.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 38.4 mt -59.41 148.27 73.82 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -72.45 -178.57 3.42 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.701 1.601 . . . . 0.0 111.285 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -52.25 -58.74 10.41 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.434 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.71 147.41 63.11 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 CA-C-N 121.924 1.723 . . . . 0.0 109.028 175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -75.36 -154.43 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 123.083 2.522 . . . . 0.0 112.029 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.478 HG21 ' HA2' ' A' ' 74' ' ' GLY . 19.8 m -32.34 132.52 0.13 Allowed 'General case' 0 C--O 1.243 0.733 0 C-N-CA 129.303 3.041 . . . . 0.0 112.085 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.7 57.64 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.746 1.641 . . . . 0.0 110.523 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -151.63 164.53 36.69 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.739 2.016 . . . . 0.0 107.632 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.9 p -108.09 146.86 32.02 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.365 0.666 . . . . 0.0 112.415 -175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.1 mt -140.21 173.14 11.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 126.652 1.981 . . . . 0.0 109.856 -175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -130.94 115.13 16.11 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 127.076 2.15 . . . . 0.0 105.488 175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.6 m-85 -94.04 121.4 35.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -75.58 113.7 13.31 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.653 1.221 . . . . 0.0 108.986 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.79 121.41 46.91 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.68 -0.79 10.58 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.438 2.092 . . . . 0.0 112.762 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 51.6 m -122.21 137.97 54.65 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.212 1.805 . . . . 0.0 108.716 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -94.85 -17.98 21.59 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -102.06 -23.23 14.11 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.792 1.178 . . . . 0.0 113.677 -175.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.5 m -135.03 155.51 79.07 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-O 117.609 -1.186 . . . . 0.0 108.104 175.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -69.87 169.49 63.55 Favored 'Cis proline' 0 CA--C 1.546 1.095 0 CA-C-N 119.825 0.973 . . . . 0.0 110.534 -4.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.07 77.04 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.866 3.044 . . . . 0.0 111.348 -176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.9 tpp -93.77 154.12 17.94 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.318 1.447 . . . . 0.0 110.53 -175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -144.5 144.39 31.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 C-N-CA 123.531 0.733 . . . . 0.0 109.797 175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -72.2 148.73 45.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.801 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.51 37.82 94.93 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-O 118.961 -0.911 . . . . 0.0 113.024 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 87.9 t -143.46 152.61 16.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 126.661 1.984 . . . . 0.0 106.771 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.7 m -94.59 129.03 41.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.86 0.838 . . . . 0.0 110.538 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -124.7 172.16 9.51 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 127.33 2.252 . . . . 0.0 111.567 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.678 HD11 ' HG3' ' A' ' 113' ' ' MET . 0.6 OUTLIER -116.51 125.78 52.41 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 130.829 3.651 . . . . 0.0 103.493 175.565 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -120.28 114.09 21.37 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.713 1.205 . . . . 0.0 107.884 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.678 ' HG3' HD11 ' A' ' 111' ' ' LEU . 13.4 mtm -117.53 112.91 21.23 Favored 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 102.899 -3.001 . . . . 0.0 102.899 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -149.68 -137.29 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 126.25 1.881 . . . . 0.0 109.383 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.67 175.68 9.41 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.685 1.194 . . . . 0.0 108.755 175.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.57 144.85 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -116.31 113.19 22.61 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -78.31 63.52 3.22 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.89 2.076 . . . . 0.0 109.842 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 177.59 -24.57 0.0 OUTLIER 'General case' 0 C--O 1.238 0.459 0 C-N-CA 130.953 3.701 . . . . 0.0 112.21 176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -116.33 -33.38 4.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.111 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.37 -167.37 18.81 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.687 1.613 . . . . 0.0 110.464 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.35 137.43 30.92 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 121.137 1.225 . . . . 0.0 109.218 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.252 14.7 p -121.31 155.96 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.439 HD11 HG21 ' A' ' 130' ' ' VAL 0.277 1.0 OUTLIER -138.52 74.05 40.96 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 -174.861 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.99 168.8 9.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 124.832 3.688 . . . . 0.0 111.836 -175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.37 -19.05 55.81 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 CA-C-N 121.012 1.397 . . . . 0.0 113.429 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -85.37 23.56 1.3 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.521 1.529 . . . . 0.0 111.384 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.3 m -88.45 143.19 27.14 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.109 0.964 . . . . 0.0 110.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -92.67 115.4 28.07 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 175.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.439 HG21 HD11 ' A' ' 124' ' ' LEU . 33.3 t -136.98 125.53 34.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -175.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 34.0 m -151.03 172.12 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.748 1.619 . . . . 0.0 109.656 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 37.6 mt -65.03 142.48 58.4 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.428 1.091 . . . . 0.0 109.796 175.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -73.82 126.75 31.09 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.984 0.913 . . . . 0.0 109.059 175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.1 mtp180 -139.15 156.52 72.12 Favored Pre-proline 0 N--CA 1.468 0.438 0 C-N-CA 125.106 1.362 . . . . 0.0 108.4 175.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.51 -49.46 11.96 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.234 2.623 . . . . 0.0 114.867 -175.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -58.11 -47.6 82.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.561 -176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -58.02 -47.02 84.3 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 125.267 1.427 . . . . 0.0 110.439 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -54.37 -51.39 64.95 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.458 1.503 . . . . 0.0 110.598 -177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -62.92 -36.24 82.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.252 176.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 67.2 mt -62.81 -47.27 93.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 120.24 1.382 . . . . 0.0 110.183 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 40' ' ' LEU . 4.6 mt -63.04 -38.7 92.25 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.061 1.301 . . . . 0.0 109.368 177.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 27.1 m -60.94 -44.38 97.34 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.678 -0.638 . . . . 0.0 109.665 175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -59.37 -45.93 90.07 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.245 -0.909 . . . . 0.0 109.95 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 14.6 mt -63.41 -30.43 71.56 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 124.551 1.141 . . . . 0.0 111.669 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -69.93 -45.77 66.79 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.824 0.849 . . . . 0.0 110.013 175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -75.56 -35.63 60.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 118.956 -0.545 . . . . 0.0 112.131 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -76.19 171.66 14.14 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.247 1.019 . . . . 0.0 109.974 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -99.13 134.84 41.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 17.6 m -67.11 144.96 98.66 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.57 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 120.2 7.82 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.763 2.309 . . . . 0.0 107.748 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.64 71.49 1.46 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 103.471 -2.788 . . . . 0.0 103.471 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -124.1 113.19 28.18 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.138 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -114.12 -155.22 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.911 1 C-N-CA 125.517 4.145 . . . . 0.0 105.338 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 C--O 1.254 1.309 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 175.126 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 119.026 -0.511 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -85.64 61.69 5.38 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 124.048 3.165 . . . . 0.0 110.27 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.9 p30 -138.13 69.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.758 1.266 . . . . 0.0 112.303 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -158.38 116.16 1.76 Allowed Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 125.79 1.636 . . . . 0.0 107.585 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -79.08 158.63 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.794 2.996 . . . . 0.0 112.398 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 91.3 m -73.92 165.56 24.91 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.072 1.349 . . . . 0.0 110.069 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.4 t -83.82 112.36 39.69 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.179 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.45 175.6 9.2 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.714 2.276 . . . . 0.0 110.819 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -68.38 -16.38 63.9 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -54.13 142.18 26.47 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.806 1.642 . . . . 0.0 110.008 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -136.64 44.72 2.35 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.947 0.899 . . . . 0.0 109.052 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -146.06 155.54 42.85 Favored 'General case' 0 C--N 1.338 0.1 0 O-C-N 121.106 -0.996 . . . . 0.0 108.658 175.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.2 ttp85 -90.21 145.31 25.11 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.203 1.801 . . . . 0.0 109.113 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 173.98 11.02 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.818 1.247 . . . . 0.0 110.213 -176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.43 -172.8 50.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.974 0.797 . . . . 0.0 111.133 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -108.05 170.98 7.67 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 175.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.09 -46.68 83.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -62.6 -48.29 80.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.624 0.769 . . . . 0.0 110.984 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -55.17 -54.61 41.13 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.569 0.748 . . . . 0.0 109.951 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -62.95 -40.94 99.18 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 117.592 -1.194 . . . . 0.0 111.996 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CD2' HG11 ' A' ' 50' ' ' VAL . 34.6 t80 -56.89 -44.22 82.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.9 1.227 . . . . 0.0 110.986 175.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.8 m -64.01 -44.51 92.41 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.601 0.637 . . . . 0.0 111.446 176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.28 -58.93 5.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.263 1.025 . . . . 0.0 111.209 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.4 p -55.74 140.72 40.92 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.611 1.565 . . . . 0.0 113.094 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -93.45 -8.99 40.05 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.721 0.808 . . . . 0.0 109.467 175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.8 tp -124.68 122.86 38.69 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.91 1.684 . . . . 0.0 108.185 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.622 HG11 ' CD2' ' A' ' 44' ' ' PHE . 13.3 t -139.93 113.6 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 175.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.9 m -149.81 171.76 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 125.404 1.482 . . . . 0.0 109.116 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.539 HG22 ' HA ' ' A' ' 111' ' ' LEU . 3.1 p -133.53 141.89 47.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.502 ' HA ' ' H ' ' A' ' 73' ' ' ILE . . . -164.03 161.35 22.56 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.955 -1.091 . . . . 0.0 112.192 -177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 109' ' ' SER . 32.3 m -95.83 128.04 42.37 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.39 113.78 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 29.3 mmmt -85.48 -41.01 15.74 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.048 0.939 . . . . 0.0 110.431 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 m -146.53 165.77 28.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 110.144 -175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 61.6 mtp -142.46 131.15 22.68 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 127.751 2.42 . . . . 0.0 105.265 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 t -139.69 157.33 26.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -175.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 73.4 mtt85 -67.71 150.01 49.25 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.211 0.604 . . . . 0.0 109.511 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.9 mm-40 -138.7 171.46 8.17 Favored Pre-proline 0 CA--C 1.535 0.404 0 C-N-CA 126.768 2.027 . . . . 0.0 109.775 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.14 163.61 22.34 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.569 2.179 . . . . 0.0 112.174 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.26 -151.2 52.25 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -85.2 9.05 16.17 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -70.48 171.59 43.59 Favored Glycine 0 N--CA 1.437 -1.289 0 C-N-CA 126.58 2.038 . . . . 0.0 117.181 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.95 139.27 17.58 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.215 2.606 . . . . 0.0 105.171 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -99.39 124.17 44.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 177.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.0 t -100.8 123.17 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.6 m -98.5 124.6 43.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -122.31 174.72 6.32 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.259 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.833 -176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.8 t -137.45 46.05 2.16 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 120.032 1.287 . . . . 0.0 113.753 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 61.3 mt 36.14 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 119.959 3.318 . . . . 0.0 119.959 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.502 ' H ' ' HA ' ' A' ' 53' ' ' ALA . 28.3 mm -75.48 -26.83 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 O-C-N 119.874 -1.767 . . . . 0.0 109.906 175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.72 163.18 36.96 Favored Glycine 0 CA--C 1.518 0.278 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.58 148.83 41.57 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.55 -51.07 1.17 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -132.37 124.1 28.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.4 p -138.16 61.55 1.59 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.696 1.998 . . . . 0.0 107.519 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.45 28.01 3.98 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-O 119.762 -0.466 . . . . 0.0 113.593 -175.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.13 6.88 0.08 OUTLIER Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.266 1.889 . . . . 0.0 114.163 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' HG ' HG11 ' A' ' 116' ' ' VAL . 77.6 mt -114.43 142.12 46.78 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 120.243 2.022 . . . . 0.0 111.136 175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -88.12 72.82 9.1 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 111.705 -2.498 . . . . 0.0 105.961 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.35 125.18 81.21 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -82.78 -174.89 2.21 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.287 2.658 . . . . 0.0 112.48 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -49.73 -55.46 23.12 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 117.157 -1.401 . . . . 0.0 108.937 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.88 115.31 3.9 Favored 'Trans proline' 0 CA--C 1.551 1.329 0 N-CA-C 108.105 -1.537 . . . . 0.0 108.105 175.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -74.67 -152.09 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 124.945 3.763 . . . . 0.0 109.924 177.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -34.83 124.38 0.55 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.037 2.135 . . . . 0.0 109.547 176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.61 -16.98 5.85 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 128.499 2.952 . . . . 0.0 111.734 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -77.92 154.6 31.5 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 119.135 1.467 . . . . 0.0 111.112 -175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 82.2 p -100.11 135.78 41.02 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -130.6 152.86 49.51 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.91 2.084 . . . . 0.0 109.495 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -108.17 114.06 27.66 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -89.74 119.82 30.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -75.74 113.52 13.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.42 114.28 63.43 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.62 5.21 1.73 Allowed 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.619 2.879 . . . . 0.0 114.307 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.6 m -145.53 166.69 24.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.875 2.07 . . . . 0.0 109.044 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -123.57 -22.58 4.97 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.598 1.159 . . . . 0.0 113.307 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -65.12 -44.83 87.42 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.368 1.067 . . . . 0.0 110.288 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.2 m -143.96 162.96 38.24 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.602 1.561 . . . . 0.0 109.15 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -63.36 157.39 68.26 Favored 'Cis proline' 0 CA--C 1.538 0.71 0 CA-C-N 119.671 0.918 . . . . 0.0 110.394 -3.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 80.38 1.14 Allowed 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 123.236 2.624 . . . . 0.0 111.897 -175.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.0 tpp -94.09 152.99 18.36 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.492 2.317 . . . . 0.0 107.943 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -137.27 143.23 42.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -69.96 142.28 52.89 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.48 31.97 62.61 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 119.465 -0.63 . . . . 0.0 114.53 175.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 98.6 t -140.55 155.33 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.744 1.618 . . . . 0.0 108.266 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 8.6 m -97.19 131.28 44.08 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.596 0.758 . . . . 0.0 111.393 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -128.48 170.07 13.59 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.011 2.125 . . . . 0.0 111.594 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.539 ' HA ' HG22 ' A' ' 52' ' ' THR . 0.2 OUTLIER -114.73 126.51 54.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 130.395 3.478 . . . . 0.0 102.996 175.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.61 113.97 20.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.524 ' HG2' HG13 ' A' ' 50' ' ' VAL . 5.5 mtm -116.61 113.13 22.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -156.27 -139.09 2.67 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -134.49 173.04 12.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -176.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.451 HG11 ' HG ' ' A' ' 81' ' ' LEU . 2.4 t -133.41 148.29 30.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -116.49 112.81 21.93 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 100.7 -3.815 . . . . 0.0 100.7 174.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -87.44 78.68 8.61 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 177.22 -25.12 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 130.841 3.656 . . . . 0.0 109.801 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -125.98 -32.1 2.81 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.155 1.782 . . . . 0.0 115.011 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 112.31 -158.13 14.5 Favored Glycine 0 CA--C 1.532 1.124 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 139.85 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 121.803 1.669 . . . . 0.0 111.672 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.34 152.93 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.611 HD11 HG21 ' A' ' 130' ' ' VAL . 1.6 tm? -145.79 74.57 13.46 Favored Pre-proline 0 CA--C 1.54 0.583 0 O-C-N 120.418 -1.426 . . . . 0.0 111.775 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.52 170.4 15.1 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 124.288 3.325 . . . . 0.0 111.792 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.03 -9.74 26.1 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.077 1.852 . . . . 0.0 113.727 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.28 25.2 1.69 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 61.3 m -105.34 137.84 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 127.37 2.268 . . . . 0.0 109.154 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.38 113.79 21.42 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 104.994 -2.225 . . . . 0.0 104.994 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.611 HG21 HD11 ' A' ' 124' ' ' LEU . 78.9 t -134.09 116.63 23.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -175.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.1 m -146.74 169.21 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.799 1.64 . . . . 0.0 108.874 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 73.0 mt -64.02 138.44 58.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -64.99 128.15 34.58 Favored 'General case' 0 N--CA 1.461 0.075 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.1 mmt85 -142.82 147.87 43.64 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 125.479 1.512 . . . . 0.0 107.767 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.38 -38.04 45.63 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.052 2.501 . . . . 0.0 113.704 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -54.56 -49.41 70.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.669 0.747 . . . . 0.0 110.487 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -66.32 -43.75 85.35 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.804 178.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -51.19 -52.24 46.2 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.109 1.364 . . . . 0.0 111.597 -177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.62 -47.67 84.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.838 0.855 . . . . 0.0 110.989 176.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 76.4 mt -60.9 -48.65 88.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-O 118.538 -0.744 . . . . 0.0 109.711 -176.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.8 mt -63.57 -38.08 89.76 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.969 1.259 . . . . 0.0 109.692 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.4 m -61.5 -46.72 88.8 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 175.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -59.31 -43.32 92.65 Favored 'General case' 0 N--CA 1.462 0.164 0 O-C-N 121.567 -0.708 . . . . 0.0 110.273 176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.66 -26.42 67.79 Favored 'General case' 0 N--CA 1.461 0.086 0 C-N-CA 124.326 1.05 . . . . 0.0 112.192 178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 t -71.4 -39.44 71.15 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.281 1.032 . . . . 0.0 109.595 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -70.47 -56.61 6.18 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -62.23 163.22 8.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.111 1.364 . . . . 0.0 108.979 -177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -100.52 152.02 20.89 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.236 1.014 . . . . 0.0 108.481 176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 62.2 m -68.25 156.91 89.03 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 122.354 0.262 . . . . 0.0 111.051 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.95 102.82 1.49 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.314 2.676 . . . . 0.0 109.785 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -140.18 64.19 1.45 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -141.26 142.79 28.2 Favored Pre-proline 0 C--O 1.237 0.437 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 176.3 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.829 1.686 . . . . 0.0 109.632 176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.257 1.47 0 N-CA-C 105.154 -2.165 . . . . 0.0 105.154 175.299 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.236 0.361 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -88.81 53.85 1.93 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.131 3.221 . . . . 0.0 109.472 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -114.48 69.33 0.71 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 123.327 1.537 . . . . 0.0 107.499 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.9 133.56 12.44 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.753 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -77.73 179.56 6.39 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.514 2.809 . . . . 0.0 110.531 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -75.25 162.53 28.37 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.3 t -82.8 119.92 75.36 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.99 169.5 10.2 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.286 2.658 . . . . 0.0 111.561 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -68.62 -15.04 63.4 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.836 0.854 . . . . 0.0 111.69 175.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -60.75 153.77 23.39 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.988 1.715 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.1 t -147.7 74.17 1.3 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.899 0.88 . . . . 0.0 109.074 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -156.92 152.96 27.37 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.975 -1.078 . . . . 0.0 108.668 176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -92.29 145.49 24.45 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 124.323 1.049 . . . . 0.0 108.6 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 p -137.59 163.62 30.76 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.669 0.747 . . . . 0.0 110.926 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.14 171.06 42.35 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 124.583 1.087 . . . . 0.0 112.389 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.6 p -94.07 159.1 15.31 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.791 0.836 . . . . 0.0 109.731 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.79 -44.44 93.34 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.081 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -61.48 -43.55 98.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.866 0.757 . . . . 0.0 111.363 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 m -64.41 -52.33 58.7 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -63.93 -36.03 82.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 117.943 -1.027 . . . . 0.0 111.958 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.573 ' CD2' HG11 ' A' ' 50' ' ' VAL . 51.9 t80 -63.65 -33.46 75.67 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.429 1.468 . . . . 0.0 111.317 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.3 -40.65 51.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 118.701 -0.666 . . . . 0.0 112.315 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.86 -51.17 68.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.388 0.675 . . . . 0.0 110.975 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 p -60.38 152.73 24.61 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.205 1.402 . . . . 0.0 112.209 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.9 t -111.6 -4.02 14.89 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 121.548 -0.72 . . . . 0.0 110.608 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 50.7 tp -127.88 118.47 23.7 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.573 HG11 ' CD2' ' A' ' 44' ' ' PHE . 10.8 t -137.01 113.86 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 177.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 28.8 m -146.86 172.0 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.186 1.395 . . . . 0.0 109.767 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 111' ' ' LEU . 4.1 p -132.02 140.53 48.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 175.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -161.89 167.23 25.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.097 -1.002 . . . . 0.0 112.355 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.4 m -102.97 126.9 50.33 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -70.2 113.44 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 -44.77 15.11 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 176.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.6 m -146.54 170.9 15.95 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.367 1.067 . . . . 0.0 110.122 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.01 124.57 18.13 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 127.26 2.224 . . . . 0.0 105.667 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -119.86 148.39 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.294 1.838 . . . . 0.0 107.655 -175.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -74.84 154.07 38.43 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.849 1.204 . . . . 0.0 109.388 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 72.0 mm-40 -138.49 176.24 2.8 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.205 1.402 . . . . 0.0 109.313 -175.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.07 139.86 14.58 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.408 2.739 . . . . 0.0 114.493 176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.46 -130.48 40.71 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.54 1.543 . . . . 0.0 110.926 176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -86.15 6.98 26.74 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.159 0.984 . . . . 0.0 110.342 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.54 163.74 51.37 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-O 123.203 1.446 . . . . 0.0 113.16 -175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -153.84 131.27 11.31 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.398 1.879 . . . . 0.0 106.061 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.421 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -101.98 138.22 39.24 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.7 t -105.81 122.98 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -91.77 124.25 35.76 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -124.9 172.13 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 124.906 1.282 . . . . 0.0 111.017 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -138.41 35.96 2.27 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.53 0.605 . . . . 0.0 112.191 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.268 25.1 mt 38.71 80.76 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.955 2.206 . . . . 0.0 116.955 175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 26.3 mm -77.51 -20.7 14.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.228 1.011 . . . . 0.0 109.052 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -168.17 169.84 41.68 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.079 1.8 . . . . 0.0 110.891 175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.38 154.35 42.2 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.199 1.399 . . . . 0.0 108.473 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.545 ' HD2' HG12 ' A' ' 50' ' ' VAL . 26.4 m-85 -136.33 -41.12 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.29 1.036 . . . . 0.0 109.881 175.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -144.51 138.24 27.43 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 p -137.48 67.39 1.43 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 129.19 2.996 . . . . 0.0 106.104 175.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.49 51.51 4.58 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.654 2.073 . . . . 0.0 109.695 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.62 -66.4 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 127.462 2.458 . . . . 0.0 111.02 175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.25 128.07 34.59 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 123.269 0.628 . . . . 0.0 111.885 -175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.29 85.67 7.18 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -62.1 147.73 90.05 Favored Pre-proline 0 C--O 1.235 0.316 0 O-C-N 121.156 -0.965 . . . . 0.0 108.54 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.28 170.07 18.08 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.6 t -46.31 -55.55 13.47 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.745 1.218 . . . . 0.0 111.396 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.03 138.03 39.11 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 CA-C-N 121.086 1.424 . . . . 0.0 109.356 175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.79 -154.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.561 3.507 . . . . 0.0 111.909 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.456 HG21 ' HA2' ' A' ' 74' ' ' GLY . 87.1 m -34.15 137.07 0.11 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.492 2.717 . . . . 0.0 112.499 177.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 114.2 64.52 0.43 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -175.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -157.23 162.89 39.27 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.009 2.524 . . . . 0.0 106.237 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 52.0 p -108.82 157.4 18.62 Favored 'General case' 0 N--CA 1.466 0.325 0 O-C-N 121.211 -0.931 . . . . 0.0 111.986 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -151.69 169.17 22.83 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.043 2.137 . . . . 0.0 109.757 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -123.22 114.09 19.8 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -92.71 120.14 32.8 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -73.94 121.92 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.81 1.244 . . . . 0.0 110.12 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.58 123.95 30.67 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.91 -9.56 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.293 1.995 . . . . 0.0 113.885 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 18.2 m -145.39 158.31 43.86 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.832 1.653 . . . . 0.0 109.759 -176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -109.24 -16.76 13.99 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -66.05 -50.79 62.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.776 1.171 . . . . 0.0 110.651 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 m -134.86 161.39 63.98 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.93 1.292 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.94 158.71 81.29 Favored 'Cis proline' 0 CA--C 1.543 0.971 0 O-C-N 122.73 0.858 . . . . 0.0 111.463 -3.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.58 90.6 0.41 Allowed 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.483 2.789 . . . . 0.0 110.949 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 46.6 tpp -103.91 138.86 39.89 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 127.061 2.144 . . . . 0.0 111.36 -175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 33.2 mtpt -133.57 137.63 45.61 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 122.033 0.921 . . . . 0.0 110.26 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -68.12 144.49 55.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.64 -1.618 . . . . 0.0 107.439 175.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.06 24.16 69.78 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 115.102 0.801 . . . . 0.0 115.102 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 83.6 t -133.94 152.24 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.094 2.157 . . . . 0.0 107.627 -176.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.0 m -98.53 130.9 45.11 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.074 0.95 . . . . 0.0 109.229 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -128.47 169.38 14.39 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.278 2.231 . . . . 0.0 112.882 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HA ' HG22 ' A' ' 52' ' ' THR . 13.2 tp -115.76 124.21 50.2 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 131.071 3.748 . . . . 0.0 102.017 175.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.06 113.75 19.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.482 ' HG2' HG13 ' A' ' 50' ' ' VAL . 11.7 mtm -115.49 112.91 22.96 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 101.454 -3.536 . . . . 0.0 101.454 175.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.29 -140.89 3.1 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 126.473 1.987 . . . . 0.0 110.877 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -138.73 176.89 8.3 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.705 -1.467 . . . . 0.0 109.56 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.1 t -130.55 132.86 64.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -115.28 114.22 24.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 100.433 -3.914 . . . . 0.0 100.433 175.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -88.56 80.12 7.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -173.04 -34.93 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.286 2.635 . . . . 0.0 108.146 -175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -134.71 -10.95 2.38 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.654 1.582 . . . . 0.0 113.655 -177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 109.0 -162.66 12.75 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.58 1.086 . . . . 0.0 111.919 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -67.29 136.83 41.59 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.046 1.83 . . . . 0.0 110.043 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.6 p -120.89 147.87 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 130' ' ' VAL 0.269 1.8 tm? -137.38 73.71 49.21 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 -174.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.37 175.09 8.24 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 124.493 3.462 . . . . 0.0 111.701 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.6 -17.6 35.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.91 1.74 . . . . 0.0 113.694 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.46 22.37 1.56 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.567 1.53 . . . . 0.0 111.305 178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 45.4 m -98.95 124.54 43.98 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.324 0.65 . . . . 0.0 111.337 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -76.19 113.87 14.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 175.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 124' ' ' LEU . 50.3 t -134.23 114.21 18.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.192 0.52 . . . . 0.0 110.168 -175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.6 m -145.29 169.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 124.972 1.309 . . . . 0.0 108.943 -177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.17 140.47 58.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 123.436 0.694 . . . . 0.0 109.609 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.18 139.79 54.59 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -142.63 148.24 45.77 Favored Pre-proline 0 C--O 1.237 0.423 0 C-N-CA 126.045 1.738 . . . . 0.0 106.775 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -67.3 -36.21 21.65 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 123.239 2.626 . . . . 0.0 111.018 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -58.63 -43.7 89.77 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.41 -0.806 . . . . 0.0 110.276 175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -66.81 -43.85 82.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.435 176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -51.45 -49.56 61.49 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.648 1.179 . . . . 0.0 111.64 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 12.8 tp-100 -60.79 -46.84 88.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.176 1.391 . . . . 0.0 111.208 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.3 -50.83 77.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.467 178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.03 -33.82 76.61 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.489 1.04 . . . . 0.0 109.778 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.4 m -62.8 -40.4 97.25 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.784 -0.573 . . . . 0.0 109.541 175.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -60.78 -42.59 97.83 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.202 -0.936 . . . . 0.0 109.893 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.67 -30.38 71.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.766 0.826 . . . . 0.0 111.338 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 31.2 t -65.4 -46.74 78.87 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.324 0.966 . . . . 0.0 108.79 175.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -67.31 -49.99 61.98 Favored 'General case' 0 C--O 1.236 0.377 0 O-C-N 121.871 -0.518 . . . . 0.0 110.414 -178.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.4 mtm-85 -75.93 162.32 28.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.754 0.821 . . . . 0.0 112.906 -176.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -75.89 155.24 35.41 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 16.9 m -66.96 145.71 98.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 118.915 -0.564 . . . . 0.0 110.925 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -77.41 93.42 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.752 1.634 . . . . 0.0 110.613 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -160.85 83.2 0.66 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.912 2.085 . . . . 0.0 108.646 175.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -113.97 159.03 37.65 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.03 43.58 1.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 121.976 1.784 . . . . 0.0 112.131 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.249 1.031 0 C-N-CA 128.786 2.834 . . . . 0.0 103.4 176.456 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.478 ' HA ' ' OE2' ' A' ' 117' ' ' GLU . 4.9 p . . . . . 0 CA--C 1.513 -0.463 0 CA-C-O 119.914 -0.089 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.37 125.17 14.02 Favored 'Trans proline' 0 N--CA 1.444 -1.434 0 N-CA-C 107.89 -1.619 . . . . 0.0 107.89 159.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -66.76 40.78 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 1 C-N-CA 133.042 4.537 . . . . 0.0 113.664 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.37 147.77 96.84 Favored Pre-proline 0 C--N 1.322 -0.615 0 C-N-CA 126.702 2.001 . . . . 0.0 111.411 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -79.7 -178.06 4.29 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 124.183 3.256 . . . . 0.0 112.73 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 27.2 m -58.45 176.12 0.2 Allowed 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 126.663 1.985 . . . . 0.0 108.406 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.7 t -83.79 128.49 63.18 Favored Pre-proline 0 C--O 1.241 0.621 0 O-C-N 119.765 -1.835 . . . . 0.0 111.374 -174.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.84 173.34 14.64 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 124.219 3.279 . . . . 0.0 111.042 177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.76 -11.45 59.98 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.667 -0.646 . . . . 0.0 110.914 175.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -57.46 123.28 14.94 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 175.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.4 t -146.64 52.07 1.11 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.55 0.691 . . . . 0.0 109.261 -175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -144.87 161.44 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 126.59 1.956 . . . . 0.0 106.169 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -106.56 147.54 29.32 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.459 2.304 . . . . 0.0 105.882 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -140.79 176.31 8.9 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.477 1.511 . . . . 0.0 109.686 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.32 169.85 38.36 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 125.488 1.518 . . . . 0.0 113.954 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -84.06 155.99 22.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.32 1.448 . . . . 0.0 108.525 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.1 tt -64.05 -47.41 80.3 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -62.72 -50.07 72.55 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 119.145 -0.455 . . . . 0.0 110.364 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.4 m -65.97 -40.23 91.07 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.486 -175.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -63.44 -47.04 83.55 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-O 116.355 -1.783 . . . . 0.0 110.142 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.564 ' CD2' HG11 ' A' ' 50' ' ' VAL . 12.1 t80 -52.17 -42.75 63.7 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.51 1.504 . . . . 0.0 110.535 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 60.7 m -63.22 -46.27 87.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.154 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.55 88.19 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.568 0.747 . . . . 0.0 112.946 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.8 p -76.15 131.16 39.21 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.884 1.274 . . . . 0.0 111.817 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.3 t -88.81 -6.71 57.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.706 0.803 . . . . 0.0 108.929 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.486 ' HB2' HG23 ' A' ' 116' ' ' VAL . 27.8 tp -118.03 114.7 23.53 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 127.732 2.413 . . . . 0.0 109.134 177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.564 HG11 ' CD2' ' A' ' 44' ' ' PHE . 23.4 t -139.59 113.5 6.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.14 168.52 3.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.19 1.396 . . . . 0.0 108.524 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 111' ' ' LEU . 2.9 p -134.23 140.99 46.85 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -162.58 170.58 18.34 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 121.421 -0.8 . . . . 0.0 111.205 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -109.28 133.94 52.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.8 t -74.51 114.21 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.314 0.645 . . . . 0.0 109.602 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -77.72 -53.08 7.95 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.4 m -141.22 168.31 20.1 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.877 1.271 . . . . 0.0 110.739 -175.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 54.2 mtp -140.73 141.58 34.89 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 128.02 2.528 . . . . 0.0 105.846 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t -141.87 146.15 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.3 mtt-85 -73.59 139.4 45.51 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 120.203 -1.561 . . . . 0.0 108.921 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 45.4 mm-40 -117.74 169.0 8.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 C-N-CA 125.662 1.585 . . . . 0.0 108.642 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.39 152.82 24.73 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.254 2.636 . . . . 0.0 115.548 -175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.26 -125.91 39.14 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.0 tp10 -89.25 9.66 25.03 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.616 0.766 . . . . 0.0 111.274 -176.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.64 171.32 49.25 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 118.18 2.032 . . . . 0.0 118.18 -175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -152.27 139.15 18.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.468 3.107 . . . . 0.0 106.528 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -103.71 152.16 22.15 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.691 1.196 . . . . 0.0 108.567 175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.63 123.43 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 175.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m -97.67 126.6 43.08 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.36 172.7 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.194 0.998 . . . . 0.0 110.189 -175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -128.1 36.38 4.31 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.306 17.4 mt 40.16 80.37 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 127.694 2.398 . . . . 0.0 115.511 174.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.9 mm -78.02 -28.43 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 119.077 0.853 . . . . 0.0 109.815 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -159.1 157.43 28.5 Favored Glycine 0 CA--C 1.519 0.287 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 175.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.92 138.7 35.83 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -132.42 -31.74 1.38 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.301 -175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -151.69 125.82 9.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.1 p -143.71 67.29 1.28 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.376 2.27 . . . . 0.0 109.693 -175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.65 46.01 3.57 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.948 1.261 . . . . 0.0 110.833 176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.27 -48.97 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 126.05 1.786 . . . . 0.0 111.072 176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.75 124.14 21.63 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 117.451 0.625 . . . . 0.0 109.336 176.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -78.47 64.82 3.63 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 129.108 2.963 . . . . 0.0 108.375 175.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.7 mt -57.98 123.64 65.36 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.39 -174.74 2.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.402 2.735 . . . . 0.0 111.55 -175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.1 t -49.46 -53.55 39.31 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.16 -1.4 . . . . 0.0 110.663 176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.22 133.49 24.83 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 121.72 1.65 . . . . 0.0 107.965 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.51 -153.82 0.04 OUTLIER 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 124.083 3.189 . . . . 0.0 110.96 178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.411 HG21 ' HA2' ' A' ' 74' ' ' GLY . 52.3 m -34.87 131.28 0.38 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 128.584 2.754 . . . . 0.0 111.145 176.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.7 14.72 1.86 Allowed Glycine 0 CA--C 1.541 1.68 0 C-N-CA 125.196 1.379 . . . . 0.0 112.573 -175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.63 131.37 53.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.213 1.506 . . . . 0.0 107.718 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.5 p -76.66 137.21 39.28 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 121.686 -0.634 . . . . 0.0 110.354 -177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.3 mt -134.91 160.9 36.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.425 0.69 . . . . 0.0 111.194 -176.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -124.17 113.63 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 126.699 2.0 . . . . 0.0 107.709 -175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -97.18 121.84 39.51 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.404 ' HB3' HG23 ' A' ' 123' ' ' VAL . 43.3 t80 -78.06 113.63 16.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 t -104.06 114.16 64.68 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 103.702 -2.703 . . . . 0.0 103.702 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.41 6.08 3.34 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.378 2.718 . . . . 0.0 113.119 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 58.0 m -135.97 151.09 49.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 127.411 2.284 . . . . 0.0 108.486 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -117.24 -5.74 11.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.502 0.721 . . . . 0.0 109.707 175.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -71.32 -58.3 3.66 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.435 2.694 . . . . 0.0 109.354 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 15.5 m -143.91 165.99 21.56 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 129.224 3.01 . . . . 0.0 110.9 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.2 152.52 98.34 Favored 'Cis proline' 0 CA--C 1.544 0.99 0 CA-C-N 119.671 0.918 . . . . 0.0 112.489 -2.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.37 112.32 2.54 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.839 3.026 . . . . 0.0 110.741 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.4 ttp -138.18 163.45 31.68 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -144.57 150.3 37.26 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 124.058 0.943 . . . . 0.0 110.047 -176.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.09 146.87 52.21 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.09 33.02 84.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.743 0.687 . . . . 0.0 113.993 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 76.4 t -136.7 154.87 32.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 119.089 1.445 . . . . 0.0 107.234 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 m -103.32 131.55 50.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.733 1.213 . . . . 0.0 111.704 -175.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.95 175.65 9.37 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.117 0.967 . . . . 0.0 113.518 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' HA ' HG22 ' A' ' 52' ' ' THR . 11.5 tp -113.01 128.13 56.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 130.799 3.64 . . . . 0.0 103.774 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.13 114.28 22.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 3.9 mtm -117.76 113.15 21.41 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 103.524 -2.769 . . . . 0.0 103.524 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -155.53 -137.55 2.39 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.475 1.512 . . . . 0.0 111.005 -175.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -132.3 176.15 8.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.544 1.172 . . . . 0.0 110.9 176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.486 HG23 ' HB2' ' A' ' 49' ' ' LEU . 21.3 t -130.21 139.81 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 O-C-N 121.117 -0.989 . . . . 0.0 109.275 176.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' OE2' ' HA ' ' A' ' 24' ' ' SER . 19.2 mm-40 -103.36 112.84 25.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 175.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -82.58 63.55 6.78 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -157.55 -42.22 0.07 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 129.393 3.077 . . . . 0.0 108.223 -175.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -142.88 -11.53 0.77 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.597 1.703 . . . . 0.0 115.597 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.67 -163.52 13.12 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-N 119.589 1.086 . . . . 0.0 111.727 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.32 141.36 51.37 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.273 1.982 . . . . 0.0 113.202 -175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -122.94 128.7 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.423 HD11 HG21 ' A' ' 130' ' ' VAL . 2.0 tm? -120.59 79.65 30.36 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.53 1.532 . . . . 0.0 110.529 -174.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.13 173.63 8.18 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.659 3.573 . . . . 0.0 113.072 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.19 -22.27 73.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.013 1.809 . . . . 0.0 113.249 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -83.6 23.12 0.99 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.258 0.936 . . . . 0.0 111.12 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 54.5 m -95.92 134.19 39.21 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 124.632 1.173 . . . . 0.0 110.424 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -79.32 113.44 17.46 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.423 HG21 HD11 ' A' ' 124' ' ' LEU . 79.1 t -134.81 114.31 17.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 C-N-CA 123.192 0.597 . . . . 0.0 110.502 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 m -147.26 169.81 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 125.518 1.527 . . . . 0.0 110.27 -176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.0 mp -64.12 147.28 52.6 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.546 0.738 . . . . 0.0 109.831 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -75.12 137.84 41.66 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -143.61 142.8 21.62 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 116.681 -1.628 . . . . 0.0 107.977 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.55 -38.89 65.62 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.913 3.075 . . . . 0.0 116.283 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -65.77 -47.68 74.35 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.792 0.723 . . . . 0.0 110.251 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -58.13 -45.33 87.53 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 121.84 -0.538 . . . . 0.0 110.013 176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -49.63 -55.44 13.63 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.908 1.683 . . . . 0.0 109.632 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -58.19 -43.38 87.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.183 0.993 . . . . 0.0 111.684 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 75.2 mt -61.46 -46.68 96.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 118.931 0.787 . . . . 0.0 109.4 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.83 -37.71 85.02 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.486 1.039 . . . . 0.0 109.079 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 78.9 m -59.99 -38.97 84.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.311 0.96 . . . . 0.0 109.499 175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -62.72 -42.73 99.8 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.41 -0.806 . . . . 0.0 110.037 175.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.8 mt -69.35 -23.56 63.78 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.683 1.193 . . . . 0.0 112.428 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.4 t -72.63 -33.31 66.54 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.282 -0.887 . . . . 0.0 109.01 175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -76.26 -65.59 0.9 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.366 1.466 . . . . 0.0 110.273 176.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -74.97 147.3 40.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.7 1.2 . . . . 0.0 110.831 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -76.86 166.45 23.32 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 174.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 23.3 m -88.47 122.98 69.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 103.923 -2.621 . . . . 0.0 103.923 174.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -84.18 93.46 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 N-CA-C 108.195 -1.502 . . . . 0.0 108.195 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.02 84.4 0.66 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 -177.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -113.21 132.64 22.33 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.5 172.7 15.82 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.159 2.573 . . . . 0.0 110.434 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.5 t . . . . . 0 C--O 1.247 0.942 0 N-CA-C 101.521 -3.511 . . . . 0.0 101.521 176.15 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 p . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.32 164.44 26.58 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.542 2.828 . . . . 0.0 112.189 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -83.1 70.39 10.04 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.385 1.874 . . . . 0.0 111.796 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.52 140.14 96.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.502 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.25 171.38 14.01 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.746 2.297 . . . . 0.0 110.962 177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 18.5 m -58.17 158.95 6.38 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.248 1.023 . . . . 0.0 110.557 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.8 t -97.22 102.81 13.35 Favored Pre-proline 0 C--O 1.239 0.544 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -78.46 166.6 23.93 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.634 2.223 . . . . 0.0 110.004 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.78 -15.34 59.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -63.57 164.05 10.16 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.624 1.97 . . . . 0.0 110.182 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 52.6 t -139.54 104.96 5.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.835 1.254 . . . . 0.0 109.125 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -148.08 166.11 28.79 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 -135.56 148.48 49.12 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -134.28 176.58 8.47 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.91 1.684 . . . . 0.0 111.695 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 -158.82 53.72 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 p -123.18 176.37 6.12 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.526 1.13 . . . . 0.0 108.043 176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.9 tt -65.6 -49.0 70.37 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -60.9 -46.28 91.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.921 0.488 . . . . 0.0 110.803 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.0 m -62.56 -48.62 78.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 122.87 0.468 . . . . 0.0 110.319 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -64.17 -37.27 86.87 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.411 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.591 ' CD2' HG11 ' A' ' 50' ' ' VAL . 24.2 t80 -57.13 -40.78 77.82 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 120.298 1.408 . . . . 0.0 110.265 175.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 72.5 m -72.91 -33.76 66.18 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.513 -0.742 . . . . 0.0 111.861 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.93 -39.13 66.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.164 0.986 . . . . 0.0 113.043 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -76.05 147.3 38.8 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 111.133 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.4 t -93.77 -11.51 31.19 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.299 0.64 . . . . 0.0 109.368 175.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.422 HD21 ' CE2' ' A' ' 94' ' ' PHE . 28.8 tp -127.26 120.08 27.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.073 1.349 . . . . 0.0 108.261 -175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.591 HG11 ' CD2' ' A' ' 44' ' ' PHE . 26.7 t -138.86 113.89 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.6 m -148.11 172.17 2.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.034 1.334 . . . . 0.0 109.326 -176.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.9 p -130.99 143.21 50.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 174.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.627 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -159.87 171.64 19.07 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 121.224 -0.923 . . . . 0.0 111.162 -176.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 87.4 m -120.69 132.49 55.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -72.56 113.68 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 56' ' ' LYS . 26.4 mmmt -80.98 -51.62 8.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -140.16 168.02 20.78 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.457 1.103 . . . . 0.0 109.89 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 41.6 mtp -137.13 123.78 21.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 100.669 -3.826 . . . . 0.0 100.669 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.6 t -124.07 145.45 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -62.52 151.5 37.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 118.892 0.769 . . . . 0.0 109.446 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 6.1 mm-40 -135.86 173.14 6.01 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 106.726 175.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -53.29 136.71 63.25 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.379 2.719 . . . . 0.0 115.24 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 59.5 -123.78 34.39 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 125.525 1.536 . . . . 0.0 111.028 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -76.55 1.88 15.47 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.931 0.892 . . . . 0.0 112.084 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -67.88 158.35 51.71 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 122.857 1.254 . . . . 0.0 114.449 -175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -150.19 137.88 19.94 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.809 2.044 . . . . 0.0 105.827 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -107.16 123.31 48.08 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.45 123.14 44.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 175.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.3 m -98.07 124.2 42.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.627 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 17.8 m -126.9 176.16 7.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.822 0.849 . . . . 0.0 110.072 -175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -135.34 44.01 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . 0.293 67.4 mt 39.49 81.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.91 2.189 . . . . 0.0 116.91 175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 32.1 mm -79.07 -28.18 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 120.004 1.274 . . . . 0.0 112.6 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -157.22 158.62 29.06 Favored Glycine 0 N--CA 1.461 0.33 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 176.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.51 140.05 33.4 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.68 1.192 . . . . 0.0 108.332 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -137.13 -30.88 0.84 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.519 0.728 . . . . 0.0 111.391 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -151.85 127.32 10.02 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 175.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.9 p -140.31 59.55 1.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.463 2.705 . . . . 0.0 107.199 175.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.92 45.99 3.58 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 124.853 1.216 . . . . 0.0 110.746 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.27 -43.18 0.04 OUTLIER Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.92 3.153 . . . . 0.0 111.459 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.23 128.19 34.88 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 122.107 0.956 . . . . 0.0 113.302 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -81.9 75.78 8.83 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.2 mt -58.71 150.23 59.12 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.114 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -65.58 175.27 4.46 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.114 1.209 . . . . 0.0 109.684 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 t -49.14 -62.29 2.55 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 125.076 1.35 . . . . 0.0 109.738 177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.98 153.2 37.05 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 CA-C-N 121.186 1.459 . . . . 0.0 109.99 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.53 -155.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 1 C-N-CA 125.815 4.343 . . . . 0.0 112.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.416 HG21 ' HA2' ' A' ' 74' ' ' GLY . 85.3 m -33.26 124.75 0.39 Allowed 'General case' 0 C--O 1.253 1.249 0 C-N-CA 130.149 3.38 . . . . 0.0 114.414 -177.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.42 56.04 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.83 2.157 . . . . 0.0 110.98 -176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.58 154.48 37.63 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.845 1.258 . . . . 0.0 107.956 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.8 p -86.62 151.82 23.12 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.627 0.727 . . . . 0.0 111.405 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.3 mt -152.58 152.8 32.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 126.326 1.851 . . . . 0.0 108.092 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -112.94 113.22 25.18 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CE2' HD21 ' A' ' 49' ' ' LEU . 3.3 m-85 -84.95 119.7 25.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -77.14 113.11 14.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 t -106.7 113.38 62.95 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 103.781 -2.674 . . . . 0.0 103.781 175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -73.42 -12.39 25.0 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 121.708 1.605 . . . . 0.0 113.834 -175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.5 m -141.83 119.16 11.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.267 1.427 . . . . 0.0 107.429 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -5.57 47.9 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.04 -1.038 . . . . 0.0 111.192 -176.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -59.46 -58.15 9.87 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.74 1.216 . . . . 0.0 110.696 -177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 16.8 m -152.3 163.78 22.44 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 127.286 2.234 . . . . 0.0 110.032 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -65.8 161.7 71.42 Favored 'Cis proline' 0 CA--C 1.545 1.07 0 CA-C-N 119.779 0.957 . . . . 0.0 113.556 1.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.81 133.84 37.96 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 123.48 2.787 . . . . 0.0 112.206 -176.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 5.3 ttm -149.65 167.16 27.17 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.873 0.869 . . . . 0.0 111.613 -177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -150.73 147.65 27.59 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.962 2.505 . . . . 0.0 107.386 175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -69.22 149.42 48.58 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.24 41.81 99.49 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-O 118.73 -1.039 . . . . 0.0 113.08 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 89.8 t -137.74 149.83 25.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -94.41 136.37 34.78 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.372 1.069 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.08 175.79 9.28 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 126.763 2.025 . . . . 0.0 112.868 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.11 123.98 43.64 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 131.07 3.748 . . . . 0.0 101.343 175.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.83 115.13 22.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.365 1.466 . . . . 0.0 107.979 -176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.496 ' HG2' HG13 ' A' ' 50' ' ' VAL . 18.1 mtm -117.37 113.17 21.72 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 104.294 -2.484 . . . . 0.0 104.294 175.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -152.96 -139.94 2.99 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.354 1.454 . . . . 0.0 112.079 -175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -132.6 175.35 9.39 Favored 'General case' 0 C--O 1.233 0.219 0 O-C-N 120.836 -1.391 . . . . 0.0 111.344 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.8 t -136.89 145.45 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -127.76 114.66 17.56 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 103.556 -2.757 . . . . 0.0 103.556 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -71.28 63.8 0.37 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.388 1.475 . . . . 0.0 114.874 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 170.29 -22.27 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 1 C-N-CA 132.361 4.264 . . . . 0.0 111.81 175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -113.22 -4.6 13.72 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.421 1.088 . . . . 0.0 110.718 -175.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 72.78 -154.75 50.34 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 124.467 1.032 . . . . 0.0 113.162 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.47 126.59 11.7 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.025 2.483 . . . . 0.0 110.53 -176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . 0.266 2.7 p -116.78 127.99 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.56 79.52 29.96 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.412 1.485 . . . . 0.0 109.586 -174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.96 170.58 13.98 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.422 3.415 . . . . 0.0 112.708 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -63.46 -26.31 70.45 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.411 2.074 . . . . 0.0 114.033 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -86.74 23.58 1.66 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.846 1.258 . . . . 0.0 111.208 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.6 m -83.37 142.34 31.1 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 108.305 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -82.94 114.05 20.96 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -135.94 119.87 24.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 123.16 0.584 . . . . 0.0 110.151 -175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 25.3 m -144.75 167.01 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 125.306 1.443 . . . . 0.0 108.662 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.0 mp -64.51 149.31 48.87 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.789 0.804 . . . . 0.0 110.266 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.1 t60 -69.25 131.5 44.98 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.915 0.886 . . . . 0.0 109.021 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.1 mtm-85 -141.08 147.75 48.93 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.54 -37.85 55.72 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 123.539 2.826 . . . . 0.0 114.753 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -59.77 -49.23 78.52 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -58.08 -46.89 84.71 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 124.009 0.923 . . . . 0.0 109.433 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -51.76 -50.45 60.65 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 109.987 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -63.69 -42.45 97.99 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.634 -0.666 . . . . 0.0 111.847 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 55.8 mt -57.64 -50.76 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 119.062 0.846 . . . . 0.0 109.347 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.4 mt -65.84 -32.17 73.54 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.793 0.724 . . . . 0.0 109.368 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 23.8 m -66.47 -41.79 88.5 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.524 0.602 . . . . 0.0 110.121 175.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.18 -47.16 85.73 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.146 -0.971 . . . . 0.0 109.433 176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.29 -24.23 66.52 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.491 1.116 . . . . 0.0 112.127 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -69.75 -55.99 8.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 0.0 109.858 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 54.5 mmtt -72.48 -39.51 67.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.858 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 35.7 mtp85 -75.54 164.15 26.64 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.587 0.755 . . . . 0.0 110.426 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -87.41 156.63 19.5 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 17.8 m -64.05 148.4 95.33 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 121.418 -0.801 . . . . 0.0 111.761 176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.55 97.4 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 124.009 3.139 . . . . 0.0 109.526 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.1 m -153.13 75.3 1.07 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.591 0.756 . . . . 0.0 110.082 -176.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -117.67 113.91 38.05 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 176.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -85.2 174.96 6.77 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.923 3.082 . . . . 0.0 113.884 -175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 C--O 1.249 1.074 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 175.604 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.1 p . . . . . 0 N--CA 1.473 0.717 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.27 166.88 19.88 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.57 2.18 . . . . 0.0 111.878 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -84.66 44.53 1.06 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.096 1.759 . . . . 0.0 112.283 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.03 115.68 9.58 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.896 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.64 158.33 35.76 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.262 2.641 . . . . 0.0 114.582 -175.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 99.2 m -64.53 162.5 15.29 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.172 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 35.4 t -83.28 115.6 59.99 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -70.17 154.29 66.25 Favored 'Trans proline' 0 C--N 1.352 0.713 0 N-CA-C 106.571 -2.126 . . . . 0.0 106.571 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -68.3 -46.27 70.75 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 118.924 -1.11 . . . . 0.0 111.068 -175.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.55 165.6 16.54 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.3 t -134.25 117.19 16.17 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.542 -1.349 . . . . 0.0 108.434 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -155.09 166.04 34.83 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.468 2.307 . . . . 0.0 111.32 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.0 ttp85 -116.92 132.72 56.63 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.796 2.038 . . . . 0.0 106.84 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.5 p -142.19 176.49 8.93 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.458 1.503 . . . . 0.0 107.963 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.58 -164.55 54.64 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.7 p -124.9 163.61 21.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 tt -64.04 -43.97 93.94 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.53 -48.12 80.91 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 118.581 0.628 . . . . 0.0 111.059 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.4 m -61.68 -50.61 71.78 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 118.502 0.592 . . . . 0.0 110.177 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -59.63 -44.84 93.32 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.853 -1.546 . . . . 0.0 110.37 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.562 ' CD2' HG11 ' A' ' 50' ' ' VAL . 22.4 t80 -52.5 -51.22 60.55 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.098 1.317 . . . . 0.0 111.042 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 64.4 m -64.42 -37.98 89.42 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 118.546 -0.74 . . . . 0.0 111.845 -175.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.01 -60.4 2.52 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.007 0.523 . . . . 0.0 111.703 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.5 p -53.17 124.68 15.13 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.879 0.871 . . . . 0.0 110.931 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 t -81.99 -4.84 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.383 0.992 . . . . 0.0 109.51 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.455 HD21 ' HE2' ' A' ' 94' ' ' PHE . 34.1 tp -118.33 120.84 38.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.138 2.175 . . . . 0.0 108.658 176.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.562 HG11 ' CD2' ' A' ' 44' ' ' PHE . 38.4 t -144.05 113.59 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 174.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.5 m -149.38 167.56 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.365 1.466 . . . . 0.0 108.704 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p -127.01 140.61 52.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -157.83 168.17 27.95 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 120.787 -1.196 . . . . 0.0 111.379 -178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -114.87 130.85 56.96 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.53 113.49 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -176.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -71.42 -50.49 31.4 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.8 m -157.22 168.96 25.89 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.377 1.471 . . . . 0.0 110.072 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 62.6 mtp -137.33 133.87 35.4 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.022 2.129 . . . . 0.0 108.033 -177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -136.66 148.02 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 124.901 1.28 . . . . 0.0 107.833 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -75.43 145.97 41.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.613 1.097 . . . . 0.0 109.701 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.506 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.2 mm-40 -123.27 171.08 7.21 Favored Pre-proline 0 C--N 1.328 -0.359 0 C-N-CA 127.102 2.161 . . . . 0.0 111.726 -175.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.3 153.38 34.13 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.181 2.587 . . . . 0.0 113.361 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.89 -124.19 6.91 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 106.066 -2.814 . . . . 0.0 106.066 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -117.4 23.94 11.46 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.482 1.113 . . . . 0.0 108.46 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.52 179.57 53.08 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-O 123.836 1.798 . . . . 0.0 117.374 -175.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -150.62 136.11 17.99 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.988 2.115 . . . . 0.0 107.037 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.506 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -102.69 123.59 46.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 175.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.03 123.22 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m -99.78 125.22 45.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 3.6 m -131.91 174.49 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.369 0.667 . . . . 0.0 109.813 -175.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.9 t -132.17 41.56 3.22 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt 38.24 80.58 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 127.242 2.217 . . . . 0.0 115.918 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 34.5 mm -77.11 -24.86 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.406 0.682 . . . . 0.0 112.201 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.07 162.74 34.96 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 126.145 1.831 . . . . 0.0 109.209 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -149.21 150.2 32.23 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.535 1.134 . . . . 0.0 108.827 -179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -143.22 -49.6 0.33 Allowed 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.139 0.899 . . . . 0.0 111.879 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -131.98 123.68 27.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.5 p -141.18 65.37 1.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.71 2.404 . . . . 0.0 109.253 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.07 42.46 3.15 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.871 1.7 . . . . 0.0 110.929 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.76 -66.16 0.02 OUTLIER Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 125.699 1.618 . . . . 0.0 110.601 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.5 mt -71.04 130.49 41.67 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.195 0.521 . . . . 0.0 111.728 -175.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -84.88 80.04 9.42 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.3 mt -58.91 139.15 87.15 Favored Pre-proline 0 C--O 1.238 0.455 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.46 174.07 12.18 Favored 'Trans proline' 0 N--CA 1.446 -1.266 0 C-N-CA 120.971 1.114 . . . . 0.0 111.165 -175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.0 t -44.92 -59.71 3.89 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 116.514 -1.707 . . . . 0.0 110.004 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.78 118.59 5.56 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 121.963 1.775 . . . . 0.0 108.836 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.75 -152.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 124.005 3.137 . . . . 0.0 112.803 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 25.4 m -35.84 124.59 0.71 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.487 2.715 . . . . 0.0 113.206 -175.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.95 30.06 0.44 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.9 1.714 . . . . 0.0 114.174 -175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -125.04 158.86 32.72 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.032 1.333 . . . . 0.0 108.808 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 88.1 p -98.54 153.68 18.46 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.193 -0.942 . . . . 0.0 112.155 -176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.0 mt -148.71 162.38 39.86 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.076 1.75 . . . . 0.0 109.458 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -126.11 114.04 17.86 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.906 1.682 . . . . 0.0 107.163 176.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.455 ' HE2' HD21 ' A' ' 49' ' ' LEU . 32.9 m-85 -96.63 121.2 38.2 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.451 1.101 . . . . 0.0 110.15 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.31 113.73 18.7 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 124.155 0.909 . . . . 0.0 110.435 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 t -104.9 123.75 38.93 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -78.71 -6.96 15.54 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.461 2.774 . . . . 0.0 115.536 -175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 17.0 m -137.42 121.03 17.28 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 127.708 2.403 . . . . 0.0 107.051 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -16.09 61.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -175.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -82.49 -30.34 29.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.028 1.285 . . . . 0.0 114.417 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 87.7 m -136.66 155.76 76.56 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-O 117.804 -1.093 . . . . 0.0 110.038 -175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.65 165.88 71.93 Favored 'Cis proline' 0 CA--C 1.54 0.795 0 CA-C-N 120.395 1.177 . . . . 0.0 112.064 2.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -64.82 104.36 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.934 2.423 . . . . 0.0 109.274 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.2 ttt -139.35 163.74 31.7 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.529 1.132 . . . . 0.0 109.283 -175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -143.56 153.89 43.03 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.761 1.225 . . . . 0.0 110.232 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -75.49 142.08 42.95 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.73 21.98 67.62 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 125.055 1.312 . . . . 0.0 114.36 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 86.3 t -134.11 156.69 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 125.285 1.434 . . . . 0.0 109.485 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.7 m -95.78 132.71 40.72 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.821 1.648 . . . . 0.0 111.717 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -139.61 168.5 19.68 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.27 1.828 . . . . 0.0 111.712 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.6 tp -108.31 129.23 55.23 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 129.306 3.042 . . . . 0.0 102.86 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.0 114.07 22.6 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.5 mtm -119.33 113.01 20.16 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 103.002 -2.962 . . . . 0.0 103.002 175.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.02 -134.05 1.66 Allowed Glycine 0 CA--C 1.526 0.778 0 CA-C-N 120.112 1.323 . . . . 0.0 112.225 -175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -134.84 172.02 13.57 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 117.97 0.885 . . . . 0.0 112.015 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 49' ' ' LEU . 4.8 t -133.16 140.15 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.397 -0.815 . . . . 0.0 110.337 178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -121.57 115.41 22.76 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.869 2.067 . . . . 0.0 111.624 -175.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -71.82 63.69 0.46 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.07 2.548 . . . . 0.0 112.428 -177.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.2 t30 163.39 -22.53 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.189 1 C-N-CA 134.041 4.936 . . . . 0.0 114.084 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -113.5 -4.83 13.5 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.29 1.036 . . . . 0.0 113.023 -175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.37 -162.38 49.43 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.134 -1.587 . . . . 0.0 109.134 -177.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.408 ' HB2' ' CD2' ' A' ' 94' ' ' PHE . 91.3 Cg_endo -73.78 143.32 33.33 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 118.63 1.215 . . . . 0.0 110.675 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 6.3 p -126.22 126.83 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 130' ' ' VAL . 2.2 tm? -120.28 78.4 26.63 Favored Pre-proline 0 C--N 1.325 -0.5 0 C-N-CA 125.722 1.609 . . . . 0.0 109.972 -174.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -66.27 164.42 28.18 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.686 2.924 . . . . 0.0 110.946 179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.05 -18.06 56.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.094 1.863 . . . . 0.0 114.707 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -84.13 22.85 1.13 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.443 1.019 . . . . 0.0 110.771 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 63.0 m -88.7 137.43 32.33 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 125.519 1.527 . . . . 0.0 107.25 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -78.79 113.62 17.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 124' ' ' LEU . 99.3 t -136.76 116.67 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -175.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.23 170.21 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.924 1.29 . . . . 0.0 109.615 -175.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.08 132.16 49.69 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.15 0.98 . . . . 0.0 108.825 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -65.81 138.19 57.74 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -133.8 160.02 70.18 Favored Pre-proline 0 C--O 1.238 0.471 0 C-N-CA 126.488 1.915 . . . . 0.0 107.035 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.02 -42.92 2.74 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.928 2.419 . . . . 0.0 110.415 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -58.53 -41.58 85.8 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.61 0.764 . . . . 0.0 111.252 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -63.75 -38.85 92.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.452 -0.785 . . . . 0.0 111.21 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -57.24 -50.01 74.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.284 1.033 . . . . 0.0 110.294 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -63.3 -34.83 78.54 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.972 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 73.8 mt -68.87 -47.61 75.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.511 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mt -61.39 -39.06 89.32 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.501 1.501 . . . . 0.0 108.973 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 80.5 m -61.09 -47.03 88.2 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -57.33 -46.38 83.31 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 123.875 0.87 . . . . 0.0 109.466 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.57 -33.78 76.35 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.071 0.948 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.6 t -69.38 -49.39 55.82 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -68.61 -36.6 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.82 0.848 . . . . 0.0 111.564 -175.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -76.71 176.51 8.37 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 127.278 2.231 . . . . 0.0 110.355 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -98.11 145.1 26.9 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 175.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 33.1 m -69.52 159.05 85.25 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.13 106.19 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.285 2.657 . . . . 0.0 108.736 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.5 t -146.36 56.09 1.16 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -116.68 113.36 40.33 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -102.54 145.68 0.21 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.944 2.43 . . . . 0.0 108.862 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.261 1.677 0 C-N-CA 128.994 2.918 . . . . 0.0 103.524 175.623 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -85.08 61.02 5.79 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.221 2.614 . . . . 0.0 112.608 -171.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -141.54 59.54 1.5 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 123.49 1.614 . . . . 0.0 112.23 -176.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.31 127.51 6.78 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 125.422 1.489 . . . . 0.0 108.421 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -83.56 -172.22 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.967 3.778 . . . . 0.0 110.73 177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.3 m -50.04 153.92 1.26 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.215 1.406 . . . . 0.0 110.201 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 15.5 t -86.19 127.45 61.52 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.52 174.33 11.81 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.616 2.877 . . . . 0.0 112.959 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -21.04 55.75 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.094 0.958 . . . . 0.0 112.712 177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.59 131.42 50.88 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.645 0.657 . . . . 0.0 109.612 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 47.7 t -152.24 79.12 1.24 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.664 0.745 . . . . 0.0 109.697 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? -133.71 157.53 45.6 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.009 1.724 . . . . 0.0 106.576 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 57.9 ttp85 -107.56 152.64 23.99 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.2 p -133.84 174.02 10.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.746 0.818 . . . . 0.0 109.236 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.14 -154.2 41.08 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 123.98 0.8 . . . . 0.0 111.366 176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.7 p -127.84 168.58 14.98 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.868 0.867 . . . . 0.0 108.837 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.82 -41.35 97.89 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.41 -43.97 88.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.01 -176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -66.48 -51.15 59.84 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.846 0.748 . . . . 0.0 111.033 177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -52.34 -44.66 65.31 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 117.729 -1.129 . . . . 0.0 112.609 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.496 ' CD2' HG11 ' A' ' 50' ' ' VAL . 23.9 t80 -52.41 -42.34 63.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.491 0.716 . . . . 0.0 112.704 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 59.1 m -75.82 -33.81 60.11 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -38.68 86.83 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.181 0.9 . . . . 0.0 111.713 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 p -68.36 130.58 43.31 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.454 0.701 . . . . 0.0 111.066 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 t -81.95 -8.14 59.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.865 0.866 . . . . 0.0 109.99 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 52.0 tp -133.93 123.37 24.54 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.971 1.708 . . . . 0.0 107.998 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 44' ' ' PHE . 39.4 t -136.41 116.97 17.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.7 m -147.6 169.49 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 110.103 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 p -128.84 137.65 51.6 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 175.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 70' ' ' VAL . . . -151.75 171.01 18.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.834 -175.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.2 m -117.59 126.28 52.27 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.18 113.55 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -80.82 -52.48 7.45 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.493 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 9.6 m -145.11 171.42 14.53 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 125.418 1.487 . . . . 0.0 109.795 175.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.406 ' HB3' HD21 ' A' ' 66' ' ' LEU . 24.6 mtp -133.76 134.8 43.39 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -127.79 143.82 39.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -175.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -70.92 137.0 48.89 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.515 -1.365 . . . . 0.0 108.234 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.545 ' CG ' ' HB2' ' A' ' 67' ' ' ALA . 4.5 mm-40 -114.71 168.84 7.41 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 125.8 1.64 . . . . 0.0 108.86 178.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -60.37 161.52 20.01 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.331 2.02 . . . . 0.0 112.273 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.89 -145.01 49.19 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.731 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -88.73 14.2 10.69 Favored 'General case' 0 CA--C 1.551 0.991 0 O-C-N 121.554 -0.968 . . . . 0.0 110.619 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.19 177.22 53.05 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.106 1.336 . . . . 0.0 115.588 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD21 ' HB3' ' A' ' 58' ' ' MET . 2.2 tm? -152.76 140.19 19.64 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.73 2.812 . . . . 0.0 106.17 -178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.545 ' HB2' ' CG ' ' A' ' 61' ' ' GLU . . . -100.83 145.02 29.08 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 175.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -118.23 123.25 71.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 176.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 m -101.63 129.86 47.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.697 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 30.5 m -138.22 176.36 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.883 0.873 . . . . 0.0 111.48 -175.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.9 t -131.36 39.52 3.52 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.912 1.285 . . . . 0.0 112.185 -176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.6 mt 36.42 81.2 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.281 2.232 . . . . 0.0 115.553 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.4 mm -74.52 -32.48 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 118.736 -0.649 . . . . 0.0 111.504 176.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' HA2' HG21 ' A' ' 88' ' ' THR . . . -158.13 161.96 31.92 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 125.023 1.296 . . . . 0.0 110.242 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.49 152.74 40.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.67 1.588 . . . . 0.0 108.053 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -139.79 -24.42 0.84 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.643 0.589 . . . . 0.0 112.379 -176.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -157.99 138.86 13.11 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.826 2.05 . . . . 0.0 106.117 175.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.0 p -146.85 72.38 1.27 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.214 3.006 . . . . 0.0 105.74 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.72 50.07 4.34 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 126.618 2.056 . . . . 0.0 109.353 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.19 -70.74 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 126.088 1.804 . . . . 0.0 113.302 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.7 mt -60.5 131.73 51.66 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 124.275 1.03 . . . . 0.0 111.425 -175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -82.27 89.18 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.9 mt -66.32 139.79 96.46 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.24 -175.87 1.68 Allowed 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.529 2.153 . . . . 0.0 112.07 -175.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.8 t -42.83 -58.8 3.51 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.853 1.661 . . . . 0.0 109.215 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.07 147.56 21.04 Favored 'Trans proline' 0 CA--C 1.55 1.311 0 N-CA-C 107.095 -1.925 . . . . 0.0 107.095 175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -69.75 -154.95 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.099 1 C-N-CA 126.141 4.561 . . . . 0.0 111.665 175.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.565 HG21 ' HA2' ' A' ' 74' ' ' GLY . 4.4 m -34.01 139.84 0.07 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.953 2.501 . . . . 0.0 113.311 177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 134.52 -1.27 3.98 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 127.088 2.28 . . . . 0.0 114.496 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -89.32 148.55 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.351 1.576 . . . . 0.0 108.579 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.1 p -77.29 149.9 35.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.174 -0.954 . . . . 0.0 109.184 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.8 mt -147.34 161.03 41.83 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.94 0.896 . . . . 0.0 110.034 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -127.42 116.93 21.21 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.93 124.59 42.44 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.231 1.012 . . . . 0.0 109.499 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.452 ' HB3' HG23 ' A' ' 123' ' ' VAL . 28.5 t80 -74.06 114.02 11.9 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.733 1.213 . . . . 0.0 109.775 175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.09 115.61 58.21 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -72.43 1.24 6.39 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.783 2.322 . . . . 0.0 113.11 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 95.1 m -132.02 113.63 13.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.744 1.217 . . . . 0.0 109.204 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -80.98 -12.5 59.37 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.734 -0.604 . . . . 0.0 112.287 175.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -83.55 -35.83 24.47 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.437 1.095 . . . . 0.0 113.753 -175.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 17.0 m -157.16 163.04 26.34 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 126.564 1.946 . . . . 0.0 110.003 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.37 153.31 81.91 Favored 'Cis proline' 0 CA--C 1.541 0.871 0 O-C-N 122.626 0.803 . . . . 0.0 111.29 -3.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.7 122.47 8.58 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.229 2.619 . . . . 0.0 111.808 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 13.1 ttp -145.8 160.51 41.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.409 1.883 . . . . 0.0 108.685 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -134.48 145.42 48.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.262 -0.899 . . . . 0.0 109.862 -176.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 85.5 tttt -64.02 142.71 58.31 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.17 35.33 77.4 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.935 -0.925 . . . . 0.0 113.044 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 53.8 t -140.83 159.3 23.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 C-N-CA 126.926 2.09 . . . . 0.0 107.5 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.5 m -101.43 133.65 45.73 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.38 1.072 . . . . 0.0 111.502 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 104' ' ' MET . 45.7 m-85 -137.21 165.4 26.22 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.629 1.572 . . . . 0.0 111.303 -177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.39 124.63 51.31 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 129.942 3.297 . . . . 0.0 103.522 175.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.17 119.55 32.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.836 1.654 . . . . 0.0 107.524 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.0 mtm -120.68 113.25 19.94 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -148.14 -137.7 2.93 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 126.109 1.814 . . . . 0.0 111.525 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -136.63 176.49 8.65 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.172 1.389 . . . . 0.0 108.689 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.3 132.01 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.14 113.84 27.67 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -80.07 63.56 4.62 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -159.52 -42.47 0.05 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 128.484 2.714 . . . . 0.0 110.452 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.7 mtt180 -126.24 -4.32 6.77 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.25 1.02 . . . . 0.0 113.118 -177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 101.59 -151.77 18.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -71.77 137.31 29.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.821 1.681 . . . . 0.0 110.013 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 95' ' ' TYR . 2.6 p -119.99 153.06 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 177.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.54 80.18 39.26 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 -175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -62.15 171.0 5.59 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.997 3.798 . . . . 0.0 113.624 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.55 -19.11 64.76 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 121.756 1.637 . . . . 0.0 113.195 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -86.6 23.19 1.71 Allowed 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 125.117 1.367 . . . . 0.0 112.942 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.9 m -87.75 129.69 35.08 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.821 -0.549 . . . . 0.0 110.135 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -80.57 115.48 20.1 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 175.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.5 117.49 35.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 123.735 0.814 . . . . 0.0 109.194 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.8 m -145.49 167.34 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 C-N-CA 125.199 1.4 . . . . 0.0 109.52 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.79 136.54 57.01 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.444 0.698 . . . . 0.0 110.7 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -67.25 144.35 55.98 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.233 0.613 . . . . 0.0 109.898 177.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 150.3 29.88 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 127.585 2.354 . . . . 0.0 107.481 175.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -66.84 -34.26 31.1 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 122.593 2.195 . . . . 0.0 111.401 -176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -61.58 -43.09 99.5 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.023 -0.423 . . . . 0.0 111.087 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.32 -41.91 76.05 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.415 176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -48.15 -55.93 9.13 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 124.749 1.22 . . . . 0.0 109.911 176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -55.41 -44.11 75.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.687 1.595 . . . . 0.0 111.905 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.54 -49.21 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.004 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mt -63.22 -41.03 99.06 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.012 0.824 . . . . 0.0 108.977 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 24.5 m -59.43 -43.57 93.08 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.921 0.888 . . . . 0.0 110.639 175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -67.25 -40.54 86.25 Favored 'General case' 0 CA--C 1.52 -0.199 0 O-C-N 121.434 -0.791 . . . . 0.0 110.593 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.81 -33.37 75.07 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 119.1 -0.476 . . . . 0.0 109.742 175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.1 t -66.11 -35.7 81.2 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.519 1.128 . . . . 0.0 111.028 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -75.88 -40.65 54.13 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 120.855 -1.153 . . . . 0.0 109.344 175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.6 mtp85 -69.35 176.36 3.41 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 122.605 1.193 . . . . 0.0 109.024 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -136.0 137.99 41.79 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.811 2.444 . . . . 0.0 104.792 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' CYS . . . . . . . . . . . . . 18.1 m -68.14 147.58 98.34 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.237 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.27 100.7 1.39 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.315 2.677 . . . . 0.0 108.28 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 67.3 m -145.34 73.11 1.34 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.824 1.249 . . . . 0.0 107.872 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.49 113.1 48.34 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -101.46 -161.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 124.172 3.248 . . . . 0.0 108.092 175.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.246 0.876 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 175.158 . . . . . . . . 0 0 . 1 stop_ save_